Citrus Sinensis ID: 013833
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.618 | 0.111 | 0.382 | 4e-44 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.577 | 0.273 | 0.412 | 6e-43 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.634 | 0.214 | 0.379 | 5e-42 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.618 | 0.689 | 0.374 | 2e-41 | |
| Q5GIG6 | 834 | Serine/threonine-protein | yes | no | 0.834 | 0.435 | 0.330 | 2e-40 | |
| Q66L42 | 940 | Mitogen-activated protein | no | no | 0.602 | 0.278 | 0.372 | 4e-40 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.606 | 0.245 | 0.370 | 5e-40 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.613 | 0.408 | 0.371 | 7e-40 | |
| Q7TQP6 | 835 | Serine/threonine-protein | no | no | 0.834 | 0.434 | 0.327 | 9e-40 | |
| P80192 | 1104 | Mitogen-activated protein | yes | no | 0.606 | 0.239 | 0.370 | 9e-40 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 179 bits (454), Expect = 4e-44, Method: Composition-based stats.
Identities = 112/293 (38%), Positives = 168/293 (57%), Gaps = 24/293 (8%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ ++EID +EL+F + IGKG FGE+ + YWR T VAIK I + + F++EV
Sbjct: 2105 RSEYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEV 2162
Query: 207 NLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFA 261
+L KLRHPN+VQFLGA T ++TE++ GG L ++L + L +P + A
Sbjct: 2163 GILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLA 2222
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLL----------VNSSAD-HLKVGDFGLSKLIK 310
LDIA+GM YLH I+HRDL RN+LL V+S D K+ DFGLS+L
Sbjct: 2223 LDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM 2282
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Q S +MT G YMAPEVFK +K DV+S+ M+L+E+L + P + +P +
Sbjct: 2283 EQAS----QMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMK 2338
Query: 371 AAKYVA-EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
A A E +RP + + +E+ +CW ++ + RP+F I+ L+++++
Sbjct: 2339 MAHLAAYESYRPPIPLTT-SSKWKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 109/264 (41%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
IG+G FG++ KA WRG VA+K+I D + F EV+++ KL HP V F+GA
Sbjct: 183 IGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETEIFDKEVSIMSKLCHPTCVMFIGAC 242
Query: 225 TERKP---LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHN--EPNV 277
+ P +I EY+ GG L + L EK + L PS ++ A DIA GM YLH +
Sbjct: 243 SLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIARDIAEGMNYLHTNFKEGP 302
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
I+HRDL N+LL NSS K+ DFGLSK +K + +MT GS +MAPE FK
Sbjct: 303 IVHRDLTSSNILL-NSSYTVAKINDFGLSKEMKPGPT----EMTAAMGSLAWMAPECFKA 357
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397
Y +KVDV+SFA+IL+E++ P EP A ++A GF P EL
Sbjct: 358 ENYTEKVDVYSFAIILWEIVTCRDPYNGMEPLRLA-FLASVEDYRLPLNGFPPYWVELIS 416
Query: 398 KCWAADMNQRPSFLDILKRLEKIK 421
KCW + RPSF +IL+ L +I+
Sbjct: 417 KCWNITPSLRPSFKEILQILNQIE 440
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 112/295 (37%), Positives = 156/295 (52%), Gaps = 19/295 (6%)
Query: 130 QNGSHFEPKPVPPP----LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAI 185
QN H P P P + +WE+ SE+ A IG+G +G++ + WRGT VA+
Sbjct: 820 QNKDHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIG--ARIGRGGYGQVFRGSWRGTEVAV 877
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HK 244
K + + +L I D R EV+LL KLRHPNIV F+GA TE ++TEYL G L +
Sbjct: 878 KMLFNDNVNLKL-ISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 245 YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
L E + + D ARGM YLH+ +IIHRDLK N+L+ +S +KV DFG
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSW--QVKVADFG 994
Query: 305 LSKLIKVQNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
L+ + SH K M G TG ++APEV Y +K DV+S+A++L+E+L P
Sbjct: 995 LATV----KSHTFAKTMCGTTG---WVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPY 1047
Query: 364 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
A + + + G R A P+ L +CW D RPSF +IL +E
Sbjct: 1048 AGKNTMQVVRSIDRGERLPMPA-WCPPKYAALMNRCWETDPTHRPSFPEILPIME 1101
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 109/291 (37%), Positives = 160/291 (54%), Gaps = 22/291 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRL--VIQDFRHE 205
+W D S+L + G+ I + ++ VA+K + +P+ ++ + Q F+ E
Sbjct: 78 EWTADLSQLFIGNK--FASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSE 135
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALD 263
V LL +L HPNIVQF+ A + +ITEY+ G+L YL KE +LS T + ALD
Sbjct: 136 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALD 195
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I+RGM YLH++ +IHRDLK N+LL + +KV DFG S L + G
Sbjct: 196 ISRGMEYLHSQG--VIHRDLKSNNLLLNDEM--RVKVADFGTSCL-----ETQCREAKGN 246
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPF 382
G+YR+MAPE+ K + Y +KVDV+SF ++L+E+ P P +AA VAE RP
Sbjct: 247 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPP 306
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK----IKETLPTDHH 429
A P L L ++CW+ + ++RP F +I+ LEK +KE LP H
Sbjct: 307 LPA-SCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 135/409 (33%), Positives = 200/409 (48%), Gaps = 46/409 (11%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
V+ LL+++ ++ R D T LH A HG I + + L++ GAD+N A D +++ D
Sbjct: 321 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 380
Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
+ K + + L H Y Q G VP PL
Sbjct: 381 EQTCLMWAYEKGHDAIVTLLKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 440
Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
K D + + SE++F IIG GSFG++ K R VAIKR +
Sbjct: 441 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 498
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
+ + F EV++L +L HP +VQF+GA + ++T+Y+ GG L L E K L
Sbjct: 499 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 558
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
+ + A+D+A+GM YLH+ IIHRDL N+LL H V DFG S+ ++
Sbjct: 559 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ--- 613
Query: 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
S D MT + G+ R+MAPEVF +Y K DVFS+A+ L+E+L GE P A+ +P AA
Sbjct: 614 SLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAA 673
Query: 373 KYVAEGH-RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+A H RP P + L + W A RP F +++++LE+
Sbjct: 674 ADMAYHHIRPPIGYSIPKP-ISSLLMRGWNACPEGRPEFSEVVRKLEEC 721
|
May play a role in cardiac physiology. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 105/282 (37%), Positives = 148/282 (52%), Gaps = 20/282 (7%)
Query: 154 PSELDFSS---SAIIGKGSFGEILKAYWRGTPVAIK--RILPSLSDDRLVIQDFRHEVNL 208
P E+ F IIG G FG++ +A WRG VA+K R+ P D + + R E L
Sbjct: 90 PQEIPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPE-RDPAVTAEQVRQEARL 148
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
L+HPNI+ GA L L+ EY RGG L + L + + P VN+A+ +ARGM
Sbjct: 149 FGALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGR-RVPPHVLVNWAVQVARGM 207
Query: 269 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 321
YLHN+ P IIHRDLK N+L++ + +H LK+ DFGL++ H KM+
Sbjct: 208 NYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAR-----EWHKTTKMS 262
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+Y +MAPEV + + K DV+SF ++L+E+L GE P + A VA
Sbjct: 263 A-AGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLT 321
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
L E+CW D + RP F ILK+LE I+++
Sbjct: 322 LPIPSTCPEPFARLLEECWDPDPHGRPDFGSILKQLEVIEQS 363
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 165 bits (418), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 104/281 (37%), Positives = 147/281 (52%), Gaps = 17/281 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLL 209
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 131 EIDFAELTLEE--IIGIGGFGKVYRAFWAGDEVAVKAARHDPDEDISQTIENVRQEAKLF 188
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 189 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 247
Query: 270 YLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
YLH+E V IIHRDLK N+L++ S LK+ DFGL++ H KM+
Sbjct: 248 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 302
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 303 -AGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 361
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+L E CW D + RPSF IL +L I+E+
Sbjct: 362 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEES 402
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 106/285 (37%), Positives = 168/285 (58%), Gaps = 18/285 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
WEID +E+ ++ A +G G+FG + K RG VAIK++ ++ ++ + +F+ EV+L+
Sbjct: 165 WEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEEN-TMNEFKKEVSLM 223
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR--- 266
KLR+P+++ F+GA T + L ++TE + G +H L+ K S A+ IAR
Sbjct: 224 AKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTV 283
Query: 267 -GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GM +LH + I+H DLKP N+L+ + +KV DFGLSK +K +S D K+ G+ G
Sbjct: 284 LGMTWLH--ASNILHLDLKPANLLVDQNWV--VKVADFGLSKYMK-PDSKD--KLLGQAG 336
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPF 382
S YMAPE+ ++ YD KVDVFSF+++L+E+L + P L + P V + +RP
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427
F L++L +CW ++RPSF +I K ++I ET+ D
Sbjct: 397 I-PDYFPTRLKDLLARCWDHYPSRRPSFAEISK--QRILETILID 438
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 134/409 (32%), Positives = 199/409 (48%), Gaps = 46/409 (11%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
V+ LL+++ ++ R D T LH A HG I + + L++ GAD+N A D +++ D
Sbjct: 322 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 381
Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
+ K + + L H Y Q G VP PL
Sbjct: 382 EQTCLMWAYEKGHDAIVTLLKHYKRPQEELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 441
Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
K D + + SE++F IIG GSFG++ K R VAIKR +
Sbjct: 442 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
+ + F EV++L +L HP +VQF+GA + ++T+Y+ GG L L E K L
Sbjct: 500 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 559
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
+ + A+D+A+GM YLH+ IIHRDL N+LL H V DFG S+ ++
Sbjct: 560 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ--- 614
Query: 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
S D MT + G+ R+MAPEVF +Y K DVFS+++ L+E+L GE P A+ +P AA
Sbjct: 615 SLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAA 674
Query: 373 KYVAEGH-RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+A H RP P + L + W A RP F +++ +LE+
Sbjct: 675 ADMAYHHIRPPIGYSIPKP-ISSLLIRGWNACPEGRPEFSEVVSKLEEC 722
|
May play a role in cardiac physiology. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 104/281 (37%), Positives = 148/281 (52%), Gaps = 17/281 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLL 209
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 138 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 195
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 196 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 254
Query: 270 YLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
YLH+E V IIHRDLK N+L++ S LK+ DFGL++ H KM+
Sbjct: 255 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 309
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 310 -AGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 368
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+L E CW D + RPSF +IL +L I+E+
Sbjct: 369 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTIEES 409
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | ||||||
| 255562954 | 431 | protein kinase, putative [Ricinus commun | 0.990 | 1.0 | 0.903 | 0.0 | |
| 225462932 | 435 | PREDICTED: dual specificity protein kina | 1.0 | 1.0 | 0.875 | 0.0 | |
| 449434754 | 446 | PREDICTED: dual specificity protein kina | 0.990 | 0.966 | 0.883 | 0.0 | |
| 449478377 | 446 | PREDICTED: LOW QUALITY PROTEIN: dual spe | 0.990 | 0.966 | 0.881 | 0.0 | |
| 224101399 | 440 | predicted protein [Populus trichocarpa] | 0.949 | 0.938 | 0.908 | 0.0 | |
| 15223025 | 438 | VH1-interacting kinase [Arabidopsis thal | 1.0 | 0.993 | 0.853 | 0.0 | |
| 297844308 | 438 | kinase family protein [Arabidopsis lyrat | 1.0 | 0.993 | 0.851 | 0.0 | |
| 116643246 | 449 | flag-tagged protein kinase domain of put | 1.0 | 0.968 | 0.853 | 0.0 | |
| 18700097 | 438 | At1g14000/F7A19_9 [Arabidopsis thaliana] | 1.0 | 0.993 | 0.853 | 0.0 | |
| 356521649 | 421 | PREDICTED: dual specificity protein kina | 0.947 | 0.978 | 0.861 | 0.0 |
| >gi|255562954|ref|XP_002522482.1| protein kinase, putative [Ricinus communis] gi|223538367|gb|EEF39974.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/435 (90%), Positives = 415/435 (95%), Gaps = 4/435 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
MSSG SS G +G S+DKQKEKARVSRTS+ILWHAHQNDAAAVRKLLEED+SL
Sbjct: 1 MSSGTSSAGGE----RGPPPPSSDKQKEKARVSRTSMILWHAHQNDAAAVRKLLEEDRSL 56
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V ARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK NM+ELL
Sbjct: 57 VRARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHNMIELL 116
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKAYWRG
Sbjct: 117 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKAYWRG 176
Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEYLRGG
Sbjct: 177 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEYLRGG 236
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
DLH+YLKEKGALSPSTA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS+ADHLKV
Sbjct: 237 DLHQYLKEKGALSPSTAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSNADHLKV 296
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE
Sbjct: 297 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 356
Query: 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
PPLANYEPYEAAK+VAEGHRP F AKGFT ELRELT++CWAADMN+RPSFL+ILKRLEKI
Sbjct: 357 PPLANYEPYEAAKFVAEGHRPTFHAKGFTIELRELTDQCWAADMNRRPSFLEILKRLEKI 416
Query: 421 KETLPTDHHWNIFNA 435
KE LP DHHW++FNA
Sbjct: 417 KEVLPADHHWSLFNA 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462932|ref|XP_002266329.1| PREDICTED: dual specificity protein kinase pyk1 isoform 1 [Vitis vinifera] gi|296087790|emb|CBI35046.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/435 (87%), Positives = 409/435 (94%)
Query: 1 MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
MS + + G ++ G ++DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL
Sbjct: 1 MSCRDDNSGGHSSTSAAGKDKASDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL
Sbjct: 61 VHARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELL 120
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+S+IIGKGSFGEILKA WRG
Sbjct: 121 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSSIIGKGSFGEILKACWRG 180
Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT++KPLMLITEYLRGG
Sbjct: 181 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTDKKPLMLITEYLRGG 240
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
DLH+YLKEKG+LSPSTA+ FA+DIARGMAYLHNEPNVIIHRDLKPRNVLLVN+ ADHLKV
Sbjct: 241 DLHQYLKEKGSLSPSTAITFAMDIARGMAYLHNEPNVIIHRDLKPRNVLLVNTGADHLKV 300
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG+
Sbjct: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGD 360
Query: 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
PPL+NYEPYEAAKYVAEG RP FRAKG+ EL+ELTE+CWAADMN RPSFL+ILKRLEKI
Sbjct: 361 PPLSNYEPYEAAKYVAEGQRPMFRAKGYITELKELTEQCWAADMNHRPSFLEILKRLEKI 420
Query: 421 KETLPTDHHWNIFNA 435
KE LP DHHWNIF A
Sbjct: 421 KEILPPDHHWNIFTA 435
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434754|ref|XP_004135161.1| PREDICTED: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/439 (88%), Positives = 416/439 (94%), Gaps = 8/439 (1%)
Query: 3 SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
+G+ SPG +T +G + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10 AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67
Query: 57 DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK M
Sbjct: 68 DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127
Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187
Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 367
Query: 357 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
LEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRELTE+CWA+DMN+RPSFL+ILKR
Sbjct: 368 LEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRELTEECWASDMNKRPSFLEILKR 427
Query: 417 LEKIKETLPTDHHWNIFNA 435
LEKIKE LPTDHHWN+FNA
Sbjct: 428 LEKIKENLPTDHHWNLFNA 446
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478377|ref|XP_004155301.1| PREDICTED: LOW QUALITY PROTEIN: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/439 (88%), Positives = 415/439 (94%), Gaps = 8/439 (1%)
Query: 3 SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
+G+ SPG +T +G + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10 AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67
Query: 57 DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK M
Sbjct: 68 DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127
Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187
Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVD FSFAMILYEM
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDXFSFAMILYEM 367
Query: 357 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
LEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRELTE+CWA+DMN+RPSFL+ILKR
Sbjct: 368 LEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRELTEECWASDMNKRPSFLEILKR 427
Query: 417 LEKIKETLPTDHHWNIFNA 435
LEKIKE LPTDHHWN+FNA
Sbjct: 428 LEKIKENLPTDHHWNLFNA 446
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101399|ref|XP_002312262.1| predicted protein [Populus trichocarpa] gi|222852082|gb|EEE89629.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/414 (90%), Positives = 398/414 (96%), Gaps = 1/414 (0%)
Query: 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
+A KQKEKARVSRTSLILWHAHQNDAAAVRKLLEED SLV ARDYD RTPLHVASLHGWI
Sbjct: 26 TAGKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDPSLVSARDYDKRTPLHVASLHGWI 85
Query: 82 DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP 141
DVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL ++GGLSYGQNGSHFEPKPVP
Sbjct: 86 DVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELLKSYGGLSYGQNGSHFEPKPVP 145
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD 201
PP PNKCDWEI+PSELDFS+S IIGKGSFGEILKA WRGTPVA+KRILPSLSDDRLVIQD
Sbjct: 146 PPQPNKCDWEIEPSELDFSNSNIIGKGSFGEILKASWRGTPVAVKRILPSLSDDRLVIQD 205
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH+YLKEKGALSPSTA+NFA
Sbjct: 206 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGALSPSTAINFA 265
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
LDIARGMA LHNEPNVI+HRDLKPRNVLLVNS+ADHLKVGDFGLSKLIKVQNSHDVYKMT
Sbjct: 266 LDIARGMACLHNEPNVIVHRDLKPRNVLLVNSNADHLKVGDFGLSKLIKVQNSHDVYKMT 325
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP +N+EPYEAAKYVAEGHRP
Sbjct: 326 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPFSNFEPYEAAKYVAEGHRP 385
Query: 382 FFRAKGFTP-ELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNIFN 434
FR+KGF ELRELT++CWAADMN+RP+FL+ILKRLEKIKE LPTDHHW+IFN
Sbjct: 386 TFRSKGFNVFELRELTDQCWAADMNRRPTFLEILKRLEKIKENLPTDHHWHIFN 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223025|ref|NP_172853.1| VH1-interacting kinase [Arabidopsis thaliana] gi|5080776|gb|AAD39286.1|AC007576_9 Similar to protein kinases [Arabidopsis thaliana] gi|111074450|gb|ABH04598.1| At1g14000 [Arabidopsis thaliana] gi|332190976|gb|AEE29097.1| VH1-interacting kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/438 (85%), Positives = 405/438 (92%), Gaps = 3/438 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILKRL
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILKRL 420
Query: 418 EKIKETLPTDHHWNIFNA 435
EKIKETLP+DHHW +F +
Sbjct: 421 EKIKETLPSDHHWGLFTS 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297844308|ref|XP_002890035.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297335877|gb|EFH66294.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/438 (85%), Positives = 405/438 (92%), Gaps = 3/438 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPASGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPATAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF+HR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFRHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILKRL
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILKRL 420
Query: 418 EKIKETLPTDHHWNIFNA 435
EKIKETLP+DHHW +F +
Sbjct: 421 EKIKETLPSDHHWGLFTS 438
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643246|gb|ABK06431.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/438 (85%), Positives = 405/438 (92%), Gaps = 3/438 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILKRL
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILKRL 420
Query: 418 EKIKETLPTDHHWNIFNA 435
EKIKETLP+DHHW +F +
Sbjct: 421 EKIKETLPSDHHWGLFTS 438
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
| >gi|18700097|gb|AAL77660.1| At1g14000/F7A19_9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/438 (85%), Positives = 405/438 (92%), Gaps = 3/438 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAVGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILKRL
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILKRL 420
Query: 418 EKIKETLPTDHHWNIFNA 435
EKIKETLP+DHHW +F +
Sbjct: 421 EKIKETLPSDHHWGLFTS 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521649|ref|XP_003529466.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/412 (86%), Positives = 391/412 (94%)
Query: 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV 83
+K+KEK RVSRTSLILWHAHQNDA +VRKLL+ED SLV ARDYDNRTPLHVASLHGWIDV
Sbjct: 10 EKEKEKQRVSRTSLILWHAHQNDAGSVRKLLQEDPSLVKARDYDNRTPLHVASLHGWIDV 69
Query: 84 AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPP 143
A CLIE+GADVNAQDRWKNTPLADAEGAKK N++ELL +HGGLS+GQNGSHFEPKPV PP
Sbjct: 70 ATCLIEFGADVNAQDRWKNTPLADAEGAKKSNVIELLQSHGGLSFGQNGSHFEPKPVAPP 129
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR 203
LPNKCDWE++P+ELDFS+S IGKGSFGEILKA+WRGTPVA+KRILPSLS+DRLVIQDFR
Sbjct: 130 LPNKCDWEVEPTELDFSNSVRIGKGSFGEILKAHWRGTPVAVKRILPSLSEDRLVIQDFR 189
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
HEVNLLVKLRHPNIVQFLGAVT RKPLMLITEYLRGGDLH+YLKEKGALSP+TA+NF++D
Sbjct: 190 HEVNLLVKLRHPNIVQFLGAVTARKPLMLITEYLRGGDLHQYLKEKGALSPATAINFSMD 249
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI VQ+SHDVYKMTGE
Sbjct: 250 IVRGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLITVQSSHDVYKMTGE 309
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383
TGSYRYMAPEVFKHR+YDKKVDV+SFAMILYEMLEGEPP A+ EPYE AKY AEGHRP F
Sbjct: 310 TGSYRYMAPEVFKHRRYDKKVDVYSFAMILYEMLEGEPPFASREPYEGAKYAAEGHRPHF 369
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNIFNA 435
RAKG+TPEL+ELTE+CWA DM+QRPSF++ILKRLEKIKE LPT++HW++F +
Sbjct: 370 RAKGYTPELQELTEQCWAHDMSQRPSFIEILKRLEKIKENLPTENHWHLFTS 421
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | ||||||
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 1.0 | 0.993 | 0.835 | 2e-200 | |
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.868 | 0.823 | 0.433 | 2.4e-76 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.885 | 0.817 | 0.431 | 8.1e-76 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.862 | 0.787 | 0.396 | 2.2e-66 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.885 | 0.803 | 0.387 | 4.5e-66 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.885 | 0.807 | 0.392 | 1.4e-62 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.597 | 0.452 | 0.416 | 2.3e-48 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.616 | 0.470 | 0.394 | 1.6e-47 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.6 | 0.478 | 0.404 | 3.3e-47 | |
| UNIPROTKB|F1P6V7 | 835 | TNNI3K "Uncharacterized protei | 0.586 | 0.305 | 0.387 | 3.5e-45 |
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1940 (688.0 bits), Expect = 2.0e-200, P = 2.0e-200
Identities = 366/438 (83%), Positives = 396/438 (90%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFE KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LREL KCW ADMNQRPSFLDILKRL
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRELIVKCWDADMNQRPSFLDILKRL 420
Query: 418 EKIKETLPTDHHWNIFNA 435
EKIKETLP+DHHW +F +
Sbjct: 421 EKIKETLPSDHHWGLFTS 438
|
|
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 173/399 (43%), Positives = 246/399 (61%)
Query: 38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
+++ A++ D +++L++ + RD D+RT LHVA+ G DV + L++ A+V+ +
Sbjct: 47 LMYLANEGDIEGIKELIDSGID-ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPK 105
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSEL 157
DRW +TP ADA K +++++L HG + H + ++EI+PSEL
Sbjct: 106 DRWGSTPFADAIFYKNIDVIKILEIHGA-KHPMAPMHVKTAREVP------EYEINPSEL 158
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVKLRHPN 216
DF+ S I KG++ A WRG VA+K++ LSDD V + F E+ LL +LRHPN
Sbjct: 159 DFTQSKEITKGTY---CMAMWRGIQVAVKKLDDEVLSDDDQV-RKFHDELALLQRLRHPN 214
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EP 275
IVQFLGAVT+ P+M++TEYL GDL + LK KG L P+TAV +ALDIARGM+YLH +
Sbjct: 215 IVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKGQLKPATAVRYALDIARGMSYLHEIKG 274
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ IIHRDL+P N+L +S HLKV DFG+SKL+ V+ T + S RY+APEVF
Sbjct: 275 DPIIHRDLEPSNILRDDSG--HLKVADFGVSKLVTVKEDKP---FTCQDISCRYIAPEVF 329
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELR 393
+YD K DVFSFA+I+ EM+EG P A E EA++ A HRP F+A K + L+
Sbjct: 330 TSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEAYAGKHRPLFKAPSKNYPHGLK 389
Query: 394 ELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNI 432
L E+CW +RP+F +I+KRLE I + W +
Sbjct: 390 TLIEECWHEKPAKRPTFREIIKRLESILHHMGHKRQWRM 428
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 8.1e-76, P = 8.1e-76
Identities = 174/403 (43%), Positives = 239/403 (59%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +++ A++ D + K+L+ + V RD D RT LHVA+ G DV + L+ GA V
Sbjct: 50 TIRLMYLANEGDIDGINKMLDSGTN-VDYRDIDARTALHVAACQGRTDVVELLLSRGAKV 108
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+ +DRW +TPLADA K ++++LL HG ++EI P
Sbjct: 109 DTKDRWGSTPLADAVYYKNHDVIKLLEKHGA-------KPTIAPMHVLTDKEVPEYEIHP 161
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
+ELDFS+S I KG+F KA WRG VA+K + D + FR E+ LL K+RH
Sbjct: 162 TELDFSNSVKISKGTFN---KASWRGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRH 218
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH-N 273
PN+VQFLGAVT+ P+M++TEYL GDL +YL KG L P+ AV FAL+IARGM YLH +
Sbjct: 219 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEH 278
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS--HDVYKMTGETGSYRYMA 331
+P IIH DL+P N+L +S HLKV DFG+SKL+ V+ + D +T S+RYMA
Sbjct: 279 KPEAIIHCDLEPPNILRDDSG--HLKVADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMA 336
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFT 389
PEV+++ +YD KVDVFSFA+IL EM+EG P E E K E RP F A K +
Sbjct: 337 PEVYRNEEYDTKVDVFSFALILQEMIEGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYP 396
Query: 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNI 432
L+EL + CW + ++RP+F I+ LE I + + W +
Sbjct: 397 FGLQELIQDCWDKEASKRPTFRVIISTLELISDRIARKRSWKV 439
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
Identities = 156/393 (39%), Positives = 228/393 (58%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D V+ LL+E V++ D D RT LH+A+ G +DV K L+ A++
Sbjct: 76 TMQLLFVACRGDVEGVQDLLDEGID-VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANI 134
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T ADA+ ++ +L A G + ++E++P
Sbjct: 135 DARDRWGSTAAADAKYYGNMDVFNILKARGA----KVPKTKRTPMVVANPREVPEYELNP 190
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
EL + I KG + ++ K W GT V++K + L D I F+HE+ L K+RH
Sbjct: 191 QELQVRKADGISKGIY-QVAK--WNGTKVSVKILDKDLYKDSDTINAFKHELTLFEKVRH 247
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
PN+VQF+GAVT+ P+M+++EY GDL YL++KG LSP+ + FALDIARGM YLH
Sbjct: 248 PNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARGMNYLHEC 307
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG---ETGSYRYM 330
+P +IH DLKP+N++L S HLKV FGL K+ + G + +Y M
Sbjct: 308 KPEPVIHCDLKPKNIML--DSGGHLKVAGFGLISFAKLSSDKSKILNHGAHIDPSNY-CM 364
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGFT 389
APEV+K +D+ VD +SF ++LYEM+EG P P EA K + EG RP F+AK +
Sbjct: 365 APEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPKPPEEAVKLMCLEGRRPSFKAKSKS 424
Query: 390 -P-ELRELTEKCWAADMNQRPSFLDILKRLEKI 420
P E+REL E+CW + RP+F +I+ RL+KI
Sbjct: 425 CPQEMRELIEECWDTETFVRPTFSEIIVRLDKI 457
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 4.5e-66, P = 4.5e-66
Identities = 156/403 (38%), Positives = 232/403 (57%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D + +LL+E V++ D D RT LH+A+ G + V K L+ A++
Sbjct: 79 TMQLLFMASKGDVRGIEELLDEGID-VNSIDLDGRTALHIAACEGHLGVVKALLSRRANI 137
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T ADA+ ++ LL A G + + ++E++P
Sbjct: 138 DARDRWGSTAAADAKYYGNLDVYNLLKARGA----KVPKTRKTPMTVSNPREVPEYELNP 193
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
E+ S I KG++ ++ K W GT V++K + D I FRHE+ LL K+RH
Sbjct: 194 LEVQVRKSDGISKGAY-QVAK--WNGTRVSVKILDKDSYSDPERINAFRHELTLLEKVRH 250
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
PN++QF+GAVT+ P+M++ EY GDL YL++KG LSPS A+ FALDIARGM YLH
Sbjct: 251 PNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHEC 310
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDV--YKMTGETGSYRYM 330
+P+ IIH DLKP+N+LL LK+ FG+ +L K+ Q+ V +K + +Y Y+
Sbjct: 311 KPDPIIHCDLKPKNILL--DRGGQLKISGFGMIRLSKISQDKAKVANHKAHIDLSNY-YI 367
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKG-- 387
APEV+K +D +VD SF +ILYE+ EG P P E A+ + EG RP F+ K
Sbjct: 368 APEVYKDEIFDLRVDAHSFGVILYEITEGVPVFHPRPPEEVARMMCLEGKRPVFKTKSRS 427
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
+ P+++EL EKCW + RP+F +I+ RL+KI W
Sbjct: 428 YPPDIKELIEKCWHPEAGIRPTFSEIIIRLDKIVANCSKQGWW 470
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
Identities = 158/403 (39%), Positives = 224/403 (55%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D V +LL E V++ D D RT LH+AS G DV K L+ A++
Sbjct: 77 TMQLLFMASKGDVNGVEELLNEGID-VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANI 135
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T DA+ + LL A G + + ++E++P
Sbjct: 136 DARDRWGSTAAVDAKYYGNVEVYNLLKARGAKAPKTR----KTPMTVGNPKEVPEYELNP 191
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
EL I KG++ ++ K W GT V++K S SD V F +E+ LL K R
Sbjct: 192 LELQVRKVDGISKGTY-QVAK--WNGTRVSVKIFDKDSYSDPERV-NAFTNELTLLAKAR 247
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
HPNIVQF+GAVT+ P+M++ E GDL YL++KG LSPS A+ FALDIARGM YLH
Sbjct: 248 HPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHE 307
Query: 274 -EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDVYKMTGETG-SYRYM 330
+P+ IIH +L P+N+LL LK+ FGL KL K+ ++S V + S Y+
Sbjct: 308 CKPDPIIHCELMPKNILL--DRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQIDKSNYYI 365
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFR--AKG 387
APE++K +DK+ DV SF +ILYE+ EG P E A+ + EG RP R +K
Sbjct: 366 APEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPKPPEEVAESICIEGKRPTIRTKSKS 425
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
+ PEL+EL E+CW +++ RP F +I+ RL+KI W
Sbjct: 426 YPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTNCSKQGWW 468
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 2.3e-48, P = 2.3e-48
Identities = 115/276 (41%), Positives = 167/276 (60%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
WEI+ L F I GS+G++ K + VAIK + P D L ++F EV ++
Sbjct: 283 WEINLKHLKFGHK--IASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLE-KEFAQEVFIM 339
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGM 268
K+RH N+VQF+GA T+ L ++TE++ GG ++ YL K+KG T A+DI +GM
Sbjct: 340 RKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGM 399
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
+YLH N IIHRDLK N+L+ + +KV DFG+++ +K Q MT ETG+YR
Sbjct: 400 SYLHQ--NNIIHRDLKAANLLMDENEV--VKVADFGVAR-VKAQTG----VMTAETGTYR 450
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAKG 387
+MAPEV +H+ YD K DVFS+ ++L+E+L G+ P P +AA V + G RP K
Sbjct: 451 WMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTI-PKN 509
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KE 422
P+L EL E+ W D QRP F +I+++L++I KE
Sbjct: 510 THPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKE 545
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
Identities = 112/284 (39%), Positives = 170/284 (59%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+WEID +L + GS+GE+ + + VAIK + P + + +++F EV +
Sbjct: 284 EWEIDMKQLKIEKK--VACGSYGELFRGTYCSQEVAIKILKPERVNAEM-LREFSQEVYI 340
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
+ K+RH N+VQF+GA T L ++TE++ G ++ +L K KG + + ALD+++G
Sbjct: 341 MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKG 400
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YLH N IIHRDLK N+L+ + +KV DFG+++ VQ V MT ETG+Y
Sbjct: 401 MNYLHQ--NNIIHRDLKTANLLM--DEHEVVKVADFGVAR---VQTESGV--MTAETGTY 451
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAK 386
R+MAPEV +H+ YD + DVFS+A++L+E+L GE P + P +AA V + G RP K
Sbjct: 452 RWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKI-PK 510
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEK-IKETLPTDHH 429
P+L EL EKCW D RP+F +I++ L + I+E + H
Sbjct: 511 ETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERH 554
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 112/277 (40%), Positives = 172/277 (62%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+WEID ++L + GS+G++ + + VAIK + P ++ + +++F EV +
Sbjct: 278 EWEIDVTQLKIEKK--VASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEM-LREFSQEVFI 334
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
+ K+RH N+VQFLGA T L ++TE++ G ++ +L K+K A T + ALD+A+G
Sbjct: 335 MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKG 394
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M+YLH N IIHRDLK N+L+ +KV DFG+++ VQ V MT ETG+Y
Sbjct: 395 MSYLHQ--NNIIHRDLKTANLLMDEHGL--VKVADFGVAR---VQIESGV--MTAETGTY 445
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAK 386
R+MAPEV +H+ Y+ K DVFS+A++L+E+L G+ P A P +AA V + G RP K
Sbjct: 446 RWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKK 505
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KE 422
P+++ L E+CW D QRP F +I++ L++I KE
Sbjct: 506 TH-PKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKE 541
|
|
| UNIPROTKB|F1P6V7 TNNI3K "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 3.5e-45, Sum P(2) = 3.5e-45
Identities = 105/271 (38%), Positives = 153/271 (56%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
SE++F IIG GSFG++ K R VAIKR + + + F EV++L +L H
Sbjct: 461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 518
Query: 215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
P I+QF+GA + + ++T+Y+ GG L L E K L + + A+D+A+GM YLH
Sbjct: 519 PCIIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N IIHRDL N+LL H V DFG S+ ++ S D MT + G+ R+MAP
Sbjct: 579 NLTQPIIHRDLNSHNILLCEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWMAP 633
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFT- 389
EVF +Y K DVFS+A+ L+E+L GE P A+ +P AA +A H RP G++
Sbjct: 634 EVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHLRPPI---GYSI 690
Query: 390 PE-LRELTEKCWAADMNQRPSFLDILKRLEK 419
P+ + L + W A RP F +++ +LE+
Sbjct: 691 PKPISSLLMRGWNACPEGRPEFSEVVTKLEE 721
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005943001 | SubName- Full=Chromosome undetermined scaffold_161, whole genome shotgun sequence; (435 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 435 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-86 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-85 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-80 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-77 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-74 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-72 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-67 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-48 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-48 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-47 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-47 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-43 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-43 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-43 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-43 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-42 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-42 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-41 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-39 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-38 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-38 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-37 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-36 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-36 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-34 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-34 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-34 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-34 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-34 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-33 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-33 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-33 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-33 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-33 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-33 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-32 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-32 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-31 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-31 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-30 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-30 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-29 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-29 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-29 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-29 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-28 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-27 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-27 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-25 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-25 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-25 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-21 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 4e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-14 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 9e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-06 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 1e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-05 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 1e-05 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-05 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 7e-05 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-04 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 4e-04 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 6e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 7e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 9e-04 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 7e-86
Identities = 97/262 (37%), Positives = 146/262 (55%), Gaps = 18/262 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPN+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNV 63
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPN 276
V+ LG TE +PL ++ EY+ GGDL YL++ + LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IHRDL RN L+ +K+ DFGLS+ + D Y+ G R+MAPE K
Sbjct: 123 -FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLK 176
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
K+ K DV+SF ++L+E+ GE P E +Y+ G+R + PEL +L
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-PQPPNCPPELYDL 235
Query: 396 TEKCWAADMNQRPSFLDILKRL 417
+CWA D RP+F ++++ L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 3e-85
Identities = 100/263 (38%), Positives = 148/263 (56%), Gaps = 19/263 (7%)
Query: 164 IIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPNI
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNI 63
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP 275
V+ LG TE +PLM++ EY+ GGDL YL++ LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDL RN L+ +K+ DFGLS+ + D YK+ G R+MAPE
Sbjct: 124 --FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYKVKGGKLPIRWMAPESL 176
Query: 336 KHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
K K+ K DV+SF ++L+E+ GE P E +Y+ +G+R + PEL +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL-PKPPNCPPELYK 235
Query: 395 LTEKCWAADMNQRPSFLDILKRL 417
L +CWA D RP+F ++++ L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 247 bits (634), Expect = 4e-80
Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 25/265 (9%)
Query: 165 IGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G+FGE+ K +G T VA+K + S++ ++F E +++ KL HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNV 277
+ LG T+ +PL ++TEY+ GGDL +L++ G L+ + AL IA+GM YL ++
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK 336
+HRDL RN L+ + +K+ DFGLS+ I D Y+ G ++MAPE K
Sbjct: 123 FVHRDLAARNCLV--TENLVVKISDFGLSRDIY---EDDYYRKRGGGKLPIKWMAPESLK 177
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPEL 392
K+ K DV+SF ++L+E+ GE P E + + +G+R P + EL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP----ENCPDEL 233
Query: 393 RELTEKCWAADMNQRPSFLDILKRL 417
EL +CWA D RP+F ++++ L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 3e-77
Identities = 94/271 (34%), Positives = 144/271 (53%), Gaps = 26/271 (9%)
Query: 164 IIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G+FGE+ K +G T VA+K + S++ +DF E ++ KL HPN+V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVV 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE---------KGALSPSTAVNFALDIARGMA 269
+ LG TE +PL L+ EY+ GGDL YL++ K LS ++FA+ IA+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY-R 328
YL ++ +HRDL RN L+ +K+ DFGLS+ + D Y+ R
Sbjct: 120 YLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRDV---YDDDYYRKKTGGKLPIR 172
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+MAPE K + K DV+SF ++L+E+ G P E +Y+ +G+R + +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-PKPEY 231
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLE 418
EL EL CW D RP+F ++++RLE
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 88/256 (34%), Positives = 132/256 (51%), Gaps = 15/256 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+GSFG++ A + T VAIK I + + E+ +L KL+HPNIV+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ EY GGDL LK++G LS A + I + YLH+ I+HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS--KGIVHR 121
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLKP N+LL H+K+ DFGL++ + K+T G+ YMAPEV + Y
Sbjct: 122 DLKPENILLDEDG--HVKLADFGLARQL-----DPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 342 KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPF-FRAKGFTPELRELTEKC 399
K VD++S +ILYE+L G+PP + + E K + + PF +PE ++L K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 400 WAADMNQRPSFLDILK 415
D +R + + L+
Sbjct: 235 LVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 3e-72
Identities = 95/260 (36%), Positives = 138/260 (53%), Gaps = 17/260 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G GSFG + KA +GT VA+K + + R E+ +L +L HPNIV+ +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A ++ L L+ EY GGDL YL G LS A AL I RG+ YLH+ IIHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+LL + +K+ DFGL+K + +S +T G+ YMAPEV Y
Sbjct: 123 DLKPENILLDEN--GVVKIADFGLAKKLLKSSSS----LTTFVGTPWYMAPEVLLGGNGY 176
Query: 341 DKKVDVFSFAMILYEMLEGEPPLAN---YEPYEAAKYVAEGHRPFFRAKGFT--PELREL 395
KVDV+S +ILYE+L G+PP + + + + + F K + E ++L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 396 TEKCWAADMNQRPSFLDILK 415
+KC D ++RP+ +IL+
Sbjct: 237 IKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 9e-67
Identities = 88/257 (34%), Positives = 122/257 (47%), Gaps = 46/257 (17%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + A + G VAIK I S L ++ E+ +L KL HPNIV+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ EY GG L LKE LS + L I G+ YLH+ IIHR
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHR 116
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KY 340
DLKP N+LL + + +K+ DFGLSKL+ + D + G+ YMAPEV + Y
Sbjct: 117 DLKPENILLDSDN-GKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400
+K D++S +ILYE+ PEL++L K
Sbjct: 172 SEKSDIWSLGVILYEL---------------------------------PELKDLIRKML 198
Query: 401 AADMNQRPSFLDILKRL 417
D +RPS +IL+ L
Sbjct: 199 QKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 4e-55
Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 27/277 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W I+ EL ++ IGKG FG+++ +RG VA+K L DD Q F E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVK----CLKDDSTAAQAFLAEASVM 54
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
LRHPN+VQ LG V + PL ++TEY+ G L YL+ +G ++ + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YL E +HRDL RNVL+ S KV DFGL+K + D K+
Sbjct: 115 MEYL--EEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAK--EASQGQDSGKL-----PV 163
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFF 383
++ APE + +K+ K DV+SF ++L+E+ G P + +V +G+R P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP-- 221
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+G PE+ ++ + CW D +RP+F + ++L I
Sbjct: 222 --EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 3e-52
Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 20/267 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+++ ++G+GSFG + A + T +A+K + D ++ E+ +L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 216 NIVQFLGAVTERKPLML--ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
NIV++ G+ + + L EY+ GG L LK+ G L + I G+AYLH+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYM 330
N I+HRD+K N+L+ S +K+ DFG +K + D+ G G+ +M
Sbjct: 120 --NGIVHRDIKGANILV--DSDGVVKLADFGCAKRL-----GDIETGEGTGSVRGTPYWM 170
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA--KYVAEGHRPFFRAKGF 388
APEV + +Y + D++S + EM G+PP + AA K + G P +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI-PEHL 229
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+ E ++ KC D +RP+ ++L+
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 5e-51
Identities = 95/276 (34%), Positives = 142/276 (51%), Gaps = 20/276 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
WE E F+ +G G FGE+ + W+ VAIK + SDD L QDF+ EV
Sbjct: 1 WERPREE--FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK---SDDLLKQQDFQKEVQA 55
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
L +LRH +++ + +P+ +ITE + G L +L+ E L ++ ++ A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAYL E IHRDL RN+L+ KV DFGL++LIK DVY + +
Sbjct: 116 GMAYL--EEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIK----EDVYLSSDKKIP 167
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR-PFFR 384
Y++ APE H + K DV+SF ++LYEM G+ P +E + G+R P
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP--C 225
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
E+ ++ +CWAA+ RPSF + + L+ I
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 84/256 (32%), Positives = 135/256 (52%), Gaps = 18/256 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IGKG FGE+ KA + G VAIK I L S +I E+ +L K +HPNIV++
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN----EIQILKKCKHPNIVKYY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-ALDIARGMAYLHNEPNVIIH 280
G+ ++ L ++ E+ GG L LK + + + ++ +G+ YLH+ N IIH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS--NGIIH 121
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+K N+LL S +K+ DFGLS ++ ++ M G + +MAPEV + Y
Sbjct: 122 RDIKAANILL-TSDG-EVKLIDFGLSA--QLSDTKARNTMVG---TPYWMAPEVINGKPY 174
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKC 399
D K D++S + E+ EG+PP + P +A +A P R + ++ E ++ +KC
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234
Query: 400 WAADMNQRPSFLDILK 415
+ +RP+ +LK
Sbjct: 235 LQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 6e-48
Identities = 79/261 (30%), Positives = 140/261 (53%), Gaps = 22/261 (8%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
IGKGSFG++ R G +K I L ++S+ +D +EV +L KL HPNI++
Sbjct: 8 IGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEP 275
+ + E+ L ++ EY GGDL + +K++ +++ + + + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP+N+ L +S +K+GDFG+SK+ + ++ D+ K G+ Y++PE+
Sbjct: 122 RKILHRDIKPQNIFL--TSNGLVKLGDFGISKV--LSSTVDLAKTV--VGTPYYLSPELC 175
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+++ Y+ K D++S +LYE+ + P E A + +G P ++ ++ ELR L
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ-YSSELRNL 234
Query: 396 TEKCWAADMNQRPSFLDILKR 416
D +RPS IL+
Sbjct: 235 VSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 7e-48
Identities = 94/271 (34%), Positives = 145/271 (53%), Gaps = 21/271 (7%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
I+PSEL F +G G FG + WR VAIK I ++S++ DF E ++
Sbjct: 1 INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGM 268
+KL HP +VQ G T++KPL ++TE++ G L YL+++ G LS ++ D+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTGETGSY 327
YL E N IHRDL RN L+ SS +KV DFG+++ + D Y +G
Sbjct: 114 EYL--ERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPV 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAK 386
++ PEVF KY K DV+SF ++++E+ EG+ P YE + ++ G R +R K
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPK 224
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILKRL 417
+ + E+ CW RP+F ++L+ +
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 9e-48
Identities = 96/273 (35%), Positives = 145/273 (53%), Gaps = 25/273 (9%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
IDPSEL F +G G FG + WRG VAIK I ++S+D DF E ++
Sbjct: 1 IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+KL HPN+VQ G T+++P+ ++TEY+ G L YL+E KG L ++ D+ M
Sbjct: 54 MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 326
YL E N IHRDL RN L+ + +KV DFGL++ + D Y T G+
Sbjct: 114 EYL--ESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYV----LDDQY--TSSQGTKF 163
Query: 327 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFR 384
++ PEVF + ++ K DV+SF ++++E+ EG+ P + E + V+ G+R +R
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LYR 222
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
K E+ + CW RP+F +L +L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 95/272 (34%), Positives = 141/272 (51%), Gaps = 23/272 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
I PSEL IG G FG + YW VAIK I + +DF E +++
Sbjct: 1 IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMM 54
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
KL HP +VQ G TER P+ L+ E++ G L YL+ ++G S T + LD+ GMA
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--- 326
YL E + +IHRDL RN L+ + +KV DFG+++ + D Y T TG+
Sbjct: 115 YL--ESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFV----LDDQY--TSSTGTKFP 164
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ +PEVF KY K DV+SF ++++E+ EG+ P N E + + G R ++
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-LYKP 223
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
+ + + EL + CW RPSF +L +L
Sbjct: 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 102/284 (35%), Positives = 145/284 (51%), Gaps = 36/284 (12%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSD-DRLVIQDFRHE 205
IDPS + +IG G FGE+ + + VAIK + SD RL DF E
Sbjct: 1 IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTE 55
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
+++ + HPNI++ G VT+ +P+M+ITEY+ G L K+L+E G + V I
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI 115
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTG 322
A GM YL V HRDL RN+ LVNS +L KV DFGLS+ + ++S Y G
Sbjct: 116 ASGMKYLSEMNYV--HRDLAARNI-LVNS---NLVCKVSDFGLSRRL--EDSEATYTTKG 167
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHR- 380
R+ APE +RK+ DV+SF ++++E M GE P + + K V +G+R
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL 227
Query: 381 PFFRAKGFTPE-----LRELTEKCWAADMNQRPSFLDILKRLEK 419
P P L +L CW D N+RP+F I+ L+K
Sbjct: 228 P-------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 8e-47
Identities = 94/279 (33%), Positives = 136/279 (48%), Gaps = 30/279 (10%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ W G T VA+K + P + F E +
Sbjct: 1 WEIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRH +VQ +E +P+ ++TEY+ G L +LK E L V+ A IA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAYL E IHRDL RN+L+ ++L K+ DFGL++LI+ D Y T
Sbjct: 115 GMAYL--ESRNYIHRDLAARNILV----GENLVCKIADFGLARLIED----DEY--TARE 162
Query: 325 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
G+ ++ APE + ++ K DV+SF ++L E++ G P E + V G+R
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222
Query: 381 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
P R EL +L +CW D +RP+F + LE
Sbjct: 223 MP--RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-45
Identities = 78/256 (30%), Positives = 131/256 (51%), Gaps = 9/256 (3%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FG + Y G +A+K++ P + + + E+ LL L+H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ G + + + L + EY+ GG + LK GAL+ + + I G+ YLH+ N+I+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS--NMIV 126
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRD+K N+L SA ++K+GDFG SK ++ S M TG+ +M+PEV
Sbjct: 127 HRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTG-MKSVTGTPYWMSPEVISGEG 183
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
Y +K DV+S + EML +PP A +E A +A +P+ R +
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRT 243
Query: 400 WAADMNQRPSFLDILK 415
+ + +RPS ++L+
Sbjct: 244 FVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-43
Identities = 79/260 (30%), Positives = 132/260 (50%), Gaps = 16/260 (6%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IGKG+FG++ K + T VA+K +L D + + F E +L + HPNIV+ +G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD--LKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 224 VTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+++P+ ++ E + GG L +L K+K L+ + +LD A GM YL E IHRD
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNCIHRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--YRYMAPEVFKHRKY 340
L RN L+ + LK+ DFG+S+ + +Y ++ ++ APE + +Y
Sbjct: 119 LAARNCLV--GENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
+ DV+S+ ++L+E G+ P + + + G+R + E+ L +C
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MPAPQLCPEEIYRLMLQC 231
Query: 400 WAADMNQRPSFLDILKRLEK 419
WA D RPSF +I L+
Sbjct: 232 WAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 82/267 (30%), Positives = 135/267 (50%), Gaps = 17/267 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL + + IG+G+ GE+ KA R T VAIK++ + L+I E+ ++
Sbjct: 16 DPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMK 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMA 269
+HPNIV + + L ++ EY+ GG L + + ++ ++ +G+
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YLH+ +IHRD+K N+LL S +K+ DFG + Q + + K G+ +
Sbjct: 131 YLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFA----AQLTKEKSKRNSVVGTPYW 182
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGF 388
MAPEV K + Y KVD++S ++ EM EGEPP P A + +G P + +
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+PE ++ KC D +RPS ++L+
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 80/267 (29%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 165 IGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNI 217
+G G+FG ++K + VA+K +L + + +F E +++ +L HP I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK----TLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V+ +G V + +PLML+ E G L KYLK++ + S A +A GMAYL E
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESKH 115
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFK 336
+HRDL RNVLLVN K+ DFG+S+ + + D Y+ T ++ APE
Sbjct: 116 FVHRDLAARNVLLVNR--HQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWYAPECIN 171
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ K+ K DV+S+ + L+E G P + E + G R R + E+ +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPEECPQEIYSI 230
Query: 396 TEKCWAADMNQRPSFLDILKRLEKIKE 422
CW RP+F ++ + E
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 35/290 (12%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS-DDRLVIQD 201
WE+ ++ +G+GSFG + + +G T VAIK + + S +R+ +
Sbjct: 1 WELPREKITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI---E 55
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------GALS 253
F +E +++ + ++V+ LG V+ +P +++ E + GDL YL+ + G
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 254 PST--AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
P+ + A +IA GMAYL +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDI-- 169
Query: 312 QNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
D Y+ G+ R+MAPE K + K DV+SF ++L+EM E P
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 370 EAAKYVAEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
E K+V +G H + +L EL CW + RP+FL+I+ L+
Sbjct: 229 EVLKFVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 96/277 (34%), Positives = 147/277 (53%), Gaps = 17/277 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 205
EI PS + + +IG G FGE+ + + VAIK + P ++ + QDF E
Sbjct: 1 EIHPSHI--TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSE 56
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
+++ + H NI++ G VT+ KP M+ITEY+ G L KYL++ G S V I
Sbjct: 57 ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL + V HRDL RN+ LVNS+ + KV DFGLS++++ + Y +G
Sbjct: 117 AAGMKYLSDMNYV--HRDLAARNI-LVNSNLE-CKVSDFGLSRVLE-DDPEGTYTTSGGK 171
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHRPFF 383
R+ APE +RK+ DV+SF ++++E M GE P + +E K + +G R
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LP 230
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ +L +CW D +RP F+DI+ L+K+
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 84/261 (32%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRHPNI 217
+G GSFG + + W + PVA+K L D+L ++ DF E ++ L H N+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEP 275
++ G V PLM++TE G L L++ G ST ++A+ IA GM YL ++
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEV 334
IHRDL RN+LL +S D +K+GDFGL + + + D Y M + + APE
Sbjct: 118 --FIHRDLAARNILL--ASDDKVKIGDFGLMRALP--QNEDHYVMEEHLKVPFAWCAPES 171
Query: 335 FKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV-AEGHRPFFRAKGFTPEL 392
+ R + DV+ F + L+EM GE P A + K + EG R R + ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-LERPEACPQDI 230
Query: 393 RELTEKCWAADMNQRPSFLDI 413
+ +CWA + RP+F +
Sbjct: 231 YNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 85/254 (33%), Positives = 128/254 (50%), Gaps = 15/254 (5%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IGKGSFGE+ KA + T VAIK I L D+ I+D + E+ L + R P I ++
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE---IEDIQQEIQFLSQCRSPYITKYY 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
G+ + L +I EY GG LK G L + ++ G+ YLH E IHR
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK--IHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + D +K+ DFG+S Q + + K G+ +MAPEV K YD
Sbjct: 123 DIKAANILL-SEEGD-VKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 401
+K D++S + E+ +GEPPL++ P + + + P F+ ++ C
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236
Query: 402 ADMNQRPSFLDILK 415
D +RPS ++LK
Sbjct: 237 KDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 7e-42
Identities = 92/275 (33%), Positives = 145/275 (52%), Gaps = 23/275 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ EL + IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 1 WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 53
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M YL E N +HRDL RNVL+ S + KV DFGL+K + ++ D K+
Sbjct: 114 AMEYL--EANNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--EASSTQDTGKL-----P 162
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAP 221
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
G P + ++ ++CW D RPSFL + ++LE I
Sbjct: 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 92/277 (33%), Positives = 142/277 (51%), Gaps = 26/277 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEID + + +G G FGE+ + W TPVA+K + P D +DF E +
Sbjct: 1 WEIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRHP ++Q T +P+ ++TE ++ G L +YL+ AL ++ A +A
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETG 325
GMAYL E IHRDL RNVL+ ++ KV DFGL+++IK D+Y+ G
Sbjct: 115 GMAYL--EAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIK----EDIYEAREGAKF 166
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---P 381
++ APE + ++ K DV+SF ++L E++ G P E + V +G+R P
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP 226
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
G EL ++ CW D + RP+F + +LE
Sbjct: 227 ----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-41
Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 47/277 (16%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRH-----------EVNLL 209
IGKGSFG + K ++R SD ++++ D+ + EVN+L
Sbjct: 7 TIGKGSFGTVRK---------VRRK----SDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53
Query: 210 VKLRHPNIVQFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALD 263
+L+HPNIV++ + +R + L ++ EY GGDL K KE+ +
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 264 IARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+ + HN N ++HRDLKP N+ L + +++K+GDFGL+K++ HD
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFGLAKIL----GHDSSFA 167
Query: 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380
G+ YM+PE H YD+K D++S ++YE+ PP + A + EG
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK- 226
Query: 381 PFFR--AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
FR ++ EL E+ + D ++RPS ++L+
Sbjct: 227 --FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 6e-41
Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 18/265 (6%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
E + ++G G+FG + K W PVAIK + ++ E
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAY 61
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
++ + HP++V+ LG + + LIT+ + G L Y++ K + +N+ + IA+
Sbjct: 62 VMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GM+YL E ++HRDL RNVL+ + H+K+ DFGL+KL+ V Y G
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKE--YHAEGGKVP 174
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++MA E HR Y K DV+S+ + ++E++ G P E + +G R +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP 233
Query: 386 KGFTPELRELTEKCWAADMNQRPSF 410
T ++ + KCW D RP+F
Sbjct: 234 PICTIDVYMVLVKCWMIDAESRPTF 258
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 7e-41
Identities = 79/252 (31%), Positives = 130/252 (51%), Gaps = 20/252 (7%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IG+G+FG + K G VAIK+I ++ E++LL L+HPNIV+++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
G++ L +I EY G L + +K+ G S + + +G+AYLH + +IHR
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHR 123
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLS-KLIKV-QNSHDVYKMTGETGSYRYMAPEVFKHRK 339
D+K N+L + +K+ DFG++ KL V ++ V G+ +MAPEV +
Sbjct: 124 DIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASV------VGTPYWMAPEVIEMSG 175
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY--VAEGHRPFFRAKGFTPELRELTE 397
D++S + E+L G PP + P AA + V + H P +G +PEL++
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIVQDDHPPL--PEGISPELKDFLM 232
Query: 398 KCWAADMNQRPS 409
+C+ D N RP+
Sbjct: 233 QCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 85/261 (32%), Positives = 131/261 (50%), Gaps = 18/261 (6%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKGSFG++L + T A+K + R ++ E N+L ++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
A + L L+ EY GG+L +L ++G S A +A +I + YLH+ II+RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRD 118
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
LKP N+LL AD H+K+ DFGL+K + S + + G+ Y+APEV + Y
Sbjct: 119 LKPENILL---DADGHIKLTDFGLAK----ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 401
K VD +S ++LYEML G+PP + E + + + F + +PE R+L
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRF-PEFLSPEARDLISGLLQ 229
Query: 402 ADMNQRPSFLDILKRLEKIKE 422
D +R E+IK
Sbjct: 230 KDPTKRLGSGGA----EEIKA 246
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 89/279 (31%), Positives = 142/279 (50%), Gaps = 35/279 (12%)
Query: 165 IGKGSFGEILKAYWR-GTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ P VA+K + + S+D +DF E LL +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--------------EKGALSPSTAVNFALD 263
V+F G TE P +++ EY+ GDL+K+L+ G L+ S + A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTG 322
IA GM YL ++ V HRDL RN L+ D + K+GDFG+S+ + + D Y++ G
Sbjct: 131 IASGMVYLASQHFV--HRDLATRNCLV---GYDLVVKIGDFGMSRDVY---TTDYYRVGG 182
Query: 323 ETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
T R+M PE +RK+ + DV+SF ++L+E+ G+ P E + + +G R
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG-R 241
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
R + E+ ++ CW D QR + DI +RL+K
Sbjct: 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-39
Identities = 86/278 (30%), Positives = 147/278 (52%), Gaps = 27/278 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
WE++ +++ +G G +GE+ + W+ VA+K +L +D + +++F E
Sbjct: 1 WEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAA 54
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIA 265
++ +++HPN+VQ LG T P +ITE++ G+L YL+E + ++ + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGET 324
M YL E IHRDL RN L+ +HL KV DFGLS+L+ D Y T
Sbjct: 115 SAMEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT----GDTY--TAHA 163
Query: 325 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
G+ ++ APE + K+ K DV++F ++L+E+ G P + + + + +G+R
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
R +G P++ EL CW + + RPSF +I + E
Sbjct: 224 -MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 25/274 (9%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
IDP +L F +G G FG + WRG VAIK I S+S+D +F E ++
Sbjct: 1 IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGM 268
+KL H +VQ G T+++P+ ++TEY+ G L YL+E G PS + D+ GM
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 326
AYL E IHRDL RN LV+ +KV DFGLS+ + D Y T GS
Sbjct: 114 AYL--ESKQFIHRDLAARNC-LVDDQGC-VKVSDFGLSRYV----LDDEY--TSSVGSKF 163
Query: 327 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384
R+ PEV + K+ K DV++F ++++E+ G+ P + E + V++G R +R
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYR 222
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
+ ++ + CW +RP+F +L +E
Sbjct: 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 73/207 (35%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGA 223
+G+GSFGE+ A VA+K + L ++ F E+ +L L HP NIV+
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ EY+ GG L LK+ KG LS S A+ I + YLH IIH
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIH 124
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK--VQNSHDVYKMTGETGSYRYMAPEVFKH- 337
RD+KP N+LL + +K+ DFGL+KL+ S + G+ YMAPEV
Sbjct: 125 RDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 338 --RKYDKKVDVFSFAMILYEMLEGEPP 362
D++S + LYE+L G PP
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 30/279 (10%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG++ + G VA+K + S + DF E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ--HRSDFEREIEILRTLDHENIV 69
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEP 275
++ G + + L LI EYL G L YL+ + ++ + F+ I +GM YL ++
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDL RN+L+ S D +K+ DFGL+K++ + K GE+ + Y APE
Sbjct: 130 --YIHRDLAARNILV--ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 336 KHRKYDKKVDVFSFAMILYEMLE-GEP---PLANYEPYEAAKYVAEGHRPFF-------- 383
+ K+ DV+SF + LYE+ G+P P A +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 384 --RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
R E+ +L + CW A+ RPSF D++ ++++
Sbjct: 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 16/257 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKR--ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G GSFG + + G A+K + + ++ E+ LL KL+HPNIVQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
LG E L + E + GG L K LK+ G+ + I G+ YLH+ +H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD--RNTVH 125
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-K 339
RD+K N+L+ + +K+ DFG++K + + +K GS +MAPEV +
Sbjct: 126 RDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFK-----GSPYWMAPEVIAQQGG 178
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEK 398
Y D++S + EM G+PP + E A K P + E ++ K
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI-PDHLSDEAKDFILK 237
Query: 399 CWAADMNQRPSFLDILK 415
C D + RP+ ++L+
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 92/276 (33%), Positives = 139/276 (50%), Gaps = 17/276 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEV 206
ID S + +IG G FGE+ R PVAIK + ++ + +DF E
Sbjct: 1 IDASCIKIEK--VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEA 56
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIA 265
+++ + HPNI+ G VT+ KP+M++TEY+ G L +L K G + V IA
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GM YL + V HRDL RN+ LVNS+ KV DFGLS++++ + Y G
Sbjct: 117 SGMKYLSDMGYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVLE-DDPEAAYTTRGGKI 171
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384
R+ APE +RK+ DV+S+ ++++E++ GE P + K + EG+R
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPA 230
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
L +L CW D N+RP F I+ L+K+
Sbjct: 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 86/272 (31%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
I KG++G + A + T AIK I + + + E ++L + + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ +K L L+ EYL GGDL L+ G+L A + +I + YLH+ N IIHRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYMAPEVFKHR 338
LKP N+L+ S HLK+ DFGLSK+ V+ ++ E G+ Y+APEV +
Sbjct: 119 LKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
+ K VD +S ILYE L G PP P E + + G + + E +L K
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236
Query: 399 CWAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
D +R K +E+IK +H +
Sbjct: 237 LLVPDPEKRLGA----KSIEEIK-----NHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 86/276 (31%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 164 IIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G+G FGE+ A +G T V +K + + D + +FR E+++ KL H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA--------LSPSTAVNFALDIARG 267
+V+ LG E +P +I EY GDL ++L+ K LS V IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M +L N +HRDL RN L+ SS +KV LSK V NS + YK+
Sbjct: 130 MDHLSN--ARFVHRDLAARNCLV--SSQREVKVSLLSLSK--DVYNS-EYYKLRNALIPL 182
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP---LANYEPYEAAKYVAEGHRPFF 383
R++APE + + K DV+SF ++++E+ +GE P L++ E + G
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ---AGKLELP 239
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
+G L +L +CWA + RPSF +++ L +
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 87/259 (33%), Positives = 138/259 (53%), Gaps = 17/259 (6%)
Query: 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
++GKG+FGE+ K + TPVA+K L + L I+ F E +L + HPNIV+ +G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
T+R+P+ ++ E + GGD +L K+K L V FALD A GMAYL E IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNCIHR 117
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG-ETGSYRYMAPEVFKHRKY 340
DL RN L+ ++ LK+ DFG+S+ Q +Y +G + ++ APE + +Y
Sbjct: 118 DLAARNCLVGENNV--LKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTEK 398
+ DV+S+ ++L+E G P +A + V +G+R P+ + ++ ++
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--MSCPQKCPDDVYKVMQR 229
Query: 399 CWAADMNQRPSFLDILKRL 417
CW RP F ++ K L
Sbjct: 230 CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 71/204 (34%), Positives = 113/204 (55%), Gaps = 18/204 (8%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+G++G + KA + G VA+K+I ++ + R E++LL +L+HPNIV+ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + L L+ EY DL KYL ++ G LSP+ + + RG+AY H+ + I+H
Sbjct: 65 DVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS--HRILH 121
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKH 337
RDLKP+N+L+ + LK+ DFGL++ + T E T YR APE+
Sbjct: 122 RDLKPQNILI--NRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYR--APEILLGS 173
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
+ Y VD++S I EM+ G+P
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 90/304 (29%), Positives = 147/304 (48%), Gaps = 40/304 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDR 196
LP +WE+ L + +G+G+FG+++KA G VA+K + ++
Sbjct: 1 LPLDPEWELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
L D E+ ++ + +H NI+ LG T+ PL ++ EY G+L +L+ +
Sbjct: 59 LS--DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 250 ----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-L 298
L+ V+FA +ARGM +L IHRDL RNVL+ + DH +
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLV---TEDHVM 171
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-M 356
K+ DFGL++ I + D Y+ T ++MAPE R Y + DV+SF ++L+E
Sbjct: 172 KIADFGLARDI---HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 357 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
G P E K + EG+R + + T EL L CW +QRP+F +++
Sbjct: 229 TLGGSPYPGIPVEELFKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287
Query: 417 LEKI 420
L+++
Sbjct: 288 LDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 89/265 (33%), Positives = 136/265 (51%), Gaps = 19/265 (7%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDD-----RLVIQDFRHEVNLLVKLRH 214
A+IG GSFG + G +A+K++ LPS+S R ++ E+ LL +L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIVQ+LG+ + L + EY+ GG + L GA + NF I +G+ YLHN
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE----TGSYRYM 330
IIHRD+K N+L+ N +K+ DFG+SK K++ + K G GS +M
Sbjct: 126 G--IIHRDIKGANILVDNKGG--IKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWM 179
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
APEV K Y +K D++S ++ EML G+ P + +A + E P +
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI-PSNISS 238
Query: 391 ELRELTEKCWAADMNQRPSFLDILK 415
E + EK + D N+RP+ ++LK
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
E F +G+GS+G + KA + G VAIK ++P D +Q+ E+++L +
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-VVPVEED----LQEIIKEISILKQCD 56
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLH 272
P IV++ G+ + L ++ EY G + +K + L +G+ YLH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ N IHRD+K N+LL + K+ DFG+S Q + + K G+ +MAP
Sbjct: 117 S--NKKIHRDIKAGNILL--NEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWMAP 168
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---FFRAKGFT 389
EV + Y+ K D++S + EM EG+PP ++ P A + ++P + ++
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPEKWS 226
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
PE + +KC D +RPS + +L+
Sbjct: 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 83/253 (32%), Positives = 129/253 (50%), Gaps = 19/253 (7%)
Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ R TPVA+K +L D + F E +L + HPNIV+ +G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
T+++P+ ++ E ++GGD +L+ +G L + + A GM YL E IHR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESKHCIHR 118
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG--ETGSYRYMAPEVFKHRK 339
DL RN L+ + LK+ DFG+S+ + VY TG + ++ APE + +
Sbjct: 119 DLAARNCLVTEKNV--LKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 340 YDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTE 397
Y + DV+SF ++L+E G P AN + + + +G R P+ + L E
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--LPCPELCPDAVYRLME 230
Query: 398 KCWAADMNQRPSF 410
+CW D QRPSF
Sbjct: 231 RCWEYDPGQRPSF 243
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 36/279 (12%)
Query: 164 IIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
+G G+FGE+ + GT VA+K + +D +F E +L+
Sbjct: 2 FLGSGAFGEV----YEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSN 55
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------LSPSTAVNFALDI 264
HPNIV+ LG +P +I E + GGDL YL++ L+ ++ LD+
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMT 321
A+G YL E IHRDL RN L+ D +K+GDFGL++ I D Y+
Sbjct: 116 AKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYRKE 170
Query: 322 GETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379
GE R+MAPE K+ + DV+SF ++++E+L G+ P E ++V G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230
Query: 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
R + + ++ +L CWA D ++RP+F I + L+
Sbjct: 231 R-LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 16/260 (6%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG G+FG++ A G +A+K RI + D I++ E+ +L L+HPN+V++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
G R+ + + EY GG L + L+ L + L + G+AYLH+ + I+H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS--HGIVH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+KP N+ L ++ +K+GDFG + +K + ++ G+ YMAPEV K
Sbjct: 123 RDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 341 DKK---VDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFFRAK-GFTPELREL 395
D++S ++ EM G+ P + + + V GH+P +PE ++
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 396 TEKCWAADMNQRPSFLDILK 415
++C +D +RP+ ++L+
Sbjct: 241 LDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 89/276 (32%), Positives = 142/276 (51%), Gaps = 29/276 (10%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ +L IIG+G FG +L+ + G VA+K I ++ Q F E ++
Sbjct: 1 WLLNLQKLTLG--EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTA--VNFALDIARG 267
KL H N+V+ LG + L ++ E + G+L +L+ +G S + F+LD+A G
Sbjct: 54 TKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKL--IKVQNSHDVYKMTGET 324
M YL E ++HRDL RN+L+ S D + KV DFGL+++ + V NS K T
Sbjct: 113 MEYL--ESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--- 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383
APE KH+K+ K DV+S+ ++L+E+ G P E + V +G+R
Sbjct: 165 ------APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-ME 217
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
+G ++ L CW + +RPSF + ++LEK
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 89/281 (31%), Positives = 140/281 (49%), Gaps = 39/281 (13%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ A VA+K + + R QDF+ E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFAL 262
V+F G TE +PL+++ EY+R GDL+++L+ G L+ + A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKM 320
IA GM YL + +HRDL RN L+ L K+GDFG+S+ I S D Y++
Sbjct: 130 QIASGMVYLASLH--FVHRDLATRNCLV----GQGLVVKIGDFGMSRDIY---STDYYRV 180
Query: 321 TGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378
G T R+M PE +RK+ + D++SF ++L+E+ G+ P EA + + +G
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240
Query: 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
R R + PE+ + + CW + QR DI RL+
Sbjct: 241 -RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 87/289 (30%), Positives = 143/289 (49%), Gaps = 41/289 (14%)
Query: 164 IIGKGSFGEILKAY---WRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G+G FG+++KA +G T VA+K + + S L +D E NLL ++ HP+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNLLKQVNHPH 64
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS--------------------- 255
+++ GA ++ PL+LI EY + G L +L+E + PS
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 256 ---TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
++FA I+RGM YL ++HRDL RNVL+ +K+ DFGLS+ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEE 180
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA 371
+S+ K + ++MA E Y + DV+SF ++L+E++ G P P
Sbjct: 181 DSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ G+R R + + E+ L CW + ++RP+F DI K LEK+
Sbjct: 239 FNLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 24/271 (8%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IGKG+FG++ R T A+K + ++ +++ +E +L +L HP +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + + + L+ + L GGDL +L +K S + +I + YLH+ IIHR
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS--KGIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+LL H+ + DF ++ + T +G+ YMAPEV + Y
Sbjct: 125 DIKPDNILLDEQG--HVHITDFNIATKV-----TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA--EGHRPFFRAKGFTPELRELTEKC 399
VD +S + YE L G+ P + + A E + ++ E + K
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY-PATWSTEAIDAINKL 236
Query: 400 WAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
D +R L+ +K +H +
Sbjct: 237 LERDPQKRLGD-----NLKDLK-----NHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 21/268 (7%)
Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IG G FGE+ + R VAIK + ++ + +DF E +++ + HPNI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNII 68
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNV 277
G VT+ +P+M+ITE++ G L +L++ G + V IA GM YL +E N
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEV 334
+HRDL RN+ LVNS+ KV DFGLS+ ++ S Y T G R+ APE
Sbjct: 128 -VHRDLAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY--TSSLGGKIPIRWTAPEA 182
Query: 335 FKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-L 392
+RK+ DV+S+ ++++E++ GE P + + + + +R P L
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--LPPPMDCPTAL 240
Query: 393 RELTEKCWAADMNQRPSFLDILKRLEKI 420
+L CW D N RP F I+ L+K+
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 14/250 (5%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS G + K + T A+K+I + D + E+ L P +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
A + + ++ EY+ GG L LK+ G + A I +G+ YLH + + IIHRD
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+KP N+L+ +S +K+ DFG+SK++ + T G+ YM+PE + Y
Sbjct: 126 IKPSNLLI--NSKGEVKIADFGISKVL---ENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 343 KVDVFSFAMILYEMLEGEPPLA---NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
D++S + L E G+ P +E + + +G P A+ F+PE R+ C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 400 WAADMNQRPS 409
D +RPS
Sbjct: 240 LQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH---PNI 217
+IG+G++G + + G VA+K I L + DD + D + EV LL +LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPNI 64
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ G+ + L +I EY GG + + L + G ++ ++ + Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+IHRD+K N+L+ N+ ++K+ DFG++ L+ QNS K + G+ +MAPEV
Sbjct: 122 VIHRDIKAANILVTNTG--NVKLCDFGVAALL-NQNSS---KRSTFVGTPYWMAPEVITE 175
Query: 338 -RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396
+ YD K D++S + +YEM G PP ++ + + A + + P G++ LRE
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235
Query: 397 EKCWAADMNQRPSFLDILK 415
C + +R S ++LK
Sbjct: 236 AACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 83/273 (30%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G G+FGE+ + +RG VA+K + S D+ DF E ++ K H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE----SDFLMEALIMSKFNHQ 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGM 268
NIV+ +G ER P ++ E + GGDL +L+E +L+ + A D+A+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-S 326
YL E N IHRD+ RN LL + K+ DFG+++ I Y+ G
Sbjct: 130 KYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY---RASYYRKGGRAMLP 184
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++M PE F + K DV+SF ++L+E+ G P E ++V G R
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
P R +T+ CW RP+F IL+R++
Sbjct: 245 GCPGPVYRIMTD-CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 45/283 (15%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ K G T VAIK + + V Q+FR E L+ L+HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYL----------------KEKGALSPSTAVNFA 261
V LG T+ +P ++ EYL GDLH++L K +L S ++ A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYK 319
+ IA GM YL + + +HRDL RN L+ + L K+ DFGLS+ I S D Y+
Sbjct: 131 IQIAAGMEYLSS--HHFVHRDLAARNCLV----GEGLTVKISDFGLSRDIY---SADYYR 181
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377
+ ++ R+M PE + K+ + D++SF ++L+E+ G P + E + +
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 378 GH---RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
P + + L +CW +RP F DI RL
Sbjct: 242 RQLLPCP----EDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 18/273 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
D + IG+G FG++ + + VA+K S V + F E ++ +
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQF 64
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
HP+IV+ +G +TE P+ ++ E G+L YL K +L ++ + ++ ++ +AYL
Sbjct: 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
++ V HRD+ RNVL+ SS D +K+GDFGLS+ + YK + ++MA
Sbjct: 124 ESKRFV--HRDIAARNVLV--SSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
PE R++ DV+ F + ++E+L G P + + + G R P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN-CPP 235
Query: 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
L L KCWA D ++RP F ++ +L I +
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 163 AIIGKGSFGEILKA--YWRGTPVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+F +A GT +A+K++ + S+ V++ R E+ L+ +L HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ LGA E L E++ GG + L + GA + +N+ + RG++YLH N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE--NQ 123
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 332
IIHRD+K N LL++S+ L++ DFG + + + + GE G+ +MAP
Sbjct: 124 IIHRDVKGAN-LLIDSTGQRLRIADFGAAARLAAKGTG-----AGEFQGQLLGTIAFMAP 177
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRPFFRAKGFT 389
EV + +Y + DV+S ++ EM +PP + +A + +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
P LR++T +C RP ++LK
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 84/255 (32%), Positives = 122/255 (47%), Gaps = 37/255 (14%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
VA+K + P SD+ +DF EV +L +L PNI + LG T PL +I EY+ GDL
Sbjct: 49 VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 243 HKYLKE-----------KGALSPSTAVNFALDIARGMAYL--HNEPNVIIHRDLKPRNVL 289
+++L++ +LS ST + A IA GM YL N +HRDL RN
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNC- 161
Query: 290 LVNSSADHLKVGDFGLSKLIKVQN--SHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDV 346
LV + +K+ DFG+S+ N S D Y++ G R+MA E K+ K DV
Sbjct: 162 LVGKNY-TIKIADFGMSR-----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 347 FSFAMILYE--MLEGEPP---LANYEPYEAAKYV---AEGHRPFFRAKGFTPELRELTEK 398
++F + L+E L E P L + + E A + R ++ EL +
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275
Query: 399 CWAADMNQRPSFLDI 413
CW D RP+F +I
Sbjct: 276 CWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 87/287 (30%), Positives = 134/287 (46%), Gaps = 43/287 (14%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
IG+G+FG + +A G T VA+K + S D + DF+ E L+ + HPNI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE----------------------KGALSPS 255
V+ LG KP+ L+ EY+ GDL+++L+ LS +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
+ A +A GMAYL +HRDL RN L+ + +K+ DFGLS+ I S
Sbjct: 131 EQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY---SA 183
Query: 316 DVYKMTG-ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373
D YK + + R+M PE + +Y + DV+++ ++L+E+ G P E
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 374 YVAEGHRPFFRAKGFTP-ELRELTEKCWAADMNQRPSFLDILKRLEK 419
YV +G+ P EL L CW+ + RPSF I + L++
Sbjct: 244 YVRDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 11/259 (4%)
Query: 164 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQ 219
++GKG++G + +G +A+K++ S+ +++ EV+LL L+H NIVQ
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+LG + + + E++ GG + L G L + I G+AYLHN N ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--NCVV 124
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGETGSYRYMAPEVFKH 337
HRD+K NV+L+ + +K+ DFG ++ + H + + G+ +MAPEV
Sbjct: 125 HRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELT 396
Y +K D++S ++EM G+PPLA+ + A Y+ R F+ +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 397 EKCWAADMNQRPSFLDILK 415
C D ++RPS L +L+
Sbjct: 243 TSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 30/283 (10%)
Query: 165 IGKGSFGEILKAY-WRGTPVAIKRILP--SLSDDRLVI-QDFRHEVNLLVKLRHPNIVQF 220
+G+G+FG++ A + +P K ++ +L D L +DF+ E LL L+H +IV+F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDI 264
G + PL+++ EY++ GDL+K+L+ KG L S ++ A I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLL--VKIGDFGMSRDVY---STDYYRVGGHT 185
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382
R+M PE +RK+ + DV+SF +IL+E+ G+ P E + + +G R
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVL 244
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
R + E+ ++ CW + QR + +I K L + + P
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 84/283 (29%), Positives = 141/283 (49%), Gaps = 36/283 (12%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKG+FG + + G VA+K++ S ++ ++DF E+ +L L+H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEILKSLQHDNIV 68
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
++ G R+ L L+ EYL G L YL K + L + +A I +GM YL ++
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+HRDL RN+L+ + + +K+GDFGL+K++ + + GE+ + Y APE
Sbjct: 129 --YVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 336 KHRKYDKKVDVFSFAMILYEML-----EGEPP------LANYEP-----YEAAKYVAEGH 379
K+ DV+SF ++LYE+ PP + N + Y + +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 380 R-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
R P G E+ + ++CW D +QRPSF ++ ++E I+
Sbjct: 244 RLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 75/258 (29%), Positives = 132/258 (51%), Gaps = 13/258 (5%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K ++ VA+K IL + ++D + + E N++ +L +P IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+G + E + ML+ E G L+K+L++ ++ ++ GM YL E +H
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL--EETNFVH 118
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDL RNVLLV + + K+ DFGLSK + ++ K G+ ++ APE + K+
Sbjct: 119 RDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKW-PVKWYAPECMNYYKF 175
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
K DV+SF ++++E G+ P + E + + G R + PE+ +L + C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECPQRCPPEMYDLMKLC 234
Query: 400 WAADMNQRPSFLDILKRL 417
W +++RP F + RL
Sbjct: 235 WTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 18/265 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI + +G G FGE+ Y+ T VA+K + P + +Q F E NL
Sbjct: 1 WEIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANL 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ L+H +V+ VT+ +P+ +ITEY+ G L +LK E G + ++F+ IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAY+ E IHRDL+ NVL+ S + K+ DFGL+++I+ ++ G
Sbjct: 115 GMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE---DNEYTAREGAKFP 167
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + K DV+SF ++LYE++ G+ P + + G+R R
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MPRM 226
Query: 386 KGFTPELRELTEKCWAADMNQRPSF 410
+ EL ++ + CW +RP+F
Sbjct: 227 ENCPDELYDIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 77/260 (29%), Positives = 130/260 (50%), Gaps = 31/260 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
DF +G GSFG ++ +G+ A+K LS ++V ++ +E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQS 57
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+RHP +V G+ + L L+ EY+ GG+L +L++ G A +A + + YL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ I++RDLKP N+LL S ++K+ DFG +K +K G T G+
Sbjct: 118 HS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVK-----------GRTYTLCGTP 162
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
Y+APE+ + Y K VD ++ +++YEML G PP + P + + + EG F
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF--PSF 220
Query: 388 FTPELRELTEKCWAADMNQR 407
F+P+ ++L D+ +R
Sbjct: 221 FSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 93/299 (31%), Positives = 151/299 (50%), Gaps = 39/299 (13%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE + L F +G G+FG++++A G VA+K + P+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78
Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 251
S +R + E+ ++ L H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 79 SSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
L+ ++F+ +A+GMA+L IHRDL RNVLL + +K+ DFGL++ I
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDI 191
Query: 310 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM--LEGEP-P--L 363
++ Y + G ++MAPE + Y + DV+S+ ++L+E+ L P P
Sbjct: 192 MNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248
Query: 364 ANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
+ + Y K + EG+R P E+ ++ + CW AD +RP+F I++ + K
Sbjct: 249 VDSKFY---KLIKEGYRMAQPEHAPA----EIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 91/272 (33%), Positives = 136/272 (50%), Gaps = 21/272 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P + ++ G+ + L +I EYL GG L E G L + +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
MAPEV K YD K D++S + E+ +GEPP + P + + + + P ++
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN-YS 226
Query: 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
L+E E C +N+ PSF K L K K
Sbjct: 227 KPLKEFVEAC----LNKEPSFRPTAKELLKHK 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+ G + KA R T VA+K++ + + Q R E+ L +HP +V+ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+L+ EY+ DL + L+ E+ L + ++ + +G+AY+H N I+HR
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHR 123
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+L+ S+ LK+ DFGL+ ++ + + + + + Y APE+ + RKY
Sbjct: 124 DLKPANLLI--SADGVLKIADFGLA---RLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
D VD+++ I E+L G P
Sbjct: 179 DPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 74/201 (36%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG + A G VAIK+I+ S L + +R E+ LL LRH NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 223 A-VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ + + +TE L G DLH+ L + L F I RG+ Y+H+ ++HR
Sbjct: 77 IFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHR 132
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N +L+N + D LK+ DFGL++ +Q+ MTG + Y APE+ +KY
Sbjct: 133 DLKPSN-ILINENCD-LKICDFGLAR---IQDPQ----MTGYVSTRYYRAPEIMLTWQKY 183
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
D +VD++S I EMLEG+P
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 87/265 (32%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WE+ L +G G FGE+ Y+ G T VAIK SL + + F E NL
Sbjct: 1 WEVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSMSPEAFLAEANL 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ +L+HP +V+ L AV ++P+ +ITEY+ G L +LK E L+ + ++ A IA
Sbjct: 55 MKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ ++ G
Sbjct: 114 GMAFI--ERKNYIHRDLRAANILV--SETLCCKIADFGLARLIE---DNEYTAREGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-MPRP 225
Query: 386 KGFTPELRELTEKCWAADMNQRPSF 410
EL EL CW +RP+F
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 84/267 (31%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
DF +GKGS+G + K R A+K + L S+S +D +E+ +L +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVN 57
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAV-NFALDIARGMA 269
HPNI+ + A + L ++ EY GDL K + K+K L P + + + RG+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
LH I+HRDLK N+LLV + D +K+GD G+SK++K K +T G+
Sbjct: 118 ALHE--QKILHRDLKSANILLVAN--DLVKIGDLGISKVLK--------KNMAKTQIGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
YMAPEV+K R Y K D++S +LYEM PP + V G P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI- 224
Query: 388 FTPELRELTEKCWAADMNQRPSFLDIL 414
++ +L+ RP+ IL
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 86/265 (32%), Positives = 131/265 (49%), Gaps = 19/265 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ W G T VA+K + P + + F E +
Sbjct: 1 WEIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRH +VQ L AV +P+ ++TEY+ G L +LK E AL V+ A +A
Sbjct: 55 MKKLRHDKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAY+ E IHRDL+ N+L+ + K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIE---DNEYTARQGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MPCP 225
Query: 386 KGFTPELRELTEKCWAADMNQRPSF 410
+ L EL +CW D +RP+F
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKG F + KA G VA+K++ D QD E++LL +L HPN++++L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYLHNEPNVI 278
+ E L ++ E GDL K+ K++ L P + + + + + ++H++ I
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--I 127
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+KP NV + + +K+GD GL + + + + G+ YM+PE
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPERIHEN 181
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKYVAEGHRPFFRAKGFTPELRELT 396
Y+ K D++S +LYEM + P + Y K + + P A ++ ELR+L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 397 EKCWAADMNQRP 408
+C D +RP
Sbjct: 242 SRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 86/279 (30%), Positives = 137/279 (49%), Gaps = 17/279 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P + ++ G+ + L +I EYL GG L+ G +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
MAPEV + YD K D++S + E+ +GEPP ++ P + + + P + F+
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE-FS 226
Query: 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 428
+E + C D + RP+ ++LK +K T +
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSY 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ + A VAIKRI L + + + R EV + + HPN+V++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ L L+ YL GG L K +G L + ++ +G+ YLH+ N I
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI 124
Query: 280 HRDLKPRNVLLVNSSADH--LKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRYMAPEVF 335
HRD+K N+LL + +K+ DFG+S + + V K G+ +MAPEV
Sbjct: 125 HRDIKAGNILL----GEDGSVKIADFGVSASLADGGDRTRKVRKTF--VGTPCWMAPEVM 178
Query: 336 K-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF----RAKGFTP 390
+ YD K D++SF + E+ G P + Y P + + P K ++
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238
Query: 391 ELRELTEKCWAADMNQRPSFLDILK 415
R++ C D ++RP+ ++LK
Sbjct: 239 SFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VAIK+I + + R E+ LL +L HPNI++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ E++ DL+K +K++ L S ++ + +G+A+ H+ + I+HR
Sbjct: 66 VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGILHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+L+ ++ LK+ DFGL++ T + Y APE+ + Y
Sbjct: 123 DLKPENLLI--NTEGVLKLADFGLARSFGSPVRP----YTHYVVTRWYRAPELLLGDKGY 176
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
VD++S I E+L P
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 93/316 (29%), Positives = 150/316 (47%), Gaps = 38/316 (12%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE+ + L +G+G FG+++ A G VA+K + +D
Sbjct: 1 LPADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
L D E+ ++ + +H NI+ LGA T+ PL ++ EY G+L +YL+ +
Sbjct: 59 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
L+ V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV-- 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ V N K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 MKIADFGLAR--DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 358 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
G P E K + EGHR + T EL + +CW A +QRP+F +++
Sbjct: 231 TLGGSPYPGIPVEELFKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
Query: 417 LEKIKETLPTDHHWNI 432
L+++ TD + ++
Sbjct: 290 LDRVLTVTSTDEYLDL 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-31
Identities = 89/266 (33%), Positives = 132/266 (49%), Gaps = 17/266 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P I ++ G+ + L +I EYL GG LK G L + +I +G+ Y
Sbjct: 58 QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSERK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
MAPEV K YD K D++S + E+ +GEPP ++ P + + P +
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
P +E E C D RP+ ++LK
Sbjct: 228 P-FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 97/307 (31%), Positives = 148/307 (48%), Gaps = 44/307 (14%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE L +G+G FG++++A G VA+K + + +D
Sbjct: 1 LPLDPKWEFPRDRLVLGKP--LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 195 DRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
L D E+ L+ + +H NI+ LG T+ PL +I EY G+L ++L+ +
Sbjct: 59 KDLA--DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL E IHRDL RNVL+ + +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLV--TEDNV 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ + + D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 173 MKIADFGLARGV---HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
Query: 357 --LEGEP-PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413
L G P P E E K + EGHR + T EL L +CW A QRP+F +
Sbjct: 230 FTLGGSPYPGIPVE--ELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
Query: 414 LKRLEKI 420
++ L+K+
Sbjct: 287 VEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 22/263 (8%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FGE+ Y G +A+K++ P + + E+ LL LRH IVQ
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 220 FLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ G + E K L + EY+ GG + LK GAL+ + + I +G++YLH+ N+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--NM 126
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 332
I+HRD+K N+L SA ++K+GDFG SK I+ + M+G TG+ +M+P
Sbjct: 127 IVHRDIKGANIL--RDSAGNVKLGDFGASKRIQT-----IC-MSGTGIKSVTGTPYWMSP 178
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392
EV Y +K DV+S A + EML +PP A YE A +A G +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238
Query: 393 RELTEKCWAADMNQRPSFLDILK 415
R+ ++ + + +RP+ +L+
Sbjct: 239 RDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 32/283 (11%)
Query: 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVK 211
F+ ++GKG FG + +A + VA+K + + S D I++F E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKE 57
Query: 212 LRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYL------KEKGALSPSTAVN 259
HPN+++ +G + M+I +++ GDLH +L +E L T V
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
F +DIA GM YL ++ IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 118 FMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMT--VCVADFGLSKKIY---SGDYYR 170
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAE 377
+ +++A E Y DV++F + ++E M G+ P A E E Y+ +
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
Query: 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
G+R + ++ EL +CW+ + RPSF + +LE I
Sbjct: 231 GNR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH-----EVNLLV 210
DF IIG+GSF ++ A + AIK + D R +I++ + E +L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLT 56
Query: 211 KL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+L HP I++ + + L + EY G+L +Y+++ G+L +A +I +
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK------------VQNSHDV 317
YLH+ IIHRDLKP N+LL H+K+ DFG +K++ +
Sbjct: 117 YLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 318 YKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
K S+ Y++PE+ + K D+++ I+Y+ML G+PP Y +
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 410
+ + F F P+ ++L EK D R
Sbjct: 233 KILKLEYSF--PPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 80/269 (29%), Positives = 133/269 (49%), Gaps = 36/269 (13%)
Query: 164 IIGKGSFGE-ILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++GKG+FGE L Y R + V K + L LS+ +D +E+ +L L+HPNI+
Sbjct: 7 VLGKGAFGEATL--YRRTEDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNII 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPN 276
+ + L++ EY GG L+ K +++KG L V + L I ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEV 334
I+HRD+K N+ L + A +K+GDFG+SK++ + S ET G+ YM+PE+
Sbjct: 122 -ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSM------AETVVGTPYYMSPEL 172
Query: 335 FKHRKYDKKVDVFSFAMILYEML------EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388
+ KY+ K D+++ +LYE+L + PL K V + P +
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQGNYTPV--VSVY 225
Query: 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417
+ EL L D +RP+ ++L +
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 25/257 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
D +G G+FG + R A+K + +P + + Q +E +L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P I++ +++ L ++ EY+ GG+L YL+ G S ST + +A +I + YLH++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 330
I++RDLKP N+LL H+K+ DFG +K K+ T G+ Y+
Sbjct: 121 E--IVYRDLKPENILL--DKEGHIKLTDFGFAK-----------KLRDRTWTLCGTPEYL 165
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
APEV + + ++K VD ++ +++YEML G PP + P+ + + G F R
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDL 223
Query: 391 ELRELTEKCWAADMNQR 407
++L +K D +R
Sbjct: 224 YAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRL------VIQDFRHEVNLLVKLRH 214
+IGKG++G + A G +A+K++ LP+ R +++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIVQ+LG T + L + EY+ GG + L+ G F + G+AYLH++
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 275 PNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I+HRDLK N+L+ AD + K+ DFG+SK K + +D + GS +MAPE
Sbjct: 128 G--ILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 334 VF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFR---AKG 387
V + Y KVD++S ++ EM G P ++ E A K + P +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
+P + C+ + + RP+ ++L+
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 16/263 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF IGKGSFG + K + A+K+I S +R ++ E +L KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSS 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAV-NFALDIARGMAYLHN 273
I+++ + ++ L ++ EY GDLHK LK ++G P V F + I G+A+LH+
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I+HRD+K N+ L + D++K+GD G++KL+ + T G+ Y++PE
Sbjct: 120 --KKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT---NFANT-IVGTPYYLSPE 171
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392
+ + + Y++K DV++ ++LYE G+ P AN + K + P ++ ++ +L
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--SQMYSQQL 229
Query: 393 RELTEKCWAADMNQRPSFLDILK 415
+L ++C D QRP +L+
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 20/254 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G++G++ KA G VAIK I DD +IQ E+++L + RHPNIV + G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67
Query: 223 AVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ R L ++ EY GG L Y +G LS + +G+AYLH IHR
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--TGKIHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF---KHR 338
D+K N+LL + +K+ DFG+S + + + K G+ +MAPEV +
Sbjct: 126 DIKGANILL--TEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFFRAKG-FTPELREL 395
YD K D+++ + E+ E +PP+ + P A +++ + P + K ++P +
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 396 TEKCWAADMNQRPS 409
+KC D +RP+
Sbjct: 240 IKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 81/267 (30%), Positives = 138/267 (51%), Gaps = 19/267 (7%)
Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IGKG FG + + A+K L ++D V Q F E ++ HPN++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
LG +E PL+++ Y++ GDL ++ E + + F L +A+GM YL ++
Sbjct: 60 SLLGICLPSEGSPLVVLP-YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
V HRDL RN +L S +KV DFGL++ I + + V+ TG ++MA E
Sbjct: 119 FV--HRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 336 KHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE-LR 393
+ +K+ K DV+SF ++L+E++ G PP + + ++ Y+ +G R + P+ L
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--LLQPEYCPDPLY 232
Query: 394 ELTEKCWAADMNQRPSFLDILKRLEKI 420
E+ CW RP+F +++ R+E+I
Sbjct: 233 EVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 95/305 (31%), Positives = 146/305 (47%), Gaps = 40/305 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE+ L +G+G FG+++ A G T VA+K + ++
Sbjct: 7 LPEDPRWEVPRDRLVLGKP--LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE 64
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-- 251
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 65 KDL--SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 252 --------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV-- 178
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ I + D YK T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 179 MKIADFGLARDI---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
Query: 357 LE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
G P E K + EGHR + T EL + CW A +QRP+F +++
Sbjct: 236 FTLGGSPYPGVPVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 416 RLEKI 420
L++I
Sbjct: 295 DLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-29
Identities = 90/305 (29%), Positives = 144/305 (47%), Gaps = 40/305 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 4 LPEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 62 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 254 ----------PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
P + F +ARGM YL ++ IHRDL RNVL+ ++
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNV-- 175
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ + N+ D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 176 MKIADFGLARDV---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 357 LE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
G P E K + EGHR + T EL + CW A + RP+F +++
Sbjct: 233 FTLGGSPYPGIPVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 416 RLEKI 420
L++I
Sbjct: 292 DLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 11/226 (4%)
Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKL 212
+++ ++G+G+FG + Y G +A K++ P + + E+ LL L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 213 RHPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H IVQ+ G + +R K L + EY+ GG + LK GAL+ S + I GM+Y
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ N+I+HRD+K N+L SA ++K+GDFG SK ++ + TG+ +M
Sbjct: 122 LHS--NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGT-GIRSVTGTPYWM 176
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
+PEV Y +K DV+S + EML +PP A YE A +A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 36/283 (12%)
Query: 165 IGKGSFGE-ILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG+ L Y G VA+K + ++ E+N+L L H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
++ G +E+ K L LI EY+ G L YL K L+ + + FA I GMAYLH++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GETGSYRYMAPEV 334
IHRDL RNVLL N +K+GDFGL+K V H+ Y++ G++ + Y A E
Sbjct: 128 -YIHRDLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 335 FKHRKYDKKVDVFSFAMILYEML-----EGEPPLANYEPYEAAK----------YVAEGH 379
K K+ DV+SF + LYE+L + PP E + + G
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
R K E+ L + CW + RP+F ++ L+++
Sbjct: 242 R-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 90/275 (32%), Positives = 138/275 (50%), Gaps = 23/275 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G+G FGE+ W GT VAIK + P ++ + F E +
Sbjct: 1 WEIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
+ KLRH +V V+E +P+ ++TE++ G L +LKE L V+ A IA
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAY+ E IHRDL+ N+L+ D+L K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIE---DNEYTARQGAK 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFF 383
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-MP 223
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
+G L EL + CW D ++RP+F I LE
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 17/260 (6%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K ++ VAIK +L + +++ V + E ++ +L +P IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKN-ENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+G V E + LML+ E GG L+K+L +K ++ S V ++ GM YL E +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGKNFV 117
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFKHR 338
HRDL RNVLLVN + K+ DFGLSK + +S+ YK + ++ APE R
Sbjct: 118 HRDLAARNVLLVNQH--YAKISDFGLSKALGADDSY--YKARSAGKWPLKWYAPECINFR 173
Query: 339 KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397
K+ + DV+S+ + ++E G+ P + E ++ +G R A+ PE+ L +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE-CPPEMYALMK 232
Query: 398 KCWAADMNQRPSFLDILKRL 417
CW RP+F + +R+
Sbjct: 233 DCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 33/283 (11%)
Query: 165 IGKGSFGEILKAY-WRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ A + P VA+K + + + R +DF E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------------LSPSTAVNFALDI 264
V+F G E PL+++ EY++ GDL+K+L+ G L+ S ++ A I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 130 AAGMVYLASQH--FVHRDLATRNCLVGENLL--VKIGDFGMSRDVY---STDYYRVGGHT 182
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382
R+M PE +RK+ + DV+S ++L+E+ G+ P E + + +G R
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-RVL 241
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
R + E+ +L CW + + R + +I L+ + + P
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 76/253 (30%), Positives = 121/253 (47%), Gaps = 19/253 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+ G + K R T +A+K I ++ + Q R E+++L K P IV F G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILR-ELDILHKCNSPYIVGFYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A + + EY+ GG L K LKE +G + A+ + +G+ YLH + IIHR
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+L+ +S +K+ DFG+S ++ NS G+ YMAPE + Y
Sbjct: 126 DVKPSNILV--NSRGQIKLCDFGVSG--QLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYE-----PYEAAKYVAEGHRPFFRAKGFTPELRELT 396
K D++S + L E+ G P +E +Y+ P + F+P+ ++
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 397 EKCWAADMNQRPS 409
C D +RPS
Sbjct: 238 NLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 85/282 (30%), Positives = 140/282 (49%), Gaps = 32/282 (11%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP+ F +IG+G++G++ KA + G VAIK I+ + D+ ++ + E N+L
Sbjct: 3 DPTG-IFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDE---EEEIKEEYNILR 57
Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
K HPNI F GA ++ P L L+ E GG DL K L++KG + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 261 AL-DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
L + RG+AYLH N +IHRD+K +N+LL ++ +K+ DFG+S Q + +
Sbjct: 118 ILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNA--EVKLVDFGVSA----QLDSTLGR 169
Query: 320 MTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
G+ +MAPEV YD + DV+S + E+ +G+PPL + P A
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 375 VAEGHRP-FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ P + ++ + + +C + QRP ++L+
Sbjct: 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 82/261 (31%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKGSFG + K + + + +P L+ + V + E LL KL HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65
Query: 219 QFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+F + ER +ITEY G DL + LS + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRDLK +N+ L N + LK+GDFG+S+L+ S D+ T TG+ YM+PE
Sbjct: 126 R--ILHRDLKAKNIFLKN---NLLKIGDFGVSRLL--MGSCDL--ATTFTGTPYYMSPEA 176
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
KH+ YD K D++S ILYEM + EG P + ++ +L
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETYSRQLNS 235
Query: 395 LTEKCWAADMNQRPSFLDILK 415
+ + D + RPS +IL+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 73/212 (34%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG G++G + A G VAIK+I D + R E+ LL LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 222 GAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NE 274
+ P + ++TE + DLHK +K L+ F I RG+ YLH N
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN- 123
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAP 332
+IHRDLKP N +LVNS+ D LK+ DFGL++ + + +T T YR AP
Sbjct: 124 ---VIHRDLKPSN-ILVNSNCD-LKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR--AP 175
Query: 333 EV---FKHRKYDKKVDVFSFAMILYEMLEGEP 361
E+ Y K +D++S I E+L +P
Sbjct: 176 ELLLSSSR--YTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-29
Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 54/287 (18%)
Query: 165 IGKGSFGEI-------LKAY-------WRGTP--VAIKRILPSLSDDRLVIQDFRHEVNL 208
+G+G FGE+ L + + G P VA+K + ++ + DF E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKI 70
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN--------- 259
+ +L++PNI++ LG PL +ITEY+ GDL+++L ++ S T N
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 260 ---FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
A+ IA GM YL + +HRDL RN L+ N +K+ DFG+S+ + S D
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT--IKIADFGMSRNLY---SGD 183
Query: 317 VYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAK 373
Y++ G R+MA E K+ DV++F + L+EM L +PY + +
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDE 239
Query: 374 YVAEGHRPFFRAKGF------TP----ELRELTEKCWAADMNQRPSF 410
V E FFR +G TP + +L +CW+ D+ RP+F
Sbjct: 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 79/265 (29%), Positives = 136/265 (51%), Gaps = 19/265 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ + Y + T VA+K + P + ++ F E N+
Sbjct: 1 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
+ L+H +V+ L AV ++P+ +ITE++ G L +LK ++G+ P ++F+ IA
Sbjct: 55 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I+ ++ G
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE---DNEYTAREGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPRP 225
Query: 386 KGFTPELRELTEKCWAADMNQRPSF 410
+ EL + +CW +RP+F
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 86/268 (32%), Positives = 132/268 (49%), Gaps = 25/268 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G+G FGE+ W GT VAIK + P + + F E +
Sbjct: 1 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQV 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
+ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L V+ A IA
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAY+ E +HRDL+ N+L+ ++L KV DFGL++LI+ ++ G
Sbjct: 114 GMAYV--ERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE---DNEYTARQGAK 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHRPFF 383
++ APE + ++ K DV+SF ++L E+ +G P E V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--M 222
Query: 384 RAKGFTPE-LRELTEKCWAADMNQRPSF 410
PE L +L +CW + +RP+F
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-29
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 27/274 (9%)
Query: 156 ELDFSSS---AIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLV 210
E ++ + ++GKG++G + A T V AIK I D R V Q E+ L
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYV-QPLHEEIALHS 60
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSP--STAVNFALDIARG 267
L+H NIVQ+LG+ +E + E + GG L L+ K G L T + + I G
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGETGS 326
+ YLH+ N I+HRD+K NV LVN+ + +K+ DFG SK L + + + TG+
Sbjct: 121 LKYLHD--NQIVHRDIKGDNV-LVNTYSGVVKISDFGTSKRLAGINPCTETF-----TGT 172
Query: 327 YRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY---VAEGHRP 381
+YMAPEV R Y D++S + EM G+PP +AA + + + H
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ + E + +C+ D ++R S D+L+
Sbjct: 233 I--PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 164 IIGKGSFGEILKAYWR---GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
I+G+G FG +++ G+ VA+K + + I++F E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVM 64
Query: 219 QFLGAVTERKPL------MLITEYLRGGDLHKYL-KEKGALSP-----STAVNFALDIAR 266
+ +G E L M+I +++ GDLH +L + P T + F +DIA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV--GDFGLSKLIKVQNSHDVYKMTGET 324
GM YL N IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 125 GMEYLSNRN--FIHRDLAARNCML----REDMTVCVADFGLSKKIY---SGDYYRQGRIA 175
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPF 382
+++A E R Y K DV++F + ++E+ G+ P E +E Y+ G+R
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-L 234
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ + EL +L CW AD RP+F + + LE I
Sbjct: 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 31/276 (11%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNIVQF 220
+G+ +FG+I K Y G A + +L D Q +F+ E +L+ +L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-----------------KEKGALSPSTAVNFALD 263
LG VT+ +P+ ++ EYL GDLH++L K +L ++ A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
IA GM YL + + +H+DL RN+L+ H+K+ D GLS+ I S D Y++ +
Sbjct: 133 IAAGMEYLSS--HFFVHKDLAARNILI--GEQLHVKISDLGLSREIY---SADYYRVQPK 185
Query: 324 T-GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381
+ R+M PE + K+ D++SF ++L+E+ G P + E + V + +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-RQL 244
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
++ P + L +CW ++RP F DI RL
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + S R I R E ++L P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
IV+ + + + L L+ EY+ GGDL L K TA + ++ + +H
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--------KVQNSHDVYKMTGET--- 324
IHRD+KP N+L+ + H+K+ DFGL K + + +SH++
Sbjct: 122 --FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 325 --------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365
G+ Y+APEV + Y + D +S +ILYEML G PP +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 34/275 (12%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR----HEV 206
DP + IG+GS G + A + G VA+K++ L Q R +EV
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-------DLRKQQRRELLFNEV 67
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-----HKYLKEKGALSPSTAVNFA 261
++ +HPNIV+ + L ++ E+L GG L H + E+ + AV A
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKA 127
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
L ++LH + +IHRD+K ++LL +S +K+ DFG Q S +V +
Sbjct: 128 L------SFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCA----QVSKEVPRRK 173
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+ +MAPEV Y +VD++S +++ EM++GEPP N P +A K + + P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 382 FFR-AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ +P LR ++ D QR + ++L
Sbjct: 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 93/292 (31%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
D +IG+G+FG++LKA + AIKR+ S D +DF E+ +L KL
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 256
HPNI+ LGA R L L EY G+L +L++ LS
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
++FA D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR------GQE 175
Query: 317 VY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374
VY K T R+MA E + Y DV+S+ ++L+E++ G P E +
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
+ +G+R + E+ +L +CW +RPSF IL L ++ E T
Sbjct: 236 LPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVN 207
WEI EL G G+FG++ KA + T + A K I ++ ++DF E++
Sbjct: 7 WEI-IGEL--------GDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEID 54
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIA 265
+L + +HPNIV A L ++ E+ GG L + E+G P +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML 113
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGET 324
+ +LH+ + +IHRDLK N+LL + +K+ DFG+S K D +
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQKRDTF-----I 164
Query: 325 GSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
G+ +MAPEV FK YD K D++S + L E+ + EPP P + +
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 380 RP-FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P + ++ + + C D + RP+ ++LK
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 74/215 (34%), Positives = 116/215 (53%), Gaps = 25/215 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D ++IQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VIIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL ++++ G AV +A +IA G+
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
+LH++ II+RDLK NV+L + H+K+ DFG+ K + T T G+
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCK------ENIFGGKTTRTFCGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y+APE+ ++ Y K VD ++F ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 94/290 (32%), Positives = 139/290 (47%), Gaps = 40/290 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVK 211
D +IG+G+FG++++A + AIK + S +D R DF E+ +L K
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR----DFAGELEVLCK 58
Query: 212 L-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-------------KEKGALSPSTA 257
L HPNI+ LGA R L + EY G+L +L KE G S T+
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 258 ---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ FA D+A GM YL + IHRDL RNVL+ + A K+ DFGLS+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS--KIADFGLSR------G 168
Query: 315 HDVY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372
+VY K T R+MA E + Y K DV+SF ++L+E++ G P E
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
Query: 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ + +G+R + + E+ EL +CW +RP F I +L ++ E
Sbjct: 229 EKLPQGYR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 73/259 (28%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQF 220
IG+GSFG+I A + + ++ + ++ +++ + EV LL K++HPNIV F
Sbjct: 7 KIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGAL-SPSTAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ EY GGDL K + +++G L S +++ + I+ G+ ++H+ I
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--I 122
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + + K+GDFG+++ + +S ++ G+ Y++PE+ ++R
Sbjct: 123 LHRDIKSQNIFL-SKNGMVAKLGDFGIARQL--NDSMELAYTC--VGTPYYLSPEICQNR 177
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFTPELRELTE 397
Y+ K D++S +LYE+ + P ++ + +G+ P + F+ +LR L
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI--SPNFSRDLRSLIS 235
Query: 398 KCWAADMNQRPSFLDILKR 416
+ + RPS ILKR
Sbjct: 236 QLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 25/216 (11%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---H---EVNLLVKLRHPN 216
+G G FG E++K + A+K + + I + H E +L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV+ ++K + ++ EY GG+L L+++G TA + + YLHN
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN--R 112
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
II+RDLKP N+LL S ++K+ DFG +K K+++ + G Y+APE+
Sbjct: 113 GIIYRDLKPENLLL--DSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPE---YVAPEIIL 165
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYE 370
++ YD VD +S ++LYE+L G PP +P E
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 74/259 (28%), Positives = 137/259 (52%), Gaps = 22/259 (8%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS---LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++G+G+FG + + V IK+I P D+RL Q+ E +L L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQN---ECQVLKLLSHPNII 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPN 276
++ E K LM++ EY GG L +Y++++ L T ++F + I + ++H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-- 120
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
+I+HRDLK +N+LL + +K+GDFG+SK++ ++ K G+ Y++PE+ +
Sbjct: 121 LILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKS-----KAYTVVGTPCYISPELCE 174
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ Y++K D+++ +LYE+ + A P K ++ P + ++P+LR+L
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI--SDRYSPDLRQL 232
Query: 396 TEKCWAADMNQRPSFLDIL 414
D ++RP I+
Sbjct: 233 ILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 87/269 (32%), Positives = 131/269 (48%), Gaps = 47/269 (17%)
Query: 179 RGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
+G P VA+K + P + + DF EV +L +L+ PNI++ LG + PL +ITEY
Sbjct: 43 KGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100
Query: 237 LRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNV 277
+ GDL+++L A+S S+ ++ AL IA GM YL +
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFK 336
+HRDL RN L+ +K+ DFG+S+ + + D Y++ G R+MA E
Sbjct: 159 FVHRDLATRNCLV--GENLTIKIADFGMSRNLY---AGDYYRIQGRAVLPIRWMAWECIL 213
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAKYVAEGHRPFFRAKG-----FT 389
K+ DV++F + L+E+L L +PY + V E FFR +G F
Sbjct: 214 MGKFTTASDVWAFGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFR 269
Query: 390 PE-----LRELTEKCWAADMNQRPSFLDI 413
P L EL +CW+ D +RPSF DI
Sbjct: 270 PPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG++ + G VA+K + P + I D + E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 69
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
++ G TE + LI E+L G L +YL + K ++ + +A+ I +GM YL +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
V HRDL RNVL+ + +K+GDFGL+K I+ + K ++ + Y APE
Sbjct: 130 YV--HRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 336 KHRKYDKKVDVFSFAMILYEML----EGEPPLANY----EPYEAAKYVA-------EGHR 380
K+ DV+SF + LYE+L P+ + P V EG R
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
R E+ +L KCW ++R +F ++++ E I
Sbjct: 245 -LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 26/266 (9%)
Query: 165 IGKGSFGEILKAYWRGTP---VAIKRIL---PSLSDDRL----VIQDFRHEVNLLVK-LR 213
+G G+FG + K + +A+K I P+ D+ I D EV ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRG---GDLHKYLKEKGALSPSTAV-NFALDIARGMA 269
HPNIV++ E L ++ + + G G+ LKEK + N + + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YLH E I+HRDL P N++L D + + DFGL+K K S K+T G+ Y
Sbjct: 128 YLHKEKR-IVHRDLTPNNIML--GEDDKVTITDFGLAKQ-KQPES----KLTSVVGTILY 179
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
PE+ K+ Y +K DV++F ILY+M +PP + A + E ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
++ ++ C D RP DI++
Sbjct: 240 EDVTDVITSCLTPDAEARP---DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RH 214
++GKGSFG++L A +GT A+K L D +++QD E + K +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK----VLKKD-VILQDDDVECTMTEKRVLALAGKH 55
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P + Q + L + EY+ GGDL +++ G A +A +I G+ +LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
II+RDLK NVLL S H+K+ DFG+ K + + G+ Y+APE+
Sbjct: 116 G--IIYRDLKLDNVLL--DSEGHIKIADFGMCK----EGILGGVTTSTFCGTPDYIAPEI 167
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
++ Y VD ++ ++LYEML G+ P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++GKGSFG+++ A +GT AIK + L DD + V L + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
++ L + EYL GGDL +++ G + A +A +I G+ +LH I
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK--KGI 117
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAP 332
I+RDLK NVLL H+K+ DFG+ K M GE G+ Y+AP
Sbjct: 118 IYRDLKLDNVLL--DKDGHIKIADFGMCKE----------NMNGEGKASTFCGTPDYIAP 165
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
E+ K +KY++ VD +SF ++LYEML G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 17/255 (6%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAIK++ L L+I +E+ ++ + +HPNIV +L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII----NEILVMRENKHPNIVNYL 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 139
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPELRELTEKCW 400
KVD++S ++ EM+EGEPP N P A +A P + + R+ +C
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 401 AADMNQRPSFLDILK 415
D+ +R S ++L+
Sbjct: 254 EMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
DP + ++ IG+G+ G + A G VAIK+I L L+I +E+ ++
Sbjct: 16 DPKK-KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII----NEILVM 70
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+L++PNIV FL + L ++ EYL GG L + E + + + + +
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALE 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH N +IHRD+K NVLL + +K+ DFG I + S K + G+ +
Sbjct: 130 FLH--ANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYW 181
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGF 388
MAPEV + Y KVD++S ++ EM+EGEPP N P A +A P + +
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+P R+ +C D+ +R S ++L+
Sbjct: 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-27
Identities = 76/273 (27%), Positives = 133/273 (48%), Gaps = 24/273 (8%)
Query: 164 IIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV---KLRH 214
++G G FG + K W PVAIK I DR Q F+ + ++ L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDH 68
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN 273
IV+ LG + L L+T+ G L ++++ + +L P +N+ + IA+GM YL
Sbjct: 69 AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL-- 125
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
E + ++HR+L RN+LL S +++ DFG++ L+ + Y + ++MA E
Sbjct: 126 EEHRMVHRNLAARNILL--KSDSIVQIADFGVADLLYPDDKKYFY--SEHKTPIKWMALE 181
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392
+Y + DV+S+ + ++EM+ G P A P+E + +G R + + T ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LAQPQICTIDV 240
Query: 393 RELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
+ KCW D N RP+F ++ ++ P
Sbjct: 241 YMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSD-DRLVIQDFRHEVNLLVKL-RHPNI 217
+G G+FG + A + G VAIK++ S + L EV L KL HPNI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKLNEHPNI 60
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEP 275
V+ E L + EY+ G +L++ +K + S S + I +G+A++H
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPEV 334
+ HRDLKP N+L+ S + +K+ DFGL++ I+ + + Y T R Y APE+
Sbjct: 118 HGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTDYVST------RWYRAPEI 169
Query: 335 F-KHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y VD+++ I+ E+ P
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 76/216 (35%), Positives = 116/216 (53%), Gaps = 25/216 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL ++++ G AV +A +I+ G+
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
+LH II+RDLK NV+L S H+K+ DFG+ K H V +T T G+
Sbjct: 116 FLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCK------EHMVDGVTTRTFCGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
Y+APE+ ++ Y K VD +++ ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
A IG+G++G++ KA + T VA+K+I + I R E+ LL KLRHPNIV+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNV 277
VT + + ++ EY+ DL L + S + + G+ YLH+ N
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--NG 120
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV- 334
I+HRD+K N+L+ N LK+ DFGL++ +NS D T T YR PE+
Sbjct: 121 ILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSAD---YTNRVITLWYR--PPELL 173
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+Y +VD++S IL E+ G+P
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 21/230 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL +++ G AV +A +IA G+
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH++ II+RDLK NV+L S H+K+ DFG+ K +N D G+ Y
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
+APE+ ++ Y K VD ++F ++LYEML G+ P + E + + E +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 33/290 (11%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
WE+ ++ S +G+GSFG + + +G T VAIK + + S + +F
Sbjct: 1 WEVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EF 56
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSPS 255
+E +++ + ++V+ LG V++ +P ++I E + GDL YL+ +P
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 256 T---AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
+ + A +IA GMAYL+ N +HRDL RN ++ +K+GDFG+++ I
Sbjct: 117 SLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIY-- 170
Query: 313 NSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE 370
D Y+ G+ R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 171 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 371 AAKYVAEGHRPFFRAKGFTPE-LRELTEKCWAADMNQRPSFLDILKRLEK 419
++V EG P+ L EL CW + RPSFL+I+ +++
Sbjct: 230 VLRFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 18/273 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E +F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ +P++ + LG + + LIT+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
YL E ++HRDL RNVL+ H+K+ DFGL+KL+ Y G +
Sbjct: 123 NYL--EERRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGADEKE--YHAEGGKVPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+MA E HR Y + DV+S+ + ++E++ G P E + + +G R +
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPI 235
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
T ++ + KCW D + RP F +++ K+
Sbjct: 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 86/276 (31%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG-----DLHKYLKEKGALSPSTAVNFA---L 262
+LRHPN +++ G L+ EY G ++HK P V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK--------KPLQEVEIAAICH 122
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+G+AYLH+ IHRD+K N+LL + +K+ DFG + L+ NS
Sbjct: 123 GALQGLAYLHSHER--IHRDIKAGNILL--TEPGTVKLADFGSASLVSPANSF------- 171
Query: 323 ETGSYRYMAPEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
G+ +MAPEV +YD KVDV+S + E+ E +PPL N A ++A+
Sbjct: 172 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 230
Query: 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P + ++ R + C RPS ++LK
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 20/261 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G F E+ +A G PVA+K++ D D E++LL +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
N++++ + E L ++ E GDL K+ K++ L P V + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 329
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL--ANYEPYEAAKYVAEGHRPFFRAKG 387
M+PE Y+ K D++S +LYEM + P Y K + + P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 388 FTPELRELTEKCWAADMNQRP 408
++ ELR+L C D +RP
Sbjct: 233 YSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 11/219 (5%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FG + Y G +A+K++ P + + E+ LL L H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 220 FLGAV--TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ G + + L + E++ GG + LK GAL+ + + I G++YLH+ N+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS--NM 126
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
I+HRD+K N+L S ++K+GDFG SK ++ M TG+ +M+PEV
Sbjct: 127 IVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGT-GMKSVTGTPYWMSPEVISG 183
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
Y +K D++S + EML +PP A +E A +A
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---H 214
A IG+G++G + KA R G VA+K++ LS++ + + R E+ LL +L H
Sbjct: 4 LAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEH 60
Query: 215 PNIVQFL----GAVTERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
PNIV+ L G T+R+ L L+ E++ DL YL + K L P T + + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ +LH+ + I+HRDLKP+N+L+ +S +K+ DFGL+++ + +T +
Sbjct: 120 VDFLHS--HRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFE-----MALTSVVVTL 170
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
Y APEV Y VD++S I E+ P
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 76/219 (34%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKR----ILPSLSDDRLVIQDFRHEVNLLVK 211
DF +G+G +G++ A + T VA+KR +L L++ R V+ E ++L
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT----ERDILTT 57
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ +V+ L A + + L L EY+ GGD L G LS A + ++ + L
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H IHRDLKP N L+ ++ H+K+ DFGLSK I V ++ V GS YMA
Sbjct: 118 HELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGI-VTYANSV------VGSPDYMA 166
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
PEV + + YD VD +S +LYE L G PP + P E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 77/273 (28%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E + ++G G+FG + K W PVAIK IL + + ++ F E ++
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ HP++V+ LG V + L+T+ + G L Y+ E K + +N+ + IA+GM
Sbjct: 64 ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + Y G +
Sbjct: 123 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+MA E +RK+ + DV+S+ + ++E++ G P E + +G R +
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LPQPPI 235
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
T ++ + KCW D + RP F ++ ++
Sbjct: 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 43/277 (15%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
+ S ++ +G+FG I V +K + S+ ++ + E LL L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGL 65
Query: 213 RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLK-----EKG---ALSPSTAVNFALD 263
H NI+ L E +P ++ Y+ G+L +L+ E ALS V+ A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT-- 321
IA GM+YLH +IH+D+ RN ++ +K+ D LS+ D++ M
Sbjct: 126 IACGMSYLHKRG--VIHKDIAARNCVIDEEL--QVKITDNALSR--------DLFPMDYH 173
Query: 322 ----GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376
E ++MA E +++Y DV+SF ++L+E++ G+ P +P+E A Y+
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
Query: 377 EGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSF 410
+G+R P EL + CWA D +RPSF
Sbjct: 234 DGYRLAQPI----NCPDELFAVMACCWALDPEERPSF 266
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 15/258 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKGS+GE+ R G IK++ + R + E LL +L+HPNIV +
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYR 65
Query: 222 GAVT-ERKPLMLITEYLRGGDLHKYLKE-KGALSP-STAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ + GGDL+ LKE KG L P + V + + IA + YLH + I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--I 123
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRDLK +NV L ++ +KVGD G++++++ Q + G+ YM+PE+F ++
Sbjct: 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCD----MASTLIGTPYYMSPELFSNK 177
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
Y+ K DV++ +YEM + + + EG P K ++PEL EL
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-PKDYSPELGELIAT 236
Query: 399 CWAADMNQRPSFLDILKR 416
+ +RPS IL++
Sbjct: 237 MLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 74/241 (30%), Positives = 118/241 (48%), Gaps = 35/241 (14%)
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-----------KEK 249
DF E+ ++ +L+ PNI++ L PL +ITEY+ GDL+++L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+S ST + A IA GM YL + +HRDL RN L+ + +K+ DFG+S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYT--IKIADFGMSRNL 180
Query: 310 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
S D Y++ G R+M+ E K+ DV++F + L+E+L L +P
Sbjct: 181 Y---SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP 233
Query: 369 YE--AAKYVAEGHRPFFRAKG---FTPE-------LRELTEKCWAADMNQRPSFLDILKR 416
Y + + V E FFR +G + P+ L +L CW + +RPSF +I
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293
Query: 417 L 417
L
Sbjct: 294 L 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 82/262 (31%), Positives = 116/262 (44%), Gaps = 18/262 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L FS IG GSFG + A VAIK++ S QD EV L
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
KLRHPN +Q+ G L+ EY G K L +G+AY
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL S +K+GDFG + ++ N G+ +M
Sbjct: 131 LHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPANXF--------VGTPYWM 178
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 388 FTPELRELTEKCWAADMNQRPS 409
++ R + C RP+
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 91/282 (32%), Positives = 137/282 (48%), Gaps = 36/282 (12%)
Query: 164 IIGKGSFGEILKAYWRGTPV----AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218
+IG+G+FG++LKA + + AIKR+ S D +DF E+ +L KL HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFAL 262
LGA R L L EY G+L +L++ LS ++FA
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 321
D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +VY K T
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVA--KIADFGLSR------GQEVYVKKT 169
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
R+MA E + Y DV+S+ ++L+E++ G P E + + +G+R
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ E+ +L +CW +RPSF IL L ++ E
Sbjct: 230 -LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 85/295 (28%), Positives = 142/295 (48%), Gaps = 43/295 (14%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD--DRLVIQD 201
EI+ S + F +G+ FG++ K + GT VAIK +L D + + ++
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK----TLKDKAEGPLREE 54
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 246
F+HE + +L+HPNIV LG VT+ +PL +I Y DLH++L
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
K L P+ V+ IA GM +L + ++H+DL RNVL+ + ++K+ D GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL--NVKISDLGL 170
Query: 306 SKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363
+ + + D YK+ G + R+M+PE + K+ D++S+ ++L+E+ G P
Sbjct: 171 FREVY---AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 364 ANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTEKCWAADMNQRPSFLDILKRL 417
Y + + + +R P + L +CW ++RP F DI RL
Sbjct: 228 CGYSNQDVIEMIR--NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++G +LK + T VAIK+ S DD V + EV +L +LRH NIV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A + L L+ EY+ L + L+ G L P ++ + + +AY H+ + IIHR
Sbjct: 68 AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKY 340
D+KP N+L+ S + LK+ DFG ++ ++ T YR APE+ Y
Sbjct: 125 DIKPENILV--SESGVLKLCDFGFARALR-ARPASPLTDYVATRWYR--APELLVGDTNY 179
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
K VDV++ I+ E+L+GEP
Sbjct: 180 GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 17/248 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE-VNLLVKLRHPNIVQFL 221
I KG+FG + A R G AIK + S + + + + E ++++ P + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L L+ EYL GGD +K G L A + ++ G+ LH IIHR
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHR 121
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+L+ HLK+ DFGLS+ G+ Y+APE D
Sbjct: 122 DIKPENLLI--DQTGHLKLTDFGLSRNGLENKKF--------VGTPDYLAPETILGVGDD 171
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEKC 399
K D +S +++E L G PP P + + P + +PE +L +
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 400 WAADMNQR 407
D +R
Sbjct: 232 LCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G F E+ +A PVA+K++ D QD E++LL +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
N++++L + E L ++ E GDL KY K++ L P V + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 329
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYEAAKYVAEGHRPFFRAKG 387
M+PE Y+ K D++S +LYEM + P + + + + P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH 232
Query: 388 FTPELRELTEKCWAADMNQRP 408
++ +LREL C D +QRP
Sbjct: 233 YSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
NK WE+ P + + + +G G++G++ A+ T VAIK++ + +R
Sbjct: 7 NKTVWEV-PDR--YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL + H N++ L T L L+T L G DL+ +K + LS
Sbjct: 64 -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQ-KLSDDHI 120
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
I RG+ Y+H+ IIHRDLKP N + VN + LK+ DFGL++
Sbjct: 121 QFLVYQILRGLKYIHSAG--IIHRDLKPSN-IAVNEDCE-LKILDFGLAR----HTDD-- 170
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+MTG + Y APE+ Y++ VD++S I+ E+L G+
Sbjct: 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 18/275 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 22 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+++HPN +++ G L+ EY G K L +G+AY
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ + +IHRD+K N+LL + +K+ DFG + + NS G+ +M
Sbjct: 141 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASIASPANSF--------VGTPYWM 188
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
++ R + C RP+ ++LK + ++E
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 19/256 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG FGE+ + T A K++ R Q +E +L K+ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
A + L L+ + GGDL ++ G + A+ +A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVY 118
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP NVLL + ++++ D GL+ +K K+ G G+ YMAPEV + Y
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQGEVY 171
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFRAKGFTPELRELT 396
D VD F+ LYEM+ G P E E + E F+PE ++L
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLC 229
Query: 397 EKCWAADMNQRPSFLD 412
E D +R
Sbjct: 230 EALLQKDPEKRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K R T VA+K I L + E++L+ +L+H NIV+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK---EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ LML+ EY+ DL KY+ +GAL P+T +F + +G+A+ H N ++
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVL 122
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 338
HRDLKP+N LL+N + LK+ DFGL++ + V + E + Y AP+V R
Sbjct: 123 HRDLKPQN-LLINKRGE-LKLADFGLARAFGIP----VNTFSNEVVTLWYRAPDVLLGSR 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
Y +D++S I+ EM+ G P
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 18/273 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E + ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ P + + LG + + L+T+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 AGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
+YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + + Y G +
Sbjct: 123 SYL--EEVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDIDETE--YHADGGKVPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+MA E HR++ + DV+S+ + ++E++ G P E + +G R +
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQPPI 235
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
T ++ + KCW D RP F +++ ++
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 75/262 (28%), Positives = 135/262 (51%), Gaps = 26/262 (9%)
Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GSFG+ ++K+ G IK I S + ++ R EV +L ++HPNIVQ+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQE 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAV-NFALDIARGMAYLHNEPNVIIH 280
+ E L ++ +Y GGDL+K + ++G L P + ++ + I + ++H+ I+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILH 124
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+K +N+ L +K+GDFG++ +V NS T G+ Y++PE+ ++R Y
Sbjct: 125 RDIKSQNIFLTKDGT--IKLGDFGIA---RVLNSTVELARTC-IGTPYYLSPEICENRPY 178
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY------VAEGHRPFFRAKGFTPELRE 394
+ K D+++ +LYEM + +EA + G P + ++ +LR
Sbjct: 179 NNKSDIWALGCVLYEMCTLK------HAFEAGNMKNLVLKIIRGSYPPVSSH-YSYDLRN 231
Query: 395 LTEKCWAADMNQRPSFLDILKR 416
L + + + RPS IL++
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 69/232 (29%), Positives = 115/232 (49%), Gaps = 23/232 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRL-VIQDFRHEVNLLVKLRH 214
DF +G GSFG + A +GT AIK L ++ +Q E ++L++L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P IV + + + + + E++ GG+L +L++ G A + ++ YLH++
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 330
II+RDLKP N+LL + H+KV DFG +K K+ T G+ Y+
Sbjct: 138 D--IIYRDLKPENLLL--DNKGHVKVTDFGFAK-----------KVPDRTFTLCGTPEYL 182
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
APEV + + + K VD ++ ++LYE + G PP + P+ + + G F
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 19/258 (7%)
Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L + +Y+ GG+L +L+ + + A +A +IA + YLH+ II+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL S H+ + DFGL K I+ + + T E Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE-----YLAPEVLRKQP 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
YD+ VD + +LYEML G PP Y A Y ++P + R L E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF--YSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL 230
Query: 400 WAADMNQR----PSFLDI 413
D +R FL+I
Sbjct: 231 LQKDRTKRLGAKDDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP E+ F IG GSFG + A T VA+K++ S QD EV L
Sbjct: 18 DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+L+HPN +++ G + L+ EY G K L +G+AY
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 136
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ + +IHRD+K N+LL + +K+ DFG + NS G+ +M
Sbjct: 137 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSPANSF--------VGTPYWM 184
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
+T R + C +RP+ ++L+
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 19/259 (7%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++G+GSFG L + A+K I LP S ++D R E LL K++HPNIV F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAF 63
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPS-TAVNFALDIARGMAYLHNEPNVI 278
+ L ++ EY GGDL + +K ++G L P T + + + + G+ ++H + +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--V 121
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + +K+GDFG ++L+ + G+ Y+ PE++++
Sbjct: 122 LHRDIKSKNIFLTQNG--KVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEIWENM 175
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397
Y+ K D++S ILYE+ + P AN K ++P ++ ELR L +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL--PSHYSYELRSLIK 233
Query: 398 KCWAADMNQRPSFLDILKR 416
+ + + RPS IL R
Sbjct: 234 QMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-24
Identities = 81/275 (29%), Positives = 128/275 (46%), Gaps = 29/275 (10%)
Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+G FG +++ VA+K + ++ R ++DF E + + HPN+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 221 LGAV---TERKPL---MLITEYLRGGDLHKYL------KEKGALSPSTAVNFALDIARGM 268
+G E + ++I +++ GDLH +L L V F DIA GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY- 327
YL ++ IHRDL RN +L N + + + V DFGLSK K+ N D Y+ G
Sbjct: 126 EYLSSKS--FIHRDLAARNCML-NENMN-VCVADFGLSK--KIYNG-DYYRQ-GRIAKMP 177
Query: 328 -RYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHRPFFRA 385
+++A E R Y K DV+SF + ++E+ G+ P E E Y+ +G+R +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQP 236
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
L L CW + RPSF + LEK
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 18/259 (6%)
Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
+G G+FG++ KA + T V A +++ + S++ L +D+ E+++L HPNIV+ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
L ++ E+ GG + + E + L+ + YLH N IIHRD
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRD 128
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-----KH 337
LK N+L +K+ DFG+S +N+ + + G+ +MAPEV K
Sbjct: 129 LKAGNILFTLDG--DIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELRELT 396
R YD K DV+S + L EM + EPP P +A+ P + ++ E ++
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 397 EKCWAADMNQRPSFLDILK 415
+KC +++ R + +L+
Sbjct: 243 KKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 77/268 (28%), Positives = 133/268 (49%), Gaps = 33/268 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRH---PN 216
+G+G++G + K GT +A+KRI + S RL++ +L + +R P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM-------DLDISMRSVDCPY 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVN-FALDIARGMAYLHN 273
V F GA+ + + E + +K + +KG P + A+ I + + YLH+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAP 332
+ +VI HRD+KP NVL+ + +K+ DFG+S L+ D T + G YMAP
Sbjct: 122 KLSVI-HRDVKPSNVLI--NRNGQVKLCDFGISGYLV------DSVAKTIDAGCKPYMAP 172
Query: 333 EVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKG 387
E + YD K DV+S + + E+ G P +++ P++ K V E P A+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
F+PE ++ KC + +RP++ ++L+
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + G A+K + + +R + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + L + +++ GG+L +L+ + + A +A +IA + YLH+ I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL S H+ + DFGL K I ++ + G+ Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIRKQP 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE----LREL 395
YD VD + +LYEML G PP + E + H+P G + L EL
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEEL 230
Query: 396 TEKCWAADMNQRPSFLDI 413
EK + + FL+I
Sbjct: 231 LEKDRQRRLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
++ P + + + IG+G++G + A + G VAIK+I P + + Q E+ +
Sbjct: 2 DVGP---RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKI 56
Query: 209 LVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
L + +H NI+ L + + ++ E + DL+K +K + LS F
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQ 114
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I RG+ Y+H+ NV+ HRDLKP N LL+N++ D LK+ DFGL+++ HD E
Sbjct: 115 ILRGLKYIHS-ANVL-HRDLKPSN-LLLNTNCD-LKICDFGLARIA--DPEHDHTGFLTE 168
Query: 324 TGSYR-YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ R Y APE+ + Y K +D++S IL EML P
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 3 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKK 58
Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
H NI + GA ++ P L L+ E+ G + +K KG L
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I RG+++LH +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 170
Query: 323 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
G+ +MAPEV YD K D++S + EM EG PPL + P A +
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P ++K ++ + + E C + +QRP+ ++K
Sbjct: 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 27/254 (10%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPN 216
++GKGSFG++L A +G A+K +L D ++I D + L + +P
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+ ++ L + E+L GGDL ++++KG A +A +I G+ +LH+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS--K 115
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
II+RDLK NV+L H+K+ DFG+ K +N + + G+ Y+APE+ +
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLA---NYEPYEAAKYVAEGHRPFFRAKGFTPELR 393
KY VD +SF ++LYEML G+ P E +E+ + V H P + T E +
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHYP----RWITKESK 224
Query: 394 ELTEKCWAADMNQR 407
++ EK + D +R
Sbjct: 225 DILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 78/275 (28%), Positives = 118/275 (42%), Gaps = 20/275 (7%)
Query: 156 ELDFSS---SAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
ELD S I+G G FGE+ + R PVAI + SD + + F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEAL 58
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
L + H NIV+ G +T +M++TEY+ G L +L K +G L + +A
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GM YL +H+ L V LVNS K+ F + K + +Y
Sbjct: 119 GMKYLSEMG--YVHKGLAAHKV-LVNSDLV-CKISGFRRLQEDKSEA---IYTTMSGKSP 171
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385
+ APE ++ + DV+SF ++++E M GE P + + K V +G R
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LPAP 230
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ L +L CW + +RP F I L K+
Sbjct: 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 71/226 (31%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +I G++G + + T A+K+I R IQ E ++L +P
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V + ++ L ++ EY+ GGD LK GAL A + + + YLHN
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 324
I+HRDLKP N+L+ +S H+K+ DFGLSK+ + + ++Y+ + +T
Sbjct: 122 --IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
G+ Y+APEV + Y K VD ++ +ILYE L G P P E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 77/252 (30%), Positives = 118/252 (46%), Gaps = 13/252 (5%)
Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP N+LL S H+ + DFGL K +N + G+ Y+APEV + Y
Sbjct: 120 RDLKPENILL--DSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400
D+ VD + +LYEML G PP Y A Y ++P T R L E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
Query: 401 AADMNQRPSFLD 412
D +R D
Sbjct: 232 QKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G+GS+G ++K + G VAIK+ L S DD++V + E+ +L +LRH N+V +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+K L L+ E++ L K L S + I RG+ + H+ + IIHR
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS--HNIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-VFKHRKY 340
D+KP N+L+ S +K+ DFG ++ + +VY T YR APE + KY
Sbjct: 125 DIKPENILVSQSGV--VKLCDFGFARTLAAPG--EVYTDYVATRWYR--APELLVGDTKY 178
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
+ VD+++ ++ EML GEP
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 17/255 (6%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAIK++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS--NQVIHR 139
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCW 400
KVD++S ++ EM+EGEPP N P A +A P + + + R+ +C
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 401 AADMNQRPSFLDILK 415
D+++R S ++L+
Sbjct: 254 EMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 4e-23
Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 31/275 (11%)
Query: 165 IGKGSFGE----ILKAYWRGTP---VAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPN 216
+G+GSFG + +G VA+K + S S +R+ +F +E +++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK--------EKGALSPS--TAVNFALDIAR 266
+V+ LG V++ +P +++ E + GDL YL+ G P+ + A +IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TG 325
GMAYL+ + +HRDL RN ++ + +K+GDFG+++ I D Y+ G+
Sbjct: 131 GMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDIY---ETDYYRKGGKGLL 183
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384
R+MAPE K + D++SF ++L+E+ E P + K+V +G +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQ 242
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
+ +L CW + RP+FL+I+ L+
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQ 219
+IGKGSFG++L A + G+ A+K + + E N+L+K L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ + L + +Y+ GG+L +L+ + A +A ++A + YLH+ II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--II 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+RDLKP N+LL S H+ + DFGL K ++ + + + G+ Y+APEV +
Sbjct: 119 YRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEETTSTF-----CGTPEYLAPEVLRKE 171
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL 363
YD+ VD + +LYEML G PP
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 58/160 (36%), Positives = 88/160 (55%), Gaps = 8/160 (5%)
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
+ E N+L ++HP IV + A L LI EYL GG+L +L+ +G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I+ + +LH + II+RDLKP N+LL + H+K+ DFGL K ++ H+
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCK----ESIHEGTVTHT 159
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAPE+ + K VD +S ++Y+ML G PP
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 8e-23
Identities = 73/255 (28%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAI+++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 194
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCW 400
KVD++S ++ EM+EGEPP N P A +A P + + + R+ +C
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 401 AADMNQRPSFLDILK 415
D+ +R S ++L+
Sbjct: 255 DMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G++G + +A + VA+K++ D + I R E+ LL+ LRHPNIV+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 222 GAVTERK--PLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVI 278
V + + L+ EY DL L + V L + RG+ YLH N I
Sbjct: 73 EVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE--NFI 129
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 337
IHRDLK N+LL + LK+ DFGL++ MT + + Y APE+
Sbjct: 130 IHRDLKVSNLLLTDKG--CLKIADFGLARTY----GLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
Y +D+++ IL E+L +P
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
IG+G++G + KA R VA+KR+ L DD + E+ LL +L+H NIV+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ K L L+ EY DL KY G + P +F + +G+A+ H+ ++H
Sbjct: 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL+N + + LK+ DFGL++ + V + E + Y P+V F +
Sbjct: 123 RDLKPQN-LLINKNGE-LKLADFGLARAFGIP----VRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y +D++S I E+ PL
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 164 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQ 219
++G+GSFG++ L G + L L ++D + E ++L ++ HP IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPNVI 278
A L LI ++LRGGDL L K + V F L ++A + +LH+ I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG--I 119
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
I+RDLKP N+LL H+K+ DFGLSK ++ K G+ YMAPEV R
Sbjct: 120 IYRDLKPENILL--DEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 339 KYDKKVDVFSFAMILYEMLEGEPP 362
+ + D +SF ++++EML G P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G+G++ + KA + G VAIK+I + D + R E+ LL +L+HPNI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVI 278
L + + L+ E++ DL K +K+K L+P+ ++ L RG+ YLH+ N I
Sbjct: 67 LLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--NWI 123
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 337
+HRDLKP N+L+ +S LK+ DFGL++ N KMT + + Y APE+ F
Sbjct: 124 LHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPN----RKMTHQVVTRWYRAPELLFGA 177
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLA 364
R Y VD++S I E+L P L
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
+P E DF IG G++G++ KA G AIK I +D V+Q E+ ++
Sbjct: 6 NPQE-DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMK 61
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H NIV + G+ R L + E+ GG L G LS S + + +G+ Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH++ +HRD+K N+LL ++ H+K+ DFG+S Q + + K G+ +M
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNG--HVKLADFGVS----AQITATIAKRKSFIGTPYWM 173
Query: 331 APEVFK-HRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
APEV RK Y++ D+++ + E+ E +PP+ + P A
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 31/281 (11%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DPS+ + IGKG++G++ K + G+ A+K IL + D + ++ E N+L
Sbjct: 15 DPSD-TWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHD---IDEEIEAEYNILK 69
Query: 211 KLR-HPNIVQFLGA-----VTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFA 261
L HPN+V+F G V L L+ E GG DL K ++G + +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 262 LDIA-RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
L A G+ +LH N IHRD+K N+LL +K+ DFG+S Q + +
Sbjct: 130 LHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRR 181
Query: 321 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375
G+ +MAPEV + YD + DV+S + E+ +G+PPLA+ P A +
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
Query: 376 AEGHRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 415
P + ++ E + KC D +RP+ D+L+
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VA+K+I ++D V E++LL +L HPNIV+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
V L L+ E+L DL KY+ L P ++ + +G+AY H+ + ++H
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL++ LK+ DFGL++ V V T E + Y APE+ R+
Sbjct: 123 RDLKPQN-LLIDREGA-LKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ P
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-- 219
IG G++G + A + VAIK+I P D + + E+ +L +H NI+
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 220 --FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ K + ++ + L DLH + L+ F + RG+ Y+H+
Sbjct: 71 DILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN-- 127
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 336
+IHRDLKP N LLVN L++GDFG+++ + + Y MT + Y APE+
Sbjct: 128 VIHRDLKPSN-LLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 337 HRKYDKKVDVFSFAMILYEML 357
+Y +D++S I EML
Sbjct: 186 LPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-22
Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 13 DPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKK 68
Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
H NI + GA ++ P L L+ E+ G + +K KG AL
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I RG+A+LH + +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 129 EILRGLAHLH--AHKVIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 180
Query: 323 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
G+ +MAPEV YD + D++S + EM EG PPL + P A +
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P ++K ++ + + E C + RPS +LK
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLL 209
++DP+E+ + +G G+FG++ KA + T A +++ + S++ L +D+ E+ +L
Sbjct: 7 DLDPNEV-WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEIL 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
HP IV+ LGA L ++ E+ GG + + E +G P V +
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEA 122
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH+ IIHRDLK NVLL +K+ DFG+S +N + + G+
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDG--DIKLADFGVS----AKNVKTLQRRDSFIGTP 174
Query: 328 RYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP- 381
+MAPEV K YD K D++S + L EM + EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ ++ E R+ + RPS +L+
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++GKGSFG++ A +GT AIK + L DD + V L + HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTH 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
++ L + EYL GGDL +++ A +A +I G+ +LH++ I+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IV 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
+RDLK N+LL + H+K+ DFG+ K +N K G+ Y+APE+ +K
Sbjct: 119 YRDLKLDNILL--DTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Y+ VD +SF ++LYEML G+ P ++ E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 26/272 (9%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
++ +L+ S G G +K GT +A K + + V + E+ ++
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMH 58
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ R P IV F GA + + E++ G L + K+ G + A+ + G+ Y
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNS-HDVYKMTGETGSYR 328
L+N I+HRD+KP N+ LVN S +K+ DFG+S +LI NS D + G+
Sbjct: 119 LYNVHR-IMHRDIKPSNI-LVN-SRGQIKLCDFGVSGELI---NSIADTF-----VGTST 167
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-----HR--- 380
YM+PE + KY K DV+S + + E+ G+ P A + + G +
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 381 ---PFFRAKGFTPELRELTEKCWAADMNQRPS 409
P + F +LR+ + C D +RP+
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 15/264 (5%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K + R ++ + EV ++ +H N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L ++ E+L+GG L + + L+ + + + YLH++ +IHRD
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQG--VIHRD 142
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL +K+ DFG Q S DV K G+ +MAPEV Y
Sbjct: 143 IKSDSILLTLDG--RVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 401
+VD++S +++ EM++GEPP + P +A K + + P + A +P LR+ E+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 402 ADMNQRPSFLDILKRLEKIKETLP 425
+ +R + ++L ++ LP
Sbjct: 257 REPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF-- 220
+G GS G + A VA+K+I L+D + V R E+ ++ +L H NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 221 ------------LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
+G++TE + ++ EY+ DL L E+G LS A F + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGL 127
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
Y+H+ NV+ HRDLKP NV +N+ LK+GDFGL++++ SH Y G +
Sbjct: 128 KYIHS-ANVL-HRDLKPANVF-INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 329 YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEP 361
Y +P + Y K +D+++ I EML G+P
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 72/257 (28%), Positives = 116/257 (45%), Gaps = 19/257 (7%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y + AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL + H+++ D GL+ + + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 390
K+ +Y D ++ +LYEM+ G+ P + E + V E + ++ F+P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY--SEKFSP 230
Query: 391 ELRELTEKCWAADMNQR 407
+ R L + D +R
Sbjct: 231 DARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G+FGE+ KA G VA+K+IL D I R E+ +L KL+HPN+V +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 273
ER + ++T Y+ DL L+ L+ S + L + G+ YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR----- 328
N I+HRD+K N+L+ N LK+ DFGL++ + G T Y
Sbjct: 134 --NHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 329 --YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLA 364
Y PE+ R+Y VD++ + EM P L
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VA+K+I + + R E++LL +L HPNIV+ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ E+L DL K++ + ++ + +G+A+ H+ + ++H
Sbjct: 67 VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLH 123
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL+N+ +K+ DFGL++ V V T E + Y APE+ +
Sbjct: 124 RDLKPQN-LLINTEG-AIKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGCKY 177
Query: 340 YDKKVDVFSFAMILYEML 357
Y VD++S I EM+
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG+G+FG + K + GT +A+KRI + D + +++++++ P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 222 GAV-TERKPLM---LITEYLRGGDLHK--YLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
GA+ E + L+ L +K Y K + A+ + + YL E
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-- 333
IIHRD+KP N+LL + ++K+ DFG+S ++ +S + K T + G YMAPE
Sbjct: 128 K-IIHRDVKPSNILLDRNG--NIKLCDFGISG--QLVDS--IAK-TRDAGCRPYMAPERI 179
Query: 334 -VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR---AKGF 388
YD + DV+S + LYE+ G+ P + ++ V +G P + F
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+P C D ++RP + ++L+
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-21
Identities = 59/189 (31%), Positives = 86/189 (45%), Gaps = 11/189 (5%)
Query: 180 GTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-GAVTERKPLMLITEY 236
G VAIK R + ++ + FR E L +L HPNIV L L + EY
Sbjct: 3 GHEVAIKLLRTD-APEEEHQRAR-FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
+ G L + L GAL L + +A HN I+HRDLKP+N+++ +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVR 118
Query: 297 -HLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYMAPEVFKHRKYDKKVDVFSFAMI 352
H KV DFG+ L+ DV +T T G+ Y APE + D++++ +I
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 353 LYEMLEGEP 361
E L G+
Sbjct: 179 FLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV---KLR 213
F A++G+G FG++L A ++ T AIK + R ++ E + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
HP +V + + EY GGDL ++ S AV +A + G+ YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHE 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV-YKMTGET--GSYRYM 330
N I++RDLK N+LL + +K+ DFGL K + + T G+ ++
Sbjct: 120 --NKIVYRDLKLDNLLL--DTEGFVKIADFGLCK-------EGMGFGDRTSTFCGTPEFL 168
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
APEV Y + VD + +++YEML GE P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + +++ L LI E+L GGD+ L +K LS + + + +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 318
IHRD+KP N+LL + H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 319 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 365 NYEPYEAAKYV 375
+ P E + V
Sbjct: 238 SETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R T +A+K+I D+ + R E++LL +++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNFALDIARGMAYLHNEPNVIIH 280
V K L L+ EYL DL K++ + P + I RG+AY H+ + ++H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLH 125
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL++ + LK+ DFGL++ + V T E + Y APE+ R
Sbjct: 126 RDLKPQN-LLIDRRTNALKLADFGLARAFGIP----VRTFTHEVVTLWYRAPEILLGSRH 180
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ +P
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 38/274 (13%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+G+ G + K + G A+K I + D L Q R E+ + + P IV++
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILR-ELEINKSCKSPYIVKYY 65
Query: 222 GAVTERKPLML--ITEYLRGGDL---HKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
GA + + EY GG L +K +K++G + A + +G++YLH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEV 334
IIHRD+KP N+LL + +K+ DFG+S V + G TG+ YMAPE
Sbjct: 126 --IIHRDIKPSNILL--TRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPER 174
Query: 335 FKHRKYDKKVDVFSFAMILYEML--------EGEPPLANYEPYEAAKYVAEGHRPFFR-- 384
+ + Y DV+S + L E+ EGEPPL P E Y+ P +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDE 231
Query: 385 ---AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
++ E ++ ++C D +RP+ D+L+
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 73/258 (28%), Positives = 110/258 (42%), Gaps = 20/258 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG FGE+ R T A K++ R + E +L K+ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
A + L L+ + GGDL ++ +E A + I G+ +LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRI 118
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
I+RDLKP NVLL N ++++ D GL+ +K S K G G+ +MAPE+ +
Sbjct: 119 IYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQS----KTKGYAGTPGFMAPELLQGE 172
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+YD VD F+ + LYEM+ P E E + + + F+P +
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSPASKS 230
Query: 395 LTEKCWAADMNQRPSFLD 412
E A D +R F D
Sbjct: 231 FCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
DF+ +G GSFG ++ A ++ PVAIKR S + + E +L + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P V G+ + L L+ E++ GG+ +L+ +A I YL +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL +K+ DFG +K++ + Y + G + Y+APE+
Sbjct: 151 N--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTRT----YTLCG---TPEYIAPEI 199
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ + K D ++ + +YE+L G PP EP + + EG + K +
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNNCKH 257
Query: 395 LTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
L +K + D+ +R + ++ K + +KE H W
Sbjct: 258 LMKKLLSHDLTKR--YGNLKKGAQNVKE-----HPW 286
|
Length = 340 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D++ IG+G++G + K + T VA+K+I S++ V E++LL +L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHP 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLH 272
NIV + + L LI E+L DL KYL + + ++ I +G+ + H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ ++HRDLKP+N+L+ N +K+ DFGL++ + V T E + Y AP
Sbjct: 119 SRR--VLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIP----VRVYTHEVVTLWYRAP 170
Query: 333 EVF-KHRKYDKKVDVFSFAMILYEMLEGEP 361
EV +Y VD++S I EM +P
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 73/251 (29%), Positives = 115/251 (45%), Gaps = 37/251 (14%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + ++ L LI E+L GGD+ L +K L+ + + + +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 318
IHRD+KP N+LL S H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 319 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 365 NYEPYEAAKYV 375
+ P E K V
Sbjct: 238 SETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 52/255 (20%)
Query: 158 DFSSSAIIGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE +++ G A+K++ S ++ + R E ++L + +P
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF------ALDIARGMA 269
+V+ + + L LI EYL GGD+ L +K + + A+D +
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
Y IHRD+KP N+LL H+K+ DFGL +K + + Y++
Sbjct: 122 Y--------IHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 325 -----------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
G+ Y+APEVF Y+K+ D +S +I+YE
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 356 MLEGEPPLANYEPYE 370
ML G PP + P E
Sbjct: 232 MLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R G A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILL--DDYGHIRISDLGLAVEIP-----EGETIRGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 390
K+ +Y D + ++YEM+EG+ P + E + V E + ++ F+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSE 230
Query: 391 ELRELTEKCW--------------AADMNQRPSFLDIL-KRLE 418
R + + A ++ P F KRLE
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 15/254 (5%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K++ R ++ + EV ++ H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L ++ E+L GG L + ++ L + R ++YLHN+ +IHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRD 143
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL +S +K+ DFG Q S +V K G+ +MAPEV Y
Sbjct: 144 IKSDSILL--TSDGRIKLSDFGFC----AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 401
+VD++S +++ EM++GEPP N P +A + + + P + + + LR +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 402 ADMNQRPSFLDILK 415
+ +QR + ++L+
Sbjct: 258 REPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 49/289 (16%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF +G G+ G + K R + + + R L L + E+ +L + P I
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LK+ G + + ++ + RG+ YL + +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-HK 120
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+L VNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 121 IMHRDVKPSNIL-VNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 170
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL-----ANYEP---------------------- 368
+ Y + D++S + L EM G P+ E
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 369 ---------YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRP 408
+E Y+ P + F+ E ++ +KC + +R
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 74/245 (30%), Positives = 118/245 (48%), Gaps = 12/245 (4%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKGSFG++++ R T A+K I + R + E +L ++ P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L L+ ++ GG+L +L+ +G S A + ++ + LH + NVI +RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVI-YRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
LKP N+LL H+ + DFGL KL N D K G+ Y+APE+ Y K
Sbjct: 119 LKPENILL--DYQGHIALCDFGLCKL----NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 402
VD ++ ++LYEML G PP + E + + + P GF + ++L +
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSR 230
Query: 403 DMNQR 407
D +R
Sbjct: 231 DPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 70/257 (27%), Positives = 113/257 (43%), Gaps = 19/257 (7%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A KR+ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y A+ +A +I G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
++RDLKP N+LL + H+++ D GL+ +K+ + G G+ YMAPEV
Sbjct: 122 N--TVYRDLKPENILLDDYG--HIRISDLGLA--VKIPEGESI---RGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAKGFTP 390
+++Y D + ++YEM+EG+ P + E + V E + + F+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSE 230
Query: 391 ELRELTEKCWAADMNQR 407
E + + + D QR
Sbjct: 231 EAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
++GKGSFG+++ A +GT AIK L D +++QD + + K +HP
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIK----VLKKD-VILQDDDVDCTMTEKRILALAAKHP 56
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ + L + EY+ GGDL ++ + +A ++ + +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-- 114
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ +I+RDLK N+LL + H K+ DFG+ K + + T G+ Y+APE+
Sbjct: 115 HGVIYRDLKLDNILL--DAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ +Y VD ++ +++YEM+ G+PP
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQ 219
+G+G++G + A T VAIK+I S L + R E+ LL R H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 220 -------FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
F G E + + E L DLH+ ++ L+ + +F I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ NV+ HRDLKP N LLVN+ + LK+ DFGL++ + MT + Y AP
Sbjct: 123 S-ANVL-HRDLKPGN-LLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 333 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
E+ + Y K +DV+S IL E+L +P
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 221
IGKG++G++ K + G+ A+K IL +SD V ++ E N+L L HPN+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISD---VDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 222 GAVTERK-----PLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIAR-GMAYLH 272
G + L L+ E GG +L K L G +++ L A G+ +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N N IIHRD+K N+LL +K+ DFG+S Q + + G+ +MAP
Sbjct: 146 N--NRIIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRRNTSVGTPFWMAP 197
Query: 333 EVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AK 386
EV + YD + DV+S + E+ +G+PPL + P + + P +
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILK 415
+ +C D RPS +L+
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 15/254 (5%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K++ R ++ + EV ++ +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L ++ E+L GG L + ++ L + + ++ LH + +IHRD
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL + +K+ DFG Q S +V + G+ +MAPE+ Y
Sbjct: 142 IKSDSILLTHDG--RVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWA 401
+VD++S +++ EM++GEPP N P +A K + + P + +P L+ ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 402 ADMNQRPSFLDILK 415
D QR + ++LK
Sbjct: 256 RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
+GKG++G + KA R T VA+K+I + + + FR E+ L +L HPNIV+ L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 222 G---AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
A ++ + L+ EY+ DLH ++ L + + + Y+H+ +
Sbjct: 74 NVIKAENDKD-IYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSGN--V 128
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI-KVQNSHDVYKMTGETGSYRYMAPEV-FK 336
IHRDLKP N+LL +S +K+ DFGL++ + +++ + + +T + Y APE+
Sbjct: 129 IHRDLKPSNILL--NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
+Y K VD++S IL EML G+P
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
I +G++G + +A + G VA+K++ + I R E+N+L+KL+HPNIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKE 71
Query: 223 AV--TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVII 279
V + + ++ EY+ DL ++ K S L + G+A+LH+ N I+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD--NWIL 128
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 338
HRDLK N+LL N LK+ DFGL++ + + T + Y APE+ +
Sbjct: 129 HRDLKTSNLLLNNRGI--LKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
+Y +D++S I E+L +P
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 165 IGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
IG G+FG + W G VA+K+ +P++ + + + E+ +L +H N+
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNV- 61
Query: 219 QFLGAVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
L A+ +P + ++TE ++ DLHK + LS F I RG+ Y
Sbjct: 62 --LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ I+HRD+KP N LLVNS+ LK+ DFGL+ +V+ + MT E + Y
Sbjct: 119 LHSAG--ILHRDIKPGN-LLVNSNC-VLKICDFGLA---RVEEPDESKHMTQEVVTQYYR 171
Query: 331 APEVFK-HRKYDKKVDVFSFAMILYEMLEG 359
APE+ R Y VD++S I E+L
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV A L I + + GGDLH +L + G S +A +I G+ ++HN
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-- 116
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPEL 392
K YD D FS +L+++L G P + + +E + + F+PEL
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL--PDSFSPEL 226
Query: 393 RELTEKCWAADMNQR 407
+ L E D+++R
Sbjct: 227 KSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 165 IGKGSFGEILKA-YWRGTPVA---IKRILPSLSDDRLVIQD-FRHEVNLLVKLRHPNIVQ 219
IG G FG++L RG A +K + S + D Q F EV +L HPN++Q
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE 274
LG E P +L+ E+ GDL YL+ A ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY--RYMA 331
IH DL RN L +AD +K+GD+GL+ ++ + Y +T + + R++A
Sbjct: 119 -ADFIHSDLALRNCQL---TADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLA 170
Query: 332 PEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH---- 379
PE+ + R D KK +++S + ++E+ + P + + K V
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230
Query: 380 -RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413
+P K ++ E+ + CW D RP+ ++
Sbjct: 231 PKPQLDLK-YSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 220
IG+G++G++ KA + G VA+K+ + ++ + R E++LL L IV+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66
Query: 221 LGAV-TERKP----LMLITEYLRGGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAY 270
L E K L L+ EYL DL K++ G L T +F + +G+A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
H ++HRDLKP+N LLV+ LK+ D GL + + V T E + Y
Sbjct: 126 CHKHG--VMHRDLKPQN-LLVDKQKGLLKIADLGLGRAFSIP----VKSYTHEIVTLWYR 178
Query: 331 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ +G G++G++ KA G A+K I DD +IQ E+ ++ + +H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHC 66
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
NIV + G+ R+ L + EY GG L G LS + +G+AYLH++
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+HRD+K N+LL ++ +K+ DFG++ I + + K G+ +MAPEV
Sbjct: 127 K--MHRDIKGANILLTDNG--DVKLADFGVAAKI----TATIAKRKSFIGTPYWMAPEVA 178
Query: 336 ---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
K+ Y++ D+++ + E+ E +PP+ + P A
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (218), Expect = 1e-18
Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 49/286 (17%)
Query: 165 IGKGSFGEILKAYWRGTP-----VAIK-RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
IG G FGE+ + T AI R L +LVI EVN++ +L+H NIV
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVMRELKHKNIV 75
Query: 219 QFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLH 272
+++ + + L ++ E+ GDL K K G + V+ + +AY H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 273 N---EPN--VIIHRDLKPRNVLL---------VNSSADHL------KVGDFGLSKLIKVQ 312
N PN ++HRDLKP+N+ L + + A++L K+GDFGLSK I ++
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195
Query: 313 N-SHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369
+ +H G+ Y +PE+ H + YD K D+++ I+YE+ G+ P ++
Sbjct: 196 SMAHSC------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HKAN 247
Query: 370 EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 414
++ ++E R P KG + EL L + +RPS L L
Sbjct: 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 11/246 (4%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG+FG+++ K G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L + EY GG+L +L + S A + +I + YLH+E NV+ +R
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV-YR 120
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 121 DLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWA 401
+ VD + +++YEM+ G P N + + + + F R PE + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS--PEAKSLLSGLLK 232
Query: 402 ADMNQR 407
D QR
Sbjct: 233 KDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV A L I + + GGDLH +L + G S + +A +I G+ ++HN
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-- 116
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
K YD D FS +L+++L G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K + T VA+K I L + E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ +K L L+ EYL DL +Y+ G LS F + RG+AY H ++HR
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAPEVF-KH 337
DLKP+N+L+ S LK+ DFGL++ V + S++V T YR P+V
Sbjct: 128 DLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYR--PPDVLLGS 178
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
+Y +D++ I YEM G P
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG G + +GT A+K + R ++ E +L L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ +Y GG+L + L+ LS A +A ++ + YLH I++
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVY 126
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK------------LIKVQNSHDVYKMTGET---- 324
RDLKP N+LL S H+ + DF LSK L K V + ET
Sbjct: 127 RDLKPENILLHESG--HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 325 ---------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APEV + VD ++ ++LYEML G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y A+ +A ++ G+ L E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL + H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDRG--HIRISDLGLAVQIP-----EGETVRGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 390
+ KY D + ++YEM++G+ P + E + V E + ++ F+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSE 230
Query: 391 ELRELTEKCW--------------AADMNQRPSFLDI-LKRLE 418
+ + + AA + Q P F +I KRLE
Sbjct: 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IGKGS+G + A G VAIK+I +SD +++ E+ LL LRHP+IV
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 219 QFLGAV-----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+ + E K + ++ E L DLH+ +K L+P F + R + Y+H
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ HRDLKP+N+ L N+ LK+ DFGL+++ ++ T + Y APE
Sbjct: 122 --ANVFHRDLKPKNI-LANADCK-LKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 176
Query: 334 VFK--HRKYDKKVDVFSFAMILYEMLEGEP 361
+ KY +D++S I E+L G+P
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + A T VAIK+I + D+R+ + E+ LL L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 223 AVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ + ++ E L DLH+ ++ LS F + RG+ Y+H+
Sbjct: 72 IMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 336
++HRDLKP N LL+N++ D LK+ DFGL++ S MT + Y APE+
Sbjct: 129 VLHRDLKPSN-LLLNANCD-LKICDFGLART----TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
+Y +DV+S I E+L +P
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ D +G G++G + A R G VAIK++ + + +R
Sbjct: 7 NKTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY-----LRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T L ++ G DL K +K + LS
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQ 121
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++
Sbjct: 122 FLVYQMLKGLKYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------QTDS 170
Query: 319 KMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+MTG + Y APEV Y + VD++S I+ EML G+P
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LKE + ++ + RG+AYL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQ 124
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 174
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-----FTP 390
+ Y + D++S + L E+ G P+ P +A + A RP + +P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPVVDGEEGEPHSISP 231
Query: 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
R M+ RP+ + I + L+ I P
Sbjct: 232 RPRPPGRPVSGHGMDSRPA-MAIFELLDYIVNEPP 265
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 164 IIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++GKG+FG+++ KA R + I R ++ D + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 59
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
A L + EY GG+L +L + + A + +I + YLH+ ++
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VV 117
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
+RD+K N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 118 YRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLAN 365
Y + VD + +++YEM+ G P N
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 24/212 (11%)
Query: 163 AIIGKGSFGEILKAY---WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPN 216
A IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPN 65
Query: 217 IVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMA 269
+V+ T L L+ E++ DL YL + + + T + + RG+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH+ + ++HRDLKP+N+L+ +S+ +K+ DFGL+++ Q + +T Y
Sbjct: 125 FLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVT-----LWY 175
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG++G + K R T V A+K I L + + E+++L K P IV F G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNF-ALDIARGMAYLHNEPNVII 279
A + + EY+ G L K A P + + +G+ +L E N II
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-II 125
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAPEVFK-- 336
HRD+KP NVL+ + +K+ DFG+S L+ ++ G YMAPE K
Sbjct: 126 HRDVKPTNVLV--NGNGQVKLCDFGVSGNLVASLAKTNI-------GCQSYMAPERIKSG 176
Query: 337 ----HRKYDKKVDVFSFAMILYEMLEGE---PPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
+ Y + DV+S + + EM G PP + + +G P G++
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL-PSGYS 235
Query: 390 PELRELTEKCWAADMNQRPSFLDIL 414
+ ++ KC N+RP++ +L
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K R G VA+K I S+ + V E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L + EY+ DL +Y+ + G L P F + RG+AY+H + I+HR
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGL--SKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 338
DLKP+N+L+ S LK+ DFGL +K I Q + E + Y P+V
Sbjct: 128 DLKPQNLLI--SYLGELKLADFGLARAKSIPSQT------YSSEVVTLWYRPPDVLLGAT 179
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLA 364
Y +D++ I EML+G+P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG+FG+++ + G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L + EY+ GG+L +L + S + +I + YLH+ I++R
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS--GKIVYR 119
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 120 DLKLENLML--DKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYE 367
+ VD + +++YEM+ G P N +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 165 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+G++G + KA G AIK+ + Q E+ LL +L+H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 221 LGAV---TERKPLMLI--TEYLRGGDL-----HKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++ +L E+ DL ++ ++ PS + I G+ Y
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH+ N ++HRDLKP N+L++ + +K+GD GL++L + + +
Sbjct: 124 LHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 329 YMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y APE+ +H Y K +D+++ I E+L EP
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNI 217
A IG G++G + KA G VA+K + ++D L + R EV LL +L HPNI
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 218 VQFL----GAVTERK-PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAY 270
V+ + + T+R+ + L+ E++ DL YL + L T + RG+ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH N I+HRDLKP N+L+ +S +K+ DFGL+++ Q + +T Y
Sbjct: 124 LHA--NCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVT-----LWYR 174
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPV-AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+FGE+ L + V A+K LS ++ + F E +++
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWEERDIMAH 99
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
IVQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M + IHRD+KP N+LL + HLK+ DFG +K+ + V T G+
Sbjct: 160 SMGF--------IHRDVKPDNMLL--DKSGHLKLADFG--TCMKMDANGMVRCDTA-VGT 206
Query: 327 YRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPP 362
Y++PEV K Y ++ D +S + LYEML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 20/250 (8%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQD-FRH---EVNLLVKLRHPNI 217
++GKG+FG+++ + G A+K L + ++ +D H E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ L + EY GG+L +L + S A + +I + YLH+
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+++RDLK N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 116 VVYRDLKLENLML--DKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397
Y + VD + +++YEM+ G P N + + + + F R +PE + L
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLA 227
Query: 398 KCWAADMNQR 407
D QR
Sbjct: 228 GLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 47/278 (16%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----------FRHEVNLLVKLRH 214
+G+G+F I K R + I+ + +V++ F +L+ +L H
Sbjct: 3 LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 273
++V+ G V R +++ EY++ G L +L EK +S ++ A +A + YL
Sbjct: 61 KHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL-- 117
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
E ++H ++ +N+L+ + +K+ D G +T + R
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------------IPITVLSREER 164
Query: 329 -----YMAPEVFK--HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++APE + D +SF L E+ GE PL+ E ++ + HR
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 381 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
P EL L +CW D +RPSF IL+ L
Sbjct: 225 LPMPD----CAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 66/201 (32%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
+ + L L+ EYL DL +YL G L V F + RG++Y H I+HR
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 128 DLKPQN-LLINEKGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
+D++ ILYEM G P
Sbjct: 182 STPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKG FGE+ ++ G A K++ L S +++ + E +L K+ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL----EKEILEKVNSPFIV 56
Query: 219 QFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
A + L L+ + GGDL H Y + L ++++ I G+ +LH+
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD- 115
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I++RD+KP NVLL + ++ D GL+ +K D +T G+ YMAPE+ K
Sbjct: 116 -IVYRDMKPENVLL--DDQGNCRLSDLGLAVELK-----DGKTITQRAGTNGYMAPEILK 167
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
Y VD F+ +YEM+ G P +++
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++G+G++G +LK + T VAIK+ S ++ + R E+ +L L+ N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV+ A R L L+ EY+ L + + P ++ + + + + H N
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK--N 119
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I+HRD+KP N+L+ S D LK+ DFG ++ + ++ + T + Y +PE+
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNAN---YTEYVATRWYRSPELLL 174
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
Y K VD++S IL E+ +G+P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LK+ G + ++ + +G+ YL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 124
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 174
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ Y + D++S + L EM G P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 162 SAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
A IG+G+FGE+ KA + T VA+K++L + I R E+ +L L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 220 FLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR--- 266
L + K L+ E+ DL L + V F L +I +
Sbjct: 76 -LIEICRTKATPYNRYKGSFYLVFEFCEH-DL-------AGLLSNKNVKFTLSEIKKVMK 126
Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
G+ Y+H N I+HRD+K N+L+ LK+ DFGL++ + + + T
Sbjct: 127 MLLNGLYYIHR--NKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTN 182
Query: 323 ETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEM 356
+ Y PE+ R Y +D++ I+ EM
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 85/350 (24%), Positives = 146/350 (41%), Gaps = 103/350 (29%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
WE L +G+G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITE---------YLRG---------- 239
E+ +L+ + H N+V LGA T+ PLM+I E YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRN 115
Query: 240 --------------------------GDLHKYLKEKGA----------------LSPSTA 257
++++K L+
Sbjct: 116 KSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
++++ +ARGM +L + IHRDL RN+LL ++ +K+ DFGL++ D+
Sbjct: 176 ISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNV--VKICDFGLAR--------DI 223
Query: 318 YKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEM--LEGEP-PLANYEP 368
YK G R +MAPE + Y + DV+SF ++L+E+ L P P +
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 369 YEAAKYVAEGHRPFFRAKGF-TPELRELTEKCWAADMNQRPSFLDILKRL 417
E + + EG R RA + TPE+ + CW + RP+F ++++ L
Sbjct: 284 -EFCRRLKEGTR--MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
V K L L+ EYL DL +Y+ + G + V F I RG+AY H ++HR
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHR 128
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 129 DLKPQN-LLINERGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSSEY 182
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
++D++ I +EM G P
Sbjct: 183 STQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
IG+G+F E+LKA R G AIK + V R E+ L +L HPNI++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LR-EIQALRRLSPHPNILRLI 64
Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ +RK L L+ E L +L++ +K K L ++ + + + ++H N I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--NGI 121
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPE-VFK 336
HRD+KP N+L+ D LK+ DFG + I + + Y T R Y APE +
Sbjct: 122 FHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYIST------RWYRAPECLLT 172
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
Y K+D+++ + +E+L P
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI------LPSLSDDRLVIQDFRH-----EVNLL 209
A +G+G++G++ KAY G VAIK++ D +LV H E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+++H NI+ + E + L+ + + DL K + K L+ S L I G+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS----------KLIKVQNSHDVYK 319
LH +HRDL P N+ + +S K+ DFGL+ L K + +
Sbjct: 134 VLHK--WYFMHRDLSPANIFI--NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 320 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT + + Y APE+ KY VD++S I E+L G+P
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL--VIQDFRHE 205
+ D ++L+ IG G+ G++ K ++ G +A+K++ + + + ++ D
Sbjct: 10 YPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-- 65
Query: 206 VNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
+V H P IV+ G + I L L K LK +G + +
Sbjct: 66 ---VVLKSHDCPYIVKCYGYFI-TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTV 121
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMT 321
I + + YL + VI HRD+KP N+LL ++S + +K+ DFG+S +L+ D T
Sbjct: 122 AIVKALHYLKEKHGVI-HRDVKPSNILL-DASGN-VKLCDFGISGRLV------DSKAKT 172
Query: 322 GETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVA 376
G YMAPE + KYD + DV+S + L E+ G+ P N + +E +
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232
Query: 377 EGHRPFFR-AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ P +GF+P+ + C D +RP + ++L+
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 16/225 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQ 219
IGKG+FG++ + + T A+K + + + E N+LV+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ L L+T+Y+ GG+L +L+++G S A + ++ + +LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK--YDIV 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHR 338
+RDLKP N+LL + H+ + DFGLSK N K T G+ Y+APEV
Sbjct: 119 YRDLKPENILL--DATGHIALCDFGLSKANLTDN-----KTTNTFCGTTEYLAPEVLLDE 171
Query: 339 K-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
K Y K VD +S ++++EM G P + + + +A G F
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
R P +V A L LI +Y+ GG+L +L ++ + S + +I + +LH
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
II+RD+K N+LL S H+ + DFGLSK + Y G + YMAP
Sbjct: 123 QLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCG---TIEYMAP 175
Query: 333 EVFK--HRKYDKKVDVFSFAMILYEMLEGEPPL----ANYEPYEAAKYVAEGHRPFFRAK 386
EV + +DK VD +S ++ +E+L G P E ++ + + PF K
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF--PK 233
Query: 387 GFTPELRELTEKCWAADMNQR 407
+ E R+ +K D +R
Sbjct: 234 TMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY----LK 247
L+D+R R E++ L H IV+ L+LI EY GGDL+K LK
Sbjct: 103 LNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
E I + +H+ ++HRDLK N+ L+ + +K+GDFG SK
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGI--IKLGDFGFSK 217
Query: 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
S DV + G+ Y+APE+++ ++Y KK D++S +ILYE+L P
Sbjct: 218 QYSDSVSLDV--ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
Query: 368 PYEAAKYVAEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 414
E + V G + PF + ++ L + + + RP+ +L
Sbjct: 276 QREIMQQVLYGKYDPF--PCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
++GKGSFG+++ A + G A+K L D +++QD E + K HP
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVK----VLKKD-VILQDDDVECTMTEKRILSLARNHP 56
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ Q L + E++ GGDL ++++ + A +A +I + +LH++
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
II+RDLK NVLL + H K+ DFG+ K + + + G+ Y+APE+
Sbjct: 117 --IIYRDLKLDNVLLDHEG--HCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ Y VD ++ ++LYEML G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + S +G G++G + A+ G VA+K++ + +R
Sbjct: 9 NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T + L + + +L G DL+ +K + L+
Sbjct: 66 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 123
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 124 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 172
Query: 319 KMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG 359
+MTG + Y APE+ + Y++ VD++S I+ E+L G
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 48/275 (17%)
Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNI 217
IG G FG+++ + + V +K + S S +Q+ E L+H N+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-----VQEQMKFLEEAQPYRSLQHSNL 57
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLH 272
+Q LG TE P +L+ E+ GDL YL+ E P+T A +IA G+ +LH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SYRYM 330
N IH DL RN LL ++ +K+GD+GLS + Y +T + R++
Sbjct: 118 K--NNFIHSDLALRNCLL--TADLTVKIGDYGLSHN----KYKEDYYVTPDQLWVPLRWI 169
Query: 331 APEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382
APE+ + K+ +V+S + ++E+ E G P + + Y
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ--- 226
Query: 383 FRAKGFTPELR--------ELTEKCWAADMNQRPS 409
+ K P L+ E+ + CW QRPS
Sbjct: 227 -QLKLPKPRLKLPLSDRWYEVMQFCWLQP-EQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS+G + K R G VAIK+ + S DD ++ + E+ +L +L+HPN+V +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES-EDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
++ L L+ EY L++ K + + + + H + IHRD
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYD 341
+KP N+L+ + +K+ DFG ++++ D Y T YR APE+ +Y
Sbjct: 126 VKPENILI--TKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYR--APELLVGDTQYG 179
Query: 342 KKVDVFSFAMILYEMLEGEP 361
VDV++ + E+L G+P
Sbjct: 180 PPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 13/173 (7%)
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
AL ++F+ +A+GM++L ++ IHRDL RN+LL + K+ DFGL++ I+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRIT--KICDFGLARDIR 265
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
+S+ V K ++MAPE + Y + DV+S+ ++L+E+ G P P
Sbjct: 266 -NDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PV 322
Query: 370 EAA--KYVAEGHRPFFRAKGFTP-ELRELTEKCWAADMNQRPSFLDILKRLEK 419
++ K + EG+R + P E+ ++ + CW AD +RP+F I++ +E+
Sbjct: 323 DSKFYKMIKEGYRML--SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 14/191 (7%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
E LL + HP++++ + + + DL+ YL K L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I G+ YLH + IIHRD+K N+ + + D + +GD G ++ V + G
Sbjct: 166 ILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQF-PVVAPAFL----GL 216
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---R 380
G+ APEV KY+ K D++S ++L+EML + P +YV H
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 381 PFFRAKGFTPE 391
PE
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
+IG+GS+ ++L + T A+K + L +D I + E ++ + HP +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + EY+ GGDL +++ + L A ++ +I+ + YLH II+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLK NVLL S H+K+ D+G+ K ++ ++ + G+ Y+APE+ +
Sbjct: 120 RDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEILRGED 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALD 263
EV+LL L+H NIV + K L L+ EYL DL +YL + G V F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
+ RG+ Y H ++HRDLKP+N LL+N + LK+ DFGL++ S + E
Sbjct: 113 LLRGLNYCHRRK--VLHRDLKPQN-LLINERGE-LKLADFGLAR----AKSIPTKTYSNE 164
Query: 324 TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y P++ Y ++D++ I YEM G P
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K + G VA+K I L ++ E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI--RLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L L+ EY+ DL +Y+ K G L P F + RG++Y+H I+HR
Sbjct: 71 IIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N+L+ S LK+ DFGL++ V + + + E + Y P+V +Y
Sbjct: 128 DLKPQNLLI--SDTGELKLADFGLARAKSVPS----HTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 341 DKKVDVFSFAMILYEMLEG 359
+D++ I EM++G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 86/349 (24%), Positives = 146/349 (41%), Gaps = 95/349 (27%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
WE L +G+G+FG++++A G VA+K + + S+ R ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLI---------TEYLRG---------- 239
E+ +L+ + H N+V LGA T+ PLM+I + YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKT 115
Query: 240 ------------GDLHKYLKE------------------------------------KGA 251
GD+ + LK K
Sbjct: 116 KDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKV 175
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
L+ + ++ +A+GM +L + IHRDL RN+LL S + +K+ DFGL++ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR--DI 229
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE-PY 369
D + ++MAPE R Y + DV+SF ++L+E+ G P +
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
Query: 370 EAAKYVAEGHRPFFRAKGFT-PELRELTEKCWAADMNQRPSFLDILKRL 417
E + + EG R RA +T PE+ + CW + +QRP+F ++++ L
Sbjct: 290 EFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 59/183 (32%), Positives = 94/183 (51%), Gaps = 13/183 (7%)
Query: 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFA--LDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L+ +Y GDL + +K + + + + A L I +A H +IHRD+K N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVF 347
L S +K+GDFG SK+ S DV G T G+ Y+APE+++ + Y KK D+F
Sbjct: 176 LC--SNGLVKLGDFGFSKMYAATVSDDV----GRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 348 SFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQ 406
S ++LYE+L + P E K +A + P +PE++E+ ++D +
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL--PPSISPEMQEIVTALLSSDPKR 287
Query: 407 RPS 409
RPS
Sbjct: 288 RPS 290
|
Length = 496 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IGKG GE+ AY VA+K+I LS++ L+ + F E + L HP IV
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLK---EKGALSP----STAVNFALDI----ARGMAY 270
++ P+ Y+ G L LK +K +LS T+V L I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN--------------SHD 316
+H++ ++HRDLKP N+LL + + D+G + K++
Sbjct: 129 VHSKG--VLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+ G+ YMAPE + D+++ +ILY+ML
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLR 213
D+ +IG+G+FGE+ + T L LS ++ + F E +++
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGM 268
P +VQ A + + L ++ EY+ GGDL + EK A + V ALD M
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
+ IHRD+KP N+LL S HLK+ DFG + N + + G+
Sbjct: 162 GF--------IHRDVKPDNMLLDKSG--HLKLADFGTCMKM---NKEGMVRCDTAVGTPD 208
Query: 329 YMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 363
Y++PEV K + Y ++ D +S + LYEML G+ P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-15
Identities = 38/86 (44%), Positives = 55/86 (63%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A N V KLL E+ + V+A+D D RTPLH+A+ +G +++ K L+E GADVNA+D
Sbjct: 11 LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARD 70
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ NTPL A ++++LL HG
Sbjct: 71 KDGNTPLHLAARNGNLDVVKLLLKHG 96
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-15
Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT L A V+ LLE+ V+ARD D TPLH+A+ +G +DV K L+++GAD
Sbjct: 41 RTPLH-LAAKNGHLEIVKLLLEKGAD-VNARDKDGNTPLHLAARNGNLDVVKLLLKHGAD 98
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELL 120
VNA+D+ TPL A +++LL
Sbjct: 99 VNARDKDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQF 220
+IG+GS+ ++L + T A+K I L +D I + E ++ HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + E++ GGDL +++ + L A ++ +I+ + +LH II+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLK NVLL + H+K+ D+G+ K + + G+ Y+APE+ + Y
Sbjct: 120 RDLKLDNVLL--DAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
VD ++ ++++EM+ G P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ ++S +G G++G + A + G VAIK++ + + +R
Sbjct: 7 NKTVWEL---PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T E + L+ Y++ DL K + LS
Sbjct: 64 -ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKV 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 120 QYLVYQMLCGLKYIHSAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------HAD 168
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
+MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +++G+G FGE+ ++ G A+K + S+ + + F E ++L P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNE 274
I Q A ++ L L+ EY GGDL L + + A + ++ + +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
V HRD+KP NVL+ H+K+ DFG + + N K+ G+ Y+APEV
Sbjct: 122 GYV--HRDIKPENVLI--DRTGHIKLADFGSAARLTA-NKMVNSKLP--VGTPDYIAPEV 174
Query: 335 FK------HRKYDKKVDVFSFAMILYEMLEGEPPLA 364
Y + D +S +I YEM+ G P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 252 LSPSTA---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
SP T + ++ +ARGM +L + IHRDL RN+LL S + +K+ DFGL++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR- 222
Query: 309 IKVQNSHDVYKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361
D+YK GS R +MAPE + Y + DV+SF ++L+E+ G
Sbjct: 223 -------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 275
Query: 362 PLANYEPYEA-AKYVAEGHRPFFRAKGF-TPELRELTEKCWAADMNQRPSFLDILKRL 417
P + E + + +G R RA TPE+ + CW D +RP+F +++ L
Sbjct: 276 PYPGVQINEEFCQRLKDGTR--MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
D+ +IG+G+FGE+ L + V ++L SD F E +++
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 99
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
P +VQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M +IHRD+KP N+LL HLK+ DFG +K+ + V T G+
Sbjct: 160 SMG--------LIHRDVKPDNMLL--DKHGHLKLADFG--TCMKMDETGMVRCDTA-VGT 206
Query: 327 YRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 363
Y++PEV K + Y ++ D +S + L+EML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-15
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
PS +F I +G+FG++ A+K + + ++ ++ + E + L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ P IV ++ + L+ EYL GGD+ L G AV + ++A + YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
H IIHRDLKP N+L+ N H+K+ DFGLSK+
Sbjct: 121 HRHG--IIHRDLKPDNMLISNEG--HIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+PN ++ +VT K +LI +Y++ GDL LK++G LS + + + LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ IIH D+K NVL + + D + + D+GL K+I + +D G+ Y +PE
Sbjct: 128 --HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPE 176
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
K YD D ++ ++ YE+L G+ P E
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 49/258 (18%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +IGKG+FGE+ ++ G A+K +L S + + + E ++L + P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V + + + L LI E+L GGDL L + S + + + +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 324
IHRD+KP N+L+ H+K+ DFGLS Q+ Y+ + G++
Sbjct: 122 --FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 325 --------------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMI 352
G+ Y+APE+F + Y ++ D +S I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 353 LYEMLEGEPPLANYEPYE 370
++E L G PP + +E
Sbjct: 238 MFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVA 184
S + S P L SEL+ IG G+ G + K R T A
Sbjct: 57 SSSSSASGSAP-SAAKSL----------SELE--RVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 185 IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH- 243
+K I + +D + Q R E+ +L + HPN+V+ + ++ E++ GG L
Sbjct: 104 LKVIYGN-HEDTVRRQICR-EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 244 KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
++ ++ L+ + A I G+AYLH I+HRD+KP N LL+N SA ++K+ DF
Sbjct: 162 THIADEQFLA-----DVARQILSGIAYLHRRH--IVHRDIKPSN-LLIN-SAKNVKIADF 212
Query: 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEV----FKHRKYDKKV-DVFSFAMILYEMLE 358
G+S+++ + + G+ YM+PE H YD D++S + + E
Sbjct: 213 GVSRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 359 GEPPLA 364
G P
Sbjct: 269 GRFPFG 274
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 25/262 (9%)
Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
D I+G G+ G + KAY +A+K I ++ + + + E+ +L K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P I+ F GA + + TE++ GG L Y + A+ + +G+ YL +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRD+KP N +LVN+ +K+ DFG+S + V + Y G+ YMAPE
Sbjct: 115 K--ILHRDVKPSN-MLVNTRG-QVKLCDFGVSTQL-VNSIAKTY-----VGTNAYMAPER 164
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-------PYEAAKYVAEGHRPFFRAKG 387
+Y DV+S + E+ G P + P + + + + P
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 388 FTPELRELTEKCWAADMNQRPS 409
F+ + +C +RP+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQ 200
NK WE+ P + + +G G++G + AY VA+K++ SL R +
Sbjct: 7 NKTVWEV-PER--YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSP 254
+ R LL ++H N++ L T + L+T L G DL+ +K + LS
Sbjct: 64 ELR----LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ-KLSD 117
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ RG+ Y+H+ IIHRDLKP NV VN + L++ DFGL++ +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDCE-LRILDFGLAR-----QA 168
Query: 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGE 360
D +MTG + Y APE+ + Y++ VD++S I+ E+L+G+
Sbjct: 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-13
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 3/83 (3%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A + V+ LLE+ + D T LH+A+ +G +++ K L+E+GADVNA+D+
Sbjct: 5 AKNGNLELVKLLLEKGADV---NLGDTDTALHLAARNGNLEIVKLLLEHGADVNAKDKDG 61
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
NT L A +++LL HG
Sbjct: 62 NTALHLAARNGNLEIVKLLLEHG 84
|
Length = 91 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
E ++L + HP+I+Q G T K LI + DL+ YL K ++ + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
R + YLH N IIHRD+K N+ +N D + +GDFG + N++ Y G
Sbjct: 192 LRAIQYLHE--NRIIHRDIKAENIF-INHPGD-VCLGDFGAACFPVDINANKYY---GWA 244
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
G+ APE+ Y VD++S ++L+EM L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 203 RHEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
R E +L +R P +V A L LI +Y+ GG+L +L ++ ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
+I + +LH II+RD+K N+LL S H+ + DFGLSK Y
Sbjct: 112 GEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 322 GETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPL 363
G + YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 168 G---TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 89/364 (24%), Positives = 149/364 (40%), Gaps = 101/364 (27%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE L F +G G+FG++++A G VA+K + S
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGK--TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81
Query: 193 SDDR--------------------------------LVIQDFRHEVNLLVKLRHP----- 215
+D+R LVI ++ +LL LR
Sbjct: 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141
Query: 216 NIVQFLGAVTER----KPLMLITEYLRGGD------LHKYLKEKGALSPSTA-------- 257
N V L ++E K + L +Y+R Y++ + S S+
Sbjct: 142 NFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201
Query: 258 -------------VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
+ F+ +A+GM +L ++ IHRD+ RNVLL + K+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRV--AKICDFG 257
Query: 305 LSKLIKVQNSHDVYKMTGETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359
L++ I + +S+ V K G+ R +MAPE Y + DV+S+ ++L+E+ G
Sbjct: 258 LARDI-MNDSNYVVK-----GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311
Query: 360 EPP----LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ P L N + Y+ K + RP F PE+ + + CW + +RP+F I +
Sbjct: 312 KSPYPGILVNSKFYKMVKRGYQMSRPDFAP----PEIYSIMKMCWNLEPTERPTFSQISQ 367
Query: 416 RLEK 419
+++
Sbjct: 368 LIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
+IG+GS+ ++L + A+K + L D I + E ++ + +P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L L+ EY+ GGDL +++ + L A +A +I + +LH II+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLK NVLL + H+K+ D+G+ K + ++ + G+ Y+APE+ + +
Sbjct: 120 RDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGDTTSTF-----CGTPNYIAPEILRGEE 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIK----RIL--PSLSDDRLVIQDFRHEVNLLVK 211
+F ++G G++G++ K ++L +L ++ R E N+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+R P +V A L LI +Y+ GG++ +L ++ S ++ +I + +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH I++RD+K N+LL S H+ + DFGLSK + Y G YM
Sbjct: 121 LHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI---EYM 173
Query: 331 APEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPL 363
APE+ + + + K VD +S ++++E+L G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F IG+G++G++ KA + G VA+K++ + I R E+ +L +L H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--------------LSPSTAVNFAL 262
IV VT+++ D + K+KGA L S V+F+
Sbjct: 68 IVNLKEIVTDKQ------------DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 263 D--------IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
D + G+ Y H + +HRD+K N+LL N +K+ DFGL++L NS
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG--QIKLADFGLARLY---NS 168
Query: 315 HDVYKMTGETGSYRYMAPE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ T + + Y PE + +Y +DV+S IL E+ +P
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
+ E ALS V F+ +A GM +L ++ V HRDL RNVL+ +
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV--HRDLAARNVLICEGKL--V 278
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM- 356
K+ DFGL++ I +++S+ + K G T ++MAPE + Y DV+SF ++L+E+
Sbjct: 279 KICDFGLARDI-MRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 357 -LEGEP----PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 410
L G P P+ N + Y A K G+R + + E+ E+ +KCW RP F
Sbjct: 336 TLGGTPYPELPM-NEQFYNAIK---RGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDF 389
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + R FR E N+LV
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
I A + L L+ +Y GGDL L + P F + ++ + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 275 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
V HRD+KP NVLL +N H+++ DFG +K+ V + + G+ Y++PE
Sbjct: 122 HYV--HRDIKPDNVLLDMNG---HIRLADFG--SCLKMNQDGTV-QSSVAVGTPDYISPE 173
Query: 334 VFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 363
+ + KY + D +S + +YEML GE P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRIL--PSLSDDRLVIQDFRHEVNLL---------- 209
IIG GSFG + +A T VAIK++L P + L+I + +N++
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIA 265
K NI FL V E P + HKY+K AL ++ +
Sbjct: 133 FKKNEKNI--FLNVVMEFIPQTV----------HKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 324
R +AY+H++ I HRDLKP+N LL++ + LK+ DFG +K L+ Q S
Sbjct: 181 RALAYIHSK--FICHRDLKPQN-LLIDPNTHTLKLCDFGSAKNLLAGQRS------VSYI 231
Query: 325 GSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APE+ Y +D++S I+ EM+ G P
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 42/122 (34%), Positives = 55/122 (45%), Gaps = 6/122 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A DA R LL + RDYD RTPLH+A +G + V + L+E+GAD D+
Sbjct: 90 AASGDAVGARILLTGGAD-PNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 102 NTPLADAEGAKKFNMMELLNAHG--GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDF 159
TPL AE +++LL+ H G N PP L D I DF
Sbjct: 149 KTPLELAEENGFREVVQLLSRHSQCHFELGANAKPDSFTGKPPSLE---DSPISSHHPDF 205
Query: 160 SS 161
S+
Sbjct: 206 SA 207
|
Length = 664 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 45/247 (18%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+FGE+ T A+K + + R + E ++L + + +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ ++ L + +Y+ GGD+ L G A + ++ + +H IHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRD 126
Query: 283 LKPRNVLLVNSSADHLKVGDFGLS------------------------------------ 306
+KP N+L+ H+K+ DFGL
Sbjct: 127 IKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 307 -KLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
K ++ + + + G+ Y+APEV Y + D +S +ILYEML G+PP
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 364 ANYEPYE 370
P E
Sbjct: 245 LADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + R FR E ++LV
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
I A + L L+ +Y GGDL L + P F L ++ + +H
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKMTGETGSYRYM 330
V HRD+KP NVLL H+++ DFG L VQ++ V G+ Y+
Sbjct: 122 GYV--HRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAV-------GTPDYI 170
Query: 331 APEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 13/186 (6%)
Query: 240 GDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
++ L + G+ L+ ++F +ARGM +L ++ V HRDL RNVLL +
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--HRDLAARNVLL--AQGKI 275
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ I ++ Y G T ++MAPE Y DV+S+ ++L+E+
Sbjct: 276 VKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 357 --LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 414
L G P + G+R + T E+ ++ KCW ++ +RPSFL +
Sbjct: 333 FSLGGTPYPGMIVDSTFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
Query: 415 KRLEKI 420
+E +
Sbjct: 392 DIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY G VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---------- 266
T +K L L+ E L +L + + LD R
Sbjct: 83 VFTPQKSLEEFQDVYLVME-LMDANLCQ------------VIQMDLDHERMSYLLYQMLC 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
G+ +LH+ IIHRDLKP N+ +V S LK+ DFGL++ + + MT +
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNI-VVKSDCT-LKILDFGLAR-----TAGTSFMMTPYVVT 180
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359
Y APEV Y + VD++S I+ EM+ G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + A+ G VA+K++ + + +R E+ LL + H NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL---------HN 273
T +K L E+ D++ ++ A + ++ LD R M+YL H
Sbjct: 88 VFTPQKSL---EEF---QDVYLVMELMDA-NLCQVIHMELDHER-MSYLLYQMLCGIKHL 139
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
IIHRDLKP N+++ + LK+ DFGL++ + MT + Y APE
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTN-----FMMTPYVVTRYYRAPE 192
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEG 359
V Y + VD++S I+ E+++G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 62/279 (22%), Positives = 120/279 (43%), Gaps = 22/279 (7%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
I+ ++D +S +I + I K + V I+ +++I +E+ L +
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR 74
Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
+ NI++ G V + L LI EY G L + L ++ LS T ++ A+D +G
Sbjct: 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKG 134
Query: 268 MAYLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ L+ N+P +++L + L+ + LK+ GL K++ +V M
Sbjct: 135 LYNLYKYTNKP----YKNLTSVSFLVTENYK--LKIICHGLEKILSSPPFKNVNFMV--- 185
Query: 325 GSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y + ++ +Y K D++S ++L+E+ G+ P N E + +
Sbjct: 186 ----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
E++ + E C + D +RP+ +IL L K
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 165 IGKGSFGE-ILKAYWRGTPVA---IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG G FG+ +L + T VA +K + + S +F + + L+HPNI+Q
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV----NFALDIARGMAYLHNEPN 276
LG E P +L+ EY GDL YL ++ ++ + A +IA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEV 334
+H DL RN L +S +KVGD+G I + Y T + R++APE+
Sbjct: 120 -FLHSDLALRNCFL--TSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 335 FKHR-------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386
+ K +V++ + L+E+ E P ++ E +V + + K
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ----QVK 228
Query: 387 GFTPELR--------ELTEKCWAADMNQRPSFLDILKRL 417
F P+L E+ + CW + +R + ++ + L
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLSP-EKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
KL+HPNIV+ +G K LI EY+ G +L + L+ LS A+ IA+ + +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 271 LHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH P V++ +L P +++ HL++ L L+ + S
Sbjct: 796 LHCRCSPAVVVG-NLSPEKIIIDGKDEPHLRLS---LPGLLCTDTKCFI--------SSA 843
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEA----AKYV-AEGH--- 379
Y+APE + + +K D++ F +IL E+L G+ P A + + + A+Y ++ H
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 380 --RPFFRAKGFTPELRELTE------KCWAADMNQRPSFLDILKRLE 418
P R + E+ E C A D RP D+LK LE
Sbjct: 904 WIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + A+K + R FR E ++LV +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-------ALDIARGM 268
I A + L L+ +Y GGDL L + P F A+D +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
Y +HRD+KP N+L+ H+++ DFG +K+ V + + G+
Sbjct: 122 HY--------VHRDIKPDNILM--DMNGHIRLADFG--SCLKLMEDGTV-QSSVAVGTPD 168
Query: 329 YMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 363
Y++PE+ + KY + D +S + +YEML GE P
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-10
Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 32 VSRTSLILWHA-HQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
+ T L A + V+ LLE V+A+D D T LH+A+ +G +++ K L+E+
Sbjct: 25 LGDTDTALHLAARNGNLEIVKLLLEHGAD-VNAKDKDGNTALHLAARNGNLEIVKLLLEH 83
Query: 91 GADVNAQD 98
GAD+N +D
Sbjct: 84 GADINLKD 91
|
Length = 91 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/259 (23%), Positives = 104/259 (40%), Gaps = 53/259 (20%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLRH 214
F +G G+FGE+ A R + +L +++++ + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V+ + ++ L + +Y+ GGD+ L G A + ++ + +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL---------SKLIKV-----QNSHDVYKM 320
IHRD+KP N+L+ H+K+ DFGL SK + Q+S D
Sbjct: 121 G--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 321 TGETGSYR-----------------------------YMAPEVFKHRKYDKKVDVFSFAM 351
G+ + R Y+APEV Y + D +S +
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 352 ILYEMLEGEPPLANYEPYE 370
ILYEML G+PP P E
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV---QFL 221
+G+G++G + KA + + L + + + R E+ LL +L+HPN++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67
Query: 222 GAVTERKPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+ ++RK + L+ +Y H K K+ L S + I G+ YLH
Sbjct: 68 LSHSDRK-VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 274 EPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y A
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRA 183
Query: 332 PE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
PE + R Y K +D+++ I E+L EP
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 52/293 (17%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F +G G+FGE+ A T A+K + +R + + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+V+ + ++ L + +Y+ GGD+ L A + ++ + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG- 121
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK----------------- 319
IHRD+KP N+L+ H+K+ DFGL + ++ Y+
Sbjct: 122 -FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 320 -----------MTGE---------------TGSYRYMAPEVFKHRKYDKKVDVFSFAMIL 353
T E G+ Y+APEV + Y + D +S +IL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 354 YEMLEGEPPLANYEPYEAAKYVA--EGHRPFFRAKGFTPELREL-TEKCWAAD 403
+EML G+PP P E V E +PE +L T+ C +A+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 62/272 (22%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 165 IGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G+G+F +I K R T V +K + S R + F +++ +L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-- 273
++V G +++ EY++ G L YLK+ L + + L++A+ +A+ +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---WKLEVAKQLAWALHFL 116
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
E + H ++ +NVLL+ +K+ D G+S I V ++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVL-PKEIL-----LERI 168
Query: 328 RYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPFFRA 385
++ PE ++ + D +SF L+E+ G + PL+ + + ++ + H+ A
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ--LPA 226
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRL 417
+T EL L +C + + RPSF I++ L
Sbjct: 227 PKWT-ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
E+++L + H I+ + A + + ++ + DL Y+ G L A+ +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+AYLH IIHRD+K N+ L ++ +GDFG + K+ D + G +
Sbjct: 195 LEALAYLHGRG--IIHRDVKTENIFLDEP--ENAVLGDFGAA--CKLDAHPDTPQCYGWS 248
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
G+ +PE+ Y K D++S ++L+EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
+G+G++G + KA + L + + + R E+ LL +L+HPN++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 225 TER--KPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ + L+ +Y H K K+ L + I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 275 PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y AP
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRAP 184
Query: 333 E-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
E + R Y K +D+++ I E+L EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 223 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
T +K L + I L +L + ++ + L + G+ +LH+
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 338 RKYDKKVDVFSFAMILYEMLEG 359
Y + VD++S I+ EM++G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-09
Identities = 28/58 (48%), Positives = 38/58 (65%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
ARD D RTPLH+A+ +G ++V K L+E GADVNA+D TPL A +++LL
Sbjct: 2 ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLL 59
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 26/244 (10%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-MLITEYLRGGD 241
V +K + PS D L F +L+ ++ H ++ F+ V R +++ E++ G
Sbjct: 47 VVLKVLDPSHRDIALA---FFETASLMSQVSHIHLA-FVHGVCVRGSENIMVEEFVEHGP 102
Query: 242 LHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-----NSSA 295
L L KEKG + + + A +A ++YL ++ ++H ++ +N+LL ++
Sbjct: 103 LDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTS 160
Query: 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILY 354
+K+ D G+S + V ++ ++APE D +SF L
Sbjct: 161 PFIKLSDPGVS-FTALSREERVERIP-------WIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 355 EM-LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413
E+ +GE PL P E ++ + HR + EL L +C + QRPSF I
Sbjct: 213 EICFDGEVPLKERTPSEKERFYEKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTI 269
Query: 414 LKRL 417
L+ L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-08
Identities = 18/33 (54%), Positives = 26/33 (78%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
D TPLH+A+ +G ++V K L+E GADVNA+D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 204 HEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTA 257
HE LL +L HP ++ L G +T +++ +Y DL+ YL L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYLGARLRPLGLAQV 262
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
A + + Y+H E IIHRD+K NV LVN D + +GDFG + + S
Sbjct: 263 TAVARQLLSAIDYIHGEG--IIHRDIKTENV-LVNGPED-ICLGDFGAACFARGSWSTPF 318
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
+ G G+ APEV Y VD++S ++++E
Sbjct: 319 H--YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
T +K L L+ E L +L + ++ + L + G+ +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 140 -IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 337 HRKYDKKVDVFSFAMILYEML 357
Y + VD++S I+ EM+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 41 HAHQNDAAAVRKLLE--EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ + + + LLE D + + RD D TPLH A+L+G D+ + L+E GAD N+++
Sbjct: 118 NPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRN 177
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+ T L A + +++LL G
Sbjct: 178 SYGVTALDPAAKNGRIELVKLLLDKGL 204
|
Length = 235 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
PN+V + + L+ ++ GG L ++ + + +A ++ + LH E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+ RDL P N+LL H+++ F + +V++S D GE Y APEV
Sbjct: 105 G--IVCRDLNPNNILL--DDRGHIQLTYFS--RWSEVEDSCD-----GEAVENMYCAPEV 153
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEG 359
+ + D +S IL+E+L G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 14/118 (11%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE + L F +G G+FG++++A G VA+K + PS
Sbjct: 21 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 249
+R + E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 79 LTER---EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 50/232 (21%)
Query: 165 IGKGSFG----EILKAYWRGTPVAIKRI-LPSLSDDRLV-IQDFRHEVNLLVKLRHPNIV 218
IGK + K T VA+K+I L S S + L +Q E+ +L+HPNI+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNIL 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFAL-DIARGMAYLHNEP 275
++ + L +++ + G LK L P A+ F L D+ + Y+H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIHS-- 119
Query: 276 NVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQNSHDVY 318
IHR +K ++LL + V DF S +K
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS-VKNLP----- 173
Query: 319 KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
+++PEV + + Y++K D++S + E+ G P +
Sbjct: 174 ----------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 29/155 (18%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRH--- 214
+I KG+ I + G IK R+ P L D+R+ + R+E LL + R
Sbjct: 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPEL-DERIRRERTRNEARLLSRARKAGV 59
Query: 215 --PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
P + + ++ EY+ G L ++E +I R + LH
Sbjct: 60 NTPVVYDV-----DPDNKTIVMEYIEGKPLKDVIEEGN-------DELLREIGRLVGKLH 107
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I+H DL N+++ D L + DFGL K
Sbjct: 108 K--AGIVHGDLTTSNIIV---RDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
P LP WE+ L + +G G+FG +++A G VA+K +L S +
Sbjct: 23 PMQLPYDSAWEMPRDNLVLGRT--LGSGAFGRVVEATAHGLSHSQSTMKVAVK-MLKSTA 79
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
Q E+ ++ L H NIV LGA T+ P+ +ITEY R GDL YL
Sbjct: 80 R-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK--AYW--RGTPV---AIKRILPSLS 193
P LP WE L I+G G+FG++++ AY R PV A+K + P+
Sbjct: 23 PMQLPYDSRWEFPRDGLVLGR--ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
Q E+ ++ L H NIV LGA T+ P+ +ITEY GDL YL
Sbjct: 81 SSEK--QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 7e-06
Identities = 15/30 (50%), Positives = 24/30 (80%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
D TPLH+A+ +G +++ K L+E+GAD+NA
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADINA 30
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 67/292 (22%)
Query: 180 GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
GT V ++ L + +++ L ++EV L RHPNI+ T L +I+ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKA--LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 239 GGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
G + LK +S + N RG+ YLH N IHR++K ++L+ S D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILI---SGD 137
Query: 297 HLKVGDFGLSKLIKV----QNSHDVYKMTG-ETGSYRYMAPEVFKH--RKYDKKVDVFSF 349
L V GLS L + Q + VY T +++PE+ + Y+ K D++S
Sbjct: 138 GL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 350 AMILYEMLEGEPPLAN---------------YEPYEAAKYVAEG---------------- 378
+ E+ G P + Y P + + E
Sbjct: 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGE 256
Query: 379 ----------------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL 414
P +K F+P + L E C D +RPS +L
Sbjct: 257 SVVAAGMTQTMTSERLRTP--SSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-05
Identities = 16/38 (42%), Positives = 23/38 (60%)
Query: 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
RT LH A++ G +++ K L+E G D+N D NT L
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTAL 38
|
Length = 54 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 165 IGKGSFGEILKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
I +G+ EI + G IK R P L D+R+ + R E ++ + R +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PEL-DERIRRERTRREARIMSRARKAGV 61
Query: 218 -VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
V + V + ++ EY+ G + LK+ + + + +I R + LH+
Sbjct: 62 NVPAVYFVDPENFI-IVMEYIEG----EPLKDLINSNGMEELELSREIGRLVGKLHS--A 114
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
IIH DL N++L S + + DFGL++
Sbjct: 115 GIIHGDLTTSNMIL---SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-05
Identities = 18/53 (33%), Positives = 32/53 (60%)
Query: 53 LLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
LLE ++A D + TPLH+A+ +G +++ + L++ G D+N +D T L
Sbjct: 1 LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--- 79
D+ + + A + D V+ LL V+A+D D TPLH+A+L+G
Sbjct: 62 VDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGAD-VNAKDADGDTPLHLAALNGNPP 120
Query: 80 --WIDVAKCLIEYGA---DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
I+VAK L+E GA N +D NTPL A +++ELL G
Sbjct: 121 EGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGA 171
|
Length = 235 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 15/33 (45%), Positives = 22/33 (66%)
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
MAPEV + + Y +K D++S + LYE L+ E P
Sbjct: 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 30/244 (12%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
V +K + PS D L F +++ ++ H +IV G +++ E++ G L
Sbjct: 35 VILKVLDPSHRDISLA---FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 243 HKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---- 297
++ K L+ A +A ++YL E ++H ++ +N+LL D
Sbjct: 92 DLFMHRKSDVLTTPWKFKVAKQLASALSYL--EDKDLVHGNVCTKNILLAREGIDGECGP 149
Query: 298 -LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYE 355
+K+ D G+ I V + + + ++APE + K D +SF L+E
Sbjct: 150 FIKLSDPGIP--ITVLSRQECVERI------PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
Query: 356 M-LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP---ELRELTEKCWAADMNQRPSFL 411
+ GE PL + E ++ TP EL +L C D NQRP F
Sbjct: 202 ICYNGEIPLKDKTLAEKERFYEGQCMLV------TPSCKELADLMTHCMNYDPNQRPFFR 255
Query: 412 DILK 415
I++
Sbjct: 256 AIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 3e-05
Identities = 15/55 (27%), Positives = 27/55 (49%), Gaps = 1/55 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
+ + A V+ LLE+ ++ D D T LH+A+ +G ++V K L+
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVD-INRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)
Query: 163 AIIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+I +G+ I + G P +K RI P L D++L + R E +L K R
Sbjct: 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPEL-DEKLRRERTRREARILAKAREAG 60
Query: 217 I-VQFLGAVTERKPLMLIT-EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ V + V LI EY+ G L L+E + ++ R + LH
Sbjct: 61 VPVPIVYDVDP--DNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK- 110
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I+H DL N++L S + DFGL +
Sbjct: 111 -AGIVHGDLTTSNIIL---SGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 2/96 (2%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
K +T L +A + K+L E + V+ D + P+H+A H + D+ K L+
Sbjct: 120 KDAELKT--FLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLL 177
Query: 89 EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
E GA N +D +PL +A + ++LL HG
Sbjct: 178 EKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHG 213
|
Length = 434 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 1e-04
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 2/49 (4%)
Query: 72 LHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
LH+A+ +G +++ K L+E GADVN D +T L A +++LL
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLL 47
|
Length = 91 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 2e-04
Identities = 16/30 (53%), Positives = 24/30 (80%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
D RTPLH+A+ +G ++V K L++ GAD+NA
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADINA 30
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 52/241 (21%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEV 206
+ID S F +++G+G+FG++++A+ R V I R +P + +D + E+
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT------RDAKIEI 176
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH------KY-------LKEKGALS 253
+ K+R + +R PLM I Y + H KY + + G S
Sbjct: 177 QFMEKVRQAD-------PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--------------HLK 299
+ Y H E + ++H DLKP N+L+ S ++
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359
+ D G + + T + Y +PEV + D++S I+YE+ G
Sbjct: 289 ICDLG-------GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 360 E 360
+
Sbjct: 342 K 342
|
Length = 467 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA-KKFNMMEL 119
V+ D N +PLH A H + L+E GA +A+D+ NTPL + G K +++++L
Sbjct: 194 VNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKL 253
Query: 120 LNAHG 124
L HG
Sbjct: 254 LLEHG 258
|
Length = 477 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 17/111 (15%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRIL--PSLSDDRLVIQ 200
WE L ++G G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLRLGK--VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMS 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEK 249
E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L +L+ K
Sbjct: 60 ----ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 26/80 (32%), Positives = 39/80 (48%)
Query: 44 QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103
+ D AV +LL+ + D TPLH+A++ +D+ K LI GAD + + K +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFS 137
Query: 104 PLADAEGAKKFNMMELLNAH 123
PL A +ELL H
Sbjct: 138 PLHLAVMMGDIKGIELLIDH 157
|
Length = 413 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
A + V+ LL+ + V+ARD D RTPLH+A+ +G ++V K L+
Sbjct: 81 ARNGNLDVVKLLLKHG-ADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 50 VRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
+ KLL E V+A+ Y T LH S+ K L+EYGAD+N+ + +K TPL+ A
Sbjct: 250 ILKLLLEHGVDVNAKSYILGLTALHS-SIKS-ERKLKLLLEYGADINSLNSYKLTPLSSA 307
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 4/73 (5%)
Query: 39 LWHAHQNDAAA--VRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVN 95
L HA Q + + V KLLE V+A++ TPL++ + +G+ + + LI GADVN
Sbjct: 277 LHHASQAPSLSRLVPKLLERGAD-VNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVN 335
Query: 96 AQDRWKNTPLADA 108
A DR TPL A
Sbjct: 336 AADRLYITPLHQA 348
|
Length = 682 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/64 (35%), Positives = 35/64 (54%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D + +T LH A G ++ K L EYGADVN +D P+ A F++++LL
Sbjct: 117 VNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLL 176
Query: 121 NAHG 124
G
Sbjct: 177 LEKG 180
|
Length = 434 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 38/159 (23%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+IGKG+ +I K + G IK R+ P L D+RL + R E LL + R +
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL-DERLRTERTRAEARLLSEARRAGV 398
Query: 218 VQFLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
P++ ++ EY+ G DL L+ + +
Sbjct: 399 ---------PTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG--------NPELVRKVGEIV 441
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
A LH I+H DL N ++ + D L + DFGL K
Sbjct: 442 AKLHK--AGIVHGDLTTSNFIVRD---DRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDRW 100
+ + VR LLE V+A + TPLH+ + +DV K LI+ GADVNA+D+
Sbjct: 58 SSEKVKDIVRLLLEAGAD-VNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKV 116
Query: 101 KNTPL 105
TPL
Sbjct: 117 GRTPL 121
|
Length = 471 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.71 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.71 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.71 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.7 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.69 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.68 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.68 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.67 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.67 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.67 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.66 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.65 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.65 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.64 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.64 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.64 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.64 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.63 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.63 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.63 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.63 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.63 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.62 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.6 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.6 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.6 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.59 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.59 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.59 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.59 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.58 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.58 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.57 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.56 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.55 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.53 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.52 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.52 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.52 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.52 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.5 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0515 | 752 | consensus p53-interacting protein 53BP/ASPP, conta | 99.48 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=392.40 Aligned_cols=248 Identities=29% Similarity=0.506 Sum_probs=224.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-cEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 234 (435)
+.+.+..||+|..|+||+++++ ++.+|+|.+.. ..++...+++.+|+++++.++||+||++++.|..+. .++|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 5567889999999999999997 77899999843 334555688999999999999999999999998888 499999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+||||.++++..+++++....+++.++++||.|||+ ++ ||||||||+|||+ +..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLv--NskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLV--NSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeee--ccCCCEEeccccccHHhhhh-
Confidence 999999999999998999999999999999999999996 66 9999999999999 99999999999999877643
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...++.||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...+....|..+..|.++...+
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 346789999999999999999999999999999999999999999764 6678888899988887776669
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
|+++++||..||++||.+|||+.|+++|=
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 99999999999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-53 Score=402.62 Aligned_cols=273 Identities=45% Similarity=0.758 Sum_probs=236.0
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECCCc-EEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
..|.++...+ ...+.||+|+||+||++.|+|+. ||+|++......... .+.|.+|+.+|.+++|||||+++|++.+
T Consensus 34 ~~~~i~~~~l--~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDEL--PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHHh--hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456665544 44456999999999999999998 999998765544444 6899999999999999999999999998
Q ss_pred CC-cEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEee
Q 013833 227 RK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGD 302 (435)
Q Consensus 227 ~~-~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~D 302 (435)
.. .++|||||+++|+|.+++.+ ...++...+++++.||++||+|||++++ ||||||||+|||+ +..+ ++||+|
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv--~~~~~~~KI~D 187 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILV--DLKGKTLKIAD 187 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEE--cCCCCEEEECC
Confidence 87 79999999999999999987 5789999999999999999999999765 9999999999999 8887 999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccC--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGH 379 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~ 379 (435)
||+++...... ..+....||+.|||||++. ...|+.|+||||||+++|||+||..||.+.........+. .+.
T Consensus 188 FGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 188 FGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL 263 (362)
T ss_pred Cccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 99998765432 1334478999999999999 6699999999999999999999999999999877766665 555
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCccc
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 431 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 431 (435)
+|..+ ..+++.+..++.+||..||+.||++.+++..|+.+...+..+..|.
T Consensus 264 Rp~~p-~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~ 314 (362)
T KOG0192|consen 264 RPPIP-KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED 314 (362)
T ss_pred CCCCC-ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence 55544 4599999999999999999999999999999999998887765553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=408.44 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=235.7
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
..++...+|..++.||+|||+.||.+++ .|..||+|++.+....+....+.+.+|+++.++|+|||||+++++|++.+
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 3444557899999999999999999997 48899999998877666777789999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|||+|+|..++|..++++.++++|.+++.+++||+.||.|||+.+ |||||||..|+++ +++.+|||+|||||..
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL--~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFL--NENMNVKIGDFGLATQ 167 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheee--cCcCcEEecccceeee
Confidence 99999999999999999999999999999999999999999999988 9999999999999 9999999999999999
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
+...+. ...+.||||.|.|||++....++..+||||+||++|-|+.|++||...+-.+....|....... |..+
T Consensus 168 le~~~E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~--P~~l 241 (592)
T KOG0575|consen 168 LEYDGE----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM--PSHL 241 (592)
T ss_pred ecCccc----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc--cccc
Confidence 886644 4567899999999999999999999999999999999999999999998888888888766544 4478
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+.++||..+|+.||.+|||+++++.+
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=393.67 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=220.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHH----HHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL----VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..|.+.+.||+|+||.|-+|..+ |+.||||++.+....... ......+|+++|++|+|||||+++++|+..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 36778899999999999999875 889999999776544311 123356999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~ 309 (435)
||||||++||.|.+++-.++.+.+.....+++|++.|+.|||++| |+||||||+|||+..+ .+-.+||+|||+|...
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999 9999999999999444 4467999999999987
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCC---CcchHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFRA 385 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 385 (435)
.... .+.+.||||.|.|||++.++.+. .++|+||+||+||-+++|.+||.+..... ..++|.+|...+.++
T Consensus 330 g~~s-----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 330 GEGS-----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccce-----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 6322 57789999999999999876543 47899999999999999999998765444 778899988777654
Q ss_pred --CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 --KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 --~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..++++..+||.+||..||++|||+.++|++
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 5689999999999999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=399.34 Aligned_cols=263 Identities=33% Similarity=0.602 Sum_probs=233.1
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECCC-cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
...|+++.. .+...+.||+|.||+||.|.+++. .||+|.++..... .+.|.+|+.+|++|+|++||++++++.
T Consensus 198 ~d~wei~r~--~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPRE--ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHH--HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 567887755 346677999999999999999977 8999988654332 267889999999999999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
.++.+|||||||+.|+|.+||+. .+.+...+.+.++.||++||+||++++ +|||||.+.|||| +.+..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV--~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILV--DEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheee--ccCceEEEccc
Confidence 98899999999999999999997 446899999999999999999999988 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|||+..... .+....+..-+..|.|||++....|+.+||||||||+||||+| |+.||.+++..+..+.+.+|++.+
T Consensus 348 GLAr~~~d~---~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 348 GLARLIGDD---EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred ccccccCCC---ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 999944322 2223334456789999999999999999999999999999999 999999999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+ ..||+++.+++..||..+|++|||++.+...|+.+...
T Consensus 425 ~P-~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RP-EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CC-CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 65 47999999999999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=380.63 Aligned_cols=249 Identities=33% Similarity=0.526 Sum_probs=225.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|+++++||+|+||+|++++.+ ++.+|+|++.+........++...+|..+|.+++||+||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 37899999999999999999875 7789999998876666666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+.||.|.-.|.+.+.++++.+..++.+|+.||.|||++| ||||||||+|||+ |.+|+++|+|||+++.....+.
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILL--d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILL--DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeee--cCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999998 9999999999999 9999999999999985543322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
...+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+.....+.+..+..+.. +..++.+.++
T Consensus 181 ----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-p~~ls~~ard 255 (357)
T KOG0598|consen 181 ----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-PGYLSEEARD 255 (357)
T ss_pred ----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-CccCCHHHHH
Confidence 34568999999999999999999999999999999999999999999999999999998875543 3458999999
Q ss_pred HHHHHhhhcccCCC----CHHHHH
Q 013833 395 LTEKCWAADMNQRP----SFLDIL 414 (435)
Q Consensus 395 li~~cl~~dp~~Rp----s~~~ll 414 (435)
++..+|..||++|. ++.++.
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhh
Confidence 99999999999995 455544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-52 Score=379.17 Aligned_cols=251 Identities=35% Similarity=0.611 Sum_probs=218.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|...+.||+|+||+||+|+++ +..||||.+.+... .....+-+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 6888888999999999999986 78999999876543 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CC---CcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SA---DHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~---~~vkl~Dfg~a~~~~~ 311 (435)
||+||+|.+|+++.+.+++.+++.++.||+.||++||+++ ||||||||+|||+... .. -.+||+|||+|+.+.+
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999977 9999999999999543 22 4699999999998875
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 390 (435)
.. ...+.+|++.|||||++....|+.|+|+||+|+++|++++|..||...+..+....+..+.... ..+..++.
T Consensus 168 ~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 168 GS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 43 3456799999999999999999999999999999999999999999999988887777655332 23345677
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.+++...++.+|.+|.++.+.+.+
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhh
Confidence 78899999999999999888775543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-53 Score=367.89 Aligned_cols=253 Identities=30% Similarity=0.547 Sum_probs=221.9
Q ss_pred CCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeee-eE-EeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG-AV-TERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~-~~~~~~~lv 233 (435)
+|++.++||+|+||+||++.. +|..+|.|.+.-... +....++...|+.+|++|+|||||++++ .+ .+...++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 689999999999999999986 488999998874333 4555688999999999999999999998 34 444558999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhc--CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~--~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
||+|.+|+|.++++. ...+++.++++++.|++.||..+|+ ..+.|+||||||.||++ +.+|.|||.|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeeccchhHh
Confidence 999999999999874 3459999999999999999999999 33449999999999999 999999999999999
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.+..... ......|||.||+||.+...+|+.+|||||+||++|||..-++||.+.+-.+..++|.++..|+.+...
T Consensus 177 ~l~s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 177 FLSSKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred HhcchhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 9875432 345678999999999999999999999999999999999999999999999999999999888877778
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+|.+++.+|..|+..||+.||+.-.++..+
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 999999999999999999999854444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=379.31 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=230.4
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
..+|..++.||.|+|++|++|..+ ++.||||++.+.....+..++....|-.+|.+| .||.|++++-.|.|+..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 448999999999999999999975 778999999877766666677788999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|+||+++|+|.++|++.|.|++..++.++.||+.||+|||++| ||||||||+|||+ +.+++++|+|||.|..+.+.
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILL--d~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILL--DKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeE--cCCCcEEEeeccccccCChh
Confidence 9999999999999999999999999999999999999999988 9999999999999 99999999999999988765
Q ss_pred Ccc------c-ccc--ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 313 NSH------D-VYK--MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 313 ~~~------~-~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
... . ... ...+.||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+.+...+.+.|......+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f- 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF- 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC-
Confidence 432 1 111 145789999999999999999999999999999999999999999999999988888765544
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.++++.+++||+++|..||.+|++.+||.+|
T Consensus 307 -p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 -PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 45799999999999999999999999988766
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=351.14 Aligned_cols=237 Identities=31% Similarity=0.568 Sum_probs=220.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||.|+||.|.+++.+ |..+|+|++.+...-+-..++...+|.++|+.+.||+++++++.+.+.+.+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 7888999999999999999986 77899999877655555566788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||-|..++++.++|+++.++.++.||+.||+|||+++ |++|||||+|||+ |.+|.+||+|||+|..+...
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLl--D~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLL--DQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeee--ccCCcEEEEeccceEEecCc---
Confidence 9999999999999999999999999999999999999988 9999999999999 99999999999999987632
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.-+.||||.|+|||++..+.|...+|.|+|||++|||+.|.+||.+.++..+..+|.++.-.+ |..+++++++|
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f--P~~fs~~~kdL 271 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF--PSYFSSDAKDL 271 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC--CcccCHHHHHH
Confidence 345799999999999999999999999999999999999999999999999999999987655 45689999999
Q ss_pred HHHHhhhcccCC
Q 013833 396 TEKCWAADMNQR 407 (435)
Q Consensus 396 i~~cl~~dp~~R 407 (435)
+..+|+.|-.+|
T Consensus 272 l~~LL~vD~t~R 283 (355)
T KOG0616|consen 272 LKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhhhhHhh
Confidence 999999999999
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=349.15 Aligned_cols=385 Identities=28% Similarity=0.419 Sum_probs=315.0
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
..-|.|.-|+.|.+||++ |+++++..+++.|+..|+.||.++....||||+||.+||-++|+.||+..+|||+.|..|
T Consensus 23 tehdln~gddhgfsplhw--aakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehg 100 (448)
T KOG0195|consen 23 TEHDLNVGDDHGFSPLHW--AAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHG 100 (448)
T ss_pred cccccccccccCcchhhh--hhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccC
Confidence 344677778889999976 778889999999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCCCCCCC-------------------CCCC-CCcccCC-------
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPP-------------------LPNK-CDWEIDP------- 154 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~~~~~~-------------------~~~~-~~~~~~~------- 154 (435)
+|||||||..|...+++-|+..|+.++..|+..+.|.....+ .|.+ ..|.-..
T Consensus 101 ntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdat 180 (448)
T KOG0195|consen 101 NTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDAT 180 (448)
T ss_pred CCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccc
Confidence 999999999999999999999999999988887766433222 1211 1222110
Q ss_pred -------CCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 155 -------SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 155 -------~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
+........+|.....|+.|+|+|+|..++.|++.......+ ...+|..|.-.|+-+.||||+.+++.+...
T Consensus 181 lsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 181 LSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 011122345788999999999999999999998755433322 336799999999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
..+.++..||+.|||..+++.... .+..++.+++.++++|+.|||+..+-|----|.+..++++++-..++...|--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 999999999999999999987543 688999999999999999999986444444789999999443333444445433
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCC---CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRP 381 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~ 381 (435)
+. +..+....|.||+||.+..++.+ ..+|+|||.+++|||.|...||.+..+.+...++. ++.++
T Consensus 340 sf-----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv 408 (448)
T KOG0195|consen 340 SF-----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV 408 (448)
T ss_pred ee-----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence 32 23345568899999999877654 57999999999999999999999999999887766 56666
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
.++ .++++.+..++.-|...||.+||.++.++-.|+++.
T Consensus 409 ~ip-pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIP-PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCC-CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 554 579999999999999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=361.95 Aligned_cols=257 Identities=30% Similarity=0.545 Sum_probs=212.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC--cEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 232 (435)
.+|...+.||+|+||.||++... |...|||.+..... .. .+.+.+|+++|.+++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 46788899999999999999986 68899998754421 11 577899999999999999999999754444 6899
Q ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCccccc
Q 013833 233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIK 310 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~ 310 (435)
+|||+++|+|.+++.+.+ .++++.+.++.+||++||.|||++| ||||||||+|||+ +. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILL--DPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEE--eCCCCeEEeccCccccccc
Confidence 999999999999999877 7999999999999999999999988 9999999999999 77 6899999999998776
Q ss_pred ccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCC-CCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGH-RPFFRAKG 387 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~ 387 (435)
... ..........||+.|||||++..+ .....+|||||||++.||+||.+||.. ....+....+.... .| ..+..
T Consensus 170 ~~~-~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ 247 (313)
T KOG0198|consen 170 SKG-TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDS 247 (313)
T ss_pred ccc-ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcc
Confidence 411 111123356799999999999853 334599999999999999999999997 45444444444333 44 34556
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+|++.++|+..|+..||++||||.++|++.....+
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999998665443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-49 Score=372.68 Aligned_cols=247 Identities=31% Similarity=0.561 Sum_probs=222.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|.....||+|+.|.||.+... ++.||||.+.......+ +-+.+|+.+|+.++|+|||.+++.|..++.+|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 6777889999999999999865 67899999866544332 567899999999999999999999988899999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||+||+|.|++... .+++.++..+++++++||.|||.+| |+|||||.+|||+ ..+|.+||+|||++..+.....
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL--~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILL--TMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEe--ccCCcEEEeeeeeeeccccccC-
Confidence 99999999999754 4999999999999999999999988 9999999999999 8888999999999988765432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 394 (435)
...+..|||.|||||++....|+++.||||||++++||+.|.+||-..++......+.....|.+. +..+|++|++
T Consensus 425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 345678999999999999999999999999999999999999999999999888888888777654 4679999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
|+.+||..|+++|+++.+||+|
T Consensus 502 FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999976
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=366.73 Aligned_cols=250 Identities=32% Similarity=0.543 Sum_probs=224.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
...|+...+||+|+||.||+|.+. ++.||+|++.-... +..++++.+|+.+|.+++++||.++++.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 346788899999999999999985 67899999865443 34568999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||||.||++.+.++....+++.++..++++++.||.|||+++ .+|||||+.|||+ ..+|.+||+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~--s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILL--SESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeE--eccCcEEEEecceeeeeechh
Confidence 999999999999988777799999999999999999999998 9999999999999 677999999999998765432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
....++.|||.|||||++....|+.++||||||++.+||.+|.+||.+..++.....|.+..+|.+.. .+++.++
T Consensus 166 ----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~k 240 (467)
T KOG0201|consen 166 ----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFK 240 (467)
T ss_pred ----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHH
Confidence 23467899999999999998999999999999999999999999999999987777777777776665 8999999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||..||.+||+.||+|.+|+++
T Consensus 241 EFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 241 EFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHhhcCcccCcCHHHHhhh
Confidence 99999999999999999999976
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=351.85 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=225.1
Q ss_pred cCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 152 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.......|++..+||.|..++||+|+.. +..||||++.-+..... ++.+++|+..|+.++||||++++-.|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 3334458999999999999999999985 77899999966555443 6889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
+|+||.||.+||+.+.++.. ..+++..+..++++++.||.|||.+| .||||||+.|||+ +.+|.|||+|||.+.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi--~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILI--DSDGTVKLADFGVSA 174 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEE--cCCCcEEEcCceeee
Confidence 99999999999999999873 34999999999999999999999988 9999999999999 999999999999887
Q ss_pred cccccCccccccccCCCcCccccCccccC--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR- 384 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 384 (435)
.+...+.........+.||+.|||||++. ...|+.|+||||||++..||.+|..||..+.+......-.++..|...
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 76665544443347789999999999953 457999999999999999999999999999999887776676665322
Q ss_pred -------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 -------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 -------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.++..++.+|..||++||++|||+.+++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 13467789999999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=366.37 Aligned_cols=251 Identities=33% Similarity=0.539 Sum_probs=219.4
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-cH-HHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-DR-LVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 230 (435)
...|.+++.||+|+||.|+.|.+. +..||+|++.+.... .. ...+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 347999999999999999999874 789999976554222 11 23356778999999999 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC-CcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~-~~vkl~Dfg~a~~~ 309 (435)
++||||+.||+|.+++.+.+++.+.++..+++||++|++|||++| |+||||||+|||+ +.+ +++||+|||++...
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENill--d~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILL--DGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEe--cCCCCCEEEecccccccc
Confidence 999999999999999999889999999999999999999999998 9999999999999 777 99999999999877
Q ss_pred cccCccccccccCCCcCccccCccccCCCC-CC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... ....+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|..||.+.+.......+..+.... +..
T Consensus 172 ~~~~----~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~--p~~ 245 (370)
T KOG0583|consen 172 PGED----GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI--PSY 245 (370)
T ss_pred CCCC----CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC--CCC
Confidence 4111 1456789999999999999877 86 78999999999999999999999988888888877765443 345
Q ss_pred C-CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 388 F-TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 388 ~-~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+ +++++.|+.+||..||.+|+++.+++.+
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 6 9999999999999999999999999944
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=372.04 Aligned_cols=249 Identities=30% Similarity=0.465 Sum_probs=225.7
Q ss_pred CCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|++++.||+|+.|.|-+|++ +|+.+|||++.+...........+.+|+-+|+-+.||||+.++++|++...+|+|+||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 66778999999999999997 4999999999776444444446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
++||-|++++.++|++++.++.++++||+.|+.|||..+ |+||||||+|+|+ +..++|||+|||+|.......
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLL--d~~~nIKIADFGMAsLe~~gk--- 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLL--DVKNNIKIADFGMASLEVPGK--- 166 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhh--hcccCEeeeccceeecccCCc---
Confidence 999999999999999999999999999999999999988 9999999999999 888889999999998654332
Q ss_pred cccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
...+.||+|.|+|||++.+.+|+ .++||||.|||||.|+||+.||++.+-.....++..|.... +..+|+++++|
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M--Ps~Is~eaQdL 242 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM--PSNISSEAQDL 242 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC--CCcCCHHHHHH
Confidence 35678999999999999999986 79999999999999999999999999888888898887543 57899999999
Q ss_pred HHHHhhhcccCCCCHHHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
|.+||..||++|.|.+||++|-.
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHhccCccccccHHHHhhCch
Confidence 99999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=342.31 Aligned_cols=249 Identities=24% Similarity=0.453 Sum_probs=207.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+.+.++|+|+||+||+|+++ |+-||||++..+. +++...+-..+|+++|++++|||+|.++.+|.....+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 6888889999999999999986 7889999986543 334444556799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+. ++.+-+.+ ...++.+.+..++.|++.|+.|+|+.+ +|||||||+|||+ ..+|.+||||||+|+.+..++.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILI--TQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEE--ecCCcEEeccchhhHhhcCCcc
Confidence 9977 55555555 345889999999999999999999987 9999999999999 8999999999999998875332
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF---------- 383 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 383 (435)
..+....|.+|.|||.+.+ ..|+.++|||++||++.||++|.+-|++....+....|........
T Consensus 157 ----~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 157 ----NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred ----hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2345677999999999876 7899999999999999999999999999887665444332211110
Q ss_pred ----------C------C---CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 ----------R------A---KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ----------~------~---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+ + ..++.-+.+|+..||..||++|++.+|++++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 0 2345668899999999999999999999965
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=360.89 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=222.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|+.++.||+|+||.||+|+.+ |..+|+|+++++......+++..+.|-.+|....+|+||+++..|.+.+.+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 48999999999999999999865 8899999999887777778889999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||++..+|.+.+.|+++.+..++.+++.|++.||+.| +|||||||+|+|| |..|++||+||||+.-+.....
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLi--D~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLI--DAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheee--cCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999 9999999999999 9999999999999865432100
Q ss_pred c-------------------ccc-----c-------------------ccCCCcCccccCccccCCCCCCCcchHHHHHH
Q 013833 315 H-------------------DVY-----K-------------------MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAM 351 (435)
Q Consensus 315 ~-------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 351 (435)
. +.. . .....|||-|+|||++.+..|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 000 0 11236999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHHHhhhcccCCCC---HHHHHHH
Q 013833 352 ILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELRELTEKCWAADMNQRPS---FLDILKR 416 (435)
Q Consensus 352 il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 416 (435)
|+|||+.|.+||.+.++.+..+.|.... ..+.....++++.++||.+|+. ||++|.- ++||.+|
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 9999999999999999999998887655 3333345678999999999999 9999964 5555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=364.11 Aligned_cols=247 Identities=32% Similarity=0.531 Sum_probs=221.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||+|+.+ .+.||+|.+.+.... +..++.+.+|+++++.++||||+.++++|+....+|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6888899999999999999976 568999998765443 4456889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.| +|..++...+.++++++..++.++++||.|||+.+ |+|||+||+|||+ +..|.+|+||||+|+......
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILL--EKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeee--cCCCceeechhhhhhhcccCc--
Confidence 9977 99999999999999999999999999999999977 9999999999999 999999999999999776432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.......|||.|||||.+.+..|+..+|+|||||++||+++|++||....-....+.|.....+ ++...+..+..|
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nf 230 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNF 230 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHH
Confidence 2345678999999999999999999999999999999999999999988888888877764433 345789999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+..+|.+||..|.|..+++.|
T Consensus 231 l~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHhhcChhhcccHHHHhcC
Confidence 999999999999999999866
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=351.66 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=220.7
Q ss_pred CCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CC
Q 013833 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RK 228 (435)
Q Consensus 153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 228 (435)
+....+......||+|++|.||+|.++|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 33333444446899999999999999999999999876655555556788999999999999999999999876 35
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
.+++||||+++|+|.+++...+.+++.....++.|++.||.|||+. + ++||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill--~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLV--TENYKLKIICHGLEK 171 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEE--CCCCcEEEcccchHh
Confidence 6899999999999999999888899999999999999999999984 6 8899999999999 888999999999987
Q ss_pred cccccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.........+
T Consensus 172 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 244 (283)
T PHA02988 172 ILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244 (283)
T ss_pred hhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 654321 23457899999999976 689999999999999999999999999888777766665443333334
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..+++++++++.+||+.||++|||+.++++.|+.+..
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 4689999999999999999999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=360.78 Aligned_cols=268 Identities=33% Similarity=0.610 Sum_probs=232.7
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC---C---CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceee
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 220 (435)
.+.|++....+.+. ++||+|+||.||+|..+ + .+||+|..+.+.......+.++.+|+++|++++||||+++
T Consensus 149 r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 149 RQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 45699988877665 89999999999999874 2 2389998875444557778999999999999999999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEE
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vk 299 (435)
+|+.....++++|||+|.||+|.+++++++ .++..+..+++.+.+.||+|||+++ +|||||.++|+|+ +.++.+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~--~~~~~vK 302 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLY--SKKGVVK 302 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHhee--cCCCeEE
Confidence 999999999999999999999999999877 4999999999999999999999988 9999999999999 7777899
Q ss_pred EeeccCcccccccCcccccccc-CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH-H
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV-A 376 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~-~ 376 (435)
|+|||+++.-.... ... .-.-+..|+|||.+....|++++|||||||++||+++ |..||.+....+....+ .
T Consensus 303 ISDFGLs~~~~~~~-----~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYV-----MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred eCccccccCCccee-----eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 99999987543110 111 1135789999999999999999999999999999999 89999999999999888 5
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 377 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.+++...+ ...|.++..++.+||..+|++||++.++.+.|+.+.+....
T Consensus 378 ~~~r~~~~-~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 378 NGYRMPIP-SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCccCCCC-CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 56665544 46888999999999999999999999999999999887654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=345.16 Aligned_cols=249 Identities=27% Similarity=0.498 Sum_probs=229.0
Q ss_pred CCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
-+|++.+.||+|.||.|-++.. .|+.||||.++++..+++.-+-.+++|+++|+.|+||||++++.+|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3788999999999999999986 38999999999998888877788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||..+|.|.||+.+.+.+++.++..+++||.+|+.|||..+ ++|||||.+|||+ |.++++||+|||++..+....
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILL--D~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILL--DQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheee--cCCCCeeeeccchhhhhcccc-
Confidence 99999999999999999999999999999999999999977 9999999999999 999999999999998876433
Q ss_pred cccccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
...++||+|-|.+||++.+..|. +.+|-|||||+||-|+.|..||++.+-....++|..|.... ..-|....
T Consensus 208 ----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~ 280 (668)
T KOG0611|consen 208 ----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDAS 280 (668)
T ss_pred ----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHH
Confidence 35678999999999999999885 78999999999999999999999999999999999886544 23477889
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
-||..||..+|++|.|..++..+-
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhh
Confidence 999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=363.58 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=225.7
Q ss_pred CCCCcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
....|+|....+ ..++.||+|+.|.||+|+.++..||||+++. .-..++..|++|+|||||.+.|+|.
T Consensus 115 q~e~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 115 QEELWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hhhhccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeec
Confidence 445688875533 5567899999999999999999999997632 1135788999999999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
....+|||||||..|-|..+|+...++++.....|..+|+.||.|||... |||||||+-|||| ..+..|||+|||-
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLI--s~~d~VKIsDFGT 258 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILI--SYDDVVKISDFGT 258 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEe--eccceEEeccccc
Confidence 99999999999999999999999999999999999999999999999977 9999999999999 7777899999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
++...... ++..++||..|||||++.....++|+|||||||+||||+||..||.+.+...++.-+-.+......+
T Consensus 259 S~e~~~~S-----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 259 SKELSDKS-----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP 333 (904)
T ss_pred hHhhhhhh-----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc
Confidence 98765432 4566899999999999999999999999999999999999999999888776665555555555567
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..+|+.|+-||+.||+..|..||+++|++.||+...-
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 7899999999999999999999999999999987664
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=375.27 Aligned_cols=262 Identities=34% Similarity=0.581 Sum_probs=229.6
Q ss_pred CCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+....+.||+|+||.||+|... .+.||||.++... +....++|++|++++..++|||||+++|+|.+++.+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 4455679999999999999864 3469999886433 233558999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 231 MLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~--------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
|+|+|||..|+|.+||+.. ++++..+.+.++.||+.||+||-++. +|||||...|+|| .+.-
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLV--ge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLV--GENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhcee--ccce
Confidence 9999999999999999742 12788999999999999999999977 9999999999999 8888
Q ss_pred cEEEeeccCcccccccCcccccccc-CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~ 374 (435)
.|||+|||+++.+-. .+++... ...-+.+|||||.+..++|+++|||||+||+|||+++ |.-||.+....+.++.
T Consensus 641 ~VKIsDfGLsRdiYs---sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYS---SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhh---hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999997653 3444444 3345789999999999999999999999999999999 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCc
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 429 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 429 (435)
+..+.. ..-+.++|.++++|+..||+.+|++||++.||-..|+...+..+...+
T Consensus 718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 999887 444568999999999999999999999999999999999988776544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.06 Aligned_cols=258 Identities=29% Similarity=0.544 Sum_probs=210.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeC-
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER- 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 227 (435)
.+|++.+.||+|+||.||+|.+. +..||+|.+..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 47889999999999999999752 35799998864322 23346788999999999 899999999987654
Q ss_pred CcEEEEEecCCCCCHHHHHHHc----------------------------------------------------------
Q 013833 228 KPLMLITEYLRGGDLHKYLKEK---------------------------------------------------------- 249 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~---------------------------------------------------------- 249 (435)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998752
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCc
Q 013833 250 ----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325 (435)
Q Consensus 250 ----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~g 325 (435)
..+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....... ........+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~ 238 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKGSARL 238 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEE--cCCCcEEEeecccccccccCcc--hhcccCCCC
Confidence 23778888999999999999999988 9999999999999 7888999999999986543211 111223345
Q ss_pred CccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhc
Q 013833 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAAD 403 (435)
Q Consensus 326 t~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 403 (435)
++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+..+..+. .+..+++++.+++.+||+.|
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQGD 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHccCC
Confidence 788999999998999999999999999999997 99999876533 3334444444333 34568999999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHhh
Q 013833 404 MNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 404 p~~Rps~~~ll~~L~~~~~~ 423 (435)
|++|||+.++++.|+.+.++
T Consensus 318 p~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 318 PKERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=322.47 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=227.9
Q ss_pred CCCCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
....|.++ +|++++.||+|-||.||+|+.+ +--||+|++.++........+.+.+|+++.+.|+||||++++++
T Consensus 15 ~~~~~~l~----dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 15 ATKTWTLD----DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred cccccchh----hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34567776 7999999999999999999976 45699999877665444445778999999999999999999999
Q ss_pred EEeCCcEEEEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 224 VTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~l~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
|.+..+.|+++||..+|.|...+. ....+++.....++.|++.||.|+|.++ +|||||||+|+|+ +..|.+||+
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLl--g~~~~lkiA 166 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLL--GSAGELKIA 166 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhcc--CCCCCeecc
Confidence 999999999999999999999998 4567999999999999999999999987 9999999999999 889999999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
|||-+...... ...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+..+.+.+....
T Consensus 167 dfGwsV~~p~~------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~ 240 (281)
T KOG0580|consen 167 DFGWSVHAPSN------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK 240 (281)
T ss_pred CCCceeecCCC------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc
Confidence 99999865422 245679999999999999999999999999999999999999999998888888888765433
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
. +..++.+.+++|.+|+.++|.+|....|++++-.
T Consensus 241 ~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 F--PSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred C--CcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 3 3679999999999999999999999999998743
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=329.22 Aligned_cols=252 Identities=28% Similarity=0.461 Sum_probs=219.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|++.++||+|.|+.||++.+. |+.+|+|++........ ..+++.+|+++.+.|+||||+++++.+......|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 36888899999999999999875 77889998754433333 3478899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+|+|++|..-+-..-.+++..+..+++||+.+|.|+|..+ |||||+||+|+|+.. +...-+||+|||+|..+..+
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g- 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG- 166 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence 99999999766665566899999999999999999999977 999999999999944 34446999999999987722
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 391 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 391 (435)
....+..|||.|||||++...+|+.++|||+.||+||-|+.|.+||.+.+...+.+.|..+..-...+ ..++++
T Consensus 167 ----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 167 ----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred ----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 14677899999999999999999999999999999999999999999999888888888776433222 568999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++||.+||..||.+|.|+.+.|++
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCC
Confidence 9999999999999999999999865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=355.06 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=210.9
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+.||+|+||.||++.++ ++.||+|.+.+...........+.+|+.++++++||||+++++.+..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 7789999886544333444567789999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 241 sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
+|.+++...+.+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~----~~ 152 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCC----cc
Confidence 99999998888999999999999999999999988 9999999999999 8889999999999875332211 22
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHh
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 400 (435)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..+... .+..+++++++||.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHc
Confidence 3457999999999999999999999999999999999999999888776666666554332 23568999999999999
Q ss_pred hhcccCCC-----CHHHHHHH
Q 013833 401 AADMNQRP-----SFLDILKR 416 (435)
Q Consensus 401 ~~dp~~Rp-----s~~~ll~~ 416 (435)
..||++|| ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcC
Confidence 99999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=350.10 Aligned_cols=246 Identities=28% Similarity=0.496 Sum_probs=215.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||+|.+...........+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5788899999999999999986 78899998864333223344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEEecCcchhccCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999999765422
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..+.... +..+++.++++
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~l 228 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF--PRHLDLYAKDL 228 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC--CccCCHHHHHH
Confidence 123468999999999999999999999999999999999999999988877777776654332 34578999999
Q ss_pred HHHHhhhcccCCCC-----HHHHHHH
Q 013833 396 TEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
|.+||+.||.+||+ +.+++++
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99999999999995 8998876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=356.27 Aligned_cols=246 Identities=29% Similarity=0.510 Sum_probs=216.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+...........+.+.+|+.++++++||||+++++.+.+++.+|+|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 7899999999999999999986 67899998865432233345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.|++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--CCCCCEEEeeccCceEcCCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999999865422
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..+.... +..++..+++|
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 245 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF--PNWFDGRARDL 245 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC--CCCCCHHHHHH
Confidence 123568999999999999999999999999999999999999999888887777777664332 34588999999
Q ss_pred HHHHhhhcccCCCC-----HHHHHHH
Q 013833 396 TEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
|.+||+.||.+||+ +.+++.+
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999986 7888866
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.36 Aligned_cols=268 Identities=32% Similarity=0.580 Sum_probs=226.9
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
..|+|... .+.++..||+|.||+||+|.|-|. ||||++...... .+.++.|++|+.++++-+|.||+-+.|++...
T Consensus 385 ~~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPE--EVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHH--Hhhccceeccccccceeecccccc-eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 46777765 446788999999999999999886 999988765544 44789999999999999999999999999887
Q ss_pred CcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
.. .||+.+|+|.+|..+++.. ..|+..+.+.|++|+++||.|||.++ |||||||..||++ .+++.|||.|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl--~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFL--HEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEE--ccCCcEEEecccce
Confidence 66 9999999999999999853 45899999999999999999999988 9999999999999 77799999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---C
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---R 380 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~ 380 (435)
..-..-.... +.....|..-|||||++.. ..|++.+||||||+++|||++|..||....+..++..+-+|+ +
T Consensus 536 tvk~~w~g~~--q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 536 TVKTRWSGEQ--QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeeeecccc--ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 7544332111 2334567889999999864 478999999999999999999999999777777777777773 3
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+.....+++.++++|+..||.+++++||.+.+|+..|+.+..++++
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 3334467889999999999999999999999999988888775544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.59 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=209.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCC-cEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK-PLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~l 232 (435)
.+|.+.+.||.|.||.||+|+.+ +..||||.+++....-++ -.-.+|+..|++++ |||||++.+++.+.+ .+++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 47999999999999999999975 778999998766544222 22357999999999 999999999998887 8999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||||+. +|.++++.+ ..|+++.+..|+.||++||+|+|.+| +.|||+||+|||+ .+...|||+|||+|+.+.+
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi--~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILI--SGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEe--cccceeEeccccccccccc
Confidence 9999955 999999864 46999999999999999999999988 9999999999999 7677999999999998876
Q ss_pred cCccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----------- 379 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 379 (435)
.. ..+....|.+|.|||++. ...|+.+.|||++|||++|+.+-++-|++.+..+...+|.+-.
T Consensus 163 kp-----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP-----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC-----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 54 345667899999999975 5678999999999999999999999999998876655544211
Q ss_pred ----------CCCCCC-------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ----------RPFFRA-------KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ----------~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.|...+ ...++++.++|.+|+..||++||||.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 2367899999999999999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=337.71 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=224.4
Q ss_pred CCCCCCceeecCCceeEEEEEECC--CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|++++.||+|.-|+||++..++ +.+|+|++.+.....+..+.+...|-+||+.++||+++.+|..++.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 367888999999999999999986 689999998877666777888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+||+|...++++. .|+++.+..++.+++.||+|||..| ||+|||||+|||| .++|+|-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILv--redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILV--REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEE--ecCCcEEeeeccccccCCCC
Confidence 9999999999998743 5999999999999999999999999 9999999999999 99999999999997655221
Q ss_pred Cc------------------------------c-c---------------------cccccCCCcCccccCccccCCCCC
Q 013833 313 NS------------------------------H-D---------------------VYKMTGETGSYRYMAPEVFKHRKY 340 (435)
Q Consensus 313 ~~------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 340 (435)
.. . . ......+.||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0 0 011233579999999999999999
Q ss_pred CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCC----HHHHHHH
Q 013833 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPS----FLDILKR 416 (435)
Q Consensus 341 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~ 416 (435)
+..+|+|+|||++|||+.|..||.+.+..+....|......+.....++..+++||.++|.+||.+|.. |.+|-+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999999999988888776655545578899999999999999999987 7777654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=348.77 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=210.0
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+.||+|+||.||++.++ +..||+|.+.............+.+|+.+++.++||||+++++.+...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 7789999986544333444567788999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 241 sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
+|..++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~~ 152 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--cCCCCEEecccHHhccccCCCC----cc
Confidence 99999988888999999999999999999999988 9999999999999 8888999999999875322211 22
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHh
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 400 (435)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... .+..++++++++|.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLL 230 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 3457899999999999999999999999999999999999999888776666665544322 23568999999999999
Q ss_pred hhcccCCC-----CHHHHHHH
Q 013833 401 AADMNQRP-----SFLDILKR 416 (435)
Q Consensus 401 ~~dp~~Rp-----s~~~ll~~ 416 (435)
+.||++|| ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHcC
Confidence 99999998 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=349.22 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=210.7
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+.||+|+||.||++.++ +..||+|.+.+...........+.+|+.+++.++||||+++++.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 7789999987654333445577889999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 241 sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~~ 152 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLML--DKDGHIKITDFGLCKEGITDAA----TM 152 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEE--CCCCcEEEecCcCCccCCCccc----cc
Confidence 99999988888999999999999999999999988 9999999999999 8889999999999875332111 23
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHh
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 400 (435)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... .+..+++++.+||.+||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L 230 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLL 230 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc--CCCCCCHHHHHHHHHHc
Confidence 3457899999999999899999999999999999999999999887776666655544332 23568999999999999
Q ss_pred hhcccCCC-----CHHHHHHH
Q 013833 401 AADMNQRP-----SFLDILKR 416 (435)
Q Consensus 401 ~~dp~~Rp-----s~~~ll~~ 416 (435)
..||++|+ ++.+++++
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcC
Confidence 99999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=351.14 Aligned_cols=248 Identities=32% Similarity=0.463 Sum_probs=214.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.+. +..||+|++.+...........+.+|+.++..++||||+++++.+.++...|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5888999999999999999985 67899999865433333345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEEEeCcCCccccc----
Confidence 9999999999988888999999999999999999999988 9999999999999 8889999999999976543
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC------CCCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR------AKGFT 389 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 389 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......... ...++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 123457899999999999999999999999999999999999999988877665555432211111 12468
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++.++|.+||..+|++||++.+++++
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 999999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=344.64 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=212.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 231 (435)
...|+.++.||+|.||.||++++. |+.||+|++.-...+. .......+|+.+|++|+||||+++.+.+.+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346888999999999999999985 7789999987655443 3345667899999999999999999998776 6899
Q ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
||+|||+. +|.-++...+ .|++.++..++.||+.||+|||++| |+|||||.+|||| |.+|.+||+|||||+++.
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLi--dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILI--DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEE--cCCCCEEeccccceeecc
Confidence 99999977 8988887654 5999999999999999999999988 9999999999999 999999999999999887
Q ss_pred ccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---------- 379 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------- 379 (435)
..... ..+....|.+|.|||.+.+ ..|+...|+||.||||.||++|++.|++.+..+....|.+-.
T Consensus 270 ~~~~~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 270 PSGSA---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCCc---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 65432 2455678999999999876 579999999999999999999999999998877766554221
Q ss_pred --CCCC-------C--------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 --RPFF-------R--------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 --~~~~-------~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.|.. + ...+++...+|+..+|..||.+|.||.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0100 0 12467788899999999999999999998864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=351.90 Aligned_cols=246 Identities=27% Similarity=0.465 Sum_probs=215.7
Q ss_pred CCCCCceeecCCceeEEEEEECC---CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||+|.+++ ..||+|.+...........+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 78889999999999999998652 479999886543333334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEecCCCCeecCCC--
Confidence 99999999999998888999999999999999999999988 9999999999999 88899999999999765421
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++......+..+... .+..+++.+++
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 257 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--FPKFLDNNCKH 257 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHH
Confidence 22457899999999999888999999999999999999999999998887777777766433 24568999999
Q ss_pred HHHHHhhhcccCCC-----CHHHHHHH
Q 013833 395 LTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+|.+||+.||++|+ ++++++++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 89999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=346.88 Aligned_cols=242 Identities=29% Similarity=0.442 Sum_probs=208.4
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|+||.||++.+. +..||+|.+.+...........+.+|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 678999988654333344456788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccC
Q 013833 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (435)
Q Consensus 243 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 322 (435)
.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~~~~ 152 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDD----KTNT 152 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCC----cccc
Confidence 999988888999999999999999999999988 9999999999999 8889999999999875432211 2234
Q ss_pred CCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013833 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 402 (435)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 402 (435)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... .+..++++++++|.+||+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHcCC
Confidence 57899999999999999999999999999999999999999988877766666654332 2456899999999999999
Q ss_pred cccCCC---CHHHHHHH
Q 013833 403 DMNQRP---SFLDILKR 416 (435)
Q Consensus 403 dp~~Rp---s~~~ll~~ 416 (435)
||++|| ++.+++++
T Consensus 231 dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 231 DPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHcCCCCCHHHHHcC
Confidence 999997 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.95 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=217.3
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
..+|...++||+|+||.|+++..+ +..+|||.+++...-.+..++..+.|.+++...+ ||+++.++..|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 447889999999999999999987 5689999999887776777788999999998885 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+.||++..++ ..+.|++..+..++..++.||.|||++| |||||||.+|||+ |..|++||+|||+++..-..
T Consensus 447 vmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLL--D~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLL--DTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEE--cccCcEEecccccccccCCC
Confidence 99999999954444 3467999999999999999999999988 9999999999999 99999999999999865433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
+. ...+++|||.|||||++.+..|+..+|+|||||+||||+.|..||++.+..+....|...... .|..+|.+.
T Consensus 522 g~----~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~--yP~~ls~ea 595 (694)
T KOG0694|consen 522 GD----RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSKEA 595 (694)
T ss_pred CC----ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--CCCcccHHH
Confidence 32 467899999999999999999999999999999999999999999999999988888765432 356799999
Q ss_pred HHHHHHHhhhcccCCCCH
Q 013833 393 RELTEKCWAADMNQRPSF 410 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~ 410 (435)
.+++.++|.++|++|.-+
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 999999999999999744
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=339.52 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=205.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+..+.||+|+||+||++.+. ++.||+|.+.+...........+.+|+.++++++|++|+++++.+.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999874 78999998865433323333567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888643 35899999999999999999999988 9999999999999 888899999999997653221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHcCCCCCCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA----AKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 389 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+.... ...+..++
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~s 229 (285)
T cd05631 157 -----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--EEYSEKFS 229 (285)
T ss_pred -----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--ccCCccCC
Confidence 12345689999999999999999999999999999999999999987543222 22222211 12234689
Q ss_pred HHHHHHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
+++.+|+.+||+.||++||+ +++++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.08 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=211.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||++.++ ++.||+|++.+...........+.+|+.++.+++||||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5888999999999999999875 67899998865433333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++.+.+.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi--~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCCEEEeeccCcccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999998765321100
Q ss_pred c-------------------------------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 316 D-------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 316 ~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0 000123579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCC-CCC-CCCCCHHHHHHHHHHhh--hcccCCCCHHHHHHH
Q 013833 365 NYEPYEAAKYVAEGHRP-FFR-AKGFTPELRELTEKCWA--ADMNQRPSFLDILKR 416 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~cl~--~dp~~Rps~~~ll~~ 416 (435)
+.+..+....+...... .++ ...++++++++|.+++. .++..||++.+++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 88887777776653222 112 23478999999998664 233356899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=332.62 Aligned_cols=254 Identities=27% Similarity=0.481 Sum_probs=216.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.+.||+|+||.||+|.++ +..||+|.+..... ......+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 46888899999999999999763 45899998865432 233467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+||||+++++|.+++... +.+++.+++.++.|++.||+|||+++ ++||||||+||++ +.++.++++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili--~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLV--NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEE--cCCCcEEECCCccccccc
Confidence 999999999999999874 46899999999999999999999988 9999999999999 888899999999876543
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... ........++..|+|||.+.+..++.++|||||||++|++++ |..||.+....+....+.++..+.. +..++
T Consensus 159 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (266)
T cd05064 159 SEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-PRNCP 234 (266)
T ss_pred ccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-CCCCC
Confidence 221 111122345678999999999999999999999999999875 9999998888777777777655443 45689
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
..+.+++.+||+.+|++||++.++++.|.++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.16 Aligned_cols=253 Identities=30% Similarity=0.491 Sum_probs=225.6
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
...|++.+.||+|.||.||++..+ |+.+|+|.+.+.........+...+|+.+|++++ ||||+.+.++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 347888999999999999999986 7789999998776655445578899999999999 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC--CCcEEEeeccCccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--ADHLKVGDFGLSKLIK 310 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~--~~~vkl~Dfg~a~~~~ 310 (435)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.... ++.++++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999876 4999999999999999999999988 99999999999996543 3589999999999887
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGF 388 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 388 (435)
... .....+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+..+...+..+ ..+
T Consensus 191 ~~~-----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 191 PGE-----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred CCc-----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 622 4567899999999999999999999999999999999999999999999888888888776533222 467
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+..+++||..|+..||.+|+|+.++++|
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 8999999999999999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=313.98 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=209.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|...++||+|.||.||+|++. |+.||||+++.....+... ....+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 6788899999999999999985 8899999997665443222 345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+. +|..+++... .+++.++..++.++++|++|||++. |+||||||.|+|+ +++|.+||+|||+|+.+.+...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLI--SSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEE--cCCCcEEeecccchhccCCCCc
Confidence 9955 9999998744 6899999999999999999999987 9999999999999 9999999999999999887654
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCC----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPF---------- 382 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~---------- 382 (435)
.. .....|.+|.|||.+.+ +.|+...||||.||++.||+-|.+-|++.+..+....+.... .|.
T Consensus 157 ~~----~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQ----THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cc----ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 22 22367999999998865 679999999999999999999999999888766554433221 110
Q ss_pred -----------CC----CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----------FR----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----------~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ....+.+.-+|+..||..||.+|+++.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 02346778999999999999999999999876
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.37 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=209.5
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+.||+|+||.||++.++ +..||+|.+.+...........+.+|+++++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 7789999987654333444567788999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 241 sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
+|.+++.....+++.++..++.||+.||.|||+ .| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGA----T 152 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCc----c
Confidence 999999888889999999999999999999997 67 9999999999999 8889999999999875332211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... .+..+++++.++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~ 230 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGL 230 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 23456899999999999999999999999999999999999999888776666655544322 2356899999999999
Q ss_pred hhhcccCCC-----CHHHHHHH
Q 013833 400 WAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 400 l~~dp~~Rp-----s~~~ll~~ 416 (435)
|+.||++|+ ++.+++++
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcC
Confidence 999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.46 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=214.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||++.++ ++.||||.+.............+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6888999999999999999985 77899999865433333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++...+.+++.++..++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEeecccceeccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999998765322110
Q ss_pred ccc----------------------------------cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC
Q 013833 316 DVY----------------------------------KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361 (435)
Q Consensus 316 ~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~ 361 (435)
... ......||+.|+|||++....++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 000 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHHhhhcccCCCC---HHHHHHH
Q 013833 362 PLANYEPYEAAKYVAEGHRPFF--RAKGFTPELRELTEKCWAADMNQRPS---FLDILKR 416 (435)
Q Consensus 362 p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 416 (435)
||...+..+....+........ ....++++++++|.+|+. +|.+|++ +.+++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9998888777666655432221 223578999999999997 9999997 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.61 Aligned_cols=252 Identities=26% Similarity=0.439 Sum_probs=211.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++.++ +..+|+|.+.... .....+.+.+|++++++++||||+++++++..++.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 347899999999999999999986 6789999876432 233456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+++++|.+++.....+++..+..++.|++.||.|||++ .+|+||||||+|||+ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEE--cCCCcEEEccCccccccccc-
Confidence 99999999999998888899999999999999999999985 139999999999999 88889999999998765422
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------------------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY------------------- 374 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~------------------- 374 (435)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 158 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred -----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 12345689999999999998999999999999999999999999976554333221
Q ss_pred ---------------------------HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 375 ---------------------------VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 375 ---------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+.....+......+++++++||.+||+.||++|||+.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 11222222233357889999999999999999999999998853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=352.40 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=210.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+.++.||+|+||+||+|.++ +..||+|++.+...........+.+|+.++++++||||+++++.+.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999985 67899999865443344456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++.+.+.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++++||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili--~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE--CCCCCEEEeeCcCCccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999997643211000
Q ss_pred c-------------------------------------------cccccCCCcCccccCccccCCCCCCCcchHHHHHHH
Q 013833 316 D-------------------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (435)
Q Consensus 316 ~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 352 (435)
. ........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0 000123469999999999998899999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHHHh--hhcccCCCCHHHHHHH
Q 013833 353 LYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELRELTEKCW--AADMNQRPSFLDILKR 416 (435)
Q Consensus 353 l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~~ll~~ 416 (435)
+|||++|..||...+..+....+.... ........+++++++||.+|+ ..++..||++.+++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999877766555554322 112222358999999999854 5566669999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=338.54 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=216.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-----------cHHHHHHHHHHHHHHHhCCCCcceeeeeeE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 224 (435)
+|++.+.||+|.||.|-+|++. ++.||||++.+.... ....+++.++|+.+|++|.|||||+++.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 7999999999999999999985 788999998653211 112246788999999999999999999998
Q ss_pred Ee--CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 225 TE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 225 ~~--~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.+ .+.+|||+|||..|.+...-.....+++.+++.++++++.||+|||.+| ||||||||+|+|+ +++|+|||+|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl--~~~g~VKIsD 253 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLL--SSDGTVKISD 253 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEE--cCCCcEEeec
Confidence 66 4679999999988876544333333899999999999999999999999 9999999999999 8889999999
Q ss_pred ccCcccccccCcc-ccccccCCCcCccccCccccCCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 013833 303 FGLSKLIKVQNSH-DVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 303 fg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 377 (435)
||.+......... .........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....+...+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998866333111 111234478999999999987632 34789999999999999999999999999999999887
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
....+.....+.+.+++||.+||.+||+.|.+..++..|.....+
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 765554445678999999999999999999999999988765543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=348.10 Aligned_cols=264 Identities=31% Similarity=0.524 Sum_probs=213.0
Q ss_pred CCCCcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcc
Q 013833 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNI 217 (435)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 217 (435)
....|.++. .+|++.+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.+++.+ +||||
T Consensus 26 ~~~~~~~~~--~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 26 YDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINI 101 (375)
T ss_pred Cccccccch--HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcce
Confidence 334455543 36888999999999999999742 457999988643322 2346788999999999 89999
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC-----------------------------------------------
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------------------------------------- 250 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------------------------------------- 250 (435)
+++++++.++...++||||+++|+|.+++....
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 999999999999999999999999999986421
Q ss_pred ----------------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 251 ----------------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 251 ----------------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.++++.+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEE--ECCCcEEEec
Confidence 3678889999999999999999988 9999999999999 7778899999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY-EAAKYVAEGHR 380 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~-~~~~~~~~~~~ 380 (435)
||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+..+.+
T Consensus 258 fG~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 335 (375)
T cd05104 258 FGLARDIRNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335 (375)
T ss_pred CccceeccCcccc--cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence 9999866433211 11122335678999999999999999999999999999998 89999876543 33444555544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+. .+...+.++++|+.+||+.||++|||+.++++.|++.
T Consensus 336 ~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 ML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 33 2345788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=348.86 Aligned_cols=266 Identities=29% Similarity=0.488 Sum_probs=214.2
Q ss_pred CCCCCcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCc
Q 013833 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216 (435)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 216 (435)
|....|.+.. .+|++.+.||+|+||.||++.+. +..||+|.+...... .....+.+|+.+++.+ +|||
T Consensus 28 ~~~~~~~~~~--~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~n 103 (374)
T cd05106 28 PYNEKWEFPR--DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKN 103 (374)
T ss_pred cccccccccH--HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCc
Confidence 3444555543 37889999999999999999863 246999988654322 3346788999999999 8999
Q ss_pred ceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHc-----------------------------------------------
Q 013833 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------------------------------------- 249 (435)
Q Consensus 217 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------------------------------------- 249 (435)
|+++++.+.....+++||||+.+|+|.+++...
T Consensus 104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 999999999999999999999999999998642
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 250 -----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 250 -----------------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
.++++.++++++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~--~~~~~~kL~DfGla 259 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLL--TDGRVAKICDFGLA 259 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEE--eCCCeEEEeeceee
Confidence 13678889999999999999999988 9999999999999 77889999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHcCCCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA-KYVAEGHRPFFR 384 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~ 384 (435)
......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ..+..+..+. .
T Consensus 260 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~-~ 336 (374)
T cd05106 260 RDIMNDSNY--VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS-R 336 (374)
T ss_pred eeccCCcce--eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-C
Confidence 765432211 11122335678999999998899999999999999999997 99999876543333 3333333332 3
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
+..+++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3457899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=343.80 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=208.1
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||++.++ ++.||+|.+.+.........+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 678999988654332333446677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.++|+|||++........ .
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGK----T 152 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875432211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+... .+..++++++++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLSQDAVDILKAF 230 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 33457899999999999999999999999999999999999999988887777777655432 2345899999999999
Q ss_pred hhhcccCCCCH------HHHHHH
Q 013833 400 WAADMNQRPSF------LDILKR 416 (435)
Q Consensus 400 l~~dp~~Rps~------~~ll~~ 416 (435)
|+.||++||++ ++++++
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=361.45 Aligned_cols=263 Identities=34% Similarity=0.606 Sum_probs=234.2
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEEC--C---CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 224 (435)
.+|+++ ...+.++||.|.||+|++|..+ | ..||||.++.... +....+|..|+.||-+++||||+++.|++
T Consensus 624 kEId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 345544 4466779999999999999975 3 4799999876544 34457899999999999999999999999
Q ss_pred EeCCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 225 TERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 225 ~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
...+.++||.|||++|+|+.||+.+ +.|+.-++..+++.|++||+||.+++ +|||||.+.|||| +.+-.+|++||
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV--NsnLvCKVsDF 775 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV--NSNLVCKVSDF 775 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee--ccceEEEeccc
Confidence 9999999999999999999999874 57999999999999999999999999 9999999999999 99999999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+++.++... ...+...+..-+.+|.|||.+..++++..|||||+|+++||.++ |..||.++...+..+.|.++++.+
T Consensus 776 GLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 776 GLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred cceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 9999886654 33444555556789999999999999999999999999999888 999999999999999999999876
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++.+||..+.+|+..||++|-.+||.+.||+..|.++..
T Consensus 855 -pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 855 -PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 457899999999999999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=343.05 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=211.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC-cceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+.+.........+.+..|.+++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999986 568999988654333334456788899999999765 6888999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++|++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--cCCCCEEEeecCcceecCCCCC
Confidence 99999999999988888999999999999999999999988 9999999999999 8888999999999864322211
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...... .+..+++++.+
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 230 (324)
T cd05587 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVS 230 (324)
T ss_pred ----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence 223456899999999999999999999999999999999999999988887777777665432 23568999999
Q ss_pred HHHHHhhhcccCCCCH-----HHHHHH
Q 013833 395 LTEKCWAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~-----~~ll~~ 416 (435)
++.+||..||.+|++. .+++++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.85 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=216.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||+||+|.+. ++.||+|++.+...........+.+|+.++..++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5888999999999999999986 78999999865433333345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++.+.+.+++.+++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEeecCCCCccCcccCcc
Confidence 9999999999988888999999999999999999999988 9999999999999 88899999999999866543200
Q ss_pred -------------------------ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 013833 316 -------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (435)
Q Consensus 316 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 370 (435)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011234568999999999999999999999999999999999999999888777
Q ss_pred HHHHHHcC--CCCCCCCCCCCHHHHHHHHHHhhhcccCCCC-HHHHHHH
Q 013833 371 AAKYVAEG--HRPFFRAKGFTPELRELTEKCWAADMNQRPS-FLDILKR 416 (435)
Q Consensus 371 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~ 416 (435)
....+... .........+++++.+||.+||. ||.+||+ +.+++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 66666652 22222223479999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=351.90 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=210.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||||.+.+.........+.+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5888899999999999999875 77899998865433233445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++...+.+++..+..++.|++.||+|||+.| |+||||||+|||+ +.++.++|+|||+++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEEeeccccccccccccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999999643211000
Q ss_pred cc-------------------------------------------ccccCCCcCccccCccccCCCCCCCcchHHHHHHH
Q 013833 316 DV-------------------------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (435)
Q Consensus 316 ~~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 352 (435)
.. .......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00 00012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CC-CCCCCHHHHHHHHHHhhhcccCC---CCHHHHHHH
Q 013833 353 LYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FR-AKGFTPELRELTEKCWAADMNQR---PSFLDILKR 416 (435)
Q Consensus 353 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~ 416 (435)
+|||++|..||......+....+....... ++ ...++.++++||.+||. +|.+| +++.+++.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999887766666655432221 11 23578999999999997 67765 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=341.29 Aligned_cols=243 Identities=30% Similarity=0.487 Sum_probs=204.0
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||.||+|.++ +..||+|.+...........+.+..|..++.. .+||||+++++++..+..+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 56799998865433223334555667777765 4899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++.++..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~----~ 152 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEG----K 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999975432221 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.... +. .+..++.++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-PH-FPRWISKEAKDCLSKL 230 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CC-CCCCCCHHHHHHHHHH
Confidence 334578999999999998899999999999999999999999999888777666665433 22 2356899999999999
Q ss_pred hhhcccCCCCHH-HHHH
Q 013833 400 WAADMNQRPSFL-DILK 415 (435)
Q Consensus 400 l~~dp~~Rps~~-~ll~ 415 (435)
|+.||++||++. ++++
T Consensus 231 l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 231 FERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ccCCHHHcCCChHHHHc
Confidence 999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=342.01 Aligned_cols=244 Identities=30% Similarity=0.482 Sum_probs=208.6
Q ss_pred ceeecCCceeEEEEEE-----CCCcEEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+.||+|+||.||++.. .++.||+|.+..... ........+.+|+.+++.++||||+++++.+..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 367899998864321 1222335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+.+++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEeeCcCCeecccCCC--
Confidence 999999999998888999999999999999999999988 9999999999999 8889999999999875432221
Q ss_pred cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 396 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..+.... +..++++++++|
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li 231 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL--PPYLTPEARDLL 231 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHH
Confidence 1234568999999999998889999999999999999999999999888777766666654332 346899999999
Q ss_pred HHHhhhcccCCC-----CHHHHHHH
Q 013833 397 EKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 397 ~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
.+||+.||++|| ++.+++++
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcC
Confidence 999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=343.77 Aligned_cols=250 Identities=29% Similarity=0.505 Sum_probs=222.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc-EEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 233 (435)
..|..++.+|+|+||.++.++++ ++.+++|.+.-.....+.. ....+|+.++++++|||||.+.+.|.+++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 47899999999999999999876 6689999987665555443 467889999999999999999999998888 9999
Q ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+||+||+|.+.+.+.. .++++.+..|+.|++.|+.|||+.. |+|||||+.||++ ..++.|+|.|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFL--TKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhc--cccCceeecchhhhhhcCC
Confidence 99999999999998643 5899999999999999999999866 9999999999999 7788899999999998876
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..+ ...+..||+.||+||.+.+..|..|+|||||||++|||++-+++|...+-......+.++...+. +..++.+
T Consensus 159 ~~~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-p~~ys~e 233 (426)
T KOG0589|consen 159 EDS----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-PSMYSSE 233 (426)
T ss_pred chh----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-CccccHH
Confidence 542 23457899999999999999999999999999999999999999999998888888888774333 4568999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.+|..||+.+|+.||++.+++.+
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999999999999999999977
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=342.32 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=209.5
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
++||+|+||.||+|.++ ++.||+|.+.+...........+..|.+++..+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999986 568999998654333333446677889988866 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNGV----T 152 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeecccceecccCCc----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875432221 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... .+..+++++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSKEAVSILKAF 230 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 23456899999999999999999999999999999999999999998887777777665432 2345789999999999
Q ss_pred hhhcccCCC-------CHHHHHHH
Q 013833 400 WAADMNQRP-------SFLDILKR 416 (435)
Q Consensus 400 l~~dp~~Rp-------s~~~ll~~ 416 (435)
|+.||++|| ++.+++++
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcC
Confidence 999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=351.13 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=211.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+.++.||+|+||+||+|.++ ++.||+|.+.+...........+.+|+.++++++||||+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999985 67899998865433334455778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl--~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEeECCCCccccccccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88899999999997533211000
Q ss_pred -------------------------------------------ccccccCCCcCccccCccccCCCCCCCcchHHHHHHH
Q 013833 316 -------------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (435)
Q Consensus 316 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i 352 (435)
.........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000123468999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCCHHHHHHHHHHhhhcccCCCC---HHHHHHH
Q 013833 353 LYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTEKCWAADMNQRPS---FLDILKR 416 (435)
Q Consensus 353 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 416 (435)
+|||++|..||...++.+....+...... ......+++++.++|.+|+ .+|++|++ +.+++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999988877766665543222 1222468999999999976 59999987 8888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=341.38 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=211.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|.+.+.||+|+||.||++.++ +..||+|.+.+...........+..|..++..+ .||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778889999999999999986 568999988764433333445667788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++|+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEE--CCCCcEEEccCCCceecCCCCC
Confidence 99999999999988888999999999999999999999988 9999999999999 8889999999999875432211
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...... .+..+++++.+
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 230 (323)
T cd05616 157 ----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVA 230 (323)
T ss_pred ----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcCCHHHHH
Confidence 233457899999999999999999999999999999999999999998887777777665433 23568999999
Q ss_pred HHHHHhhhcccCCCCH-----HHHHHH
Q 013833 395 LTEKCWAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~-----~~ll~~ 416 (435)
++.+||+.||++|++. .+++++
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=341.50 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=207.6
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHH---HhCCCCcceeeeeeEEeCCcEEEE
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL---VKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
|++.+.||+|+||.||++.++ ++.||+|.+.+.........+.+.+|++++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999875 678999998654322233345666776655 566899999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++|++|..++.. +.+++.++..++.||+.||.|||+.| |+||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCcEEeCcccCCccCCCCC
Confidence 999999999988864 46999999999999999999999988 9999999999999 888999999999987543221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+..+... .+..+++++.
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~ 229 (324)
T cd05589 156 D----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSREAI 229 (324)
T ss_pred C----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 1 233467899999999999999999999999999999999999999988877776666655432 2356899999
Q ss_pred HHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 394 ELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
++|.+||+.||++|| ++.+++++
T Consensus 230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999999999 67887765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=335.03 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=205.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ +..||+|.+...... ....+.+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 5888999999999999999986 668999988654332 2234677899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++++.|..+......+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccCcccccccccc
Confidence 9988777666555567999999999999999999999988 9999999999999 88889999999999876432211
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--------------- 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------- 380 (435)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 157 ---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 12345689999999999988899999999999999999999999987665433222211100
Q ss_pred ------CCCC---------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ------PFFR---------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ------~~~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+... ...++.++.+||.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 01367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=330.64 Aligned_cols=253 Identities=32% Similarity=0.548 Sum_probs=216.0
Q ss_pred CCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||+|.+.+ ..|++|.+.... .......+.+|+.++++++||||+++++++.+....
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 68889999999999999998753 358999875432 233446789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+++|||+++++|.+++... ..++..+++.++.|++.||.|||+.+ ++||||||+||++ +.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~--~~ 159 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV--GE 159 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE--cC
Confidence 9999999999999999764 44788899999999999999999988 9999999999999 78
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++.++|+|||++........ ........+++.|+|||.+....++.++|||||||++|||++ |..||.+....+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88999999999976543221 111223456888999999988899999999999999999998 999999888888777
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.+..+..+.. +..+|+++.+|+.+||+.||.+||++.+++++|+.
T Consensus 238 ~i~~~~~~~~-~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCC-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 7776655443 45789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=350.43 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=210.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||+|.+.+...........+.+|++++++++||||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999975 67899998864332223334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEE--CCCCCEEEEeCCCCccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999997533210000
Q ss_pred ---------------------------------------ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHH
Q 013833 316 ---------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356 (435)
Q Consensus 316 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 356 (435)
.........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001234699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCCHHHHHHHHHHhhhcccCCC---CHHHHHHH
Q 013833 357 LEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTEKCWAADMNQRP---SFLDILKR 416 (435)
Q Consensus 357 ~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~ll~~ 416 (435)
++|..||.+..+.+....+...... ......+++++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999988876665555433221 1122358899999999977 5999999 99999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.56 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=208.8
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||++.++ +..||+|.+.+...........+.+|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 568999998754333333446677899999888 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++.+.+.+++.++..++.||+.||.|||+++ |+||||||+||++ +.++.++|+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGV----T 152 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEE--CCCCcEEecccCCCeecCcCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875322211 1
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+...... .+..+++++++||.+|
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSF 230 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHH
Confidence 23456899999999999999999999999999999999999999988877766666554332 2356899999999999
Q ss_pred hhhcccCCCCH-----HHHHHH
Q 013833 400 WAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 400 l~~dp~~Rps~-----~~ll~~ 416 (435)
|..||++||++ .+++++
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.98 Aligned_cols=243 Identities=29% Similarity=0.464 Sum_probs=203.9
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
++||+|+||.||++.++ +..||+|.+.+...........+..|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 678999988654322222335567788888754 899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++.++..++.|++.||+|||+.| |+||||||+|||+ +.++.++|+|||++........ .
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGDN----R 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEeCccCCCeecccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999874322111 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... . .+..++.+++++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~li~~~ 230 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-H-YPRWITKESKDILEKL 230 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C-CCCCCCHHHHHHHHHH
Confidence 3346789999999999999999999999999999999999999998887766666654432 2 2345899999999999
Q ss_pred hhhcccCCCCHH-HHHH
Q 013833 400 WAADMNQRPSFL-DILK 415 (435)
Q Consensus 400 l~~dp~~Rps~~-~ll~ 415 (435)
|+.||++||++. ++++
T Consensus 231 l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 231 FERDPTRRLGVVGNIRG 247 (316)
T ss_pred ccCCHHHcCCChHHHHc
Confidence 999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=366.36 Aligned_cols=259 Identities=34% Similarity=0.614 Sum_probs=223.9
Q ss_pred CCCCCceeecCCceeEEEEEEC---CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR---GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~---~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+..+.||+|+||.||.|... +. .||+|.+.+. .+.....+|.+|+.+|+.++||||++++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4466779999999999999874 32 3888877543 3455668999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 231 MLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+|++|||+||+|..||++. ..++....+.++.||++|++||+++. +|||||.+.|+|+ +....|||+||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL--~~~r~VKIaDF 846 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLL--DERRVVKIADF 846 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheee--cccCcEEEccc
Confidence 9999999999999999875 24899999999999999999999977 9999999999999 77789999999
Q ss_pred cCcccccccCccccccccCC-CcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
|+|+.+.. .+++..... .-+..|||||.+..+.|+.|+|||||||++||++| |..||.+....+....+.++.+.
T Consensus 847 GlArDiy~---~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 847 GLARDIYD---KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred chhHhhhh---chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 99994432 233333333 34679999999999999999999999999999999 99999999999988877777754
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
. ++..||..+.++|..||+.+|++||++..|++.+.++....-.
T Consensus 924 ~-~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 924 D-PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred C-CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 4 5568999999999999999999999999999999988865544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=341.33 Aligned_cols=264 Identities=35% Similarity=0.576 Sum_probs=211.3
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
.++...+.+|....+||+|+||.||+|...+ +.||||++....... ..+|.+|+.++.+++|||+++++|||.+.+
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 3455566789988999999999999999875 889999775543321 256999999999999999999999999988
Q ss_pred -cEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCC-CceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 -PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 -~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~-~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
..+||+|||++|+|.+++.... .++|.++++|+.++++||+|||+.. ++||||||||+|||+ |.+.++||+|||
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~aKlsDFG 222 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFNAKLSDFG 222 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCCEEccCcc
Confidence 4999999999999999998754 7999999999999999999999953 369999999999999 999999999999
Q ss_pred CcccccccCccccccccCC-CcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---H---HHH-HHHHH
Q 013833 305 LSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---P---YEA-AKYVA 376 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~---~~~-~~~~~ 376 (435)
+|+....... ..... .||.+|+|||++..+..+.|+|||||||++.||+||+.|.+... . .+. ...+.
T Consensus 223 La~~~~~~~~----~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 223 LAKLGPEGDT----SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CcccCCcccc----ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9965543111 11112 79999999999999999999999999999999999998877432 1 111 12222
Q ss_pred cC-----CCCCCCCCCCC--HH---HHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 377 EG-----HRPFFRAKGFT--PE---LRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 377 ~~-----~~~~~~~~~~~--~~---l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++ .++.+.....+ .+ +..+..+|++.+|++||++.|+++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 22 23332212333 23 5677899999999999999999999966554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=315.48 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=219.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 229 (435)
.|...+.||.|..++|-++.++ |..+|+|++...... .....+.-.+|+.+|+++. ||+|+++.++|+.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 5677789999999999999876 678899887432111 1233455678999999985 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+++|+|.|+.|-|+|++.+.-.+++....++++|++.|++|||.++ ||||||||+|||+ +++.+++|+|||+|..+
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILl--ddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILL--DDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheee--ccccceEEeccceeecc
Confidence 9999999999999999999888999999999999999999999988 9999999999999 88899999999999988
Q ss_pred cccCccccccccCCCcCccccCccccCC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
.+.. .....||||+|+|||.+.. ..|+...|+|++||++|.|+.|.+||......-..+.|.+|...+.
T Consensus 174 ~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 174 EPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred CCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 7654 3556799999999999853 4688899999999999999999999998888888889999887665
Q ss_pred CC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+ .+++.+.++||.+||+.||++|.|+.+.|.|
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 54 4678899999999999999999999999976
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.97 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=202.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||+|.++ +..||+|.+....... ....+.+|+.++++++||||+++++++..+...++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 6888999999999999999875 6789999886443221 12456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.+ +|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEECcCcceeeccCCCc
Confidence 9975 9999987644 4789999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------------- 380 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------- 380 (435)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 ----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred ----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1234567999999999865 5689999999999999999999999988776554433321100
Q ss_pred --------CCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 --------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 --------~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++++++||.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 012467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=336.02 Aligned_cols=249 Identities=25% Similarity=0.457 Sum_probs=208.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++.++ +..+|+|.+.... .......+.+|++++++++||||+++++++.+++.+++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 347899999999999999999986 6678999875432 233446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+.+++|.+++...+.+++..+..++.|++.||.|||+. + ++||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEE--cCCCCEEEeeCCcchhhhhh
Confidence 99999999999998888899999999999999999999974 5 9999999999999 88889999999998765332
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------------------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK------------------- 373 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~------------------- 373 (435)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 158 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred c------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 1 233568999999999998889999999999999999999999997554332211
Q ss_pred -------------------------HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 374 -------------------------YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 374 -------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.....+......++.++++||.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 1112222222223467899999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.47 Aligned_cols=239 Identities=31% Similarity=0.463 Sum_probs=201.4
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||++.++ ++.||+|.+.+...........+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 7889999886543222222344445544 56789999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|..++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSK----T 152 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875322211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... .+..+++++.++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGL 230 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 33457899999999999999999999999999999999999999988877776666654332 2345799999999999
Q ss_pred hhhcccCCCCHH
Q 013833 400 WAADMNQRPSFL 411 (435)
Q Consensus 400 l~~dp~~Rps~~ 411 (435)
|+.||++||++.
T Consensus 231 l~~~p~~R~~~~ 242 (323)
T cd05575 231 LQKDRTKRLGAK 242 (323)
T ss_pred hhcCHHhCCCCC
Confidence 999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=325.78 Aligned_cols=256 Identities=27% Similarity=0.497 Sum_probs=216.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+......+......+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 6888899999999999999974 78999998765444444555778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEE--cCCCCEEECccccceeccc
Confidence 9999999988853 344889999999999999999999988 9999999999999 7788999999999886643
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.....+......++
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 221 1234568889999999988889999999999999999999999996543 3445555555555554445678
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
..+++++.+||..+|++||++.++++.|++++
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 89999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=337.21 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=203.9
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||+|.++ +..||+|.+.............+..|..++.. ++||||+++++++.+.+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999986 56899998865432222233556677788876 4899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
|+|.+++.....+++.++..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDA----K 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCCC----c
Confidence 999999988778999999999999999999999988 9999999999999 8888999999999875322211 1
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... . .+..++.++++++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~~~li~~~ 230 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-C-YPRWLTREAKDILVKL 230 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C-CCccCCHHHHHHHHHH
Confidence 2345689999999999988999999999999999999999999998887776666654432 2 2345889999999999
Q ss_pred hhhcccCCCCHH-HHHH
Q 013833 400 WAADMNQRPSFL-DILK 415 (435)
Q Consensus 400 l~~dp~~Rps~~-~ll~ 415 (435)
|+.||++||++. ++++
T Consensus 231 l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 231 FVREPERRLGVKGDIRQ 247 (316)
T ss_pred hccCHhhcCCChHHHHc
Confidence 999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=333.67 Aligned_cols=253 Identities=33% Similarity=0.534 Sum_probs=205.0
Q ss_pred CCCCCceeecCCceeEEEEEEC------------------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccee
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 219 (435)
+|++.+.||+|+||.||+|.+. +..||+|.+.... ......++.+|+.++.+++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 6888899999999999999753 2369999886533 2334567899999999999999999
Q ss_pred eeeeEEeCCcEEEEEecCCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013833 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (435)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH 280 (435)
+++++.+.+..++||||+.+++|.+++.... .++..+++.++.||+.||.|||+.+ |+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 9999999999999999999999999986532 3577888999999999999999988 999
Q ss_pred CCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc--
Q 013833 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-- 358 (435)
Q Consensus 281 ~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-- 358 (435)
|||||+|||+ +.++.+||+|||+++........ .......++..|+|||++....++.++||||||+++|+|++
T Consensus 162 ~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLV--GENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEE--cCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999 78889999999999865433211 11223345788999999988899999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHc----CCC--CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 359 GEPPLANYEPYEAAKYVAE----GHR--PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 359 g~~p~~~~~~~~~~~~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+..||......+....+.. ... ....+..+++.+.+++.+||+.||++|||+.++.+.|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6678887765554433221 111 11123457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=319.71 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=207.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 233 (435)
.|+.+..|++|+||.||+|+++ +.-||+|+++-+.......+ .-.+|+.+|.+++|||||.+-.+.... +.+|||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 7899999999999999999987 56799999876554433222 235799999999999999999887554 569999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+. +|..++..- .+|...++.-++.|+++|++|||... |+|||||++|+|+ ...|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm--~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLL--SHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheee--ccCCcEEecccchhhhhcCC
Confidence 999977 999999874 47999999999999999999999977 9999999999999 88999999999999998866
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CC---------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP--------- 381 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--------- 381 (435)
.. .++....|.+|.|||.+.+ ..|++..|+||+|||+.||+++.+-|++....+....|..-. .|
T Consensus 231 ~k----~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 LK----PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cc----cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 33 4556678999999999876 579999999999999999999999999988766655543211 00
Q ss_pred --------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 --------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 --------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+....+++.-.+|+..+|..||.+|.||.|.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00111245778899999999999999999999876
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.57 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=203.2
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
++||+|+||.||++.++ +..||+|.+.+...........+..|..++..+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 678999998765444444556788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEECcCccccccccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999874322111 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--------HH-HHHHHHHcCCCCCCCCCCCCH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--------PY-EAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||.... .. .....+..... . .+..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~p~~~~~ 230 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-IPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-CCCCCCH
Confidence 234578999999999999999999999999999999999999996321 11 12223333322 2 2356899
Q ss_pred HHHHHHHHHhhhcccCCCC------HHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPS------FLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps------~~~ll~~ 416 (435)
++.++|.+||+.||.+|++ +.+++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999987 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.47 Aligned_cols=267 Identities=30% Similarity=0.529 Sum_probs=216.2
Q ss_pred CCCCCcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCc
Q 013833 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN 216 (435)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 216 (435)
|..+.|+++. .+|.+++.||+|+||.||+|.+.+ ..||||.+..... ....+.+.+|+.+++++. |||
T Consensus 27 ~~~~~~~~~~--~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~Hpn 102 (400)
T cd05105 27 PYDSRWEFPR--DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLN 102 (400)
T ss_pred CCCCceeccc--cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCC
Confidence 3445566653 378889999999999999998642 3599998864332 333467899999999996 999
Q ss_pred ceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHc-----------------------------------------------
Q 013833 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------------------------------------- 249 (435)
Q Consensus 217 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------------------------------------- 249 (435)
|+++++++.+....|+||||+++|+|.+++...
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 999999999999999999999999999988642
Q ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013833 250 -------------------------------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (435)
Q Consensus 250 -------------------------------------------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH 280 (435)
..+++.++..++.|++.||.|||+.+ |+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH 260 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVH 260 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence 13677888899999999999999988 999
Q ss_pred CCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 013833 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (435)
Q Consensus 281 ~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g 359 (435)
|||||+|||+ +.++.+||+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 261 ~dikp~Nill--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g 336 (400)
T cd05105 261 RDLAARNVLL--AQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336 (400)
T ss_pred CCCChHhEEE--eCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999 77889999999999865432211 11223456788999999998899999999999999999997 9
Q ss_pred CCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 360 EPPLANYEPYE-AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 360 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..||....... ....+..+..+. .+..++.++.+++.+||+.+|++|||+.++.+.|+++.+
T Consensus 337 ~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 337 GTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 99998765433 334444444333 345689999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.70 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=201.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----CcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 230 (435)
+|++.+.||+|+||.||+|.++ +..||+|.+....... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4788899999999999999975 7789999886433222 2235678999999999999999999987543 247
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|+||||+ +++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILA--NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEccCccccccc
Confidence 9999999 5699999988888999999999999999999999988 9999999999999 888999999999998654
Q ss_pred ccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---------- 378 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------- 378 (435)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 155 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322111 12234578999999999865 67899999999999999999999999876543322111100
Q ss_pred ----------------CCCC-C--CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 ----------------HRPF-F--RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ----------------~~~~-~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+. . ....+++++.+++.+||+.||++|||+.+++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0 012467889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=322.53 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=212.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-----CCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 230 (435)
+|...+.||+|+||.|..+.++ |..||||++...... ....++..+|+.+|+.++|+||+.+++.+.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555789999999999999986 788999998654433 3445788899999999999999999998754 3568
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|+|+|+| +.+|.+.++.+..++++.+..++.||++||.|+|+.+ |+||||||.|+|+ +.+..+||+|||+|+...
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~--n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLL--NADCDLKICDFGLARYLD 176 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheee--ccCCCEEeccccceeecc
Confidence 9999999 6699999998888999999999999999999999988 9999999999999 888899999999999886
Q ss_pred ccCccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---------- 379 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------- 379 (435)
.. .....++....|.+|.|||++. ...|+...||||+|||+.||++|++-|++.+.......+.+-.
T Consensus 177 ~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 177 KF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 43 1122456778899999999975 5679999999999999999999999998877544333222111
Q ss_pred ------------CCCCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 380 ------------RPFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 380 ------------~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
.|..+ ..+.++...+|+++||..||.+|+|++|+|.| |..+.+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 01101 13578899999999999999999999999987 555554
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.50 Aligned_cols=249 Identities=28% Similarity=0.525 Sum_probs=210.7
Q ss_pred eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+|+||.||+|.++ +..+|+|++.... ......+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 6899999999999753 5679999875443 23344578899999999999999999999875 4567899999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 154 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENY-YKA 154 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEE--cCCCeEEECCCccccccCCCCCe-eee
Confidence 999999988778999999999999999999999988 9999999999999 77889999999999876433221 111
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 398 (435)
.....++..|+|||.+....++.++|+|||||++|||++ |..||......+....+..+..+.. +..+++++.++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~li~~ 233 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC-PQRCPPEMYDLMKL 233 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC-CCCCCHHHHHHHHH
Confidence 122344678999999988889999999999999999998 9999998888777777777665443 34689999999999
Q ss_pred HhhhcccCCCCHHHHHHHHHHH
Q 013833 399 CWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 399 cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
||+.||++||++.+|.+.|+++
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=336.52 Aligned_cols=243 Identities=29% Similarity=0.451 Sum_probs=206.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|+..+.||+|+||+||++.++ +..||+|++.+.........+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999985 6789999886543333334466778999998886 577888999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill--~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeccccccccCCCCc
Confidence 99999999999998888999999999999999999999988 9999999999999 8888999999999875432211
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...... .+..++.++++
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 230 (323)
T cd05615 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--YPKSLSKEAVS 230 (323)
T ss_pred ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCccCCHHHHH
Confidence 123456899999999999999999999999999999999999999988887777766654432 23568999999
Q ss_pred HHHHHhhhcccCCCCH
Q 013833 395 LTEKCWAADMNQRPSF 410 (435)
Q Consensus 395 li~~cl~~dp~~Rps~ 410 (435)
++.+||+.+|.+|++.
T Consensus 231 li~~~l~~~p~~R~~~ 246 (323)
T cd05615 231 ICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHcccCHhhCCCC
Confidence 9999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=341.90 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=212.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||+||++.++ ++.||+|.+...........+.+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5888899999999999999975 77899999875443334445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++.+. +.+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEE--CCCCCEEeccCCCCeECCCCCc
Confidence 99999999999875 67999999999999999999999988 9999999999999 8889999999999986643321
Q ss_pred cccccccCCCcCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 386 (435)
. ......||+.|+|||++. ...++.++|||||||++|+|++|..||...........+........ ...
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 158 V---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred e---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 1 123346899999999986 45678899999999999999999999998877666666655432221 123
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++++++|+..||. +|.+|||+.+++++
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 578999999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=336.95 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=202.1
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||.||++.++ ++.||+|.+.+...........+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999985 678999998765444444556788899988877 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|..++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875432211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHcCCCCCCCCCCCCH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------PYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.... .. .+..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~-~p~~~~~ 230 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR-IPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CC-CCCCCCH
Confidence 234578999999999999999999999999999999999999995311 111222233322 22 2346889
Q ss_pred HHHHHHHHHhhhcccCCCC------HHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPS------FLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps------~~~ll~~ 416 (435)
++.++|.+||+.||++||+ +.+++++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.90 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=212.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
...|.+.+.||+|+||.||++... +..|++|.+... +......+.+|+.+++.++||||+++++++..++.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 335888999999999999999864 456888876432 23344677889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
||||++||+|.+++.. ..++++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFL--MPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEE--CCCCcEEEEeCcCcee
Confidence 9999999999988753 346899999999999999999999988 9999999999999 8888999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..+..+.. +..+
T Consensus 219 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~ 295 (478)
T PTZ00267 219 YSDSVSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF-PCPV 295 (478)
T ss_pred cCCcccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CccC
Confidence 6432211 113345799999999999999999999999999999999999999998887777777666554432 3468
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++++|.+||..||++||++.+++++
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 8999999999999999999999998754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.55 Aligned_cols=239 Identities=28% Similarity=0.426 Sum_probs=204.3
Q ss_pred ceeecCCceeEEEEEE-----CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+.||+|+||.||++.. .++.||+|++.+..... .....+.+|++++++++||||+++++++.++..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999875 36789999886533221 12345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
++++|.+++.+...+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEE--CCCCcEEEeeccCCcccCCCCC---
Confidence 99999999988888999999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+...... .+..++++++++|.
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~ 230 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLR 230 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHH
Confidence 223457899999999999889999999999999999999999999988877777666654432 23468999999999
Q ss_pred HHhhhcccCCCCHHH
Q 013833 398 KCWAADMNQRPSFLD 412 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~ 412 (435)
+||+.||++||++.+
T Consensus 231 ~~l~~~P~~R~~a~~ 245 (318)
T cd05582 231 ALFKRNPANRLGAGP 245 (318)
T ss_pred HHhhcCHhHcCCCCC
Confidence 999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.49 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=211.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.++ +..||+|.+.+...........+.+|+.+++.++||||+++++++.++..+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 37889999999999999999985 6789999885432222233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--cCCCCEEEEeccceeeccCCCc
Confidence 999999999998654 5889999999999999999999988 9999999999999 8889999999999976543221
Q ss_pred cccccccCCCcCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 388 (435)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+........ ....+
T Consensus 198 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 198 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred ---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 122345799999999998653 478899999999999999999999998887766666665432221 12357
Q ss_pred CHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
+.++++||.+||+.+|++ |+++.+++++
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.13 Aligned_cols=241 Identities=30% Similarity=0.444 Sum_probs=200.6
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHH-HHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE-VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||++.++ +..||+|++.+...........+..| ..+++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999986 56799998864322222222334444 4457889999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~----~ 152 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNG----T 152 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCC----C
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875432211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ....+++.+.++|.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~ 230 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGL 230 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC--CCCCCCHHHHHHHHHH
Confidence 33457899999999999999999999999999999999999999988877776666554322 2346899999999999
Q ss_pred hhhcccCCCCHHHH
Q 013833 400 WAADMNQRPSFLDI 413 (435)
Q Consensus 400 l~~dp~~Rps~~~l 413 (435)
|+.||.+||++.+.
T Consensus 231 l~~~p~~R~~~~~~ 244 (325)
T cd05602 231 LQKDRTKRLGAKDD 244 (325)
T ss_pred cccCHHHCCCCCCC
Confidence 99999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.54 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=214.6
Q ss_pred CCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC---
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--- 228 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 228 (435)
....+|++.+.||+|+||+||++.+. ++.||||.+...... ......+.+|+.++..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33458999999999999999999874 789999988654433 334567889999999999999999988764332
Q ss_pred -----cEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEE
Q 013833 229 -----PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (435)
Q Consensus 229 -----~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vk 299 (435)
.+++||||+++|+|.++++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl--~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL--CSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--eCCCCEE
Confidence 36899999999999999865 245899999999999999999999988 9999999999999 8888999
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 379 (435)
|+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.
T Consensus 184 L~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 99999998665332211 1234579999999999999999999999999999999999999999888777776666655
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.... +..+++++++++.+||+.||++||++.+++++
T Consensus 262 ~~~~-~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDPL-PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 4433 35689999999999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.49 Aligned_cols=255 Identities=34% Similarity=0.592 Sum_probs=217.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.+.||+|+||.||+|.++ ...|++|.+.... ......++.+|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 36888999999999999999874 2478999875433 2334467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++|||+++++|.+++... +.+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCCEEECccchhhccc
Confidence 999999999999999764 46899999999999999999999987 9999999999999 888899999999998775
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..... +..++
T Consensus 158 ~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (266)
T cd05033 158 DSEA--TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDCP 234 (266)
T ss_pred cccc--ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCC
Confidence 2221 111223345678999999998899999999999999999998 9999988887777777766554433 34689
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+.+.+++.+||+.+|++||++.+++++|.++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.29 Aligned_cols=254 Identities=31% Similarity=0.475 Sum_probs=226.9
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+..|.-++.||.|+||.||-+++. ...||||++.-+-....+.-+++..|+++|++++|||+|.+-++|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 446788899999999999999975 567999998766555555558899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||- ||-.|++.- ..++.+-++..|+.+.+.||.|||+.+ .||||||+.|||+ ...|.|||+|||.|....+.
T Consensus 105 MEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILL--se~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 105 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILL--SEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEe--cCCCeeeeccccchhhcCch
Confidence 99994 488888764 457999999999999999999999998 9999999999999 88999999999999877643
Q ss_pred CccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
+.++|||.|||||++. .+.|+-++||||||++..||...++|+.+++.+....-|..+..|.++...++
T Consensus 180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS 251 (948)
T KOG0577|consen 180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 251 (948)
T ss_pred --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH
Confidence 4588999999999974 57899999999999999999999999999999999999999999988888899
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..|++||..||++-|.+|||..+++++---.++
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 999999999999999999999999987544443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.19 Aligned_cols=252 Identities=31% Similarity=0.574 Sum_probs=214.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||.||+|... +..|++|.+.... ...+.+.+|+.+++.++||||+++++.+.+.+..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 47889999999999999999875 5679999875432 224678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++.+. ..++..++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLV--SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEe--cCCCcEEECCCccceecCCCc
Confidence 99999999999763 45888999999999999999999987 9999999999999 888899999999998764322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
. .......++..|+|||.+....++.++|||||||++|+|++ |..||...........+..+.+... ...++.++
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (261)
T cd05072 158 Y---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDEL 233 (261)
T ss_pred e---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHH
Confidence 1 11223345778999999988889999999999999999998 9999998887777777766654432 34688999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+++.+||..+|++||+++++++.|+++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.80 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=206.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.++||+|+||+||++.+. ++.||+|.+.............+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 77899998865433333333567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE--CCCCCEEEeeCCCceecCCCC
Confidence 99999999988653 35899999999999999999999988 9999999999999 888899999999987654221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHcCCCCCCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA----KYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 389 (435)
......|++.|+|||++.+..++.++||||+||++|+|++|..||.+....... ..+.... ...+..++
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 229 (285)
T cd05605 157 -----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--EEYSEKFS 229 (285)
T ss_pred -----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--cccCcccC
Confidence 123456899999999999889999999999999999999999999876543222 2222211 12234588
Q ss_pred HHHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+.+++|+.+||..||++|| ++.+++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999 89999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.25 Aligned_cols=251 Identities=30% Similarity=0.598 Sum_probs=214.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|++.+.||+|+||.||+|.++ ++.|++|.+... ......+.+|++++++++||||+++++++..+..++++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 5777889999999999999975 678999987532 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCcEEeCCCccccccccce
Confidence 99999999999763 35889999999999999999999988 9999999999999 788899999999998664322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..+..+.. +..++.++
T Consensus 159 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (263)
T cd05052 159 YT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER-PEGCPPKV 234 (263)
T ss_pred ee---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-CCCCCHHH
Confidence 11 1112234678999999998999999999999999999998 9999998877776666666554443 45689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+++.+||+.+|++|||+.++++.|+.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=343.57 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=211.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++..+ ++.||+|.+.............+.+|+.++..++||+|+++++.+.+++.+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999999985 67899998864332233445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli--~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEeeccCCccccccccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88899999999998755321100
Q ss_pred c-------------------------------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 316 D-------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 316 ~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0 000123479999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCC-CCC-CCCCCHHHHHHHHHHhhhcccCCCC---HHHHHHH
Q 013833 365 NYEPYEAAKYVAEGHRP-FFR-AKGFTPELRELTEKCWAADMNQRPS---FLDILKR 416 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 416 (435)
+.++......+...... .++ ...++++++++|.+|+. ||.+|++ +.+++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 88887776666543221 111 23478999999999874 9999984 7788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=320.67 Aligned_cols=254 Identities=30% Similarity=0.536 Sum_probs=214.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc--HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
.|.+.+.||+|++|.||.+... +.++++|.+....... ......+.+|+.++++++||||+++++++.++...++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 5888899999999999999874 7899999876543221 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++.......
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceeccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 788899999999987654321
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.. ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.........+..++..+.
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 11 10112345788999999999888999999999999999999999999887776655555544333334456899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||..+|++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=337.68 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=205.6
Q ss_pred CCCCCceeecCCceeEEEEEE-----CCCcEEEEEccCCCC-CcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||++.. .+..||+|++.+... ......+.+..|+.++..++ ||+|+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999876 367899998864322 22233466788999999995 89999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++||||+++++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEE--CCCCCEEEeeCcCCcccc
Confidence 999999999999999988888999999999999999999999988 9999999999999 888899999999997654
Q ss_pred ccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~ 385 (435)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+..... . .+
T Consensus 157 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~-~~ 231 (332)
T cd05614 157 SEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-P-FP 231 (332)
T ss_pred ccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-C-CC
Confidence 32211 12245789999999999765 47889999999999999999999996432 2233333433322 2 23
Q ss_pred CCCCHHHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
..+++.+++++.+||+.||++|| ++++++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 46899999999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=325.70 Aligned_cols=248 Identities=40% Similarity=0.732 Sum_probs=206.8
Q ss_pred CCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 161 SSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 161 ~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+.+.||.|.||.||+|.+. +..|+||.+... ......+.+.+|++.+++++||||+++++++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 3468999999999999987 567999988442 23344688999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+++|+|.+++... ..+++.++..++.||+.||.|||+.+ ++|+||+++||++ +.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILL--DSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--ETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc
Confidence 999999999999986 67999999999999999999999987 9999999999999 88889999999999876322
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. ............|+|||.+....++.++||||||+++|||++ |..||.+....+....+.++.++. .+..++..
T Consensus 157 ~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (259)
T PF07714_consen 157 SK--YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-IPDNCPKD 233 (259)
T ss_dssp SS--EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-SBTTSBHH
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce-eccchhHH
Confidence 11 112233456788999999988889999999999999999999 789999998888888887776655 34568999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+.++|.+||..+|++|||+.++++.|
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=320.13 Aligned_cols=248 Identities=33% Similarity=0.634 Sum_probs=211.7
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||++.++ +..+|+|.+..... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 5777889999999999999986 45799998753322 125788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEE--cCCCeEEECCCCCccccCCCce-
Confidence 999999999975 346899999999999999999999988 9999999999999 7888999999999876532211
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.......++..|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+..+..+.. +...+.++.+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 232 (256)
T cd05114 156 --TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-PKLASMTVYE 232 (256)
T ss_pred --eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-CCCCCHHHHH
Confidence 11223345678999999998899999999999999999999 9999998888777777777665443 3457889999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++.+||+.+|++||++.++++.|
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=323.88 Aligned_cols=260 Identities=29% Similarity=0.521 Sum_probs=219.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46888899999999999999752 345888977532 23345778999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG-------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
+++||||+++++|.+++...+ .+++.+++.++.|++.||+|||++| ++||||||+||++ +.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili--~~~~ 157 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GENL 157 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--ccCC
Confidence 999999999999999997543 3899999999999999999999988 9999999999999 8888
Q ss_pred cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 375 (435)
.++|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+
T Consensus 158 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred cEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999976543211 111223345778999999998899999999999999999998 99999988877777777
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
..+..+.. +..++.++.+|+.+||+.+|.+|||+.++++.|+++.+....
T Consensus 236 ~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~ 285 (288)
T cd05093 236 TQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV 285 (288)
T ss_pred HcCCcCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence 77654433 346889999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.05 Aligned_cols=256 Identities=30% Similarity=0.554 Sum_probs=208.9
Q ss_pred CCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe-CC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-RK 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~ 228 (435)
+|++.+.||+|+||.||+|.+. ++.||+|.+..... ....+.+..|+.+++++ +||||+++++++.. +.
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 7899999999999999999753 35799998864332 23346778899999999 79999999998754 46
Q ss_pred cEEEEEecCCCCCHHHHHHHc-----------------------------------------------------------
Q 013833 229 PLMLITEYLRGGDLHKYLKEK----------------------------------------------------------- 249 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~----------------------------------------------------------- 249 (435)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCc
Q 013833 250 --GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327 (435)
Q Consensus 250 --~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 327 (435)
..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++..+..... ........++.
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~ 239 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKGDARLPL 239 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--eCCCcEEEeccccchhcccCcc--hhhccCCCCCc
Confidence 25788999999999999999999988 9999999999999 7788999999999987643221 11122334567
Q ss_pred cccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhccc
Q 013833 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE-AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMN 405 (435)
Q Consensus 328 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 405 (435)
.|+|||++.+..++.++|||||||++|+|++ |..||.+....+ ....+..+..+. .+..+++++.+++.+||+.+|+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR-APEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC-CCccCCHHHHHHHHHHccCChh
Confidence 8999999999999999999999999999998 999998754433 233444444333 3346789999999999999999
Q ss_pred CCCCHHHHHHHHHHHHh
Q 013833 406 QRPSFLDILKRLEKIKE 422 (435)
Q Consensus 406 ~Rps~~~ll~~L~~~~~ 422 (435)
+||++.+++++|+++.+
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=336.35 Aligned_cols=265 Identities=30% Similarity=0.601 Sum_probs=232.7
Q ss_pred CCCCCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeee
Q 013833 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222 (435)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 222 (435)
|+...|+++.. +....++||.|.||.||.|.|+ ...||||.++. +...+++|..|+.+|+.++|||+|++++
T Consensus 257 Pn~DkWEmeRt--dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 257 PNADKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred CCcchhhccch--heeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 56677887754 3466779999999999999998 56799997754 3456789999999999999999999999
Q ss_pred eEEeCCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEE
Q 013833 223 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (435)
Q Consensus 223 ~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl 300 (435)
+|..+..+|||+|||..|+|.+||++ ...++.-..+.++.||.+||+||..++ +|||||.+.|.|| ..+..||+
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLV--gEnhiVKv 406 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHIVKV 406 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccc--cccceEEe
Confidence 99999999999999999999999986 234677778889999999999999987 9999999999999 88889999
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~ 379 (435)
+|||+++++... .+....+...++.|.|||.+....++-|+|||+|||+|||+.| |..||++.+.......+.+++
T Consensus 407 ADFGLsRlMtgD---TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 407 ADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred eccchhhhhcCC---ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 999999987532 2223334456788999999999999999999999999999999 999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
++.- +.+||+.+.+|+..||+..|.+||++.++-+.|+.+..+
T Consensus 484 RM~~-PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 484 RMDG-PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccC-CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 8874 458999999999999999999999999999999988754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.33 Aligned_cols=258 Identities=29% Similarity=0.576 Sum_probs=214.6
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
..+|+..+.||+|+||.||+|.+. +. .||+|.+.... .....+++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 447899999999999999999873 33 48999875432 233446788999999999999999999988765 5
Q ss_pred EEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++++||+.+|+|.+++.... .++...++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill--~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEe--cCCCcEEEcccccccc
Confidence 679999999999999998743 5889999999999999999999988 9999999999999 8888999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+..+..+.. +..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (316)
T cd05108 159 LGADEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPI 235 (316)
T ss_pred ccCCCc--ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC-CCC
Confidence 654322 111223345678999999999999999999999999999998 9999998877666555555544332 346
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
++.++.+++.+||..+|++||++.+++..|..+...
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 789999999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=336.78 Aligned_cols=240 Identities=30% Similarity=0.469 Sum_probs=201.7
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||+||++.++ |+.+|+|++.+...........+..|.. +++.++||||+++++.+..++..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999975 7889999886543322233344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|..++...+.+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSD----T 152 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCC----C
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875322211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ....+..+.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~l 230 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEEL 230 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC--CCCCCHHHHHHHHHH
Confidence 234578999999999999999999999999999999999999999888777766666543222 335889999999999
Q ss_pred hhhcccCCCCHHH
Q 013833 400 WAADMNQRPSFLD 412 (435)
Q Consensus 400 l~~dp~~Rps~~~ 412 (435)
|+.+|.+||++.+
T Consensus 231 l~~~p~~R~~~~~ 243 (325)
T cd05604 231 LEKDRQRRLGAKE 243 (325)
T ss_pred hccCHHhcCCCCC
Confidence 9999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=319.85 Aligned_cols=251 Identities=33% Similarity=0.578 Sum_probs=213.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 36888899999999999999875 56799998764332 13568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++.... .++..++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV--GENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEE--cCCCCEEECCcceEEEccCCc
Confidence 999999999997644 6899999999999999999999988 9999999999999 888899999999998765321
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ...+...+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+....... .+..++..+
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (261)
T cd05068 158 YE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-CPPGCPKEL 233 (261)
T ss_pred cc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCcCCHHH
Confidence 11 1122233467999999998899999999999999999999 999999888777666666654433 234678999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.76 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=198.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ ++.||+|.+....... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 37899999999999999999985 7789999886433221 1245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+. ++|.+++... +.++++++..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECCCCcceeccCCC
Confidence 9995 5888887654 56899999999999999999999988 9999999999999 888899999999987543222
Q ss_pred ccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcC-CCC---------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEG-HRP--------- 381 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~-~~~--------- 381 (435)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +....+... ..+
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 1 2234568999999999865 45888999999999999999999999875432 111111100 000
Q ss_pred ---C-----------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ---F-----------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ---~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....+++.+++|+.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0001245778999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=326.99 Aligned_cols=242 Identities=28% Similarity=0.433 Sum_probs=200.1
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|+||+||++.++ ++.||+|.+...........+.+..|+++++.++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 778999988654333333446678899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 243 HKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 243 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCccceecCCCCc----
Confidence 988743 346899999999999999999999988 9999999999999 7888999999999976543221
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... .....+... +...+..+++++++
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 230 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKS 230 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHH
Confidence 223457899999999999999999999999999999999999999765422 112222222 12223468999999
Q ss_pred HHHHHhhhcccCCC-----CHHHHHHH
Q 013833 395 LTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
++.+||+.||++|| ++++++++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 231 FCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=340.75 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=209.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.++ ++.+|+|.+.+...........+.+|+.+++.++||||+++++.+.++..+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999986 6789999885432222333456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++... .+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEEecccceecccCCc
Confidence 999999999999654 5899999999999999999999988 9999999999999 8889999999999986643221
Q ss_pred cccccccCCCcCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CC-CCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FR-AKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~ 388 (435)
.......||+.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+....... .+ ...+
T Consensus 198 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 198 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred ---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 122356799999999998754 37889999999999999999999999888776666666543222 12 2357
Q ss_pred CHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
+..+++++.+||..++.+ |+++.+++++
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 899999999999865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=351.29 Aligned_cols=265 Identities=21% Similarity=0.392 Sum_probs=218.5
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeee-eEE
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLG-AVT 225 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~-~~~ 225 (435)
..+.....++++.++|.+|||+.||+|.+. |..+|+|++... ++..++...+|+.+|++|+ |+|||.+++ ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 345555668888999999999999999985 379999988543 6777899999999999997 999999999 321
Q ss_pred e------CCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc
Q 013833 226 E------RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (435)
Q Consensus 226 ~------~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~ 297 (435)
. ...++|.||||.||+|-|+++. ...|++.++++|+.|+++|+.+||.+.++|||||||-+|||| ..+|+
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~ 184 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGN 184 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCC
Confidence 1 1346899999999999999984 456999999999999999999999999999999999999999 88899
Q ss_pred EEEeeccCcccccccCc-cccc----cccCCCcCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 013833 298 LKVGDFGLSKLIKVQNS-HDVY----KMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (435)
Q Consensus 298 vkl~Dfg~a~~~~~~~~-~~~~----~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 369 (435)
.||||||.+...-.... .... ......-|+.|.|||.+ .+...++|+|||+|||+||.|+....||.+....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999999875543321 0000 01112358999999987 4678999999999999999999999999977544
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
. |..+...+.+...++..+.+||..||+.||++||++.|++..+.++...
T Consensus 265 a----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 A----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred e----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 3 3445444444457899999999999999999999999999999988753
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.00 Aligned_cols=256 Identities=27% Similarity=0.516 Sum_probs=216.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ +..+++|.+............++.+|+.+++.++||||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 5788899999999999999964 78899998765444444455788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|.+++.. ...+++.+++.++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEECcchhhhcccc
Confidence 9999999999874 345899999999999999999999988 9999999999999 8888999999999876643
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ......+.....+......++
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 221 12234688999999999888899999999999999999999999975433 334444555444444455688
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
+++++++.+||..+|++|||+.++++.++++.
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=334.45 Aligned_cols=239 Identities=30% Similarity=0.432 Sum_probs=199.7
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHH-HHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV-NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
++||+|+||.||++.++ +..||+|.+.+...........+..|. .+++.++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 678999988654322222234455554 467889999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|..++.....+++.++..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEE----T 152 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCC----c
Confidence 999999988788999999999999999999999988 9999999999999 8889999999999875322211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ..+...+.++.+++.+|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--QLPGGKTVAACDLLVGL 230 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 2345789999999999988999999999999999999999999998877666666655432 22346789999999999
Q ss_pred hhhcccCCCCHH
Q 013833 400 WAADMNQRPSFL 411 (435)
Q Consensus 400 l~~dp~~Rps~~ 411 (435)
|+.||.+||++.
T Consensus 231 l~~~p~~R~~~~ 242 (321)
T cd05603 231 LHKDQRRRLGAK 242 (321)
T ss_pred ccCCHhhcCCCC
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.86 Aligned_cols=257 Identities=32% Similarity=0.572 Sum_probs=220.4
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEcc-CCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
+.++..+..+...+||+|+|-+||+|.+. |..||.-.+. ......+..+++|..|+.+|+.|+||||+++++.|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 44444455556668999999999999986 5555543221 13344566679999999999999999999999999876
Q ss_pred Cc--EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KP--LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~--~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
.. +.+|+|.+..|+|..|+++.+.++...+..|++||+.||.|||++.++|||||||.+||+| +...|.|||.|+|+
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFi-nG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFV-NGNLGEVKIGDLGL 192 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEE-cCCcCceeecchhH
Confidence 55 7899999999999999999999999999999999999999999999999999999999998 35668999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~ 384 (435)
|....... ....+|||.|||||.+- ..|++.+||||||+++.||+|+..||... ++..+++++..|..|...
T Consensus 193 Atl~r~s~------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 193 ATLLRKSH------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred HHHhhccc------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 99876442 23468999999999987 89999999999999999999999999864 678889999999888765
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+--.+++++||.+||.. .++|||+.+||++
T Consensus 266 ~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 554578999999999999 9999999999865
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=322.27 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=218.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.+.||+|+||.||++.+. +..+++|.+.... ....+.+.+|+.++++++||||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 35777889999999999999853 2358888764322 2334678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~ 293 (435)
.++||||+++++|.+++..++ .+++..++.++.||+.||.|||+++ ++||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~--~ 157 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV--G 157 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--c
Confidence 999999999999999997643 3788999999999999999999988 9999999999999 8
Q ss_pred CCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 013833 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372 (435)
Q Consensus 294 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~ 372 (435)
.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred cCCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 888999999999976543221 111223456788999999998999999999999999999999 99999888877777
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
..+..+..+.. +..+|..+.+++.+||+.+|++|||+.++++.|.++.+..+.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 236 ECITQGRVLER-PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred HHHhCCCCCCC-CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 76666555433 345789999999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.73 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=210.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++.++ ++.+|+|.+.+...........+.+|+.+++.++||||+++++.+.++..+++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 358999999999999999999986 678999987543222233345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEE--CCCCCEEEEeCCceeEcCcCC
Confidence 9999999999998754 5899999999999999999999988 9999999999999 888999999999998664322
Q ss_pred ccccccccCCCcCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKG 387 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 387 (435)
. .......||+.|+|||++... .++.++|||||||++|+|++|..||...+.......+...... ......
T Consensus 197 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 197 M---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred c---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 1 122346799999999998754 3788999999999999999999999988877766666654322 222346
Q ss_pred CCHHHHHHHHHHhhhcccC--CCCHHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQ--RPSFLDILKRL 417 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~--Rps~~~ll~~L 417 (435)
++.+++++|.+||..++.+ |+++.+++++.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 8999999999999844443 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.09 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=198.8
Q ss_pred CCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEE-----e
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT-----E 226 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~ 226 (435)
+|++.+.||+|+||.||+|.+. ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 6888999999999999999873 56799998865433222 123455677666655 6999999999875 3
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
...+++||||+. ++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~--~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--cCCCCEEEcccc
Confidence 456899999995 5999998763 34899999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF- 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~- 383 (435)
++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|.+||.+....+....+.+......
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 997654321 22345689999999999888999999999999999999999999998776655544432211000
Q ss_pred ------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 ------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....+++.+++++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.55 Aligned_cols=244 Identities=24% Similarity=0.394 Sum_probs=202.7
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||.||++..+ ++.||+|++.+.........+.+.+|+.++.++ +||+|+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 678999998765544445567788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGD----T 152 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--eCCCCEEEeccccceeccCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875322211 2
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC------CHHH-HHHHHHcCCCCCCCCCCCCHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY------EPYE-AAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+ ....+... . ...+..++..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~p~~~~~~~ 230 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-P-IRIPRFLSVKA 230 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-C-CCCCCCCCHHH
Confidence 23467899999999999999999999999999999999999999532 1222 22333332 2 22345689999
Q ss_pred HHHHHHHhhhcccCCCCH------HHHHHH
Q 013833 393 RELTEKCWAADMNQRPSF------LDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~------~~ll~~ 416 (435)
.+++.+||+.||++|+++ .+++++
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=316.06 Aligned_cols=250 Identities=29% Similarity=0.516 Sum_probs=210.4
Q ss_pred ceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
++||+|+||.||+|.+. +..+++|.+...... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999864 257999988654432 33467889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
.+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+|||+ +.++.++|+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~~~~-~ 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDY-Y 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEE--cCCCcEEeccccccceeecCCcc-c
Confidence 99999999988778999999999999999999999988 9999999999999 88889999999999876543221 1
Q ss_pred ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 013833 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396 (435)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 396 (435)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.... .+..++..+++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP-RPEECPQEIYSIM 231 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC-CCCCCCHHHHHHH
Confidence 11122234568999999998899999999999999999998 999999888777777776654433 3456889999999
Q ss_pred HHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 397 EKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 397 ~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
.+||..+|++||++.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=318.45 Aligned_cols=249 Identities=31% Similarity=0.602 Sum_probs=211.7
Q ss_pred CCCCCceeecCCceeEEEEEECCC-cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||.+.+++. .+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 578888999999999999988754 599998754322 125688999999999999999999999988899999999
Q ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+.+++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||.++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCCEEECCCccceecCCCce-
Confidence 9999999999864 36899999999999999999999988 9999999999999 7888999999999876543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.++.. +...+..+++
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYA 232 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-CCCCCHHHHH
Confidence 11122345678999999988889999999999999999999 9999998887776667766655443 3457899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
++.+||+.+|++||++.++++.|+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=317.09 Aligned_cols=249 Identities=32% Similarity=0.612 Sum_probs=211.0
Q ss_pred CCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||.||++.+++ ..+++|.+...... ...+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 367888999999999999998864 47999987543222 2467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++|++|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV--GEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEE--CCCCcEEECCcccceecccccc
Confidence 99999999999764 46899999999999999999999988 9999999999999 8888999999999876542211
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+.++.. +..++.++.
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTEVY 231 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHHHH
Confidence 01112234567999999998899999999999999999999 8999988887777777776655443 345899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+++.+||..+|++|||+.++++.|
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=317.26 Aligned_cols=249 Identities=30% Similarity=0.523 Sum_probs=214.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.++ +..|++|.+...... ......+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 3677789999999999999985 678999987644333 3344778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--eCCCCEEEcccccceeccCcc
Confidence 99999999999874 46899999999999999999999988 9999999999999 778899999999988665432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..+..+... ..++.+++
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (256)
T cd08529 156 N----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-QMYSQQLA 230 (256)
T ss_pred c----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-cccCHHHH
Confidence 1 123346788999999999999999999999999999999999999988877777777766655543 36889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++.+||+.+|++||++.+++++
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=321.06 Aligned_cols=254 Identities=30% Similarity=0.499 Sum_probs=210.6
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
..+|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3478899999999999999998653 469999875322 2223456889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
..++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++||||||+||++ +.++.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~--~~~~~~ 158 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTV 158 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE--cCCCCE
Confidence 9999999999999999997522 2567788899999999999999987 9999999999999 788899
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 377 (435)
+|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 159 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 159 KIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EECCCCCccccCCcce--eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999876543211 001112345788999999998899999999999999999999 7899998887776666665
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
...+.. +..++..+++++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCcCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 544333 3568899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=322.20 Aligned_cols=253 Identities=31% Similarity=0.529 Sum_probs=214.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.+.||+|+||.||+|.+. +..||+|.+..... ....+.+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 36888899999999999999863 35799998754332 2234788999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG--------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~ 295 (435)
.++||||+++++|.+++...+ .+++.++..++.|++.||.|||+.+ ++||||||+||++ +.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~ 158 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV--GYD 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEE--cCC
Confidence 999999999999999997643 3788899999999999999999988 9999999999999 888
Q ss_pred CcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 013833 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (435)
Q Consensus 296 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~ 374 (435)
+.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CeEEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999765322110 01122345788999999999999999999999999999998 9999988887777777
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+..+..+.. +..++..+++++.+||+.||++||++.++++.|+
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 776655443 3468999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=335.17 Aligned_cols=266 Identities=30% Similarity=0.540 Sum_probs=215.3
Q ss_pred CCCCCcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCc
Q 013833 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN 216 (435)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 216 (435)
+....|++... +|.+.+.||+|+||.||+|.+.+ ..||+|++..... ....+.+.+|+.+|.++. |||
T Consensus 27 ~~~~~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 27 PYDSAWEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCCcceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCC
Confidence 34445666544 67788999999999999998643 4799999865432 223357889999999997 999
Q ss_pred ceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC----------------------------------------------
Q 013833 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG---------------------------------------------- 250 (435)
Q Consensus 217 iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------------------------------------------- 250 (435)
|+++++.+......++||||+.+|+|.+++++.+
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 9999999999999999999999999999997532
Q ss_pred ----------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhcCCCce
Q 013833 251 ----------------------------------------------------ALSPSTAVNFALDIARGMAYLHNEPNVI 278 (435)
Q Consensus 251 ----------------------------------------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~i 278 (435)
.++...++.++.||+.||.|||+.+ +
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--i 260 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--C 260 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--c
Confidence 2566778889999999999999987 9
Q ss_pred EeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc
Q 013833 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 358 (435)
Q Consensus 279 vH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t 358 (435)
+||||||+|||+ +..+.++|+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 261 vHrdlkp~NiLl--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 261 VHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred CcccCCcceEEE--eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 999999999999 77889999999999865332111 11223356788999999998889999999999999999998
Q ss_pred -CCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 359 -GEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 359 -g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
|..||......+.. ..+..+.++. .+..++.++.+++.+||..+|++||++.++++.|+++.
T Consensus 337 ~g~~P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 337 LGGTPYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred cCCCCCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 89999876654443 3344444433 33468899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=321.37 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=206.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ +..||+|.+...... ....+.+|+.++++++||||+++++.+..+..+++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 47899999999999999999974 678999988543222 2356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++++|.+++...+.+++.++..++.|++.||.|||+.+ |+||||+|+||++ +.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILL--TDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEECcCccceeeccccc
Confidence 99999999999988888999999999999999999999988 9999999999999 8888999999999986643221
Q ss_pred cccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCC-C-CCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPF-F-RAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~-~-~~~~~ 388 (435)
......+++.|+|||.+. ...++.++|+|||||++|+|++|..||....+......+.... .+. . ....+
T Consensus 162 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 162 ----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred ----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 123346888999999884 3457889999999999999999999997665544332222221 111 1 11346
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+..+++||.+||..+|++|||+++++++|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 88999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=332.59 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=199.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|+..+.||+|+||.||++.++ ++.||||.+.... .......+.+|+++++.++|+||+++++++.+++.+++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 36788889999999999999985 7899999885432 2334467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++++|.+.. ..++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 152 e~~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGTH----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEcccccceecccccc
Confidence 999999986532 3567888899999999999999988 9999999999999 8888999999999986643211
Q ss_pred cccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCCCCCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---AAKYVAEGHRPFFRAK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 386 (435)
......||..|+|||.+.. ...+.++|||||||++|+|++|+.||......+ ....+.....+ ..+.
T Consensus 224 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 298 (353)
T PLN00034 224 ----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP-EAPA 298 (353)
T ss_pred ----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC-CCCC
Confidence 1234578999999998743 234568999999999999999999997433222 22222222222 2334
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++.++++||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 688999999999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=316.89 Aligned_cols=247 Identities=34% Similarity=0.634 Sum_probs=211.4
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE-EeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||.||++..++..+++|.+.... ..+.+.+|+.++++++|+|++++++++ .++...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 378888999999999999999999999999875321 236788999999999999999999975 45567899999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.++++..+ .+++..++.++.|++.||.|||++| ++||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEE--cCCCcEEecCCccceeccccC
Confidence 999999999998644 3789999999999999999999988 9999999999999 888899999999987543221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
....++..|+|||++....++.++|||||||++|+|++ |..||......+....+..+..+.. ...+++.+
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPVV 228 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCCHHH
Confidence 12334668999999998899999999999999999997 9999988777777666666554433 35689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+++.+||+.+|++|||+.++++.|+.+
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.32 Aligned_cols=248 Identities=29% Similarity=0.555 Sum_probs=208.3
Q ss_pred eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+|+||.||+|.++ +..||+|.+.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999864 3468999875442 2334467899999999999999999999875 4578999999999
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 240 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 240 ~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
++|.+++.. ...+++.++++++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++...........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDSYYK- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEE--cCCCcEEeccCCccccccCCcccee-
Confidence 999999975 456899999999999999999999988 9999999999999 7888999999999986543322111
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
......++..|+|||.+....++.++||||||+++|++++ |..||.+....+....+..+.++..+ ..+++++.+++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~ 232 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP-AECPPEMYALMK 232 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC-CCCCHHHHHHHH
Confidence 1222334678999999988889999999999999999996 99999998888877777777665433 468999999999
Q ss_pred HHhhhcccCCCCHHHHHHHHHHH
Q 013833 398 KCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+||..+|++||++.++.+.|+.+
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhh
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=322.68 Aligned_cols=241 Identities=27% Similarity=0.426 Sum_probs=196.5
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|+||.||++..+ |..||+|.+.............+..|+.++++++||||+++++.+..+..+++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 789999988543322222234556799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 243 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~-----~~ 151 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGK-----TI 151 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEE--cCCCCEEEeeceeeeecCCCc-----ee
Confidence 98886543 4888999999999999999999988 9999999999999 888899999999987654321 12
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFRAKGFTPELRELT 396 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li 396 (435)
....|++.|+|||++.+..++.++|||||||++|+|++|..||..... .+.......... ......+++++++++
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 230 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDIC 230 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHH
Confidence 235689999999999988899999999999999999999999976432 222222222222 222346899999999
Q ss_pred HHHhhhcccCCCCHHHHHH
Q 013833 397 EKCWAADMNQRPSFLDILK 415 (435)
Q Consensus 397 ~~cl~~dp~~Rps~~~ll~ 415 (435)
.+||+.||++||++.++++
T Consensus 231 ~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 231 RLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHhccCHhhCCCCccchh
Confidence 9999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.69 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=212.0
Q ss_pred CCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
+|++.+.||+|+||.||+|.+ .+..+++|.+.... .......+.+|+.+++.++||||+++++++..+...|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 577888999999999999985 24679999886432 2334467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 232 LITEYLRGGDLHKYLKEK-----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+||||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||+ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili--~~ 159 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI--GE 159 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE--cC
Confidence 999999999999998632 23788889999999999999999988 9999999999999 77
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 889999999999865432211 11233445778999999988889999999999999999998 999998877766666
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.+.....+. .+..+++.+++++.+||+.||++||++.+++++|..
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 666554433 345689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=319.09 Aligned_cols=253 Identities=33% Similarity=0.600 Sum_probs=216.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..+|++.+.||.|+||.||+|.++ +..+++|.+..... .....+.+|+.+++.++||||+++++++.+...+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 347889999999999999999986 57899998754332 22467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+++++|.+++.+. ..++..++..++.||+.||.|||+.+ ++|+||||+||++ +.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV--GEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEE--cCCceEEEccccchhhcCCc
Confidence 999999999999863 35899999999999999999999988 9999999999999 88889999999999766432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+..+.++.. +..+++.
T Consensus 158 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (261)
T cd05148 158 V----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQE 232 (261)
T ss_pred c----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC-CCCCCHH
Confidence 1 11223446778999999998899999999999999999998 8999998887777777766554443 3568999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+.+++.+||+.||++|||+.++++.|+.+
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.60 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=216.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|... ++.|++|.+......+....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 6888899999999999999985 78999998865444444445788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|.+++.. ...+++.+++.++.|++.||.|||+.| ++||||+|+||++ +.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~--~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEE--CCCCcEEEeccceeeeccC
Confidence 9999999999864 234899999999999999999999988 9999999999999 8888999999999876543
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+..+..+..+...++
T Consensus 159 ~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred CCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 321 1223457889999999998899999999999999999999999996543 3344445555555544444688
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
..++++|.+||..+|++|||+.++++.|..+.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 89999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.26 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=197.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++.+. ++.||+|... ...+.+|++++++++||||+++++++..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 347999999999999999999985 6789999642 14567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+|++ +++|..++.....+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||++.......
T Consensus 162 ~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 162 LPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFI--NHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEE--cCCCCEEEEeCCccccccccc
Confidence 9999 4699999988778999999999999999999999988 9999999999999 888899999999997543221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH-----------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------YEAAKYV----------- 375 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~----------- 375 (435)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 237 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 237 AN---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cc---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11 22345799999999999999999999999999999999999987743211 0000000
Q ss_pred ---------------HcCC--CCCCC-----CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 376 ---------------AEGH--RPFFR-----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 376 ---------------~~~~--~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.... .+... ...++.++.+||.+||+.||++|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 00000 01356789999999999999999999999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=322.55 Aligned_cols=246 Identities=26% Similarity=0.503 Sum_probs=218.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
-|.++.+||+|+||.||++.++ |..+|||.+... .-++++..|+.+|++++.|+||++++.|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 5788899999999999999986 788999987432 235788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||.-|++.+.++. +.+++++++..+++..+.||+|||... -||||||+.|||+ +.+|+.||+|||.+-.+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDT-- 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDT-- 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEE--cccchhhhhhccccchhhhh--
Confidence 9988999999985 668999999999999999999999986 7999999999999 99999999999998765432
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 393 (435)
....++..|||.|||||++..-.|+.++||||||++..||..|++||.+..+......+....+|.+. +..++.++-
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHH
Confidence 22456788999999999999999999999999999999999999999999998887777776666543 345788999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||..||.+.|++|.|+.+++++
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhh
Confidence 99999999999999999999876
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.81 Aligned_cols=262 Identities=29% Similarity=0.493 Sum_probs=219.4
Q ss_pred CCCCCCCCCceeecCCceeEEEEEECC------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE- 226 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 226 (435)
....+|++.+.||+|+||.||+|.+.. ..|++|.+... ......+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344578889999999999999999753 67899987533 234445778999999999999999999998765
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK--------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
+...++++||+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~ 156 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVI--DEELQV 156 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEE--cCCCcE
Confidence 56789999999999999999753 35889999999999999999999987 9999999999999 778899
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 377 (435)
||+|||+++.+....... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....+.+....+..
T Consensus 157 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 157 KITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred EECCCCCcccccCCceEE--eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 999999998654332111 1122345778999999998889999999999999999999 9999998888777777666
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+..+.. ...+++++.+++.+||..+|++|||+.++++.|..+.+++
T Consensus 235 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 235 GYRLAQ-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred CCCCCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 654433 3457899999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.48 Aligned_cols=247 Identities=31% Similarity=0.567 Sum_probs=206.3
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+.||+|+||.||++.++ ++.+|+|.+.... .......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999874 7789999875432 2334467899999999999999999999999999999999999999
Q ss_pred CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 241 DLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 241 sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
+|.+++...+ .+++.+++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++........ ...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~ 152 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVY--AST 152 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEE--cCCCcEEECccccCcccccccc--ccc
Confidence 9999997644 5899999999999999999999988 9999999999999 8888999999999875442110 000
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 398 (435)
......+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+....++. .+..++..+.+++.+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 231 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPELCPDAVYRLMER 231 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-CcccCCHHHHHHHHH
Confidence 111223567999999998889999999999999999998 999998877766666565544443 345678999999999
Q ss_pred HhhhcccCCCCHHHHHHHHH
Q 013833 399 CWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 399 cl~~dp~~Rps~~~ll~~L~ 418 (435)
||+.+|++|||+.++++.|+
T Consensus 232 ~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.56 Aligned_cols=247 Identities=34% Similarity=0.644 Sum_probs=215.5
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
.+|++.+.||+|+||.||++...++.|++|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3778889999999999999999999999998864432 347789999999999999999999999989999999999
Q ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+++++|.++++... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV--SEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEE--eCCCCEEEccccccccccccc-
Confidence 99999999998755 6899999999999999999999988 9999999999999 888899999999998663221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.....+..|+|||.+....++.++|+||||+++|++++ |..||......+....+..+..+.. +..+++++.
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA-PEGCPPEVY 229 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC-ccCCCHHHH
Confidence 12234667999999988889999999999999999997 9999998887776666666554433 346899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
++|.+||..+|++|||+.++++.|.+
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=327.09 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=220.4
Q ss_pred CCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
-|.+.+.||+|.|+.|-++++ +|..||||++.+...++ ..-..+.+|++.|+.++|||||++|.+......+|+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 477888999999999999875 69999999997765543 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+=++|+|+|||.++ ..+.++.+..++.||+.|+.|||..- +|||||||+||.+- ..-|-|||.|||++..+.+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFF-EKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFF-EKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEe-eecCceEeeeccccccCCCcc-
Confidence 99999999999874 45999999999999999999999977 99999999998763 567899999999998887654
Q ss_pred cccccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
+..+.||+..|.|||++.+..|+ +.+||||||||||-|++|++||...+..+..-.|.++...- +..++.+++
T Consensus 174 ----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--PshvS~eCr 247 (864)
T KOG4717|consen 174 ----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--PSHVSKECR 247 (864)
T ss_pred ----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--chhhhHHHH
Confidence 46678999999999999999998 57999999999999999999999999988888888876543 457899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||..||..||++|.+.++|...
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhcc
Confidence 99999999999999999998754
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.56 Aligned_cols=254 Identities=32% Similarity=0.556 Sum_probs=213.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc------HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
+|.+.+.||+|+||.||+|.+. +..+++|.+....... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999874 6789999886543322 1234678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILV--DNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEE--cCCCCEEecccCCCccc
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88889999999999877
Q ss_pred cccCccc--cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 310 KVQNSHD--VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 310 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
....... ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....+.. +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI-PSN 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC-Ccc
Confidence 5322110 1112234578899999999988899999999999999999999999998776655555555444433 346
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++..++++|.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 88999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.36 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=215.1
Q ss_pred CCCCCceeecCCceeEEEEEECCC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|.++..||.|+||.||++..+.+ ..|-|.+. ....+.+++|.-|+.+|..+.||+|+++++.|.-++.++|+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 356677899999999999998744 45667663 2345678999999999999999999999998888889999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||.||-...++-. ...+++.++..+++|++.||.|||+++ |||||||+.|||+ ..+|.|+|+|||.+.......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILL--TLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEE--EecCcEeeecccccccchhHH-
Confidence 9999999888765 557999999999999999999999987 9999999999999 888899999999886543221
Q ss_pred cccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 388 (435)
.....++|||+|||||++. ..+|+.++||||||++|.||..+.+|....+++...-.+....+|.+ .+..+
T Consensus 185 ---qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~W 261 (1187)
T KOG0579|consen 185 ---QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHW 261 (1187)
T ss_pred ---hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchh
Confidence 1345689999999999874 46899999999999999999999999999999998888887766654 45678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+..|.+|+.+||.+||..||++.+|++|
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 9999999999999999999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=335.20 Aligned_cols=243 Identities=27% Similarity=0.426 Sum_probs=202.2
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
||+|+||+||++.++ +..||+|++.+...........+..|..++..+ .||||+++++.+.+...+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 788999988543322223334555677777665 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~----~ 152 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILL--DATGHIALCDFGLSKANLTDNK----T 152 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCC----C
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875432221 2
Q ss_pred ccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 398 (435)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..+... ++...++++++++|.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~ 231 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKG 231 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence 3346799999999998754 5889999999999999999999999988877776666655432 2334578999999999
Q ss_pred HhhhcccCCC----CHHHHHHH
Q 013833 399 CWAADMNQRP----SFLDILKR 416 (435)
Q Consensus 399 cl~~dp~~Rp----s~~~ll~~ 416 (435)
||..||++|| ++.+++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=319.82 Aligned_cols=257 Identities=33% Similarity=0.574 Sum_probs=214.9
Q ss_pred CCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||+|.... ..+++|.+..... ......+.+|+.+++.++||||+++++.+..+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 46788899999999999998642 3588887754332 33447788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCC
Q 013833 231 MLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~ 286 (435)
++++||+.+++|.+++... ..+++.+++.++.|++.||.|||+.+ ++||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence 9999999999999998642 23778899999999999999999988 999999999
Q ss_pred cEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 013833 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 365 (435)
Q Consensus 287 NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~ 365 (435)
|||+ +.++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 157 nill--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 157 NVLV--AEGRKMKISDFGLSRDVYEEDS--YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred eEEE--cCCCcEEeccccccccccCccc--hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999 7788999999999976543221 111223345778999999988889999999999999999998 9999998
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 366 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
..+.+....+.....+.. +..++.++++|+.+||+.+|++||++.++++.|+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 233 IAPERLFNLLKTGYRMER-PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHHHHhCCCCCCC-CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 887777666666554432 456889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=324.37 Aligned_cols=256 Identities=35% Similarity=0.567 Sum_probs=211.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.+.||+|+||.||+|.++ +. .+++|.+.... .......+.+|+.++.++ +||||+++++++..++.+++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 6788899999999999999875 33 35777654322 233446788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
||||+++++|.+++...+ .+++.+++.++.|++.||+|||+.| ++||||||+|||+ +.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili--~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe--cCCC
Confidence 999999999999997542 4788999999999999999999988 9999999999999 8888
Q ss_pred cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 375 (435)
.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||...+..+....+
T Consensus 162 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred cEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999999986432111 1112234667999999988889999999999999999998 99999887776666666
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
..+..+. .+..+++++.+++.+||+.+|++||++.+++..|..+.+.-.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred hcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 5543332 234578999999999999999999999999999998776444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.34 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=211.8
Q ss_pred CCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc----
Q 013833 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 229 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 229 (435)
|.+++.||+|+||.||+|... +..||+|.+...... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999864 256999988654333 3345678999999999999999999998765544
Q ss_pred --EEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 230 --LMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 230 --~~lv~e~~~g~sL~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~ 155 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCML--REDMTVCVA 155 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEE--CCCCeEEEC
Confidence 79999999999999998542 25899999999999999999999988 9999999999999 888899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |..||.+....+....+..+..
T Consensus 156 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 156 DFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred Cccceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999866533211 11112335678999999988899999999999999999999 9999998887777777766654
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+.. +..+++++.+++.+||+.||++|||+.++++.|+++
T Consensus 234 ~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC-CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 443 456899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=316.77 Aligned_cols=258 Identities=28% Similarity=0.553 Sum_probs=214.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|++.+.||+|+||+||+|.+. +. .+++|.+... .......++..|+..+++++||||+++++++. +...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 36788899999999999999984 43 4777776432 22334467888999999999999999999875 4567
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili--~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL--KSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEEcCCccceec
Confidence 889999999999999976 456899999999999999999999988 9999999999999 88889999999999865
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... ........++..|+|||.+.+..++.++||||||+++||+++ |..||.+..+......+..+..+. .+..+
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (279)
T cd05111 160 YPDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA-QPQIC 236 (279)
T ss_pred cCCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-CCCCC
Confidence 43221 112233457788999999988899999999999999999998 999999888777666666655443 33457
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+.++.+++.+||..+|++|||+.++++.|..+.+.-
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.61 Aligned_cols=255 Identities=33% Similarity=0.598 Sum_probs=215.4
Q ss_pred CCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.+.||+|+||.||+|.++ +..+|+|.+..... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 6788899999999999999863 23689998764332 3345688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||+++++|.+++... +.++..++..++.|++.||.|||+.+ ++||||||+|||+ +.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEE--CCCCeEEeCCCCccccccc
Confidence 99999999999999874 46899999999999999999999988 9999999999999 8888999999999987654
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... ........++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.++.++.. ...+++
T Consensus 159 ~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (267)
T cd05066 159 DPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PMDCPA 236 (267)
T ss_pred ccce-eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC-CCCCCH
Confidence 3221 111222334678999999998899999999999999999887 9999998877777777776654432 346889
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+++++.+||+.+|++||++.++++.|.++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.46 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=222.4
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|..+++||+|.||.|-+++-+ ++.+|+|++++........+..-..|-++|+..+||++..+...|...+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 347888999999999999999876 789999999988877777778888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+.||.|.-.+.+...++++....+..+|++||.|||+++ ||+||||.+|.|+ |.+|++||+|||++..--..+
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlL--DkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLL--DKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhhee--ccCCceEeeecccchhccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 999999999999997543222
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
..+.++||||.|+|||++....|+..+|+|.+||++|||++|+.||.+.+.......|......+ +..++++.+
T Consensus 323 ----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF--Pr~ls~eAk 396 (516)
T KOG0690|consen 323 ----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF--PRTLSPEAK 396 (516)
T ss_pred ----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC--CccCCHHHH
Confidence 25778999999999999999999999999999999999999999999888777766666544333 457999999
Q ss_pred HHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 394 ELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
.|+..+|.+||.+|. ++.++.++
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999999994 45555543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=318.10 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=203.6
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--C---
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--K--- 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~--- 228 (435)
+..|...+++|+|+||.||+|... +..||||+...+... -.+|+.+|+.+.|||||++..+|... .
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 457888899999999999999975 578999988654322 24799999999999999999887442 1
Q ss_pred cEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
...+|||||+. +|.++++. +..++.-.+.-+.+||++||.|||+.| |+||||||+|+|++ ..+|.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD-~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVD-PDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEc-CCCCeEEeccCC
Confidence 35689999966 99999985 456888899999999999999999988 99999999999992 344899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--- 380 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--- 380 (435)
.|+.+...... .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|++.+..+....+.+...
T Consensus 172 SAK~L~~~epn-----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 172 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred cceeeccCCCc-----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 99988765532 34567899999999875 5799999999999999999999999999887655443332210
Q ss_pred ----------------CC--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 381 ----------------PF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 381 ----------------~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
|. ......+++..+|+.++|+.+|.+|.++.|++.+ +..+++
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00 1224578999999999999999999999999865 555554
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.94 Aligned_cols=255 Identities=34% Similarity=0.540 Sum_probs=212.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.+.||+|+||.||+|..+ +. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++.....+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 6788889999999999999875 32 46888765322 223346788999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
||||+++++|.+++.... .+++.+++.++.|++.||+|||+.| |+||||||+|||+ +.++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~ 156 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV--GENL 156 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE--CCCC
Confidence 999999999999997532 4788999999999999999999988 9999999999999 7888
Q ss_pred cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 375 (435)
.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 157 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 157 ASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred eEEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999986432111 1111233567999999998889999999999999999997 99999988877777666
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
..+..+.. +..++.++++|+.+||+.+|.+|||+.++++.|+.+....
T Consensus 232 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRMEK-PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 66554433 3468999999999999999999999999999999888744
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.49 Aligned_cols=260 Identities=30% Similarity=0.536 Sum_probs=218.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 225 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 225 (435)
..+|.+.+.||+|+||.||++.+. +..|++|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 457889999999999999999752 2368999875432 223347789999999999 8999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEE
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIl 289 (435)
.....+++|||+.+++|.+++.+. ..++..++..++.||+.||.|||+.| ++||||||+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 999999999999999999999763 23677888999999999999999988 999999999999
Q ss_pred EecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCH
Q 013833 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 368 (435)
Q Consensus 290 l~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~ 368 (435)
+ +.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 170 i--~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 V--TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred E--cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9 78889999999999866433211 11223345678999999988889999999999999999998 8899998888
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 369 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
.+....+..+.++.. +..++.++++++.+||+.+|++|||+.++++.|.++..-.
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 EELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 777777766655433 3568999999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=322.41 Aligned_cols=262 Identities=32% Similarity=0.587 Sum_probs=218.2
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 220 (435)
.|.+. ..+|++.+.||+|+||.||++.+.+ ..+|+|.+..... ......+.+|+.+++++ +||||+++
T Consensus 6 ~~~~~--~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELP--RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccC--HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 44444 3478889999999999999998742 4689998765432 23346788999999999 79999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlk 284 (435)
++++..+..++++|||+++++|.+++... +.+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlk 159 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLA 159 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccc
Confidence 99999999999999999999999999642 35889999999999999999999987 9999999
Q ss_pred CCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 013833 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363 (435)
Q Consensus 285 p~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~ 363 (435)
|+||++ +.++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 160 p~Nil~--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 160 ARNVLV--TEDHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred eeeEEE--cCCCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence 999999 7888999999999987653321 111122335678999999998999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 364 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
......+....+..+..+.. +..++..+.+|+.+||..+|++|||+.++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 236 PGIPVEELFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCHHHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 98887777777766655443 3467899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.12 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=204.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-----cE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 230 (435)
+|++.+.||+|+||.||++.+. ++.||+|.+..... .....+++.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4678899999999999999974 78999998854332 2334467889999999999999999999987766 78
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLV--NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEE--CCCCCEEeccccceeecc
Confidence 99999995 589999888788999999999999999999999988 9999999999999 888999999999998654
Q ss_pred ccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG----------- 378 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----------- 378 (435)
.... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++.+....+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 3221 122344678999999998764 4789999999999999999999999887765444333211
Q ss_pred -------------CCCC------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 -------------HRPF------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 -------------~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+. ......++++.+||.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1110 0113457899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.65 Aligned_cols=258 Identities=34% Similarity=0.559 Sum_probs=215.2
Q ss_pred CCCCCCceeecCCceeEEEEEECC---------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 226 (435)
.+|.+.+.||+|+||.||++.+.+ ..+|+|.+..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 378999999999999999998632 3599998865432 23346788899999999 79999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
....++||||+.+++|.+++.... .++..+++.++.|++.||.|||+.| ++||||||+||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE
Confidence 999999999999999999997642 3788899999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~ 369 (435)
+.++.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred --cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 78889999999998765422110 01112234578999999998889999999999999999998 89999887776
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+....+..+..+.. +..++.++.+++.+||..+|++|||+.++++.|.++...
T Consensus 250 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcCCCCCC-CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 66666666554332 346889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.34 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=208.6
Q ss_pred CCCceeecCCceeEEEEEECCC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------Cc
Q 013833 160 SSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP 229 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 229 (435)
.+.+.||+|+||.||+|.+... .+|+|.+..... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678899999999999997632 589998765433 234457889999999999999999999976432 24
Q ss_pred EEEEEecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 230 LMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
.+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCML--NENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEE--cCCCCEEECCC
Confidence 6899999999999998742 124789999999999999999999988 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|++........ ........+++.|++||.+.+..++.++||||||+++|+|++ |..||......+....+..+..+.
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 157 GLSKKIYNGDY--YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CcccccCcccc--eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99987643221 001122345778999999999999999999999999999999 899999888777777777665443
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
. +..++..++++|.+||+.+|++|||+.++++.|+++
T Consensus 235 ~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 Q-PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3 346889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=321.65 Aligned_cols=249 Identities=28% Similarity=0.461 Sum_probs=205.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+..+.||+|+||.||++.+. ++.||+|.+.............+.+|+.++++++|++|+.+++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999986 67899998865444333334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|++|++|.+++...+ .+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeccceeecCCCc
Confidence 999999999986533 5899999999999999999999988 9999999999999 888899999999987553221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCCH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 390 (435)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+...... .....+++
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (285)
T cd05630 157 -----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-EYSEKFSP 230 (285)
T ss_pred -----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh-hcCccCCH
Confidence 123457899999999999999999999999999999999999999865421 122222222121 12346889
Q ss_pred HHHHHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
++++|+.+||+.||++||| +.+++++
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999999999 8899874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=318.93 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=211.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||.||+|..+ +..||+|.+..... ......+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 37889999999999999999753 34799998754322 2233567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEE
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vk 299 (435)
.++||||+.+|+|.+++...+ .++...+..++.|++.||.|||+.+ ++||||||+||++ +.++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili--~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMV--AHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEE--cCCCcEE
Confidence 999999999999999997532 2456788899999999999999988 9999999999999 7888999
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~ 378 (435)
|+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+..+
T Consensus 160 L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999876543221 111122345678999999998899999999999999999998 78999888877776666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 379 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..+.. +..+++.+++++.+||+.+|++|||+.++++.|.+...
T Consensus 238 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 238 GYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 44433 34578999999999999999999999999988887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=318.71 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=205.6
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|+..+.||+|+||+||++.+. ++.+|+|.+.............+.+|+++++.++|+||+.+++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999985 678999988654333333345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--CCCCCEEEecCCcceecCCCC-
Confidence 9999999888653 35899999999999999999999988 9999999999999 778899999999987653221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFFRAKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 392 (435)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..... .......+++++
T Consensus 157 ----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 157 ----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred ----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 12345689999999999988999999999999999999999999987665433222221111 111234688999
Q ss_pred HHHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 393 RELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
.+|+.+||+.||++||+ +.+++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 99999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.08 Aligned_cols=250 Identities=32% Similarity=0.546 Sum_probs=211.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.++||+|+||.||+|..+ ++.||+|.+...... ..++.+|+.++++++||||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 36888999999999999999975 678999988644332 257889999999999999999999874 456899999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+.+++|.+++... ..++..++..++.|++.||+|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILV--SETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEE--cCCCCEEEccCcceeecCCCC
Confidence 99999999998763 35889999999999999999999988 9999999999999 888899999999997654221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
. .......++..|+|||.+....++.++|+||||+++|++++ |..||.+.+..+....+..+..+. .+..++.++
T Consensus 157 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd05067 157 Y---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-RPDNCPEEL 232 (260)
T ss_pred c---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCHHH
Confidence 1 11123345778999999998889999999999999999999 999999888777777766665443 234678999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.+++.+||..+|++||++++++..|+.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.38 Aligned_cols=261 Identities=31% Similarity=0.544 Sum_probs=217.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 226 (435)
.+|.+.+.||+|+||.||++.+. ...+|+|.+..... ......+.+|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 37888999999999999999752 23689998764322 33456788999999999 69999999999998
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
...++++|||+.+++|.+++... ..++..++..++.|++.||.|||++| ++||||||+|||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE
Confidence 89999999999999999999753 24788899999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~ 369 (435)
+.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred --cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 778899999999998664322110 1112234567999999988899999999999999999999 89999988877
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+....+..+..+.. +..++.++++++.+||..+|++|||+.++++.|.++......
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 244 ELFKLLREGHRMDK-PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 77777776654433 346889999999999999999999999999999999875544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=329.23 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=206.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||++.++ ++.||+|.+.+.........+.+.+|..++..++||||+++++++.++..+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6888999999999999999975 67899998864322233344668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++|++|.+++.+ ...+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEE--CCCCCEEEEECCceeecCCCCC
Confidence 9999999999976 456899999999999999999999988 9999999999999 8889999999999876543221
Q ss_pred cccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---FRAK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 386 (435)
. ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+....+....+....... ....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 158 V---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred c---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 1 1223468999999999863 457889999999999999999999999887766655554432111 1123
Q ss_pred CCCHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
.++++++++|.+||..++++ |+++.+++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 47899999999988654443 7899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=314.73 Aligned_cols=249 Identities=32% Similarity=0.556 Sum_probs=210.5
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||++.+. +..+++|.+...... .+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 6888999999999999999876 567999988654332 256889999999999999999999875 4567899999
Q ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili--~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV--GDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--eCCceEEeCCceeeeeccCccc
Confidence 9999999999763 35899999999999999999999988 9999999999999 7788999999999976543221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+..+.. +...+..++
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (260)
T cd05070 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQDCPISLH 233 (260)
T ss_pred c---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCcCCHHHH
Confidence 1 1122345678999999988889999999999999999999 8999998888777777766544433 356889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
+|+.+||..+|++|||+.++.+.|++
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.03 Aligned_cols=247 Identities=38% Similarity=0.659 Sum_probs=214.3
Q ss_pred ceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+.||+|+||.||++.+. +..+++|.+....... ..+.+.+|+++++.++|+||+++++++..+..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 36999999999999986 6689999886544332 4578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 238 RGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 238 ~g~sL~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||+|+||++ +.++.++|+|||.+..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRD 154 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEE--CCCCcEEEcccccccc
Confidence 999999999875 67999999999999999999999988 9999999999999 8889999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ........++..|+|||.+....++.++||||||+++|+|++ |..||......+....+..+..... +..
T Consensus 155 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 231 (262)
T cd00192 155 VYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-PEY 231 (262)
T ss_pred cccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-Ccc
Confidence 654321 112334557889999999988889999999999999999999 6999999888777777776554443 356
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+++++.+++.+||..+|++|||+.+++++|+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=302.29 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=208.6
Q ss_pred CCCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC----
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK---- 228 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 228 (435)
...+|++.+.||.|||+.||++.. .+..+|+|++.-.. .+.++...+|++..++++||||++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 355899999999999999999884 57789999986554 334477889999999999999999998764433
Q ss_pred -cEEEEEecCCCCCHHHHHHH---cC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 229 -PLMLITEYLRGGDLHKYLKE---KG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 229 -~~~lv~e~~~g~sL~~~l~~---~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
..||++.|...|||.+.+.. .+ .+++.+++.|+.++++||++||+..+++.||||||.|||+ .+.+.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEec
Confidence 38999999999999999874 33 6999999999999999999999988889999999999999 77889999999
Q ss_pred cCcccccccCcc--cc---ccccCCCcCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCHH--HHHH
Q 013833 304 GLSKLIKVQNSH--DV---YKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAK 373 (435)
Q Consensus 304 g~a~~~~~~~~~--~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~ 373 (435)
|.++...-.-.. +. ..+.....|..|.|||.+.-+ ..++++|||||||+||.|+.|..||...... ...-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 998866433211 11 112234579999999998644 5678999999999999999999999643221 0111
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+..+....+....+|+.+.++|+.||+.||.+||++.+++..+..+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 12232333333345899999999999999999999999999998865
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.40 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=211.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.++||+|+||.||+|.+. ++.||+|.+...........+++.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 6888999999999999999985 77899999876555545555789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 236 YLRGGDLHKYLKEK-----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
|++|++|.+++... ..++...++.++.||+.||.|||+.| |+||||||+|||+ +.++.++|+|||
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILL--d~dg~vKLiDFG 158 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL--GLFGEVVILDWG 158 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEE--cCCCCEEEEecC
Confidence 99999999998641 23456778899999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCcc--------------ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 013833 305 LSKLIKVQNSH--------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (435)
Q Consensus 305 ~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 370 (435)
++......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866221100 0011123469999999999999999999999999999999999999998755433
Q ss_pred HHHHHHcCCC-CCCCCCCCCHHHHHHHHHHhhhcccCCC-CHHHHHHHHHHHHhh
Q 013833 371 AAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRP-SFLDILKRLEKIKET 423 (435)
Q Consensus 371 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~ 423 (435)
.......... ...+...+|+.+.+++.+||+.||++|| +++++++.|+.+.+.
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 3221111111 1111246889999999999999999995 667788888887653
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.15 Aligned_cols=253 Identities=28% Similarity=0.496 Sum_probs=213.3
Q ss_pred CCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 5778889999999999999864 3579999886432 223346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
++++||+.+++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||||+||++ +.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~--~~ 159 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV--FD 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe--cC
Confidence 9999999999999998532 24788889999999999999999988 9999999999999 77
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++.+||+|||+++....... ........+++.|+|||.+....++.++|||||||++|||++ |..||.+....+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CCceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 78899999999876543221 111223345788999999988889999999999999999998 889999888877777
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.+..+..... +..++.++.+++.+||+.+|++||++.+++..|+.
T Consensus 238 ~i~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 7777655433 35689999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.28 Aligned_cols=255 Identities=31% Similarity=0.538 Sum_probs=209.4
Q ss_pred CCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.+.||+|+||.||+|.+.+ ..|++|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 368888999999999999998854 468888764332 23334668889999999999999999999988889
Q ss_pred EEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEe
Q 013833 230 LMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVG 301 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~ 301 (435)
.++||||++|++|.+++...+ .+++.++++++.||+.||.|||+.+ ++||||||+||++..+. ...+||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence 999999999999999997643 4889999999999999999999988 99999999999994322 2369999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++....... .........+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.....
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 162 DFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred cCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999986632211 001112234568999999998899999999999999999997 9999998877766666655544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+. .+..++..+.+++.+||+.+|++|||+.+++++|.
T Consensus 240 ~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 33 34568999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.88 Aligned_cols=254 Identities=31% Similarity=0.497 Sum_probs=209.9
Q ss_pred CCCCCCceeecCCceeEEEEEECC------------------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcce
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG------------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 218 (435)
.+|++.+.||+|+||.||++.+.. ..||+|.+..... ....+.+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCEe
Confidence 378899999999999999988642 3589998765432 23457889999999999999999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCc
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~N 287 (435)
++++++..+...+++||++.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999998755 6899999999999999999999988 9999999999
Q ss_pred EEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCC
Q 013833 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLAN 365 (435)
Q Consensus 288 Ill~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t--g~~p~~~ 365 (435)
|++ +.++.++|+|||++......... .......+++.|+|||.+....++.++|||||||++|+|++ |..||..
T Consensus 161 ili--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLV--GKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eee--cCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999 77789999999998765432211 11223456788999999988889999999999999999998 7788887
Q ss_pred CCHHHHHHHHHcCC-----C-CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 366 YEPYEAAKYVAEGH-----R-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 366 ~~~~~~~~~~~~~~-----~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
....+....+.... . ....+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 76655554444321 1 11123457899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.33 Aligned_cols=257 Identities=27% Similarity=0.568 Sum_probs=213.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|+..+.||+|+||+||+|.+. +. +||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 36888899999999999999864 33 48999875432 233346788999999999999999999988754 56
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++++||+++|+|.+++... +.+++.+++.++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLV--KSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE--cCCCcEEECCCCceeec
Confidence 8999999999999999864 56899999999999999999999988 9999999999999 77888999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+..+..+.. +..+
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (279)
T cd05109 160 DIDET--EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ-PPIC 236 (279)
T ss_pred ccccc--eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC-CccC
Confidence 43221 111222345678999999998899999999999999999998 9999988877766666666554433 3468
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+.++.+++.+||..||++||++.++++.|..+...
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 99999999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.02 Aligned_cols=255 Identities=28% Similarity=0.538 Sum_probs=210.9
Q ss_pred CCCCCceeecCCceeEEEEEE-CCCcEEEEEccCCCCC---cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+|+..+.||+|+||.||++.. .+..+|+|.+...... .......+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999999999987 4778999987643322 123346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+||+++++|.+++.+.+.+++..+..++.|++.||+|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEE--CCCCeEEeccchhhHhhhhcc
Confidence 999999999999988788999999999999999999999988 9999999999999 888899999999987653221
Q ss_pred cc--ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCCH
Q 013833 314 SH--DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFTP 390 (435)
Q Consensus 314 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 390 (435)
.. .........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.... .....+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11 0111223468899999999998889999999999999999999999998776655443333321 11223456899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.++|.+||..+|++||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999998864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=320.47 Aligned_cols=255 Identities=31% Similarity=0.520 Sum_probs=210.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 228 (435)
.+|.+.+.||+|+||.||++.+. +..+|+|.+..... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 37888999999999999999752 33699998764332 33446789999999999 7999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
..++||||+.+++|.++++... .+++.++..++.|++.||.|||+.+ ++|+||||+|||+ +.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEE--cCCCeEEECCCccc
Confidence 9999999999999999997643 3899999999999999999999988 9999999999999 78889999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHcCCCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA-KYVAEGHRPFFR 384 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~ 384 (435)
......... .......++..|+|||.+....++.++|||||||++|+|++ |..||......+.. ..+..+..+ ..
T Consensus 189 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 265 (302)
T cd05055 189 RDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQ 265 (302)
T ss_pred ccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CC
Confidence 865433211 11222345788999999998899999999999999999998 99999877654433 333333332 23
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+...++++++++.+||..+|++|||+.++++.|.++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 446789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=314.25 Aligned_cols=255 Identities=35% Similarity=0.637 Sum_probs=214.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CC---cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|+..+.||+|+||.||++..+ +. .+++|.+.... .....+.+.+|++++++++||||+++.+++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 6778889999999999999874 32 68999875432 23334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||+++++|.+++... +.+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILV--NSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEE--cCCCcEEECCCccceeccc
Confidence 99999999999999764 56899999999999999999999988 9999999999999 7888999999999976643
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... .........++.|+|||.+....++.++|||||||++|+|++ |..||......+....+..+.... ....++.
T Consensus 160 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~ 237 (268)
T cd05063 160 DPEG-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-APMDCPS 237 (268)
T ss_pred cccc-ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-CCCCCCH
Confidence 3211 111112233567999999998889999999999999999997 999998888777777776654333 2345789
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
++.+++.+||+.+|++||++.++++.|.++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=313.79 Aligned_cols=250 Identities=32% Similarity=0.542 Sum_probs=209.7
Q ss_pred CCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||++.+++ ..|++|.+...... .+.+.+|+.+++.++||||+++++++.+ ...++||||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 68899999999999999998764 47999988653322 2568899999999999999999988754 567999999
Q ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEE--cCCCcEEeccCCceeecccccc
Confidence 9999999999763 34789999999999999999999987 9999999999999 7788999999999976643321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+..... ...++..+.
T Consensus 158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 233 (262)
T cd05071 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLH 233 (262)
T ss_pred c---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC-ccccCHHHH
Confidence 1 1123346778999999988899999999999999999999 8899988877666666655543332 346899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
+++.+||+.+|++||++.++++.|+..
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.93 Aligned_cols=256 Identities=31% Similarity=0.483 Sum_probs=208.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ceeeeeeEEeCC------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERK------ 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------ 228 (435)
.|..+++||+|+||+||+|+.+ |+.||+|++...... +..-....+|+.+|+.++|+| |+.+++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5778889999999999999975 788999998765442 112244578999999999999 999999987776
Q ss_pred cEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
.+++|+||+ ..+|.+++...+ .++...+..+++||+.||+|||+++ |+||||||+|||+ +.+|.+||+|||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi--~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLI--SSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEE--CCCCcEeeeccc
Confidence 789999999 459999998744 4788899999999999999999988 9999999999999 889999999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-C-
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-P- 381 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~- 381 (435)
+|+...-+.. ......+|.+|.|||++.+. .|+...||||+|||+.||++++.-|++....+....|.+-.. |
T Consensus 166 lAra~~ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 9996653322 24556789999999999876 799999999999999999999999999887666554432211 0
Q ss_pred ---------------CCC----C-------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhh
Q 013833 382 ---------------FFR----A-------KGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 423 (435)
Q Consensus 382 ---------------~~~----~-------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~ 423 (435)
.++ + ...++...+++..||+.+|.+|.|+..++.| +..+.+.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 000 0 1123578899999999999999999999987 6555433
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.22 Aligned_cols=248 Identities=28% Similarity=0.497 Sum_probs=212.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.++ +..+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+++.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4778899999999999999975 67899998754322 2344778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++.. ...++++.++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL--TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--CCCCcEEEcccCcceeecccc
Confidence 9999999999875 335899999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+..... +..++..++
T Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (255)
T cd08219 155 A----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL-PSHYSYELR 229 (255)
T ss_pred c----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC-CcccCHHHH
Confidence 1 12335688999999999988899999999999999999999999998877666666666554433 346889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||+.||++||++.+++..
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.42 Aligned_cols=257 Identities=30% Similarity=0.544 Sum_probs=207.4
Q ss_pred CCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe-CC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-RK 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~ 228 (435)
+|++.+.||+|+||.||+|.+. ++.||||.+..... ......+.+|+.++.++ +||||+++++++.. +.
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 7899999999999999999742 56899998864332 23346788999999999 68999999998754 45
Q ss_pred cEEEEEecCCCCCHHHHHHHcC----------------------------------------------------------
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG---------------------------------------------------------- 250 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~---------------------------------------------------------- 250 (435)
.++++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986521
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccccc
Q 013833 251 ---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321 (435)
Q Consensus 251 ---------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 321 (435)
.++..++..++.|++.||.|||+++ |+||||||+|||+ +.++.++|+|||++........ .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 239 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKG 239 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEE--cCCCcEEEEecccccccccCcc--hhhcC
Confidence 3577788899999999999999988 9999999999999 7888999999999976532211 11122
Q ss_pred CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 322 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+..+..+.. +..+++++.+++.+|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC-CCCCCHHHHHHHHHH
Confidence 2345678999999988899999999999999999997 99999875433 23333444443332 345788999999999
Q ss_pred hhhcccCCCCHHHHHHHHHHHHhh
Q 013833 400 WAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 400 l~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
|+.+|++|||+.+++++|+.+.+.
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.59 Aligned_cols=253 Identities=30% Similarity=0.526 Sum_probs=213.0
Q ss_pred CCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||.||++.+++ ..|++|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 478889999999999999998753 569999875432 22334578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEE
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vk 299 (435)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill--~~~~~~k 159 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV--AEDLTVK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE--cCCCCEE
Confidence 999999999999999997532 3677889999999999999999987 9999999999999 8889999
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~ 378 (435)
|+|||+++....... ........++..|+|||.+....++.++|||||||++|++++ |..||.+.+..+..+.+..+
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 999999876543321 111223456789999999988889999999999999999998 99999988887777777755
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 379 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
..+.. +..++.++.+++.+||+.+|++|||+.+++..|+
T Consensus 238 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCC-CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 44433 4567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=339.57 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=197.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 227 (435)
..+|++.+.||+|+||.||+|.+. +..||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 347999999999999999999974 6789999875421 2335799999999999999998876332
Q ss_pred --CcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC-CcEEE
Q 013833 228 --KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKV 300 (435)
Q Consensus 228 --~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~-~~vkl 300 (435)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.+ +.+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl--~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLI--DPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEE--cCCCCceee
Confidence 246799999965 78777653 456899999999999999999999988 9999999999999 654 46999
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 379 (435)
+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+....
T Consensus 213 ~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred eccccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999998664322 1234568999999999865 468999999999999999999999998876654433332110
Q ss_pred -------------------CCC--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 380 -------------------RPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 380 -------------------~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
.+. ..+...++++.+||.+||+.||.+|||+.|++++ +..+.+
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 0123467899999999999999999999999966 455544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.51 Aligned_cols=251 Identities=29% Similarity=0.588 Sum_probs=221.0
Q ss_pred CCceeecCCceeEEEEEEC----CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 161 SSAIIGKGSFGEILKAYWR----GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 161 ~~~~lg~G~~g~V~~~~~~----~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..++||.|.||.||+|.+. |. .||||..+.....+. .+.|.+|+.+|++++||||++++|++.+. ..||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 3568999999999999863 33 588998766444333 47899999999999999999999999865 679999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|.++-|-|..|++.+. .++..+...++.||+.||.|||+.. +|||||...|||+ .+...|||+|||+++.++.+
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLV--sSp~CVKLaDFGLSR~~ed~- 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILV--SSPQCVKLADFGLSRYLEDD- 544 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheee--cCcceeeecccchhhhcccc-
Confidence 9999999999998754 5899999999999999999999987 9999999999999 77889999999999988754
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.++......-+..|||||.+.-+.++..+|||.|||++||++. |..||.+....+.+-.+..|.+++.++ +||+.+
T Consensus 545 --~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~-nCPp~L 621 (974)
T KOG4257|consen 545 --AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP-NCPPAL 621 (974)
T ss_pred --chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC-CCChHH
Confidence 3444445556789999999999999999999999999999988 999999999888888888888887665 699999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..++.+||..+|.+||.+.++...|..+.+
T Consensus 622 YslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999988775
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.43 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=215.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||+||++.+. +..||+|.+.... .....+.+.+|+++++.++||||+++++.+.....+++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 47888999999999999999986 7789999875432 2333477889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+ ++||||+|+||++ +.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILV--NSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEE--CCCCcEEEccCCcccchhhhc
Confidence 999999999999888889999999999999999999997 46 9999999999999 788899999999986543221
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHcCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-----------EAAKYVAEGHRPF 382 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~~ 382 (435)
.....|+..|+|||++.+..++.++|+|||||++|++++|..||...... +....+.....+.
T Consensus 159 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd06620 159 ------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232 (284)
T ss_pred ------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC
Confidence 12356899999999998889999999999999999999999999865431 2223333333333
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH---HHhhCCCCCcc
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK---IKETLPTDHHW 430 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~---~~~~~~~~~~~ 430 (435)
+....++.++.+|+.+||+.||++|||+.+++++..- ..+.-...++|
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~~~~ 283 (284)
T cd06620 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW 283 (284)
T ss_pred CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCcccc
Confidence 3333478899999999999999999999999987433 33333445777
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=328.77 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=208.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ +..+|+|.+.+...........+.+|..++..++|++|+++++.+.+...+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5788899999999999999986 56799998754322223334568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEeecchheecccCCc
Confidence 9999999999987 457899999999999999999999988 9999999999999 8888999999999876533221
Q ss_pred cccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-C--CCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-F--RAK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~--~~~ 386 (435)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+....... . ...
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 158 ---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred ---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 1123357899999999986 3468899999999999999999999999888777776666543221 1 123
Q ss_pred CCCHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
.+++++++|+.+||..++++ |+++.+++++
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 57999999999999665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.19 Aligned_cols=257 Identities=29% Similarity=0.579 Sum_probs=215.3
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|.+.+.||+|+||.||+|.+.. ..|++|...... .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 3467888999999999999998642 368999775433 23344688999999999999999999998875 457
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++.... .+++.++..++.|++.||.|||+.+ ++||||||+||++ +..+.++|+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV--SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEE--ecCCCeEEccCceeeec
Confidence 89999999999999998744 5899999999999999999999988 9999999999999 78889999999998765
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ........++..|+|||.+....++.++||||||+++|++++ |..||......+....+..+..+.. +..+
T Consensus 158 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (270)
T cd05056 158 EDES---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM-PPNC 233 (270)
T ss_pred cccc---ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCC
Confidence 4331 111223345678999999988889999999999999999986 9999998887777666766655543 3568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+.+++.+||..+|++|||+.++++.|.++...
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.71 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=198.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
.+|++.+.||+|+||.||++.++ +..||+|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 37899999999999999999875 778999988654332 233467789999999999999999999886443
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEecCCCccc
Confidence 47999999965 67776643 4889999999999999999999988 9999999999999 8889999999999975
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---------- 378 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------- 378 (435)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 173 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 173 ACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 43221 123456899999999999999999999999999999999999999876543322111100
Q ss_pred -----------CCCCC-------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 379 -----------HRPFF-------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 379 -----------~~~~~-------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
..+.. .....++++++||.+||..||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 0112457899999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.37 Aligned_cols=252 Identities=33% Similarity=0.568 Sum_probs=211.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|...+.||+|+||.||++... +..+++|.+... .......+.+|+++++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 36777889999999999999642 447888876532 23344688999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG---------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
.+++|||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+|||+ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~--~~ 157 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV--GQ 157 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE--cC
Confidence 999999999999999997643 3788999999999999999999988 9999999999999 77
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+...
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCCEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 889999999998755432110 01122345788999999998999999999999999999998 999998887777777
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.+..+..+. .+..+++.+++++.+||+.||++||++.++++.|+
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 776665443 33568999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=328.77 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=207.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||+|.+.+...........+.+|..++..++|++|+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888899999999999999986 66899998854322223334568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++||+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEE--cCCCCEEEEeccceeeccCCCc
Confidence 9999999999987 467899999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCC--CC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFR--AK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~ 386 (435)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+..... ...+ ..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 11223568999999999875 4678899999999999999999999998887766666554322 1111 13
Q ss_pred CCCHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
.+++++++++.+||..++.+ |+++++++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 47899999999999876654 4689998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=312.01 Aligned_cols=249 Identities=33% Similarity=0.570 Sum_probs=208.9
Q ss_pred CCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|.+...||+|+||.||++.+++ ..+++|.+..... ..+.+.+|++++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 57888899999999999999864 4789998754322 2256888999999999999999998875 4567899999
Q ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV--GDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCeEEECCCccceEccCCcc
Confidence 99999999997643 4789999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+....+..+..+.. +..++..++
T Consensus 158 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (260)
T cd05069 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQGCPESLH 233 (260)
T ss_pred c---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CcccCHHHH
Confidence 1 1122345678999999988889999999999999999999 9999998887777766666544433 346889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
+++.+||..+|++||+++++++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=310.56 Aligned_cols=253 Identities=28% Similarity=0.563 Sum_probs=206.0
Q ss_pred ceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE-eCCcEEEEEec
Q 013833 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEY 236 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 236 (435)
+.||+|+||.||+|.+. ...+|+|.+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999863 246999987432 22334578889999999999999999999765 45568999999
Q ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+.+++|.+++... ..++...+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||+++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCccccccccCCcce
Confidence 9999999999764 34677888899999999999999988 9999999999999 78889999999999765432111
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.........++..|+|||.+....++.++||||||+++|||++ |.+||...+..+....+..+..+. .+..+++.+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-QPEYCPDPLYE 233 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-CCCcCCHHHHH
Confidence 1111223345778999999988899999999999999999999 567888877777776666654443 23457899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 395 LTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++.+||..+|++||++.++++.|+++..
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=315.47 Aligned_cols=248 Identities=33% Similarity=0.542 Sum_probs=214.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||.|+||.||++.+. +..+++|.+..... ......+.+|+.+++.++||||+++++.+.++..+++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 5788899999999999999975 67899998754432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++... .+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEcccccceeeccccc-
Confidence 99999999999765 7899999999999999999999988 9999999999999 8888999999999987754321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+.....+......+++++.++
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 22345678899999999988899999999999999999999999988777666666666655554444489999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||..+|++|||+++++++
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=312.58 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=213.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--C---CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
.|++.+.||+|+||.||+|.++ + ..|++|.+.... .......+..|+.+++.++||||+++++++.++...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 5678889999999999999875 2 259999875432 34445789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||+++++|.+++.. .+.+++.+++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEE--cCCCcEEECCCcccccccc
Confidence 9999999999999986 456899999999999999999999988 9999999999999 8888999999999876643
Q ss_pred cCcccccc-ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 312 QNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
........ ......+..|+|||.+....++.++|||||||++||+++ |..||......+....+........ +..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-PMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-cccCC
Confidence 32211111 111122457999999998999999999999999999887 9999998887777666655543332 34688
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
..+.+++.+||..+|++||++.+++..|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=318.05 Aligned_cols=246 Identities=30% Similarity=0.547 Sum_probs=213.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.+. ++.+|+|.+.............+.+|+.++++++||||+++++++.++..+++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788899999999999999985 67899998865443333445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|.||++ +.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 88889999999998865432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..+..+. +..+++.++++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 228 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF--PSFFSPDAKDL 228 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC--CccCCHHHHHH
Confidence 223468899999999988888999999999999999999999998887666666665544322 34578999999
Q ss_pred HHHHhhhcccCCC-----CHHHHHHH
Q 013833 396 TEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
|.+||..||.+|+ ++++++++
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcC
Confidence 9999999999998 78888755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=311.58 Aligned_cols=252 Identities=32% Similarity=0.545 Sum_probs=213.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..+|++.+.||+|+||.||++.++ +..+++|.+...... .+++.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 347888999999999999999876 467999987643322 367889999999999999999999999888999999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+++++|.+++.... .++..++..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV--GENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEE--cCCCCEEECccccceeccch
Confidence 9999999999997643 5899999999999999999999987 9999999999999 88889999999998766432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ........++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+..+..... +...+.+
T Consensus 157 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (261)
T cd05034 157 E---YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-PPNCPEE 232 (261)
T ss_pred h---hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHH
Confidence 1 111122334678999999998889999999999999999998 9999998887777777766544332 3457899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
+++++.+||+.+|++||++.++++.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=319.70 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=207.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.+. +..+++|.+.... .......+.+|++++++++||||+++++.+.+++.+++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 5888899999999999999986 5678888775432 23344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+ ++||||||+|||+ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEE--ecCCcEEEccCCCcccccccc-
Confidence 99999999999888889999999999999999999997 46 9999999999999 778899999999987553221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA------------------ 376 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------------ 376 (435)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 234568899999999988889999999999999999999999997554333222221
Q ss_pred ------------------cCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 377 ------------------EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 377 ------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
....+..+...++.++++|+.+||..+|++|||+.+++++.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111222222346789999999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=321.73 Aligned_cols=265 Identities=31% Similarity=0.560 Sum_probs=219.1
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcce
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 218 (435)
.|++. ..+|++.+.||+|+||.||++.+. +..||+|.+.... .....+.+.+|+.+++++ +||||+
T Consensus 6 ~~~~~--~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 6 KWELS--RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred ccccC--HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45544 447899999999999999999753 1258999775432 233457889999999999 799999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~D 282 (435)
++++++..+...+++|||+.+++|.+++.+.. .++..++..++.|++.||.|||+.| ++|||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~d 159 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRD 159 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence 99999999999999999999999999997532 3677888999999999999999988 99999
Q ss_pred CCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 013833 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (435)
Q Consensus 283 lkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~ 361 (435)
|||+|||+ +.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 160 lkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 235 (334)
T cd05100 160 LAARNVLV--TEDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235 (334)
T ss_pred cccceEEE--cCCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence 99999999 7788999999999976543211 111222334578999999999999999999999999999998 899
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 362 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
||.+.+..+....+..+..+.. +..++.++.+++.+||+.+|++|||+.++++.|.++....
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 236 PYPGIPVEELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 9998887777777766554433 3467899999999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=310.63 Aligned_cols=248 Identities=31% Similarity=0.578 Sum_probs=208.7
Q ss_pred ceeecCCceeEEEEEEC---CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+.||+|++|.||++.+. ++ .||+|.+...... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 36899999999999874 22 6899988665443 445789999999999999999999999888 8899999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 238 ~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++..+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEE--ecCCEEEeccccccccccccccc
Confidence 9999999998754 6899999999999999999999988 9999999999999 77789999999999877543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.........+..+|..+.+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN 232 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHH
Confidence 111223456788999999998899999999999999999998 999998887777666655433333334467899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
++.+||+.+|++|||+.++++.|.
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.41 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=205.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.+. ++.|++|.+..... .....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 6888899999999999999874 67899998754322 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++.+++.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILL--TDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECcceeeeEccCccc-
Confidence 9999999999988888999999999999999999999988 9999999999999 8888999999999876542211
Q ss_pred ccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFF--RAKGFT 389 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~ 389 (435)
......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+........... .+.. ....++
T Consensus 162 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 162 ---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred ---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 223456899999999974 4568889999999999999999999997665544333322221 1111 112478
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..++++|.+||..+|++|||+.+++++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=314.73 Aligned_cols=244 Identities=25% Similarity=0.457 Sum_probs=203.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.+. +..||+|.+.... .......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4677889999999999999874 6789999885442 23334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEE--CCCCCEEEeeCCcceecccc---
Confidence 99999997653 4788899999999999999999988 9999999999999 88899999999999765432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------YEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 388 (435)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.....+.......
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence 12345789999999999988999999999999999999999999965322 12223333333333334457
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++++++++.+||+.+|++||++.+++++-
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 89999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=309.82 Aligned_cols=249 Identities=31% Similarity=0.529 Sum_probs=209.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-CCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 234 (435)
.|++.+.||+|++|.||++.++ ++.+++|.+...... ....+.+.+|+.++++++|||++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4788899999999999999875 678999988543332 2334678899999999999999999988764 44679999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+++++|.+++... ..+++.+++.++.|++.|+.+||+.| ++||||||+||++ +.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~--~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFL--TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEE--ecCCcEEEecccceEEeccc
Confidence 999999999999763 35899999999999999999999988 9999999999999 88889999999999866433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+..+..+.. +..+++++
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (257)
T cd08223 156 CD----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM-PKDYSPEL 230 (257)
T ss_pred CC----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-ccccCHHH
Confidence 21 12345688999999999999999999999999999999999999987776665555555554332 34688999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++.+||+.+|++|||+.+++++
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=309.69 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=214.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||.|+||.||.+... +..+++|.+....... ....++.+|+.++++++|+||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 4788899999999999988864 7789999875443322 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+++++|.+++.+. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE--eCCCCEEECcCcceEEccccc
Confidence 99999999999864 45899999999999999999999988 9999999999999 778899999999998664432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+..+..+.. ...++.++.
T Consensus 156 ~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08221 156 S----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSELI 230 (256)
T ss_pred c----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-ccccCHHHH
Confidence 1 12345689999999999888899999999999999999999999998887777767666554443 356889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+++.+||..+|++||++.++++++
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=311.15 Aligned_cols=254 Identities=31% Similarity=0.537 Sum_probs=207.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 230 (435)
.+|+..+.||+|+||.||++.+. +..|++|.+...... .......+.+|+.++++++||||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999874 678999987544322 22345678899999999999999999998865 3568
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCCCccccc
Confidence 899999999999999988778999999999999999999999988 9999999999999 888899999999987654
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....................+..+++
T Consensus 158 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGT-GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCC-ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 3211100 112345788999999999888999999999999999999999999877665544444332222222345788
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++++ +||..+|++||++.+++++
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 899999 6777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=313.81 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=203.0
Q ss_pred CCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--Cc
Q 013833 158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 229 (435)
.|+..+.||+|+||+||++.. .+..||+|.+..... ......+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 348889999999999988753 256799998865422 22346788999999999999999999987653 45
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++++|||+++++|.+++... .+++.+++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEE--cCCCcEEEeeccccccc
Confidence 89999999999999999764 5999999999999999999999988 9999999999999 78889999999999866
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHH
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------------EAAKY 374 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------------~~~~~ 374 (435)
...... ........++..|+|||.+....++.++||||||+++|+|++|..||...... .....
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 532211 00112234567799999998888999999999999999999999998643211 11111
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
+..+..+. .+..++.++++++.+||+.+|++|||+.+++..|+.+.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11222211 23457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=321.74 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=203.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|.+.+.||+|+||.||++.++ +..||+|.+....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 36889999999999999999875 6789999886443222 1245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++ +|.+++...+ .++..++..++.||+.||.|||+.| |+||||||+||++ +.++.+||+|||++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECccccceecCCCc
Confidence 99965 8988887643 5899999999999999999999988 9999999999999 888899999999987643322
Q ss_pred ccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------------- 379 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 379 (435)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 K----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred c----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 1 1223467899999999865 468899999999999999999999998776544433222110
Q ss_pred --------CCCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 380 --------RPFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 380 --------~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
.+.. ....++++++++|.+||+.||.+|||+.+++++ +..+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 012468899999999999999999999999985 44444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.20 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=203.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 233 (435)
+|.+++.||+|+||+||++.+. +..+|+|.+...... ......+..|+.++++++||||++++++|.+ ...+|||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 7999999999999999999986 567899987654333 3344778899999999999999999998854 3568999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCC-----CceEeCCCCCCcEEEec------------
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP-----NVIIHRDLKPRNVLLVN------------ 292 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-----~~ivH~Dlkp~NIll~~------------ 292 (435)
|||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.+ ..||||||||+||||..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999999875 356999999999999999999999843 23999999999999943
Q ss_pred ---CCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 013833 293 ---SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (435)
Q Consensus 293 ---~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 367 (435)
+..+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 123459999999998654321 1234568999999999854 458899999999999999999999998665
Q ss_pred HHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 368 PYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 368 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..... ..+... +.++....+.++.+||..||..+|.+||++.|++.+
T Consensus 248 ~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 44333 333332 233334678999999999999999999999999954
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=317.28 Aligned_cols=249 Identities=27% Similarity=0.491 Sum_probs=209.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|+..+.||+|+||.||++.+. +..+++|.+...... ..+.+.+|+.+++.+.||||+++++.+..+...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 347899999999999999999874 678999987654332 236688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+++++|.+++.. ..+++.++..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill--~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEECccccchhccccc
Confidence 999999999999864 45899999999999999999999988 9999999999999 788899999999987654322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 392 (435)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+......+..... +...+..+++.+
T Consensus 171 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 171 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred c----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 1 12234688999999999988899999999999999999999999987776444333332222 222235688999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++.+||..+|++||++.+++++
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhC
Confidence 999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=313.81 Aligned_cols=247 Identities=29% Similarity=0.528 Sum_probs=205.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeC------C
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER------K 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~ 228 (435)
.|+..+.||+|+||.||+|.+. ++.||+|.+...... ...+.+|+.+++++ +||||+++++.+... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5788889999999999999875 678999987543221 25678899999998 699999999988653 4
Q ss_pred cEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
.++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili--~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEE--CCCCCEEEccCCCc
Confidence 589999999999999999863 35899999999999999999999988 9999999999999 88889999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
........ ......|++.|+|||++. ...++.++|||||||++|+|++|..||.................+
T Consensus 159 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 159 AQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred eecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 76543221 223456899999999986 346788999999999999999999999877766555554444444
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......++.++++|+.+||..+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 44445688999999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.46 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=207.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCC--CCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 231 (435)
+|++.+.||+|+||.||.+.+. +..|++|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 6888999999999999999875 6789999875332 22234457889999999999999999999988663 4678
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
++|||+++++|.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILR--DSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--cCCCCEEECcCcccccccc
Confidence 99999999999999988778899999999999999999999988 9999999999999 8888999999999886543
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....................+..++..
T Consensus 159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred cccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 2110 001223458889999999988889999999999999999999999998776555544444333222234457788
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+++.+||. +|++||++++++++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999995 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=316.25 Aligned_cols=248 Identities=30% Similarity=0.535 Sum_probs=210.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||.|+||.||++.+. ++.|++|.+...... ..+.+.+|+.+++.++||||+++++++..++.+++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 47899999999999999999864 788999988543322 2367789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+.+++|.+++... .+++.++..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccchhcccccc
Confidence 999999999998654 5899999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 393 (435)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...++......+.....+ ...+..+++.++
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred ----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 122346788999999999888999999999999999999999999988776555444433322 223456889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||..||++||++.+++++
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=320.12 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=213.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++... +..||+|.+.+.........+.+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999985 67899999876554444456778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+.|++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEE--cCCCCEEEeecchhhcccccc
Confidence 99999999999764 46899999999999999999999988 9999999999999 778899999999987654322
Q ss_pred cccc-------------------------ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 013833 314 SHDV-------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (435)
Q Consensus 314 ~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 368 (435)
.... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1100 011234678899999999988899999999999999999999999988776
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCC----HHHHHHH
Q 013833 369 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPS----FLDILKR 416 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~ 416 (435)
......+............++++++++|.+||..+|++||+ +.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 65555554433333223347899999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=312.83 Aligned_cols=253 Identities=32% Similarity=0.556 Sum_probs=213.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|+..+.||+|+||.||++..+ ...+++|.+... ......+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 36888899999999999999964 346899976432 223345778999999999999999999999999899
Q ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEE
Q 013833 230 LMLITEYLRGGDLHKYLKEKG---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl 300 (435)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l 158 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLV--SSQREVKV 158 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEE--eCCCcEEE
Confidence 999999999999999998755 6899999999999999999999988 9999999999999 77889999
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~ 379 (435)
+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..+.
T Consensus 159 ~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 159 SLLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 9999987543221 112233456778999999988888999999999999999999 889998777666666666554
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
........++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 444344568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.37 Aligned_cols=246 Identities=35% Similarity=0.567 Sum_probs=204.5
Q ss_pred eeecCCceeEEEEEECC--C--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 164 IIGKGSFGEILKAYWRG--T--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.||+|+||.||++.+++ . .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.....+++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999753 2 46888765322 223346788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 239 GGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 239 g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
+++|.+++.... .++++++..++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili--~~~~~~kl~d 155 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIAD 155 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEE--cCCCeEEECC
Confidence 999999997543 3788999999999999999999988 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
||++....... .......+..|+|||++....++.++|+||||+++|+|++ |..||.+.+..+....+..+..+
T Consensus 156 fgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05047 156 FGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230 (270)
T ss_pred CCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC
Confidence 99986332111 1112234667999999988889999999999999999997 99999887776666666655444
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
.. +..++.++.+++.+||..+|.+|||+.++++.|.++.
T Consensus 231 ~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 EK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC-CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 32 3457899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.32 Aligned_cols=245 Identities=32% Similarity=0.592 Sum_probs=206.5
Q ss_pred eeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
+||+|+||.||++... +..+|+|.+..... ......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6899999999999865 56799998764432 23335688999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccccc
Q 013833 243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321 (435)
Q Consensus 243 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 321 (435)
.+++... ..+++.++..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........ ....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~---~~~~ 152 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIY---SSSG 152 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEE--cCCCeEEECCCccceecccccc---ccCC
Confidence 9998763 45899999999999999999999988 9999999999999 8888999999999875432211 0111
Q ss_pred CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHh
Q 013833 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400 (435)
Q Consensus 322 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 400 (435)
...++..|+|||++....++.++||||||+++|++++ |..||...........+..+.+... +..++..+.+++.+||
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l 231 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-PQKCPDDVYKVMQRCW 231 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHHc
Confidence 2234677999999998889999999999999999998 9999998877776666666655433 3458899999999999
Q ss_pred hhcccCCCCHHHHHHHHH
Q 013833 401 AADMNQRPSFLDILKRLE 418 (435)
Q Consensus 401 ~~dp~~Rps~~~ll~~L~ 418 (435)
..+|++||++.++++.|.
T Consensus 232 ~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 232 DYKPENRPKFSELQKELA 249 (250)
T ss_pred ccCcccCCCHHHHHHHhc
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=316.60 Aligned_cols=254 Identities=28% Similarity=0.513 Sum_probs=205.8
Q ss_pred CCCCCCceeecCCceeEEEEEECC----------------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceee
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG----------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 220 (435)
.+|++.+.||+|+||.||++.+.+ ..||+|.+.... .......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 478899999999999999987642 248999886542 23345678999999999999999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcE
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NI 288 (435)
++++......++||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.+ ++||||||+||
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNC 160 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhE
Confidence 999999999999999999999999986532 3678889999999999999999988 99999999999
Q ss_pred EEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 013833 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANY 366 (435)
Q Consensus 289 ll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t--g~~p~~~~ 366 (435)
++ +.++.+||+|||++........ ........++..|+|||.+....++.++|+||||+++|+|++ |..||...
T Consensus 161 ll--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 161 LV--GNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EE--cCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99 7788999999999976543221 111223345778999999998899999999999999999988 67888877
Q ss_pred CHHHHHHHHHc-----CCC-CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 367 EPYEAAKYVAE-----GHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 367 ~~~~~~~~~~~-----~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
...+....+.. ... ....+..+++.+.+|+.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 66554433321 111 11123457899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=316.65 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=195.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEEe-----C
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE-----R 227 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~ 227 (435)
+|++.+.||+|+||+||++.++ ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4788899999999999999985 67899998865432221 113345566666555 79999999998754 3
Q ss_pred CcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
...+++|||+.+ +|.+++... ..+++.++..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccCc
Confidence 457999999965 899988763 34899999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----- 380 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----- 380 (435)
+....... ......+|..|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 98664322 12234678999999999988999999999999999999999999987665443333221100
Q ss_pred ----------CCC----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ----------PFF----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ----------~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+ ....++.++++++.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.27 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=206.7
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|++.+.||+|+||.||++.+. +..+++|.+... .....+.+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577789999999999999986 557788877432 234457788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+++++|..++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--ccCCCEEEcccccccccccccc-
Confidence 999999998865 456899999999999999999999988 9999999999999 8888999999999876532211
Q ss_pred ccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFT 389 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 389 (435)
......+++.|+|||.+. +..++.++|+|||||++|+|++|.+||...+..+....+.....+. ..+..++
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 223456899999999984 3457789999999999999999999999887766655554443332 2234688
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++++||.+||+.+|++||++.+++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=310.09 Aligned_cols=257 Identities=30% Similarity=0.594 Sum_probs=215.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|++.+.||+|+||.||+|.++ +. .+++|.+..... ......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 46888899999999999999864 32 589997754432 3445678899999999999999999999877 788
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||+++..
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEE--cCCCeEEECCCcccccc
Confidence 9999999999999999874 46899999999999999999999988 9999999999999 78889999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... ........++..|+|||.+....++.++|+||||+++|++++ |..||.+....+....+..+.... .+..+
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (279)
T cd05057 160 DVDEK--EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP-QPPIC 236 (279)
T ss_pred cCccc--ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC-CCCCC
Confidence 53321 111222334678999999988899999999999999999998 999999888777766666554333 33457
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+.+++.+||..+|++||++.++++.|.++...
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 89999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.36 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=210.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.+. ++.|++|.+.............+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999986 56899998865433333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||+++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEE--CCCCCEEEeeCCCccccCcCccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999988642211100
Q ss_pred c-----------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-C
Q 013833 316 D-----------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-F 383 (435)
Q Consensus 316 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~ 383 (435)
. ........++..|+|||.+....++.++|+||||+++|+|++|..||.+....+....+..+..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0 001122457889999999998899999999999999999999999999887776666655543222 1
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCH---HHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSF---LDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~---~~ll~~ 416 (435)
....++.+++++|.+||+.+|++||++ .+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 223578999999999999999999985 554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.60 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=212.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+.... .......+.+|+.++++++||||+++++++.++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 47888999999999999999863 4679999876433 23344678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCc
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~N 287 (435)
.+++|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n 160 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN 160 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence 999999999999999997432 3678888999999999999999988 9999999999
Q ss_pred EEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 013833 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANY 366 (435)
Q Consensus 288 Ill~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~ 366 (435)
|++ +.++.++|+|||++......... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus 161 il~--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLV--GENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEe--cCCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999 88889999999998755332110 01122334678999999998899999999999999999998 88999888
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 367 EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
...+....+..+..+.. +..++.++.+|+.+||+.+|++|||+.++++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 87777777666554332 34688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=326.19 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=200.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++.+.||+|+||.||++.+. ++.||||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 37999999999999999999975 778999988654332 23346778899999999999999999887543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEE--CCCCcEEEEeCCCccc
Confidence 57999999965 78887754 4888999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------- 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------- 381 (435)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 176 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 54321 223456899999999999999999999999999999999999999887765544433221110
Q ss_pred --------------CCC-------------------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 --------------FFR-------------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 --------------~~~-------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... ....+..+++||.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 01134678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=310.04 Aligned_cols=248 Identities=31% Similarity=0.536 Sum_probs=209.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.+. +..+++|.+...... ..+.+.+|+.++++++||||+++++.+.++..++++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 6888899999999999999975 678999988654322 34788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILL--TEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEE--CCCCCEEECccccchhhhhhhh
Confidence 99999999999876 68999999999999999999999988 9999999999999 8888999999999976653321
Q ss_pred cccccccCCCcCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CC-C-CCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP-F-FRAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~-~-~~~~~~ 388 (435)
......++..|+|||.+... .++.++|+||||+++|+|++|..||....+......+.... .+ . .....+
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 157 ----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred ----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 12335678899999999776 88899999999999999999999998877665544444331 11 1 112345
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.++++++.+||..+|.+|||+.+++.+
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 7889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.83 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=208.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|++.+.||+|+||.||++.+. +..+++|.+... .....+.+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 6889999999999999999985 678999987543 33445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL--TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEE--cCCCCEEEccCccceecccccc
Confidence 9999999988765 456899999999999999999999988 9999999999999 7788999999998875432211
Q ss_pred cccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 388 (435)
......+++.|+|||.+. ...++.++|+|||||++|+|++|..||...+.......+.....+. ..+..+
T Consensus 166 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 166 ----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred ----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence 123345788999999985 3456789999999999999999999998877665555555444332 223567
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.++.++|.+||..+|++||++.+++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 8899999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.21 Aligned_cols=248 Identities=34% Similarity=0.644 Sum_probs=211.4
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||++.+. +..+++|.+...... ...+.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 5777889999999999999886 778999987643322 25688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+++++|.+++... +.++++.++.++.|++.+|.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEE--cCCCeEEECCCcceeecccCcc-
Confidence 9999999999764 46899999999999999999999988 9999999999999 7888999999999876542211
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..+.. +...+..+.+
T Consensus 156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (256)
T cd05112 156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-PRLASQSVYE 232 (256)
T ss_pred --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC-CCCCCHHHHH
Confidence 11123345678999999998899999999999999999998 9999998887777777766655433 3457899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L 417 (435)
|+.+||..+|++|||+.++++.|
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhh
Confidence 99999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.60 Aligned_cols=244 Identities=33% Similarity=0.636 Sum_probs=209.3
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+|++.+.||+|+||.||++...++.|++|.+.... ....+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 68888999999999999999889999999875422 235788999999999999999999988655 479999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 238 ~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
.+++|.+++.... .+++.+++.++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV--SEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCcEEECCCccceecccc---
Confidence 9999999997643 4789999999999999999999987 9999999999999 88889999999998754321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+..+.. ...+++.+.+
T Consensus 154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (254)
T cd05083 154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-PEGCPADVYV 228 (254)
T ss_pred ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC-CCcCCHHHHH
Confidence 112234568999999988899999999999999999997 9999998887777777766655443 4568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
++.+||+.+|++||++.+++..|++
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.43 Aligned_cols=255 Identities=27% Similarity=0.511 Sum_probs=208.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC---cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|+..+.||+|+||.||++... +..+|+|.+...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778889999999999999874 778999988643322 12345788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~~ 311 (435)
|+||+++++|.+++.+.+.+++..+..++.|++.||.|||++| ++|+||+|+||++ +.++ .++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccccccccccc
Confidence 9999999999999988888999999999999999999999988 9999999999999 6555 599999999987654
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 388 (435)
.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.........+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 3211111122345788999999998888999999999999999999999999754422 2222222222222233457
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+++.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 8999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.25 Aligned_cols=250 Identities=28% Similarity=0.497 Sum_probs=211.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+|+..+.||+|+||.||+|..+ +..|++|.+..... ......+.+.+|+.+++.++||||+++++++.++..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999975 78899998754332 1234457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccceeccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 788899999999987654332
Q ss_pred ccccccccCCCcCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
......++..|++||.+.... ++.++|+||||+++|+|++|..||...........+.........+..+++.+
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 157 -----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred -----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHH
Confidence 123456889999999987776 89999999999999999999999987765555444444222223345688999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+||+.+|++||++.+++.+
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=325.88 Aligned_cols=247 Identities=27% Similarity=0.364 Sum_probs=198.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 37899999999999999999875 778999988654333 23346778899999999999999999987543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill--~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--CCCCCEEEeeCccccc
Confidence 57999999965 77777754 4889999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------- 379 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 379 (435)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 169 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred CCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54321 2234578999999999999999999999999999999999999998766433322111100
Q ss_pred ------------CCCC-------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------------RPFF-------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------------~~~~-------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. .....+.++++||.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=307.09 Aligned_cols=249 Identities=29% Similarity=0.550 Sum_probs=210.2
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||.||++.+. +..+++|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 7888999999999999999865 567999977542 2234678899999999999999999999877 778999999
Q ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+++++|.+++.+. ..++..++..++.|++.||.|||+.+ ++|+||||+||++ +..+.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCCcceeeccCCCc
Confidence 9999999999763 34788899999999999999999988 9999999999999 8888999999999976543211
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......++..|+|||.+....++.++|+||||+++|++++ |..||...+.......+..+.... .....+.++.
T Consensus 158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (260)
T cd05073 158 T---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-RPENCPEELY 233 (260)
T ss_pred c---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-CcccCCHHHH
Confidence 1 1122345678999999988889999999999999999999 999999887766666666654433 2356889999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.82 Aligned_cols=249 Identities=34% Similarity=0.561 Sum_probs=203.5
Q ss_pred CCCCceeecCCceeEEEEEECC--CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|++++.||+|+||+||++...+ ..+|+|.+........ ......+|+.++++++||||+++++++.+....++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 5678899999999999999874 4699999876543322 223345699999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+.+++|.+++...+.+++.++..++.||+.||.+||+.+ ++|+||||+||++ +.++.++|+|||.+......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILL--DENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEE--STTSEEEESSGTTTEESTST----
T ss_pred ccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc----
Confidence 999999999997888999999999999999999999988 9999999999999 88899999999999754111
Q ss_pred cccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCCCC--CCCCCCCCH
Q 013833 317 VYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA---KYVAEGHRP--FFRAKGFTP 390 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~ 390 (435)
........++..|+|||++. +..++.++|+||||+++|+|++|..||......... ........+ .......++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 11344567899999999998 888999999999999999999999999987332222 221111100 000112248
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.++|.+||+.||++|||+.+++++
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.87 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=211.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.++ +..+++|.+... .....+.+.+|+.++++++||||+++++.+..+...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 6888999999999999999985 678999987532 33445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++.+. ..+++.++..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--CCCCCEEEccCccchhhccccc
Confidence 99999999998764 46999999999999999999999988 9999999999999 8889999999998876543221
Q ss_pred cccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 388 (435)
......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...........+..+..+.. .+..+
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 159 ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred ----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 123346889999999975 34567899999999999999999999998877666666665544432 23468
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.++.++|.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 8999999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.22 Aligned_cols=249 Identities=26% Similarity=0.490 Sum_probs=213.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++..+ +..|++|.+....... .....+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4788899999999999999874 7789999876433222 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+.+++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEEeeccceeecCcch
Confidence 999999999997643 5789999999999999999999988 9999999999999 888899999999997654322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+..+.. +..++.+++
T Consensus 156 ~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08218 156 E----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV-SSHYSYDLR 230 (256)
T ss_pred h----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC-cccCCHHHH
Confidence 1 11234578899999999988899999999999999999999999988877777766666655443 346899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||+.+|++||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.08 Aligned_cols=247 Identities=31% Similarity=0.531 Sum_probs=210.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+..+.||+|+||.||+|.++ +..||+|.+..... ......+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 5778889999999999999975 67899998754322 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++.. +.+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEE--cCCCCEEEcccccceeccCCcc-
Confidence 9999999999865 56899999999999999999999987 9999999999999 7888999999999976643221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+.....+. ....++..+.++
T Consensus 157 ---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT-LTGEFSKPFKEF 232 (277)
T ss_pred ---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC-CchhhhHHHHHH
Confidence 1223457889999999988889999999999999999999999999887766655554443333 334578899999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHcccCcccCcCHHHHHhC
Confidence 999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=308.33 Aligned_cols=253 Identities=28% Similarity=0.509 Sum_probs=211.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||+||++.+. +..+++|.+....... ..+.+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 6888999999999999999874 6789999886443322 45788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
++++++|.+++... ..+++..+..++.|++.||.|||+.| ++||||+|+||++ +.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~--~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL--GEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccchHHHhccC
Confidence 99999999999763 45899999999999999999999988 9999999999999 77889999999999876654
Q ss_pred CccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC----CC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----KG 387 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 387 (435)
............++..|+|||.+... .++.++|+||||+++|+|++|..||...+.............+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 32211112334688999999998776 78899999999999999999999998877655554444443332221 25
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++.+++.+||..||++||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 78999999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.74 Aligned_cols=249 Identities=31% Similarity=0.472 Sum_probs=211.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|...+.||+|+||.||++... +..|++|.+...........+++.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 35888999999999999999874 7789999886544444455577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+. |+|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILL--TEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--CCCCCEEEeecCcceecCCC-
Confidence 9996 578777764 456899999999999999999999988 9999999999999 88889999999998755322
Q ss_pred ccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.....+......++.
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence 2345788999999874 456888999999999999999999999988776666555555555555556788
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.++++|.+||+.+|++||++.+++.+..
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 9999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.97 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=208.6
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||.|+||.||++.+. +..+++|.+.+.........+.+.+|+.+++.++||||+++++.+.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 789999998765544444557899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccC
Q 013833 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (435)
Q Consensus 243 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 322 (435)
.+++.+...+++..+..++.||+.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~-----~~~~ 151 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ-----KTWT 151 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--cCCCCEEEeeCCcccccCccc-----cccc
Confidence 999988778999999999999999999999988 9999999999999 888899999999998765332 1223
Q ss_pred CCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHh
Q 013833 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCW 400 (435)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 400 (435)
..+++.|++||.+....++.++|+||||+++|+|++|..||.... +.+....+..+......+...+++++++|.+||
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 231 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence 467889999999988889999999999999999999999998776 555555555433333334456899999999999
Q ss_pred hhcccCCCC-----HHHHHHH
Q 013833 401 AADMNQRPS-----FLDILKR 416 (435)
Q Consensus 401 ~~dp~~Rps-----~~~ll~~ 416 (435)
..+|++||+ +.+++++
T Consensus 232 ~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 232 RRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cCChhhCcCCcccCHHHHhcC
Confidence 999999999 7777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.05 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=205.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 228 (435)
..|++.+.||+|+||.||++.+. +..|++|.+.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 45788999999999999999742 5679999875432 233446789999999999999999999988765 5
Q ss_pred cEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||++|++|.+++.+.. .+++.++..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~--~~~~~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEE--cCCCCEEECCCcccc
Confidence 6899999999999999997643 5899999999999999999999988 9999999999999 778899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---------------CHHHHH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---------------EPYEAA 372 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~---------------~~~~~~ 372 (435)
......... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+... ......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 765432211 1122345677899999998888999999999999999999987664221 011112
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
..+..+.... .+..++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2233333222 2346899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.85 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=207.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||.|+||.||++.++ +..||+|.+....... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 6889999999999999999875 6789999885443222 12456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEE--CCCCcEEECcCcchhccCCCCC
Confidence 996 5999988763 46899999999999999999999988 9999999999999 8888999999999875433221
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------------- 379 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 379 (435)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+....+....
T Consensus 160 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 ----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred ----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1223457889999999865 457889999999999999999999998776544332221110
Q ss_pred -------CCCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhhCCC
Q 013833 380 -------RPFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPT 426 (435)
Q Consensus 380 -------~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~~~ 426 (435)
.+.. ....+++++++||.+||+.||.+|||+.+++++ +..+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~ 298 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHK 298 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhc
Confidence 0000 012478899999999999999999999999984 6666666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.85 Aligned_cols=248 Identities=39% Similarity=0.704 Sum_probs=212.0
Q ss_pred CCCceeecCCceeEEEEEECC------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 160 SSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
++.+.||.|+||.||++.+.. ..||+|.+..... ....+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 566789999999999999864 6799998854432 22457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||+++++|.+++..... +++.++..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~--~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV--GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEE--ccCCeEEEcccCCceeccc
Confidence 999999999999986544 899999999999999999999988 9999999999999 8888999999999987654
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
... .......+++.|+|||.+....++.++|+||||+++|+|++ |.+||...........+.....+.. +..++.
T Consensus 156 ~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (258)
T smart00219 156 DDY---YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK-PENCPP 231 (258)
T ss_pred ccc---cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCcCCH
Confidence 321 11112336789999999988889999999999999999998 8999988887777777776665544 345899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++.+++.+||..+|++|||+.++++.|
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.45 Aligned_cols=254 Identities=29% Similarity=0.550 Sum_probs=210.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||++... +..+++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4788899999999999999874 678999988655433 3456889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEcccccccccCCCCCc
Confidence 9999999999988777899999999999999999999988 9999999999999 77889999999999876543321
Q ss_pred ccccccCCCcCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCC-CCCCH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRA-KGFTP 390 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~ 390 (435)
.........+++.|+|||.+.+.. ++.++||||||+++|++++|..||.... .......+..+..+..+. ..+++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 111122356788999999998766 8899999999999999999999997663 333333333333333222 24589
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.++|.+||+.+|++||++.+++.+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=337.33 Aligned_cols=246 Identities=19% Similarity=0.299 Sum_probs=193.3
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC------CcceeeeeeEEe
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH------PNIVQFLGAVTE 226 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~ 226 (435)
...+|++.+.||+|+||+||+|.+. +..||||++.... .....+..|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3457999999999999999999875 6789999885321 122445667777776654 458888888865
Q ss_pred C-CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCC--------
Q 013833 227 R-KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD-------- 296 (435)
Q Consensus 227 ~-~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~-------- 296 (435)
. ..+|+|||++ |++|.+++.+.+.+++.++..++.||+.||.|||+ .| ||||||||+|||+ +..+
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl--~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILM--ETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--ecCCcccccccc
Confidence 4 5789999988 77999999888889999999999999999999998 47 9999999999999 4333
Q ss_pred --------cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 013833 297 --------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (435)
Q Consensus 297 --------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 368 (435)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 599999998764321 12346789999999999999999999999999999999999999987776
Q ss_pred HHHHHHHHcCCC--------------------------CCCCC--------------CCCCHHHHHHHHHHhhhcccCCC
Q 013833 369 YEAAKYVAEGHR--------------------------PFFRA--------------KGFTPELRELTEKCWAADMNQRP 408 (435)
Q Consensus 369 ~~~~~~~~~~~~--------------------------~~~~~--------------~~~~~~l~~li~~cl~~dp~~Rp 408 (435)
.+....+..... +...+ ...++.+.+||.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 544333221110 00000 00135578999999999999999
Q ss_pred CHHHHHHH
Q 013833 409 SFLDILKR 416 (435)
Q Consensus 409 s~~~ll~~ 416 (435)
|+.|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=312.88 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=204.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.++ ++.||+|.+....... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5788899999999999999985 7789999876443221 122557889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|..++.....+++.+++.++.||+.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILI--TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEE--cCCCcEEECccccceecCCCcc-
Confidence 9999888888877777999999999999999999999988 9999999999999 8888999999999987654321
Q ss_pred ccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------------- 379 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------- 379 (435)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+....
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999865 557889999999999999999999998776544333221100
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. ....++..+.+|+.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.71 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=204.3
Q ss_pred CCCCCceeecCCceeEEEEEEC------------------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccee
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 219 (435)
+|++.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 6888999999999999998643 2258999875432 2334568899999999999999999
Q ss_pred eeeeEEeCCcEEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcE
Q 013833 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (435)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NI 288 (435)
+++++..++..++||||+.+++|.+++.... .+++.++..++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence 9999999999999999999999999997642 2567789999999999999999988 99999999999
Q ss_pred EEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 013833 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANY 366 (435)
Q Consensus 289 ll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t--g~~p~~~~ 366 (435)
|+ +.++.++|+|||++..+...... .......+++.|++||......++.++|+|||||++|||++ |..||...
T Consensus 162 li--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LV--GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EE--cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99 77889999999999865432211 11122334678999999888889999999999999999998 77899877
Q ss_pred CHHHHHHHHHc-----CCC-CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 367 EPYEAAKYVAE-----GHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 367 ~~~~~~~~~~~-----~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+..+....... ... ....+..+++.+++|+.+||+.||++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 66554432211 111 11123457899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=329.38 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=199.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
.+|.+.+.||+|+||.||++... +..|++|.+... ....+|++++++++||||+++++++......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 47999999999999999999764 357899976432 234579999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||++. ++|.+++...+.+++.+++.++.||+.||.|||++| ||||||||+|||+ +.++.++|+|||++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill--~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFL--DEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEccCccccccCcc
Confidence 999995 699999977778999999999999999999999988 9999999999999 88889999999999765433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH-------------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVA------------- 376 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~------------- 376 (435)
.. ........||+.|+|||++....++.++|||||||++|+|++|..||.+.... .....+.
T Consensus 239 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 239 PD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 21 11223457899999999999999999999999999999999999999654321 1111110
Q ss_pred -------------cCCCCCC------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 377 -------------EGHRPFF------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 377 -------------~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...++.. ....++.+++++|.+||..||++|||+.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011110 012456789999999999999999999999987
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.64 Aligned_cols=250 Identities=30% Similarity=0.611 Sum_probs=216.3
Q ss_pred CCCCCceeecCCceeEEEEEEC---CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
.....++||+|.||.|++|.|+ |+ .||||.+....... ...+|.+|+.+|.+|+|||++++||++.+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 4567789999999999999996 33 69999886544332 56899999999999999999999999987 67899
Q ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 233 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|||++++|||.+.|++ .+.|-....-.++.||+.||.||.+++ +|||||...|+|+ -....|||+|||+.+.+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlll--asprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLL--ASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhhee--cccceeeeecccceeccC
Confidence 9999999999999987 345788888899999999999999988 9999999999999 667789999999999887
Q ss_pred ccCcccccccc-CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 311 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... .|.+. ...-...|+|||.+....|+.++|||++||++|||+| |..||.+.....+.+.+.++.+.. .++.|
T Consensus 264 ~ned--~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp-RPk~c 340 (1039)
T KOG0199|consen 264 ENED--MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP-RPKYC 340 (1039)
T ss_pred CCCc--ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC-CCCCC
Confidence 5443 22222 2345678999999999999999999999999999999 999999999999999998766554 44679
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++.+++++..||..+|++|||+..|...+
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 99999999999999999999999997443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=326.65 Aligned_cols=245 Identities=31% Similarity=0.422 Sum_probs=204.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-C-----CcceeeeeeEEeCCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-----PNIVQFLGAVTERKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~ 229 (435)
+|.+.++||+|+||.|-+|.+. ++.||||+++.. .....+-..|+++|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7889999999999999999985 678999988653 233455678999999997 3 589999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
+|||+|.+ ..+|.++++.+. .++...++.++.||+.||.+||+.+ |||+||||+|||+++-....|||+|||+|.
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999988 569999999754 5899999999999999999999988 999999999999987777799999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF---- 383 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 383 (435)
..... ....+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|++.+..+....|.+-...+.
T Consensus 340 ~~~q~-------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 340 FESQR-------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccCCc-------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 76532 2256778999999999999999999999999999999999999998887665443332110000
Q ss_pred ----------------------------------------------CC-----------CCCCHHHHHHHHHHhhhcccC
Q 013833 384 ----------------------------------------------RA-----------KGFTPELRELTEKCWAADMNQ 406 (435)
Q Consensus 384 ----------------------------------------------~~-----------~~~~~~l~~li~~cl~~dp~~ 406 (435)
.+ ..-...+.+|+.+||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00 001245789999999999999
Q ss_pred CCCHHHHHHH
Q 013833 407 RPSFLDILKR 416 (435)
Q Consensus 407 Rps~~~ll~~ 416 (435)
|+|+.+.++|
T Consensus 493 R~tp~qal~H 502 (586)
T KOG0667|consen 493 RITPAQALNH 502 (586)
T ss_pred cCCHHHHhcC
Confidence 9999999987
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=331.16 Aligned_cols=243 Identities=35% Similarity=0.535 Sum_probs=201.8
Q ss_pred eeecCCceeEEEEEECCC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCC
Q 013833 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 241 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~s 241 (435)
+||+|.||+||.|++..+ ..|||.+.... ....+-+.+|+.+.++|+|.|||+++|.+.+++.+-|+||-++|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999998754 67888775432 2234678899999999999999999999999999999999999999
Q ss_pred HHHHHHH-cCCC--CHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 242 LHKYLKE-KGAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 242 L~~~l~~-~~~~--~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
|.++++. .|++ .+.++-.+.+||++||.|||+.. |||||||-+|||+ +.-.|.+||+|||-++.+..-+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLv-NTySGvlKISDFGTsKRLAginP---- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLV-NTYSGVLKISDFGTSKRLAGINP---- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEE-eeccceEEecccccchhhccCCc----
Confidence 9999986 6787 78888899999999999999966 9999999999998 45678999999999987754332
Q ss_pred cccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCCHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l 395 (435)
-..++.||..|||||++.. +.|+..+|||||||++.||.||++||.......... ++---...+..+..++.+.+.|
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 3456789999999999975 468999999999999999999999998765433322 2211111122345678899999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
|.+|+.+||.+||++.+++..
T Consensus 812 ilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHcCCCcccCccHHHhccC
Confidence 999999999999999999854
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.17 Aligned_cols=249 Identities=28% Similarity=0.495 Sum_probs=208.4
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++... +..||+|.+...... ..+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 347899999999999999999974 788999988543322 235678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEECcCccceEccCCc
Confidence 999999999999865 45899999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 392 (435)
. ......+++.|+|||.+.+..++.++|+|||||++|++++|..||...++......+.....+. ..+..++..+
T Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06656 170 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245 (297)
T ss_pred c----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHH
Confidence 1 1223467889999999998889999999999999999999999998766543332233222222 2345678899
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+||+.+|++||++.+++++
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.65 Aligned_cols=249 Identities=31% Similarity=0.475 Sum_probs=220.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
-.|.+.+.||+|.|+.|.++++. +..||||.+.+....... .+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 36888999999999999999974 889999998876655443 355899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+.+|.+++|+.+++...+.++..++.|+.+|++|||+++ |||||||++|||+ +.+.++||+|||++..+....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL--~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILL--DENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccc--ccccceeeeccccceeecccc-
Confidence 99999999999999999999999999999999999999988 9999999999999 999899999999999887443
Q ss_pred cccccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
...+++|++.|.|||++.+..|. +.+|+||+|+++|.|+.|..||++.+-.+....+..+.... +..++.++.
T Consensus 210 ----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI--p~~ms~dce 283 (596)
T KOG0586|consen 210 ----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI--PFYMSCDCE 283 (596)
T ss_pred ----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc--cceeechhH
Confidence 35678999999999999988875 78999999999999999999999888766666555554322 234678999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++|.++|.++|.+|++.+++.++-
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred HHHHHhhccCccccCCHHHhhhhc
Confidence 999999999999999999998763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=309.29 Aligned_cols=255 Identities=30% Similarity=0.536 Sum_probs=202.8
Q ss_pred CCCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 228 (435)
..|++.+.||+|+||.||++.. .+..|++|.+... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4688889999999999999874 2668999987543 23345678999999999999999999997643 35
Q ss_pred cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
.+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV--ESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEE--CCCCeEEECCCcccc
Confidence 689999999999999999764 46899999999999999999999988 9999999999999 888899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----------------HH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----------------EA 371 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----------------~~ 371 (435)
.......... ......++..|+|||.+.+..++.++|+||||+++|||++|..|+...... ..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 7653321100 111123455699999999888999999999999999999988775433211 01
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
...+..... ...+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111222222 223356889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=307.04 Aligned_cols=245 Identities=26% Similarity=0.431 Sum_probs=194.7
Q ss_pred eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+.....+++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 6899999999999753 3468888764332 233346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 240 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 240 ~sL~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
++|.+++.... ..++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQL--TADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEe--cCCCcEEEeccccccccccchh
Confidence 99999997643 2467788899999999999999988 9999999999999 8888999999999865432211
Q ss_pred cccccccCCCcCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC---
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF--- 383 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~--- 383 (435)
. .......+++.|+|||++.. ..++.++|||||||++|+|++ |..||......+....+........
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 156 Y--ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred e--eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 0 01123345778999998743 356789999999999999999 8899988776665554443332221
Q ss_pred -CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 384 -RAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 384 -~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
.+..+++.+.+++..|| .||++|||+.++++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12357889999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=317.30 Aligned_cols=256 Identities=19% Similarity=0.353 Sum_probs=199.7
Q ss_pred CCceeecC--CceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 161 SSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 161 ~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+.++||+| +|++||++.++ +..||+|.+...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45689999 78899999875 778999988654333 33446788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE--ecCCcEEEcccchhhccccccc
Confidence 9999999999753 45899999999999999999999988 9999999999999 7788999999986554322111
Q ss_pred ccc---ccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-------
Q 013833 315 HDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------- 382 (435)
Q Consensus 315 ~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------- 382 (435)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||..............+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 000 00112346778999999975 468899999999999999999999998665433222222111110
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 383 -------------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 383 -------------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
.....+++.+.+|+.+||+.||++|||+++++++ +.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0012356789999999999999999999999975 44444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.80 Aligned_cols=248 Identities=29% Similarity=0.502 Sum_probs=204.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE------R 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~ 227 (435)
..|++.+.||+|+||.||++.+. +..+|+|.+... ......+..|+.+++++ +||||+++++++.. .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 47888899999999999999985 678999987432 22335678899999998 69999999998743 4
Q ss_pred CcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
..++++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++ +.++.++|+|||+
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili--~~~~~~~l~dfg~ 167 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL--TENAEVKLVDFGV 167 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCcc
Confidence 5789999999999999999763 35888889999999999999999988 9999999999999 7888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 380 (435)
+........ ......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+......+.....
T Consensus 168 ~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 168 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred hhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 876543221 123456889999999986 34678899999999999999999999987766555444444444
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+......++.++.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 444455689999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=307.12 Aligned_cols=237 Identities=23% Similarity=0.414 Sum_probs=191.4
Q ss_pred ceeecCCceeEEEEEEC--------------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 163 AIIGKGSFGEILKAYWR--------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
+.||+|+||.||+|... ...|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999999999853 2258888764322 233467888999999999999999999999888
Q ss_pred cEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-------cEEE
Q 013833 229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKV 300 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-------~vkl 300 (435)
..++||||+++++|..++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++ .+++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILL--AREGIDGECGPFIKL 153 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEE--ecCCccCCCCceeEe
Confidence 89999999999999999876 456899999999999999999999988 9999999999999 4333 3899
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHcC
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~ 378 (435)
+|||++...... ....++..|+|||.+. ...++.++|||||||++|+|+ +|..||......+.... ..+
T Consensus 154 ~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~ 224 (262)
T cd05077 154 SDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEG 224 (262)
T ss_pred CCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-Hhc
Confidence 999998754321 2345788899999986 467889999999999999997 58899887665444332 222
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 379 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
.... ....++++++||.+||+.||++||++.++++.|
T Consensus 225 ~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2221 122467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=308.91 Aligned_cols=239 Identities=25% Similarity=0.425 Sum_probs=192.6
Q ss_pred eeecCCceeEEEEEEC--------------------------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc
Q 013833 164 IIGKGSFGEILKAYWR--------------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 217 (435)
.||+|+||.||+|... ...|++|.+.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 6999999999998741 1358888774321 2234678889999999999999
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC--
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-- 294 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-- 294 (435)
+++++++.++...++||||+++++|..++.+ .+.+++..+..++.|++.||.|||+++ |+||||||+|||+....
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999999976 456899999999999999999999988 99999999999994321
Q ss_pred ---CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHH-cCCCCCCCCCHH
Q 013833 295 ---ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369 (435)
Q Consensus 295 ---~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~~ 369 (435)
...++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||....+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 234899999988644321 12356788999998865 56889999999999999985 699999877665
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+........... +...++.+.++|.+||+.+|++|||+.++++.|.
T Consensus 229 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFYEKKHRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHhccCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 544433332221 1235678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=305.67 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=194.5
Q ss_pred ceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
+.||+|+||.||+|.+. +..+++|.+..... ......+.+|+.++++++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 24689998754432 2233578889999999999999999999998889999999999
Q ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 239 GGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 239 g~sL~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+++|.+++.... ..++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLL--TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEECCccccccccCcc
Confidence 999999997532 3567788889999999999999988 9999999999999 778899999999987543221
Q ss_pred ccccccccCCCcCccccCccccCCC-------CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC---
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHR-------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF--- 382 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~--- 382 (435)
. ........++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+............
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 155 Y--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred e--eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 1 1112234578889999998642 35789999999999999996 999998777655443322222111
Q ss_pred -CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 383 -FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 383 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
......++.+.+++.+|| .+|++|||+++|++.|+
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 112346788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=304.68 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=210.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCC--CCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 230 (435)
.+|++.+.||+|+||.||++.++ +..|++|.+.... .........+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36888999999999999999874 7789999874322 12234557889999999999999999999988664 458
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++++||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECccccccccc
Confidence 899999999999999988778999999999999999999999988 9999999999999 788899999999998654
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
...... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....+...+..+++
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 321111 1122356889999999999888999999999999999999999999887766655555444333444567899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++++.+||+ +|..||++.+++.+
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 99999999999 57999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=305.38 Aligned_cols=247 Identities=29% Similarity=0.530 Sum_probs=208.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|+..+.||+|+||.||++.++ +..+++|.+.... ..+.+.+|++++++++||||+++++.+.++...|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 47888999999999999999986 5789999875321 1578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--CCCCcEEEcccccchhcccCc
Confidence 99999999999976 446899999999999999999999988 9999999999999 888899999999998765432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 392 (435)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+.....+.. .+..++.++
T Consensus 154 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 154 A----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred c----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 1 12234578899999999988999999999999999999999999987766554443333222221 223577899
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=303.61 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=209.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++..+ +..+++|.+....... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 4778899999999999999875 6789999886543332 335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 312 (435)
|+++++|.+++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++ +. ++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccCCCceecCCC
Confidence 99999999999763 34899999999999999999999988 9999999999999 53 346899999999876433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+........ +..+++++
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 229 (256)
T cd08220 156 S-----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI-SDRYSPDL 229 (256)
T ss_pred c-----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC-CCCcCHHH
Confidence 2 12234678899999999988899999999999999999999999988776666555555443332 34589999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+||+.+|++|||+.+++.+
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.80 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=199.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|++|.||+|.++ +..||+|.+....... .....+.+|+.++++++||||+++++++.++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4778889999999999999975 7789999886543222 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|+. ++|.+++... ..+++.+++.++.||+.||.|||+.+ ++||||||+||++ +.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--cCCCcEEECcccceeecCCC
Confidence 996 5898888652 45899999999999999999999988 9999999999999 88889999999998765432
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------------ 379 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------ 379 (435)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.........+....
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 VR----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cc----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 11 1223456889999998865 457889999999999999999999998765433221111000
Q ss_pred -------------CC--CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 -------------RP--FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 -------------~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ......++++++++|.+||..||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00113478999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.40 Aligned_cols=247 Identities=33% Similarity=0.528 Sum_probs=209.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+..+.||+|+||.||+|.+. +..||+|.+..... ....+.+.+|+.++++++||||+++++.+..+...++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4677788999999999999875 67899998754322 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEE--eCCCCEEEccccccccccCcch-
Confidence 9999999998864 46899999999999999999999988 9999999999999 7788999999999976543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+..+..+. ....++.++.++
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT-LEGQYSKPFKEF 232 (277)
T ss_pred ---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC-CCcccCHHHHHH
Confidence 1223457889999999998899999999999999999999999998776665555554444433 234578899999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.96 Aligned_cols=247 Identities=30% Similarity=0.561 Sum_probs=207.3
Q ss_pred ceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCC
Q 013833 163 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 241 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~s 241 (435)
+.||+|+||.||++.+. ++.|++|.+...... .....+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 36999999999999976 789999987654332 344678999999999999999999999999999999999999999
Q ss_pred HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 242 LHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 242 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
|.+++.. ...++...+..++.+++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........ ....
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~--~~~~ 152 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIY--TVSD 152 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEE--cCCCcEEEeeccccccccCCcc--eecc
Confidence 9999976 346899999999999999999999987 9999999999999 8888999999999976542111 0011
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+....... .+..++.++.+++.+|
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 231 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-APQLCPEEIYRLMLQC 231 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHH
Confidence 11234567999999988889999999999999999999 899998887766666665544332 3456889999999999
Q ss_pred hhhcccCCCCHHHHHHHHH
Q 013833 400 WAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 400 l~~dp~~Rps~~~ll~~L~ 418 (435)
|..+|++|||+.++++.|.
T Consensus 232 l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 232 WAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hccChhhCcCHHHHHHHhh
Confidence 9999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=316.81 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=210.5
Q ss_pred CCCCCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 153 DPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 153 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
......|+..++||+|+||.||.+.. +|+.+|.|.+.+...+.+.......+|-.+|++++.++||.+-..|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34456889999999999999998875 4889999988665544444445567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
|+||..|+||+|.-.|-..+ .|+++.++.++.+|+.||++||+++ ||+||+||+|||+ |+.|+|+|+|+|+|..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILL--Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILL--DDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheee--ccCCCeEeeccceEEe
Confidence 99999999999988887644 6999999999999999999999998 9999999999999 9999999999999998
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFR 384 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~ 384 (435)
+.... ...+..||.+|||||++.+..|+.+.|+|||||++|||+.|+.||...... ++.+.+.+. +...
T Consensus 337 i~~g~-----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey 409 (591)
T KOG0986|consen 337 IPEGK-----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEY 409 (591)
T ss_pred cCCCC-----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhc
Confidence 76543 345568999999999999999999999999999999999999999765432 333333332 2223
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFL 411 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~ 411 (435)
+..+|++.+++...+|.+||++|.-.+
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 467999999999999999999996543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=309.79 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=210.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.++ +..|++|.+...........+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999986 78899998876544444456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.|++|.+++.....+++.++..++.||++||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--cCCCCEEEeecccccccCCCc--
Confidence 9999999999988778999999999999999999999988 9999999999999 888899999999988665432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
......|+..|+|||.+....++.++|+||||+++|+|++|..||..... ......... ..+ ..+..++..+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~ 229 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADV-LYPATWSTEA 229 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccc-cCcccCcHHH
Confidence 12345678899999999988899999999999999999999999987663 333332222 222 2334688999
Q ss_pred HHHHHHHhhhcccCCCCH--HHHHH
Q 013833 393 RELTEKCWAADMNQRPSF--LDILK 415 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~--~~ll~ 415 (435)
.++|.+||+.||.+||++ +++++
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHhc
Confidence 999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=304.60 Aligned_cols=249 Identities=29% Similarity=0.521 Sum_probs=210.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 233 (435)
+|++.+.||.|+||.||++.+. +..+++|.+...... ....+++.+|+.++++++||||+++++.+.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 4778889999999999999874 678999987654332 3344778899999999999999999997753 4567999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-----cCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLH-----NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH-----~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
|||+++++|.+++.. ...+++.+++.++.||+.||.||| +.+ ++|+||+|+||++ +.++.++|+|||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili--~~~~~~kl~d~g 155 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFL--DANNNVKLGDFG 155 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEE--ecCCCEEEeccc
Confidence 999999999999875 356899999999999999999999 766 9999999999999 788899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..+..+..
T Consensus 156 ~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 230 (265)
T cd08217 156 LAKILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI- 230 (265)
T ss_pred ccccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC-
Confidence 9987654321 12234689999999999988899999999999999999999999998876666666666654433
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+..++..+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 34688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.88 Aligned_cols=247 Identities=30% Similarity=0.548 Sum_probs=210.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.++ +..+++|.+..... ......+.+|+.++++++||||+++++.+.....+++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5777889999999999999986 77899998865433 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+.+++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEE--CCCCCEEEeecccchhhHHHH
Confidence 99999999999875 679999999999999999999999 88 9999999999999 778899999999987664322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
. ....++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+....+.....+......+
T Consensus 156 ~------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 156 A------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred h------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 1 1156788999999999889999999999999999999999999754 2334444455554444443348
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++++|.+||..+|++|||+.+++.+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 8999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=306.70 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=206.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-------cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
+|.+.+.||+|+||.||+|... +..+|+|.+...... .....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5777889999999999999864 778999987532111 1122456889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..++||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLV--DADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEE--cCCCeEEEeecccccc
Confidence 99999999999999999988888999999999999999999999988 9999999999999 8889999999999876
Q ss_pred ccccCccccccccCCCcCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCC--
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFF-- 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~-- 383 (435)
....... .......++..|+|||.+.... ++.++|+||||+++|++++|..||......+....+.... .+..
T Consensus 158 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 158 SDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 5432111 1123345788999999987654 7889999999999999999999998766554443332221 1111
Q ss_pred -CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 -RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 -~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....++.+++++|.+||..+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 113568999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=317.41 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=213.0
Q ss_pred CCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 159 FSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
..++++||+|.||+|.+|...+ ..||+|.++..... ....+|..|+++|.+|+||||+.++++|..++.+|+++|||
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4567799999999999999886 89999988765443 23478999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 238 ~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
++|+|.+|+..+. ....+...+++.||++||.||.+.+ +|||||.+.|+|+ ++++++||+|||+++.+-.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~-- 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGD-- 691 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceee--cCcccEEecCcccccccccCC--
Confidence 9999999998763 3456677789999999999999998 9999999999999 999999999999999665432
Q ss_pred cccccc-CCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHcC---CCC---CCCCC
Q 013833 316 DVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANYEPYEAAKYVAEG---HRP---FFRAK 386 (435)
Q Consensus 316 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t--g~~p~~~~~~~~~~~~~~~~---~~~---~~~~~ 386 (435)
.+... ...-+.+|||+|.+.-+++++++|+|+||+++||+++ ...||......+..+....- ..+ ...+.
T Consensus 692 -yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 -YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred -ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 22222 3345789999999999999999999999999999876 78999988776655443211 111 12345
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
-+|.++.+++.+||+.|-++||+++++...|.+.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 6899999999999999999999999999998765
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.27 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=198.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+...... ......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 37899999999999999999875 678999988654322 22335677899999999999999999887543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..|++++++ +++|.+++.. +.+++.++..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAV--NEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEE--CCCCCEEEcCCcccee
Confidence 478999988 7799988754 46999999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------- 379 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------- 379 (435)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 168 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 168 ADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5422 234568999999999876 568899999999999999999999998766543332221110
Q ss_pred --------------CCCCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 --------------RPFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 --------------~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+... ....++.+.+||.+||..||++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 02356778999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=307.51 Aligned_cols=248 Identities=29% Similarity=0.530 Sum_probs=205.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCC-----
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK----- 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~----- 228 (435)
.+|++.+.||+|+||.||+|.++ +..+++|.+..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 47899999999999999999985 56899998754322 236788999999999 6999999999986544
Q ss_pred -cEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 229 -PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 229 -~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~--~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILL--TKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--ccCCeEEECCC
Confidence 48999999999999999865 347899999999999999999999988 9999999999999 78889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
|++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|..||...........+...
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 158 GVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99876543221 1233568899999998753 34678999999999999999999999877665555555555
Q ss_pred CCCCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 HRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+.... ..++.++++||.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 4433332 3377899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=308.58 Aligned_cols=248 Identities=29% Similarity=0.565 Sum_probs=208.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 232 (435)
.|+..+.||+|+||.||+|.+. +..|++|.+..... ......+.+|+.++++++ |||++++++++.++...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778889999999999999974 77899998764432 233467889999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+++++|.+++.. +.+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEE--cCCCCEEEccCCceeecCCC
Confidence 9999999999999865 47899999999999999999999988 9999999999999 77889999999999876543
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....+......++.+
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06917 155 SS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL 230 (277)
T ss_pred cc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHH
Confidence 21 1233468899999999865 457889999999999999999999998877655554444443343333348899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.30 Aligned_cols=253 Identities=30% Similarity=0.481 Sum_probs=213.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|...+.||+|+||.||++.+. +..+++|.+.............+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4788889999999999999974 67899998865544444555778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.| +|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEE--CCCCCEEEecCCCccccCC---
Confidence 9965 78777754 556899999999999999999999988 9999999999999 7888999999998865432
Q ss_pred cccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+.....+......+++.
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 12346788999999973 4568899999999999999999999998877766666666655555555568899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+++++.+||+.+|.+||++.++++++..+...
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999999886655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=307.64 Aligned_cols=247 Identities=32% Similarity=0.568 Sum_probs=204.4
Q ss_pred ceeecCCceeEEEEEECC--------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 163 AIIGKGSFGEILKAYWRG--------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+.||+|+||.||++.++. ..+++|.+..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999998752 4689997754322 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-----cEEEee
Q 013833 235 EYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-----HLKVGD 302 (435)
Q Consensus 235 e~~~g~sL~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-----~vkl~D 302 (435)
||+++++|.+++.+. ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++ +.++ .++|+|
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~~~~~l~d 154 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLV--SEKGYDADRVVKIGD 154 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEE--ecCCCCCCcceEECC
Confidence 999999999999742 23788999999999999999999988 9999999999999 5554 799999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+..+
T Consensus 155 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 155 FGLARDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred cccccccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 999976543211 111223345788999999998999999999999999999998 99999888777766666655444
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.. +..+|+.+.+++.+||..+|++||++.++++.|.
T Consensus 233 ~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 233 QK-PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CC-cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32 3468899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=310.54 Aligned_cols=257 Identities=28% Similarity=0.576 Sum_probs=211.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|+..+.||+|+||.||++.+. +. .+|+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 46788889999999999999874 33 478887754322 33335688999999999999999999988654 46
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++++||+++|+|.+++.... .++++.+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill--~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV--KSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeee--cCCCceEEccccccccc
Confidence 79999999999999997744 5899999999999999999999988 9999999999999 77889999999999866
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..+..+.. +..+
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (303)
T cd05110 160 EGDEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ-PPIC 236 (303)
T ss_pred cCccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC-CCCC
Confidence 43221 111223445778999999998899999999999999999997 9999988776666666655544432 3457
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+++++.+||..+|++||++.++++.|..+.+.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=303.51 Aligned_cols=249 Identities=29% Similarity=0.536 Sum_probs=214.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|++|.||++.++ +..|++|.+...... .....+.+|+..+++++||||+++++++......++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5778899999999999999986 778999988654332 345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++.....+++..++.++.|++.||.|||+ .+ ++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI--NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEE--CCCCCEEEccCccceecccCCC
Confidence 99999999999887889999999999999999999999 98 9999999999999 8889999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .....++..|+|||.+....++.++|+||||+++|+|++|..||... ...+....+.....+......++..
T Consensus 156 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 156 Q----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred c----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 1 12345788999999999889999999999999999999999999877 3444455555544444433338999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.++|.+||..+|++||++.+++++
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=309.29 Aligned_cols=250 Identities=28% Similarity=0.511 Sum_probs=202.1
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEE-----eC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT-----ER 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~ 227 (435)
..+|++.+.||+|+||.||++.++ ++.+++|.+..... ....+.+|+.+++.+ +||||+++++++. .+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 457899999999999999999875 67899997643221 125677899999999 6999999999873 34
Q ss_pred CcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
..+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~kl~df 168 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILL--TTEGGVKLVDF 168 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEE--CCCCCEEEccC
Confidence 568999999999999998753 345889999999999999999999988 9999999999999 77888999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
|++........ ......|++.|+|||.+.. ..++.++|||||||++|+|++|..||...........+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 169 GVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99876543211 1233468999999999753 45788999999999999999999999877665444333333
Q ss_pred CCCC-CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 379 HRPF-FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 379 ~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
..+. ..+..++.++.+++.+||+.+|++|||+.++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2222 12344678999999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=309.99 Aligned_cols=246 Identities=27% Similarity=0.497 Sum_probs=204.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ +..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5788899999999999999986 7889999875432 23334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|..++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||++ +.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV--NGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEE--CCCCCEEEeecCCcccccC
Confidence 99999999998763 368999999999999999999996 46 9999999999999 7788999999999876532
Q ss_pred cCccccccccCCCcCccccCccccCCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHcCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK---YVAEGHRPF 382 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~~~ 382 (435)
.. .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.......... .+..+..+.
T Consensus 156 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 156 SL------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred Cc------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 21 2234578899999998544 35789999999999999999999997655433322 233333333
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. +..+++++++||.+||+.+|++||++.+++.+
T Consensus 230 ~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 L-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C-CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 3 34589999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=313.04 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=186.8
Q ss_pred CceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEEEEe
Q 013833 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE 235 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 235 (435)
.++||+|+||+||+|.++ +..||+|.+...... ..+.+|+.++++++||||+++++++.. +..++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 458999999999999864 467999987543221 446789999999999999999998854 456899999
Q ss_pred cCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec--CCCCcEEEeecc
Q 013833 236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG 304 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--~~~~~vkl~Dfg 304 (435)
|+. ++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||+.. +..+.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 985 5898887532 24889999999999999999999988 999999999999943 345689999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHH
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------EAAKY 374 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------~~~~~ 374 (435)
+++....... .........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||...... .....
T Consensus 158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred ceeccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9987643321 1112334578999999999876 45889999999999999999999999643210 00000
Q ss_pred HHc-CCCC------------------------C-----------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 375 VAE-GHRP------------------------F-----------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 375 ~~~-~~~~------------------------~-----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ...+ . ......+.++.+||.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000 0 0001235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=304.29 Aligned_cols=247 Identities=32% Similarity=0.544 Sum_probs=210.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
-|+..+.||+|+||.||++.++ +..+|+|.+.... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3677889999999999999874 6789999875432 22344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.+++|.+++.. +.+++..+..++.|++.++.|||+.+ ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEE--CCCCCEEEeecccceecccchh-
Confidence 9999999999864 46899999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+..+..+.. ...++.++.++
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL-EGNYSKPLKEF 232 (277)
T ss_pred ---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCC-CcccCHHHHHH
Confidence 12234678899999999888899999999999999999999999988777666666655544432 34688999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.75 Aligned_cols=252 Identities=26% Similarity=0.506 Sum_probs=211.1
Q ss_pred CCCCCceeecCCceeEEEEEECC---CcEEEEEccCCC-------CCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSL-------SDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE 226 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 226 (435)
.|++.+.||+|+||.||++.+++ ..+|+|.+.... ........++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999999864 679999875322 1223445667889988875 799999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 227 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
++..+++|||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++ +.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~--~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIML--GEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEE--CCCCcEEEe
Confidence 9999999999999999998743 3458999999999999999999996 56 9999999999999 888899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
|||++....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........+......
T Consensus 157 dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 157 DFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 999997654332 223456889999999999888999999999999999999999999877766666666555544
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
......+++++.++|.+||+.||++||++.++..+++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 4344467899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.25 Aligned_cols=239 Identities=23% Similarity=0.411 Sum_probs=192.0
Q ss_pred eeecCCceeEEEEEECC---------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 164 IIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.||+|+||.||+|.++. ..+++|.+... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 68999999999998742 24777866432 1233467888999999999999999999999988999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC------CcEEEeeccCcc
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA------DHLKVGDFGLSK 307 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~------~~vkl~Dfg~a~ 307 (435)
||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||++..+.. +.++++|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999998654 5899999999999999999999988 999999999999943222 137999999887
Q ss_pred cccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
..... ....+++.|+|||++.+ ..++.++||||||+++|+|++| ..||...++.......... .. .+
T Consensus 157 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~-~~ 225 (258)
T cd05078 157 TVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR--HQ-LP 225 (258)
T ss_pred ccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc--cc-CC
Confidence 54321 22457889999999976 4578999999999999999998 5677666655443333222 11 22
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
...+.++.+++.+||+.+|++|||++++++.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=303.24 Aligned_cols=236 Identities=25% Similarity=0.452 Sum_probs=191.9
Q ss_pred ceeecCCceeEEEEEECCC------------cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 163 AIIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+.||+|+||.||++.+... .+++|.+..... ....+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 3689999999999998633 377776543221 14778899999999999999999999887 778
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-------cEEEee
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKVGD 302 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-------~vkl~D 302 (435)
++||||+++++|.+++...+ .++...+..++.||+.||.|||+++ |+||||||+|||+ +.++ .++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill--~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV--ARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE--ecCccccCCceeEEeCC
Confidence 99999999999999998766 6899999999999999999999988 9999999999999 5555 799999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~ 379 (435)
||++...... ....++..|+|||++... .++.++||||||+++|+|++ |..||......+.........
T Consensus 152 fg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 152 PGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred CCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 9999865431 123466789999999876 78899999999999999999 688887765444333333222
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
... ......+.+++.+||..+|++|||+.++++.|+
T Consensus 224 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111 122478999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.63 Aligned_cols=247 Identities=27% Similarity=0.486 Sum_probs=208.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|...+.||+|++|.||++.++ +..+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555679999999999999875 6789999874322 2233568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.|++|.+++.. +.+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEE--cCCCcEEEcccccchhhccCCc-
Confidence 9999999999977 67899999999999999999999988 9999999999999 8888999999998875542211
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 394 (435)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.....+... ...++..+.+
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 122346889999999998888999999999999999999999999888777666666655433322 2337899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.+||+.+|++||++.+++++
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHcccChhhCcCHHHHccC
Confidence 9999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.54 Aligned_cols=256 Identities=30% Similarity=0.539 Sum_probs=207.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 228 (435)
..|+..+.||+|+||.||++.+. +..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 36778889999999999999864 568999988654332 345789999999999999999999998877 56
Q ss_pred cEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..+++|||+++++|.+++.... .++..++..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILV--ESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEccccccc
Confidence 7899999999999999998754 5899999999999999999999988 9999999999999 788999999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH---------------HH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---------------AA 372 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---------------~~ 372 (435)
........ ........++..|++||.+....++.++|+||||+++|+|++|..|+....... ..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76533211 111112345667999999988899999999999999999999999986532211 12
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
..+...... ..+..++.++.+++.+||+.+|++|||+.++++.|+++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222222 22346789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=291.41 Aligned_cols=247 Identities=26% Similarity=0.508 Sum_probs=206.4
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEe
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+.+..||.|+.|+|+++.++ |.-.|||.+.+.. ..+..+++...+.++.... .|+||+++|+|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 355668999999999999987 5789999986543 3344577888888776665 8999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
.| ...+..++++ .+++++..+-.+...+..||.||.++ .+|+|||+||+|||+ |..|++||||||.+-.+-.+.
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILl--De~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEE--ccCCCEEeecccccceeeccc-
Confidence 88 5577777765 56788888888999999999999876 359999999999999 999999999999997665332
Q ss_pred cccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCC-CCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRA-KGFT 389 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~-~~~~ 389 (435)
......|-+.|||||.+.. ..|+-++||||||++++||.||+.||.+.+ ..+..-.+.+...|.++. .+++
T Consensus 247 ----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 247 ----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred ----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 3455678999999999964 468889999999999999999999999754 456666666665555554 4599
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.|++|+..||++|+.+||.+.+|+++
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999999976
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.91 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=197.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.++ |..+++|.+...... ......+.+|+.++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4778889999999999999985 788999988654322 1223567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--cCCCcEEECccchhhccCCCCC
Confidence 996 588888765 567999999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCC-------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGH------------- 379 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~------------- 379 (435)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..|| .+.+..+....+....
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred ----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 12334578899999998764 4789999999999999999988875 3333322222211100
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. ....++++++++|.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 012467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.65 Aligned_cols=254 Identities=30% Similarity=0.528 Sum_probs=207.9
Q ss_pred CCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-----
Q 013833 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 228 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 228 (435)
|.+.+.||+|+||.||+|.++ +..||+|.+...... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 566789999999999999863 467999988654433 334577889999999999999999999875432
Q ss_pred -cEEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 229 -PLMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 229 -~~~lv~e~~~g~sL~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
..+++++|+.+++|.+++... ..++...+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili--~~~~~~kl~ 155 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCML--NENMTVCVA 155 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEE--cCCCCEEEC
Confidence 247899999999999887532 14788999999999999999999988 9999999999999 788899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++....... ........+++.|++||.+....++.++||||||+++|+|++ |.+||.+.+..+....+..+..
T Consensus 156 dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 156 DFGLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999886543221 111122345678999999998889999999999999999999 8999988887776666665544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
... ...++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~~-~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQ-PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 332 245789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.44 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=204.7
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER 227 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 227 (435)
-.|......|++++.||+||.+.||++...+ +.||+|++.- ...+...+..|.+|+..|.+|+ |.+||+++++-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3455667789999999999999999999763 4577776543 3445677899999999999996 89999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCCCCH-HHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGALSP-STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~~~~-~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
+.+|||||+= ..+|..+|++.....+ ..+..+..|++.++.++|..| |||.||||.|+|++ .|.+||+|||.|
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV---kG~LKLIDFGIA 506 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV---KGRLKLIDFGIA 506 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE---eeeEEeeeechh
Confidence 9999999964 5699999998665433 577789999999999999999 99999999999984 568999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCC-----------CCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKY 374 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~ 374 (435)
..+...... .....-+||+.||+||.+... +.++++||||||||||+|+.|++||...... .....
T Consensus 507 ~aI~~DTTs--I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a 584 (677)
T KOG0596|consen 507 NAIQPDTTS--IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA 584 (677)
T ss_pred cccCccccc--eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence 988755322 123456899999999998543 2568999999999999999999999876532 22233
Q ss_pred HHcC-CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 375 VAEG-HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 375 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+- ....++...-..++.++++.||..||++||+..+||++
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3322 11122222122349999999999999999999999965
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=310.74 Aligned_cols=246 Identities=27% Similarity=0.471 Sum_probs=205.8
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|.....||+|+||.||++... +..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 445567999999999999874 6789999874322 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+++++|.+++.. +.+++.++..++.||+.||.|||+.+ |+||||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEccCcchhhcccccc--
Confidence 999999998854 46899999999999999999999988 9999999999999 7788999999999875543221
Q ss_pred cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCHHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELREL 395 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 395 (435)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+.. ....++..++++
T Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 12234678999999999888899999999999999999999999988776655554444332222 123578899999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||..||.+|||+.+++++
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=309.85 Aligned_cols=250 Identities=28% Similarity=0.500 Sum_probs=204.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||+|.++ ++.||+|.+....... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5788899999999999999985 6789999876543332 234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|..+......+++.+++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCcEEEEeeeeeeeccCCcc-
Confidence 9999999888876667999999999999999999999988 9999999999999 8888999999999886644321
Q ss_pred ccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------------- 379 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------- 379 (435)
......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred ---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1233457889999999865 457889999999999999999999997665433322221100
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. ....++..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 013568889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=309.40 Aligned_cols=248 Identities=26% Similarity=0.457 Sum_probs=207.5
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|.....||+|+||.||++... ++.|++|.+...... ..+.+.+|+.+++.++||||+++++++..++..++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 444557999999999999874 788999987543222 235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+++++|.+++.. ..+++.+++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEE--ccCCcEEEeechhHhhcccccc--
Confidence 999999998755 46899999999999999999999988 9999999999999 8888999999999875543221
Q ss_pred cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCHHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELREL 395 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 395 (435)
......++..|+|||.+.+..++.++|||||||++|+|++|..||......+....+.....+.. ....++..+.++
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 12335688999999999988899999999999999999999999988777666655544332221 224578899999
Q ss_pred HHHHhhhcccCCCCHHHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
|.+||+.+|++||++.+++++--
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChh
Confidence 99999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.67 Aligned_cols=249 Identities=30% Similarity=0.545 Sum_probs=212.3
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
...|+..+.||+|+||.||++.++ +..+++|.+..... ..+.+.+|+++++.++|+||+++++.+......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346888899999999999999986 78899998864332 346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
+||+++++|.+++.... .++..++..++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEE--cCCCCEEECccchhhhhccc
Confidence 99999999999998876 7999999999999999999999988 9999999999999 88889999999988765432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 391 (435)
.. ......+++.|++||.+.+..++.++|+||||+++|+|++|..||....+......+.....+... ...++.+
T Consensus 170 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd06614 170 KS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPE 245 (286)
T ss_pred hh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHH
Confidence 21 122345788999999999888999999999999999999999999987776555555444333322 2348899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++|.+||+.+|.+||++.+++.+
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=324.94 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=195.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|.+.+.||+|+||.||++.+. ++.||||... ...+.+|++++++++||||+++++++..+...++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888999999999999999986 5679999532 134568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|++. ++|.+++... ..+++.+++.++.||+.||.|||++| ||||||||+|||+ +.++.++|+|||+++......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLV--NGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEE--CCCCCEEEcccCCceeccccc
Confidence 9994 6898888764 46999999999999999999999988 9999999999999 888899999999998654322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCC------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--------PYEAAKYVAEGH------ 379 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--------~~~~~~~~~~~~------ 379 (435)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... .....+.+....
T Consensus 315 ~~--~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 315 ST--PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred cc--ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 11 11234579999999999999999999999999999999999876543221 122222222111
Q ss_pred --------------------CCCCCC------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 --------------------RPFFRA------KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 --------------------~~~~~~------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.... ..++.++.+||.+||+.||.+|||+.|+|++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 1345689999999999999999999999986
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.95 Aligned_cols=246 Identities=31% Similarity=0.505 Sum_probs=197.6
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+.....||+|+||.||++.+. +..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 334458999999999999875 5679999775432 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCccccccc
Q 013833 237 LRGGDLHKYLKEK-GAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~--~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 312 (435)
+++++|.+++... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||++ +. .+.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCeEEEecchhheecccC
Confidence 9999999999764 455 78888899999999999999988 9999999999999 54 568999999998765432
Q ss_pred CccccccccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHH-HcCCCCCCCCCCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYV-AEGHRPFFRAKGF 388 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~ 388 (435)
.. ......+++.|+|||.+... .++.++|+||||+++|+|++|..||......... ... .....+. .+..+
T Consensus 163 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (268)
T cd06624 163 NP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE-IPESL 237 (268)
T ss_pred CC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC-CCccc
Confidence 21 12234578999999998654 3788999999999999999999999765432211 111 1112222 23468
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++++++.+||+.+|++|||+.+++.+
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 8999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.51 Aligned_cols=247 Identities=28% Similarity=0.544 Sum_probs=200.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHH-HHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||++.++ |..||+|.+........ . ..+..|+.. ++.++||||+++++++..+...+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-Q-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-H-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 5788899999999999999985 78999998865433222 2 344455554 66678999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 235 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 235 e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
||++ ++|.+++.. ...+++.+++.++.|++.||.|||++ + ++||||||+||++ +.++.+||+|||++...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLI--NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeeccccccc
Confidence 9996 588888764 23589999999999999999999996 6 9999999999999 88889999999998765
Q ss_pred cccCccccccccCCCcCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~ 384 (435)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... ...+....+..+..+..+
T Consensus 155 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd06617 155 VDSV-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229 (283)
T ss_pred cccc-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence 4221 1123457889999998865 45688999999999999999999999753 333444444455555555
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+|.++.++|.+||..+|++||++.+++++
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 55689999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=351.62 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=218.0
Q ss_pred CCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.....||.|.||.||-|.. +|.-.|+|-+...... ........+|..++..++|||+|+++++-.+.+..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 667778999999999999986 4778899987654433 4455778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||+||+|.+.+...+..++.....+-.|++.|+.|||+.| ||||||||.||++ +.+|.+|+.|||.|..+......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~L--d~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILL--DFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceee--ecCCcEEeecccceeEecCchhc
Confidence 9999999999988777788888889999999999999999 9999999999999 88889999999999988765322
Q ss_pred ccccccCCCcCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.........||+-|||||++.+. +...++|||||||++.||+||+.||...+. +.+...+..|..|.++.. ++++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 22234466899999999999764 456789999999999999999999987764 555566778887776654 9999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
-++||.+||..||++|.++.||+++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999988765
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.73 Aligned_cols=247 Identities=32% Similarity=0.472 Sum_probs=207.5
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|+||.||++.+. +..+++|.+...........+.+.+|++++++++||||+++++.+..+...|+++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 789999988655443344567889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc----cc
Q 013833 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD----VY 318 (435)
Q Consensus 243 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----~~ 318 (435)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEE--cCCCCEEEEecccchhcccCcccccccccc
Confidence 999988778999999999999999999999988 9999999999999 888899999999987654332100 01
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 398 (435)
......++..|++||.+....++.++||||||+++|++++|..||......+....+..+.........++..+.+++.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK 236 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence 12234578899999999888899999999999999999999999998887777766666444333333358999999999
Q ss_pred HhhhcccCCCCHHHHHH
Q 013833 399 CWAADMNQRPSFLDILK 415 (435)
Q Consensus 399 cl~~dp~~Rps~~~ll~ 415 (435)
||+.+|++|||+..+.+
T Consensus 237 ~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 237 LLVPDPEKRLGAKSIEE 253 (265)
T ss_pred HhcCCHhhcCCCccHHH
Confidence 99999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=319.18 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=192.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
...|++.+.||+|+||.||+|.+. +..||+|..... ....|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 347999999999999999999986 457999975322 234689999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||++. ++|.+++.. ...+++.+++.++.||+.||.|||+++ ||||||||+|||+ +..+.++|+|||++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEecCccccccccC
Confidence 99995 588888865 456899999999999999999999988 9999999999999 88889999999998753322
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCC-CCCCHH----------HHHHHHHc-CCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPY----------EAAKYVAE-GHR 380 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~-~~~~~~----------~~~~~~~~-~~~ 380 (435)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... .....+.. +..
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 211 P-----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred c-----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1 123456899999999999999999999999999999999855444 321110 01111110 000
Q ss_pred CC------------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PF------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+. .....++.++.+||.+||+.||++|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0112456778889999999999999999999976
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=304.37 Aligned_cols=242 Identities=27% Similarity=0.411 Sum_probs=193.2
Q ss_pred eeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHH---HHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL---LVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.||+|+||.||++.+. ++.+|+|.+.+...........+.+|..+ +...+||+|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 67899998865443322222333444433 344579999999999998899999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
+++|.+++...+.+++.++..++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC-----
Confidence 9999999988888999999999999999999999988 9999999999999 888899999999987553221
Q ss_pred cccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....|+..|+|||.+. +..++.++|+||+||++|+|++|..||...... ............ ..+..++++++++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 229 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV-ELPDSFSPELKSL 229 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCc-CCccccCHHHHHH
Confidence 12346899999999986 456889999999999999999999999754321 111122111122 2234689999999
Q ss_pred HHHHhhhcccCCC-----CHHHHHHH
Q 013833 396 TEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
|.+||..||++|| ++++++++
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.15 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=204.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||+|.++ ++.|++|.+....... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4788899999999999999975 7789999886544322 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+ +++|.+++.. ...+++.+++.++.||+.+|.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEE--cCCCcEEEeeeeecccccCCCC
Confidence 99 9999999875 456899999999999999999999988 9999999999999 7788999999999987654321
Q ss_pred cccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----------- 382 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 382 (435)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.........+.......
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 112345688999999998654 46889999999999999999998887766544433322211000
Q ss_pred ----------C-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 ----------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ----------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....+.++.++|.+||+.+|++|||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 002457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=303.91 Aligned_cols=249 Identities=28% Similarity=0.492 Sum_probs=203.4
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeC-----
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER----- 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 227 (435)
..+|++.+.||+|+||.||++..+ ++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 347899999999999999999975 7789999875422 1225677899999999 799999999988643
Q ss_pred CcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
..+++||||+++++|.++++. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili--~~~~~~kl~df 172 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILL--TTEGGVKLVDF 172 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEeec
Confidence 358999999999999998863 346899999999999999999999988 9999999999999 77889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
|++........ ......++..|+|||.+... .++.++|+|||||++|+|++|..||...........+...
T Consensus 173 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 173 GVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99886543221 12234678899999998643 3678999999999999999999999887765555555444
Q ss_pred CCCCC-CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 HRPFF-RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+.. .+..++..+.++|.+||+.+|++||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 33322 233567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.28 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=203.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+|+..+.||+|+||.||+|.++ ++.|++|.+...... .......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 679999998654433 122235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+ +++|.+++.... .+++.++..++.||++||.|||+++ |+|+||+|+||++ +.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEE--cCCCCEEEccceeeeeccCC
Confidence 9999 889999998766 7999999999999999999999988 9999999999999 88899999999999876543
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---------- 381 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------- 381 (435)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+....+......
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 1223356788999998854 46788999999999999999998888776654433332211000
Q ss_pred ------------CC----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ------------FF----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ------------~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. .....+.++.++|.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 012356889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.17 Aligned_cols=243 Identities=30% Similarity=0.448 Sum_probs=198.4
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|+||+||++.+. ++.+++|.+.............+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 788999988654333333345667899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccc
Q 013833 243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 243 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
.+++.+.. .+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||.+....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-----~~ 151 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGK-----KI 151 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEccCcchhhhccCC-----cc
Confidence 99998755 6899999999999999999999988 9999999999999 888899999999987654321 12
Q ss_pred cCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHH
Q 013833 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~ 398 (435)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+... ..+...+..+++.++++|.+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence 3345788999999998888999999999999999999999999765431111111111 11222334579999999999
Q ss_pred HhhhcccCCC-----CHHHHHHH
Q 013833 399 CWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 399 cl~~dp~~Rp-----s~~~ll~~ 416 (435)
||+.+|++|| ++.+++.+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HccCChhHccCCCcccHHHHHhC
Confidence 9999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.17 Aligned_cols=252 Identities=32% Similarity=0.472 Sum_probs=212.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|+..+.||+|+||.||+++++ +..+++|.+............++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35788889999999999999985 6789999886543334444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+. ++|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEE--CCCCcEEECCcccceeecCc-
Confidence 9996 588887754 456899999999999999999999988 9999999999999 77889999999998765422
Q ss_pred ccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+..+..+......++.
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (308)
T cd06634 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241 (308)
T ss_pred -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccH
Confidence 2345788999999974 356788999999999999999999999887776666666666666555567889
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
.++++|.+||..+|++||++.+++++.....
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 9999999999999999999999998755443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.44 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=207.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|.+.+.||+|+||.||++... +..+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47889999999999999999864 67899998743322 22367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++++|.+++.+. .+++.++..++.|++.||.|||+++ ++||||+|+||++ +.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili--~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEE--cCCCCEEEccCcceeccccccc
Confidence 999999999999754 5789999999999999999999988 9999999999999 7788999999998876543321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 393 (435)
......+++.|++||.+....++.++|+||||+++|++++|..||...+.......+.....+. .....++..++
T Consensus 171 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred ----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 1233468889999999988889999999999999999999999998776554433333222222 22345688999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||..+|++||++.+++.+
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=294.96 Aligned_cols=249 Identities=30% Similarity=0.575 Sum_probs=213.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|++|.||++.+. +.+|++|.+...... ......+.+|++++++++|||++++++++.++...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4778889999999999999875 678999988665432 2345789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..+..++.|++.+|.|||+.| ++||||+|+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--CCCCCEEEeccccceecCCCccc
Confidence 9999999999988888999999999999999999999988 9999999999999 77889999999999876543321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................+. .+..+++.++++
T Consensus 156 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (254)
T cd06627 156 ----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISPELKDF 230 (254)
T ss_pred ----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC-CCCCCCHHHHHH
Confidence 233467889999999988888999999999999999999999998777655554444443333 345688999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||..+|++|||+.+++.+
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=294.90 Aligned_cols=247 Identities=33% Similarity=0.576 Sum_probs=209.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|++|.||++.++ +..+++|.+..... ...+.+.+|+.+++.++||+|+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3677889999999999999986 77899998865433 234778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.+ ++||||+|+||++ +.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL--TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEE--ccCCeEEEeecccccccccccc
Confidence 99999999999875 57999999999999999999999988 9999999999999 7788999999999987654321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 393 (435)
.....++..|+|||.+....++.++|+||||+++|+|++|..||...+.............+... ...++..+.
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence 23346788999999998888999999999999999999999999887655554444433333222 223488999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||+.||++|||+.+++++
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.00 Aligned_cols=239 Identities=28% Similarity=0.388 Sum_probs=196.5
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHH-HhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.||+|+||.||+|.+. ++.||+|.+.+...........+..|..++ ...+|||++++++.+..++.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999974 779999988654322222233445555444 455899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccccc
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 319 (435)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEeecccceeccc--------
Confidence 999999988888999999999999999999999988 9999999999999 7888999999998875432
Q ss_pred ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCCHHHHHHHH
Q 013833 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP--FFRAKGFTPELRELTE 397 (435)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 397 (435)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..+... ......+++++.+++.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 12345788999999998888899999999999999999999999888776665555443321 1122357899999999
Q ss_pred HHhhhcccCCCCHHHH
Q 013833 398 KCWAADMNQRPSFLDI 413 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~l 413 (435)
+||+.+|++||++.++
T Consensus 230 ~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 230 RLLCMDPAKRLGANGY 245 (260)
T ss_pred HHccCCHHHccCCCcH
Confidence 9999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.61 Aligned_cols=249 Identities=29% Similarity=0.502 Sum_probs=208.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||++.++ +..+++|.+....... ...+.+.+|+.+++.++|+||+++++.+..+...++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778889999999999999985 6789999875532222 223567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~~~ 312 (435)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++ .++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--cCCCCeEEecccccchhccCC
Confidence 999999999997643 4789999999999999999999988 9999999999999 6554 5799999998766433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....+.. ...++.++
T Consensus 156 ~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (257)
T cd08225 156 ME----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI-SPNFSRDL 230 (257)
T ss_pred cc----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC-CCCCCHHH
Confidence 21 11234578899999999888899999999999999999999999987776666655555444333 24578999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++|.+||..+|++|||+.+++++
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=298.17 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=192.5
Q ss_pred eeecCCceeEEEEEEC-C---CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFGEILKAYWR-G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+|+||.||++... + ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 6999999999999753 2 2456776543322 23347889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 240 GDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 240 ~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
++|.+++.+. ..++...+..++.||+.||.|||+.+ ++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEE--cCCccEEecccccccccCcchh-
Confidence 9999999753 23566778899999999999999988 9999999999999 8888999999998864321110
Q ss_pred ccccccCCCcCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC----C
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF----F 383 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~----~ 383 (435)
........++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+..+.... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 011224567889999999753 245789999999999999997 678998777666555443332111 1
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
....+++.+.+++..|| .+|++||++.++++.|.
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 12347889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=305.23 Aligned_cols=245 Identities=30% Similarity=0.490 Sum_probs=207.7
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|...+.||+|+||+||+|.+. +..|++|.+.............+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999874 778999988655444445556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+. ++|.+++.. ...+++.++..++.||+.+|.|||+.| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili--~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEE--CCCCCEEEeecCCCcccCC----
Confidence 95 578887765 456899999999999999999999988 9999999999999 7888999999998864321
Q ss_pred ccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.....|+..|+|||.+. ...++.++||||||+++|+|++|..||...+.......+.....+......++..+
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 22456788999999984 45688899999999999999999999988877666666655555554455678899
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|+.+||+.+|++||++.+++.+
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.84 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=204.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||+|+||.||+|.++ +..|++|.+...... ....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5788899999999999999986 678999987654332 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++++.|..+..+...+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILV--SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEEeeecccccCCCccc
Confidence 9988777776766667999999999999999999999988 9999999999999 78899999999998876543321
Q ss_pred ccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------------- 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------- 380 (435)
......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+....+....+.....
T Consensus 157 ---~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 ---PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ---cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 12235678899999999887 889999999999999999999999987654433222211000
Q ss_pred -------CC---------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -------PF---------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -------~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+. ..+..+++++++||.+||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0112348889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.28 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=228.7
Q ss_pred CCCCCceeecCCceeEEEEEECCCc--EEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
++..+..||-|+||.|-++..++.. +|+|++++...-+....+....|-++|..+..|+||+++..|.+...+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 5667788999999999999887654 79998877655555556788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
-|-||.||..++..+.|++.++..++..+++|++|||++| ||+|||||+|.++ +.+|-+||.|||+|..+.....
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllL--d~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLL--DNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheee--ccCCceEEeehhhHHHhccCCc-
Confidence 9999999999999999999999999999999999999998 9999999999999 9999999999999999886653
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.-+++|||.|.|||++.++.++.++|.||||+++|||++|.+||.+.+++.....|.+|......|..++....++
T Consensus 576 ----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 576 ----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred ----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 3468999999999999999999999999999999999999999999999999999999998888888899999999
Q ss_pred HHHHhhhcccCCCC-----HHHHHHH
Q 013833 396 TEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
|.++...+|.+|.. ..+|.+|
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhh
Confidence 99999999999975 5666665
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=292.11 Aligned_cols=241 Identities=27% Similarity=0.472 Sum_probs=202.6
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe----CCcEEEEEe
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RKPLMLITE 235 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e 235 (435)
++||-|-.|.|..|.++ +..+|+|++... ...++|+++.-.. .|||||.++++|++ ...+.+|||
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 58999999999999986 778999987532 4557888876666 59999999998754 356789999
Q ss_pred cCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~ 312 (435)
.|+||.|++.+..++. |++.++..|+.||..|+.|||+.+ |.||||||+|+|.+. ..+..+||+|||+|+.-...
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 9999999999988665 999999999999999999999998 999999999999943 44557999999999865432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCC--C
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFRA--K 386 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~--~ 386 (435)
. ...+.+.||.|.|||++...+|+...|+||+||++|-|++|.+||..... -....+|..+..-+..+ .
T Consensus 218 ~-----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 218 G-----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred c-----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 2 35678899999999999999999999999999999999999999965442 23456677776554333 3
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.+|+..+++|..+|..+|++|.|..+++++-.
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 57889999999999999999999999997644
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.33 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=213.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|.+.+.||+|+||.||++..+ +..|++|.+.+...........+.+|+.++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788899999999999999984 7889999886644333444567889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++++++|.+++.+.+.+++.+++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i--~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEecCCccccccCCccc
Confidence 99999999999998888999999999999999999999988 9999999999999 8888999999999886654321
Q ss_pred cc----------------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 315 HD----------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 315 ~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
.. ........++..|+|||.+....++.++|+||||++++++++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 10 01222345788999999998888999999999999999999999999987765555555433
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCH----HHHHHH
Q 013833 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSF----LDILKR 416 (435)
Q Consensus 379 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~ll~~ 416 (435)
... .+..+++.+.+|+.+||+.+|++||++ .+++++
T Consensus 238 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCC--CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 322 234678999999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=295.74 Aligned_cols=249 Identities=30% Similarity=0.546 Sum_probs=214.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.+. +..+++|.+...... ......+.+|+++++.++|||++++.+.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4778889999999999999986 788999988654332 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
++++++|.+++... ..+++.++..++.+++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~--~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFL--TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEE--cCCCcEEECCccceeeccc
Confidence 99999999999763 67999999999999999999999988 9999999999999 7788999999999987654
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
... ......|++.|+|||.+....++.++|+||+|+++|+|++|..||...+.............+.. +..++..
T Consensus 156 ~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (258)
T cd08215 156 TVD----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI-PSQYSSE 230 (258)
T ss_pred Ccc----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCCHH
Confidence 321 12334688899999999888899999999999999999999999988877766666655544333 3468899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+++.+||..+|++|||+.+++++
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=302.77 Aligned_cols=254 Identities=15% Similarity=0.209 Sum_probs=190.7
Q ss_pred CCCCCCCceeecCCceeEEEEEECCC-----cEEEEEccCCCCCcHHHH--------HHHHHHHHHHHhCCCCcceeeee
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVI--------QDFRHEVNLLVKLRHPNIVQFLG 222 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~ 222 (435)
..+|.+.++||+|+||.||+|.+.+. .+++|............. .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999997533 566665432221110000 11223344556678999999998
Q ss_pred eEEeCC----cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 223 AVTERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 223 ~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
.+.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill--~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMV--DGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCcE
Confidence 765443 347788877 4578888776656788899999999999999999988 9999999999999 788899
Q ss_pred EEeeccCcccccccCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HH----
Q 013833 299 KVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YE---- 370 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~---- 370 (435)
+|+|||+|+.+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999987653321111 112234699999999999999999999999999999999999999987632 11
Q ss_pred ----HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 371 ----AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 371 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
....+..+. .....+++++.+++..||+.+|++||++.++++.|
T Consensus 246 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 112222221 12345789999999999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=303.14 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=199.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||.|+||.||+|.++ +..|+||.+....... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 3778889999999999999985 7789999886443222 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+. ++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEeeccchhhcccCc
Confidence 995 589998875 346899999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccccccccCCCcCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCC---------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-HRPF--------- 382 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~--------- 382 (435)
. ......+++.|+|||.+.+.. ++.++||||||+++|+|+||..||...+.......+... ..+.
T Consensus 155 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred c----ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 1 122345688999999886544 688999999999999999999999776543322221110 0000
Q ss_pred ----------C-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 ----------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ----------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....++++++++|.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 012467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=294.67 Aligned_cols=252 Identities=29% Similarity=0.535 Sum_probs=212.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 233 (435)
+|+..+.||+|++|.||+|.+. +..+++|.+...... ....+.+.+|+.++++++||||+++++.+.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3677889999999999999986 778999988654432 34557889999999999999999999999888 889999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+||+++++|.+++.....+++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEcccccEEeccccc
Confidence 999999999999988778999999999999999999999988 9999999999999 778899999999998776443
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. .......++..|+|||.+....++.++||||||+++|+|++|..||.... .......+.........+..++..+
T Consensus 156 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred cc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence 21 01233567889999999988889999999999999999999999998765 3333333332223333345678999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+||..+|++||++.+++++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=296.95 Aligned_cols=247 Identities=30% Similarity=0.485 Sum_probs=212.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||.|+||.||++.++ +..+++|.+....... .....+.+|+.+++.++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4778889999999999999875 6689999886544332 334677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|.+++.+ ...++++.++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILL--VANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--ecCCcEEEeeccchhhhcc
Confidence 9999999999876 346899999999999999999999988 9999999999999 6688999999999987654
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. .....+++.|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+..+... ..++.+
T Consensus 156 ~~------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (256)
T cd08530 156 NM------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP-PIYSQD 228 (256)
T ss_pred CC------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc-hhhCHH
Confidence 31 12345788999999999999999999999999999999999999988877766666666555443 368899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++.+||+.+|++||++.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=302.89 Aligned_cols=247 Identities=28% Similarity=0.546 Sum_probs=198.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|...+.||+|+||.||++.+. ++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4666788999999999999985 678999988654322 33467889999999996 999999999998888999999
Q ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 235 e~~~g~sL~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
||+. ++|.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||++ +.++.++|+|||++..
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILL--DRNGNIKLCDFGISGQ 157 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEE--ccCCcEEEeecchhHH
Confidence 9985 46655432 235689999999999999999999974 6 9999999999999 7788999999999976
Q ss_pred ccccCccccccccCCCcCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFR 384 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~ 384 (435)
..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||..... .+....+..+..+...
T Consensus 158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred hccCC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 54322 12234578899999999766 688999999999999999999999976542 2222233333333322
Q ss_pred C---CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 A---KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ~---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ..++.++.+|+.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 2478999999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.31 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=199.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|+..+.||+|+||.||++.+. ++.||+|.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36889999999999999999974 778999988654332 23345677899999999999999999987543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCcccee
Confidence 5799999995 5898888654 899999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------- 380 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------- 380 (435)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 168 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 54321 12334678899999999999999999999999999999999999987664333222211000
Q ss_pred -------------CCC--------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -------------PFF--------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -------------~~~--------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. .....++.++++|.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 011245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.83 Aligned_cols=241 Identities=29% Similarity=0.438 Sum_probs=193.3
Q ss_pred eeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHH---HHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE---VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.||+|+||.||++.+. ++.||+|.+.+...........+..| +..++...||+|+++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 67899998865433222211223333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
|++|.+++...+.+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC-----
Confidence 9999999988888999999999999999999999988 9999999999999 788899999999987553221
Q ss_pred cccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||.... ........ ....+. .+..++.++.+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~s~~~~~ 228 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVE-LPDSFSPELRS 228 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCC-CCCcCCHHHHH
Confidence 1234689999999998754 68899999999999999999999998663 22222222 222222 23457899999
Q ss_pred HHHHHhhhcccCCC-----CHHHHHHH
Q 013833 395 LTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
++.+||..+|.+|| ++.+++++
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.06 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=185.6
Q ss_pred CceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEEEEe
Q 013833 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE 235 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 235 (435)
..+||+|+||+||+|..+ +..||+|.+..... ...+.+|+.++++++||||+++++++.. +..+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 357999999999999964 35799998754322 1456789999999999999999998743 567899999
Q ss_pred cCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec--CCCCcEEEeecc
Q 013833 236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG 304 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--~~~~~vkl~Dfg 304 (435)
|+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+.. +.++.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 985 5888887521 24788999999999999999999988 999999999999942 345689999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----------HHHH
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----------EAAK 373 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----------~~~~ 373 (435)
+++....... .........+|+.|+|||++.+ ..++.++|||||||++|+|+||.+||...... ....
T Consensus 158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred ceeccCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 9987653321 1112234568999999999876 45889999999999999999999999643210 0000
Q ss_pred HHHcCC------------------------CC-----------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 374 YVAEGH------------------------RP-----------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 374 ~~~~~~------------------------~~-----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.... .. .......+..+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00 00011235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.54 Aligned_cols=245 Identities=26% Similarity=0.406 Sum_probs=195.7
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC--CcEEEE
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLI 233 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 233 (435)
|++.+.||+|+||.||++.++ ++.||+|.+......... ....+|+.++.++. ||||+++++++.++ +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 567789999999999999874 678999988654332221 23457888888885 99999999999887 889999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+.+ +|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||+|+||++ +. +.++|+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI--KD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--cC-CCeEEEecccccccccC
Confidence 999964 88888875 456899999999999999999999988 9999999999999 66 89999999999866433
Q ss_pred CccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---------- 381 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------- 381 (435)
.. .....++..|+|||.+. +..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 21 12345788999999764 456788999999999999999999999887765543333211000
Q ss_pred ------C-C----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ------F-F----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ------~-~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. . ....++.++.++|.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0 012467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=301.93 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=201.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 233 (435)
+|+..+.||+|+||.||+|.++ ++.+++|.+...... ......+.+|+.++++++||||+++++++... ...|+|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 6888999999999999999986 678999988654332 22224567899999999999999999998777 889999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+.+ +|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLL--NNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCcEEEeecCceeeccCC
Confidence 999964 9999987643 5899999999999999999999988 9999999999999 88899999999999866543
Q ss_pred CccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----------- 380 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 380 (435)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+.....
T Consensus 160 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LK----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cc----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 21 12334578899999998754 468899999999999999999999987765544333221100
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -------------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..++...+++.+.++|.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111157889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.40 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=196.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|++|.||++..+ ++.||+|.+....... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 6888999999999999999975 7789999886543221 11345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEE--cCCCCEEECccccccccCCCCc
Confidence 9975 999998764 46899999999999999999999988 9999999999999 8888999999999875432211
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCC------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHR------------ 380 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~------------ 380 (435)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.+.. ..+....+.+...
T Consensus 159 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 ----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred ----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346888999999865 458899999999999999999999997665 2222211111000
Q ss_pred ---------CCCC-------CCCCC--HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ---------PFFR-------AKGFT--PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ---------~~~~-------~~~~~--~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+... ...++ .++.+++.+||+.+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 01233 788999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.16 Aligned_cols=247 Identities=27% Similarity=0.479 Sum_probs=201.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 233 (435)
+|...+.||.|++|.||++.+. ++.+|+|.+...... ....++.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4677789999999999999985 678999988654322 3346788999999999999999999988553 468999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILL--TRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--ecCCeEEEeeccccccc
Confidence 999999999988753 345889999999999999999999988 9999999999999 77888999999998755
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~ 384 (435)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+....+.....+...
T Consensus 156 ~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 156 VNSL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cccc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 4221 12345788999999999889999999999999999999999999765 233444444433222211
Q ss_pred C-----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 A-----KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ~-----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ..+++.+++|+.+||+.+|++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 2346789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.72 Aligned_cols=248 Identities=30% Similarity=0.461 Sum_probs=199.9
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|++.+.||.|++|.||++.++ |..|++|.+....... .....+.+|+.+++.++|||++++++++.++...+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 567789999999999999874 7899999886543221 2225678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 237 ~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
++ ++|.+++.... .+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCcEEEeecccccccCCCcc
Confidence 95 69999998765 6899999999999999999999987 9999999999999 7788999999999976543211
Q ss_pred cccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------------- 379 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 379 (435)
......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.+..
T Consensus 155 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 ----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 11233568899999988654 57889999999999999999999998766543322221100
Q ss_pred -----------CCC--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 -----------RPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 -----------~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... .....++..+.++|.+||+.+|++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0113567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.98 Aligned_cols=243 Identities=31% Similarity=0.474 Sum_probs=212.6
Q ss_pred CCCCCCCceeecCCceeEEEEEECCC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
-.+|..+.+||+|+||.|.++..+|+ .+|||++++.......-++--..|-++|... +-|++++++..|..-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34778888999999999999998865 6999998876544333233345677777666 46899999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+.||+|--.+++-+.+.+..+..++.+|+-||-+||++| ||+||||.+|||+ +..|+|||+|||++..--..
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmL--d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEe--ccCCceEeeecccccccccC
Confidence 9999999999999999999999999999999999999999999 9999999999999 99999999999999743222
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
..+..+++|||.|+|||++...+|+.++|+||+||+||||+.|++||++.+..+....|.+..-.. ++.+|.+.
T Consensus 504 ----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy--PKslSkEA 577 (683)
T KOG0696|consen 504 ----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY--PKSLSKEA 577 (683)
T ss_pred ----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC--cccccHHH
Confidence 224667899999999999999999999999999999999999999999999999988888765443 67899999
Q ss_pred HHHHHHHhhhcccCCC
Q 013833 393 RELTEKCWAADMNQRP 408 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rp 408 (435)
.++....|.+.|.+|.
T Consensus 578 v~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHhhcCCcccc
Confidence 9999999999999995
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.04 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=202.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 232 (435)
.+|++.+.||+|+||.||++.++ +..||+|.+........ ....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 37899999999999999999985 78899998864432221 113456799999999999999999998655 56899
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||+.+ +|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLL--TDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccceeeecCC
Confidence 9999964 89888875 456899999999999999999999988 9999999999999 8888999999999987654
Q ss_pred cCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--------
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-------- 382 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 382 (435)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+.......
T Consensus 161 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 321 1222345788999999865 567899999999999999999999999887766655444321100
Q ss_pred ----------CC----------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 383 ----------FR----------AKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 383 ----------~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.. ....++++.++|.+||+.||++|||+.+++.+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 0125788999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=309.82 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=203.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 230 (435)
.+|++.+.||+|+||.||++..+ +..|++|.+...... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47888899999999999999875 788999988654322 2234667789999999999999999987753 3568
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++||||+. ++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLV--NEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEecccccceeec
Confidence 99999995 599999987778999999999999999999999988 9999999999999 888999999999997665
Q ss_pred ccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE------------ 377 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------ 377 (435)
..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 433222222334578899999999865 4688999999999999999999999987654332211111
Q ss_pred -----------CC--CCCCC----CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 -----------GH--RPFFR----AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 -----------~~--~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ..... ....+++++++|.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 00000 13468899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.20 Aligned_cols=249 Identities=28% Similarity=0.481 Sum_probs=195.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|.+.+.||+|+||.||+|..+ +..|++|.+....... ....+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 36888999999999999999875 7789999886543222 1245678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+. ++|.+++.. ...+++.++..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--cCCCcEEEeccccccccCCCC
Confidence 9995 678777654 346788899999999999999999988 9999999999999 888899999999987543322
Q ss_pred ccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHc--------------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAE-------------- 377 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~-------------- 377 (435)
. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... +....+..
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 Q----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 1 1223457889999999875 45788999999999999999999999765432 11111110
Q ss_pred ---CCCCCC-------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 ---GHRPFF-------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 ---~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+.. .....++++.+++.+||..||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 001235789999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.02 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=188.5
Q ss_pred CCCCCCceeecCCceeEEEEEECC---CcEEEE--------------EccCCCCCcHHHHHHHHHHHHHHHhCCCCccee
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG---TPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~---~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 219 (435)
.+|++.+.||+|+||+||+|..+. ..++.| .+.+...........+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 479999999999999999987541 112222 111111112233456889999999999999999
Q ss_pred eeeeEEeCCcEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+++++...+..|+|++++ +++|.+++... ......++..++.||+.||.|||++| ||||||||+|||+ +.
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl--~~ 302 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL--NC 302 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CC
Confidence 999999999999999998 45888877542 22346678889999999999999988 9999999999999 88
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC-CCCCCC--HHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP-PLANYE--PYEA 371 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~-p~~~~~--~~~~ 371 (435)
++.+||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|||++|.. ||.... +...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 88999999999987653321 11234578999999999999999999999999999999999875 443222 1111
Q ss_pred HHHHHcCC------------------------------CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 372 AKYVAEGH------------------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 372 ~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+.... ...+....++..+.++|.+||+.||++|||+.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111100 0001112456778889999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.46 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=207.3
Q ss_pred CceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecCC
Q 013833 162 SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.++||+|+++.|--+.. .|..+|||++.+.. .....+..+|++++.+++ |+||+++++||+++..+|+|||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 35799999999998875 58899999886542 233477889999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCcc--
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSH-- 315 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~~-- 315 (435)
||+|...|.++..|++.++.++..+|+.||.|||.+| |.||||||+|||..+ +.-.-||||||.++.-+.....-
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999999889999999999999999999999998 999999999999832 33345999999988765443321
Q ss_pred -ccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHHH
Q 013833 316 -DVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------------PYEAAKY 374 (435)
Q Consensus 316 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---------------~~~~~~~ 374 (435)
......+.+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.= .......
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 122344678999999999863 3468999999999999999999999995431 1334566
Q ss_pred HHcCCCCCCCC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 375 VAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 375 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
|.+|+..+... ..+|.+.+++|+.+|..|+.+|.++.+++++
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 77887655332 3578999999999999999999999999874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.56 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=197.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-----
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 228 (435)
-.+|++.+.||+|+||.||++..+ +..||+|.+........ ....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 347899999999999999999985 67899998754332221 1234568999999999999999999876543
Q ss_pred ---cEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 ---PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 ---~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
..++||||+. ++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILI--TKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--CCCCcEEECcCC
Confidence 4599999995 48888886543 6899999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---C
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---R 380 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~ 380 (435)
++..................++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9986654332211122334578899999988654 47889999999999999999999998766543332222110 0
Q ss_pred CC---------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PF---------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+. ......+..+++||.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 0001135678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.76 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=200.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+..+.||.|++|.||+|.++ +..||+|.+...... .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788899999999999999985 778999988654322 123566789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|+++ +|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLI--NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCcEEEeecchhhhhcCC
Confidence 9975 899988754 35899999999999999999999988 9999999999999 88889999999999765432
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR----------- 380 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 380 (435)
.. ......+++.|++||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.+...
T Consensus 154 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 154 VN----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred cc----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 11 1223456889999998865 4578899999999999999999999987765444333221100
Q ss_pred ---------CCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ---------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ---------~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++.+++++.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 002357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.00 Aligned_cols=246 Identities=25% Similarity=0.460 Sum_probs=206.0
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|.....||+|+||.||++..+ +..||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 344567999999999999874 6789999874322 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+++++|.+++.. +.+++..+..++.|++.+|.|||+.| ++||||+|+||++ +.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~~~-- 171 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP-- 171 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEcccccceecccccc--
Confidence 999999998754 46899999999999999999999988 9999999999999 7888999999998876543211
Q ss_pred cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCHHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPELREL 395 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 395 (435)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.....+.. ....+++.+.++
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 12234678999999999888899999999999999999999999988776665555554443332 224578999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||+.+|.+||++.+++.+
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcC
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.98 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=205.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----Cc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 229 (435)
.+|.+.+.||+|+||+||++.+. +..||+|.+....... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 36889999999999999999975 7789999886543322 2235677899999999999999999987544 34
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++|+||+. ++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLL--NANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcCcccccc
Confidence 799999995 699999988888999999999999999999999988 9999999999999 88889999999999866
Q ss_pred cccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE----------- 377 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------- 377 (435)
..... ......++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 159 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 43321 1233467889999998864 4688999999999999999999999976653322211110
Q ss_pred ----------------CCCCC--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 378 ----------------GHRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 378 ----------------~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
...+. .....+++++.++|.+||+.+|++|||+.+++++ +..+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000 0113578899999999999999999999999988 666544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.41 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=197.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCc-----
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP----- 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~----- 229 (435)
+|++.+.||+|+||.||++.+. ++.||+|.+....... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5788899999999999999975 7789999875543221 12356788999999995 6999999998877655
Q ss_pred EEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeec
Q 013833 230 LMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDF 303 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Df 303 (435)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||++ +. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~--~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLV--DKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--ecCCCeEEEeec
Confidence 8999999975 898888642 34799999999999999999999988 9999999999999 66 789999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-- 380 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-- 380 (435)
|++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 156 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 156 GLGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred ccceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99876543221 1123356888999998865 4578999999999999999999999987765544332221100
Q ss_pred -----------------CCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -----------------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -----------------~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++++.+||.+||..||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 013478899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=290.63 Aligned_cols=241 Identities=33% Similarity=0.508 Sum_probs=207.3
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||.|+||.||++.++ +..+++|.+.............+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999986 788999988766555555567889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccC
Q 013833 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (435)
Q Consensus 243 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 322 (435)
.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~----~~~~ 152 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGS----RTNT 152 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEE--cCCCcEEEeecCcceecccCCC----cccC
Confidence 999998878999999999999999999999988 9999999999999 7788999999999976643321 1234
Q ss_pred CCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhh
Q 013833 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 402 (435)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 402 (435)
..++..|++||.+.+...+.++|+||||+++|++++|..||...+.......+.....+ .+..++..+.+++.+||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR--FPEFLSPEARDLISGLLQK 230 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcC
Confidence 56788999999998888899999999999999999999999887766655555553322 2345689999999999999
Q ss_pred cccCCCCH---HHHHH
Q 013833 403 DMNQRPSF---LDILK 415 (435)
Q Consensus 403 dp~~Rps~---~~ll~ 415 (435)
||++||++ .++++
T Consensus 231 ~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 231 DPTKRLGSGGAEEIKA 246 (250)
T ss_pred CHhhCCCcccHHHHHh
Confidence 99999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=298.70 Aligned_cols=249 Identities=29% Similarity=0.450 Sum_probs=198.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|++|+||++.++ ++.|++|.+...... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6888899999999999999975 678999987554322 2233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~ 312 (435)
|++ ++|.+++..... +++..+..++.||+.||.|||+++ ++||||+|+||++ + .++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill--~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEE--ECCCCEEEEcccccccccCCC
Confidence 995 588888765443 578888899999999999999988 9999999999999 5 3457999999999765432
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CC---------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP--------- 381 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--------- 381 (435)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+.... .+
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 1223456889999998865 457889999999999999999999998776554443322110 00
Q ss_pred ----------CC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ----------FF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ----------~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ....+++++.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 013468899999999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=304.63 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=211.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-----cE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 230 (435)
+|++.+.||.|+||.||+|.+. +..+++|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4788899999999999999975 67899998865432 2233467889999999999999999999987765 78
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|++|||+. ++|.+++.+...+++..+..++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili--~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILV--NSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccCceEeec
Confidence 99999996 589999988778999999999999999999999988 9999999999999 788999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF------ 383 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 383 (435)
..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+........
T Consensus 155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44211 0112334678899999999877 889999999999999999999999988776554433332111000
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhh
Q 013833 384 -----------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 423 (435)
Q Consensus 384 -----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~ 423 (435)
....+++++.++|.+||+.+|++||++.+++.+ ++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 012367889999999999999999999999986 6666653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.47 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=197.1
Q ss_pred CCCCCceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 231 (435)
+|++.+.||+|+||.||+|.++ +..||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999984 578999998764322222336678899999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC----CCcEEEee
Q 013833 232 LITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS----ADHLKVGD 302 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~----~~~vkl~D 302 (435)
+||||+++ +|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||++ +. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~--~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV--MGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE--cCCCCccceEEECC
Confidence 99999965 787776532 25899999999999999999999988 9999999999999 66 88999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH---------HH
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---------AA 372 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---------~~ 372 (435)
||++......... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||.+..... ..
T Consensus 156 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 156 LGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999876543221 112334567899999998866 457899999999999999999999997544321 00
Q ss_pred HHHHc------------------------C-CCCCCC----------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 373 KYVAE------------------------G-HRPFFR----------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 373 ~~~~~------------------------~-~~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+.. . ...... ....+.++.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0 000000 01456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.65 Aligned_cols=259 Identities=30% Similarity=0.587 Sum_probs=226.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
+......++||+|+||+||+|.|- ..+||+|++...... ....++.+|+.+|.++.|||++++++++....
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 445667789999999999999983 348999988654433 33478899999999999999999999987665
Q ss_pred EEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
+.||++|+++|+|.||++. ++.+-.+..+.|..||++||.|||++. +|||||-..|||| ..-.++||.|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLV--ksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLV--KSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheee--cCCCeEEEEecchhhc
Confidence 8899999999999999986 456888999999999999999999988 9999999999999 7778999999999998
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
+..... .+...+..-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++...+..+.+ ...+..
T Consensus 848 l~~d~~--ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPpi 924 (1177)
T KOG1025|consen 848 LAPDEK--EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPPI 924 (1177)
T ss_pred cCcccc--cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCCC
Confidence 876543 334455566889999999999999999999999999999999 9999999999999999999888 445567
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
++-++..++.+||..|+..||+++++...+.++.+..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 9999999999999999999999999999998887643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.59 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=201.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----Cc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 229 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+.... ......++.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 37889999999999999999875 7789999875322 223346678899999999999999999886544 34
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEECcccceeec
Confidence 799999995 488888754 46899999999999999999999988 9999999999999 88889999999999765
Q ss_pred cccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------- 379 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 379 (435)
...... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 433211 112234568999999998754 568899999999999999999999997665432221111000
Q ss_pred ----------------CCCC----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 380 ----------------RPFF----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 380 ----------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
.+.. ....+++++.++|.+||+.+|++|||+.+++++ |+.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 012457889999999999999999999999988 665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.58 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=202.8
Q ss_pred CCCCCceeecCCceeEEEEEE-----CCCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 230 (435)
.|++.+.||+|+||.||++.. +|..||+|.+...... .....+.+.+|+.+++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367888999999999999986 4678999988643221 122336678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++||||+++++|.+++.....+++.++..++.|++.||.|||+.+ ++||||+|+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--CCCCCEEEeeCccceecc
Confidence 999999999999999988888999999999999999999999988 9999999999999 788899999999997654
Q ss_pred ccCccccccccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~ 384 (435)
.... .......|+..|+|||.+... .++.++||||||+++|+|++|..||.... ..+....+.....+ .
T Consensus 157 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (290)
T cd05613 157 EDEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--Y 231 (290)
T ss_pred cccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--C
Confidence 3221 112235688999999998753 46789999999999999999999996432 22333333333222 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+..+++.+.+++.+||+.+|++|| ++.+++.+
T Consensus 232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 345889999999999999999997 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.51 Aligned_cols=262 Identities=35% Similarity=0.621 Sum_probs=222.4
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcc
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNI 217 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 217 (435)
..|+++...+ .+.+.||.|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+ +||||
T Consensus 289 ~~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 289 PKWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred Cceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcch
Confidence 3688877655 44559999999999999753 236999988655444 4458899999999999 59999
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeC
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~ 281 (435)
+.+++.+.....+++|+||+..|+|.+|++..+ .++..+.+.++.||+.||+||+++. +|||
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHR 442 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHR 442 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccch
Confidence 999999999999999999999999999998765 3888999999999999999999987 9999
Q ss_pred CCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCC--cCccccCccccCCCCCCCcchHHHHHHHHHHHHc-
Q 013833 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE- 358 (435)
Q Consensus 282 Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t- 358 (435)
||.+.|||+ ..+..+||+|||+|+....... +...... -+..|||||.+....|+.++||||+|++|||++|
T Consensus 443 DLAaRNVLi--~~~~~~kIaDFGlar~~~~~~~---y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL 517 (609)
T KOG0200|consen 443 DLAARNVLI--TKNKVIKIADFGLARDHYNKDY---YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL 517 (609)
T ss_pred hhhhhhEEe--cCCCEEEEccccceeccCCCCc---eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence 999999999 7778999999999996554321 1212222 3556999999999999999999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 359 GEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 359 g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
|..||.+.. ..+..+.+.+|.++..+ ..+++++.+++..||+.+|++||++.++.+.|+...
T Consensus 518 G~~PYp~~~~~~~l~~~l~~G~r~~~P-~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 518 GGTPYPGIPPTEELLEFLKEGNRMEQP-EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCCCCcHHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999866 55667778888887654 568999999999999999999999999999999854
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=292.42 Aligned_cols=239 Identities=24% Similarity=0.392 Sum_probs=189.4
Q ss_pred CCCCCce--eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAI--IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~--lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~l 232 (435)
.|++.+. ||+|+||.||++..+ +..+++|.+....... .|+..... .+||||+++++.+...+.+++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 3444444 599999999999975 6789999875432211 12222222 279999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~~ 311 (435)
||||+++++|.++++....++++++..++.|+++||.|||+.+ ++||||||+||++ +.++ .++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--eCCCCeEEEecCccceecCC
Confidence 9999999999999988778999999999999999999999988 9999999999999 6666 899999999876542
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcCCCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA--AKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 389 (435)
. ....++..|+|||++.+..++.++||||||+++|+|++|..||........ .........+......++
T Consensus 163 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 163 P--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred C--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 2 234578999999999988999999999999999999999999975543221 111111112222234689
Q ss_pred HHHHHHHHHHhhhcccCCCC-HHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPS-FLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps-~~~ll~~ 416 (435)
+.+++||.+||+.+|.+||+ +++++++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999999996 5888854
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=302.92 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=200.8
Q ss_pred CCC-CCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHH-----------HHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 158 DFS-SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL-----------VIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 158 ~~~-~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
+|. +.+.||.|+||+||++.++ ++.||+|.+......... ....+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 5578999999999999875 778999987543322100 01246789999999999999999999
Q ss_pred EEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+..++..++||||+. ++|.+++.....++++.+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill--~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFI--NSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEE--CCCCCEEECCc
Confidence 999999999999996 599999988778999999999999999999999988 9999999999999 88889999999
Q ss_pred cCcccccccCcc----------ccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 013833 304 GLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (435)
Q Consensus 304 g~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 372 (435)
|++......... .........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999766521100 00112234568899999998764 4688999999999999999999999887765544
Q ss_pred HHHHcCCC-C--C--------------C---------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 373 KYVAEGHR-P--F--------------F---------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 373 ~~~~~~~~-~--~--------------~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+..... + . . .....+.++.++|.+||+.+|++|||+.+++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 33321100 0 0 0 012357889999999999999999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=295.72 Aligned_cols=249 Identities=26% Similarity=0.499 Sum_probs=200.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||++.++ ++.||+|.+...... .....+..|+.++.+.. ||||+++++++.+....+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 37888999999999999999987 789999988654322 23355666777666664 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||+. ++|.+++.. .+.+++.++..++.|++.||.|||+ .+ |+||||+|+||++ +.++.++|+|||++..+..
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill--~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILL--DASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEE--cCCCCEEECccccchhccC
Confidence 99984 588887765 4578999999999999999999997 46 9999999999999 7888999999999876543
Q ss_pred cCccccccccCCCcCccccCccccCCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCCCC-
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFRA- 385 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~- 385 (435)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .+....+.....+....
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 168 SKA-----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred CCc-----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 221 12335788999999987554 78899999999999999999999976433 33334444443333222
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
..++.++++|+.+||..||++||++.+++.+-
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 24789999999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.86 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=221.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|.++++||+|+||.|..++++ ++-||+|++.+-..-+.....-|..|-.+|...+.+=|++++..|.+++++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 37999999999999999999986 5679999886532222222356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|||+||+|-.++.+.+++++..+..++..|+-||..||+.| +|||||||+|||+ |..|++||+|||.+..+...+.
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLl--d~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLL--DKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEe--cccCcEeeccchhHHhcCCCCc
Confidence 99999999999999889999999999999999999999999 9999999999999 9999999999999987764432
Q ss_pred cccccccCCCcCccccCccccC----C-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK----H-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKG 387 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 387 (435)
.......|||-|.+||++. + +.|++.+|+||+||++|||+.|..||....-.+.+..|......+.. ...
T Consensus 231 ---V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 231 ---VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred ---EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccc
Confidence 2455678999999999984 3 56899999999999999999999999988888888777765433322 356
Q ss_pred CCHHHHHHHHHHhhhcccCCCC---HHHHHHHH-------HHHHhhCCC
Q 013833 388 FTPELRELTEKCWAADMNQRPS---FLDILKRL-------EKIKETLPT 426 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps---~~~ll~~L-------~~~~~~~~~ 426 (435)
+|++.++||.+.+. +|+.|.. ++++..|- ..|++..|+
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 99999999999886 4778877 88888662 466665554
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=295.79 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=202.9
Q ss_pred CCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||++... ++.||+|.+.+.... .....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999998753 567999987643221 122345678999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++||||+.+++|.+++.....+++..+..++.|++.+|.|||+.+ ++||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEEECccccccc
Confidence 999999999999999987778999999999999999999999988 9999999999999 788899999999987654
Q ss_pred ccCccccccccCCCcCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~ 384 (435)
..... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||.... ..+....+.....+ .
T Consensus 157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (288)
T cd05583 157 AEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--F 231 (288)
T ss_pred ccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--C
Confidence 33211 112345789999999987655 7889999999999999999999996432 22333333333322 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+..++.++++++.+||+.+|++|||+.++...|.
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 3457899999999999999999999776655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=291.23 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=204.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC--cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+|.+.+.||+|+||.||++.+. +..+++|.++..... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999886 334566655432211 112224567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++ +. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili--~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFL--KN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEe--ec-CCEeecccCceeec
Confidence 999999999998864 346899999999999999999999988 9999999999999 43 56999999998765
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..+..+.. +..++
T Consensus 156 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (260)
T cd08222 156 MGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL-PETYS 230 (260)
T ss_pred CCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC-cchhc
Confidence 43221 12234578899999999888899999999999999999999999987777666666655554443 34688
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++.++|.+||+.+|++||++.+++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=299.75 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=197.0
Q ss_pred eeecC--CceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+| +||+||++.+. ++.||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 56666 99999999984 789999987654333 34457889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc
Q 013833 240 GDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 240 ~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++||||||+||++ +.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCcccc
Confidence 9999999864 34899999999999999999999988 9999999999999 7788999999986543322111100
Q ss_pred c---cccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 013833 318 Y---KMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----------- 381 (435)
Q Consensus 318 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------- 381 (435)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0 01112346679999999763 4789999999999999999999999876543332222111000
Q ss_pred ----------------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhh
Q 013833 382 ----------------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 423 (435)
Q Consensus 382 ----------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~ 423 (435)
......+++.+.+|+.+||+.||++|||+.+++++ +..+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 00012356789999999999999999999999866 5555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=300.84 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=198.1
Q ss_pred CCCCCceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe----CC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RK 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~ 228 (435)
+|++.+.||+|+||.||++.+. +..||+|.+...... ....+.+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4677889999999999999986 458999987643322 22346678899999999 59999999986432 24
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+++++|++. ++|.+++.....+++.+++.++.||+.||.|||+.| ++||||||+||++ +.++.++|+|||++..
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili--~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLV--NADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEE--cCCCCEEeCcCCCcee
Confidence 5789999985 699999988778999999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--------- 378 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------- 378 (435)
................|+..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 65432211112234568999999998765 56889999999999999999999999876543222211110
Q ss_pred ------------------CCCC--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 ------------------HRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ------------------~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.... .....++..+++|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0112357899999999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.32 Aligned_cols=147 Identities=31% Similarity=0.519 Sum_probs=134.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|.+.+.||+|+||.||+|.+. ++.||||++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 37888999999999999999987 7899999987655445555678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
||+.|++|.+++...+.+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl--~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEE--cCCCCEEEEeCCCCc
Confidence 99999999999988888999999999999999999999988 9999999999999 788899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=298.52 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=198.0
Q ss_pred CCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
+.+++.+|.|+++.||++..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.+....+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44556667777777777777789999999865422 23455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc-
Q 013833 239 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH- 315 (435)
Q Consensus 239 g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~- 315 (435)
+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEE--ecCCceEEecCccceeeccccccc
Confidence 99999999863 35889999999999999999999988 9999999999999 77889999999988765432210
Q ss_pred --ccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 013833 316 --DVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP---------- 381 (435)
Q Consensus 316 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------- 381 (435)
.........++..|+|||.+.. ..++.++|+|||||++|+|++|..||..............+..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 0001223457788999999875 35889999999999999999999999876543322111111100
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ----------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......++.++.+|+.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00011234678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.52 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=201.3
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEEE
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT 234 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 234 (435)
|++.+.||.|+||.||++.+. +..+++|.+.... ........+.+|+.+++.++|||++++++++.+. ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567789999999999999986 5789999987654 2222336678899999999999999999999887 8899999
Q ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++ +|.+++... ..+++.+++.++.||+.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILI--NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--cCCCCEEEccccceeeccCCC
Confidence 99965 899988765 57999999999999999999999988 9999999999999 888999999999998765432
Q ss_pred ccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---------- 382 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 1 11223456888999998764 457899999999999999999999998777554433332211000
Q ss_pred -------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.....+++++.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0001137889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.71 Aligned_cols=249 Identities=31% Similarity=0.530 Sum_probs=197.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe---------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------- 226 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 226 (435)
+|+.++.||+||||.||+++.+ |+.||||++.... .......+.+|+.+|++|+|||||+++..|.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 6788899999999999999976 9999999997654 44555788999999999999999998721100
Q ss_pred ---------------------------------------------------------------------C----------
Q 013833 227 ---------------------------------------------------------------------R---------- 227 (435)
Q Consensus 227 ---------------------------------------------------------------------~---------- 227 (435)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CcEEEEEecCCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHhcCC
Q 013833 228 -------------------------------KPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMAYLHNEP 275 (435)
Q Consensus 228 -------------------------------~~~~lv~e~~~g~sL~~~l~~~~~~-~~~~~~~~~~qi~~~l~~LH~~~ 275 (435)
..+||-||||+..+|.++++++... .....++++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1258999999987777777766544 57889999999999999999999
Q ss_pred CceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc--------------cCccccccccCCCcCccccCccccCCCC--
Q 013833 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV--------------QNSHDVYKMTGETGSYRYMAPEVFKHRK-- 339 (435)
Q Consensus 276 ~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 339 (435)
||||||||.||++ ++++.|||+|||+|..... ..+......++..||.-|+|||++.+..
T Consensus 718 --iIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred --eeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9999999999999 8889999999999988321 0011122345678999999999997654
Q ss_pred -CCCcchHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCCCCC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHH
Q 013833 340 -YDKKVDVFSFAMILYEMLEGEPPLA-NYEPYEAAKYVAEGHRPFF---RAKGFTPELRELTEKCWAADMNQRPSFLDIL 414 (435)
Q Consensus 340 -~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll 414 (435)
|+.|+|+||||++|+||+. ||. .+++..+...+.++..|.. .... -+.-+.+|.+|++.||.+||||.|||
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999985 454 3455566666666655553 1111 23457899999999999999999998
Q ss_pred HH
Q 013833 415 KR 416 (435)
Q Consensus 415 ~~ 416 (435)
+.
T Consensus 870 ~s 871 (1351)
T KOG1035|consen 870 NS 871 (1351)
T ss_pred hc
Confidence 63
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=296.32 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=199.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 228 (435)
+|++.+.||+|+||.||+|.++ ++.|++|.+........ ....+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 6888999999999999999985 67899998865432221 2246678999999999999999999886654
Q ss_pred ---cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 ---PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 ---~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
.+++|+||+++ +|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~kl~dfg 161 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILL--NNKGQIKLADFG 161 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCcEEeCccc
Confidence 78999999976 787777653 46899999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---HR 380 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~ 380 (435)
++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+....+... ..
T Consensus 162 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 162 LARLYNSEESR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccCCccc---ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99866543211 1122345778999998864 45788999999999999999999999876655444333221 10
Q ss_pred CC-------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PF-------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~-------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+. .....+|..+.+++.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0012468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.87 Aligned_cols=247 Identities=29% Similarity=0.471 Sum_probs=198.3
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEEeCCc----
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKP---- 229 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~---- 229 (435)
|++.+.||+|+||.||++.++ ++.||+|.+........ ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567789999999999999986 68899999865443322 224566777777665 59999999999987776
Q ss_pred -EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 230 -LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 230 -~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
.+++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili--~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILV--TSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEE--ccCCCEEEeccCcc
Confidence 8999999965 8999887643 4899999999999999999999988 9999999999999 77899999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP----- 381 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----- 381 (435)
........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+....+....+......
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 77643321 22335788999999999889999999999999999999999999887766554444321100
Q ss_pred -------------CCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -------------FFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -------------~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... ...+++.+.++|.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 01345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.25 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=204.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|...+.||+|+||.||+|.+. +..||+|.+....... .....+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888999999999999999874 7889999886543322 2235678899999999999999999988654 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+++|+||+. .+|..++. ..++++.+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll--~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAV--NEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCCCCcC
Confidence 4699999995 47777653 35899999999999999999999988 9999999999999 8889999999999875
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------- 380 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------- 380 (435)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 167 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4321 223457889999999876 4688899999999999999999999987765443322221100
Q ss_pred ---------------CCCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhhCCCCCccc
Q 013833 381 ---------------PFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPTDHHWN 431 (435)
Q Consensus 381 ---------------~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~~~~~~~~ 431 (435)
+..+ ....++++.+||.+||+.||++||++.+++.+ ++.+++..+....|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~ 314 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence 0001 12467889999999999999999999999976 888776544444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.10 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=202.5
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|++.+.||+|++|.||++.+. +..+++|.+....... .....+.+|+.++++++||||+++++++..+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567789999999999999975 7789999876544332 2346788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+++ +|.+++.. ...+++.++..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLI--NTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEE--CCCCcEEEeeeeeeEecCCCcc-
Confidence 965 88888876 457899999999999999999999988 9999999999999 7888999999999977654321
Q ss_pred ccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------------- 381 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------- 381 (435)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 154 ---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 ---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 12234578889999998776 7889999999999999999999999877765443332211000
Q ss_pred -------------C--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -------------F--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -------------~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....++.++++||.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0012367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=289.86 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=198.0
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEe
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 235 (435)
|++.+.||+|+||+||+|... +..|++|.+........ .....+|+..+++++ ||||+++++.+.++...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567789999999999999985 67899998865433211 133457899999999 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+ +++|.+++.... .+++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCCEEEeecccceeccCCC
Confidence 99 779999988754 6899999999999999999999988 9999999999999 888999999999997654322
Q ss_pred ccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF---------- 382 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
......++..|+|||.+. ...++.++|+||||+++|+|++|.+||......+....+.......
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 123346788999999875 4567899999999999999999999998776544433222110000
Q ss_pred -----------C-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....+..+.+++.+||+.+|++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 001236789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.01 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=202.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeC--CcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER--KPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 232 (435)
+|++.+.||+|+||.||+|.+. +..+++|.+........ ....+.+|+.+++++ +||||+++++++... ..+++
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 6888999999999999999975 67899998865433222 235677899999999 999999999987643 46899
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+. ++|.+++... .+++.....++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill--~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILL--NSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccchhccccc
Confidence 999996 5999998765 7889999999999999999999988 9999999999999 88899999999999866543
Q ss_pred Cccc-cccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------
Q 013833 313 NSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----------- 379 (435)
Q Consensus 313 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 379 (435)
.... ........|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 2210 012233468899999998764 567889999999999999999999998765443322221110
Q ss_pred ----------------CC--CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHH
Q 013833 380 ----------------RP--FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKI 420 (435)
Q Consensus 380 ----------------~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~ 420 (435)
.. ......++.++.++|.+||+.+|++|||+.+++++ +..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 00112368899999999999999999999999986 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.44 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=201.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36899999999999999999875 77899998854432 2233456889999999999999999999886543
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill--~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccccc
Confidence 358999999 7799988864 56899999999999999999999988 9999999999999 7888999999999976
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------ 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------ 381 (435)
.... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.+.........+......
T Consensus 168 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 168 TDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5322 223457889999999875 45888999999999999999999999876654332222111000
Q ss_pred ----------------CC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHh
Q 013833 382 ----------------FF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 382 ----------------~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
.. ....+++.+.++|.+||..||++|||+.+++.+ ++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00 013578889999999999999999999999954 555544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.49 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=196.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------- 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 227 (435)
.+|.+.+.||.|+||.||+|.++ +..|++|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 47899999999999999999985 67899998754432 2336678899999999999999999776543
Q ss_pred -------CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEE
Q 013833 228 -------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLK 299 (435)
Q Consensus 228 -------~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vk 299 (435)
...++||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.| ++||||||+||++ + .++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili--~~~~~~~k 155 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFI--NTEDLVLK 155 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCceEE
Confidence 35789999996 599888864 46899999999999999999999988 9999999999999 5 345789
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
|+|||++........... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.++.+....+...
T Consensus 156 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCcccccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999976543221111 1122357889999998754 56788999999999999999999999877655443332221
Q ss_pred C------------------------CCCC----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 H------------------------RPFF----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ~------------------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .+.. ....++.++.+||.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 1 0000 012467889999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=294.37 Aligned_cols=247 Identities=32% Similarity=0.512 Sum_probs=198.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-CCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 232 (435)
..+|++.+.||.|+||.||++.++ +..||+|.+.+..... ...+.+.+|+.+++.++||||+++++++.. +...++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 347899999999999999999875 6789999876543322 233667889999999999999999998865 567899
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
++||+ +++|.++++. ..+++..+..++.|+++||.|||+.+ ++||||+|+||++ +.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili--~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI--NENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeE--CCCCCEEeCccccccccCCC
Confidence 99998 6699988864 45788889999999999999999988 9999999999999 88889999999998754321
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-------------- 377 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-------------- 377 (435)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.+
T Consensus 162 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 162 -------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred -------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 123456888999998765 5689999999999999999999999987664322111110
Q ss_pred ----------CC--CCCC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 ----------GH--RPFF---RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 ----------~~--~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. .+.. ....++++++++|.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 012467899999999999999999999999977
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.16 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=197.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------- 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------- 227 (435)
.+|++.+.||+|+||.||++.++ ++.+++|.+......+.. ...+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-chhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 37899999999999999999985 678999987554332211 24567899999999999999999887543
Q ss_pred -CcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 -KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 -~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
..+++|+||+.+ +|...+.. ...+++.++..++.|+++||.|||++| ++|+||||+||++ +.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILI--DNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECcCcc
Confidence 346999999965 78777765 446999999999999999999999988 9999999999999 8889999999999
Q ss_pred cccccccCcccc-------ccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 013833 306 SKLIKVQNSHDV-------YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 306 a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 377 (435)
+........... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 986543321111 01122356888999998765 4588999999999999999999999987776544433322
Q ss_pred CCCC-------------C---------CC------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 GHRP-------------F---------FR------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 ~~~~-------------~---------~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.... . .. ...+++.+.++|.+||+.||++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1100 0 00 01345678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.29 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=203.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+.+-+..||.|+||+|++..++ |+..|||.+..... +...+++..|.....+ -+.||||+++|....++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3455668999999999999987 78899999975544 3334677778776544 46899999999988888999999
Q ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 235 e~~~g~sL~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
|.| ..||..+-+ +...+++..+-.+..-...||+||-+. -.||||||||+|||+ +..|.|||||||.+-.+
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILL--DRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEE--ecCCCEeeecccchHhH
Confidence 999 558876654 245688888888888999999999875 359999999999999 99999999999998766
Q ss_pred cccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCC-
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRA- 385 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~- 385 (435)
..+ ...+...|-..|||||.+.. ..|+-+|||||||++|||+.||..||.+.+ ..+...++..+..|.+..
T Consensus 219 v~S-----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 219 VDS-----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred HHH-----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 432 23445678899999999964 458899999999999999999999998765 456677788887765543
Q ss_pred ---CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 ---KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..++..+..||..||.+|-..||.+.+|++.
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3478999999999999999999999998764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=288.79 Aligned_cols=248 Identities=31% Similarity=0.504 Sum_probs=201.4
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|+..+.||+|+||.||+|... ++.+++|.+...... ....+.+.+|+.++++++|||++++++++.+....++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 556778999999999999985 688999988765422 22235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+. ++|.+++.+. ..+++.++..++.|++.||.|||+.+ |+||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEE--cCCCCEEEecCCcccccCCCcc-
Confidence 97 5999999876 57999999999999999999999988 9999999999999 7788999999999986643321
Q ss_pred ccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------------- 379 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------- 379 (435)
......++..|+|||.+.+. .++.++||||||+++|++++|..||......+....+....
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12234467789999998766 78999999999999999999999998766544333221100
Q ss_pred -----CCCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 -----RPFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 -----~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. ....++..+.++|.+||..+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 012347789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=291.60 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=206.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH----HHHHHHHHHHHHHHhCCCCcceeeeeeEE-eCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR----LVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 230 (435)
+|-.+.+||+|+|+.||++.+- .+.||+|+-.....-.+ .-.+..-+|.++.+.|.||.||++++++. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 6777889999999999999874 67899997543322221 22344568999999999999999999985 55778
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~ 309 (435)
|-|+|||+|.+|.-|++.+.-+++.++..|+.||+.||.||.+..++|||-||||.|||+.+ ...|.+||+|||++...
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999954 34578999999999988
Q ss_pred cccCcccc---ccccCCCcCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHH--HHHcCC
Q 013833 310 KVQNSHDV---YKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAK--YVAEGH 379 (435)
Q Consensus 310 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~--~~~~~~ 379 (435)
+......+ .......||.+|++||++.- .+.+.++||||+|||+|.++.|+.||.... ..++.. .|....
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt 703 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT 703 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce
Confidence 75532211 12345689999999999853 357889999999999999999999997543 222221 122221
Q ss_pred C-CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 R-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .+....-++.+.++||.+||+..-++|.+..+|..+
T Consensus 704 EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 704 EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1 122235689999999999999999999999888653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.29 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=200.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc-----
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----- 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 229 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+....... ...+.+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 36889999999999999999985 6789999876543222 233667789999999999999999987765544
Q ss_pred -EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 -~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++|+||+ +++|.+++.. ..+++.++..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill--~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAV--NEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEcccccccc
Confidence 89999999 6799999875 46999999999999999999999988 9999999999999 7888999999999976
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----- 382 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----- 382 (435)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+.+.....
T Consensus 168 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 5422 233457889999999865 467889999999999999999999998776655444332221100
Q ss_pred -----------------C-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----------------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----------------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....+++++.++|.+||..+|++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 012358899999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=297.33 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=204.1
Q ss_pred CceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.++||+|.||+||-|+++ |+.||||++.+........ ..+++|+.+|+++.||.||.+.-.++..+++++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 358999999999999875 8999999997765554433 7899999999999999999999999999999999999955
Q ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCccc
Q 013833 240 GDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 240 ~sL~~~l~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
++.+++- +.+++++.....++.||+.||.|||-++ |||+||||+|||+... .-..+||||||+|+.+....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 6666654 3678999999999999999999999988 9999999999999432 23479999999999887543
Q ss_pred cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHHHHH
Q 013833 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPELRE 394 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 394 (435)
-.....|||.|+|||++..+.|...-|+||+|||+|--++|..||...+ ++-.+|.....++.+ =..++++..+
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAID 797 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHH
Confidence 2345689999999999999999999999999999999999999998654 334445444333322 2468899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
||..+|+..-.+|-|.++-+.+
T Consensus 798 lIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 798 LINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHhcchHhhccc
Confidence 9999999999999999876643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=296.37 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=197.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++.+.||+|+||.||++.+. +..||+|.+...... ....+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999864 778999988654322 22335678899999999999999999987543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH 169 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--cCCCCEEEeccccccc
Confidence 468888887 78999888653 5899999999999999999999988 9999999999999 8888999999999875
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------- 380 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------- 380 (435)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 170 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 170 TDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4321 223467889999999866 5688899999999999999999999986654433222211000
Q ss_pred ---------------CCCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 381 ---------------PFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 381 ---------------~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+..+ ....++++.+||.+||+.||++||++.+++.+=
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 113578899999999999999999999999773
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.35 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=201.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
.-.|.....+|.|+|+.|..+.+. ++..++|++.+... +-.+|+.++... +||||+++++.+.++...|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 346777778999999999999875 67789998865522 224567565555 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||.+.|+-|.+.+.....+. .++..|+.+|+.|+.|||++| +|||||||+|||+. ++.++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeec-CCCCcEEEEEechhhhCchh
Confidence 999999998888887766555 788889999999999999998 99999999999994 47789999999999877654
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..+.+-|..|.|||+.....|++.+|+||||++||+|++|+.||...... ++...+..+.. . ..+|.+
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~---s-~~vS~~ 538 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF---S-ECVSDE 538 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc---c-cccCHH
Confidence 33456799999999999999999999999999999999999999876654 33333333222 1 578999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.++||..||+.||.+||++.++..+=..
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999877444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=278.53 Aligned_cols=218 Identities=20% Similarity=0.281 Sum_probs=180.2
Q ss_pred CCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCHHHH
Q 013833 168 GSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245 (435)
Q Consensus 168 G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~ 245 (435)
|.+|.||++.++ ++.+|+|.+.... ...+|...+....||||+++++++.+....+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999985 7789999886532 223455555667799999999999999999999999999999999
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCc
Q 013833 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325 (435)
Q Consensus 246 l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~g 325 (435)
+.+...+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++++|||.+...... .....+
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~-------~~~~~~ 144 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDS-------CDGEAV 144 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEecccchhccccc-------cccCCc
Confidence 988778999999999999999999999988 9999999999999 88889999999987655432 123345
Q ss_pred CccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhccc
Q 013833 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMN 405 (435)
Q Consensus 326 t~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 405 (435)
+..|+|||.+....++.++|+||+|+++|+|++|..|+...... +..... ...+..+++.++++|.+||+.||+
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTT-LNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccc-cCCcccCCHHHHHHHHHHccCCHH
Confidence 77899999998888999999999999999999999887643211 111111 112345789999999999999999
Q ss_pred CCCCH
Q 013833 406 QRPSF 410 (435)
Q Consensus 406 ~Rps~ 410 (435)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=302.99 Aligned_cols=247 Identities=32% Similarity=0.558 Sum_probs=212.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe-----CCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-----RKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~~ 229 (435)
.|++..+||.|.+|.||+++.+ ++.+|+|+.......+ +++..|.++++.+ .|||++.+++++.. +++
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 4667789999999999998864 8889999876544333 5567788999888 59999999998743 578
Q ss_pred EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 230 LMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
+|||||||.|||..|+++. ...+.++.+..|++.++.||.+||... ++|||||-.|||+ ..++.|||+|||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLL--T~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLL--TENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEE--eccCcEEEeeeeeee
Confidence 9999999999999999985 446899999999999999999999955 9999999999999 888999999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
.+..... ...+..|||.|||||++.. ..|+..+|+||||++..||..|.+|+.++.+......|..+.+|.
T Consensus 172 QldsT~g----rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 172 QLDSTVG----RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeecccc----cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 8765433 4567889999999999964 357789999999999999999999999999998888887777766
Q ss_pred CC-CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 FR-AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+. +...+.+|-+||+.||.+|.++||+..+++++
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 55 46788999999999999999999999998854
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.53 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=199.1
Q ss_pred CCCCCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-CCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 230 (435)
.|+....||+|.||.||++..+ ...+|||.++.+...+. .....-+|+.+++.++||||+.+..++.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 6888899999999999999643 23689998876533322 12445689999999999999999998876 7889
Q ss_pred EEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC--CCCcEEEeec
Q 013833 231 MLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDF 303 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~--~~~~vkl~Df 303 (435)
++++||.+. +|++.|+-+ ..++...+..+++||+.|+.|||+.- |+||||||.||||.-+ +.|.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999977 999998742 34899999999999999999999976 9999999999999322 2389999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCH---------HHHHH
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEP---------YEAAK 373 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---------~~~~~ 373 (435)
|+++.+..+-. ..+.......|.+|.|||.+.+. -|+...|||++|||+.||+|-.+-|.+.+. .+...
T Consensus 181 GlaR~~~~plk-pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 181 GLARLFNNPLK-PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred cHHHHhhcccc-ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99998876532 22234455689999999998765 588999999999999999998887754331 11111
Q ss_pred HHHcCC-C------------CCC------------CC----------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 374 YVAEGH-R------------PFF------------RA----------KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 374 ~~~~~~-~------------~~~------------~~----------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+|.+-. . |.. .. ..-++...+|+..+|+.||.+|.|+.|.+++.=
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111100 0 000 00 112345779999999999999999999998754
Q ss_pred HHHhhCC
Q 013833 419 KIKETLP 425 (435)
Q Consensus 419 ~~~~~~~ 425 (435)
=..+.++
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 4344343
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=299.12 Aligned_cols=253 Identities=27% Similarity=0.467 Sum_probs=196.0
Q ss_pred CCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------CcEE
Q 013833 160 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KPLM 231 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~ 231 (435)
...+.||+|+||.||+++++ |..||||.+.+..... ..++.-+|+++|++++|||||++++.-++. +...
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 33468999999999999975 8899999987644322 236788999999999999999999875443 3568
Q ss_pred EEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC--cEEEeeccCc
Q 013833 232 LITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLS 306 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~--~vkl~Dfg~a 306 (435)
+|||||.||||..++++.. .+++.+++.++..+..||.|||+.| ||||||||.||++-...+| .-||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998632 4999999999999999999999977 9999999999999544434 5799999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-H---HHHHHHHHcCC--
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE-P---YEAAKYVAEGH-- 379 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~---~~~~~~~~~~~-- 379 (435)
+.++... ......||..|.+||.+-. +.|+..+|.|||||++|++.||..||.... + .+....+....
T Consensus 172 rel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 172 RELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9877543 4567889999999999984 889999999999999999999999994322 1 11221111111
Q ss_pred -----------CC------CCCCCCCCHH----HHHHHHHHhhhcccCCC--CHHHHHHHHHHHH
Q 013833 380 -----------RP------FFRAKGFTPE----LRELTEKCWAADMNQRP--SFLDILKRLEKIK 421 (435)
Q Consensus 380 -----------~~------~~~~~~~~~~----l~~li~~cl~~dp~~Rp--s~~~ll~~L~~~~ 421 (435)
.| ...+..+++. +-.++..+|..+|.+|. .+.+....+..|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 00 0112223333 45678889999999998 7777766666554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.88 Aligned_cols=256 Identities=32% Similarity=0.559 Sum_probs=200.8
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcceeeeeeEEeC----CcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTER----KPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~~~ 231 (435)
+..+.+.||+|.||+||+|.|+|..||||++... ++ ..+.+|.++.+. |+|+||+.+++.-..+ .+++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEeccc---ch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 4567789999999999999999999999998432 21 567778888775 5999999998764332 3689
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-----C-CceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-----P-NVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-----~-~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
||++|.+.|||.|||.+ ..++.+..++++..+++||.+||.. | +.|.|||||+.|||| ..++...|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEEEeecee
Confidence 99999999999999988 4689999999999999999999973 2 449999999999999 8889999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCC----CC--CcchHHHHHHHHHHHHcC----------CCCCCCCCHH
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK----YD--KKVDVFSFAMILYEMLEG----------EPPLANYEPY 369 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~slG~il~~l~tg----------~~p~~~~~~~ 369 (435)
|.........-....+...||.+|||||++.... +. ..+||||||+++||+..+ +.||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9877665433333456678999999999997542 22 469999999999999753 4677654332
Q ss_pred ----HHHHHHH--cCCCCCCCCC-CCCH---HHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 370 ----EAAKYVA--EGHRPFFRAK-GFTP---ELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 370 ----~~~~~~~--~~~~~~~~~~-~~~~---~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+..+.+. +..+|.++.. .-.+ .+.++++.||..+|.-|.|+-.+-+.|.++.+
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222221 3445554432 1222 46788999999999999999999999998875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=250.42 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=204.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|...++||+|.||+|++++.+ +.-||+|.++-...++ ..-....+|+-+++.++|.||++++++...++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 5677789999999999999875 5679999886544332 222456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||.. +|..|..+ ++.++.+.+..++.|+++||.++|+++ +.|||+||+|.|+ +.+|.+|++|||+++.+..+-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnlli--n~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLI--NRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEe--ccCCcEEecccchhhhcCCceE
Confidence 9954 99999876 788999999999999999999999988 9999999999999 9999999999999998764421
Q ss_pred cccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF---------- 382 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
-......|.+|.+|.++.+. -|+++.|+||-||++.|+.. |.+-|++.+..+..+.+......+
T Consensus 157 ----cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ----eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 23345679999999998764 58999999999999999998 888899888777666554321110
Q ss_pred ---------CCC--------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 ---------FRA--------KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ---------~~~--------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++. ..+...-+++++.+|.-+|..|.+++..+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 000 1122346899999999999999999998875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.98 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=204.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.-|..++.||-|+||+|.++... ...+|+|.+.+...-.+..+...+.|-.||..-..+-||+++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35677889999999999998754 4468999998776666677788899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
+|++||++-.+|.+-+-|.++.+..++.++..|+++.|..| +|||||||+|||| |.+|+|||+||||+.-+.=...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILI--DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEE--ccCCceeeeeccccccceeccc
Confidence 99999999999999999999999999999999999999999 9999999999999 9999999999999875532111
Q ss_pred ccccc--------------------------------------ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHH
Q 013833 315 HDVYK--------------------------------------MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356 (435)
Q Consensus 315 ~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 356 (435)
..+++ .....||+.|+|||++....|+..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00000 1123699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCHHHHHHHHHHhhhcccCCC
Q 013833 357 LEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELRELTEKCWAADMNQRP 408 (435)
Q Consensus 357 ~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 408 (435)
+.|++||...++.+...++.... ..+....++++++.++|.++.. +++.|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999888776655443221 1222346789999999876543 345553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.65 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=200.3
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcceeeeeeEEeCC----cEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~ 231 (435)
..+...+||+|.||.||+|..+++.||||++.. ...+.|.+|-++.+. ++|+||+++++.-..+. .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677899999999999999999999998842 334678888877765 57999999998765544 789
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-------CCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-------PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-------~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
||++|.+.|||.+||+.+ .+++.+..+++..+++||.|||+. .++|+|||||+.|||| ..+++..|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEeeccc
Confidence 999999999999999865 589999999999999999999984 2459999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCC-CC-----CcchHHHHHHHHHHHHcCCCCCC-CC-----------
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD-----KKVDVFSFAMILYEMLEGEPPLA-NY----------- 366 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~~l~tg~~p~~-~~----------- 366 (435)
+|..+.+..... ...+..||.+|||||++.+.. +. .+.||||+|.++|||+++..-+. +.
T Consensus 362 LAl~~~p~~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred eeEEecCCCCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999887553321 233478999999999986532 22 46899999999999998754332 10
Q ss_pred -----CHHHHHHH-HHcCCCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 367 -----EPYEAAKY-VAEGHRPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 367 -----~~~~~~~~-~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
.-.+.... +.+..||.++. ......+++.+..||..||+-|.|+.=+.+.+.++...-
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 01122333 33444554432 122356899999999999999999999998888877543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.16 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=190.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|...++||+|+||.||+|.++ +..||+|.+...... ...|++.+++++||||+++++++.+....++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3556678999999999999974 778999987543221 1346888999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++|+|.++++. +++.++..++.|+++||+|||.. .++|+||||||+||++ +.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-ecccccccc---
Confidence 9999999999963 88999999999999999999943 1339999999999999 766667664 665443221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHc------CCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-----YEAAKYVAE------GHRPFF 383 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~------~~~~~~ 383 (435)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... .+..+.... ..++..
T Consensus 835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 1123578999999999999999999999999999999999999853211 111111100 011111
Q ss_pred CC-C----CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 384 RA-K----GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 384 ~~-~----~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.. . ....++.+++.+||+.||++|||+.++++.|+++....+.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 10 0 1123577899999999999999999999999999775443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=264.02 Aligned_cols=236 Identities=37% Similarity=0.606 Sum_probs=200.4
Q ss_pred CceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCHHHHH
Q 013833 169 SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246 (435)
Q Consensus 169 ~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l 246 (435)
+||.||++.+. +..+++|.+........ .+.+.+|++.+++++|+||+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999986 58899998865443322 478899999999999999999999999989999999999999999999
Q ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcC
Q 013833 247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326 (435)
Q Consensus 247 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt 326 (435)
.....++...+..++.+++.++.+||+.+ ++|+||+|.||++ +.++.++|+|||.+....... ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~ 149 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILL--DEDGHVKLADFGLARQLDPGG-----LLTTFVGT 149 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEE--CCCCcEEEccccceeeecccc-----ccccccCC
Confidence 87666899999999999999999999988 9999999999999 777899999999998765432 22345678
Q ss_pred ccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCC-CCHHHHHHHHHHhhhcc
Q 013833 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKG-FTPELRELTEKCWAADM 404 (435)
Q Consensus 327 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp 404 (435)
..|++||.+....++.++|+||||++++++++|..||.. .........+............ ++.++.+++.+||..+|
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 899999999988899999999999999999999999987 4444444544444433322222 88999999999999999
Q ss_pred cCCCCHHHHHH
Q 013833 405 NQRPSFLDILK 415 (435)
Q Consensus 405 ~~Rps~~~ll~ 415 (435)
++||++.++++
T Consensus 230 ~~Rp~~~~~~~ 240 (244)
T smart00220 230 EKRLTAEEALQ 240 (244)
T ss_pred hhccCHHHHhh
Confidence 99999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.96 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=193.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--C----cceeeeeeEEeC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--P----NIVQFLGAVTER 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~iv~~~~~~~~~ 227 (435)
..+|.++..+|+|.||.|-.+.+. +..||||+++.- ....+..+-|+++|+++.+ | -++++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 458999999999999999999986 568999987432 1122445678999999942 2 277788889999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC------------
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS------------ 293 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~------------ 293 (435)
++.|||+|.+ |.|+.++++.++ +++..++..++.||++++.+||+.+ ++|-||||+|||+++.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCcc
Confidence 9999999988 889999998765 5889999999999999999999977 9999999999999521
Q ss_pred ------CCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 013833 294 ------SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (435)
Q Consensus 294 ------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 367 (435)
.+..|+++|||.|+..... ......|..|.|||++.+-+++.++||||+||||+|+.+|..-|...+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC-------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 1235999999999865432 234567999999999999999999999999999999999999997666
Q ss_pred HHHHH---HHHHcCC-----------------CCCCCC---------------------CCCC---HHHHHHHHHHhhhc
Q 013833 368 PYEAA---KYVAEGH-----------------RPFFRA---------------------KGFT---PELRELTEKCWAAD 403 (435)
Q Consensus 368 ~~~~~---~~~~~~~-----------------~~~~~~---------------------~~~~---~~l~~li~~cl~~d 403 (435)
..+.. +.+.... +..++. ...+ .++.+|+.+||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 43311 1111100 000000 0011 24789999999999
Q ss_pred ccCCCCHHHHHHH
Q 013833 404 MNQRPSFLDILKR 416 (435)
Q Consensus 404 p~~Rps~~~ll~~ 416 (435)
|.+|+|+.|++++
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=267.08 Aligned_cols=243 Identities=23% Similarity=0.390 Sum_probs=203.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|.++++||+|+|+.|.++.++ .+-+|+|+++++...+.+-+.-.+.|-.+..+. +||++|-++..|..+.++++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 37899999999999999999876 567999999888777665555566777777666 699999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
.||++||+|--.+.+...++++.+..+..+|+-||.|||++| ||+||||.+|||+ +..|++||+|+|+++.--.++
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvll--daeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEE--ccCCceeecccchhhcCCCCC
Confidence 999999999888888888999999999999999999999999 9999999999999 999999999999997543332
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHcCCCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-------YEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~-------~~~~~~~~~~~~~~~~~~~~~ 386 (435)
. ...+++|||.|.|||++.+..|+.+.|+|+|||+++||+.|+.||+- .+..+...++.-..... .+.
T Consensus 406 d----~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-ipr 480 (593)
T KOG0695|consen 406 D----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-IPR 480 (593)
T ss_pred c----ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-ccc
Confidence 2 45678999999999999999999999999999999999999999952 22233332222111111 234
Q ss_pred CCCHHHHHHHHHHhhhcccCCC
Q 013833 387 GFTPELRELTEKCWAADMNQRP 408 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rp 408 (435)
.++-....+++..|.+||.+|.
T Consensus 481 slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhc
Confidence 5677788999999999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=246.71 Aligned_cols=223 Identities=27% Similarity=0.492 Sum_probs=183.0
Q ss_pred CCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
....+..||+|++|.|-+.++ .|+-.|+|.+....... ..+++.+|+.+..+. .+|++|.++|.+.....++|.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 445566899999999887776 48899999987655432 236777888877665 6899999999998888999999
Q ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 235 EYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 235 e~~~g~sL~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|.| ..||..+-+ +.+.+++..+-+++..+..||.|||++ -.+||||+||+|||+ +..|+||+||||.+-.+.
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI--NYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE--ccCCcEEEcccccceeeh
Confidence 999 558876644 466799999999999999999999997 459999999999999 999999999999997665
Q ss_pred ccCccccccccCCCcCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~ 385 (435)
.+- ..+...|-..|||||.+.. ..|+-++||||||+++.||.+++.||+. .++.+..+++.+...|.++.
T Consensus 201 dSi-----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 201 DSI-----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhh-----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 331 2233567889999999853 4788999999999999999999999975 46888889999888777666
Q ss_pred CCCCHH
Q 013833 386 KGFTPE 391 (435)
Q Consensus 386 ~~~~~~ 391 (435)
..+|++
T Consensus 276 ~~FS~e 281 (282)
T KOG0984|consen 276 DTFSPE 281 (282)
T ss_pred cccCCC
Confidence 555543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.60 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=199.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 226 (435)
..|....+||+|.||+||+++.+ |+.||+|++.-+..+.... ....+|+.+|..++|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 36777889999999999999875 6778988654322222111 334679999999999999998876632
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
...+|+||++|+. +|.-++... ..++..++..++.+++.||.|+|+.. |+|||+||+|+|+ +.+|.+||+|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLI--t~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLI--TKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEE--cCCceEEeecccc
Confidence 2348999999976 888888654 46999999999999999999999976 9999999999999 9999999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---HRP 381 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~ 381 (435)
++.+...........+....|.+|.+||.+.+ +.|+++.|||+-||++.||+||.+-+.+.+.......|+.- ..+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98776543322222344567999999999875 57999999999999999999999988776654443333211 000
Q ss_pred C------------------CCC------------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 382 F------------------FRA------------KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 382 ~------------------~~~------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
. .+. -.-+++..+|+..+|..||.+|+++++++++--=.++
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 000 0113577899999999999999999999977544443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=265.90 Aligned_cols=261 Identities=25% Similarity=0.467 Sum_probs=220.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE-EeC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TER 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 227 (435)
.-+++...++-+|.||.||.|.|. .+.|.+|.++.. ..+.++..+..|.-++..+.|||+.++.++. ++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 335667778899999999999875 235777766433 2355678899999999999999999999986 445
Q ss_pred CcEEEEEecCCCCCHHHHHH-----H---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEE
Q 013833 228 KPLMLITEYLRGGDLHKYLK-----E---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~-----~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vk 299 (435)
...+.++.++.-|+|..|+. + ...++..+...++.|++.|++|||+.+ +||.||...|.++ ++.-+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvI--dd~LqVk 436 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVI--DDQLQVK 436 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhccee--hhheeEE
Confidence 67788889998899999997 2 123677788889999999999999998 9999999999999 8888999
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~ 378 (435)
|+|=.+++.+-+..-+.. -.....+..||+||.+....|+..+|||||||++|||+| |+.||...++.+....+.+|
T Consensus 437 ltDsaLSRDLFP~DYhcL--GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCL--GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred eccchhccccCccccccc--CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999987765432111 112346789999999999999999999999999999999 99999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 379 HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 379 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
++.- ++.+||+++..++..||...|++||+++|+...|.++..++.
T Consensus 515 yRla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 515 YRLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ceec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 9865 556899999999999999999999999999999999887664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.84 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=202.2
Q ss_pred CCCCCCceeecCCce-eEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFG-EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+-|...+++|.|+.| .||+|.+.|+.||||++..+ ......+|+..|+.- +|||||++++.-.+....||..
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 345556789999997 57999999999999988532 224567899999887 5999999999888889999999
Q ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec---CCCCcEEEeeccCcc
Q 013833 235 EYLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSK 307 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~---~~~~~vkl~Dfg~a~ 307 (435)
|.|.. +|.+++...+. ...-..+.++.|+++||.+||+.+ ||||||||+||||.- +...+++|+|||++.
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99955 99999986411 111345678899999999999988 999999999999943 344579999999999
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC-C
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR-A 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 385 (435)
.+....+. .....+..||-+|+|||++....-+..+|||||||++|+.++ |.+||.+.-.. ...|..+...... .
T Consensus 660 kl~~~~sS-~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 660 KLAGGKSS-FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE 736 (903)
T ss_pred ccCCCcch-hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec
Confidence 88765443 223567789999999999998888889999999999999999 58999865433 2234444322211 1
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHH------------HHHHHHhhCCCC
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILK------------RLEKIKETLPTD 427 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~------------~L~~~~~~~~~~ 427 (435)
.....+.++||.+|+.++|..||+|.+++. .|.++.+++..+
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e 790 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE 790 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence 111228899999999999999999999984 356666666653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=273.88 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=179.5
Q ss_pred CCCCCCCceeecCCceeEEEEEE------------------CCCcEEEEEccCCCCCcHH-----------HHHHHHHHH
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW------------------RGTPVAIKRILPSLSDDRL-----------VIQDFRHEV 206 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~------------------~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~ 206 (435)
..+|++.++||+|+||+||+|.. +++.||||.+......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44899999999999999999964 2457999987543211100 012234577
Q ss_pred HHHHhCCCCcc-----eeeeeeEEe--------CCcEEEEEecCCCCCHHHHHHHcC-----------------------
Q 013833 207 NLLVKLRHPNI-----VQFLGAVTE--------RKPLMLITEYLRGGDLHKYLKEKG----------------------- 250 (435)
Q Consensus 207 ~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~~----------------------- 250 (435)
.++.+++|.++ +++++++.. ....++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 566666543 345799999999999999886421
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccc
Q 013833 251 -ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329 (435)
Q Consensus 251 -~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 329 (435)
.+++..+..++.|++.+|.|||+.+ |+||||||+|||+ +.++.+||+|||++........ .......+++.|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y 376 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRY 376 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEE--CCCCcEEEEeCcCccccccCCc---cCccccCCCcce
Confidence 1345678889999999999999988 9999999999999 7788999999999975543211 111123458899
Q ss_pred cCccccCCCC--------------------CC--CcchHHHHHHHHHHHHcCCC-CCCCCCHHHHH-----------HHH
Q 013833 330 MAPEVFKHRK--------------------YD--KKVDVFSFAMILYEMLEGEP-PLANYEPYEAA-----------KYV 375 (435)
Q Consensus 330 ~aPE~~~~~~--------------------~~--~~~Dv~slG~il~~l~tg~~-p~~~~~~~~~~-----------~~~ 375 (435)
+|||.+.... ++ .+.||||+||++|+|++|.. ||.+....... +.+
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875332 11 24799999999999999875 77543221111 111
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcc---cCCCCHHHHHHH
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADM---NQRPSFLDILKR 416 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~ll~~ 416 (435)
......+......++..++|+.+||..+| .+|+|+.|+++|
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111121224578899999999999876 689999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.16 Aligned_cols=246 Identities=19% Similarity=0.207 Sum_probs=165.3
Q ss_pred CCCCCCCceeecCCceeEEEEEEC------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeee------
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA------ 223 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------ 223 (435)
..+|.+.+.||+|+||.||+|.+. +..||+|.+...... +...+| .++...+.++..+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 347899999999999999999974 568999987532211 111111 1111122222222211
Q ss_pred EEeCCcEEEEEecCCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCC
Q 013833 224 VTERKPLMLITEYLRGGDLHKYLKEKGA--------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~--------------------~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dl 283 (435)
...+...++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL 281 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV 281 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence 2455678999999999999999875321 123445679999999999999988 999999
Q ss_pred CCCcEEEecCC-CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCC----------------------CC
Q 013833 284 KPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR----------------------KY 340 (435)
Q Consensus 284 kp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 340 (435)
||+|||+ +. ++.+||+|||+|..+..... +......+++.|+|||.+... .+
T Consensus 282 KP~NILl--~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 282 KPQNIIF--SEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred CHHHEEE--eCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999 54 57899999999986543221 123456789999999975322 23
Q ss_pred CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------CCCCCC---------CCCCHHHHHHHHHHhh
Q 013833 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----------RPFFRA---------KGFTPELRELTEKCWA 401 (435)
Q Consensus 341 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~---------~~~~~~l~~li~~cl~ 401 (435)
+.++|||||||++|||+++..|+.... ......+.... .+...+ ...+....+||.+||+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 446799999999999999776654321 11111111110 000000 0112345689999999
Q ss_pred hcccCCCCHHHHHHH
Q 013833 402 ADMNQRPSFLDILKR 416 (435)
Q Consensus 402 ~dp~~Rps~~~ll~~ 416 (435)
+||++|||+.++++|
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=266.89 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=200.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC------CCcceeeeeeEEeCC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------HPNIVQFLGAVTERK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 228 (435)
.+|.+....|+|-|++|..|.+. |..||||+|... +..-+.=..|+++|++|+ --|++.++..|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 37888888999999999999985 789999998653 222244467999999996 357899999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
++|||+|.+ ..+|.+++++.|. +....+..++.|+.-||..|-.+| |+|.||||+||||. .....+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN-E~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN-ESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec-cCcceeeeccCcc
Confidence 999999988 5599999998663 788889999999999999999998 99999999999983 3445799999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR- 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 384 (435)
|....... .+....+..|.|||++.+..|+...|+||+||+||||.||+..|++.+.....+...+...++..
T Consensus 584 A~~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 584 ASFASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 98776443 22334577899999999999999999999999999999999999998877665554433222210
Q ss_pred ---------------------------------------C-----------CCCC-------HHHHHHHHHHhhhcccCC
Q 013833 385 ---------------------------------------A-----------KGFT-------PELRELTEKCWAADMNQR 407 (435)
Q Consensus 385 ---------------------------------------~-----------~~~~-------~~l~~li~~cl~~dp~~R 407 (435)
| ..+| ..|++|+..||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0 0011 348899999999999999
Q ss_pred CCHHHHHHH
Q 013833 408 PSFLDILKR 416 (435)
Q Consensus 408 ps~~~ll~~ 416 (435)
.|..|+|+|
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=267.62 Aligned_cols=207 Identities=28% Similarity=0.425 Sum_probs=177.7
Q ss_pred CcccCCC-CCCCCCCceeecCCceeEEEEEECC--CcEEEEEccCCCCCcHHHHHH-----HHHHHHHHHhCC---CCcc
Q 013833 149 DWEIDPS-ELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLR---HPNI 217 (435)
Q Consensus 149 ~~~~~~~-~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~-----~~~E~~~l~~l~---h~~i 217 (435)
.|+...+ ..+|...+.+|.|+||.|+.|.++. ..|+||.+.++..-...++++ .-.|+.+|..++ |+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 4444433 3378999999999999999999974 469999987765443333333 447999999997 9999
Q ss_pred eeeeeeEEeCCcEEEEEecC-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 218 VQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~-~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
++++++|++++.+||+||.- +|-+|++++..++.+++.++..|++|++.|+++||++| |||||||-+||.+ +++|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv--d~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV--DSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEE--ecCC
Confidence 99999999999999999965 45699999999999999999999999999999999999 9999999999999 9999
Q ss_pred cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLAN 365 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~ 365 (435)
-+||+|||.|....+.. ...+.||..|.|||++.+.+| +..-|||+||++||.++....||.+
T Consensus 708 ~~klidfgsaa~~ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eEEEeeccchhhhcCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999998776543 345689999999999999887 4678999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=237.52 Aligned_cols=251 Identities=23% Similarity=0.422 Sum_probs=194.7
Q ss_pred CCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC--CcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~ 231 (435)
.+|++.+++|+|-+++|+.|.. ....++||++++ ...+.+.+|+.+|+.|. ||||+++++...+. ....
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4799999999999999999984 467899998753 33477899999999997 99999999998664 5678
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
+++||+++.+...+. +.++...+..++.+++.||.|||++| |+|||+||+|+++.. ..-.++|+|+|+|.+..+
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh-~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeech-hhceeeeeecchHhhcCC
Confidence 999999886655544 45888999999999999999999999 999999999999932 334799999999998876
Q ss_pred cCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHc------------
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLA-NYEPYEAAKYVAE------------ 377 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~------------ 377 (435)
...-+ -...+..|..||.+-. ..|+.+-|+|||||++..|+..+.||. +.+..+....+.+
T Consensus 186 ~~eYn-----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 186 GKEYN-----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred Cceee-----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 54322 2345677899999854 568899999999999999999988874 3333222211111
Q ss_pred ----------------CCCCC----C---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhhC
Q 013833 378 ----------------GHRPF----F---RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETL 424 (435)
Q Consensus 378 ----------------~~~~~----~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~ 424 (435)
..+.. . ...-++++..+|+..+|..|..+|+|+.+.+.+ +..+.+..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 00000 0 112356899999999999999999999999866 45555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=275.49 Aligned_cols=248 Identities=27% Similarity=0.491 Sum_probs=213.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|+...++|+|.+|.||+++++ +...|+|.++-....+ ..-+.+|+-+++.++||||+-+++.+...+.++|+||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 7888899999999999999985 7889999886544433 3566789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||.||+|.+.-+-.+++++.++...+++.++||.|||++| =+|||||-.|||+ .+.|.+|+.|||.+-.+...
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanill--td~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILL--TDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceee--cccCceeecccCchhhhhhh---
Confidence 9999999999888899999999999999999999999998 7899999999999 88889999999988766532
Q ss_pred ccccccCCCcCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFR--AKGFT 389 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~ 389 (435)
..+...++||+.|||||+- ..+.|...+|+|++|++..|+-.-++|..+..+........+.. .|+.. ....+
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 2245668999999999986 35678999999999999999999999988888877666555433 22211 24578
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.|.+|++.||.++|++||+++.+|.+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheec
Confidence 889999999999999999999988753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=250.45 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=198.9
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----CcEE
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPLM 231 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 231 (435)
.+-.+-||.|+||.||.+.+. |+.|++|++..-. ..-...+++.+|+.+|.-++|.||+..++...-. ..+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344568999999999999874 8899999875432 2234457889999999999999999998865432 2357
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
+++|.| ..+|...+-+...++.+.+.-++.||++||.|||+.+ |.||||||.|.|+ +++-.+||||||+++..+.
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLV--NSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLV--NSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEe--ccCceEEecccccccccch
Confidence 888988 5599999988888999999999999999999999988 9999999999999 9999999999999997765
Q ss_pred cCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----------- 379 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 379 (435)
... ..++....|..|.|||++.+ +.|+...||||+||++.||+.++.-|...++.+..+.|.+-.
T Consensus 209 d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 432 23455667899999999876 568999999999999999999999998777765544433211
Q ss_pred -------------CCCCCC--------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 380 -------------RPFFRA--------KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 380 -------------~~~~~~--------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+++..+ ..-..+...++..+|.+||++|.+..+.+.++-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111000 011235667888899999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=255.44 Aligned_cols=129 Identities=29% Similarity=0.409 Sum_probs=109.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--------CCcceeeeeeEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVTE 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~~ 226 (435)
.+|.+.++||.|.|++||+|.+. .+.||+|+.+... .-.+....|+.+|++++ ..+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 58899999999999999999986 5689999875332 22355678999999884 2479999999854
Q ss_pred ----CCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEe
Q 013833 227 ----RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291 (435)
Q Consensus 227 ----~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~ 291 (435)
+.++|+|+|++ |.+|..+|.. ...++...+..|++||+.||.|||++ .+|||-||||+|||++
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeee
Confidence 56899999999 7799999986 34599999999999999999999997 4599999999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=244.23 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=196.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|.-++-+|.|.- .|..+.+. +++||+|+...+... ....++..+|..++..++|+||++++.++.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 46777788899988 66666654 889999988666443 33346778999999999999999999988543 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+|||+|. .+|.+++.. .++..++..++.|++.|+.|||+.| |+||||||+||++ ..+..+||.|||+|+.
T Consensus 95 e~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv--~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVV--NSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCccccee--cchhheeeccchhhcc
Confidence 4799999994 599998873 4788999999999999999999988 9999999999999 8889999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--------- 379 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 379 (435)
.... ..++....|..|.|||++.+..|.+.+||||+||++.||++|..-|++.+..+..-++.+..
T Consensus 168 e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 168 EDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 5533 23556678999999999999889999999999999999999999998766543322211110
Q ss_pred ------------CCC---------CCC---------C-CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------------RPF---------FRA---------K-GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------------~~~---------~~~---------~-~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++. ++. . .-...+++++.+||..||++|.|++++|+|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 000 0 112347899999999999999999999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-30 Score=233.22 Aligned_cols=210 Identities=42% Similarity=0.721 Sum_probs=183.4
Q ss_pred eecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 165 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
||+|++|.||++... +..+++|.+....... ..+.+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999987 7899999886543321 346789999999999999999999999998999999999998999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCcccccccCccccccc
Q 013833 243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKM 320 (435)
Q Consensus 243 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~ 320 (435)
.+++... ..++...+..++.+++.++.+||+.+ ++|+||+|.||++ +. ++.++|+|||.+........ ..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcc----hh
Confidence 9999875 46899999999999999999999988 9999999999999 66 78999999999986654321 12
Q ss_pred cCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHH
Q 013833 321 TGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399 (435)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 399 (435)
....+...|++||.+... .++.++|+|++|++++++ ..+.+++..|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~ 197 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKM 197 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHH
Confidence 234578889999999877 888999999999999999 6789999999
Q ss_pred hhhcccCCCCHHHHHHHH
Q 013833 400 WAADMNQRPSFLDILKRL 417 (435)
Q Consensus 400 l~~dp~~Rps~~~ll~~L 417 (435)
++.+|++||++.++++++
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=228.41 Aligned_cols=213 Identities=35% Similarity=0.608 Sum_probs=179.2
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
|.+.+.||.|++|.||++... +..+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 456788999999999999986 578999988654332 2457889999999999999999999999998999999999
Q ss_pred CCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+.+++|.+++..... +++..+..++.+++.++.+||+.+ ++|+||+|.||++ +..+.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILL--GMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeCceeeEecCcccc
Confidence 999999999988666 899999999999999999999988 9999999999999 77789999999999876543210
Q ss_pred ccccccCCCcCccccCcccc-CCCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHH-HHHHHHHcCCC
Q 013833 316 DVYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPY-EAAKYVAEGHR 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~-~~~~-~~~~~~~~~~~ 380 (435)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+.. ...+.+..+..
T Consensus 155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 12334577889999998 667788899999999999999999999977 3443 55555655543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=227.52 Aligned_cols=245 Identities=21% Similarity=0.376 Sum_probs=188.7
Q ss_pred CCCCCceeecCCceeEEEEEECC--CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeee-EEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGA-VTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~lv 233 (435)
.|.+.+.||+|-||.+.++.+++ +.+++|.+.++.. .+.+|.+|...--.|. |.||+..+++ |+..+.+.++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 68889999999999999999984 5799998876543 3478888887655564 8899998875 6667788899
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+||++.|+|..-+...| +-+....+++.|+++|++|+|+++ +||||||.+|||+-+.+..+|||||||+++..+..-
T Consensus 101 qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999998876543 678888999999999999999988 999999999999966566699999999998665321
Q ss_pred ccccccccCCCcCccccCccccCCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~ 384 (435)
.....+..|.+||..... ...+.+|+|.||++++.++||.+||.... +.....+...+..+..+
T Consensus 178 -------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 178 -------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred -------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 222346679999986432 34578999999999999999999997432 22222222233322222
Q ss_pred --CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 --AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 --~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+++.+..+.++-|..++++|....+.-+.
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 24578899999999999999999554444433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=219.84 Aligned_cols=271 Identities=22% Similarity=0.320 Sum_probs=223.3
Q ss_pred CCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
...|.++++||+|+||+++.|.. .+.+||||...... + ...+..|.+..+.|. .++|+..+.|..++.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-E----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-C----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 34899999999999999999985 58999999754321 1 256788999998886 6999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC---CCCcEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS---SADHLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~---~~~~vkl~Dfg~a~~ 308 (435)
|+|.+ |.||.|++.- ...|+..++..++.|++.-++|+|++. +|+|||||+|+||... ....|.++|||+|..
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99988 8899998874 456999999999999999999999988 9999999999999432 223589999999998
Q ss_pred ccccCccc---cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCC
Q 013833 309 IKVQNSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGHRPF 382 (435)
Q Consensus 309 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~ 382 (435)
+..+.... ........||.+||+-..+.++.-+.+.|+-|||-++...+-|..||.+... .+..++|-+..+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 87765422 2224456799999999999999999999999999999999999999988754 34445555444332
Q ss_pred C---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCcccccC
Q 013833 383 F---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNIFN 434 (435)
Q Consensus 383 ~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~~~ 434 (435)
. ...++|.++...+.-.-..+-.+-|+.+-+...+..+.+++-. .=+|+..|
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 2 2257899999999999999999999999999999999987765 36787765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=233.62 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=189.4
Q ss_pred CCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 231 (435)
.|..+.+||.|+|++||++.+. ...||+|.+...... .++.+|+++|..+. +.||+++.+++..++++.
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 6788899999999999999753 568999988654332 56889999999995 899999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
+|+||++.....++... ++..++..+++.++.||.++|..| ||||||||+|+|.. ...++-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n-~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYN-RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccc-cccCCceEEechhHHHHHh
Confidence 99999999988888864 678999999999999999999988 99999999999983 4556788999999983211
Q ss_pred cC------c-----------c-----c--------cc----------cccCCCcCccccCccccCC-CCCCCcchHHHHH
Q 013833 312 QN------S-----------H-----D--------VY----------KMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFA 350 (435)
Q Consensus 312 ~~------~-----------~-----~--------~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG 350 (435)
.. . . . .+ ..-...||++|.|||++.. ..-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 10 0 0 0 00 0011359999999999865 4567899999999
Q ss_pred HHHHHHHcCCCCCCCCCH-----HHH--------HHHHH--cCC---------------------------CC-------
Q 013833 351 MILYEMLEGEPPLANYEP-----YEA--------AKYVA--EGH---------------------------RP------- 381 (435)
Q Consensus 351 ~il~~l~tg~~p~~~~~~-----~~~--------~~~~~--~~~---------------------------~~------- 381 (435)
||+..++++..||..... .++ .++.. .+. .+
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999932211 000 00000 000 00
Q ss_pred -CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.......+..+.+|+.+||..||.+|.|+++.|++
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00001234578999999999999999999999976
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=229.96 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=202.9
Q ss_pred CCCCCceeecCCceeEEEEEECCC---cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC----CcceeeeeeE-EeCCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH----PNIVQFLGAV-TERKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~ 229 (435)
+|.+.+.||+|+||.||.+.+... .+|+|.......... ..+..|..++..+.. ++++.+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 789999999999999999998643 589997755432221 256778888888862 6899999988 47778
Q ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-C--CcEEEeecc
Q 013833 230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-A--DHLKVGDFG 304 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~--~~vkl~Dfg 304 (435)
.++||+.+ |.+|.++.+.. +.++..++.+++.|++.+|++||+.| ++||||||+|+++.... . ..+.|+|||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 89999988 88999998654 46999999999999999999999998 99999999999994332 1 469999999
Q ss_pred Ccc--cccccCccc---ccc-ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 305 LSK--LIKVQNSHD---VYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 305 ~a~--~~~~~~~~~---~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
+++ ......... ... .....||..|++++++.+...+.+.|+||++.++.+++.|..||.+.........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 999 432222111 111 22455999999999999999999999999999999999999999876643222222211
Q ss_pred CCCCC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 379 HRPFF---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 379 ~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
..... .....+.++.++...+-..+...+|....+...|.......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111 12345678899998888999999999999999998887653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=266.31 Aligned_cols=199 Identities=14% Similarity=0.176 Sum_probs=143.5
Q ss_pred CCC-CcceeeeeeE-------EeCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 013833 212 LRH-PNIVQFLGAV-------TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (435)
Q Consensus 212 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~D 282 (435)
++| +||..+++++ ...+.+++++|++ +++|.+++.. ...+++.+++.++.||+.||.|||++| |||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 344 5777777766 2334678889987 6699999975 345999999999999999999999988 99999
Q ss_pred CCCCcEEEec-----------------CCCCcEEEeeccCcccccccCcc------c------cccccCCCcCccccCcc
Q 013833 283 LKPRNVLLVN-----------------SSADHLKVGDFGLSKLIKVQNSH------D------VYKMTGETGSYRYMAPE 333 (435)
Q Consensus 283 lkp~NIll~~-----------------~~~~~vkl~Dfg~a~~~~~~~~~------~------~~~~~~~~gt~~y~aPE 333 (435)
|||+||||.. +.++.+|++|||+++........ . ........||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999932 23445666677766543211000 0 00011245889999999
Q ss_pred ccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHH
Q 013833 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413 (435)
Q Consensus 334 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l 413 (435)
++.+..++.++|||||||++|||++|.+|+..... ....+.....+... ....+...+++.+||+++|.+||++.++
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999988764321 12222222222111 1124567889999999999999999999
Q ss_pred HHH
Q 013833 414 LKR 416 (435)
Q Consensus 414 l~~ 416 (435)
+++
T Consensus 263 l~h 265 (793)
T PLN00181 263 LQS 265 (793)
T ss_pred hhc
Confidence 875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=207.10 Aligned_cols=261 Identities=22% Similarity=0.297 Sum_probs=212.7
Q ss_pred CCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|.+++.||+|+||.+|.|.. .|..||||........ ..+..|.++...|++ ..|+.+..+..+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 789999999999999999986 4889999976543322 456779999999985 78888888898888889999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~ 312 (435)
+.+ |.||.++++- ...++..+++.++-|++.-++|+|.++ +|||||||+|+|+.-+ -...+.++|||+|..+...
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 988 8899998873 556999999999999999999999988 9999999999999321 2236899999999988665
Q ss_pred Cccc---cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHcCCCC---CC
Q 013833 313 NSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA---AKYVAEGHRP---FF 383 (435)
Q Consensus 313 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~---~~ 383 (435)
.... ........||.+|.+-..+.+..-+...|+-|+|.+|..+.-|..||.+..+... .+.|.+.... ..
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 4321 1123345799999999988888889999999999999999999999998876433 3445444322 22
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
...++|.++.-.+.-|-...-++-|+..-+.+.+..+...+..
T Consensus 248 LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 248 LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 3468899999999999999999999999998888888776655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=210.81 Aligned_cols=162 Identities=20% Similarity=0.275 Sum_probs=129.6
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 240 ~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+|||+ +.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~--~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILL--TWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeE--cCccceee--ccceEeeccc------
Confidence 6899999874 45999999999999999999999965 9999999 88889998 9998765432
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCC-----CCCCCCH--
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFF-----RAKGFTP-- 390 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~-- 390 (435)
...||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.....+.. ....++.
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 125789999999999999999999999999999999999999765432 22222222222211 1122333
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++++++.+||..+|++||++.++++++..+..
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-25 Score=208.36 Aligned_cols=253 Identities=33% Similarity=0.490 Sum_probs=206.3
Q ss_pred CCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC-cceeeeeeEEeCCcEEEEEecC
Q 013833 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
|...+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567788999999999999988 77899988776655543457889999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCcccccccC
Q 013833 238 RGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 238 ~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~~~~ 313 (435)
.+++|.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||++ +..+ .++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~--~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--cCCCCeEEEeccCcceecCCCC
Confidence 9999998887764 7899999999999999999999988 9999999999999 7777 69999999998555433
Q ss_pred cccc--ccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCC-CC
Q 013833 314 SHDV--YKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRP-FF 383 (435)
Q Consensus 314 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~-~~ 383 (435)
.... .......|+..|++||.+.+ ..++...|+||+|++++++++|..||..... ......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2111 12356789999999999987 5788899999999999999999999877653 4444445444433 11
Q ss_pred CCCCC------CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RAKGF------TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~~~~------~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..... ...+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 1578999999999999999999887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=215.33 Aligned_cols=168 Identities=22% Similarity=0.332 Sum_probs=128.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCccee-eeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQ-FLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~ 229 (435)
...|.+.+.||+|+||+||+|.++ ++.+|||.+..... ......+.+.+|+++|++++|+|++. ++++ ..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 347899999999999999999874 56689998653321 12334567899999999999999985 4432 45
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCC-CCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dl-kp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++||||++|++|... . ... ...++.|++++|.|||+.| |+|||| ||+|||+ +.++.++|+|||+|+.
T Consensus 93 ~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv--~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLM--GPDGEAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEE--cCCCCEEEEECcccee
Confidence 7999999999999732 1 111 1467889999999999988 999999 9999999 7778999999999998
Q ss_pred ccccCccccc----cccCCCcCccccCccccCCC
Q 013833 309 IKVQNSHDVY----KMTGETGSYRYMAPEVFKHR 338 (435)
Q Consensus 309 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 338 (435)
+......... ......+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7654321110 11345688889999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-27 Score=236.27 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=195.0
Q ss_pred CCCceeecCCceeEEEEEEC--CCcEEEEEccC---CCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 160 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILP---SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
....++|.|++|.|+..... ....+.|.... ...........+..|..+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977776643 22233333221 11112222233667888888899999999888776666666669
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|||++ +|+.++.+.+.++..++-.++.|++.|++|+|+.| +.|||||++|+++ ...|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~--~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLV--TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEE--ecCCceEEeecCcceeeccCcc
Confidence 99999 99999998888999999999999999999999999 9999999999999 8888999999999998877766
Q ss_pred cccccccCCCcCccccCccccCCCCCCC-cchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCCCCCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDK-KVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-------VAEGHRPFFRAK 386 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~ 386 (435)
.......+.+|+.+|+|||++.+..|++ ..||||.|+++..|.+|+.||.-....+.... ......+.....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 5555677889999999999999999986 69999999999999999999965443322100 000011111123
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++.+.+.+|.+||+.||.+|.|+.+|++.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 577889999999999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=190.08 Aligned_cols=171 Identities=12% Similarity=0.178 Sum_probs=136.0
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHH------HHHHHHHHHhCCCCcceeeeeeEEeC----
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPNIVQFLGAVTER---- 227 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~---- 227 (435)
+|+..++||.|+||.||+....+..+|+|.+.......+..... +.+|+..+.+++||+|+.+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 78899999999999999987777789999998776666555455 57999999999999999999886543
Q ss_pred ----CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 228 ----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 228 ----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
...+|+|||++|.+|.++.. +++. ...+++.+|..||+.| ++|||+||+||++ +.+| ++|+||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili--~~~g-i~liDf 178 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIV--SKNG-LRIIDL 178 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEE--eCCC-EEEEEC
Confidence 35799999999999988742 3332 4569999999999988 9999999999999 6666 999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 357 (435)
|........... ...+....|..++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988654322111 01333455667899999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=184.12 Aligned_cols=143 Identities=21% Similarity=0.153 Sum_probs=110.5
Q ss_pred CceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHH-----------------------HHHHHHHHHHHHHhCCCCcc
Q 013833 162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRL-----------------------VIQDFRHEVNLLVKLRHPNI 217 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~i 217 (435)
...||+|+||.||+|... |++||+|++......... .......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999975 889999998654321110 01123459999999988877
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hcCCCceEeCCCCCCcEEEecCCCC
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~L-H~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
......... ..+|||||++|++|.......+.++..++..++.|++.+|.++ |+.| |+||||||+|||+ + ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli--~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLY--H-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--E-CC
Confidence 544333222 2389999999887776654556799999999999999999999 7888 9999999999999 4 36
Q ss_pred cEEEeeccCcccccc
Q 013833 297 HLKVGDFGLSKLIKV 311 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~ 311 (435)
.++|+|||+|.....
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-25 Score=211.86 Aligned_cols=226 Identities=27% Similarity=0.406 Sum_probs=189.4
Q ss_pred eeecCCceeEEEEE-----ECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecC
Q 013833 164 IIGKGSFGEILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 164 ~lg~G~~g~V~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
++|+|+||.|+++. +.+.-+|+|...+........ .....|..++...+ ||++++++..+..+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999765 346778999876544333222 25567888888887 999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
.||.|...+.....+++.....+...++-+++.+|+.+ ++|||+|++||++ +..|++++.|||+++..-...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enill--d~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceee--cccCccccCCchhhhHhHhhh----
Confidence 99999999988878888888889999999999999988 9999999999999 999999999999998654322
Q ss_pred ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
..+||..|||||++. .+...+|.||+|+++++|+||..||.. +....|.....+. +..++..+++++.
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~--p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM--PRELSAEARSLFR 219 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--chhhhHHHHHHHH
Confidence 228999999999998 778889999999999999999999997 5555555543333 4567889999999
Q ss_pred HHhhhcccCCCCH
Q 013833 398 KCWAADMNQRPSF 410 (435)
Q Consensus 398 ~cl~~dp~~Rps~ 410 (435)
.++..+|.+|.-.
T Consensus 220 ~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 220 QLFKRNPENRLGA 232 (612)
T ss_pred HHHhhCHHHHhcc
Confidence 9999999999644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=186.55 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=177.9
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECC-------------------------------------CcEEEEEccC
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------------------------------------TPVAIKRILP 190 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------------------------------------~~vavK~~~~ 190 (435)
+.|.|+ +|+++..||+|..+.||.+.... =+.|||.+-.
T Consensus 152 skFtid----dyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN 227 (598)
T KOG4158|consen 152 SKFTID----DYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN 227 (598)
T ss_pred cccchh----hhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc
Confidence 445555 79999999999999999875310 0356665422
Q ss_pred C--CCCcHHHHHHHHHHHH------HH--------Hh--------CCCCcceeeeeeEEe--------------------
Q 013833 191 S--LSDDRLVIQDFRHEVN------LL--------VK--------LRHPNIVQFLGAVTE-------------------- 226 (435)
Q Consensus 191 ~--~~~~~~~~~~~~~E~~------~l--------~~--------l~h~~iv~~~~~~~~-------------------- 226 (435)
- ...+...++.+.+|.- .+ +. -+|||||.++.+|.+
T Consensus 228 ~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~ 307 (598)
T KOG4158|consen 228 FEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW 307 (598)
T ss_pred cccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence 1 1222333444444431 11 11 259999999877643
Q ss_pred -------CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC--c
Q 013833 227 -------RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--H 297 (435)
Q Consensus 227 -------~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~--~ 297 (435)
+..+|+||..... +|..|+-.+ ..+.....-++.|+++|+.|||.+| |.|||+|++|||+.-++++ .
T Consensus 308 ~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 308 YPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred cccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcE
Confidence 2347999998855 999999654 3577777889999999999999999 9999999999999544444 5
Q ss_pred EEEeeccCcccccccCccccc--cccCCCcCccccCccccCCCC------CCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 013833 298 LKVGDFGLSKLIKVQNSHDVY--KMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (435)
Q Consensus 298 vkl~Dfg~a~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 369 (435)
+.++|||.+-.-+.-+-.-.+ ......|...-||||+....+ --.|+|.|+.|.+.||+++...||.+....
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem 463 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM 463 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh
Confidence 788999987543331111000 111235777889999986432 125899999999999999999999874332
Q ss_pred HHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 370 EAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 370 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... +...+...|. .+..+++.+++++..+|+.||.+|+++.-.-..
T Consensus 464 ~L~~r~Yqe~qLPa-lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 464 LLDTRTYQESQLPA-LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eechhhhhhhhCCC-CcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 211 1122222232 346799999999999999999999987654443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=176.95 Aligned_cols=143 Identities=17% Similarity=0.142 Sum_probs=112.5
Q ss_pred CceeecCCceeEEEEEEC-CCcEEEEEccCCCCCc-----------------------HHHHHHHHHHHHHHHhCCCCcc
Q 013833 162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKLRHPNI 217 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~~i 217 (435)
.+.||+|+||.||+|.+. |+.||||++....... ......+..|.+.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999975 8999999987653210 0012234689999999999988
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCC
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
.....+.... .++||||++|+++.........++..++..++.|++.+|.++|+ .| |+||||||+|||+ + ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll--~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILY--H-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEE--E-CC
Confidence 6555444332 48999999887655443344568889999999999999999999 88 9999999999999 5 68
Q ss_pred cEEEeeccCcccccc
Q 013833 297 HLKVGDFGLSKLIKV 311 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~ 311 (435)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 899999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=170.70 Aligned_cols=192 Identities=16% Similarity=0.096 Sum_probs=138.5
Q ss_pred CCCceeecCCceeEEEEEECCCcEEEEEccCCCCCc-HHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecC
Q 013833 160 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
.+...|++|+||+||.+...+.+++.+.+....--. ......+.+|+++|++++ ++++++++++ ...+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345689999999999888778888877553322111 111125789999999996 5889999886 3469999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCC-CCCcEEEecCCCCcEEEeeccCcccccccCcc-
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH- 315 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dl-kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~- 315 (435)
.|.+|.+.... . ...++.|++.+|.++|+.| |+|||| ||+|||+ +.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv--~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLV--QEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEE--cCCCCEEEEECCCceecCCcchHH
Confidence 99998765421 1 1357789999999999988 999999 7999999 77889999999999855433210
Q ss_pred ------cccc--ccCCCcCccccCccccCC-CCCC-CcchHHHHHHHHHHHHcCCCCCCCC
Q 013833 316 ------DVYK--MTGETGSYRYMAPEVFKH-RKYD-KKVDVFSFAMILYEMLEGEPPLANY 366 (435)
Q Consensus 316 ------~~~~--~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~slG~il~~l~tg~~p~~~~ 366 (435)
+... ......++.+++|+...- ...+ ...+.++.|.-+|.++|+..|+.+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0000 011235677777765421 1233 4679999999999999999887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-23 Score=210.91 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=180.5
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
++...+.||++.|=.|.+|++..-.|+||++.+.... .-....+...|++ ...+++||++.+.-+...++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666779999999999999987555999998654422 2112223333444 5567899999988887778888999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC---
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN--- 313 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 313 (435)
+.. +|.|.+..++.+..-+.+.|+.||+.||.-+|..| |+|||||.+|||+ .+-+-+.|+||..-+..-.+.
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILi--TSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILI--TSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEE--eeechhhhhcccccCCccCCCCCc
Confidence 955 99999988888899999999999999999999998 9999999999999 788889999998654321111
Q ss_pred ccccccccCCCcCccccCccccCCC-----------CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
.+-.+...+.....-|.|||.+-.. ..+++-||||+||++.||++ |++||.-.. .-..+.-. ...+
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-L~aYr~~~-~~~~ 255 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-LLAYRSGN-ADDP 255 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-HHhHhccC-ccCH
Confidence 1111112222334469999987542 14678999999999999998 788884211 10000000 0000
Q ss_pred C-CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 F-FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....--+..++.+|..|++.||++|.+|++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0001113468999999999999999999999876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=185.37 Aligned_cols=233 Identities=19% Similarity=0.298 Sum_probs=150.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC----------CCcceeeeeeE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----------HPNIVQFLGAV 224 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~~iv~~~~~~ 224 (435)
+.+...+.||.|+|+.||.+.+. ++++|+|.+.-.........+.+++|.-....+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34566789999999999999996 5789999876555444445677777775554432 21223333322
Q ss_pred E---------eC---C-----cEEEEEecCCCCCHHHHHH---HcCCC----CHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013833 225 T---------ER---K-----PLMLITEYLRGGDLHKYLK---EKGAL----SPSTAVNFALDIARGMAYLHNEPNVIIH 280 (435)
Q Consensus 225 ~---------~~---~-----~~~lv~e~~~g~sL~~~l~---~~~~~----~~~~~~~~~~qi~~~l~~LH~~~~~ivH 280 (435)
. .. . ..+++|+-+ .++|.+++. ..... .....+.+..|+++.+.+||+.| +||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 1 11 1 236788877 458988864 22222 12223345579999999999999 999
Q ss_pred CCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCC--------CCCCCcchHHHHHHH
Q 013833 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--------RKYDKKVDVFSFAMI 352 (435)
Q Consensus 281 ~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~i 352 (435)
+||+|+|+++ +.+|.+.|+||+.......... . ...+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll--~~~G~v~Lg~F~~~~r~g~~~~------~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLL--DQDGGVFLGDFSSLVRAGTRYR------C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE---TTS-EEE--GGGEEETTEEEE------G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEE--cCCCCEEEcChHHHeecCceee------c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999 8899999999987765543211 1 234577999997643 246789999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 013833 353 LYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR 407 (435)
Q Consensus 353 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 407 (435)
+|.|.+|..||........... .+....++|+.+++||..+|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986654322111 111223689999999999999999988
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=164.54 Aligned_cols=116 Identities=28% Similarity=0.334 Sum_probs=101.7
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhC-CCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~-g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
..+..+|.+|+.|+||+|+ |+..+..++++-|+.. |+|+|.++..|.|+||+||..|++||+++|+++||.|+++|+
T Consensus 60 q~nv~~ddkDdaGWtPlhi--a~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~ 137 (226)
T KOG4412|consen 60 QPNVKPDDKDDAGWTPLHI--AASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDK 137 (226)
T ss_pred cCCCCCCCccccCCchhhh--hhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCccccc
Confidence 5677788899999999987 6666677777777766 999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
.|+||||-|+..|..+++++|+..|+-++.++...++|.
T Consensus 138 ~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL 176 (226)
T KOG4412|consen 138 QGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPL 176 (226)
T ss_pred ccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHH
Confidence 999999999999999999999999998888888777664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=199.18 Aligned_cols=214 Identities=32% Similarity=0.478 Sum_probs=161.0
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
|...+.+.+|..++.|..|++|.||.++++ .+++|+| +.+.. . -+++ ++.....|++|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----l---ilRn---ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----L---ILRN---ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----h---hhhc---cccccCCccee---------
Confidence 455666778999999999999999999887 6788885 43211 0 0111 22223344443
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
|+-...++.-+.++.+- +.+++|||+.| |+|||+||+|.+| ..-|++|+.|||++.
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllI--T~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCccee--eecccccccchhhhh
Confidence 34445555545555333 77999999988 9999999999999 889999999999987
Q ss_pred cccccCccc-----------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 013833 308 LIKVQNSHD-----------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (435)
Q Consensus 308 ~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 376 (435)
......... .......+|||.|.|||++..+.|+..+|+|++|+|+|+.+.|+.||.+.++.+....+.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 654432211 112334689999999999999999999999999999999999999999999988776655
Q ss_pred cCC--CCCCCCCCCCHHHHHHHHHHhhhcccCCC
Q 013833 377 EGH--RPFFRAKGFTPELRELTEKCWAADMNQRP 408 (435)
Q Consensus 377 ~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 408 (435)
... .|.- ...++++.++++.++|+.+|..|.
T Consensus 272 sd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 332 2221 345789999999999999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=166.21 Aligned_cols=140 Identities=19% Similarity=0.237 Sum_probs=105.4
Q ss_pred CCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-----CCCcceeeeeeEEeCC---c-
Q 013833 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-----RHPNIVQFLGAVTERK---P- 229 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~- 229 (435)
......||+|+||.||.....+. .+||++...... ..+.+.+|+.+++.+ +||||+++++++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEECCCCcC-eEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 44556899999999996222233 478887543222 236789999999999 5799999999998764 3
Q ss_pred EEEEEec--CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHhcCCCceEeCCCCCCcEEEecC--CCCcEEEeec-
Q 013833 230 LMLITEY--LRGGDLHKYLKEKGALSPSTAVNFALDIARGM-AYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDF- 303 (435)
Q Consensus 230 ~~lv~e~--~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l-~~LH~~~~~ivH~Dlkp~NIll~~~--~~~~vkl~Df- 303 (435)
+.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+.+ ||||||||+|||+... +.+.++|+||
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 4578999999764 46655 35678888777 9999988 9999999999999432 3347999994
Q ss_pred cCcc
Q 013833 304 GLSK 307 (435)
Q Consensus 304 g~a~ 307 (435)
|...
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 5443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=163.25 Aligned_cols=137 Identities=23% Similarity=0.412 Sum_probs=114.9
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+.||+|++|.||+|.+.+..+++|.......... ....++.+|+.++..+.|++++....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999997654332211 12345788999999999999888777777777889999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
+|++|.+++..... +...++.+++.+|.++|+.+ ++|+|++|.|||+ + .+.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~--~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMIL--S-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEE--E-CCCEEEEECCcccC
Confidence 99999999875322 77889999999999999988 9999999999999 5 67899999998763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=193.17 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=185.0
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcceeeeeeEEe
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTE 226 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 226 (435)
.+......|.+.+.||+|+||.||+|... |+.||||+-+....-.-.. -.+++.+|+ -+.|..+...+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHcc
Confidence 34445568899999999999999999864 8899999876654332111 122333333 2345555555555
Q ss_pred CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-----CCCCcEEEe
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-----SSADHLKVG 301 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-----~~~~~vkl~ 301 (435)
.+.-++|+||.+.|+|.++++..+.+++..+..+..|++..++.||..+ |||+||||+|+||.. ....-++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 5667899999999999999998888999999999999999999999998 999999999999942 233469999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
|||-+..+..-.. .......++|-.+-.+|...++.++...|.|+|..+++-|+.|+.-= +..+..
T Consensus 844 DfG~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~- 909 (974)
T KOG1166|consen 844 DFGRSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSS- 909 (974)
T ss_pred ecccceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcc-
Confidence 9999876654332 22455677888999999999999999999999999999999988421 111111
Q ss_pred CCCCCCCC-----HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 382 FFRAKGFT-----PELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 382 ~~~~~~~~-----~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.....+++ .-.-+|+..+|..|-..=|...+|...|+.+..+
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred eeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 11111122 2246788888885555558888888888776643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=178.02 Aligned_cols=211 Identities=31% Similarity=0.487 Sum_probs=165.4
Q ss_pred HHhCCCCcceeeeeeEEeCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCc
Q 013833 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (435)
Q Consensus 209 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~N 287 (435)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. .-.++.--...++++|+.||.|||... ...|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecccc
Confidence 4578999999999999999999999999999999999986 335777777889999999999999964 23999999999
Q ss_pred EEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCC-------CCCcchHHHHHHHHHHHHcCC
Q 013833 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-------YDKKVDVFSFAMILYEMLEGE 360 (435)
Q Consensus 288 Ill~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~il~~l~tg~ 360 (435)
.++ +....+||+|||+.......... .......-..-|.|||.+.... .+.+.|+||+|++++|+++..
T Consensus 80 Clv--d~~w~lklt~~Gl~~~~~~~~~~--~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 80 CLV--DSRWVLKLTDFGLNSLLEETAEP--EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cee--eeeEEEEechhhhcccccccccc--cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999 99999999999998876431100 0111112345699999987631 467799999999999999999
Q ss_pred CCCCCC----CHHHHHHHHHcCCC----CCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 361 PPLANY----EPYEAAKYVAEGHR----PFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 361 ~p~~~~----~~~~~~~~~~~~~~----~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
.||+.. .+.++...+..+.. |.... ..+++++..++..||..+|++||+++++-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999753 33455555555222 22221 245668999999999999999999999999888877643
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=152.52 Aligned_cols=112 Identities=27% Similarity=0.331 Sum_probs=105.2
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
.+|+++|+..+.|.|+||+ |+..+..++.++|+++|+.|+.+|..|.||||-||.-|.++++++|+..||.+|.+|+.
T Consensus 94 r~~advna~tn~G~T~LHy--AagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~ 171 (226)
T KOG4412|consen 94 RSGADVNATTNGGQTCLHY--AAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKY 171 (226)
T ss_pred CCCCCcceecCCCcceehh--hhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCccccc
Confidence 3489999999999999976 88888999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
|+||||.|...|+.+...+|+.+|++.+..+...
T Consensus 172 G~TpL~~al~e~~~d~a~lLV~~gAd~~~edke~ 205 (226)
T KOG4412|consen 172 GFTPLHHALAEGHPDVAVLLVRAGADTDREDKEG 205 (226)
T ss_pred CccHHHHHHhccCchHHHHHHHhccceeeccccC
Confidence 9999999988899999999999999998777654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=158.40 Aligned_cols=133 Identities=26% Similarity=0.398 Sum_probs=108.5
Q ss_pred eeecCCceeEEEEEECCCcEEEEEccCCCCCc-----HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.||+|+||.||++.+.+.++++|......... .....++.+|++++..++|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999865432111 1224667899999999998876655555556667799999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
|++|.+++..... .++.+++.+|.+||+.| ++|+|++|.||++ + ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~--~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIV--R-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEE--E-CCcEEEEECCCCcC
Confidence 9999998864321 78899999999999988 9999999999999 5 67899999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=162.24 Aligned_cols=145 Identities=19% Similarity=0.183 Sum_probs=111.1
Q ss_pred CCCCCceeecCCceeEEEEE-E--CCCcEEEEEccCCCCCc---------------------HHHHHHHHHHHHHHHhCC
Q 013833 158 DFSSSAIIGKGSFGEILKAY-W--RGTPVAIKRILPSLSDD---------------------RLVIQDFRHEVNLLVKLR 213 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~-~--~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 213 (435)
-|.+.+.||+|+||.||+|. + .|+.||+|.+....... ......+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 3 48899999886543210 001134678999999997
Q ss_pred CC--cceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEe
Q 013833 214 HP--NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291 (435)
Q Consensus 214 h~--~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~ 291 (435)
+. .+++++.+ . ..++||||++|.+|..+......++..++..++.|++.++.+||+.| .++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli- 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV- 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE-
Confidence 53 34444432 2 34899999999888776544455677778899999999999999953 39999999999999
Q ss_pred cCCCCcEEEeeccCccccc
Q 013833 292 NSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 292 ~~~~~~vkl~Dfg~a~~~~ 310 (435)
+ ++.++|+|||.+....
T Consensus 183 -~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 -H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred -E-CCCEEEEEChhhhccC
Confidence 5 6789999999887543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-18 Score=178.20 Aligned_cols=148 Identities=26% Similarity=0.382 Sum_probs=118.4
Q ss_pred CCcccCCCC-CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcceeee
Q 013833 148 CDWEIDPSE-LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFL 221 (435)
Q Consensus 148 ~~~~~~~~~-~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~ 221 (435)
..|...... ..|...+.||+|+||+||++.+.+..+++|........ .....+++.+|+++++.++|++++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 345554442 34467889999999999999998777777654322111 112346688999999999999999887
Q ss_pred eeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 222 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
.+..+....++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ + ++.++|+
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl--~-~~~~~li 469 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV--R-DDRLYLI 469 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE--E-CCcEEEE
Confidence 77777777899999999999999885 34678999999999999988 9999999999999 3 4689999
Q ss_pred eccCccc
Q 013833 302 DFGLSKL 308 (435)
Q Consensus 302 Dfg~a~~ 308 (435)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999864
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=144.62 Aligned_cols=104 Identities=33% Similarity=0.453 Sum_probs=96.2
Q ss_pred hhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchh
Q 013833 36 SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFN 115 (435)
Q Consensus 36 ~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 115 (435)
-+.+|||..+...+|.++|.+..--||.+|.+|.||||-|+++||++||+.|+..|||++++...||||||-|+.+++.+
T Consensus 65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~ 144 (228)
T KOG0512|consen 65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE 144 (228)
T ss_pred HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence 35678999999999999998887789999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCC
Q 013833 116 MMELLNAHGGLSYGQNGSHFEPKP 139 (435)
Q Consensus 116 ~~~~L~~~g~~~~~~n~~~~~~~~ 139 (435)
++.+|+++|+|++.+......|..
T Consensus 145 va~~LLqhgaDVnA~t~g~ltpLh 168 (228)
T KOG0512|consen 145 VAGRLLQHGADVNAQTKGLLTPLH 168 (228)
T ss_pred HHHHHHhccCcccccccccchhhH
Confidence 999999999999988877766543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=151.45 Aligned_cols=140 Identities=20% Similarity=0.171 Sum_probs=107.6
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcH-------------------HHHHHHHHHHHHHHhCCCC--
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR-------------------LVIQDFRHEVNLLVKLRHP-- 215 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~-- 215 (435)
.|.+.+.||+|+||.||++... |+.||||++........ ........|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4677889999999999999884 88999998654321000 0112367789999999877
Q ss_pred cceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC
Q 013833 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (435)
Q Consensus 216 ~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~ 295 (435)
.++..++ ....++||||++|++|...... .....++.+++.++.++|+.| ++||||||+||++ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill--~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV--DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE--cCC
Confidence 4444443 2345899999999998765421 345678899999999999988 9999999999999 778
Q ss_pred CcEEEeeccCcccccc
Q 013833 296 DHLKVGDFGLSKLIKV 311 (435)
Q Consensus 296 ~~vkl~Dfg~a~~~~~ 311 (435)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 8999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=146.73 Aligned_cols=112 Identities=21% Similarity=0.182 Sum_probs=90.0
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCH--HHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDA--AAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVNA 96 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~--~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~ 96 (435)
+.+.+++.+|..|+|++++ ||..+.. .+++++|++.|+++|.+| ..|.||||+|+..|+.+++++|++ .|++++.
T Consensus 45 ~~g~~~~~~d~~g~t~Lh~-Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~ 123 (166)
T PHA02743 45 GDGHLLHRYDHHGRQCTHM-VAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGA 123 (166)
T ss_pred hcchhhhccCCCCCcHHHH-HHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccC
Confidence 4566777788888888864 4444432 345788889999999988 479999999999999999999985 7999999
Q ss_pred cccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
+|..|+||||+|+..++.+++++|+++|++++..+..
T Consensus 124 ~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~ 160 (166)
T PHA02743 124 INYQHETAYHIAYKMRDRRMMEILRANGAVCDDPLSI 160 (166)
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999999999999999887655443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=166.92 Aligned_cols=173 Identities=28% Similarity=0.450 Sum_probs=130.8
Q ss_pred cEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
.+||.|++|.-.+|.+++.+.. ..+....+.++.|++.+++| ++ .+|||+||.||+. ..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~--~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFF--SDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhcccccccc--ccchhhhhhhhhh
Confidence 5789999999999999997543 35777888999999999999 66 8999999999999 6666899999999
Q ss_pred cccccccCc--cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 306 SKLIKVQNS--HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 306 a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
......... .....++...||..||+||.+.+..|+.++|||+||++|+|++. =..++ ........+..+..|+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPP 479 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCCh
Confidence 887654431 01123556789999999999999999999999999999999987 22222 1222233344544442
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHH
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLD 412 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 412 (435)
..... .+.-..|+..++.+.|.+||++..
T Consensus 480 ~~~~d-~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 480 EFLQD-YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence 11111 234568999999999999994433
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=155.00 Aligned_cols=111 Identities=23% Similarity=0.169 Sum_probs=98.2
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC----CCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc-ccC
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD----YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ-DRW 100 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d----~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~-~~~ 100 (435)
...+|+.+++++++ +|++.+..+++++|+++|+++|.++ ..|.||||+|+..|+.+++++|+++|||+|.+ +..
T Consensus 25 ~~~~d~~~~~~lL~-~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~ 103 (300)
T PHA02884 25 IKKKNKICIANILY-SSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEA 103 (300)
T ss_pred hhccCcCCCCHHHH-HHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCC
Confidence 45678999999965 4556677889999999999999974 58999999999999999999999999999996 468
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
|.||||+|+..++.+++++|+.+|++++..+....+|
T Consensus 104 g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~Tp 140 (300)
T PHA02884 104 KITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTP 140 (300)
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999999998877665544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=144.89 Aligned_cols=138 Identities=20% Similarity=0.229 Sum_probs=97.7
Q ss_pred CceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHH---------------------HHHHHHHHHhCCCCc--c
Q 013833 162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQD---------------------FRHEVNLLVKLRHPN--I 217 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~~--i 217 (435)
.+.||+|+||+||++.+. +++||||++............. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987 8899999876543221111111 135666666665432 4
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCC
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA 295 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~-~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~ 295 (435)
+++++. ...++||||++|+++.. .+.... .. .++..++.+++.++.++|. .+ |+||||||+||++ + +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili--~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV--D-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE--E-C
Confidence 444433 24589999999854321 111110 11 6678899999999999999 88 9999999999999 5 7
Q ss_pred CcEEEeeccCccccc
Q 013833 296 DHLKVGDFGLSKLIK 310 (435)
Q Consensus 296 ~~vkl~Dfg~a~~~~ 310 (435)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=126.88 Aligned_cols=87 Identities=33% Similarity=0.413 Sum_probs=77.6
Q ss_pred hhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHH
Q 013833 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120 (435)
Q Consensus 41 ~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L 120 (435)
.|++.+..+++++|++.+.+++. |.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|
T Consensus 3 ~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~L 78 (89)
T PF12796_consen 3 IAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLL 78 (89)
T ss_dssp HHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHH
T ss_pred HHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHH
Confidence 36677778888888889988877 89999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 013833 121 NAHGGLSYGQN 131 (435)
Q Consensus 121 ~~~g~~~~~~n 131 (435)
+++|++++.+|
T Consensus 79 l~~g~~~~~~n 89 (89)
T PF12796_consen 79 LEHGADVNIRN 89 (89)
T ss_dssp HHTTT-TTSS-
T ss_pred HHcCCCCCCcC
Confidence 99999987654
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-17 Score=147.12 Aligned_cols=139 Identities=22% Similarity=0.229 Sum_probs=107.5
Q ss_pred Cceee-cCCceeEEEEEECCCcEEEEEccCCCC----------CcHHHHHHHHHHHHHHHhCCCCcc--eeeeeeEEeC-
Q 013833 162 SAIIG-KGSFGEILKAYWRGTPVAIKRILPSLS----------DDRLVIQDFRHEVNLLVKLRHPNI--VQFLGAVTER- 227 (435)
Q Consensus 162 ~~~lg-~G~~g~V~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~- 227 (435)
...|| .|+.|+||.+...+..++||.+..... .+.....++.+|++++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45788 999999999999888999998743211 111233567889999999998774 6777664332
Q ss_pred Cc---EEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 228 KP---LMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 228 ~~---~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
.. .++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||+.| |+||||||.|||+ +.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv--~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILL--DPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEE--cCCCCEEEEEC
Confidence 22 2599999997 699998865 3455543 568999999999988 9999999999999 76778999999
Q ss_pred cCcccc
Q 013833 304 GLSKLI 309 (435)
Q Consensus 304 g~a~~~ 309 (435)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988653
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.6e-18 Score=163.46 Aligned_cols=114 Identities=25% Similarity=0.227 Sum_probs=104.4
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
|.+++..|++|-|.+|+ |+.+|..+++++|+++|++||..+ ..|.|||||||.+|+..+|++|+++|||++.+|..|
T Consensus 68 g~~v~~~D~~g~tlLHW--AAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G 145 (600)
T KOG0509|consen 68 GESVNNPDREGVTLLHW--AAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQG 145 (600)
T ss_pred CcCCCCCCcCCccceeH--HHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCC
Confidence 77888889988888865 666888899999999999999998 679999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
.||+|.|++.++.-+|-+|+..+++++.++....+|.
T Consensus 146 ~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpL 182 (600)
T KOG0509|consen 146 LTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPL 182 (600)
T ss_pred CcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHH
Confidence 9999999999999999999999999998887777653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-19 Score=180.41 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=196.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 231 (435)
...|...+.||+|+|+.|-..... ...+|+|.+.... ...........|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 446788888999999999887764 3346666554332 23334466667888888887 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCcc
Q 013833 232 LITEYLRGGDLHKYL-KEKG-ALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 307 (435)
Q Consensus 232 lv~e~~~g~sL~~~l-~~~~-~~~~~~~~~~~~qi~~~l~~LH-~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~ 307 (435)
+++++..|+++.+.+ .... ..+...+.+++.|+..++.|+| ..+ +.||||||+|.++ +..+ .+++.|||+|.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l--~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLL--DESGSALKIADFGLAT 173 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchh--ccCCCcccCCCchhhc
Confidence 999999999999988 5443 5777888899999999999999 877 9999999999999 7777 99999999999
Q ss_pred cccccCccccccccCCCc-CccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHcCCC-CC
Q 013833 308 LIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA--KYVAEGHR-PF 382 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~-~~ 382 (435)
.+....+ ........+| ++.|+|||...+.. ..+..|+||.|+++..+++|..||......... ........ ..
T Consensus 174 ~~~~~~g-~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (601)
T KOG0590|consen 174 AYRNKNG-AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ 252 (601)
T ss_pred cccccCC-cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc
Confidence 8876221 2223445677 99999999998854 457899999999999999999999755433211 11111111 12
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHH
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~ 415 (435)
.+-..++....+++..++..+|..|.+.+++-.
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred CccccCChhhhhcccccccCCchhccccccccc
Confidence 223567888999999999999999999888653
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=153.09 Aligned_cols=110 Identities=13% Similarity=-0.017 Sum_probs=74.5
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCC-CHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~-tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
...|++++.+|..|.||+++ |+..+..+++++|++.|+++|.++..|+ ||||+|+..|+.+++++|+++|++. .|
T Consensus 81 L~~Gadvn~~d~~G~TpLh~--Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d 156 (284)
T PHA02791 81 LFSGMDDSQFDDKGNTALYY--AVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FD 156 (284)
T ss_pred HHCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--cc
Confidence 34566777777777777765 6666666777777777777777666664 6667666666666666666665432 12
Q ss_pred -cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 99 -RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 99 -~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
..|+||||+|+..|+.+++++|+++|++++..+..
T Consensus 157 ~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~ 192 (284)
T PHA02791 157 LAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSL 192 (284)
T ss_pred cccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccCC
Confidence 24677777777777777777777777777766543
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=145.56 Aligned_cols=117 Identities=21% Similarity=0.187 Sum_probs=78.4
Q ss_pred CCchhhhhhhhh-cccchhhhhhhh-cCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHH--cCcHHHHHHHHHcCCCcc
Q 013833 20 TSSADKQKEKAR-VSRTSLILWHAH-QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL--HGWIDVAKCLIEYGADVN 95 (435)
Q Consensus 20 ~~~~~~~~~~~~-~~~~~l~~~~a~-~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~--~~~~~~~~~Ll~~ga~~~ 95 (435)
.+.|++++.+++ .|.||+++.+.. .++..+++++|+++|+++|.+|..|.||||+|+. .++.+++++|+++|+++|
T Consensus 73 l~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin 152 (209)
T PHA02859 73 IENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFL 152 (209)
T ss_pred HHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcc
Confidence 356677777653 566777542221 2235677777777777777777777777777764 356777777777777777
Q ss_pred ccccCCCchhhH-hhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 96 AQDRWKNTPLAD-AEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 96 ~~~~~g~t~l~~-A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
.+|..|.||||. |+..++.+++++|+++|++++..+....+
T Consensus 153 ~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~t 194 (209)
T PHA02859 153 NKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYN 194 (209)
T ss_pred cccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence 777777777774 44566777777777777777666554443
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-17 Score=141.23 Aligned_cols=107 Identities=21% Similarity=0.213 Sum_probs=94.5
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCH---HHHHHHHHhCCCCCccCCC-CCCCHHHHHHHcCcHHHHHHHHH-cCCCcc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIE-YGADVN 95 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~---~~~~~lL~~~g~~~n~~d~-~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~ 95 (435)
..|++++.+|..|+||+++ |+..++. .+++++|++.|+++|.+|. .|+||||+|+..++.+++++|+. .|++++
T Consensus 48 ~~ga~in~~d~~g~T~Lh~-A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~ 126 (169)
T PHA02741 48 CHAAALNATDDAGQMCIHI-AAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLH 126 (169)
T ss_pred hhhhhhhccCCCCCcHHHH-HHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCC
Confidence 3578899999999999965 3444443 5888999999999999985 89999999999999999999998 599999
Q ss_pred ccccCCCchhhHhhhcCchhHHHHHHhcCCCCC
Q 013833 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
.+|.+|+||||+|...++.+++++|+++++...
T Consensus 127 ~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~~~ 159 (169)
T PHA02741 127 FCNADNKSPFELAIDNEDVAMMQILREIVATSR 159 (169)
T ss_pred cCCCCCCCHHHHHHHCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987543
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=138.45 Aligned_cols=120 Identities=21% Similarity=0.224 Sum_probs=101.2
Q ss_pred CCCCCchhhhhhhhhcccchhhhhhhhcCCHHH---HHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHH---HHHHHHc
Q 013833 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAA---VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV---AKCLIEY 90 (435)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~---~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~---~~~Ll~~ 90 (435)
.+...++++++..+.+++++++ +|+..++... ++++|.+.|+++|.+|..|+||||+||..|+.++ +++|+++
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~l~-~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~ 82 (166)
T PHA02743 4 NGTAGNNLGAVEIDEDEQNTFL-RICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNM 82 (166)
T ss_pred ccCcccchHHhhhccCCCcHHH-HHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHc
Confidence 3456788899999988888774 5677787764 4556788999999999999999999999988654 8999999
Q ss_pred CCCccccc-cCCCchhhHhhhcCchhHHHHHHh-cCCCCCCCCCCCCCC
Q 013833 91 GADVNAQD-RWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (435)
Q Consensus 91 ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~-~g~~~~~~n~~~~~~ 137 (435)
|+++|.+| ..|+||||+|+..++.+++++|+. .|++++.++.....|
T Consensus 83 Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tp 131 (166)
T PHA02743 83 GADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETA 131 (166)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCH
Confidence 99999998 589999999999999999999994 899988776655444
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=137.62 Aligned_cols=101 Identities=24% Similarity=0.240 Sum_probs=88.8
Q ss_pred hhhhhhcccchhhhhhhhcCCHH---HHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCccccccC
Q 013833 26 QKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRW 100 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~---~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~~~~~ 100 (435)
.+.+|+.|+|++++ |+..+.. +++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+. .|+++|.+|..
T Consensus 48 ~~~~d~~g~t~Lh~--a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~ 125 (154)
T PHA02736 48 VLEYNRHGKQCVHI--VSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYA 125 (154)
T ss_pred HHHhcCCCCEEEEe--ecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCC
Confidence 44567889999965 4444433 56889999999999998 489999999999999999999998 59999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
|+||||+|+..++.+++++|+++|++..
T Consensus 126 g~tpL~~A~~~~~~~i~~~Ll~~ga~~~ 153 (154)
T PHA02736 126 FKTPYYVACERHDAKMMNILRAKGAQCK 153 (154)
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=133.16 Aligned_cols=135 Identities=21% Similarity=0.227 Sum_probs=112.2
Q ss_pred CCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--CcceeeeeeEEeCCcEEEEEecCC
Q 013833 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 161 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
+++.||+|.++.||++...+..+++|....... ...+.+|+.+++.+++ .++++++.+....+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 356799999999999999888999998755432 3578889999999976 589999988887788999999998
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCC-CceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
|+.+..+ +......++.+++.+|.++|... ..++|+|++|.||++ +..+.++++|||.+...
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEecccccCC
Confidence 8777654 45566778899999999999842 239999999999999 66789999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=149.93 Aligned_cols=103 Identities=18% Similarity=0.098 Sum_probs=93.1
Q ss_pred hhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhh
Q 013833 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA 106 (435)
Q Consensus 27 ~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 106 (435)
+.+|..|+|||++ |+..+..+++++|++.|+++|..+ |+||||+|+..|+.+++++|+++|+++|.+|..|+||||
T Consensus 24 ~~~D~~G~TpLh~--Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh 99 (284)
T PHA02791 24 FKADVHGHSALYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALY 99 (284)
T ss_pred CCCCCCCCcHHHH--HHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence 3578889999976 777788899999999999998875 789999999999999999999999999999999999999
Q ss_pred HhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 107 DAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 107 ~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
+|+..|+.+++++|+++|++++.++..
T Consensus 100 ~Aa~~g~~eivk~Ll~~gadin~~~~~ 126 (284)
T PHA02791 100 YAVDSGNMQTVKLFVKKNWRLMFYGKT 126 (284)
T ss_pred HHHHcCCHHHHHHHHHCCCCcCccCCC
Confidence 999999999999999999988655443
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-17 Score=153.91 Aligned_cols=115 Identities=26% Similarity=0.316 Sum_probs=99.5
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
...|+++|.......|||. +||..++.+++++|+++|+|++..|..|.|.||+||+.||.+|+++|++.|||+|.++.
T Consensus 104 ~~~ga~VN~tT~TNStPLr--aACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~ 181 (615)
T KOG0508|consen 104 LRRGASVNDTTRTNSTPLR--AACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSY 181 (615)
T ss_pred HHhcCccccccccCCccHH--HHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcc
Confidence 4567788887777778874 58999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
.|+|+||.|++.|+.+++++|+++|+......- .++|
T Consensus 182 kGNTALH~caEsG~vdivq~Ll~~ga~i~~d~~-GmtP 218 (615)
T KOG0508|consen 182 KGNTALHDCAESGSVDIVQLLLKHGAKIDVDGH-GMTP 218 (615)
T ss_pred cCchHHHhhhhcccHHHHHHHHhCCceeeecCC-CCch
Confidence 999999999999999999999999986654332 4444
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.7e-17 Score=131.69 Aligned_cols=97 Identities=30% Similarity=0.281 Sum_probs=88.4
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
..+|.+|+++.|||+- |+++++.++++.|+..||+++++...||||||-||..++.+++-+||++|||||+..+..+|
T Consensus 88 n~vNtrD~D~YTpLHR--AaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~lt 165 (228)
T KOG0512|consen 88 NHVNTRDEDEYTPLHR--AAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLT 165 (228)
T ss_pred ccccccccccccHHHH--HHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccch
Confidence 3579999999999977 88999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCc-hhHHHHHHh
Q 013833 104 PLADAEGAKK-FNMMELLNA 122 (435)
Q Consensus 104 ~l~~A~~~~~-~~~~~~L~~ 122 (435)
|||+|+...+ ...+.+|+.
T Consensus 166 pLhlaa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 166 PLHLAAGNRNSRDTLELLLH 185 (228)
T ss_pred hhHHhhcccchHHHHHHHhh
Confidence 9999997655 455666664
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=136.71 Aligned_cols=111 Identities=22% Similarity=0.166 Sum_probs=92.3
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHH------hCCCCCccCCCCCCCHHHHHHHcCc----HHHHHHHHHcCCCc
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLE------EDQSLVHARDYDNRTPLHVASLHGW----IDVAKCLIEYGADV 94 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~------~~g~~~n~~d~~g~tpLh~Aa~~~~----~~~~~~Ll~~ga~~ 94 (435)
.++.++..|.|+++. |+..+..+++++|+ ..|+++|.+|..|+||||+|+..|+ .+++++|+++|+++
T Consensus 13 ~~~~~~~~g~t~Lh~--Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadi 90 (169)
T PHA02741 13 MIAEKNSEGENFFHE--AARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADI 90 (169)
T ss_pred HhhccccCCCCHHHH--HHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCC
Confidence 356678889999965 55555566666653 3478999999999999999999999 58999999999999
Q ss_pred ccccc-CCCchhhHhhhcCchhHHHHHHh-cCCCCCCCCCCCCCC
Q 013833 95 NAQDR-WKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (435)
Q Consensus 95 ~~~~~-~g~t~l~~A~~~~~~~~~~~L~~-~g~~~~~~n~~~~~~ 137 (435)
|.++. .|+||||+|+..++.+++++|+. .|++++..+.....|
T Consensus 91 n~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 91 NAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 99985 99999999999999999999997 588887776555443
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=140.36 Aligned_cols=109 Identities=17% Similarity=0.128 Sum_probs=92.6
Q ss_pred hhhhhhcccchhhhhhhhc-CCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHc---CcHHHHHHHHHcCCCccccccC
Q 013833 26 QKEKARVSRTSLILWHAHQ-NDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~-~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~---~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
++..+..|.||++. |+.. .+..+++++|+++|+++|.++ ..|.||||+|+.. ++.+++++|+++||++|.+|..
T Consensus 44 ~n~~~~~g~TpLh~-a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~ 122 (209)
T PHA02859 44 VNDCNDLYETPIFS-CLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDED 122 (209)
T ss_pred hhccCccCCCHHHH-HHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCC
Confidence 56778889999976 3322 347899999999999999997 4899999998864 4799999999999999999999
Q ss_pred CCchhhHhhh--cCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 101 KNTPLADAEG--AKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 101 g~t~l~~A~~--~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|.||||+|+. .++.+++++|+++|++++..+....
T Consensus 123 G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~ 159 (209)
T PHA02859 123 GKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNN 159 (209)
T ss_pred CCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCC
Confidence 9999999875 4689999999999999887665444
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=160.15 Aligned_cols=111 Identities=30% Similarity=0.341 Sum_probs=101.5
Q ss_pred CCchhhhhhhhhc-ccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARV-SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~-~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
...|++++.++.. |.|||+. |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|
T Consensus 154 l~~gadin~~~~~~g~tpLh~--A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d 231 (477)
T PHA02878 154 LSYGADINMKDRHKGNTALHY--ATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231 (477)
T ss_pred HHcCCCCCccCCCCCCCHHHH--HHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCC
Confidence 4568888999888 9999976 777788899999999999999999999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhc-CchhHHHHHHhcCCCCCCCCC
Q 013833 99 RWKNTPLADAEGA-KKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 99 ~~g~t~l~~A~~~-~~~~~~~~L~~~g~~~~~~n~ 132 (435)
..|+||||+|+.. ++.+++++|+++|++++.++.
T Consensus 232 ~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~ 266 (477)
T PHA02878 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSY 266 (477)
T ss_pred CCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCC
Confidence 9999999999975 689999999999999886653
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=157.12 Aligned_cols=113 Identities=26% Similarity=0.301 Sum_probs=102.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.++..|.||++. |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 112 ~~g~d~n~~~~~g~T~Lh~--A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~ 189 (434)
T PHA02874 112 DCGIDVNIKDAELKTFLHY--AIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNN 189 (434)
T ss_pred HCcCCCCCCCCCCccHHHH--HHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCC
Confidence 4577888889999999976 77777788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|+||||+|+..|+.+++++|++.|++++..+....
T Consensus 190 g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~ 224 (434)
T PHA02874 190 GESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGF 224 (434)
T ss_pred CCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCC
Confidence 99999999999999999999999998776654443
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.1e-16 Score=167.53 Aligned_cols=113 Identities=22% Similarity=0.193 Sum_probs=99.9
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHH----------------------
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL---------------------- 77 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~---------------------- 77 (435)
...|+++|..|..|+||||+ |+..++.+++++|+++|+++|.+|.+|+||||+|+.
T Consensus 545 l~~G~d~n~~d~~G~TpLh~--Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~ 622 (823)
T PLN03192 545 LKAKLDPDIGDSKGRTPLHI--AASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAA 622 (823)
T ss_pred HHCCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccC
Confidence 45788999999999999976 777788999999999999999999999999886554
Q ss_pred ---------cCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 78 ---------HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 78 ---------~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
.|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 623 ~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 623 GDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred chHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 555566777889999999999999999999999999999999999999998776554
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.5e-16 Score=149.46 Aligned_cols=95 Identities=25% Similarity=0.163 Sum_probs=81.4
Q ss_pred ccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcC
Q 013833 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK 112 (435)
Q Consensus 33 ~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 112 (435)
+.++++. |+.++..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++||++|.+|..|+||||+|+..|
T Consensus 188 ~~t~l~~--a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g 265 (437)
T PHA02795 188 QYTRGFL--VDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRG 265 (437)
T ss_pred ccchhHH--HHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcC
Confidence 4444443 77788889999999999999999999999999999999999999999999999999999999999999887
Q ss_pred --------chhHHHHHHhcCCCCCC
Q 013833 113 --------KFNMMELLNAHGGLSYG 129 (435)
Q Consensus 113 --------~~~~~~~L~~~g~~~~~ 129 (435)
+.+++++|++.|++++.
T Consensus 266 ~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 266 SVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred CcccccccHHHHHHHHHhCCCCCCc
Confidence 46899999988886653
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-16 Score=157.95 Aligned_cols=111 Identities=20% Similarity=0.176 Sum_probs=99.9
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhc-----CCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcC---cHHHHHHHHHc
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQ-----NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG---WIDVAKCLIEY 90 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~-----~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~---~~~~~~~Ll~~ 90 (435)
....|+++|.+|..|.||++. ++. .+..+++++|+++|+|+|.+|..|+||||+|+.++ +.+++++|+++
T Consensus 57 Ll~~Gadvn~~d~~g~TpL~~--~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~ 134 (489)
T PHA02798 57 FINLGANVNGLDNEYSTPLCT--ILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIEN 134 (489)
T ss_pred HHHCCCCCCCCCCCCCChHHH--HHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHc
Confidence 457899999999999999965 332 35689999999999999999999999999999875 78999999999
Q ss_pred CCCccccccCCCchhhHhhhcCc---hhHHHHHHhcCCCCCCCC
Q 013833 91 GADVNAQDRWKNTPLADAEGAKK---FNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 91 ga~~~~~~~~g~t~l~~A~~~~~---~~~~~~L~~~g~~~~~~n 131 (435)
|||+|.+|..|.||||+|+..++ .+++++|++.|++++..+
T Consensus 135 Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~ 178 (489)
T PHA02798 135 GADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178 (489)
T ss_pred CCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccccc
Confidence 99999999999999999999887 999999999999987654
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-16 Score=156.55 Aligned_cols=117 Identities=26% Similarity=0.249 Sum_probs=103.5
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcC---CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcC-cHHHHHHHHHcCCCc
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG-WIDVAKCLIEYGADV 94 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~---~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~-~~~~~~~Ll~~ga~~ 94 (435)
....|++++.++..|.||++. |+.. +..+++++|++.|+++|.+|..|.||||+|+..| +.+++++|+++|+++
T Consensus 33 Ll~~ga~vn~~~~~g~t~Lh~--a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~i 110 (471)
T PHA03095 33 LLAAGADVNFRGEYGKTPLHL--YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADV 110 (471)
T ss_pred HHHcCCCcccCCCCCCCHHHH--HHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCC
Confidence 356788999999999999976 3333 4999999999999999999999999999999999 599999999999999
Q ss_pred cccccCCCchhhHhh--hcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 95 NAQDRWKNTPLADAE--GAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 95 ~~~~~~g~t~l~~A~--~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
|.+|..|+||||+|+ ..++.+++++|++.|++++..+....+|
T Consensus 111 n~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~tp 155 (471)
T PHA03095 111 NAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTP 155 (471)
T ss_pred CCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence 999999999999999 5678899999999999998776655443
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=159.77 Aligned_cols=55 Identities=16% Similarity=0.085 Sum_probs=27.4
Q ss_pred CcHHHHHHHHHcCCCccccccCCCchhhHhhh--cCchhHHHHHHhcCCCCCCCCCC
Q 013833 79 GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG--AKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 79 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~--~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
|+.+++++|+++||++|.+|..|+||||+|+. .++.+++++|++.|++++.++..
T Consensus 295 g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~ 351 (764)
T PHA02716 295 IDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNI 351 (764)
T ss_pred CCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCC
Confidence 44455555555555555555555555554432 23445555555555555444433
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-16 Score=153.97 Aligned_cols=110 Identities=19% Similarity=0.128 Sum_probs=62.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc--HHHHHHHHHcCCCccc-c
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGADVNA-Q 97 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~--~~~~~~Ll~~ga~~~~-~ 97 (435)
+.|+++|.+|..|.|||++ |+..+..+++++|+++|+++|.+|..|.||||+|+..++ .+++++|+++||++|. .
T Consensus 60 ~~Gadvn~~d~~G~TpLh~--Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~ 137 (446)
T PHA02946 60 HRGYSPNETDDDGNYPLHI--ASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSV 137 (446)
T ss_pred HCcCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCccccc
Confidence 3455566666666666644 444445555666666666666666666666666555442 5566666666666653 4
Q ss_pred ccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
|..|.|||| |+..++.+++++|++.|++++..+..
T Consensus 138 d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 138 DEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CCCCCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 556666665 33445556666666666555544433
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.6e-16 Score=159.98 Aligned_cols=118 Identities=14% Similarity=0.066 Sum_probs=96.2
Q ss_pred CCCch-hhhhhh-hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc--HHHHHHHHHcCCCc
Q 013833 19 ATSSA-DKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGADV 94 (435)
Q Consensus 19 ~~~~~-~~~~~~-~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~--~~~~~~Ll~~ga~~ 94 (435)
.++.| +++|.+ ++.|.||++..++...+..+++++|+++|+++|.+|..|.||||+|+..|+ .++|++|+++|||+
T Consensus 161 LLe~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADV 240 (764)
T PHA02716 161 MVDVGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDM 240 (764)
T ss_pred HHHCCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCC
Confidence 34567 889988 888999997522233456789999999999999999999999999999995 59999999999999
Q ss_pred cccccCCCchhhHhh-------------------------------------hcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 95 NAQDRWKNTPLADAE-------------------------------------GAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 95 ~~~~~~g~t~l~~A~-------------------------------------~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|.+|..|+||||+|+ ..|+.+++++|++.|++++.++....+
T Consensus 241 N~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~T 319 (764)
T PHA02716 241 DMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRT 319 (764)
T ss_pred CCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCC
Confidence 999999999999753 346677778888888877666554443
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=109.13 Aligned_cols=55 Identities=42% Similarity=0.484 Sum_probs=33.7
Q ss_pred HHhCC-CCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHh
Q 013833 54 LEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (435)
Q Consensus 54 L~~~g-~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (435)
|++.| +++|.+|..|.||||+||..|+.+++++|+++|+|++.+|.+|+||||+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 45666 89999999999999999999999999999999999999999999999997
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.4e-16 Score=151.32 Aligned_cols=111 Identities=23% Similarity=0.209 Sum_probs=100.3
Q ss_pred CCCchhhhhhhh-hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc
Q 013833 19 ATSSADKQKEKA-RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (435)
Q Consensus 19 ~~~~~~~~~~~~-~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~ 97 (435)
.+++|+++|... .-+.||+|+ |+++++..++.+|+++|||++.+|..|.||||+||..|+.-+|-+||.+|+|+|.+
T Consensus 97 li~~gadvn~~gG~l~stPLHW--Aar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~ 174 (600)
T KOG0509|consen 97 LISHGADVNAIGGVLGSTPLHW--AARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLR 174 (600)
T ss_pred HHHcCCCccccCCCCCCCcchH--HHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCc
Confidence 367899999988 556677755 66677788889999999999999999999999999999999999999999999999
Q ss_pred ccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
|..|.||||+|+.+|+...+..|++.|+.+...+
T Consensus 175 D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d 208 (600)
T KOG0509|consen 175 DNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTD 208 (600)
T ss_pred CCCCCCHHHHHHHhcccHHHHHHHHhcccccccc
Confidence 9999999999999999888999999999887665
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-16 Score=132.94 Aligned_cols=110 Identities=23% Similarity=0.219 Sum_probs=99.0
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
..+|..|++|.|||++ || ..++..++++|++.|++++..-+...|+|++|+..|..+||++||+.+.|||..|-+|-|
T Consensus 151 n~VN~~De~GfTpLiW-Aa-a~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgT 228 (296)
T KOG0502|consen 151 NKVNACDEFGFTPLIW-AA-AKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGT 228 (296)
T ss_pred ccccCccccCchHhHH-HH-hcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCc
Confidence 3578889999999964 44 456677888999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
||-+|+.-||.++++.|++.|+++...+.+.+
T Consensus 229 pLlyAvrgnhvkcve~Ll~sGAd~t~e~dsGy 260 (296)
T KOG0502|consen 229 PLLYAVRGNHVKCVESLLNSGADVTQEDDSGY 260 (296)
T ss_pred eeeeeecCChHHHHHHHHhcCCCcccccccCC
Confidence 99999999999999999999999987766655
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=151.35 Aligned_cols=102 Identities=24% Similarity=0.154 Sum_probs=88.9
Q ss_pred hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHh
Q 013833 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (435)
.+..|.||+++ |+..+..+++++|++.|+++|.++..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|
T Consensus 98 ~~~~g~tpL~~--A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A 175 (413)
T PHA02875 98 FYKDGMTPLHL--ATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIA 175 (413)
T ss_pred ccCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 34567888865 6666777889999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCchhHHHHHHhcCCCCCCCCC
Q 013833 109 EGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 109 ~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
+..|+.+++++|++.|++++..+.
T Consensus 176 ~~~g~~eiv~~Ll~~ga~~n~~~~ 199 (413)
T PHA02875 176 MAKGDIAICKMLLDSGANIDYFGK 199 (413)
T ss_pred HHcCCHHHHHHHHhCCCCCCcCCC
Confidence 999999999999999998875543
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=111.40 Aligned_cols=90 Identities=24% Similarity=0.365 Sum_probs=80.0
Q ss_pred hhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHH
Q 013833 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME 118 (435)
Q Consensus 39 ~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~ 118 (435)
.|....|...++.+.. ..|-|||.+- .|+||||+||..|.++++++|+..||+|+.+|+.|-|||--|...||.++|+
T Consensus 7 ~W~vkNG~~DeVk~~v-~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVk 84 (117)
T KOG4214|consen 7 AWNVKNGEIDEVKQSV-NEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVK 84 (117)
T ss_pred hhhhccCcHHHHHHHH-HccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHH
Confidence 4666777777777777 5568888874 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 013833 119 LLNAHGGLSYGQ 130 (435)
Q Consensus 119 ~L~~~g~~~~~~ 130 (435)
+|++.|++....
T Consensus 85 lLL~~GAdrt~~ 96 (117)
T KOG4214|consen 85 LLLQNGADRTIH 96 (117)
T ss_pred HHHHcCccccee
Confidence 999999986544
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.2e-16 Score=142.30 Aligned_cols=101 Identities=24% Similarity=0.215 Sum_probs=89.5
Q ss_pred CCCchhhhhhhh----hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013833 19 ATSSADKQKEKA----RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGAD 93 (435)
Q Consensus 19 ~~~~~~~~~~~~----~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~ 93 (435)
..+.|++++.++ +.|.||++. |+..+..+++++|+++|+++|.++ ..|.||||+|+..|+.+++++|+++||+
T Consensus 52 LL~~GAdiN~~~~~sd~~g~TpLh~--Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAd 129 (300)
T PHA02884 52 ILKLGADPEAPFPLSENSKTNPLIY--AIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGAD 129 (300)
T ss_pred HHHCCCCccccCcccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCC
Confidence 457888998874 588999966 666777889999999999999964 6899999999999999999999999999
Q ss_pred ccccccCCCchhhHhhhcCchhHHHHHH
Q 013833 94 VNAQDRWKNTPLADAEGAKKFNMMELLN 121 (435)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (435)
+|.+|..|+||||+|+..++.+++.++.
T Consensus 130 in~kd~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 130 INIQTNDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred CCCCCCCCCCHHHHHHHhCChhHHHHhc
Confidence 9999999999999999988888876665
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=154.32 Aligned_cols=114 Identities=25% Similarity=0.247 Sum_probs=102.2
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~-~~~~~~~~Ll~~ga~~~~~~ 98 (435)
...|++++..|..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+.. ++.+++++|+++|+++|.++
T Consensus 188 l~~gad~n~~d~~g~tpLh~--A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~ 265 (477)
T PHA02878 188 LSYGANVNIPDKTNNSPLHH--AVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKS 265 (477)
T ss_pred HHCCCCCCCcCCCCCCHHHH--HHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence 45688999999999999976 7777888999999999999999999999999999976 78999999999999999998
Q ss_pred c-CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 99 R-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 99 ~-~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
. .|.||||+| .++.+++++|+++|++++..+....+|
T Consensus 266 ~~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 266 YILGLTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CCCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 6 899999999 467899999999999998887665544
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=157.66 Aligned_cols=109 Identities=19% Similarity=0.154 Sum_probs=96.0
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCC---CC-----------CCHHHHHHH-------
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY---DN-----------RTPLHVASL------- 77 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~---~g-----------~tpLh~Aa~------- 77 (435)
.++.|+++|.+|..|+||++.++|+.+++.+++++|+++|+++|.+|. .| .||||+|+.
T Consensus 122 Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~ 201 (661)
T PHA02917 122 LVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLYSES 201 (661)
T ss_pred HHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHHHhhcccccc
Confidence 357899999999999999987777888999999999999999987653 34 599999986
Q ss_pred ----cCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCch--hHHHHHHhcCCCCC
Q 013833 78 ----HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF--NMMELLNAHGGLSY 128 (435)
Q Consensus 78 ----~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~--~~~~~L~~~g~~~~ 128 (435)
+++.+++++|+++|||+|.+|.+|+||||+|+..|+. +++++|++ |+++.
T Consensus 202 ~~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~~ 257 (661)
T PHA02917 202 DTRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDNT 257 (661)
T ss_pred cccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCccc
Confidence 5689999999999999999999999999999999985 79999975 77654
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-15 Score=148.93 Aligned_cols=96 Identities=24% Similarity=0.205 Sum_probs=86.8
Q ss_pred cchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcC-
Q 013833 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK- 112 (435)
Q Consensus 34 ~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~- 112 (435)
.+.++.+++..+...+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|||+|.+|..|+||||+|+..+
T Consensus 38 ~~~Lh~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~ 117 (446)
T PHA02946 38 YHILHAYCGIKGLDERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDD 117 (446)
T ss_pred ChHHHHHHHhcCCCHHHHHHHHHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCC
Confidence 4566655566777889999999999999999999999999999999999999999999999999999999999998765
Q ss_pred -chhHHHHHHhcCCCCCC
Q 013833 113 -KFNMMELLNAHGGLSYG 129 (435)
Q Consensus 113 -~~~~~~~L~~~g~~~~~ 129 (435)
..+++++|+++|++++.
T Consensus 118 ~~~e~v~lLl~~Gadin~ 135 (446)
T PHA02946 118 EVIERINLLVQYGAKINN 135 (446)
T ss_pred chHHHHHHHHHcCCCccc
Confidence 47899999999999874
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-15 Score=150.35 Aligned_cols=108 Identities=19% Similarity=0.177 Sum_probs=99.3
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
...|++++.++..|.||+++ |+..+..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++||++|..+.
T Consensus 122 l~~gad~~~~~~~g~tpLh~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~ 199 (413)
T PHA02875 122 IARGADPDIPNTDKFSPLHL--AVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGK 199 (413)
T ss_pred HhCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCC
Confidence 45688899999999999976 7677778889999999999999999999999999999999999999999999999998
Q ss_pred CCC-chhhHhhhcCchhHHHHHHhcCCCCCC
Q 013833 100 WKN-TPLADAEGAKKFNMMELLNAHGGLSYG 129 (435)
Q Consensus 100 ~g~-t~l~~A~~~~~~~~~~~L~~~g~~~~~ 129 (435)
.|. ||+|+|+..++.+++++|+++|++++.
T Consensus 200 ~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 200 NGCVAALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred CCCchHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 875 889999999999999999999998864
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=151.71 Aligned_cols=117 Identities=20% Similarity=0.106 Sum_probs=97.0
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcH--HHHHHHHHcCCCccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI--DVAKCLIEYGADVNAQD 98 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~--~~~~~Ll~~ga~~~~~~ 98 (435)
..|++++..|..|.|++++.+....+...++++|++.|+++|.+|..|+||||+||..|+. .+++.|++.|+++|.+|
T Consensus 175 ~~g~~~~~~d~~g~t~Lh~~~~~~~~~~~i~~~Ll~~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d 254 (471)
T PHA03095 175 DAGADVYAVDDRFRSLLHHHLQSFKPRARIVRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARN 254 (471)
T ss_pred HcCCCCcccCCCCCCHHHHHHHHCCCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcC
Confidence 4566666667778888876555556777888888899999999999999999999998874 68888999999999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
..|+||||+|+..|+.+++++|++.|++++..+....+|
T Consensus 255 ~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~tp 293 (471)
T PHA03095 255 RYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTP 293 (471)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 999999999999999999999999999988776655443
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=152.22 Aligned_cols=105 Identities=19% Similarity=0.220 Sum_probs=47.3
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcC------cHHHHHHHHHcCCCc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG------WIDVAKCLIEYGADV 94 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~------~~~~~~~Ll~~ga~~ 94 (435)
..|+++|.. ..|.|+++++++..++..+++++|+++|+++|.++ .+.||||.|+.++ +.+++++|+++|||+
T Consensus 24 ~~GadvN~~-~~g~t~l~~~~~~~~~~~~iv~~Ll~~GAdvn~~~-~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadi 101 (494)
T PHA02989 24 RTGFDVNEE-YRGNSILLLYLKRKDVKIKIVKLLIDNGADVNYKG-YIETPLCAVLRNREITSNKIKKIVKLLLKFGADI 101 (494)
T ss_pred HcCCCcccc-cCCCCHHHHHHhcCCCChHHHHHHHHcCCCccCCC-CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCC
Confidence 344444444 33444444333333334444444445555554443 3344555444322 234455555555555
Q ss_pred cccccCCCchhhHhhhc---CchhHHHHHHhcCCCC
Q 013833 95 NAQDRWKNTPLADAEGA---KKFNMMELLNAHGGLS 127 (435)
Q Consensus 95 ~~~~~~g~t~l~~A~~~---~~~~~~~~L~~~g~~~ 127 (435)
|.+|..|+||||.|+.. ++.+++++|+++|+++
T Consensus 102 n~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadi 137 (494)
T PHA02989 102 NLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINV 137 (494)
T ss_pred CCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCc
Confidence 55554555555444322 3444455555555444
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-15 Score=152.24 Aligned_cols=111 Identities=27% Similarity=0.276 Sum_probs=59.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCC--HHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~--~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
..|++++..+..|.|+++. |+..+ ..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus 129 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 206 (480)
T PHA03100 129 DNGANVNIKNSDGENLLHL--YLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGD 206 (480)
T ss_pred HcCCCCCccCCCCCcHHHH--HHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCC
Confidence 4455555555555555543 33333 5555555555555555555555555555555555555555555555555555
Q ss_pred cCC------CchhhHhhhcCc--hhHHHHHHhcCCCCCCCCCC
Q 013833 99 RWK------NTPLADAEGAKK--FNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 99 ~~g------~t~l~~A~~~~~--~~~~~~L~~~g~~~~~~n~~ 133 (435)
..| .||||+|+..++ .+++++|+++|++++.++..
T Consensus 207 ~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~ 249 (480)
T PHA03100 207 IETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVY 249 (480)
T ss_pred CCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCC
Confidence 555 555555555555 55555555555555444433
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-15 Score=151.26 Aligned_cols=112 Identities=20% Similarity=0.261 Sum_probs=96.0
Q ss_pred CCchhhhhhhhhcccchhhhhhhh--cCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcC--cHHHHHHHHHcCCCcc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--WIDVAKCLIEYGADVN 95 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~--~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~--~~~~~~~Ll~~ga~~~ 95 (435)
...|++++..+..|.||+++ |+ ..+..+++++|++.|+++|..|..|.||||+|+..| +.+++++|+++|+++|
T Consensus 93 l~~ga~i~~~d~~g~tpL~~--A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din 170 (480)
T PHA03100 93 LEYGANVNAPDNNGITPLLY--AISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDIN 170 (480)
T ss_pred HHCCCCCCCCCCCCCchhhH--HHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcc
Confidence 34577788888888888866 66 788888888898999999999999999999999999 8999999999999999
Q ss_pred ccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
.+|..|.||||+|+..|+.+++++|+++|++++..+..
T Consensus 171 ~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~ 208 (480)
T PHA03100 171 AKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIE 208 (480)
T ss_pred cccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCC
Confidence 99999999999999999999999999999888765443
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.9e-15 Score=151.49 Aligned_cols=108 Identities=19% Similarity=0.167 Sum_probs=78.6
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcC--CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc---HHHHHHHHHcCCCc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQN--DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW---IDVAKCLIEYGADV 94 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~--~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~---~~~~~~Ll~~ga~~ 94 (435)
...|+++|.+|..|.||++. |+..+ +..+++++|+++|+++|.+|..|.||||+|+..|+ .+++++|+++|+|+
T Consensus 96 l~~GadiN~~d~~G~TpLh~-a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadi 174 (489)
T PHA02798 96 IENGADINKKNSDGETPLYC-LLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDI 174 (489)
T ss_pred HHCCCCCCCCCCCcCcHHHH-HHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCc
Confidence 46788889999999999865 33322 47788899999999999999999999999998887 88888888888887
Q ss_pred cccc-cCCCchhhHhhhc----CchhHHHHHHhcCCCCC
Q 013833 95 NAQD-RWKNTPLADAEGA----KKFNMMELLNAHGGLSY 128 (435)
Q Consensus 95 ~~~~-~~g~t~l~~A~~~----~~~~~~~~L~~~g~~~~ 128 (435)
|.++ ..|.||||.+... ++.+++++|+++|++++
T Consensus 175 n~~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~ 213 (489)
T PHA02798 175 NTHNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIIN 213 (489)
T ss_pred ccccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcc
Confidence 7664 3455555555432 24555555555555443
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.2e-15 Score=140.87 Aligned_cols=95 Identities=27% Similarity=0.337 Sum_probs=90.2
Q ss_pred hhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHH
Q 013833 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME 118 (435)
Q Consensus 39 ~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~ 118 (435)
+|||+.-++.+++++|+++|++||.......|||--||+-|++|+||+|+++|||++..|+.|+|-||+|+.+||.+|++
T Consensus 88 LWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~q 167 (615)
T KOG0508|consen 88 LWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQ 167 (615)
T ss_pred hhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHH
Confidence 68888889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCC
Q 013833 119 LLNAHGGLSYGQNGS 133 (435)
Q Consensus 119 ~L~~~g~~~~~~n~~ 133 (435)
+|++.|+|++...-.
T Consensus 168 yLle~gADvn~ks~k 182 (615)
T KOG0508|consen 168 YLLEQGADVNAKSYK 182 (615)
T ss_pred HHHHhCCCcchhccc
Confidence 999999999865543
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.9e-15 Score=150.77 Aligned_cols=112 Identities=13% Similarity=0.096 Sum_probs=75.4
Q ss_pred CCchhhhhhhhhcccchhhhhh-hhcCCHHHHHHHHHhCCCCC-ccCCCCCCCHHHHHHHc--CcHHHHHHHHHcCCCcc
Q 013833 20 TSSADKQKEKARVSRTSLILWH-AHQNDAAAVRKLLEEDQSLV-HARDYDNRTPLHVASLH--GWIDVAKCLIEYGADVN 95 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~-a~~~~~~~~~~lL~~~g~~~-n~~d~~g~tpLh~Aa~~--~~~~~~~~Ll~~ga~~~ 95 (435)
.+.|+++|.++..|.||++..+ ++..+..+++++|+++|+|+ +.+|..|+||||+|+.. ++.+++++|+++|||++
T Consensus 95 l~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~ 174 (494)
T PHA02989 95 LKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLF 174 (494)
T ss_pred HHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcc
Confidence 3677777777777777775421 22335667777777777777 67777777777776543 56777777777777777
Q ss_pred c-cccCCCchhhHhhhc----CchhHHHHHHhcCCCCCCCC
Q 013833 96 A-QDRWKNTPLADAEGA----KKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 96 ~-~~~~g~t~l~~A~~~----~~~~~~~~L~~~g~~~~~~n 131 (435)
. .+..|.||||+|+.. ++.+++++|++.|++++..+
T Consensus 175 ~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~ 215 (494)
T PHA02989 175 EKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN 215 (494)
T ss_pred ccccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC
Confidence 6 566777777766544 36677777777776665433
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=159.76 Aligned_cols=110 Identities=27% Similarity=0.233 Sum_probs=103.8
Q ss_pred CCCCCCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCc
Q 013833 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94 (435)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~ 94 (435)
+......+|++++.++..+.|||+. |+..++..++++|+++|+|+|.+|+.|+||||.||..|+.+|+++|+++||+|
T Consensus 522 ~~~~l~~~ga~v~~~~~r~~TpLh~--A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~v 599 (1143)
T KOG4177|consen 522 VAKILLEHGANVDLRTGRGYTPLHV--AVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASV 599 (1143)
T ss_pred HHHHHhhcCCceehhcccccchHHH--HHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCC
Confidence 4455678899999999999999987 88888899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCchhhHhhhcCchhHHHHHHhcCCC
Q 013833 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 95 ~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
|..|.+|.|||++|...|+.++++.|+..++.
T Consensus 600 na~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~ 631 (1143)
T KOG4177|consen 600 NAADLDGFTPLHIAVRLGYLSVVKLLKVVTAT 631 (1143)
T ss_pred CcccccCcchhHHHHHhcccchhhHHHhccCc
Confidence 99999999999999999999999999999988
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-15 Score=136.13 Aligned_cols=97 Identities=28% Similarity=0.280 Sum_probs=79.3
Q ss_pred hhhhhh-hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCccccccCCC
Q 013833 25 KQKEKA-RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKN 102 (435)
Q Consensus 25 ~~~~~~-~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~-ga~~~~~~~~g~ 102 (435)
|+|++. ..|.|+||+ |...+..++++.|+.+|+|||.+|.+|.|+||+||.+||.||+++||.. ++|+...|.+|.
T Consensus 331 nVNaKAsQ~gQTALML--AVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgS 408 (452)
T KOG0514|consen 331 DVNAKASQHGQTALML--AVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGS 408 (452)
T ss_pred Ccchhhhhhcchhhhh--hhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCc
Confidence 566654 567788888 8888888888888888888888888888888888888888888888864 688888888888
Q ss_pred chhhHhhhcCchhHHHHHHhc
Q 013833 103 TPLADAEGAKKFNMMELLNAH 123 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ 123 (435)
|+|.+|...||.||.-+|-.+
T Consensus 409 TAl~IAleagh~eIa~mlYa~ 429 (452)
T KOG0514|consen 409 TALSIALEAGHREIAVMLYAH 429 (452)
T ss_pred hhhhhHHhcCchHHHHHHHHH
Confidence 888888888888887766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4e-15 Score=134.35 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=141.9
Q ss_pred HHHHhCCCCcceeeeeeEEeC-----CcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCc
Q 013833 207 NLLVKLRHPNIVQFLGAVTER-----KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNV 277 (435)
Q Consensus 207 ~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ 277 (435)
.-+.++-|.||++++.++.+. ....++.|||..|+|.++|++ ...+......+|+-||++||.|||+..++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345566799999999998654 457899999999999999986 23478888889999999999999999999
Q ss_pred eEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 013833 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (435)
Q Consensus 278 ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 357 (435)
|+|+++...-|++ ..+|-||+.--.....-..-............+.++|.+||.=.....+..+|||+||....+|.
T Consensus 199 iihgnlTc~tifi--q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFI--QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheee--cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999 78888886421111110000000111112234678899999876667778899999999999998
Q ss_pred cCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 358 EGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPE-LRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 358 tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
-+..-- ...........+..-.. ++... =+.++..|++..|..||++++++-|.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~------~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII------GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee------eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 776542 22221111111111100 11112 25789999999999999999998663
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.7e-15 Score=143.74 Aligned_cols=117 Identities=12% Similarity=-0.025 Sum_probs=98.2
Q ss_pred CCCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCC-ccCC-----CCCCCHHHHHHHcCcHHHHHHHHHcC
Q 013833 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-HARD-----YDNRTPLHVASLHGWIDVAKCLIEYG 91 (435)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~-n~~d-----~~g~tpLh~Aa~~~~~~~~~~Ll~~g 91 (435)
..+++|++++.+ .+.|+++. |+..+..+++++|+++|++. |..+ ..|.|++|.|+..++.+++++|+++|
T Consensus 136 ~LI~~GADIn~~--~~~t~lh~--A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~G 211 (437)
T PHA02795 136 FMVDHGAVIYKI--ECLNAYFR--GICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYI 211 (437)
T ss_pred HHHHCCCCCCCC--CCCCHHHH--HHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCc
Confidence 356788888874 34677754 77778889999999999844 3332 34789999999999999999999999
Q ss_pred CCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 92 a~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
||+|.+|..|.||||+|+..|+.+++++|+++|++++.++....+|.
T Consensus 212 ADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpL 258 (437)
T PHA02795 212 EDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCL 258 (437)
T ss_pred CCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 99999999999999999999999999999999999998877666543
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.4e-15 Score=146.93 Aligned_cols=112 Identities=26% Similarity=0.287 Sum_probs=74.6
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCC-----------------------CCCccCCCCCCCHHHHHH
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-----------------------SLVHARDYDNRTPLHVAS 76 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g-----------------------~~~n~~d~~g~tpLh~Aa 76 (435)
...|++++..+..+.||++. |+..+..+++++|+++| +++|.+|..|.||||+|+
T Consensus 55 l~~Ga~~n~~~~~~~t~L~~--A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~ 132 (434)
T PHA02874 55 IKHGADINHINTKIPHPLLT--AIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAI 132 (434)
T ss_pred HHCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHH
Confidence 34566666666666666654 44444555555555443 445666677777777777
Q ss_pred HcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 77 LHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 77 ~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
..|+.+++++|+++|+++|.+|..|.||||+|+..++.+++++|++.|++++..+..
T Consensus 133 ~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~ 189 (434)
T PHA02874 133 KKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNN 189 (434)
T ss_pred HCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCC
Confidence 777777777777777777777777777777777777777777777777766554433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-15 Score=146.13 Aligned_cols=250 Identities=24% Similarity=0.261 Sum_probs=189.7
Q ss_pred CCCCCCceeec--CCceeEEEEEE----CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGK--GSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~--G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 229 (435)
..|.....+|. |.+|.||.+.. .+..+|+|.-+......... .+-.+|+.-...++ |++.++.+..+..++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCcccccCCc
Confidence 35667778999 99999999876 36678998754444322221 23345666666664 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHhcCCCceEeCCCCCCcEEEecCCC-CcEEEeec
Q 013833 230 LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR----GMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDF 303 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~~~~qi~~----~l~~LH~~~~~ivH~Dlkp~NIll~~~~~-~~vkl~Df 303 (435)
.++-+|++ +.+|..+...... ++...++....+..+ ||..+|+.+ ++|-|+||.||+. ..+ ...+++||
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~--~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFT--TSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheec--ccccceeecCCc
Confidence 99999988 6799999987655 788899999999999 999999977 9999999999999 566 68999999
Q ss_pred cCcccccccCcccccc-ccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCC
Q 013833 304 GLSKLIKVQNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHR 380 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~ 380 (435)
|+...+....-..+.. .....|...|++||... ..++..+|+|++|.++.+..++..++... ..+. .+..++.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---~~r~~~i 343 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---QLRQGYI 343 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---ccccccC
Confidence 9999888765333322 22236788999999875 66788899999999999999988766433 2211 1222333
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.......+.+++..+..+++.+|-.|++++.+..+
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 332334557778889999999999999999887643
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.1e-15 Score=154.79 Aligned_cols=110 Identities=22% Similarity=0.198 Sum_probs=54.8
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc-HHHHHHHHHcCCCccccccCCC
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDRWKN 102 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~-~~~~~~Ll~~ga~~~~~~~~g~ 102 (435)
++++.+|..|.||+++ |+..+..+++++|++.|++++..+..|.||||+|+..++ .+++++|+++|+++|.+|.+|+
T Consensus 366 adin~~d~~G~TpLh~--Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~ 443 (682)
T PHA02876 366 ANVNARDYCDKTPIHY--AAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLS 443 (682)
T ss_pred CCCccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCC
Confidence 3344444444444433 333333444444444444444444444444444443322 3345555555566666666666
Q ss_pred chhhHhhhcC-chhHHHHHHhcCCCCCCCCCCCC
Q 013833 103 TPLADAEGAK-KFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 103 t~l~~A~~~~-~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
||||+|+..+ +.+++++|+++|++++..+....
T Consensus 444 TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~ 477 (682)
T PHA02876 444 TPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQ 477 (682)
T ss_pred hHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCC
Confidence 6666666544 45666666666666655554433
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.7e-15 Score=149.19 Aligned_cols=112 Identities=15% Similarity=0.123 Sum_probs=94.5
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCH---HHHHHHHHhCCC--CCccCCCCCCCHHHH---HHHcC---------cH
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQS--LVHARDYDNRTPLHV---ASLHG---------WI 81 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~---~~~~~lL~~~g~--~~n~~d~~g~tpLh~---Aa~~~---------~~ 81 (435)
.+++|+++|.. ..|.|||+. ||..++. .+++++|+++|+ ++|.+|..|.||||. |+..+ ..
T Consensus 365 LIs~GAdIN~k-~~G~TpLH~-Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~ 442 (672)
T PHA02730 365 MLDNGATMDKT-TDNNYPLHD-YFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILI 442 (672)
T ss_pred HHHCCCCCCcC-CCCCcHHHH-HHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHH
Confidence 46789999985 789999965 4444432 899999999998 699999999999994 43332 23
Q ss_pred HHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCC
Q 013833 82 DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 82 ~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
+++++|+++|||+|++|..|+||||+|+..++.+++++|+++|++++..+.
T Consensus 443 ~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 443 DVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred HHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 679999999999999999999999999999999999999999999887764
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-14 Score=152.26 Aligned_cols=113 Identities=36% Similarity=0.431 Sum_probs=98.5
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
..+...+.+-+++++ +..-+...+...++++|++++.++..|.||||+||.+|+.++|++||++|||++++++.|+||
T Consensus 499 ~~~~~~~~~l~~lhl--a~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TP 576 (1143)
T KOG4177|consen 499 NDNLDAKKGLTPLHL--AADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTP 576 (1143)
T ss_pred ccCccchhccchhhh--hhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCCh
Confidence 344444555666655 666667777888889999999999999999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~~ 139 (435)
||.|+..|+.+++++|+++|++++..+...++|..
T Consensus 577 LH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~ 611 (1143)
T KOG4177|consen 577 LHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLH 611 (1143)
T ss_pred hhHHHHcChHHHHHHHHHcCCCCCcccccCcchhH
Confidence 99999999999999999999999988887776654
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.1e-15 Score=124.30 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=84.4
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCC-------CCccCCCCCCCHHHHHHHcCcH---HHHHHHHHcCCCc
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-------LVHARDYDNRTPLHVASLHGWI---DVAKCLIEYGADV 94 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~-------~~n~~d~~g~tpLh~Aa~~~~~---~~~~~Ll~~ga~~ 94 (435)
..+.+|..|.|||++ |+..|+ +++++...+. .++.+|..|+||||+||..|+. +++++|+++|+++
T Consensus 9 ~~~~~d~~g~tpLh~-A~~~g~---~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadi 84 (154)
T PHA02736 9 FASEPDIEGENILHY-LCRNGG---VTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADI 84 (154)
T ss_pred HHHhcCCCCCCHHHH-HHHhCC---HHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCc
Confidence 356678889999854 555555 3344433322 2345788999999999999987 5689999999999
Q ss_pred cccc-cCCCchhhHhhhcCchhHHHHHHh-cCCCCCCCCCCCCCC
Q 013833 95 NAQD-RWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (435)
Q Consensus 95 ~~~~-~~g~t~l~~A~~~~~~~~~~~L~~-~g~~~~~~n~~~~~~ 137 (435)
|.+| ..|+||||+|+..++.+++++|+. .|++++.++....+|
T Consensus 85 n~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tp 129 (154)
T PHA02736 85 NGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTP 129 (154)
T ss_pred cccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCH
Confidence 9998 599999999999999999999997 588887666554433
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.6e-14 Score=144.45 Aligned_cols=108 Identities=22% Similarity=0.199 Sum_probs=92.7
Q ss_pred CCchh--hhhhhhhcccchhhh-hhhhcCC---------HHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHH
Q 013833 20 TSSAD--KQKEKARVSRTSLIL-WHAHQND---------AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87 (435)
Q Consensus 20 ~~~~~--~~~~~~~~~~~~l~~-~~a~~~~---------~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~L 87 (435)
++.|+ +++.+|..|.|+++. +++...+ ..+++++|+++|+++|.+|..|.||||+|+..++.+++++|
T Consensus 402 Is~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~L 481 (672)
T PHA02730 402 VENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRL 481 (672)
T ss_pred HHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHH
Confidence 34565 688999999999962 2343221 23578999999999999999999999999999999999999
Q ss_pred HHcCCCcccccc-CCCchhhHhhhc--CchhHHHHHHhcCCCC
Q 013833 88 IEYGADVNAQDR-WKNTPLADAEGA--KKFNMMELLNAHGGLS 127 (435)
Q Consensus 88 l~~ga~~~~~~~-~g~t~l~~A~~~--~~~~~~~~L~~~g~~~ 127 (435)
+++||++|.+|. .|+||||+|+.. ++.+++++|+++|++.
T Consensus 482 I~~GAdIN~~d~~~g~TaL~~Aa~~~~~~~eIv~~LLs~ga~i 524 (672)
T PHA02730 482 LEYGASVNTTSRSIINTAIQKSSYRRENKTKLVDLLLSYHPTL 524 (672)
T ss_pred HHCCCCCCCCCCcCCcCHHHHHHHhhcCcHHHHHHHHHcCCCH
Confidence 999999999997 599999999874 7899999999999865
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-14 Score=142.65 Aligned_cols=112 Identities=25% Similarity=0.238 Sum_probs=92.3
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHH-hCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcc---
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE-EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--- 95 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~-~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~--- 95 (435)
...|++++.+.+++.||++ .||..|....+.++|. ......|..|..|.||||+|+..||.+++++||..||+.+
T Consensus 293 l~~Ga~I~~kn~d~~spLH-~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~ 371 (929)
T KOG0510|consen 293 LGFGASINSKNKDEESPLH-FAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMS 371 (929)
T ss_pred HHcCCcccccCCCCCCchH-HHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhccc
Confidence 4578888888888888885 4677777777777776 3345778889999999999999999999999999998887
Q ss_pred ccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCC
Q 013833 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
..|.+|.||||.|+..|+..+|+.|+.+|+++...+.
T Consensus 372 e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~ 408 (929)
T KOG0510|consen 372 EADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNK 408 (929)
T ss_pred ccccCCchhhhHHHHhccHHHHHHHHHcCCceeeccc
Confidence 4589999999999999999999999999998855443
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.3e-14 Score=98.44 Aligned_cols=54 Identities=41% Similarity=0.574 Sum_probs=46.3
Q ss_pred CCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHH
Q 013833 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (435)
Q Consensus 68 g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (435)
|+||||+||..|+.+++++|++.|+|+|.+|.+|.||||+|+..|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 789999999999999999999999999999999999999999999999999985
|
... |
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.3e-14 Score=149.73 Aligned_cols=113 Identities=26% Similarity=0.179 Sum_probs=83.2
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~-~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
..|++++.+|..|.||+++ |+..|...+++++|+..|+++|.+|..|.||||+|+.. ++.+++++|++.|+++|.+|.
T Consensus 295 ~~gadin~~d~~g~TpLh~-Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~ 373 (682)
T PHA02876 295 ERGADVNAKNIKGETPLYL-MAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDY 373 (682)
T ss_pred HCCCCCCCcCCCCCCHHHH-HHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCC
Confidence 4677777778788888754 44444456777777777888887777788888887774 457777777778888888888
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
.|+||||+|+..++.+++++|+++|++++..+...
T Consensus 374 ~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g 408 (682)
T PHA02876 374 CDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKI 408 (682)
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCC
Confidence 88888888887778888888887777776555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-14 Score=145.73 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=184.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+.+.+-+-+|+++.+..+.-. |.-.+.|.............+....+-.++-...+|.++....-+......+++++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 4556667889999999877643 32233332211111111111223334444444456777766655666788999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC--
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN-- 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 313 (435)
|+.+++|...++..+..+++-+...+..+..+++|||+.. ++|||++|.|++. ..+++.++.|||.........
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~--~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLI--AYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhh--cccCCcccCccccccccccccCc
Confidence 9999999999998888888888888999999999999976 8999999999999 888999999998433221110
Q ss_pred -------------------ccc------cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 013833 314 -------------------SHD------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (435)
Q Consensus 314 -------------------~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 368 (435)
... ........+|+.|.+||...+......+|+|++|+++++.++|.+||....+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 000 0112234689999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHcCCCCCCC-CCCCCHHHHHHHHHHhhhcccCCCCHH
Q 013833 369 YEAAKYVAEGHRPFFR-AKGFTPELRELTEKCWAADMNQRPSFL 411 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ 411 (435)
..+.+.+..+..+... +...+++.++++.+.+..+|.+|..+.
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8888777776655433 245688999999999999999997664
|
|
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-14 Score=142.16 Aligned_cols=107 Identities=14% Similarity=0.114 Sum_probs=70.1
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHH---HHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~---~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~ 96 (435)
++.|++++.+|..|.+.+.+++|+.++.. +++++|+++|+++|.+|..|+||||+|+..++.+++++|+++||++|.
T Consensus 359 Is~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~ 438 (631)
T PHA02792 359 LKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINI 438 (631)
T ss_pred HHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 45677777777665433222334444333 346666777777777777777777777777777777777777777777
Q ss_pred cccCCCchhhHhhh----------cCchhHHHHHHhcCCC
Q 013833 97 QDRWKNTPLADAEG----------AKKFNMMELLNAHGGL 126 (435)
Q Consensus 97 ~~~~g~t~l~~A~~----------~~~~~~~~~L~~~g~~ 126 (435)
+|..|+||||+|+. ....+++++|++++.+
T Consensus 439 kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~ 478 (631)
T PHA02792 439 TTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPT 478 (631)
T ss_pred cCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCC
Confidence 77777777777754 1124556667766654
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.1e-14 Score=145.51 Aligned_cols=105 Identities=15% Similarity=0.081 Sum_probs=92.7
Q ss_pred chhhhhhhhhcccchhhhhhhhcC-----------------------CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHc
Q 013833 22 SADKQKEKARVSRTSLILWHAHQN-----------------------DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH 78 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~-----------------------~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~ 78 (435)
.|++++.++++|.|||++ |+++ +..+++++|+++|+++|.+|..|+||||+|+..
T Consensus 385 ~ga~~~~~~~~G~TpL~~--a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~ 462 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGH--LCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRY 462 (661)
T ss_pred cCCCccccCCCCCChhHH--HHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHc
Confidence 577777777789999976 2211 145678999999999999999999999999999
Q ss_pred CcHHHHHHHHHcCCCccccccCCCchhhHhhh-cCchhHHHHHHhcCCCCC
Q 013833 79 GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG-AKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 79 ~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~-~~~~~~~~~L~~~g~~~~ 128 (435)
++.+++++|+++|||+|.+|..|+||||+|+. .++.+++++|+.++++.+
T Consensus 463 ~~~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 463 NKQSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred CCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999996 678999999999998764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.8e-13 Score=113.96 Aligned_cols=134 Identities=24% Similarity=0.386 Sum_probs=103.5
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEcc-CCCCC----cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRIL-PSLSD----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~-~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
..+++|+-+.+|.+.+.|.++++|.=. +.... ......+-.+|++++.++.--.|....-+..+.+...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 357899999999999998888888532 22221 1223355678999999997656655555566667778999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
+|..|.+++... ...++..+-.-+.-||..| |||+||.++||++ .+ +.+.++|||++..
T Consensus 82 ~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl--~~-~~i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIIL--SG-GRIYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEE--eC-CcEEEEECCcccc
Confidence 999999999765 2456777888888999988 9999999999999 43 3499999999974
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-14 Score=128.06 Aligned_cols=100 Identities=28% Similarity=0.268 Sum_probs=71.0
Q ss_pred hhhhhhhhcccchhhhhhhhc---CCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 24 DKQKEKARVSRTSLILWHAHQ---NDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~---~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
.+++..++.|+||.|+-|-+. -...++++-|...| |||++- ..|+|+||+|..+|+.++|+.||..|||||.+|.
T Consensus 293 C~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDd 371 (452)
T KOG0514|consen 293 CDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDD 371 (452)
T ss_pred ccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccC
Confidence 345555555555555432111 11223333333332 455543 3577888888889999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHG 124 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g 124 (435)
+|.|+|++|++.||.||+++|+...
T Consensus 372 DGSTALMCA~EHGhkEivklLLA~p 396 (452)
T KOG0514|consen 372 DGSTALMCAAEHGHKEIVKLLLAVP 396 (452)
T ss_pred CccHHHhhhhhhChHHHHHHHhccC
Confidence 9999999999999999999999654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=134.59 Aligned_cols=142 Identities=20% Similarity=0.278 Sum_probs=97.8
Q ss_pred ceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcH---------------------------HHH----------HHHHH
Q 013833 163 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR---------------------------LVI----------QDFRH 204 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~---------------------------~~~----------~~~~~ 204 (435)
+.||+|++|.||+|..+ |+.||||+.++.....- ..+ -++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999975 89999998765421110 000 02455
Q ss_pred HHHHHHhCC-----CCcceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHhcCCCc
Q 013833 205 EVNLLVKLR-----HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIAR-GMAYLHNEPNV 277 (435)
Q Consensus 205 E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~-~l~~LH~~~~~ 277 (435)
|++.+.++. +++|.-..-+.......++||||++|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 666666653 333222111222234568999999999999887532 1222 3345666655 467889988
Q ss_pred eEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 278 ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
++|+|+||.||++ +.++.++++|||++..+..
T Consensus 278 ~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFV--LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEE--CCCCcEEEEeCCCeeECCH
Confidence 9999999999999 7788999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.9e-14 Score=132.74 Aligned_cols=100 Identities=27% Similarity=0.326 Sum_probs=84.2
Q ss_pred chhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCch
Q 013833 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114 (435)
Q Consensus 35 ~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 114 (435)
-+|++.||..|..+-|.+.+ ..-.|+...+..|.|+||-|...||.+||++|+++|||||+.|.+||||||+|+.+++.
T Consensus 551 LaLLLDaaLeGEldlVq~~i-~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCNnv 629 (752)
T KOG0515|consen 551 LALLLDAALEGELDLVQRII-YEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCNNV 629 (752)
T ss_pred HHHHHhhhhcchHHHHHHHH-HhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcCch
Confidence 34556667766665555555 44467778888999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCC
Q 013833 115 NMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 115 ~~~~~L~~~g~~~~~~n~~~~ 135 (435)
-+++.|++.|+.+...+-+.+
T Consensus 630 ~~ckqLVe~GaavfAsTlSDm 650 (752)
T KOG0515|consen 630 PMCKQLVESGAAVFASTLSDM 650 (752)
T ss_pred HHHHHHHhccceEEeeecccc
Confidence 999999999998876555444
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-13 Score=147.24 Aligned_cols=92 Identities=27% Similarity=0.335 Sum_probs=77.0
Q ss_pred cchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCc
Q 013833 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKK 113 (435)
Q Consensus 34 ~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 113 (435)
.++++ .|| ..+..++++.|++.|+++|.+|..|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+
T Consensus 526 ~~~L~-~Aa-~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~ 603 (823)
T PLN03192 526 ASNLL-TVA-STGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKH 603 (823)
T ss_pred hhHHH-HHH-HcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCC
Confidence 34443 344 4555677778889999999999999999999999999999999999999999999999999998888888
Q ss_pred hhHHHHHHhcCCCC
Q 013833 114 FNMMELLNAHGGLS 127 (435)
Q Consensus 114 ~~~~~~L~~~g~~~ 127 (435)
.+++++|++.++..
T Consensus 604 ~~iv~~L~~~~~~~ 617 (823)
T PLN03192 604 HKIFRILYHFASIS 617 (823)
T ss_pred HHHHHHHHhcCccc
Confidence 77777766655443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-13 Score=116.89 Aligned_cols=128 Identities=19% Similarity=0.149 Sum_probs=94.7
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ceeeeeeEEeCCcEEEEEecCCCCC
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLITEYLRGGD 241 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g~s 241 (435)
+.|+.|.++.||++...+..+++|........ ...+..|+.+++.+.+.+ +++++.+.. ...++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46889999999999999999999986543211 134578889988886544 455555433 33579999999988
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCC---ceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN---VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 242 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~---~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
+.+. ... ...++.+++.+|..||+.+. .++|+|++|.||++ + ++.++++|||.+.
T Consensus 78 l~~~-----~~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~--~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE-----DFS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL--D-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-----ccc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE--E-CCeEEEEeccccc
Confidence 7653 111 12456789999999999761 14999999999999 5 5679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 435 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-38 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-37 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-36 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-36 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-36 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-36 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-36 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-35 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-35 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-35 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-34 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-34 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-34 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-33 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-32 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-32 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-31 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-31 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-30 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-30 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-30 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-30 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-30 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-30 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-30 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-30 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-30 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-30 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-29 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-29 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-29 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-29 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-29 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-29 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-29 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-29 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-28 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-28 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-28 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-28 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-28 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-27 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-27 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-27 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-27 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-27 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-27 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-26 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-26 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-26 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-26 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-26 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-26 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-26 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-26 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-26 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-26 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-26 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-26 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-26 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-26 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-26 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-26 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-26 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-26 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-26 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-26 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-26 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-26 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-26 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-26 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-26 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-26 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-26 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-26 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-26 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-26 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-26 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-26 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-26 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-26 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-25 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-25 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-25 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-25 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-25 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-25 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-25 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-25 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-24 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-24 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-24 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-24 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-24 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-24 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-24 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-23 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-23 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-23 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-23 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-23 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-23 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-23 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-23 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-23 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-23 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-23 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-23 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-23 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-23 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-23 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-23 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-23 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-23 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-23 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-23 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-23 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-23 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-23 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-23 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-22 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-22 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-22 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-22 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-22 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-22 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-21 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-21 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-20 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-19 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-19 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-18 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-18 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-18 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-18 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-18 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-17 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-14 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-13 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-13 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-122
Identities = 96/301 (31%), Positives = 153/301 (50%), Gaps = 15/301 (4%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
+ D +I +L+ IG GSFG + +A W G+ VA+K ++
Sbjct: 19 ENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 76
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LS 253
+ +F EV ++ +LRHPNIV F+GAVT+ L ++TEYL G L++ L + GA L
Sbjct: 77 R-VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++ A D+A+GM YLHN I+HR+LK N+L+ +KV DFGLS+L
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLK---- 189
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
+ G+ +MAPEV + ++K DV+SF +IL+E+ + P N P +
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249
Query: 374 YVA-EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KETLPTDHHWN 431
V + R + P++ + E CW + +RPSF I+ L + K +P + +
Sbjct: 250 AVGFKCKRLEIP-RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308
Query: 432 I 432
+
Sbjct: 309 L 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-116
Identities = 101/279 (36%), Positives = 144/279 (51%), Gaps = 17/279 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNL 208
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 2 LEIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118
Query: 269 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 321
YLH+E IIHRDLK N+L++ + LK+ DFGL++ H KM+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMS 173
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 174 A-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+L E CW D + RPSF +IL +L I
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-114
Identities = 92/293 (31%), Positives = 144/293 (49%), Gaps = 27/293 (9%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRL--- 197
P + +E+++ IGKG FG + K + VAIK ++ S+
Sbjct: 7 EFPKSRLPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 198 -VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
Q+F+ EV ++ L HPNIV+ G + P ++ E++ GDL+ L + + S
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQ 312
+ LDIA G+ Y+ N+ I+HRDL+ N+ L + + KV DFGLS+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 313 NSHDVYKMTGETGSYRYMAPEVF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
V+ ++G G++++MAPE + Y +K D +SFAMILY +L GE P Y +
Sbjct: 179 ---SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 371 AAKYVA---EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
EG RP + P LR + E CW+ D +RP F I+K L ++
Sbjct: 236 IKFINMIREEGLRPTI-PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-114
Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 21/309 (6%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
P+ +W+I +L+ +IGKG FG++ W G VAI+ I D+
Sbjct: 15 PRKASQTSIFLQEWDIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIE-RDNE 70
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
++ F+ EV + RH N+V F+GA L +IT +G L+ + K L +
Sbjct: 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN 130
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNS 314
A +I +GM YLH + I+H+DLK +NV N + + DFGL + V Q
Sbjct: 131 KTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG 185
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRK---------YDKKVDVFSFAMILYEMLEGEPPLAN 365
K+ + G ++APE+ + + K DVF+ I YE+ E P
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 366 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI-KETL 424
+ G +P G E+ ++ CWA + +RP+F ++ LEK+ K
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
Query: 425 PTDHHWNIF 433
H + +
Sbjct: 306 RLSHPGHFW 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-114
Identities = 95/282 (33%), Positives = 146/282 (51%), Gaps = 24/282 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
ID E++ ++G+G+FG + KA WR VAIK+I S+ + F E+ L
Sbjct: 3 HMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIE---SES--ERKAFIVELRQL 55
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIAR 266
++ HPNIV+ GA P+ L+ EY GG L+ L + + + A+++ L ++
Sbjct: 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 267 GMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
G+AYLH+ +P +IHRDLKP N LL+ + LK+ DFG + I+ MT G
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPN-LLLVAGGTVLKICDFGTACDIQTH-------MTNNKG 165
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFF 383
S +MAPEVF+ Y +K DVFS+ +IL+E++ P + V G RP
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
Query: 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
K + L +CW+ D +QRPS +I+K + + P
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-111
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
ID +L+F + + + GE+ K W+G + +K + R +DF E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 209 LVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDI 264
L HPN++ LGA LIT ++ G L+ L + S AV FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
ARGMA+LH +I L R+V++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDED--MTARISMADVKF---------SFQSPGRM 169
Query: 325 GSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHR 380
+ ++APE + + D + D++SFA++L+E++ E P A+ E VA EG R
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
P G +P + +L + C D +RP F I+ LEK+++
Sbjct: 230 PTI-PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 91/293 (31%), Positives = 141/293 (48%), Gaps = 25/293 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVN 207
PS+L ++GKG FG+ +K R T + +K ++ + + + F EV
Sbjct: 5 RIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVK 59
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
++ L HPN+++F+G + + K L ITEY++GG L + S V+FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----------KVQNSHD 316
GMAYLH+ IIHRDL N LV + ++ V DFGL++L+ + D
Sbjct: 120 GMAYLHSMN--IIHRDLNSHN-CLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKY 374
K G+ +MAPE+ R YD+KVDVFSF ++L E++ +Y P +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427
V + P +T +C D +RPSF+ + LE ++ L
Sbjct: 236 VRGFLDR-YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 2e-98
Identities = 86/280 (30%), Positives = 139/280 (49%), Gaps = 19/280 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGV 73
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YLH + IIHRDLK N+ L + +K+GDFGL+ + + +GS
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGSH--QFEQLSGSI 186
Query: 328 RYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFF 383
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + V G
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 384 RAK---GFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+K ++ L +C ++RPSF IL +E++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 3e-95
Identities = 76/312 (24%), Positives = 119/312 (38%), Gaps = 45/312 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
++ IGKG +GE+ WRG VA+K + E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF----RETEIYQ 84
Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
V +RH NI+ F+ A + L LIT+Y G L+ YLK L + + A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 265 ARGMAYLHNEP------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
G+ +LH E I HRDLK +N+L+ + D GL+ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 319 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
G+ RYM PEV H + D++SF +IL+E+ E Y+
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 373 KY----------------VAEGHRPFF----RAKGFTPELRELTEKCWAADMNQRPSFLD 412
+ + RP F + ++ +L +CWA + R + L
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 413 ILKRLEKIKETL 424
+ K L K+ E+
Sbjct: 322 VKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-90
Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 47/295 (15%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNIVQFL 221
+GKG +GE+ + W+G VA+K + + E + V LRH NI+ F+
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFI 68
Query: 222 GAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-- 275
+ L LIT Y G L+ YL+ L + + L IA G+A+LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 276 ----NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
I HRDLK +N+L+ + + D GL+ + + G+ RYMA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 332 PEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY----------- 374
PEV K+VD+++F ++L+E+ E Y+ Y
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 375 -----VAEGHRPFFRAKGFT----PELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ RP + F+ L +L ++CW + + R + L I K L KI
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-90
Identities = 74/311 (23%), Positives = 119/311 (38%), Gaps = 45/311 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+ IGKG FGE+ + WRG VA+K E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS----WFREAEIYQ 89
Query: 209 LVKLRHPNIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
V LRH NI+ F+ A L L+++Y G L YL + ++ + AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALST 148
Query: 265 ARGMAYLHNEPN------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
A G+A+LH E I HRDLK +N+L+ + D GL+
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 319 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
G+ RYMAPEV KH + K+ D+++ ++ +E+ +E Y+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 373 KY----------------VAEGHRPFFRAKGFT----PELRELTEKCWAADMNQRPSFLD 412
Y + RP + + + ++ +CW A+ R + L
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 413 ILKRLEKIKET 423
I K L ++ +
Sbjct: 327 IKKTLSQLSQQ 337
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 4e-81
Identities = 86/339 (25%), Positives = 130/339 (38%), Gaps = 67/339 (19%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN- 207
+ +D L +IG+G +G + K PVA+K + + Q+F +E N
Sbjct: 7 EPSLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVK-VFSFANR-----QNFINEKNI 58
Query: 208 -LLVKLRHPNIVQFLGAVTE-----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
+ + H NI +F+ R +L+ EY G L KYL ++ A
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLA 117
Query: 262 LDIARGMAYLHNEPN-------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----K 310
+ RG+AYLH E I HRDL RNVL+ N + DFGLS +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRL 175
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML---EGE 360
V+ + E G+ RYMAPEV + K+VD+++ +I +E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 361 PPLANYEPYEAAKY----------------VAEGHRPFFRA-----KGFTPELRELTEKC 399
P + Y+ A E RP F L+E E C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 400 WAADMNQRPSFLDILKRLEKI-------KETLPTDHHWN 431
W D R + +R+ ++ K PT HH +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 9e-78
Identities = 90/319 (28%), Positives = 152/319 (47%), Gaps = 32/319 (10%)
Query: 115 NMMELLNAH----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSF 170
++ L++ L+ + +P W ++ +L IG+G+F
Sbjct: 77 SIPLLIDHLLSTQQPLTKK------SGVVLHRAVPKD-KWVLNHEDLVLGE--QIGRGNF 127
Query: 171 GEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228
GE+ R T VA+K +L D + F E +L + HPNIV+ +G T+++
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185
Query: 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
P+ ++ E ++GGD +L+ +G L T + D A GM YL ++ IHRDL RN
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARN 243
Query: 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--YRYMAPEVFKHRKYDKKVD 345
L+ + + LK+ DFG+S+ VY +G ++ APE + +Y + D
Sbjct: 244 CLV--TEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 346 VFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAAD 403
V+SF ++L+E G P N + ++V +G R P + + L E+CWA +
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP--CPELCPDAVFRLMEQCWAYE 355
Query: 404 MNQRPSFLDILKRLEKIKE 422
QRPSF I + L+ I++
Sbjct: 356 PGQRPSFSTIYQELQSIRK 374
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-76
Identities = 80/314 (25%), Positives = 125/314 (39%), Gaps = 51/314 (16%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+ L + +G FG + KA VA+K I P +EV
Sbjct: 18 NLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVK-IFPIQDKQS---WQNEYEVYS 71
Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
L ++H NI+QF+GA L LIT + G L +LK +S + + A +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETM 130
Query: 265 ARGMAYLHNEPN--------VIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 315
ARG+AYLH + I HRD+K +NVLL N +A + DFGL+ + S
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKFEAGKSA 187
Query: 316 DVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
G+ G+ RYMAPEV + R ++D+++ ++L+E+
Sbjct: 188 GD--THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 371 AAKY-----------------VAEGHRPFFRAK----GFTPELRELTEKCWAADMNQRPS 409
+ V + RP R L E E+CW D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 410 FLDILKRLEKIKET 423
+ +R+ +++
Sbjct: 306 AGCVGERITQMQRL 319
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 94/281 (33%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
W IDPSEL F IG G FG + YW VAIK I + +DF E +
Sbjct: 3 WVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEV 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 267
++KL HP +VQ G E+ P+ L+TE++ G L YL+ +G + T + LD+ G
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 326
MAYL E +IHRDL RN L+ +KV DFG+++ + D Y T TG+
Sbjct: 117 MAYL--EEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL----DDQY--TSSTGTK 166
Query: 327 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR-PF 382
++ +PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY- 225
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+ + + + ++ CW RP+F +L++L +I E+
Sbjct: 226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-74
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 26/292 (8%)
Query: 145 PNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLV 198
P + I +L +G GSFG + + W VA+K + P +
Sbjct: 7 PLQSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
+ DF EVN + L H N+++ G V P+ ++TE G L L++ +G T
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+A+ +A GM YL E IHRDL RN+LL ++ D +K+GDFGL + + + D
Sbjct: 124 SRYAVQVAEGMGYL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQND--DH 177
Query: 318 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y M + + APE K R + D + F + L+EM G+ P +
Sbjct: 178 YVMQ--EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 374 YV-AEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+ EG R P R + ++ + +CWA RP+F+ + L + + T
Sbjct: 236 KIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-74
Identities = 86/293 (29%), Positives = 139/293 (47%), Gaps = 26/293 (8%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
P L WEIDP +L F +G G FG + WRG VAIK I +
Sbjct: 7 NAPSTAGLG-YGSWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE 63
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+F E +++ L H +VQ G T+++P+ +ITEY+ G L YL+E +
Sbjct: 64 ----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ D+ M YL E +HRDL RN L+ + +KV DFGLS+ +
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL---- 171
Query: 315 HDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYE 370
D Y T GS R+ PEV + K+ K D+++F ++++E+ G+ P + E
Sbjct: 172 DDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
Query: 371 AAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
A+++A+G R R + ++ + CW ++RP+F +L + + +
Sbjct: 230 TAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-74
Identities = 92/291 (31%), Positives = 142/291 (48%), Gaps = 31/291 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ 200
+ W ++ EL IGKG FG+++ +RG VA+K I + Q
Sbjct: 7 AQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-----Q 59
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--ALSPSTA 257
F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K +
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--------EA 167
Query: 318 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
+ + ++ APE + +K+ K DV+SF ++L+E+ G P +
Sbjct: 168 S--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
Query: 374 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
V +G++ G P + E+ + CW D RPSFL + ++LE IK
Sbjct: 226 RVEKGYKMD--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-74
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 25/280 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
E+ E+ +G G FG + W+G VA+K I + +F E
Sbjct: 3 MELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQT 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARG 267
++KL HP +V+F G ++ P+ ++TEY+ G L YL+ G L PS + D+ G
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 326
MA+L E + IHRDL RN L+ +KV DFG+++ + D Y G+
Sbjct: 117 MAFL--ESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVL----DDQY--VSSVGTK 166
Query: 327 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR-PF 382
++ APEVF + KY K DV++F ++++E+ G+ P Y E V++GHR
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY- 225
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
R + + ++ CW +RP+F +L +E ++E
Sbjct: 226 -RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 5e-74
Identities = 81/298 (27%), Positives = 138/298 (46%), Gaps = 23/298 (7%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLV 198
+ K + +D L +G G+FG + K Y++ VA+K IL + ++D +
Sbjct: 5 EIRPK-EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPAL 61
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
+ E N++ +L +P IV+ +G + ML+ E G L+KYL++ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
++ GM YL E + +HRDL RNVLL + + K+ DFGLSK ++ + Y
Sbjct: 121 ELVHQVSMGMKYL--EESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADE--NYY 174
Query: 319 KMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKY 374
K T ++ APE + K+ K DV+SF ++++E G+ P + E
Sbjct: 175 KAQ--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 375 VAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 431
+ +G R G E+ +L CW D+ RP F + RL + + H +
Sbjct: 233 LEKGERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 9e-74
Identities = 82/289 (28%), Positives = 142/289 (49%), Gaps = 27/289 (9%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQD 201
PN WE++ +++ +G G +GE+ + W+ VA+K + + ++
Sbjct: 2 SPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EE 55
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVN 259
F E ++ +++HPN+VQ LG T P +ITE++ G+L YL+ + +S +
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
A I+ M YL E IHRDL RN L+ +KV DFGLS+L+ D Y
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMT----GDTY- 166
Query: 320 MTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
T G+ ++ APE + K+ K DV++F ++L+E+ G P + + + +
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 376 AEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+ +R R +G ++ EL CW + + RPSF +I + E + +
Sbjct: 226 EKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-73
Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 139 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSL 192
+ ++ + + L F +GKG+FG + + VA+K++ S
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 249
+ +DF E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K
Sbjct: 83 EEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 139
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+ + + I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVL 195
Query: 310 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------- 357
+ YK+ S + APE K+ DV+SF ++LYE+
Sbjct: 196 P--QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
Query: 358 -----EGEPPLANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFL 411
G + + + R P R G E+ + +CW ++NQRPSF
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 412 DILKRLEKIKETL 424
D+ R+++I++ +
Sbjct: 312 DLALRVDQIRDQM 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 7e-73
Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 27/288 (9%)
Query: 145 PNKCDWE-IDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRL 197
PN+ + +E ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-- 59
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 119 LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEK 172
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 376 AEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+G R P T ++ + KCW D + RP F +++ K+
Sbjct: 233 EKGERLPQP----PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-72
Identities = 83/300 (27%), Positives = 138/300 (46%), Gaps = 40/300 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
+ + L F +GKG+FG + + VA+K++ S + +DF
Sbjct: 5 TQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFE 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNF 260
E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K + + +
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++ + +K+
Sbjct: 120 TSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLP--QDKEFFKV 173
Query: 321 TGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------------EGEPPL 363
S + APE K+ DV+SF ++LYE+ G
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 364 ANYEPYEAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ + + R P R G E+ + +CW ++NQRPSF D+ R+++I++
Sbjct: 234 GQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-72
Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 38/308 (12%)
Query: 139 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSL 192
P + L +G+G FG++ + G VA+K + P
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 249
+ I D + E+ +L L H NIV++ G TE + LI E+L G L +YL + K
Sbjct: 63 GGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
++ + +A+ I +GM YL +HRDL RNVL+ S +K+GDFGL+K I
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAI 176
Query: 310 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML---------EG 359
+ + Y + + S + APE K+ DV+SF + L+E+L
Sbjct: 177 --ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 360 EPPLANYEPY------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLD 412
+ + EG R P E+ +L KCW + R SF +
Sbjct: 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 413 ILKRLEKI 420
+++ E +
Sbjct: 293 LIEGFEAL 300
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-72
Identities = 84/321 (26%), Positives = 151/321 (47%), Gaps = 27/321 (8%)
Query: 115 NMMELLNAHGGLSYG--QNGSHFEPKPVPPPLPNKC----DWEIDPSELDFSSSAIIGKG 168
+ EL++ H ++ G + PK P + WE++ +++ +G G
Sbjct: 174 TLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGG 231
Query: 169 SFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226
+GE+ + W+ VA+K + + ++F E ++ +++HPN+VQ LG T
Sbjct: 232 QYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 227 RKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
P +ITE++ G+L YL+ + +S + A I+ M YL E IHR+L
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLA 345
Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKK 343
RN L+ +KV DFGLS+L+ D Y ++ APE + K+ K
Sbjct: 346 ARNCLV--GENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 344 VDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAA 402
DV++F ++L+E+ G P + + + + + +R R +G ++ EL CW
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPEGCPEKVYELMRACWQW 458
Query: 403 DMNQRPSFLDILKRLEKIKET 423
+ + RPSF +I + E + +
Sbjct: 459 NPSDRPSFAEIHQAFETMFQE 479
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-72
Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 29/294 (9%)
Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
E + W ++ EL IGKG FG+++ +RG VA+K I +
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA- 230
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--AL 252
Q F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 231 ----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K
Sbjct: 287 GGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK----- 337
Query: 313 NSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEP 368
+ + + ++ APE + +K+ K DV+SF ++L+E+ G P
Sbjct: 338 ---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 369 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ V +G++ G P + ++ + CW D RP+FL + ++LE I+
Sbjct: 393 KDVVPRVEKGYK-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-72
Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 22/282 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 9 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 64
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
E + + HP+IV+ +G +TE P+ +I E G+L +L+ K +L ++ + +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
++ +AYL E +HRD+ RNVL+ SS D +K+GDFGLS+ ++ YK +
Sbjct: 124 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DSTYYKASK 176
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 380
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
P P L L KCWA D ++RP F ++ +L I E
Sbjct: 237 P--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 6e-72
Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 22/283 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
+ I ++ + I+G+G FGE+ + + VA+K + D + F
Sbjct: 6 QYGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFM 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
E ++ L HP+IV+ +G + E +P +I E G+L YL+ K +L T V ++L
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
I + MAYL E +HRD+ RN+L+ +S + +K+GDFGLS+ I+ D YK +
Sbjct: 121 QICKAMAYL--ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYKASV 173
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 380
++M+PE R++ DV+ FA+ ++E+L G+ P E + + +G R
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 233
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
P + P L L +CW D + RP F +++ L + +
Sbjct: 234 P--KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-72
Identities = 82/315 (26%), Positives = 135/315 (42%), Gaps = 41/315 (13%)
Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAI 185
G H + + L + S +GKG+FG + + VA+
Sbjct: 2 GHHHHHHAQLYACQDP--TIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLH 243
K++ S D + +DF+ E+ +L L IV++ G R+ L L+ EYL G L
Sbjct: 58 KQLQHSGPDQQ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 244 KYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
+L+ + L S + ++ I +GM YL +HRDL RN+L+ S H+K+ D
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILV--ESEAHVKIAD 170
Query: 303 FGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGE 360
FGL+KL+ D Y + S + APE + ++ DV+SF ++LYE+ +
Sbjct: 171 FGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 361 PPLANYEPY--------------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMN 405
+ + + + EG R P E+ EL + CWA
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP--APPACPAEVHELMKLCWAPSPQ 286
Query: 406 QRPSFLDILKRLEKI 420
RPSF + +L+ +
Sbjct: 287 DRPSFSALGPQLDML 301
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-71
Identities = 90/288 (31%), Positives = 133/288 (46%), Gaps = 19/288 (6%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
P EI+ S + IIG G GE+ R PVAIK + ++
Sbjct: 35 PGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+ +DF E +++ + HPNI++ G VT + M++TEY+ G L +L+ G +
Sbjct: 93 QR--RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V + GM YL +HRDL RNVL+ S KV DFGLS++++ +
Sbjct: 151 MQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLE-DDP 205
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y TG R+ APE R + DV+SF ++++E+L GE P N +
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 374 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
V EG+R P G L +L CW D QRP F I+ L+ +
Sbjct: 266 SVEEGYRLP--APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-71
Identities = 82/311 (26%), Positives = 142/311 (45%), Gaps = 28/311 (9%)
Query: 134 HFEPKPVPPPLPNK-CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKR 187
H + + P L I PS L + +IG+G FG + A+K
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK- 59
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
L ++D + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 60 SLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
E + + F L +A+GM YL +HRDL RN +L +KV DFGL
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCML--DEKFTVKVADFGL 174
Query: 306 SKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361
++ + + Y + +TG+ ++MA E + +K+ K DV+SF ++L+E++ G P
Sbjct: 175 ARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 362 PLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
P + ++ Y+ +G R P + L E+ KCW RPSF +++ R+
Sbjct: 232 PYPDVNTFDITVYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
Query: 419 KIKETLPTDHH 429
I T +H+
Sbjct: 288 AIFSTFIGEHY 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-71
Identities = 86/309 (27%), Positives = 142/309 (45%), Gaps = 44/309 (14%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
I ++ +G+G+FG++ A VA+K + R
Sbjct: 5 SGIHVQHIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR- 61
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK---------- 247
+DF+ E LL L+H +IV+F G + PL+++ EY++ GDL+K+L+
Sbjct: 62 --KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 248 ------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
KG L S ++ A IA GM YL +HRDL RN L+ + +K+G
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLV--GANLLVKIG 175
Query: 302 DFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EG 359
DFG+S+ + S D Y++ G T R+M PE +RK+ + DV+SF +IL+E+ G
Sbjct: 176 DFGMSRDV---YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 360 EPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
+ P E + + +G P + E+ ++ CW + QR + +I K
Sbjct: 233 KQPWFQLSNTEVIECITQGRVLERP----RVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 417 LEKIKETLP 425
L + + P
Sbjct: 289 LHALGKATP 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-71
Identities = 92/292 (31%), Positives = 144/292 (49%), Gaps = 20/292 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPS 191
P K EI PS + +IG G FGE+ K + PVAIK +
Sbjct: 27 GSDPNQAVLKFTTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG 84
Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KG 250
++ + DF E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+E G
Sbjct: 85 YTEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG 142
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
S V IA GM YL +HRDL RN+L+ +S KV DFGLS++++
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 198
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369
+ Y +G R+ APE +RK+ DV+SF ++++E++ GE P +
Sbjct: 199 -DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 370 EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
E K + +G R P + +L +CW + +RP F DI+ L+K+
Sbjct: 258 EVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-70
Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 35/297 (11%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
E+ + +G G+FGE+ + G VA+K + S+
Sbjct: 20 SISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-------EKG 250
DF E ++ K H NIV+ +G + P ++ E + GGDL +L+ +
Sbjct: 78 --LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKL 308
+L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG+++
Sbjct: 136 SLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFGMARD 192
Query: 309 IKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANY 366
I Y+ G ++M PE F + K D +SF ++L+E+ G P +
Sbjct: 193 I---YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 367 EPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
E ++V G R P K + + +CW RP+F IL+R+E
Sbjct: 250 SNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 24/286 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
+EL ++G G FG + K W PV IK I Q
Sbjct: 8 RIFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVT 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
+ + L H +IV+ LG L L+T+YL G L ++++ +GAL P +N+ +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
IA+GM YL E + ++HR+L RNVLL S ++V DFG++ L+ D +
Sbjct: 123 QIAKGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLL---PPDDKQLLYS 175
Query: 323 ETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
E + ++MA E KY + DV+S+ + ++E++ G P A E + +G R
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235
Query: 381 -PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
+ + T ++ + KCW D N RP+F ++ ++ P
Sbjct: 236 LA--QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-70
Identities = 85/288 (29%), Positives = 140/288 (48%), Gaps = 19/288 (6%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
P ++ E+D + + ++G G FGE+ + VAIK + ++
Sbjct: 31 PTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+ +DF E +++ + HPNI++ G VT+ KP+M++TEY+ G L +L++ +
Sbjct: 89 QR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V IA GM YL +HRDL RN+L+ +S KV DFGL ++++ +
Sbjct: 147 IQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRVLE-DDP 201
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y G R+ +PE +RK+ DV+S+ ++L+E++ GE P + K
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
Query: 374 YVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
V EG+R P L +L CW D N RP F I+ L+K+
Sbjct: 262 AVDEGYRLP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-70
Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 27/280 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
+WE+ L +G G FGE+ Y+ G T VA+K SL + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
L+ +L+H +V+ VT+ P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ + Y T G
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILV--SDTLSCKIADFGLARLIE----DNEY--TAREG 169
Query: 326 S---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 380
+ ++ APE + + K DV+SF ++L E++ G P E + + G+R
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
R EL +L CW RP+F + LE
Sbjct: 230 V--RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 5e-70
Identities = 92/346 (26%), Positives = 154/346 (44%), Gaps = 25/346 (7%)
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG-GLSYGQNGSHFEPKPVPPP- 143
C + GA + R + K E +S + + E
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377
Query: 144 -LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRL 197
+P+ D+EI ++ IG+G FG++ + + VAIK SD
Sbjct: 378 TMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
+ F E + + HP+IV+ +G +TE P+ +I E G+L +L+ K +L ++
Sbjct: 436 --EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
+ +A ++ +AYL E +HRD+ RNVL+ SS D +K+GDFGLS+ ++
Sbjct: 493 LILYAYQLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DST 545
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
YK + ++MAPE R++ DV+ F + ++E+L G P + + +
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 376 AEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
G R P P L L KCWA D ++RP F ++ +L I
Sbjct: 606 ENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-70
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 20/286 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRH 204
+ L + +G G+FG + + +R VAIK + ++
Sbjct: 3 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
E ++ +L +P IV+ +G + LML+ E GG LHK+L ++ + S
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
++ GM YL E +HRDL RNVLL + + K+ DFGLSK + + Y
Sbjct: 119 VSMGMKYL--EEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADD--SYYTARSA 172
Query: 324 TGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR- 380
++ APE RK+ + DV+S+ + ++E L G+ P + E ++ +G R
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
PEL L CW RP FL + +R+ +L +
Sbjct: 233 E--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-70
Identities = 96/338 (28%), Positives = 152/338 (44%), Gaps = 52/338 (15%)
Query: 124 GGLSYGQNGSHFEPKPV---------PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEIL 174
G + G + S E K P + C I ++ +G+G+FG++
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVF 58
Query: 175 KAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
A VA+K + + R QDF+ E LL L+H +IV+F G TE
Sbjct: 59 LAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEG 115
Query: 228 KPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFALDIARGMAYLH 272
+PL+++ EY+R GDL+++L+ G L + A +A GM YL
Sbjct: 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL- 174
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMA 331
+HRDL RN L+ +K+GDFG+S+ I S D Y++ G T R+M
Sbjct: 175 -AGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRDI---YSTDYYRVGGRTMLPIRWMP 228
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR---PFFRAKG 387
PE +RK+ + DV+SF ++L+E+ G+ P EA + +G P +
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP----RA 284
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
PE+ + CW + QR S D+ RL+ + + P
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 7e-70
Identities = 91/319 (28%), Positives = 140/319 (43%), Gaps = 35/319 (10%)
Query: 128 YGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TP 182
+ + S P+ D ID + L I+G+G FG +++ +
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLK 64
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYL 237
VA+K + S R + ++F E + HPN+++ LG E M+I ++
Sbjct: 65 VAVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 238 RGGDLHKYLK------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
+ GDLH YL + T + F +DIA GM YL +HRDL RN +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML- 180
Query: 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFA 350
+ V DFGLSK I S D Y+ +++A E R Y K DV++F
Sbjct: 181 -RDDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 351 MILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQ 406
+ ++E+ G P + +E Y+ GHR P + EL E+ CW D
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTDPLD 292
Query: 407 RPSFLDILKRLEKIKETLP 425
RP+F + +LEK+ E+LP
Sbjct: 293 RPTFSVLRLQLEKLLESLP 311
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 7e-70
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 35/301 (11%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
E+ + +G G+FGE+ + G VA+K + S
Sbjct: 57 GKTSSISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 194 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
+ DF E ++ K H NIV+ +G + P ++ E + GGDL +L+
Sbjct: 115 EQDE--LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 248 -EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFG 304
+ +L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFG 229
Query: 305 LSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP 362
+++ I Y+ G ++M PE F + K D +SF ++L+E+ G P
Sbjct: 230 MARDIY---RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 363 LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
+ E ++V G R P K + + +CW RP+F IL+R+E
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 420 I 420
Sbjct: 343 C 343
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-70
Identities = 83/344 (24%), Positives = 149/344 (43%), Gaps = 22/344 (6%)
Query: 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNK-CDWEIDPSELDF 159
+ ++ + + G N H + + P L I PS L
Sbjct: 32 PGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIV 91
Query: 160 SSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
+ +IG+G FG + A+K L ++D + F E ++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIG-EVSQFLTEGIIMKDFSH 149
Query: 215 PNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLH 272
PN++ LG + +++ Y++ GDL ++ E + + F L +A+GM +L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+HRDL RN +L +KV DFGL++ + + V+ TG ++MA
Sbjct: 209 -ASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGF 388
E + +K+ K DV+SF ++L+E++ G PP + ++ Y+ +G R P +
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----EYC 321
Query: 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNI 432
L E+ KCW RPSF +++ R+ I T +H+ ++
Sbjct: 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 365
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-69
Identities = 88/314 (28%), Positives = 146/314 (46%), Gaps = 41/314 (13%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPV 183
N +F V P +WE+ ++ S +G+GSFG + + +G T V
Sbjct: 5 NPEYFSAADVYVPD----EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRV 58
Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH 243
AIK + + S +F +E +++ + ++V+ LG V++ +P ++I E + GDL
Sbjct: 59 AIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 244 KYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293
YL+ S S + A +IA GMAYL N +HRDL RN ++ +
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMV--A 172
Query: 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMI 352
+K+GDFG+++ I D Y+ G+ R+M+PE K + DV+SF ++
Sbjct: 173 EDFTVKIGDFGMTRDI---YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 353 LYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRP 408
L+E+ E P + ++V EG P L EL CW + RP
Sbjct: 230 LWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRP 285
Query: 409 SFLDILKRLEKIKE 422
SFL+I+ +++ E
Sbjct: 286 SFLEIISSIKEEME 299
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-69
Identities = 80/303 (26%), Positives = 145/303 (47%), Gaps = 27/303 (8%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
L D I + S +IGKG FG + + AIK L +++
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEM 63
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLK-EKGALS 253
+ ++ F E L+ L HPN++ +G + + ++ Y+ GDL ++++ + +
Sbjct: 64 Q-QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++F L +ARGM YL +HRDL RN +L + +KV DFGL++ I
Sbjct: 123 VKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCML--DESFTVKVADFGLARDI---L 175
Query: 314 SHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
+ Y + + ++ A E + ++ K DV+SF ++L+E+L G PP + +P+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 370 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
+ ++A+G R P + L ++ ++CW AD RP+F ++ +E+I L
Sbjct: 236 DLTHFLAQGRRLPQP----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
Query: 427 DHH 429
DH+
Sbjct: 292 DHY 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-69
Identities = 95/319 (29%), Positives = 144/319 (45%), Gaps = 25/319 (7%)
Query: 114 FNMMELLNAH-----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKG 168
FN ++ L A+ GL + KP L K WEI L +G+G
Sbjct: 139 FNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGL-AKDAWEIPRESLRLEV--KLGQG 195
Query: 169 SFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
FGE+ W G T VAIK +L + + F E ++ KLRH +VQ V+E
Sbjct: 196 CFGEVWMGTWNGTTRVAIK----TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKP 285
+P+ ++TEY+ G L +LK + L V+ A IA GMAY+ E +HRDL+
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRA 308
Query: 286 RNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVD 345
N+L+ KV DFGL++LI ++ G ++ APE + ++ K D
Sbjct: 309 ANILV--GENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 346 VFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADM 404
V+SF ++L E+ +G P E V G+R L +L +CW +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECPESLHDLMCQCWRKEP 422
Query: 405 NQRPSFLDILKRLEKIKET 423
+RP+F + LE +
Sbjct: 423 EERPTFEYLQAFLEDYFTS 441
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-68
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 25/287 (8%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLV 198
PN+ I E +F ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILK-ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--A 60
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 120 LNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEKE 173
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVA 376
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 377 EGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+G R P T ++ + KCW D + RP F +++ K+
Sbjct: 234 KGERLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-68
Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 39/318 (12%)
Query: 131 NGSHFEPKPVPPPLPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPV 183
+ H + D L +G+G FG++ + V
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMV 63
Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGD 241
A+K + ++ E+++L L H +I+++ G + L L+ EY+ G
Sbjct: 64 AVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
L YL + ++ + + FA I GMAYL IHRDL RNVLL + +K+G
Sbjct: 122 LRDYLP-RHSIGLAQLLLFAQQICEGMAYL--HAQHYIHRDLAARNVLL--DNDRLVKIG 176
Query: 302 DFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML--- 357
DFGL+K + H+ Y++ + S + APE K K+ DV+SF + LYE+L
Sbjct: 177 DFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 358 ------EGEPPLANYEPY------EAAKYVAEGHR-PFFRAKGFTPELRELTEKCWAADM 404
+ + + G R P R E+ L + CW +
Sbjct: 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP--RPDKCPAEVYHLMKNCWETEA 292
Query: 405 NQRPSFLDILKRLEKIKE 422
+ RP+F +++ L+ + E
Sbjct: 293 SFRPTFENLIPILKTVHE 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 3e-68
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 21/292 (7%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
P K WEI L +G G FGE+ A + T VA+K + P
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV 227
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALS 253
+ F E N++ L+H +V+ VT+ +P+ +ITE++ G L +LK E
Sbjct: 228 ----EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++F+ IA GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I
Sbjct: 283 LPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVI---E 335
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAA 372
++ G ++ APE + K DV+SF ++L E++ G P E
Sbjct: 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 373 KYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+ + G+R P R + EL + +CW +RP+F I L+
Sbjct: 396 RALERGYRMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-68
Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 20/292 (6%)
Query: 137 PKPVPPP-LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSD 194
P P K WEI L +G+G FGE+ W G T VAIK +L
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIK----TLKP 301
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--AL 252
+ + F E ++ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL 360
Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
V+ A IA GMAY+ E +HRDL+ N+L+ KV DFGL++LI
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILV--GENLVCKVADFGLARLI--- 413
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 371
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
Query: 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
V G+R L +L +CW + +RP+F + LE +
Sbjct: 474 LDQVERGYR-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-68
Identities = 65/290 (22%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
+I +L F+ +G+G+F +I K R T V +K + + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---E 57
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVN 259
F +++ KL H ++V G +L+ E+++ G L YLK+ K ++ +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL------KVGDFGLSKLIKVQN 313
A +A M +L E N +IH ++ +N+LL+ K+ D G+S +
Sbjct: 118 VAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--- 172
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 371
D+ + ++ PE ++ K + D +SF L+E+ G+ PL+ +
Sbjct: 173 PKDILQE-----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 372 AKYVAEGHR-PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
++ + H+ P EL L C + + RPSF I++ L +
Sbjct: 228 LQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 9e-68
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 18/273 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
+ IG+GSF + K VA + L+ Q F+ E
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAE 77
Query: 208 LLVKLRHPNIVQFLGA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
+L L+HPNIV+F + V +K ++L+TE + G L YLK + ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 137
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I +G+ +LH IIHRDLK N+ + +K+GD GL+ L + + V
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNI-FITGPTGSVKIGDLGLATLKRASFAKAV------ 190
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPF 382
G+ +MAPE+++ KYD+ VDV++F M + EM E P + + + V G +P
Sbjct: 191 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249
Query: 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
K PE++E+ E C + ++R S D+L
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-67
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILP 190
+ P E + +++ IG+G+FG + +A G T VA+K +L
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLK 86
Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK- 249
+ + DF+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 87 EEASADM-QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145
Query: 250 -----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286
LS + + A +A GMAYL +HRDL R
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATR 203
Query: 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVD 345
N L+ +K+ DFGLS+ I S D YK G R+M PE + +Y + D
Sbjct: 204 NCLV--GENMVVKIADFGLSRNI---YSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 346 VFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWA 401
V+++ ++L+E+ G P E YV +G+ P + EL L CW+
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP----ENCPLELYNLMRLCWS 314
Query: 402 ADMNQRPSFLDILKRLEKIKE 422
RPSF I + L+++ E
Sbjct: 315 KLPADRPSFCSIHRILQRMCE 335
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-67
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
EI S + F +G+ FG++ K + G VAIK + ++F
Sbjct: 4 KEISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEF 59
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
RHE L +L+HPN+V LG VT+ +PL +I Y GDLH++L
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 249 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
K AL P V+ IA GM YL + ++H+DL RNVL+ ++K+ D GL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLV--YDKLNVKISDLGLF 175
Query: 307 KLIKVQNSHDVYKMTGETGSY--RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363
+ + + D YK+ G R+MAPE + K+ D++S+ ++L+E+ G P
Sbjct: 176 REV---YAADYYKLLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 364 ANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419
Y + + + P + L +CW ++RP F DI RL
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-67
Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 36/302 (11%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
D I + ++GKG FG + +A + VA+K +L + I++F
Sbjct: 17 DVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVK-MLKADIIASSDIEEFL 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK------EKGA 251
E + + HP++ + +G + M+I +++ GDLH +L
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
L T V F +DIA GM YL IHRDL RN +L + + V DFGLS+ I
Sbjct: 134 LPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKI-- 187
Query: 312 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
S D Y+ + +++A E Y DV++F + ++E++ G+ P A E
Sbjct: 188 -YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 370 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
E Y+ G+R P E+ +L +CW+AD QRPSF + LE I L
Sbjct: 247 EIYNYLIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 427 DH 428
Sbjct: 303 LS 304
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-66
Identities = 97/324 (29%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIK 186
H P P +D +++ F +IG+G+FG++LKA + AIK
Sbjct: 2 KKHHHHHHGKNNPDPTI-YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIK 58
Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
R+ S D +DF E+ +L KL HPNI+ LGA R L L EY G+L +
Sbjct: 59 RMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 246 LKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L++ LS ++FA D+ARGM YL IHRDL RN+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 174
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDV 346
+ K+ DFGLS+ +VY T R+MA E + Y DV
Sbjct: 175 V--GENYVAKIADFGLSR------GQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 347 FSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAA 402
+S+ ++L+E++ G P E + + +G+R P E+ +L +CW
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWRE 280
Query: 403 DMNQRPSFLDILKRLEKIKETLPT 426
+RPSF IL L ++ E T
Sbjct: 281 KPYERPSFAQILVSLNRMLEERKT 304
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-66
Identities = 92/312 (29%), Positives = 145/312 (46%), Gaps = 48/312 (15%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 70 LPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+
Sbjct: 128 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 248 ----------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
+ ++ V+ +ARGM YL IHRDL RNVL+ + ++
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLV---TENN 240
Query: 298 -LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
+K+ DFGL++ I N+ D YK T ++MAPE R Y + DV+SF ++++E
Sbjct: 241 VMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297
Query: 356 MLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFL 411
+ G P E K + EGHR P T EL + CW A +QRP+F
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFK 353
Query: 412 DILKRLEKIKET 423
+++ L++I
Sbjct: 354 QLVEDLDRILTL 365
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-66
Identities = 93/325 (28%), Positives = 147/325 (45%), Gaps = 53/325 (16%)
Query: 129 GQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------T 181
G N + +P +P WE + L F +G G+FG++++A G
Sbjct: 1 GNNYVYIDPTQLPYDH----KWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAM 54
Query: 182 PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG 240
VA+K + PS + E+ +L L H NIV LGA T P ++ITEY G
Sbjct: 55 TVAVKMLKPSAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 241 DLHKYLKEK------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
DL +L+ K AL ++F+ +A+GMA+L IHRD
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRD 170
Query: 283 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKY 340
L RN+LL + + K+ DFGL++ I + Y + G ++MAPE + Y
Sbjct: 171 LAARNILL---THGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHR---PFFRAKGFTPELREL 395
+ DV+S+ + L+E+ G P + K + EG R P + E+ ++
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP----EHAPAEMYDI 280
Query: 396 TEKCWAADMNQRPSFLDILKRLEKI 420
+ CW AD +RP+F I++ +EK
Sbjct: 281 MKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-66
Identities = 87/315 (27%), Positives = 142/315 (45%), Gaps = 53/315 (16%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
+ WE L +G+G FG+++KA T VA+K + + S
Sbjct: 11 KILEDPKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
L +D E N+L ++ HP++++ GA ++ PL+LI EY + G L +L+E
Sbjct: 69 EL--RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 250 ------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
AL+ ++FA I++GM YL ++HRDL RN+L+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV- 183
Query: 292 NSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSF 349
+ +K+ DFGLS+ + D Y + ++MA E Y + DV+SF
Sbjct: 184 --AEGRKMKISDFGLSRDV---YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 350 AMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMN 405
++L+E++ G P P + GHR P + E+ L +CW + +
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPD 294
Query: 406 QRPSFLDILKRLEKI 420
+RP F DI K LEK+
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-65
Identities = 94/331 (28%), Positives = 148/331 (44%), Gaps = 52/331 (15%)
Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-- 180
H + Q+ P K WE +L +G+G+FG+++ A G
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPK--WEFPRDKLTLGK--PLGEGAFGQVVMAEAVGID 60
Query: 181 -------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232
VA+K + ++ L D E+ ++ + +H NI+ LGA T+ PL +
Sbjct: 61 KDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118
Query: 233 ITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDIARGMAYLHNEPN 276
I EY G+L +YL+ + ++ V+ +ARGM YL
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQ 176
Query: 277 VIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPE 333
IHRDL RNVL+ ++ K+ DFGL++ I N+ D YK T ++MAPE
Sbjct: 177 KCIHRDLAARNVLV----TENNVMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPE 229
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR---PFFRAKGFT 389
R Y + DV+SF ++++E+ G P E K + EGHR P T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCT 285
Query: 390 PELRELTEKCWAADMNQRPSFLDILKRLEKI 420
EL + CW A +QRP+F +++ L++I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-64
Identities = 99/343 (28%), Positives = 153/343 (44%), Gaps = 53/343 (15%)
Query: 115 NMMELLNAHGGLSYGQNGSHFEPKPVPPP-----LPNKCDWEIDPSELDFSSSAIIGKGS 169
M + H + + + LP WE+ L +G+G+
Sbjct: 24 GMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGA 81
Query: 170 FGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ 219
FG+++ A G T VA+K + ++ L D E+ ++ + +H NI+
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMIGKHKNIIN 139
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALD 263
LGA T+ PL +I EY G+L +YL+ + LS V+ A
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTG 322
+ARGM YL IHRDL RNVL+ + D+ +K+ DFGL++ I + D YK T
Sbjct: 200 VARGMEYL--ASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI---HHIDYYKKTT 251
Query: 323 ETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++MAPE R Y + DV+SF ++L+E+ G P E K + EGHR
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 381 ---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
P T EL + CW A +QRP+F +++ L++I
Sbjct: 312 MDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-64
Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 51/312 (16%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
P LP WE + L F +G G+FG++++A G VA+K + +
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
D + E+ ++ L +H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 90 ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 251 ------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
S ++F+ +A+GMA+L IHRD+ RNVLL + H+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLL---TNGHV 202
Query: 299 -KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
K+GDFGL++ I + Y + G ++MAPE Y + DV+S+ ++L+E+
Sbjct: 203 AKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
Query: 357 LE-GEPP----LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRP 408
G P L N + Y K V +G++ P + + + CWA + RP
Sbjct: 260 FSLGLNPYPGILVNSKFY---KLVKDGYQMAQP----AFAPKNIYSIMQACWALEPTHRP 312
Query: 409 SFLDILKRLEKI 420
+F I L++
Sbjct: 313 TFQQICSFLQEQ 324
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-62
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 25/301 (8%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSL 192
P P L +K + L + +G G+FG + + +R VAIK +
Sbjct: 318 PFSDPEELKDK-KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGA 251
++ E ++ +L +P IV+ +G + LML+ E GG LHK+L +
Sbjct: 376 EKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
+ S ++ GM YL E +HR+L RNVLL + + K+ DFGLSK +
Sbjct: 433 IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKALGA 488
Query: 312 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369
+ Y ++ APE RK+ + DV+S+ + ++E L G+ P +
Sbjct: 489 DD--SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546
Query: 370 EAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
E ++ +G R P PEL L CW RP FL + +R+ +L +
Sbjct: 547 EVMAFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
Query: 427 D 427
Sbjct: 603 K 603
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-62
Identities = 89/347 (25%), Positives = 139/347 (40%), Gaps = 58/347 (16%)
Query: 112 KKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFG 171
+ +L S + + + L WE L+F ++G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDL----KWEFPRENLEFGK--VLGSGAFG 59
Query: 172 EILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA 223
+++ A G VA+K + + E+ ++ +L H NIV LGA
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMTQLGSHENIVNLLGA 117
Query: 224 VTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNF 260
T P+ LI EY GDL YL+ K L+ + F
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYK 319
A +A+GM +L E +HRDL RNVL+ + + K+ DFGL++ I S Y
Sbjct: 178 AYQVAKGMEFL--EFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI---MSDSNYV 229
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVA 376
+ G ++MAPE Y K DV+S+ ++L+E+ G P K +
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289
Query: 377 EGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
G + P T E+ + + CWA D +RPSF ++ L
Sbjct: 290 NGFKMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-62
Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 56/320 (17%)
Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRI 188
E P +K WE L +G+G+FG++++A G VA+K +
Sbjct: 10 EHCERLPYDASK--WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 189 LPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYL 246
+ + E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL
Sbjct: 66 KEGATHSEH--RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 247 KE----------------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290
+ K L+ + ++ +A+GM +L IHRDL RN+LL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181
Query: 291 VNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFS 348
S + +K+ DFGL++ I Y G+ ++MAPE R Y + DV+S
Sbjct: 182 ---SEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 349 FAMILYEMLE-GEPPLANY----EPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCW 400
F ++L+E+ G P Y E + + EG R P TPE+ + CW
Sbjct: 236 FGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCW 288
Query: 401 AADMNQRPSFLDILKRLEKI 420
+ +QRP+F ++++ L +
Sbjct: 289 HGEPSQRPTFSELVEHLGNL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-58
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 22/276 (7%)
Query: 154 PSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
PS + + IG GS+G K + G + K + S+++ Q EVNLL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLL 59
Query: 210 VKLRHPNIVQFLGAVTERKP--LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALD 263
+L+HPNIV++ + +R L ++ EY GGDL + + + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 264 IARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+ + H + ++HRDLKP NV L ++K+GDFGL++++ +HD
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL----NHDTSFA 173
Query: 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380
G+ YM+PE Y++K D++S +LYE+ PP + E A + EG
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
++ EL E+ + RPS +IL+
Sbjct: 234 RRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-58
Identities = 64/258 (24%), Positives = 124/258 (48%), Gaps = 16/258 (6%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+GSFG+ + G IK I + +S ++ R EV +L ++HPNIVQ+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQY 88
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ +Y GGDL K + +++ + I + ++H+ I
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKI 146
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + +++GDFG+++++ NS G+ Y++PE+ +++
Sbjct: 147 LHRDIKSQNIFL--TKDGTVQLGDFGIARVL---NSTVELARA-CIGTPYYLSPEICENK 200
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
Y+ K D+++ +LYE+ + + G P ++ +LR L +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-LHYSYDLRSLVSQ 259
Query: 399 CWAADMNQRPSFLDILKR 416
+ + RPS IL++
Sbjct: 260 LFKRNPRDRPSVNSILEK 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-57
Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 45/288 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG G FG++ KA R G IKR+ + + EV L KL H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 216 NIVQFLGA----------------VTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTA 257
NIV + G ++ K L + E+ G L ++++++ L A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ I +G+ Y+H+ +I+RDLKP N+ L +K+GDFGL +K
Sbjct: 125 LELFEQITKGVDYIHS--KKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDG---- 176
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
K T G+ RYM+PE + Y K+VD+++ +IL E+L +E +K+ +
Sbjct: 177 -KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTD 230
Query: 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL---EKIKE 422
+ F + + L +K + RP+ +IL+ L +K E
Sbjct: 231 LRDGII-SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-57
Identities = 73/305 (23%), Positives = 131/305 (42%), Gaps = 18/305 (5%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI 188
G P P P + +F IG+G F E+ +A G PVA+K++
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 189 -LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
+ L D + D E++LL +L HPN++++ + E L ++ E GDL + +K
Sbjct: 66 QIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 248 EKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
+ T + + + + ++H+ ++HRD+KP NV + ++ +K+GD
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDL 180
Query: 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
GL + S G+ YM+PE Y+ K D++S +LYEM + P
Sbjct: 181 GLGRFF----SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 364 A--NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
Y K + + P + ++ ELR+L C D +RP + +++
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
Query: 422 ETLPT 426
+
Sbjct: 297 ACTAS 301
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 19/262 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
F + +G GS+GE+ K + G A+KR + + EV K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
P V+ A E L L TE G L ++ + GA L + + D +A+LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++H D+KP N+ L K+GDFGL + + +V + G RYMAPE
Sbjct: 176 --QGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPE 226
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393
+ + Y DVFS + + E+ E ++ + +G+ P G + ELR
Sbjct: 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELR 282
Query: 394 ELTEKCWAADMNQRPSFLDILK 415
+ D R + +L
Sbjct: 283 SVLVMMLEPDPKLRATAEALLA 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-56
Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
DF +G+G FG + +A + AIKRI LP+ R + EV L KL H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLEH 62
Query: 215 PNIVQFLGAVTERKP------------LMLITEYLRGGDLHKYLKEKGALSP---STAVN 259
P IV++ A E+ L + + R +L ++ + + S ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------V 311
L IA + +LH+ ++HRDLKP N+ + D +KVGDFGL + +
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
+ TG+ G+ YM+PE Y KVD+FS +IL+E+L P E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
V P + P + + + +RP ++I++
Sbjct: 237 LTDVRNLKFPPLFTQ-KYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 67/311 (21%), Positives = 127/311 (40%), Gaps = 40/311 (12%)
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
+ G+ G +F+ V + I IG G ++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMSV-----KGRIYSIL---------KQIGSGGSSKVFQVLNEK 51
Query: 180 GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEY 236
AIK + +L + D + +R+E+ L KL+ + I++ + + ++ E
Sbjct: 52 KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
DL+ +LK+K ++ P ++ ++ + +H + I+H DLKP N L+V+
Sbjct: 110 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDGM-- 164
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----------HRKYDKKVD 345
LK+ DFG++ ++ ++ V K + + G+ YM PE K K K D
Sbjct: 165 -LKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 346 VFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADM 404
V+S ILY M G+ P + + + +L+++ + C D
Sbjct: 222 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281
Query: 405 NQRPSFLDILK 415
QR S ++L
Sbjct: 282 KQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-56
Identities = 61/266 (22%), Positives = 117/266 (43%), Gaps = 24/266 (9%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFL 221
IG G ++ + AIK + +D++ + +R+E+ L KL+ + I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHS 132
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK----- 336
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 133 DLKPANFLIVD---GMLKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSSS 187
Query: 337 ------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFT 389
K K DV+S ILY M G+ P + + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
+L+++ + C D QR S ++L
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-55
Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 26/318 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
+ H + + +G+G F + G A+KR
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLH 243
IL DR ++ + E ++ HPNI++ + + L+ + + G L
Sbjct: 62 ILCHEQQDR---EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 244 KYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299
++ L+ + L I RG+ +H + HRDLKP N+LL
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPV 174
Query: 300 VGDFGLSKL--IKVQNSHDVYKM---TGETGSYRYMAPEVF---KHRKYDKKVDVFSFAM 351
+ D G I V+ S + + + Y APE+F H D++ DV+S
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234
Query: 352 ILYEMLEGEPP-LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 410
+LY M+ GE P ++ ++ + ++ + L +L D +QRP
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294
Query: 411 LDILKRLEKIKETLPTDH 428
+L +LE ++ P H
Sbjct: 295 PLLLSQLEALQPPAPGQH 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-55
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 42/284 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKL-R 213
+F IG G FG + K R G AIKR P Q+ EV L +
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD--EQNALREVYAHAVLGQ 69
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMA 269
H ++V++ A E +++ EY GG L + E + + L + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 270 YLHNEPNVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQ 312
Y+H+ ++H D+KP N+ + S+ K+GD G I
Sbjct: 130 YIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
E G R++A EV + + K D+F+ A+ + EP N + +
Sbjct: 188 QV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ +G P + + E EL + D +RPS + ++K
Sbjct: 240 ---IRQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 70/288 (24%), Positives = 115/288 (39%), Gaps = 18/288 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHE 205
D+E + +G+GSFGE+ + + T A+K++ L + E
Sbjct: 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------E 100
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
+ L P IV GAV E + + E L GG L + +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 324
G+ YLH I+H D+K NVLL +S + DFG + L +
Sbjct: 161 EGLEYLHT--RRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
G+ +MAPEV + D KVD++S ++ ML G P Y +A P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277
Query: 385 AK-GFTPELRELTEKCWAADMNQRPSFLDILK-RLEKIKETLPTDHHW 430
P + ++ + R S +++ + + ++E W
Sbjct: 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 220
IG G ++ + AIK + +L + D + +R+E+ L KL+ + I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 178
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK---- 336
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 179 SDLKPANFLIVDGM---LKLIDFGIANQMQ-PDTTSVVKDS-QVGAVNYMPPEAIKDMSS 233
Query: 337 -------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGF 388
K K DV+S ILY M G+ P + + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+L+++ + C D QR S ++L
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-53
Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF A++G+G+FG+++KA AIK+I ++++ + EV LL L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEK--LSTILSEVMLLASLNHQ 62
Query: 216 NIVQFLGAVTERKP-------------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFA 261
+V++ A ER+ L + EY G L+ + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY--- 318
I ++Y+H+ IIHRDLKP N+ + + ++K+GDFGL+K +
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 319 -------KMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
+T G+ Y+A EV Y++K+D++S +I +EM+ P E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 371 AAKYVAEGHRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
K + F +++ D N+RP +L
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-53
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 24/289 (8%)
Query: 141 PPPLPNKCDWE---IDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDR 196
P + D E + ++ F ++G G+ G I+ + VA+KRILP
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---- 60
Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSP 254
EV LL + HPN++++ +R+ + E L +Y+++K A
Sbjct: 61 --FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG 117
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKV 311
+ G+A+LH+ I+HRDLKP N+L+ +A + DFGL K +
Sbjct: 118 LEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA- 174
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEML-EGEPPLANYE 367
H + +G G+ ++APE+ VD+FS + Y ++ EG P
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 368 PYEAAKYVAEGHRPFFRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 415
+A + K REL EK A D +RPS +LK
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 80/260 (30%), Positives = 120/260 (46%), Gaps = 18/260 (6%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG++G + +AIK I D R Q E+ L L+H NIVQ+L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRY-SQPLHEEIALHKHLKHKNIVQYL 85
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAV--NFALDIARGMAYLHNEPNVI 278
G+ +E + + E + GG L L+ K G L + + I G+ YLH+ N I
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQI 143
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K NV L+N+ + LK+ DFG SK + N TG+ +YMAPE+
Sbjct: 144 VHRDIKGDNV-LINTYSGVLKISDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKG 198
Query: 339 K--YDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPELREL 395
Y K D++S + EM G+PP EP A V + + E +
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 396 TEKCWAADMNQRPSFLDILK 415
KC+ D ++R D+L
Sbjct: 259 ILKCFEPDPDKRACANDLLV 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 81/257 (31%), Positives = 122/257 (47%), Gaps = 13/257 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKGSFGE++ + T A+K I + + EV LL +L HPNI++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ L+ E GG+L + + S A + G+ Y+H N I+HR
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--NKIVHR 150
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+LL + S D ++++ DFGLS + KM + G+ Y+APEV Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVLH-GTY 204
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEK 398
D+K DV+S +ILY +L G PP Y+ K V +G F K + ++L K
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 399 CWAADMNQRPSFLDILK 415
+ R S D L
Sbjct: 265 MLTYVPSMRISARDALD 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-48
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG+F + + + T A K I LS Q E + KL+HPNIV+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRL 70
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ E L+ + + GG+L + + + S + A + I +AY H+ N I+H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVH 128
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
R+LKP N+LL + + +K+ DFGL+ + G G+ Y++PEV K
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDP 183
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
Y K VD+++ +ILY +L G PP
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 90/281 (32%), Positives = 136/281 (48%), Gaps = 17/281 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSD 194
PV LP + + DP EL F+ IGKGSFGE+ K T VAIK I L D
Sbjct: 4 SPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP 254
+ I+D + E+ +L + P + ++ G+ + L +I EYL GG L+
Sbjct: 63 E---IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET 119
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
A +I +G+ YLH+E IHRD+K NVLL S +K+ DFG++ Q +
Sbjct: 120 QIAT-ILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAG----QLT 170
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
K G+ +MAPEV K YD K D++S + E+ GEPP + P +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230
Query: 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ + + P ++ L+E E C + + RP+ ++LK
Sbjct: 231 IPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLK 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 159 FSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216
S I+G GS G ++ ++G PVA+KR+L E+ LL + HPN
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPN 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST-------AVNFALDIARGMA 269
++++ + T + L + E +L ++ K + ++ IA G+A
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------LKVGDFGLSKLIKVQNSHDVY 318
+LH+ IIHRDLKP+N+L+ SS + + DFGL K + S
Sbjct: 130 HLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 319 KMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYE 370
+ +G+ + APE+ + R+ + +D+FS + Y +L +G+ P + Y
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYS 245
Query: 371 AAKYVAEG-----HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ G + E +L + D +RP+ + +L+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
I+G+G+ + + + G AIK + E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLF 73
Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPN 276
E +LI E+ G L+ L+E L S + D+ GM +L N
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--N 131
Query: 277 VIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HR++KP N++ V K+ DFG ++ ++ + G+ Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDM 186
Query: 335 FK--------HRKYDKKVDVFSFAMILYEMLEGEPP 362
++ +KY VD++S + Y G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G G+F E+ R T A+K I S + +E+ +L K++H NIV
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLE 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
L+ + + GG+L + E+G + A + + YLH N I+HR
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHR 130
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+L + + + + DFGLSK+ + M+ G+ Y+APEV + Y
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKPY 184
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
K VD +S +I Y +L G PP
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 5e-47
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+GS+GE+ A +GT A K+I +D + F+ E+ ++ L HPNI++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L+ E GG+L + + K S A D+ +AY H + HR
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--LNVAHR 130
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N L + S D LK+ DFGL+ K M + G+ Y++P+V + Y
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-----MMRTKVGTPYYVSPQVLE-GLY 184
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
+ D +S +++Y +L G PP
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-47
Identities = 85/284 (29%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+F +IG G FG++ K R G VA+KR P + I++F E+ L RHP+
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPH 96
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLH 272
+V +G ER ++LI +Y+ G+L ++L ++S + + ARG+ YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 273 NEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQ-NSHDVYKMTGETGSYRYM 330
IIHRD+K N+LL N K+ DFG+SK +H + T G+ Y+
Sbjct: 157 TRA--IIHRDVKSINILLDENFVP---KITDFGISKKGTELDQTH-L--STVVKGTLGYI 208
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT- 389
PE F + +K DV+SF ++L+E+L + P E +AE
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQ 267
Query: 390 ---PELR------------ELTEKCWAADMNQRPSFLDILKRLE 418
P L + KC A RPS D+L +LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 74/241 (30%), Positives = 115/241 (47%), Gaps = 20/241 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELD-----FSSSAIIGKGSFGEILKAYWRGT--P 182
Q+ S P D+ ID S D F + +G+G+ + + +GT P
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
A+K + + + R E+ +L++L HPNI++ + L+ E + GG+L
Sbjct: 81 YALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVG 301
+ EKG S A + I +AYLH N I+HRDLKP N+L + D LK+
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
DFGLSK+++ Q M G+ Y APE+ + Y +VD++S +I Y +L G
Sbjct: 194 DFGLSKIVEHQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 362 P 362
P
Sbjct: 249 P 249
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G G FG +L+ + G VAIK+ LS + + E+ ++ KL HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSAR 78
Query: 222 ------GAVTERKPLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLH 272
+ +L EY GGDL KYL + L DI+ + YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 273 NEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
N IIHRDLKP N++L K+ D G +K + Q T G+ +Y+A
Sbjct: 139 E--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGE----LCTEFVGTLQYLA 191
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
PE+ + +KY VD +SF + +E + G P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 22/265 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+ GE+ A+ R T VAI+ I + + + E+ +L KL HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--NG 259
Query: 278 IIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLV 314
Query: 336 --KHRKYDKKVDVFSFAMILYEMLEGEPP-LANYEPYEAAKYVAEGHRPFFRA--KGFTP 390
Y++ VD +S +IL+ L G PP + + G F +
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 391 ELRELTEKCWAADMNQRPSFLDILK 415
+ +L +K D R + + L+
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALR 399
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 16/238 (6%)
Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSS----AIIGKGSFGEILKAYWRGT--PVAI 185
G H + ++ ++ S FS + +GKG+F + + + T A
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNAST-KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
K I R Q E + KL+HPNIV+ ++ E L+ + + GG+L +
Sbjct: 60 KIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFG 304
+ + S + A + I +AY H+ N I+HR+LKP N+LL + + +K+ DFG
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
L+ + G G+ Y++PEV K Y K VD+++ +ILY +L G PP
Sbjct: 177 LAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 28/300 (9%)
Query: 134 HFEPKPVPPPLPNKCDWEIDPSELDFSSSA------------IIGKGSFGEILKAYWRGT 181
H ++ + F +S +G G++GE+L + T
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 182 --PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
AIK I S+S EV +L L HPNI++ +++ L+ E +
Sbjct: 62 HVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-H 297
GG+L + + + A + G+ YLH + I+HRDLKP N+LL + D
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDAL 177
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGLS + + Q KM G+ Y+APEV + +KYD+K DV+S +IL+ +L
Sbjct: 178 IKIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 415
G PP E + V +G F K + ++L ++ D +R S L+
Sbjct: 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-46
Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 16/266 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP + ++ IG+G+ G + A T VAI+++ + +I + E+ ++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMR 72
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++PNIV +L + L ++ EYL GG L + E A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL +K+ DFG Q + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWM 183
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 389
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
R+ +C D+ +R S ++L+
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQ 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-46
Identities = 81/258 (31%), Positives = 122/258 (47%), Gaps = 16/258 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++GKGSFGE+LK R T A+K I S + EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E GG+L + ++ S A + G+ Y+H + I+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GT 198
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTE 397
YD+K DV+S +ILY +L G PP Y+ K V G F + + + ++L
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 398 KCWAADMNQRPSFLDILK 415
K + R + L+
Sbjct: 259 KMLTFHPSLRITATQCLE 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-46
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
I+G+G+ + + + G AIK S V E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKL 72
Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEP 275
E +LI E+ G L+ L+E L S + D+ GM +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 276 NVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
N I+HR++KP N++ V K+ DFG ++ ++ D + G+ Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYGTEEYLHPD 185
Query: 334 VFK--------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+++ +KY VD++S + Y G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-45
Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKGSFGE+LK R T A+K I + + ++ EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLF 87
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + ++ E GG+L + ++ S A + G+ Y+H + I+HR
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVHR 145
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV + Y
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GTY 199
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
D+K DV+S +ILY +L G PP
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 30/268 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +GKG FG + A + + +A+K + + + V R EV + LRHP
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
NI++ G + + LI EY G +++ L++ + ++A ++Y H+
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPE 333
+IHRD+KP N+LL SA LK+ DFG S + G+ Y+ PE
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRT-------DLCGTLDYLPPE 177
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP------LANYEPYEAAKYVAEGHRPFFRAKG 387
+ + R +D+KVD++S ++ YE L G+PP Y+ ++
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------- 229
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
T R+L + + +QRP ++L+
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI----------LPSLSDDRLVIQDFRHEVNLLVK 211
+G G++GE+L + AIK I + ++ +E++LL
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
L HPNI++ ++K L+TE+ GG+L + + + A N I G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
H + I+HRD+KP N+LL N ++ ++K+ DFGLS K+ G+ Y+
Sbjct: 163 HK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYI 215
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGF 388
APEV K +KY++K DV+S +I+Y +L G PP + K V +G F K
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 389 TPELRELTEKCWAADMNQRPSFLDILK 415
+ E +EL + D N+R + + L
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 16/266 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP L S IG+GS G + A + + VA+K + R ++ + EV ++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMR 97
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H N+V+ + + L ++ E+L+GG L + + L+ + + +AY
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAY 156
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH + +IHRD+K ++LL + +K+ DFG Q S DV K G+ +M
Sbjct: 157 LHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCA----QISKDVPKRKSLVGTPYWM 208
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 389
APEV Y +VD++S +++ EM++GEPP + P +A K + + P + +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
P LR+ E+ D +R + ++L
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLD 294
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG+F + + A I LS Q E + L+HPNIV+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD--HQKLEREARICRLLKHPNIVRL 75
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+++E LI + + GG+L + + + S + A + I + + H ++H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ--MGVVH 133
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
R+LKP N+LL + +K+ DFGL+ ++ + G G+ Y++PEV +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----AWFGFAGTPGYLSPEVLRKDP 189
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
Y K VD+++ +ILY +L G PP
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-45
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K +GT A K I S S + ++ EVN+L ++RHPNI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS--KRIA 130
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + +K+ DFG++ I+ N + G+ ++APE+ +
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFVAPEIVNY 185
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + T A K I S + ++ EV++L ++ HPNI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIA 137
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+ +
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNY 192
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G G+ GE+ A+ R T VAIK I + + + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
I++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--N 133
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVL 188
Query: 336 ---KHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y++ VD +S +IL+ L G PP
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G G F + K + T A K I S + ++ EV++L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKI 136
Query: 279 IHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVN 191
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + D++S +I Y +L G P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
+ +G F + +A G A+KR+L + + + EV + KL HPNIVQF
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 222 GAVTERKPLM-------LITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 271
A + K L+ L G L ++LK+ +G LS T + R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------- 324
H + IIHRDLK N+LL S+ +K+ DFG + I +
Sbjct: 153 HRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 325 -GSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380
+ Y PE+ + +K D+++ ILY + + P + A + G
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKY 266
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427
L + +R S +++ +L++I +
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-45
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPS-LSDDRLVIQD 201
K + ID DF +GKG FG + A + +A+K + S L + + Q
Sbjct: 6 MPKRKFTID----DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ- 60
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
R E+ + LRHPNI++ +RK + L+ E+ G+L+K L++ G + F
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
++A + Y H +IHRD+KP N+L+ LK+ DFG S
Sbjct: 121 EELADALHYCHE--RKVIHRDIKPENLLM--GYKGELKIADFGWSVHAPSLRRR------ 170
Query: 322 GET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG- 378
T G+ Y+ PE+ + + +D+KVD++ ++ YE L G PP + E + +
Sbjct: 171 --TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
Query: 379 -HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P F + ++L K QR +++
Sbjct: 229 LKFPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG++ R + IK I S ++ E+ +L L HPNI++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ + ++ E GG+L + + ALS + +AY H+ +
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHV 145
Query: 279 IHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+H+DLKP N+L ++S +K+ DFGL++L K T G+ YMAPEVFK
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-----HSTNAAGTALYMAPEVFK- 199
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
R K D++S +++Y +L G P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 41/242 (16%), Positives = 91/242 (37%), Gaps = 30/242 (12%)
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD 194
P + K ++++ + ++G+G+F ++ +A +K P+
Sbjct: 52 PAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--- 251
+ + + L ++F A + +L+ E G L +
Sbjct: 110 EFYIG---TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---------HLKV 300
+ ++FA+ + + +H+ IIH D+KP N +L N + L +
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
D G S +K+ + T + + + E+ ++ ++ ++D F A +Y ML G
Sbjct: 225 IDLGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
Query: 361 PP 362
Sbjct: 283 YM 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + T A K I S + +D EV++L +++HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 136
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 191
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
+G+GSF K + + A+K I + + + + E+ L HPNIV+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ L+ E L GG+L + +K+K S + A + ++++H+ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--VGVVH 129
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+L + + + +K+ DFG ++L N + + Y APE+
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----PLKTPCFTLHYAAPELLNQNG 185
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
YD+ D++S +ILY ML G+ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 13/236 (5%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
N ++ P + + D + +G G+FG + + R T A K
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HKYL 246
++ D+ + R E+ + LRHP +V A + +++I E++ GG+L K
Sbjct: 190 VMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
E +S AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + + TG+ + APEV + + D++S ++ Y +L G P
Sbjct: 305 AHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 88/298 (29%), Positives = 126/298 (42%), Gaps = 25/298 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGT- 181
+P P + D ++ DP +L FS IG GSFG + A
Sbjct: 21 YFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNS 79
Query: 182 -PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
VAIK++ S QD EV L KLRHPN +Q+ G L+ EY G
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 139
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
K L +G+AYLH+ +IHRD+K N+LL S +K+
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKL 195
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEML 357
GDFG + ++ NS G+ +MAPEV YD KVDV+S + E+
Sbjct: 196 GDFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
E +PPL N A ++A+ P ++ ++ R + C RP+ +LK
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-44
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 21/283 (7%)
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVI 199
++DP+E+ + +G G+FG++ KA + T A K I ++ +
Sbjct: 5 SREYEHVRRDLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---L 60
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAV 258
+D+ E+ +L HP IV+ LGA L ++ E+ GG + + E L+
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + +LH+ IIHRDLK NVL+ + +++ DFG+S +N +
Sbjct: 121 VVCRQMLEALNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVS----AKNLKTLQ 172
Query: 319 KMTGETGSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
K G+ +MAPEV K YD K D++S + L EM + EPP P
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
Query: 374 YVAEGHRPFFRAKG-FTPELRELTEKCWAADMNQRPSFLDILK 415
+A+ P ++ E R+ + + RPS +L+
Sbjct: 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-44
Identities = 42/201 (20%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + + + K + +D + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHE 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L++I E++ G D+ + + L+ V++ + + +LH+ + I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--HNIGHF 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D++P N++ + +K+ +FG ++ +K + + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
D++S ++Y +L G P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
IG GS+ + + T A+K I D D E+ +L++ +HPNI+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKR--DPTEEIEILLRYGQHPNIITL 81
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ K + ++TE ++GG+L + + S A I + + YLH ++H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA--QGVVH 139
Query: 281 RDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
RDLKP N+L V+ S + +++ DFG +K ++ +N + + ++APEV + +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLERQ 195
Query: 339 KYDKKVDVFSFAMILYEMLEGEPP 362
YD D++S ++LY ML G P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+IGKG F + + R T A+K + + S L +D + E ++ L+HP+IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
L + L ++ E++ G DL + ++ S + A ++ I + Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 276 NVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
N IIHRD+KP VLL + +K+G FG++ + G G+ +MAPEV
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFMAPEV 204
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
K Y K VDV+ +IL+ +L G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 22/269 (8%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
P E+ F +G+GS+G + KA + T VAIK++ + D +Q+ E++++
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESD---LQEIIKEISIMQ 79
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIARG 267
+ P++V++ G+ + L ++ EY G D+ + L+ +G
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKG 137
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH IHRD+K N+LL ++ H K+ DFG++ Q + + K G+
Sbjct: 138 LEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAG----QLTDTMAKRNTVIGTP 189
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+MAPEV + Y+ D++S + EM EG+PP A+ P A + P FR
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249
Query: 388 -FTPELRELTEKCWAADMNQRPSFLDILK 415
++ + ++C QR + +L+
Sbjct: 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
S + I+G G FG++ K T +A K I D+ ++ ++E++++ +L H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNE 274
N++Q A + ++L+ EY+ GG+L + ++ L+ + F I G+ ++H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+H DLKP N+L VN A +K+ DFGL++ K + K+ G+ ++APEV
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFLAPEV 259
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-43
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
++G+G+ + T A+K I R EV +L + + H N+++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ E L+ E +RGG + ++ ++ + A D+A + +LHN I H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN--KGIAH 134
Query: 281 RDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSH---DVYKMTGETGSYRYMAPEVFK 336
RDLKP N+L + + +K+ DF L IK+ ++ GS YMAPEV +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 337 -----HRKYDKKVDVFSFAMILYEMLEGEPP 362
YDK+ D++S +ILY +L G PP
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 28/261 (10%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG F + + T A K I+P L + E+++ L H ++V F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
G + + ++ E R L + K + AL+ A + I G YLH N +IH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR--NRVIH 138
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLK N+ L + +K+GDFGL+ ++ K G+ Y+APEV + +
Sbjct: 139 RDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE---RKKV-LCGTPNYIAPEVLSKKGH 192
Query: 341 DKKVDVFSFAMILYEMLEGEPP------LANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+VDV+S I+Y +L G+PP Y + +Y P P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKH----INPVAAS 244
Query: 395 LTEKCWAADMNQRPSFLDILK 415
L +K D RP+ ++L
Sbjct: 245 LIQKMLQTDPTARPTINELLN 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 45/201 (22%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG + + + T K I D+ ++E++++ +L HP ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A ++ ++LI E+L GG+L + + +S + +N+ G+ ++H + I+H
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHL 173
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N++ A +K+ DFGL+ + + T + + APE+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVG 228
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
D+++ ++ Y +L G P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEV 206
W I+ D+ +IG G+ + AY + VAIKRI L + + E+
Sbjct: 10 WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEI 64
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALD 263
+ + HPNIV + + + L L+ + L GG D+ K++ KG LD
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LD 119
Query: 264 ---IA-------RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQ 312
IA G+ YLH N IHRD+K N+LL +++ DFG+S L
Sbjct: 120 ESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILL--GEDGSVQIADFGVSAFLATGG 175
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
+ G+ +MAPEV + + YD K D++SF + E+ G P Y P +
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
Query: 372 AKYVA--------EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
G + K + R++ C D +RP+ ++L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 48/244 (19%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+GS+G + A T AIK + + + ++ + EV L+ KL HPNI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------------------ 250
+ + + L+ E GG L L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 251 ----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
N I + YLHN I HRD+KP N L + + +K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKL 211
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLE 358
DFGLSK N+ + Y MT + G+ ++APEV + Y K D +S ++L+ +L
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 359 GEPP 362
G P
Sbjct: 272 GAVP 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI------LPSLSDDRLVIQDFRHEVNLLVKL-RH 214
I+G+G + + + T A+K I S + + + + EV++L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
PNI+Q L+ + ++ G+L YL EK LS + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK- 142
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRDLKP N+LL + ++K+ DFG S + K+ G+ Y+APE+
Sbjct: 143 -LNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEI 194
Query: 335 FK------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ H Y K+VD++S +I+Y +L G PP
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 29/286 (10%)
Query: 141 PPPLPNKCDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILP--SLSDD 195
PP + +DP + +GKG F + + T A K I+P L
Sbjct: 24 APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKP 82
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
+ E+++ L H ++V F G + + ++ E R L + K + AL+
Sbjct: 83 HQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 141
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
A + I G YLH N +IHRDLK N+ L + +K+GDFGL+ ++
Sbjct: 142 EARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE- 196
Query: 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP------LANYEPY 369
K G+ Y+APEV + + +VDV+S I+Y +L G+PP Y
Sbjct: 197 --RKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ +Y P P L +K D RP+ ++L
Sbjct: 254 KKNEY----SIPKH----INPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 31/280 (11%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP+ + F ++G G++G++ K T AIK ++ D+ ++ + E+N+L
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDE---EEEIKQEINMLK 75
Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
K H NI + GA ++ P L L+ E+ G DL K K A
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-I 134
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+I RG+++LH + +IHRD+K +NVLL + +K+ DFG+S Q V +
Sbjct: 135 CREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEVKLVDFGVSA----QLDRTVGRR 186
Query: 321 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375
G+ +MAPEV + YD K D++S + EM EG PPL + P A +
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
Query: 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P ++K ++ + + E C + +QRP+ ++K
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-42
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 165 IGKGSFGEILKAYWRGTPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLV 210
+ +G F +I+ A+K + + DF++E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---- 266
+++ + G +T + +I EY+ + K+ + L + + + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+Y+HNE N I HRD+KP N+L+ +K+ DFG S+ + + K+ G
Sbjct: 159 SVLNSFSYIHNEKN-ICHRDVKPSNILM--DKNGRVKLSDFGESEY--MVDK----KIKG 209
Query: 323 ETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 362
G+Y +M PE F + KVD++S + LY M P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 19/256 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKG+F ++ A G VAIK I+ + +Q EV ++ L HPNIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ K L LI EY GG++ YL G + A + I + Y H I+HRD
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRD 139
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
LK N+LL + ++K+ DFG S K+ G+ Y APE+F+ +KYD
Sbjct: 140 LKAENLLL--DADMNIKIADFGFSNEFT-----VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPELRELTEKC 399
+VDV+S +ILY ++ G P E + V G PF+ + + L ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY----MSTDCENLLKRF 248
Query: 400 WAADMNQRPSFLDILK 415
+ +R + I+K
Sbjct: 249 LVLNPIKRGTLEQIMK 264
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLR-HP 215
+IG+G + + R T A+K + S V + R E ++L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+I+ + + + L+ + +R G+L YL EK ALS + + +++LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-- 218
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
N I+HRDLKP N+LL ++ +++ DFG S ++ K+ G+ Y+APE+
Sbjct: 219 NNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGE-----KLRELCGTPGYLAPEIL 271
Query: 336 K------HRKYDKKVDVFSFAMILYEMLEGEPP 362
K H Y K+VD+++ +IL+ +L G PP
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + R T A+K + D R EV+ + P+IV
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-----YDS---PKARQEVDHHWQASGGPHIVCI 87
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
L ++ L++I E + GG+L ++E+G A + A DI + +LH+
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ I HRD+KP N+L + D LK+ DFG +K + + Y+APE
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------ALQTPCYTPYYVAPE 199
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
V KYDK D++S +I+Y +L G PP
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 7e-41
Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 40/289 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRH 214
+FS+ I+G+G FG++ K GT VA+KR L ++R F+ EV ++ H
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERTQGGELQFQTEVEMISMAVH 86
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP----STAVNFALDIARGMAY 270
N+++ G +L+ Y+ G + L+E+ P AL ARG+AY
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 271 LHNEPNV-IIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
LH+ + IIHRD+K N+LL D VGDFGL+KL+ +++H + G G
Sbjct: 147 LHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG- 200
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRA 385
++APE K +K DVF + ++L E++ G+ + + + + +
Sbjct: 201 --HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 386 KGFT----PEL------RELTE------KCWAADMNQRPSFLDILKRLE 418
K +L E+ + C + +RP ++++ LE
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 28/305 (9%)
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
+ H GSH P E +P E + ++G G FG +
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS 66
Query: 180 -GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLML 232
PVAIK + + + + EV LL K+ +++ L +L
Sbjct: 67 DNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 233 ITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
I E DL ++ E+GAL A +F + + + HN ++HRD+K N +L+
Sbjct: 126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDEN-ILI 182
Query: 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFA 350
+ + LK+ DFG L+K D G+ Y PE ++ +Y + V+S
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDF------DGTRVYSPPEWIRYHRYHGRSAAVWSLG 236
Query: 351 MILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSF 410
++LY+M+ G+ P + E + + E + L C A + RP+F
Sbjct: 237 ILLYDMVCGDIPFEHDEEIIRGQV----FFRQR----VSSECQHLIRWCLALRPSDRPTF 288
Query: 411 LDILK 415
+I
Sbjct: 289 EEIQN 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLR----H 214
+GKG FG + + VAIK I + S + EV LL K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 215 PNIVQFLGAVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
P +++ L ++ ML+ E L DL Y+ EKG L + F + + + H+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++HRD+K N +L++ K+ DFG L+ + D G+ Y PE
Sbjct: 158 --RGVVHRDIKDEN-ILIDLRRGCAKLIDFGSGALLHDEPYTDF------DGTRVYSPPE 208
Query: 334 VFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392
+Y V+S ++LY+M+ G+ P + A+ H P +P+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----HFPAH----VSPDC 260
Query: 393 RELTEKCWAADMNQRPSFLDILK 415
L +C A + RPS +IL
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILL 283
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRHEVNLLVK 211
+G+G FG + K Y T VA+K+ + D + F E+ ++ K
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAK 86
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGM 268
+H N+V+ LG ++ L L+ Y+ G L L P A A G+
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKV-QNSHDVYKMTGET 324
+LH IHRD+K N+LL D K+ DFGL++ + + MT +
Sbjct: 147 NFLHENH--HIHRDIKSANILL-----DEAFTAKISDFGLARASEKFAQTV----MT--S 193
Query: 325 ---GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+ YMAPE + K D++SF ++L E++ G P + + + + +
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---LLLDIKEE 249
Query: 382 FFRAKG-FT----PELRELTEK-----------CWAADMNQRPSFLDILKRLEKIKET 423
+ ++ + C N+RP + + L+++ +
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 120
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG +K N +T + Y+APE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYYVAPE 233
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
V KYDK D++S +I+Y +L G PP
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
+G+G F + + + T A K + D R + HE+ +L + P ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCPRVIN 93
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++LI EY GG++ + +S + + I G+ YLH N
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NN 151
Query: 278 IIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I+H DLKP+N+LL + +K+ DFG+S+ I ++ G+ Y+APE+
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLAPEILN 206
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ D+++ +I Y +L P
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKGSF + +A T VAIK ++ ++ +V + ++EV + +L+HP+I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ + L+ E G++++YLK + S + A +F I GM YLH+ + I+
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS--HGIL 134
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRDL N+LL + ++K+ DFGL+ +K+ + T G+ Y++PE+
Sbjct: 135 HRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHE---KHYT-LCGTPNYISPEIATRSA 188
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
+ + DV+S + Y +L G PP
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 6e-40
Identities = 65/326 (19%), Positives = 113/326 (34%), Gaps = 75/326 (23%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKR------------------ILPSLSDDRL 197
DF +G+G FG + +A + AIKR L L +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 198 V-------------------------------------IQDFRHEVNLLVKLRHPNIVQF 220
V + ++ + N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGMAYLHNEPNV 277
L + + L + + R +L ++ + +L ++ + IA + +LH+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KG 184
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------VQNSHDVYKMTGETGSYRY 329
++HRDLKP N+ + D +KVGDFGL + + TG+ G+ Y
Sbjct: 185 LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
M+PE Y KVD+FS +IL+E+L E V P + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKY- 299
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
P+ + + + +RP DI++
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 17/286 (5%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ + DF + +G G+ G + K G +A K I L + E+
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIREL 82
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
+L + P IV F GA + + E++ GG L + LK+ G + ++ + +
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDVYKMTGET 324
G+ YL + I+HRD+KP N+L+ +S +K+ DFG+S +LI + NS
Sbjct: 143 GLTYLREKHK-IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSMANSF--------V 191
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
G+ YM+PE + Y + D++S + L EM G P+ + E
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHW 430
P + D + ++L + +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-40
Identities = 62/276 (22%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
E+ +L+ +G+G++G + K G +A+KRI + + + ++++
Sbjct: 3 EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58
Query: 209 LVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
++ P V F GA+ + + E + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ + +LH++ + +IHRD+KP NVL+ ++ +K+ DFG+S DV K +
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLI--NALGQVKMCDFGISG----YLVDDVAKDI-DA 170
Query: 325 GSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGH 379
G YMAPE + Y K D++S + + E+ P ++ P++ K V E
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
P A F+ E + T +C + +RP++ ++++
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 75/265 (28%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G + A VAIK I + ++ F EV+ +L H NIV
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ E L+ EY+ G L +Y++ G LS TA+NF I G+ + H+ I+H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--MRIVH 134
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFKHRK 339
RD+KP+N+L+ S LK+ DFG++K + S T G+ +Y +PE K
Sbjct: 135 RDIKPQNILI--DSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEG--HRPFFRAKGFTPELRELT 396
D+ D++S ++LYEML GEPP A K++ + + K L +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248
Query: 397 EKCWAADMNQRPS----FLDILKRL 417
+ D R D L +
Sbjct: 249 LRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 62/279 (22%), Positives = 114/279 (40%), Gaps = 22/279 (7%)
Query: 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHE 205
D + +G G+ G++ K G +A+K++ S ++ + +
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMD 73
Query: 206 VNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
+++++K P IVQ G + + E + + +G + + I
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGE 323
+ + YL + +IHRD+KP N+LL +K+ DFG+S +L+ D
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILL--DERGQIKLCDFGISGRLV------DDKAKDRS 184
Query: 324 TGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAE 377
G YMAPE YD + DV+S + L E+ G+ P N + +E V +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 378 GHRPFFRAK-GFTPELRELTEKCWAADMNQRPSFLDILK 415
P GF+ + + + C D +RP + +L+
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 26/257 (10%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++G+G G++ +A R VA+K + +LS D + + E +L+ P++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + + G DL L+ +G L+P AV I + H H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA--AGATH 157
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GET-GSYRYMAPEVFKH 337
RD+KP N+L+ S+ D + DFG++ K+T G T G+ YMAPE F
Sbjct: 158 RDVKPENILV--SADDFAYLVDFGIASAT------TDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRAKGFTPE 391
+ D+++ +LYE L G PP Y+ + + V H RP G
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP---YQGDQLS--VMGAHINQAIPRPSTVRPGIPVA 264
Query: 392 LRELTEKCWAADMNQRP 408
+ + A + R
Sbjct: 265 FDAVIARGMAKNPEDRY 281
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 26/260 (10%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+FG + A + V +K ++L + + E+ +L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 218 VQFLGAVTERKPLMLITE-YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
++ L + L+ E + G DL ++ L A + + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--K 149
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IIHRD+K N+++ + +K+ DFG + ++ + G+ Y APEV
Sbjct: 150 DIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFYTF-----CGTIEYCAPEVLM 202
Query: 337 HRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
Y +++++S + LY ++ E P E A H P+ + EL L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI----HPPYL----VSKELMSL 254
Query: 396 TEKCWAADMNQRPSFLDILK 415
+R + ++
Sbjct: 255 VSGLLQPVPERRTTLEKLVT 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++GE+ A R T VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 342 KKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
+ VDV+S ++L ML GE P ++ + + + ++ L K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--IDSAPLALLHK 244
Query: 399 CWAADMNQRPSFLDILK 415
+ + R + DI K
Sbjct: 245 ILVENPSARITIPDIKK 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
W+ +L IG+G++G + K G +A+KRI ++ + + ++
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDL 71
Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST------AVN 259
+++++ P IVQF GA+ + E + K+ K ++
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK- 129
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDV 317
L + + +L IIHRD+KP N+LL + ++K+ DFG+S +L+ + + D
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILL--DRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 318 YKMTGETGSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAA 372
G YMAPE + YD + DV+S + LYE+ G P + ++
Sbjct: 187 -------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 373 KYVAEGHRPFFRA---KGFTPELRELTEKCWAADMNQRPSFLDILK 415
V +G P + F+P C D ++RP + ++LK
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 71/201 (35%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+FG + VA+K I + ++ + E+ LRHPNIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L +I EY GG+L++ + G S A F + G++Y H+ I HRD
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
LK N LL S A LK+ DFG SK H K T G+ Y+APEV ++YD
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST--VGTPAYIAPEVLLRQEYDG 196
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
K DV+S + LY ML G P
Sbjct: 197 KIADVWSCGVTLYVMLVGAYP 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 163 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
I+G G E+ VA+K + L+ D FR E L HP
Sbjct: 18 EILGFGGMSEV----HLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 217 IVQFL--GAVTERKPLM--LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
IV G + ++ EY+ G L + +G ++P A+ D + + + H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMA 331
N IIHRD+KP N+++ S+ + +KV DFG+++ + +S + T G+ +Y++
Sbjct: 134 Q--NGIIHRDVKPANIMI--SATNAVKVMDFGIARA--IADSGNSVTQTAAVIGTAQYLS 187
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRA 385
PE + D + DV+S +LYE+L GEPP ++ VA H P R
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQHVREDPIPPSARH 243
Query: 386 KGFTPELRELTEKCWAADMNQRP-SFLDILKRLEKIKETLPTD 427
+G + +L + K A + R + ++ L ++ P +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 70/257 (27%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++GE+ A R VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 342 KKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
+ VDV+S ++L ML GE P ++ + + + ++ L K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK--IDSAPLALLHK 244
Query: 399 CWAADMNQRPSFLDILK 415
+ + R + DI K
Sbjct: 245 ILVENPSARITIPDIKK 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 32/321 (9%), Positives = 69/321 (21%), Gaps = 54/321 (16%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDD 195
P D + E + G + A+K +
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-------------------------- 229
R ++ +L + + P
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 230 LMLITEYLRG------GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
+L+ L +G + R A L + ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHF 220
Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YD 341
P N+ + L +GD + + Y E +
Sbjct: 221 TPDNLFI--MPDGRLMLGDVSALW-------KVGTRGPASSVPVTYAPREFLNASTATFT 271
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------PFFRAKGFTPELRE 394
++ + + +Y + P P + R F ++
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331
Query: 395 LTEKCWAADMNQRPSFLDILK 415
L + D +R L+ ++
Sbjct: 332 LIGRFLNFDRRRRLLPLEAME 352
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 30/262 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG++ + G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ ++ EY+ GG+L Y+ + G + A I + Y H ++++H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVH 134
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP NVLL + + K+ DFGLS ++ D + GS Y APEV R Y
Sbjct: 135 RDLKPENVLL--DAHMNAKIADFGLSNMMS-----DGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 341 D-KKVDVFSFAMILYEMLEGEPP-----LAN-YEPYEAAKYVAEGHRPFFRAKGFTPELR 393
+VD++S +ILY +L G P + ++ + + P + +
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----YIPEY----LNRSVA 239
Query: 394 ELTEKCWAADMNQRPSFLDILK 415
L D +R + DI +
Sbjct: 240 TLLMHMLQVDPLKRATIKDIRE 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----------------------RILPSLSDDRLVI 199
IGKGS+G + AY T A+K R I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 200 QDFRHEVNLLVKLRHPNIVQF---LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
+ E+ +L KL HPN+V+ L E L ++ E + G + + LS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPVMEVPT-LKPLSEDQ 138
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
A + D+ +G+ YLH IIHRD+KP N+L+ H+K+ DFG+S K ++
Sbjct: 139 ARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDAL- 193
Query: 317 VYKMTGETGSYRYMAPEVF--KHRKYD-KKVDVFSFAMILYEMLEGEPP 362
++ G+ +MAPE + + K +DV++ + LY + G+ P
Sbjct: 194 ---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRH---EVNL 208
+ E+ +++ +IG GSFG + +A + VAIK++L QD R E+ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----------QDKRFKNRELQI 85
Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYL----KEKGALSPSTAV 258
+ ++HPN+V L L+ EY+ +++ K K +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK 144
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + R +AY+H+ I HRD+KP+N LL++ + LK+ DFG +K++
Sbjct: 145 LYMYQLLRSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAKILIAGEP---- 197
Query: 319 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ YR APE+ F Y +D++S ++ E+++G+P
Sbjct: 198 -NVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+GSFG++ A VA+K + L + ++ R E++ L LRHP+I++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+T ++++ EY GG+L Y+ EK ++ F I + Y H + I+H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR--HKIVH 131
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP N+LL ++K+ DFGLS ++ D + GS Y APEV + Y
Sbjct: 132 RDLKPENLLL--DDNLNVKIADFGLSNIMT-----DGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 341 D-KKVDVFSFAMILYEMLEGEPP 362
+VDV+S ++LY ML G P
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 78/296 (26%), Positives = 135/296 (45%), Gaps = 36/296 (12%)
Query: 124 GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-- 181
G + + G+ PPP P K E DF I+G+GSF ++ A T
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPE------DFKFGKILGEGSFSTVVLARELATSR 56
Query: 182 PVAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLITE 235
AIK IL + R +I++ E +++ +L HP V+ + K L
Sbjct: 57 EYAIK-IL----EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYFGLS 110
Query: 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295
Y + G+L KY+++ G+ + + +I + YLH IIHRDLKP N+LL +
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NED 166
Query: 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAM 351
H+++ DFG +K++ ++ S+ +Y++PE+ + K D+++
Sbjct: 167 MHIQITDFGTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 352 ILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR 407
I+Y+++ G PP Y + + + F + F P+ R+L EK D +R
Sbjct: 221 IIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDLVEKLLVLDATKR 274
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 21/241 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
G+ P + + + +G+G++GE+ KA T VAIKR
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
I ++ + R EV+LL +L+H NI++ + L LI EY DL KY+
Sbjct: 67 IRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMD 124
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDF 303
+ +S +F + G+ + H+ +HRDLKP+N LL++ S LK+GDF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQN-LLLSVSDASETPVLKIGDF 181
Query: 304 GLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
GL++ + + + T E T YR PE+ R Y VD++S A I EML
Sbjct: 182 GLARAFGIP----IRQFTHEIITLWYR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
Query: 361 P 361
P
Sbjct: 236 P 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 25/244 (10%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDP----SELDFSSSAIIGKGSFGEILKAYWRGTPV--A 184
+ + F W+ ++ F ++GKG FGE+ R T A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 185 IKRILPSLSDDRLVIQD----FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
K L R+ + +E +L K+ +V A + L L+ + GG
Sbjct: 214 CK----KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269
Query: 241 DL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
DL H Y + + AV +A +I G+ LH I++RDLKP N+LL H+
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILL--DDHGHI 325
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 358
++ D GL+ + + + G G+ YMAPEV K+ +Y D ++ +LYEM+
Sbjct: 326 RISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 359 GEPP 362
G+ P
Sbjct: 381 GQSP 384
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 151 EIDPSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
E E+D F + G+G+FG + + G VAIK+++ D R ++ + +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQ-IMQ 71
Query: 208 LLVKLRHPNIVQ---FLGAVTERKP----LMLITEYLRGGDLHKYLK----EKGALSPST 256
L L HPNIVQ + + ER L ++ EY+ LH+ + + A P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
F + R + LH + HRD+KP N +LVN + LK+ DFG +K +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADGTLKLCDFGSAKKLSPSEP-- 187
Query: 317 VYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APE+ F ++ Y VD++S I EM+ GEP
Sbjct: 188 ---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
F ++G+G FGE+ + T A K L+ RL + E +L K
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACK----KLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARG 267
+ IV A + L L+ + GGD+ + ++ A+ + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ +LH II+RDLKP NVLL ++++ D GL+ + K G G+
Sbjct: 302 LEHLHQ--RNIIYRDLKPENVLL--DDDGNVRISDLGLAV----ELKAGQTKTKGYAGTP 353
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+MAPE+ +YD VD F+ + LYEM+ P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 50/321 (15%), Positives = 101/321 (31%), Gaps = 67/321 (20%)
Query: 153 DPSELDFSSSAIIGKG--SFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
+ +IGKG + A G V ++RI L + S++ + + E++
Sbjct: 22 PEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM--VTFLQGELH 78
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
+ HPNIV + L ++T ++ G DL G ++ +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGV 137
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKM 320
+ + Y+H+ +HR +K ++L+ S + + + + Q +
Sbjct: 138 LKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 321 TGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEP---------- 368
+++PEV + YD K D++S + E+ G P +
Sbjct: 194 Y-SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 369 ----------------------------------YEAAKYVAEGHRPFFRAKGFTPELRE 394
+ + F+P
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 395 LTEKCWAADMNQRPSFLDILK 415
E+C + + RPS +L
Sbjct: 313 FVEQCLQRNPDARPSASTLLN 333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS+G + K R T VAIK+ L S D + R E+ +L +L+HPN+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ L L+ EY + L + + + + + + H + IHR
Sbjct: 70 VFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHR 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
D+KP N +L+ +K+ DFG ++L+ + E T YR +PE+
Sbjct: 127 DVKPEN-ILITKH-SVIKLCDFGFARLLTGPSD----YYDDEVATRWYR--SPELLVGDT 178
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
+Y VDV++ + E+L G P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+G ++K + T VAIK+ L S D + R E+ LL +LRH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++K L+ E++ + L+ L + I G+ + H+ + IIHR
Sbjct: 92 VCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHR 148
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
D+KP N +LV+ S +K+ DFG ++ + E T YR APE+
Sbjct: 149 DIKPEN-ILVSQS-GVVKLCDFGFARTLAAP----GEVYDDEVATRWYR--APELLVGDV 200
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
KY K VDV++ ++ EM GEP
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG++ G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ + ++ EY+ GG+L Y+ + G L + I G+ Y H ++++H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR--HMVVH 139
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-----GSYRYMAPEVF 335
RDLKP NVLL + + K+ DFGLS ++ GE GS Y APEV
Sbjct: 140 RDLKPENVLL--DAHMNAKIADFGLSNMMS----------DGEFLRTSCGSPNYAAPEVI 187
Query: 336 KHRKYD-KKVDVFSFAMILYEMLEGEPP 362
R Y +VD++S +ILY +L G P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNL 208
P E+ ++ + +IG GSFG + +A G VAIK++L QD R E+ +
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKNRELQI 100
Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK----EKGALSPSTAV 258
+ KL H NIV+ L L+ +Y+ +++ + K L
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + R +AY+H+ I HRD+KP+N LL++ LK+ DFG +K +
Sbjct: 160 LYMYQLFRSLAYIHS--FGICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQLVRGE----- 211
Query: 319 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ YR APE+ F Y +DV+S +L E+L G+P
Sbjct: 212 PNVSYICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 41/324 (12%), Positives = 85/324 (26%), Gaps = 64/324 (19%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
P + + E+ ++G+ L+A + G + +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 196 RLVIQDFRHEVNLLVKLR-------------------------HPNIVQFLGAVTERK-- 228
I+ + EV L LR +++ +
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 229 ------PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
P M G L + +L + L + R +A LH+ ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---- 338
L+P +++L + + F + S + PE+ R
Sbjct: 232 LRPVDIVL--DQRGGVFLTGFEHLVRDG--------ARVVSSVSRGFEPPELEARRATIS 281
Query: 339 -------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391
D ++ +++Y + + P + F K
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADL------PITKDAALGGSEWIFRSCKNIPQP 335
Query: 392 LRELTEKCWAADMNQRPSFLDILK 415
+R L E R L ++
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAME 359
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
DF ++GKG+FG+++ + T A+K L + ++ +D H E +L
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 212 LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
RHP + A T + L + EY GG+L +L + + A + +I + Y
Sbjct: 62 TRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------ 324
LH+ +++RD+K N++L H+K+ DFGL K ++
Sbjct: 121 LHS--RDVVYRDIKLENLML--DKDGHIKITDFGLCKE----------GISDGATMKTFC 166
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APEV + Y + VD + +++YEM+ G P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
+F ++GKG+FG+++ + T A+K L + +V +D H E +L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
RHP + + L + EY GG+L +L + S A + +I + YL
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H+E N +++RDLK N++L H+K+ DFGL K + D M G+ Y+A
Sbjct: 265 HSEKN-VVYRDLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLA 317
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
PEV + Y + VD + +++YEM+ G P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 36/221 (16%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQDFRH---EVNLL 209
F ++G+GSFG++ K A+K L L ++D E ++L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----VLKKATLKVRDRVRTKMERDIL 80
Query: 210 VKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
V++ HP IV+ A TE K L LI ++LRGGDL L ++ + + ++A +
Sbjct: 81 VEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+LH+ II+RDLKP N+LL + H+K+ DFGLSK + E +Y
Sbjct: 140 DHLHS--LGIIYRDLKPENILL---DEEGHIKLTDFGLSKE----------SIDHEKKAY 184
Query: 328 ------RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
YMAPEV R + + D +SF ++++EML G P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRL 197
+PP D D F IGKGSFG++ T A+K ++ +
Sbjct: 2 MPPVFDENEDVNFD----HFEILRAIGKGSFGKVCIVQKNDTKKMYAMK----YMNKQKC 53
Query: 198 VIQD-FRH---EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
V ++ R+ E+ ++ L HP +V + + + + ++ + L GGDL +L++
Sbjct: 54 VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
T F ++ + YL N IIHRD+KP N+LL H+ + DF ++ ++
Sbjct: 114 EETVKLFICELVMALDYLQN--QRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLP--- 166
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPP 362
++T G+ YMAPE+F RK Y VD +S + YE+L G P
Sbjct: 167 --RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IG+G++G + KA G A+K+I D+ + R E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ +K L+L+ E+L DL K L +G L TA +F L + G+AY H+ ++HRD
Sbjct: 69 IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 339
LKP+N LL+N LK+ DFGL++ + V K T E T YR AP+V +K
Sbjct: 126 LKPQN-LLINREG-ELKIADFGLARAFGIP----VRKYTHEIVTLWYR--APDVLMGSKK 177
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y +D++S I EM+ G P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 76
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG A E
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------------AKE 169
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
KYDK D++S +I+Y +L G PP
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
+G+G++G + KA G VA+KRI D+ + R E++LL +L HPNIV +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L L+ E++ DL K L E K L S + + RG+A+ H + I+HRD
Sbjct: 88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 339
LKP+N LL+NS LK+ DFGL++ + V T E T YR AP+V +K
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLARAFGIP----VRSYTHEVVTLWYR--APDVLMGSKK 196
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ G+P
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKP 218
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 33/235 (14%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
N +++ + +G G G + A VAIK+I L+D + V R
Sbjct: 3 NIHGFDLGS---RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57
Query: 204 HEVNLLVKLRHPNIVQFL--------------GAVTERKPLMLITEYLRGGDLHKYLKEK 249
E+ ++ +L H NIV+ G++TE + ++ EY+ DL L+ +
Sbjct: 58 -EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE-Q 114
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
G L A F + RG+ Y+H+ ++HRDLKP N L +N+ LK+GDFGL++++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN-LFINTEDLVLKIGDFGLARIM 171
Query: 310 KVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
SH + ++ T YR +P + Y K +D+++ I EML G+
Sbjct: 172 DPHYSHKGH-LSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 38/223 (17%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLV--IQDFRH---EVN 207
F ++GKG +G++ K T A+K L +V +D H E N
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK----VLKKAMIVRNAKDTAHTKAERN 73
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
+L +++HP IV + A T K L LI EYL GG+L L+ +G TA + +I+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGET- 324
+ +LH II+RDLKP N++L + H+K+ DFGL K + T
Sbjct: 133 ALGHLHQ--KGIIYRDLKPENIML---NHQGHVKLTDFGLCKE----------SIHDGTV 177
Query: 325 -----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAPE+ +++ VD +S ++Y+ML G PP
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF ++GKGSFG++ A ++ T AIK +L D +++ D +V
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDD---DVECTMVEKRV 70
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + HP + T+ L + EYL GGDL +++ S A +A +I
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +LH+ I++RDLK N+LL H+K+ DFG+ K M G+
Sbjct: 130 GLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFGMCKE----------NMLGDAKT 175
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ +KY+ VD +SF ++LYEML G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R T VA+KR+ D+ + R E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ K L L+ E+ DL KY G L P +F + +G+ + H+ ++HR
Sbjct: 69 VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
DLKP+N LL+N + LK+ +FGL++ V + E T YR P+V F +
Sbjct: 126 DLKPQN-LLINRNG-ELKLANFGLARAF----GIPVRCYSAEVVTLWYR--PPDVLFGAK 177
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL 363
Y +D++S I E+ PL
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 52/256 (20%), Positives = 89/256 (34%), Gaps = 42/256 (16%)
Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
I G G I + PV +K ++ S D E L ++ HP+I
Sbjct: 88 IAHGGLGWI----YLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 218 VQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
VQ V ++ EY+ G L + L + A+ + L+I ++YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLH 199
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ +++ DLKP N++L + + LK+ D G I +Y G+ + AP
Sbjct: 200 SIG--LVYNDLKPENIML---TEEQLKLIDLGAVSRINSFGY--LY------GTPGFQAP 246
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392
E+ + D+++ L + P + E
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSY 297
Query: 393 RELTEKCWAADMNQRP 408
L + D QR
Sbjct: 298 GRLLRRAIDPDPRQRF 313
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 40/331 (12%), Positives = 89/331 (26%), Gaps = 57/331 (17%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
P + + E+ ++G+ L+A + G + +
Sbjct: 59 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 118
Query: 196 RLVIQDFRHEVNLLVKLR----------------------HPNIVQFLGAVTERKPLMLI 233
I+ + EV L LR P + + + + + ++
Sbjct: 119 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 234 TEYL-----------RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + G L + +L + L + R +A LH+ ++H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 236
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK----- 336
L+P +++L + + F G A +
Sbjct: 237 LRPVDIVL--DQRGGVFLTGFEHLVRD----GASAVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396
D ++ + +Y + + P + F K +R L
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADL------PNTDDAALGGSEWIFRSCKNIPQPVRALL 344
Query: 397 EKCWAADMNQRPSFLDILKR--LEKIKETLP 425
E R L ++ E+++ L
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 73
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + + P + Q T + L + EY+ GGDL ++++ G AV +A +IA
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 133 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTT 178
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 66/260 (25%), Positives = 121/260 (46%), Gaps = 31/260 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
F +G GSFG ++ + + A+K L ++V I+ +E +L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ P +V+ + + L ++ EY+ GG++ +L+ G S A +A I YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ +I+RDLKP N+L+ +++V DFG +K ++ G T G+
Sbjct: 158 HS--LDLIYRDLKPENLLI--DQQGYIQVTDFGFAK-----------RVKGRTWTLCGTP 202
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
+APE+ + Y+K VD ++ +++YEM G PP +P + + + G F
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSH 260
Query: 388 FTPELRELTEKCWAADMNQR 407
F+ +L++L D+ +R
Sbjct: 261 FSSDLKDLLRNLLQVDLTKR 280
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---------EVNLLVKLR 213
+G+G F + KA + VAIK+I +L + E+ LL +L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-------KLGHRSEAKDGINRTALREIKLLQELS 70
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLH 272
HPNI+ L A + + L+ +++ DL +K+ L+PS + L +G+ YLH
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYM 330
+ I+HRDLKP N LL++ + LK+ DFGL+K N T + T YR
Sbjct: 130 Q--HWILHRDLKPNN-LLLDENG-VLKLADFGLAKSFGSPNR----AYTHQVVTRWYR-- 179
Query: 331 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
APE+ F R Y VD+++ IL E+L P
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+GS+ ++L + T A+K + + + + + E ++ +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK----VVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 66 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 125 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 170
Query: 325 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 46/261 (17%)
Query: 125 GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSEL------DFSSSAIIGKGSFGEILKAYW 178
G+S Q P PPP P++ + PS DF +IGKGSFG++L A
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQ-QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARH 59
Query: 179 RGTPV--AIKRILPSLSDDRLVIQDFRHEVN--------LLVKLRHPNIVQFLGAV-TER 227
+ V A+K L +++ + E LL ++HP +V + T
Sbjct: 60 KAEEVFYAVK----VLQKK-AILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112
Query: 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
K L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++RDLKP N
Sbjct: 113 K-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPEN 169
Query: 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAPEVFKHRKYD 341
+LL S H+ + DFGL K + + G+ Y+APEV + YD
Sbjct: 170 ILL--DSQGHIVLTDFGLCKE----------NIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
+ VD + +LYEML G PP
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+FGE+ + A+K L+ ++ + FR E ++LV
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVN 130
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAY 270
I A + L L+ +Y GGDL L K + L A + ++ +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
+H +HRD+KP N+L+ H+++ DFG + + G Y+
Sbjct: 191 VHQ--LHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP---DYI 243
Query: 331 APEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVI-QDFRH---EVNLLVK 211
DFS IIG+G FGE+ T A+K L R+ + Q E +L
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSL 245
Query: 212 L---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
+ P IV A L I + + GGDLH +L + G S + +A +I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
++HN +++RDLKP N+LL H+++ D GL+ + K G++
Sbjct: 306 EHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK------KPHASVGTHG 355
Query: 329 YMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPP 362
YMAPEV K YD D FS +L+++L G P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+GS+ ++L + T A++ + + + + + E ++ +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----VVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 109 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 168 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 213
Query: 325 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + S +G G++G + A + G VAIK++ + + +R
Sbjct: 16 NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T L L+ ++ DL K + K S
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKI 128
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +G+ Y+H+ ++HRDLKP N L VN + LK+ DFGL++ +
Sbjct: 129 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLARHADAE----- 179
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
+F ++GKGSFG+++ A + T A+K L D ++ D +V
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVK----VLKKDVILQDD---DVECTMTEKRI 76
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + HP + Q T + L + E++ GGDL ++++ + A +A +I
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
+ +LH+ II+RDLK NVLL H K+ DFG+ K +
Sbjct: 136 ALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGMCKE----------GICNGVTT 181
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++LYEML G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 394
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + + P + Q T + L + EY+ GGDL ++++ G AV +A +IA
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 454 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTT 499
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPN 216
+G+G++ + K + T VA+K I RL ++ R EV+LL L+H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIR-EVSLLKDLKHAN 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
IV + K L L+ EYL DL +YL + G ++ F + RG+AY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAP 332
++HRDLKP+N LL+N LK+ DFGL++ + ++V T YR P
Sbjct: 119 QKVLHRDLKPQN-LLINERG-ELKLADFGLARAKSIPTKTYDNEVV-----TLWYR--PP 169
Query: 333 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
++ Y ++D++ I YEM G P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 17 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ L+ + H NI+ L T +K L ++ E + +L + ++ + L
Sbjct: 74 -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERM 129
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 130 SYLLYQMLCGIKHLHS--AGIIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 182
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT + Y APEV Y + VD++S I+ EM++G
Sbjct: 183 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 31/260 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +G GSFG + R A+K L + +V E +L
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMK----VLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ HP I++ G + + + +I +Y+ GG+L L++ A +A ++ + YL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ II+RDLKP N+LL H+K+ DFG +K + T G+
Sbjct: 123 HS--KDIIYRDLKPENILL--DKNGHIKITDFGFAK-----------YVPDVTYTLCGTP 167
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
Y+APEV + Y+K +D +SF +++YEML G P + + + + F
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPF 225
Query: 388 FTPELRELTEKCWAADMNQR 407
F ++++L + D++QR
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 62/264 (23%), Positives = 117/264 (44%), Gaps = 26/264 (9%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+GS+G++ + A+K IL L + + E+ LL +LRH N++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 221 ---LGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
L ++K + ++ EY G ++ + EK A + + G+ YLH+
Sbjct: 72 VDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I+H+D+KP N+LL ++ LK+ G+++ + + D + + GS + PE+
Sbjct: 128 QGIVHKDIKPGNLLL--TTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIA 183
Query: 336 KHRK-YD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRPFFRAKGFTPE 391
+ KVD++S + LY + G P Y+ + + +G P P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD----CGPP 239
Query: 392 LRELTEKCWAADMNQRPSFLDILK 415
L +L + + +R S I +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+F E+ + T A+K ++ ++ + FR E ++LV
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK----IMNKWDMLKRGEVSCFREERDVLVN 117
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAY 270
I Q A + L L+ EY GGDL L + G + A + +I +
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
+H +HRD+KP N+LL H+++ DFG K++ V + G+ Y+
Sbjct: 178 VHR--LGYVHRDIKPDNILL--DRCGHIRLADFGSCL--KLRADGTVRSLVA-VGTPDYL 230
Query: 331 APEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + Y + D ++ + YEM G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
K WE+ + +G G++G + A G VAIK++ + + +R
Sbjct: 17 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL +RH N++ L T + L L+ ++ G DL K +K + L
Sbjct: 74 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRI 130
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLARQADSE----- 181
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APEV +Y + VD++S I+ EM+ G+
Sbjct: 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
D+ +IG+G+FGE+ + T A+K LS ++ + F E +++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK----LLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
P +VQ A + + L ++ EY+ GGDL + + A + ++ + +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 184
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H+ IHRD+KP N+LL + HLK+ DFG + + G Y++
Sbjct: 185 HS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP---DYIS 237
Query: 332 PEVFK----HRKYDKKVDVFSFAMILYEMLEGEPP 362
PEV K Y ++ D +S + LYEML G+ P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 134 HFEPKPVPPPLP------NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAI 185
H + +++ P +++ + IG+G++G + AY VAI
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDVGP---RYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGG 240
K+I P + R E+ +L++ RH NI+ + + ++ + +
Sbjct: 58 KKISP-FEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ET 114
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHL 298
DL+K LK LS F I RG+ Y+H N ++HRDLKP N LL+N++ D L
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSN-LLLNTTCD-L 167
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 355
K+ DFGL+++ + H + +T T YR APE+ + Y K +D++S IL E
Sbjct: 168 KICDFGLARVADPDHDHTGF-LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 356 MLEGEP 361
ML P
Sbjct: 225 MLSNRP 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 54 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ L+ + H NI+ L T +K L L+ E + +L + ++ + L
Sbjct: 111 -ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERM 166
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 167 SYLLYQMLCGIKHLHSAG--IIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 219
Query: 318 YKMTGE--TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT T YR APEV Y + VD++S I+ EM+ +
Sbjct: 220 --MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 31/233 (13%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRH 204
+ ++ I GS+G + G PVAIKR+ + D +
Sbjct: 14 IAELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSD 69
Query: 205 ---------EVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGGDLHKYLK-EK 249
E+ LL HPNI+ + L L+TE + DL + + ++
Sbjct: 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR 128
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+SP F I G+ LH ++HRDL P N +L+ + D + + DF L++
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGN-ILLADNND-ITICDFNLARED 184
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
T Y APE+ + + + K VD++S ++ EM +
Sbjct: 185 TADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-30
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
K L+ + ++ +A+GM +L IHRDL RN+LL S + +K+ DFGL++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL--SEKNVVKICDFGLAR 241
Query: 308 LIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP--- 362
I Y G+ ++MAPE R Y + DV+SF ++L+E+ G P
Sbjct: 242 DI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 363 -LANYEPYEAAKYVAEGHR---PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418
+ E + + EG R P TPE+ + CW + +QRP+F ++++ L
Sbjct: 299 VKIDEEFC---RRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
Query: 419 KI 420
+
Sbjct: 352 NL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 144 LPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
LP WE L +G+G+FG++++A G VA+K + +
Sbjct: 10 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 196 RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKGALS 253
+ E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 68 --EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNE 124
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
+G Y+ I DLK R + +S
Sbjct: 125 FVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQ 160
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 37/259 (14%), Positives = 71/259 (27%), Gaps = 54/259 (20%)
Query: 163 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
G + W+ VA+ + P V+Q+ L ++ P
Sbjct: 37 IFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+ + L V R +++ E++RGG L + + SP A+ +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
+ P V + S + + M
Sbjct: 150 -VALSIDHPSRVRV--SIDGDVVLAYPA------------------------TMPDA--- 179
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH------RPFFRAKGFTP 390
+ + D+ LY +L PL + AE P +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 391 ELRELTEKCWAADMNQRPS 409
++ + + D R +
Sbjct: 235 QISAVAARSVQGDGGIRSA 253
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 38/215 (17%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-------LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G G++ + K + T VA+K + PS + R E++L+ +L+H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--------IR-EISLMKELKHE 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMA 269
NIV+ + L L+ E++ DL KY+ L + F + +G+A
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 327
+ H N I+HRDLKP+N LL+N LK+GDFGL++ + V + E T Y
Sbjct: 123 FCHE--NKILHRDLKPQN-LLINKRG-QLKLGDFGLARAFGIP----VNTFSSEVVTLWY 174
Query: 328 RYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
R AP+V R Y +D++S IL EM+ G+P
Sbjct: 175 R--APDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/306 (20%), Positives = 107/306 (34%), Gaps = 56/306 (18%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ + ++ +IG+GS+G + AY + VAIK++ D + R E+
Sbjct: 21 NVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EI 76
Query: 207 NLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
+L +L+ I++ + + L ++ E DL K K L+
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
++ G ++H IIHRDLKP N L+N +KV DFGL++ I + ++
Sbjct: 136 YNLLLGENFIHESG----IIHRDLKPAN-CLLNQDCS-VKVCDFGLARTINSEKDTNIVN 189
Query: 320 MTGETGSYR------------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
E Y APE+ Y K +D++S I E+L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
N P F P + K + +L I
Sbjct: 250 QSHINDPT---------NRFPLFPGSSCFPLSPDRNSK--------KVHEKSNRDQLNII 292
Query: 421 KETLPT 426
+ T
Sbjct: 293 FNIIGT 298
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 73/330 (22%), Positives = 113/330 (34%), Gaps = 58/330 (17%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
Q H KP DW+I + +IG GS+G + +AY + VAIK+
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQIPD---RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDL 242
IL D + R E+ +L +L H ++V+ L V + L ++ E D
Sbjct: 86 ILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF 143
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKV 300
K + L+ ++ G+ Y+H I+HRDLKP N LVN +KV
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPAN-CLVNQDCS-VKV 197
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYR-----------------------YMAPEV-FK 336
DFGL++ + + + Y APE+
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396
Y + +DV+S I E+L Y P F P +
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKENVAYHA---------DRGPLFPGSSCFPLSPDQK 308
Query: 397 EKCWAADMNQRPSFLDILKRLEKIKETLPT 426
+ + +L I L T
Sbjct: 309 AG-----NDFKFHTRGNRDQLNVIFNILGT 333
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + + +G G++G + A+ G VA+K++ + +R
Sbjct: 21 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T + L L+T + G DL+ +K + L+
Sbjct: 78 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHV 134
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 135 QFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLARHTADE----- 185
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APE+ Y++ VD++S I+ E+L G
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 33/236 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
+P + + I DF +++G+G++G + A + G VAIK+I P ++
Sbjct: 1 MPKRIVYNISS---DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRT 56
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
R E+ +L +H NI+ + +I E + DLH+ + + LS
Sbjct: 57 LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDH 113
Query: 257 AVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----- 309
F R + LH N +IHRDLKP N LL+NS+ D LKV DFGL+++I
Sbjct: 114 IQYFIYQTLRAVKVLHGSN----VIHRDLKPSN-LLINSNCD-LKVCDFGLARIIDESAA 167
Query: 310 -KVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ + M T YR APEV KY + +DV+S IL E+ P
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ KA R T VA+K++L + I R E+ +L L+H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
+ + L+ ++ DL L + S + G+ Y+H
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMA 331
N I+HRD+K NVL+ LK+ DFGL++ + + + T T YR
Sbjct: 143 --NKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--P 196
Query: 332 PEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
PE+ R Y +D++ I+ EM P
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 67/246 (27%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNIV 218
+G GSFG + + + G A+K++L QD R+ E++++ L H NI+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVL----------QDPRYKNRELDIMKVLDHVNII 63
Query: 219 QFL--------------------------------------GAVTERKPLMLITEYLRGG 240
+ + ++ K L +I EY+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PD 122
Query: 241 DLHK----YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LHK +++ ++ + + + R + ++H+ I HRD+KP+N LLVNS +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQN-LLVNSKDN 179
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 355
LK+ DFG +K + S Y APE+ +Y +D++S + E
Sbjct: 180 TLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 356 MLEGEP 361
++ G+P
Sbjct: 235 LILGKP 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 47/224 (20%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ +W D+ +G+G + E+ +A V +K + P + ++ R
Sbjct: 28 HVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKI----KR 79
Query: 204 HEVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
E+ +L LR PNI+ V + L+ E++ D + + L+ +
Sbjct: 80 -EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFY 135
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+I + + Y H+ I+HRD+KP N ++++ L++ D+GL++ H +
Sbjct: 136 MYEILKALDYCHS--MGIMHRDVKPHN-VMIDHEHRKLRLIDWGLAEFY-----HPGQEY 187
Query: 321 TGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
S + PE+ ++ YD +D++S +L M+ + P
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIV 218
IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 219 QFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYL 271
+ T + L L+ E++ DL YL + + T + + RG+ +L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRY 329
H+ + ++HRDLKP+N +LV SS +K+ DFGL+++ Q +T T YR
Sbjct: 137 HS--HRVVHRDLKPQN-ILVTSSG-QIKLADFGLARIYSFQM-----ALTSVVVTLWYR- 186
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 187 -APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLV---IQDFRHEVNLLVKLR---HPN 216
IG G++G + KA G VA+K + I R EV LL +L HPN
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75
Query: 217 IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMA 269
+V+ + + + L+ E++ DL YL + L T + RG+
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 327
+LH N I+HRDLKP N +LV S +K+ DFGL+++ Q +T T Y
Sbjct: 135 FLHA--NCIVHRDLKPEN-ILVTSGG-TVKLADFGLARIYSYQM-----ALTPVVVTLWY 185
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
R APEV Y VD++S I EM +P
Sbjct: 186 R--APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQ--DFRH---EVN 207
+F ++G G++G++ K T A+K L +V + H E
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK----VLKKATIVQKAKTTEHTRTERQ 110
Query: 208 LLVKLRH-PNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
+L +R P +V A TE K L LI +Y+ GG+L +L ++ + + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ +LH II+RD+K N+LL ++ H+ + DFGLSK + D +
Sbjct: 170 LALEHLHK--LGIIYRDIKLENILL---DSNGHVVLTDFGLSK----EFVADETERAY-D 219
Query: 325 --GSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH 204
+ D + + +GKG++G + K+ R G VA+K+I + + + FR
Sbjct: 2 RVDRHVLR---KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 205 EVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
E+ +L +L H NIV L + + + L+ +Y+ DLH ++ L P
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVV 115
Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ + + YLH ++HRD+KP N +L+N+ +KV DFGLS+
Sbjct: 116 YQLIKVIKYLHSGG----LLHRDMKPSN-ILLNAECH-VKVADFGLSRSFVNIRRVTNNI 169
Query: 320 MTGETGSYR-----------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y APE+ KY K +D++S IL E+L G+P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+G++G + KA + A+K+I + + R E+ LL +L+HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR-EIALLRELKHPNVISL 83
Query: 221 LGAVTER--KPLMLITEYLRGGDLHKYLKEKGA---------LSPSTAVNFALDIARGMA 269
+ + L+ +Y DL +K A L + I G+
Sbjct: 84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
YLH N ++HRDLKP N +LV +K+ D G ++L + +
Sbjct: 143 YLHA--NWVLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS----PLKPLADLDPV 195
Query: 327 -----YRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
YR APE+ R Y K +D+++ I E+L EP
Sbjct: 196 VVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
+IGKGSFG+++KAY VA+K ++ + F E+ +L LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-----------MVRNEKRFHRQAAEEIRILEHLR 151
Query: 214 H------PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDI 264
N++ L T R + + E L +L++ +K+ +G S FA I
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSI 209
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ + LH N IIH DLKP N+LL +KV DFG S ++ ++
Sbjct: 210 LQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------CYEHQRVYTYI 260
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APEV +Y +D++S IL E+L G P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
++IGKGSFG+++KAY R VAIK +I + F + EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----------IIKNKKAFLNQAQIEVRLLELMN 108
Query: 214 HP------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
IV R L L+ E L +L+ L+ +S + FA +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
+ +L IIH DLKP N+LL N +K+ DFG S ++ Y ++
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYI---QSR 222
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
YR +PEV YD +D++S IL EM GEP
Sbjct: 223 FYR--SPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------- 213
+G G F + A T VA+K I+ + E+ LL ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYT---EAAEDEIKLLQRVNDADNTKE 80
Query: 214 ----HPNIVQFLGAVTERKPLM----LITEYLRGGDLHKYLK--EKGALSPSTAVNFALD 263
+I++ L + P ++ E L G +L +K E + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLL----VNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ G+ Y+H IIH D+KP NVL+ + +K+ D G +
Sbjct: 140 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------CWYDEH 191
Query: 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
T + Y +PEV + D++S A +++E++ G+
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 50/231 (21%)
Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
+G+G+FG++++ VA+K I+ + + + E+ +L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK-IVKN-------VDRYCEAARSEIQVLEHLNTT 71
Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
VQ L + ++ E L G + ++KE G A I +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 310
+ +LH+ N + H DLKP N+L V S +KV DFG +
Sbjct: 131 VNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TY 186
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
H T YR APEV + + DV+S IL E G
Sbjct: 187 DDEHHSTLV---STRHYR--APEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 50/231 (21%)
Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
+G+G+FG++++ VA+K I+ + + +R E+N+L K++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK-IIRN-------VGKYREAARLEINVLKKIKEK 76
Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
V + + E L G + ++LKE + A +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 310
+ +LH N + H DLKP N+L VNS + ++V DFG +
Sbjct: 136 LRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---- 189
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ + T YR PEV + + DV+S IL+E G
Sbjct: 190 TFDHEHHTTIV-ATRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 54/235 (22%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRH-- 214
+G G+FG +L A+K ++ + I+ + E ++L K+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK-VVRN-------IKKYTRSAKIEADILKKIQNDD 92
Query: 215 ---PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMA 269
NIV++ G + LI E L G L++ + + ++I + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------------LKVGDFGLS 306
YL + H DLKP N+LL + + +K+ DFG +
Sbjct: 152 YLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ H T YR APEV + +D D++SF +L E+ G
Sbjct: 210 --TFKSDYHGSII---NTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 8e-18
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L + + D +V LL+ + +D+ TPLH A HG + V + L+++ A
Sbjct: 11 ETLLH-IASIKGDIPSVEYLLQNGSD-PNVKDHAGWTPLHEACNHGHLKVVELLLQHKAL 68
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
VN ++PL DA ++++LL ++G
Sbjct: 69 VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYG 99
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 73.6 bits (182), Expect = 4e-16
Identities = 18/64 (28%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ Y N +PLH A+ +G +D+ K L+ YGA NA + + P+ + +++ L
Sbjct: 69 VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLP 128
Query: 121 NAHG 124
+
Sbjct: 129 EKNE 132
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 62.8 bits (154), Expect = 3e-12
Identities = 15/43 (34%), Positives = 24/43 (55%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
++ T LH+AS+ G I + L++ G+D N +D TPL
Sbjct: 5 FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPL 47
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 40.9 bits (97), Expect = 1e-04
Identities = 3/36 (8%), Positives = 9/36 (25%), Gaps = 1/36 (2%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
+A + P+ + + +A
Sbjct: 102 RNAVNIFGLRPVDYTDDESMKSLLLLPEK-NESSSA 136
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 1e-16
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 1/72 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
S+ A Q + +++ L + +LV+ D TPL AS G I+ + L+E+GAD
Sbjct: 3 SLSIH-QLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 94 VNAQDRWKNTPL 105
+ + + + L
Sbjct: 62 PHILAKERESAL 73
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 3e-14
Identities = 22/102 (21%), Positives = 40/102 (39%), Gaps = 3/102 (2%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
AD A+ ++L + V LLE D ++ D++ TPL A +
Sbjct: 60 ADP-HILAKERESALS-LASTGGYTDIVGLLLERDVD-INIYDWNGGTPLLYAVRGNHVK 116
Query: 83 VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ L+ GAD+ + TP+ A + +++ H
Sbjct: 117 CVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHI 158
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 64.7 bits (159), Expect = 1e-12
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 6/73 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ + N V LL D + TP+ +A G+ V + + +
Sbjct: 103 GTPLL-YAVRGNHVKCVEALLARGAD---LTTEADSGYTPMDLAVALGYRKVQQVIENHI 158
Query: 92 ADVNAQDRWKNTP 104
+ + P
Sbjct: 159 LKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 54.0 bits (131), Expect = 7e-09
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 1/39 (2%)
Query: 68 NRTPLHVASLHGWIDVAKCLIEYGAD-VNAQDRWKNTPL 105
+ +H + G +D K + G + VN D TPL
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPL 40
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 3e-16
Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 1/72 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ + +A AVR L+ ++ ++ D +PLH A G V + LI GA
Sbjct: 6 MDDIFTQ-CREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGAR 64
Query: 94 VNAQDRWKNTPL 105
+N +R +TPL
Sbjct: 65 INVMNRGDDTPL 76
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 9e-15
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
++A + PLH A G VA+ L+ GA V+ +++ P+ A A + + E
Sbjct: 98 INAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLREL--LRE 155
Query: 119 LLNAHG 124
G
Sbjct: 156 RAEKMG 161
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 22/64 (34%), Positives = 37/64 (57%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ + + TPLH+A+ HG D+ + L++Y AD+NA + N PL A + + E L
Sbjct: 65 INVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDL 124
Query: 121 NAHG 124
A+G
Sbjct: 125 VANG 128
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 5e-09
Identities = 7/48 (14%), Positives = 14/48 (29%), Gaps = 6/48 (12%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
V + P+ A + + + G ++N P D
Sbjct: 131 VSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNR------IPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 54.0 bits (131), Expect = 7e-09
Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ + G + ++ D+N D +PL A + ++E+L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 5e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 6/77 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+ W D V+ + + D V+ R PLH A+ G +++ + L+ G
Sbjct: 8 DKEFM-WALKNGDLDEVKDYVAKGED---VNRTLEGGRKPLHYAADCGQLEILEFLLLKG 63
Query: 92 ADVNAQDRWKNTPLADA 108
AD+NA D+ TPL A
Sbjct: 64 ADINAPDKHHITPLLSA 80
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 65.5 bits (161), Expect = 2e-13
Identities = 13/48 (27%), Positives = 19/48 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
++A D + TPL A G + K L+ GAD + T
Sbjct: 66 INAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEAT 113
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 59.3 bits (145), Expect = 3e-11
Identities = 14/62 (22%), Positives = 20/62 (32%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
A +G +D K + G DVN PL A + ++E L
Sbjct: 2 PLGSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLL 61
Query: 123 HG 124
G
Sbjct: 62 KG 63
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 74.0 bits (183), Expect = 1e-15
Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A+Q D V+++L++ V D + TPL++A + I++AK LI+ GAD+N Q+
Sbjct: 10 LEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQN 69
Query: 99 RWKNTPL--ADAEGAKKFNMMELLNAHGG 125
++P A A+G + ++ + H
Sbjct: 70 SISDSPYLYAGAQGRTE--ILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 64.0 bits (157), Expect = 4e-12
Identities = 22/106 (20%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL----- 77
+ R +LI A + V+ LLE+ + + ++ T L A
Sbjct: 96 TPDLNKHNRYGGNALI-PAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGN 154
Query: 78 HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ D+ K L+E GAD + +D T + A + ++L +
Sbjct: 155 QLYQDIVKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 63.6 bits (156), Expect = 6e-12
Identities = 14/61 (22%), Positives = 22/61 (36%)
Query: 64 RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ Y+ L A+ V + L + V+ D NTPL A + + L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-11
Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 3/84 (3%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
AD + +S + + + Q + +L+ ++ + L A+ G ID
Sbjct: 63 ADI-NLQNSISDSPYL-YAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHID 120
Query: 83 VAKCLIEYG-ADVNAQDRWKNTPL 105
K L+E G D++ Q+ + T L
Sbjct: 121 NVKLLLEDGREDIDFQNDFGYTAL 144
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 42 AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ LL + ++ +T LH+A++ G + L GA V +R
Sbjct: 17 VIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAER 76
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
+T L A + +L
Sbjct: 77 GGHTALHLACRVRAHTCACVLLQPR 101
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 8e-15
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ N E+ + + A +YD TPLHVA +H ++ + L + GAD+N +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188
Query: 99 R-WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A A+ +++ELL G
Sbjct: 189 PTCGRTPLHLAVEAQAASVLELLLKAG 215
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 22/67 (32%), Positives = 31/67 (46%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + AA+V +LL + + AR Y RTPL A L +A+ L +GA
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDG 255
Query: 99 RWKNTPL 105
K +P
Sbjct: 256 GDKLSPC 262
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
++ + RTPLH+A V + L++ GAD A+ TPL A + L
Sbjct: 184 LNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARL 243
Query: 120 LNAHG 124
L AHG
Sbjct: 244 LRAHG 248
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 12/86 (13%), Positives = 23/86 (26%), Gaps = 5/86 (5%)
Query: 42 AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A +A+ V KL V + T LH+A A L++
Sbjct: 53 AILGEASTVEKLYAAGAG---VLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDAS 109
Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
+ + +++
Sbjct: 110 DTYLTQSQDCTPDTSHAPAAVDSQPN 135
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 1e-09
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADAEGAKKFNMMEL 119
D T LH+A +H L+ + A ++ Q+ T L A + + +E
Sbjct: 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEK 63
Query: 120 LNAHG 124
L A G
Sbjct: 64 LYAAG 68
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 17/96 (17%), Positives = 30/96 (31%), Gaps = 13/96 (13%)
Query: 42 AHQNDAAAVRKLLE---------EDQSLVHARDYDNRTPLHVASLH----GWIDVAKCLI 88
LL+ D L ++D T A++ +
Sbjct: 86 CRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDE 145
Query: 89 EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++ + A++ +TPL A K M+ LL G
Sbjct: 146 DWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAG 181
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 8e-04
Identities = 5/31 (16%), Positives = 7/31 (22%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
D +P + D EY
Sbjct: 251 EPEDGGDKLSPCSSSGSDSDSDNRDEGDEYD 281
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 4e-15
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 1/97 (1%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
+ L L A + + LL HA D TPLH+A+ + + + + L
Sbjct: 19 LTGEYKKDEL-LEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLL 77
Query: 88 IEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+++GADV+A+D+ PL +A + + ELL HG
Sbjct: 78 LQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHG 114
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 26/64 (40%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHA+D PLH A +G +V + L+++GA VNA D W+ TPL +A + + LL
Sbjct: 84 VHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLL 143
Query: 121 NAHG 124
+HG
Sbjct: 144 LSHG 147
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 5e-14
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 3/93 (3%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L H LL + + V+ ++ D TPLHVA+ DV + L ++G
Sbjct: 212 ETALHCAVASLHPKRKQVAELLLRKG-ANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHG 270
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
A +NA D T L A A LL ++G
Sbjct: 271 AKMNALDSLGQTALHRAALAGHLQTCRLLLSYG 303
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 1e-12
Identities = 14/64 (21%), Positives = 25/64 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH A+ ++V L+ +GAD + + + A + +
Sbjct: 117 VNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYE 176
Query: 121 NAHG 124
Sbjct: 177 FKGH 180
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 13/45 (28%), Positives = 22/45 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
++A D +T LH A+L G + + L+ YG+D + T
Sbjct: 273 MNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAA 317
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHG-WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
+ L A+ G + L + +A D K+TPL A G + +++L
Sbjct: 17 AVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQL 76
Query: 120 LNAHG 124
L HG
Sbjct: 77 LLQHG 81
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 9/88 (10%), Positives = 20/88 (22%), Gaps = 24/88 (27%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEY---------------------GADVNAQDR 99
+ ++ + +A + + Q +
Sbjct: 150 PTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQ 209
Query: 100 WKNTPL---ADAEGAKKFNMMELLNAHG 124
T L + K+ + ELL G
Sbjct: 210 SHETALHCAVASLHPKRKQVAELLLRKG 237
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 45.9 bits (110), Expect = 1e-05
Identities = 4/48 (8%), Positives = 13/48 (27%), Gaps = 7/48 (14%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
T + + + + ++ + D + L +A
Sbjct: 306 PSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD--VDYRLLEA 346
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 4e-15
Identities = 28/64 (43%), Positives = 39/64 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHA+D PLH A +G +VA+ L+++GA VN D WK TPL +A K+ + +LL
Sbjct: 68 VHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLL 127
Query: 121 NAHG 124
HG
Sbjct: 128 LQHG 131
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 69.3 bits (171), Expect = 3e-14
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA-EGAKKFNMMEL 119
V+ D TPLH A+ G ++ K L+++GAD ++R NTPL +G + +L
Sbjct: 101 VNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKDGDTD--IQDL 158
Query: 120 LNAHG 124
L
Sbjct: 159 LRGDA 163
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 2e-13
Identities = 26/83 (31%), Positives = 41/83 (49%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A D V+KL + TPLH A+ + + V + L+++GADV+A+D+
Sbjct: 16 AKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGG 75
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
PL +A + + ELL HG
Sbjct: 76 LVPLHNACSYGHYEVAELLVKHG 98
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 53.2 bits (129), Expect = 1e-08
Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ + L A+ G ++ K L + + ++TPL A G + +++E L H
Sbjct: 5 NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64
Query: 124 G 124
G
Sbjct: 65 G 65
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 40.1 bits (95), Expect = 4e-04
Identities = 8/32 (25%), Positives = 12/32 (37%), Gaps = 1/32 (3%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ D TPL + G D+ L A
Sbjct: 134 PTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 7e-15
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 2/90 (2%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
L A + D VR+LL + A + +T L V G +A L++ GA
Sbjct: 4 DRL-SGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASP 61
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N QD +P+ DA + +++L HG
Sbjct: 62 NVQDTSGTSPVHDAARTGFLDTLKVLVEHG 91
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 3e-14
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 4/65 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
+ +D +P+H A+ G++D K L+E+GADVN D P+ A EG ++
Sbjct: 61 PNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA--VVS 118
Query: 119 LLNAH 123
L A
Sbjct: 119 FLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 60.5 bits (148), Expect = 3e-11
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ D P+H+A G V L +D++ +D TPL A +++++L
Sbjct: 94 VNVPDGTGALPIHLAVQEGHTAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDIL 152
Query: 121 NAH 123
H
Sbjct: 153 QGH 155
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T+L W H V L + ++ ++ T LH A+ G+ D+ + L+ GA
Sbjct: 107 STALY-WACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGAR 165
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ ++ K A A ++++
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTD 196
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
W + V + PLH A+ G + + ++ VN D
Sbjct: 49 WWKGTSKGRTGLIPSN-----YVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLD 103
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+ +T L A +++E+L
Sbjct: 104 KAGSTALYWACHGGHKDIVEMLFTQPN 130
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 5/50 (10%), Positives = 14/50 (28%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110
R+ + + +A+ + K A + D++
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDL 215
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 4/47 (8%), Positives = 8/47 (17%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
+ + A L D+ +T
Sbjct: 6 PKPVKPGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKG 52
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 8e-15
Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A ++R L+ + + V+ D+ +PLH A L G + K L+++GA VN
Sbjct: 67 AIHGHQLSLRNLISQGWA-VNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADW 125
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
+TPL +A + ++ + LL HG
Sbjct: 126 HTPLFNACVSGSWDCVNLLLQHG 148
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 1e-12
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 1/77 (1%)
Query: 48 AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107
+ L+ + +P+H A++HG + LI G VN +PL +
Sbjct: 40 RDFPGIRLLSNPLM-GDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHE 98
Query: 108 AEGAKKFNMMELLNAHG 124
A + +++L HG
Sbjct: 99 ACLGGHLSCVKILLKHG 115
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 3e-11
Identities = 20/85 (23%), Positives = 31/85 (36%), Gaps = 7/85 (8%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A V+KLLE V+ +PLH ++A L+++GAD A++
Sbjct: 198 CENQQRACVKKLLESGAD-VNQGK-GQDSPLHAVVRTASEELACLLMDFGADTQAKNAEG 255
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
P+ E L G
Sbjct: 256 KRPVELVPPESPLA---QLFLEREG 277
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 5e-11
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ + V+ D TPL A + G D L+++GA V +
Sbjct: 100 CLGGHLSCVKILLKHG-AQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESD-L 157
Query: 102 NTPLADAEGAKK--FNMMELLNAHG 124
+P+ +A A++ + L A+G
Sbjct: 158 ASPIHEA--ARRGHVECVNSLIAYG 180
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 1/86 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + L + + TPL++A + K L+E GADVN Q
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QG 219
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ +++PL + LL G
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFG 245
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 59.0 bits (144), Expect = 5e-10
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V D +P+H A+ G ++ LI YG +++ + TPL A ++ ++ L
Sbjct: 151 VQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKL 209
Query: 121 NAHG 124
G
Sbjct: 210 LESG 213
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 3e-05
Identities = 8/58 (13%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
L + + + LL + + A++ + + P+ + + L GA +
Sbjct: 226 LHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPL-AQLFLEREGASLPK 282
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 43.2 bits (103), Expect = 7e-05
Identities = 7/64 (10%), Positives = 20/64 (31%), Gaps = 10/64 (15%)
Query: 74 VASLHGWIDVAKCLIEYGADVNAQDRWK-----NTPLADAEGAKKFNMMELLNAHGGLSY 128
+ S H + L+ G+ + + D + + P + L ++ +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPG-----IRLLSNPLMGD 55
Query: 129 GQNG 132
+
Sbjct: 56 AVSD 59
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ R+ L T LHVA+ G+ +V K LI+ DVN +D
Sbjct: 173 EERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDG 232
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A G + +L +
Sbjct: 233 WTPLHAAAHWGKE--EACRILVENL 255
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 1e-14
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 1/83 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
D V +LLE ++ + D T LH A + +D+ K L+E GA++N D
Sbjct: 48 CSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEG 106
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
PL A ++ E L + G
Sbjct: 107 WIPLHAAASCGYLDIAEYLISQG 129
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 5e-13
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
V+ +DYD TPLH A+ G + + L+E D+ A ++ T AD + + E
Sbjct: 225 VNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGY--LEE 282
Query: 119 LLNAHG 124
L
Sbjct: 283 LQKKQN 288
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 9e-13
Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME-- 118
++ D + PLH A+ G++D+A+ LI GA V A + +TPL AE + M E
Sbjct: 99 INQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAE---EEAMEELL 155
Query: 119 --LLNAHG 124
+N G
Sbjct: 156 QNEVNRQG 163
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 2e-09
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 3/98 (3%)
Query: 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
K + + L + + + + D+ A G +
Sbjct: 2 KMADAKQKRNEQL--KRWIGSETDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLR 58
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L+E GAD+N + T L A +M++ L +G
Sbjct: 59 LLERGADINYANVDGLTALHQACIDDNVDMVKFLVENG 96
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 46 DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
D A + E Q+ V+ + D D + L + + T L
Sbjct: 144 DIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTAL 203
Query: 106 --ADAEGAKKFNMMELLNAHG 124
A A+G + +++LL
Sbjct: 204 HVAAAKGYTE--VLKLLIQAR 222
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 1e-07
Identities = 6/64 (9%), Positives = 13/64 (20%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ D + + G + + + LA + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDT-EEVLRL 59
Query: 121 NAHG 124
G
Sbjct: 60 LERG 63
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+ L L H + V + ++ D + ++ ++ +TPLH+A + ++A+ L+ G
Sbjct: 9 DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAG 68
Query: 92 ADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
D +D NTPL A +G + +L
Sbjct: 69 CDPELRDFRGNTPLHLACEQGCL--ASVGVLTQSC 101
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 42 AHQNDAAAVRKLLE-----EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
Q A+V L + S++ A +Y+ T LH+AS+HG++ + + L+ GADVNA
Sbjct: 86 CEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNA 145
Query: 97 QDRWK-NTPLADAEGAKKFNMMELLNAHG 124
Q+ T L A + +++ LL G
Sbjct: 146 QEPCNGRTALHLAVDLQNPDLVSLLLKCG 174
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
V+A++ N RT LH+A D+ L++ GADVN +P G + +
Sbjct: 143 VNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQ 202
Query: 120 LNAHG 124
L
Sbjct: 203 LGQLT 207
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 6/70 (8%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD------VNAQDRWKNTPLADAEGAKKF 114
RD+ TPLH+A G + L + + A + +T L A
Sbjct: 71 PELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYL 130
Query: 115 NMMELLNAHG 124
++ELL + G
Sbjct: 131 GIVELLVSLG 140
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 8e-10
Identities = 10/75 (13%), Positives = 21/75 (28%), Gaps = 2/75 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT+L + V LL+ V+ Y +P + + + L + +
Sbjct: 152 RTALH-LAVDLQNPDLVSLLLKCGAD-VNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 209
Query: 94 VNAQDRWKNTPLADA 108
+
Sbjct: 210 NLQMLPESEDEESYD 224
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 62 HARDYDNRTPLHVASLHGW----IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
D + LH+A +H ++V + + A +N Q+ + TPL A + +
Sbjct: 2 QQLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIA 61
Query: 118 ELLNAHG 124
E L G
Sbjct: 62 EALLGAG 68
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 2e-14
Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ W A A V LL+ D + L +A G+ D+ K L++ G
Sbjct: 37 FTPLM-WAAAHGQIAVVEFLLQNGAD---PQLLGKGRESALSLACSKGYTDIVKMLLDCG 92
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
DVN D TPL A +++L G
Sbjct: 93 VDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESG 125
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 2e-14
Identities = 18/72 (25%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
S+ A Q + + +E++ ++ D + TPL A+ HG I V + L++ GAD
Sbjct: 4 SLSVH-QLAAQGEMLYLATRIEQENV-INHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 94 VNAQDRWKNTPL 105
+ + + L
Sbjct: 62 PQLLGKGRESAL 73
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 5e-14
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
++L + V+ LL+ D V+ D++ TPL A + K L+E G
Sbjct: 70 ESALS-LACSKGYTDIVKMLLDCGVD---VNEYDWNGGTPLLYAVHGNHVKCVKMLLESG 125
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
AD + + A ++ +++ +H
Sbjct: 126 ADPTIETDSGYNSMDLAVALGYRSVQQVIESHL 158
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 60.1 bits (147), Expect = 5e-11
Identities = 16/60 (26%), Positives = 23/60 (38%), Gaps = 4/60 (6%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
N +H + G + IE +N D TPL A A G ++E L +G
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQI--AVVEFLLQNG 59
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 58.9 bits (144), Expect = 1e-10
Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 6/68 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ + H N V+ LLE D + +A G+ V + + +
Sbjct: 103 GTPLL-YAVHGNHVKCVKMLLESGAD---PTIETDSGYNSMDLAVALGYRSVQQVIESHL 158
Query: 92 ADVNAQDR 99
+ +
Sbjct: 159 LKLLQNIK 166
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 2e-14
Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 7/88 (7%)
Query: 42 AHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
Q + AV +L+ Q + + +TPLH+A + V + L+ GA A D
Sbjct: 17 VVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALD 76
Query: 99 RWKNTPL--ADAEGAKKFNMMELLNAHG 124
R T A + + L
Sbjct: 77 RHGQTAAHLACEHRSPT--CLRALLDSA 102
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 8e-14
Identities = 16/64 (25%), Positives = 31/64 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+ Y + LH AS G + + + L+ GAD + ++ +TPL A + +++
Sbjct: 176 VNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGK 235
Query: 121 NAHG 124
Sbjct: 236 ATRP 239
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-12
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
+ A D + R+PL A + + + + L+++GA+VNAQ ++ L A G ++
Sbjct: 142 IDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRT 201
Query: 120 LNAHG 124
L G
Sbjct: 202 LVRSG 206
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 4e-12
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 42 AHQNDAAAVRKLLE---EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+R LL+ + AR+YD T LHVA + + L+E GAD++A D
Sbjct: 87 CEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVD 146
Query: 99 RWKN--TPLADAEGAKKFNMMELLNAHG 124
K+ +PL A +M++LL HG
Sbjct: 147 I-KSGRSPLIHAVENNSLSMVQLLLQHG 173
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 17/69 (24%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 60 LVHARDYDNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFN 115
+ D D TPLH+A + G + L+ G +++ + + TPL A +
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 116 MMELLNAHG 124
++ LL G
Sbjct: 61 VVRLLVTAG 69
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 59.0 bits (144), Expect = 4e-10
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA----DVNAQDRWKNTPLADAEGAKKFNM 116
A D +T H+A H + L++ A D+ A++ T L A +
Sbjct: 72 PMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQET 131
Query: 117 MELLNAHG 124
++LL G
Sbjct: 132 VQLLLERG 139
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 3e-06
Identities = 9/32 (28%), Positives = 13/32 (40%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ N TPL VA ID+ + A
Sbjct: 209 SSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 2e-14
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 34 RTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
RT L H + + L+ + + AR +D TPL +A+ + + LI
Sbjct: 91 RTPL---HAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSH 147
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
ADVNA D + L A + +L +G
Sbjct: 148 ADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNG 180
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 2e-13
Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+++L W A N+ A LL+ + ++ TPL +A+ G + AK L+++ A+
Sbjct: 158 KSALH-WAAAVNNVDAAVVLLKNG-ANKDMQNNREETPLFLAAREGSYETAKVLLDHFAN 215
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
+ D P A+ +++ LL+
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
++ A + + + SL + D T LH+A+ + D AK L+E AD N QD
Sbjct: 29 SEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDN 88
Query: 100 WKNTPL--ADAEGAKKFNMMELLNAHGG 125
TPL A + A+ + ++L +
Sbjct: 89 MGRTPLHAAVSADAQG--VFQILIRNRA 114
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 5e-12
Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
V+A D ++ LH A+ +D A L++ GA+ + Q+ + TPL A EG+ + +
Sbjct: 150 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYE--TAK 207
Query: 119 LLNAHG 124
+L H
Sbjct: 208 VLLDHF 213
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 50.5 bits (122), Expect = 3e-07
Identities = 20/80 (25%), Positives = 25/80 (31%), Gaps = 18/80 (22%)
Query: 61 VHARDYDNRTPLHVASLHGW-------------IDVAKCLIEYGADV-NAQDRWKNTPL- 105
V+ R D TPL +AS G V I GA + N DR T L
Sbjct: 3 VNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALH 62
Query: 106 -ADAEGAKKFNMMELLNAHG 124
A + + L
Sbjct: 63 LAARYSRS--DAAKRLLEAS 80
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 48.6 bits (117), Expect = 1e-06
Identities = 6/37 (16%), Positives = 12/37 (32%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
D+ +R P +A D+ + L +
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHHHHH 252
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 3e-14
Identities = 13/45 (28%), Positives = 23/45 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+H + L A+ G ++ + L+E GAD NA +R+ P+
Sbjct: 5 IHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPI 49
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 3e-14
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 39 LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
+ A LL + + D T P+H A+ G++D L GA ++
Sbjct: 49 IQVMMMGSAQVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105
Query: 96 AQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D W P+ AE ++ L+A
Sbjct: 106 VCDAWGRLPVDLAEEQGHRDIARYLHAAT 134
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-12
Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
L A + VR+LLE D +A + R P+ V G VA+ L+ +G
Sbjct: 13 DAGLA-TAAARGQVETVRQLLEAGAD---PNALNRFGRRPIQVMM-MGSAQVAELLLLHG 67
Query: 92 ADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
A+ N D T P+ DA + + +L+ G
Sbjct: 68 AEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 2e-08
Identities = 9/33 (27%), Positives = 14/33 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ D R P+ +A G D+A+ L D
Sbjct: 104 LDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 3e-14
Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 6/74 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
RT L A V+ LLE D V+A+D + RTPLH+A+ +G ++V K L+E G
Sbjct: 3 RTPLH-LAARNGHLEVVKLLLEAGAD---VNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
Query: 92 ADVNAQDRWKNTPL 105
ADVNA+D+ TPL
Sbjct: 59 ADVNAKDKNGRTPL 72
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 3e-12
Identities = 25/58 (43%), Positives = 37/58 (63%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 49.3 bits (119), Expect = 5e-08
Identities = 24/54 (44%), Positives = 35/54 (64%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
L A +N V KLL E + V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 39 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 3e-14
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + V+ LL Q V+ +D TP+ A+ + +D+ K L+ G+D
Sbjct: 78 STCLH-LAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSD 136
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+N +D +N L A + ++ E+L A
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAK 167
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 8e-14
Identities = 16/64 (25%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ R+PLH A+ G +D+ L++ GA+++ + TPL +A ++ L
Sbjct: 4 FKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYL 63
Query: 121 NAHG 124
G
Sbjct: 64 IKAG 67
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 2e-13
Identities = 13/64 (20%), Positives = 26/64 (40%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+HA + +PLH+A+ D + +DV +++ TPL A + +
Sbjct: 170 LHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQM 229
Query: 121 NAHG 124
+
Sbjct: 230 SKAL 233
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 4e-13
Identities = 15/64 (23%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ RD + LH A+ G +D+A+ L+ D++A + ++PL A +++ + L
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLF 196
Query: 121 NAHG 124
+
Sbjct: 197 LSRD 200
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 9e-13
Identities = 18/64 (28%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ D RTPL A+ + ++ K LI+ GA V+ +D +T L A + +++ L
Sbjct: 37 IDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYL 96
Query: 121 NAHG 124
++G
Sbjct: 97 LSNG 100
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 6e-11
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
V +D + T LH+A+ G +V + L+ G DVN QD TP+ A K ++++L
Sbjct: 70 VDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKL 129
Query: 120 LNAHG 124
L + G
Sbjct: 130 LLSKG 134
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 47.8 bits (115), Expect = 2e-06
Identities = 9/33 (27%), Positives = 16/33 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
V ++ + TPL ASL+ + A + + D
Sbjct: 203 VTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 4e-14
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L L A Q A + LL Q+ + + TPLH+ + G + VA LI++G
Sbjct: 246 VTPLHL--AAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVM 303
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V+A R TPL A +++ L H
Sbjct: 304 VDATTRMGYTPLHVASHYGNIKLVKFLLQHQ 334
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 25/91 (27%), Positives = 35/91 (38%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A LLE D +A + TPLHVA H +D+ K L+ G
Sbjct: 147 FTPLH-VAAKYGKVRVAELLLERDAH-PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGS 204
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++ TPL A + + L +G
Sbjct: 205 PHSPAWNGYTPLHIAAKQNQVEVARSLLQYG 235
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
H N+ V+ LL S H+ ++ TPLH+A+ ++VA+ L++YG NA+
Sbjct: 187 VHHNNLDIVKLLLPRGGS-PHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQG 245
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A EG + M+ LL +
Sbjct: 246 VTPLHLAAQEGHAE--MVALLLSKQ 268
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 3e-13
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ S + + TPLH+A+ G +VAK L++ A VNA+ +
Sbjct: 22 SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 80
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A G M++LL +
Sbjct: 81 QTPLHCAARIGHTN--MVKLLLENN 103
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 3e-13
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L L Q V +L + +V A TPLHVAS +G I + K L+++ AD
Sbjct: 279 LTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQAD 336
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
VNA+ + +PL A +++ LL +G
Sbjct: 337 VNAKTKLGYSPLHQAAQQGHTDIVTLLLKNG 367
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + LL+ + V+A+ D++TPLH A+ G ++ K L+E A+
Sbjct: 48 ETPLH-MAARAGHTEVAKYLLQNK-AKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNAN 105
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N +TPL A + L
Sbjct: 106 PNLATTAGHTPLHIAAREGHVETVLALLEKE 136
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 8e-13
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + V LLE+ ++ TPLHVA+ +G + VA+ L+E A
Sbjct: 114 HTPLH-IAAREGHVETVLALLEK-EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAH 171
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
NA + TPL A ++++LL G
Sbjct: 172 PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRG 202
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L +H + V+ LL+ + V+A+ +PLH A+ G D+ L++ GA
Sbjct: 312 YTPLH-VASHYGNIKLVKFLLQHQ-ADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGAS 369
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N TPLA A+ ++ ++L
Sbjct: 370 PNEVSSDGTTPLAIAKRLGYISVTDVLKVVT 400
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+T L A V+ LLE + + + TPLH+A+ G ++ L+E A
Sbjct: 81 QTPLH-CAARIGHTNMVKLLLENN-ANPNLATTAGHTPLHIAAREGHVETVLALLEKEAS 138
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ TPL A K + ELL
Sbjct: 139 QACMTKKGFTPLHVAAKYGKVRVAELLLERD 169
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 19/64 (29%), Positives = 27/64 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
TPLHVAS G + + K L++ GA N + TPL A A + + L
Sbjct: 7 GGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYL 66
Query: 121 NAHG 124
+
Sbjct: 67 LQNK 70
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 8e-12
Identities = 16/64 (25%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+A TPLH+A+ G ++ L+ A+ N ++ TPL + ++L
Sbjct: 238 ANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 297
Query: 121 NAHG 124
HG
Sbjct: 298 IKHG 301
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 4/71 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL---IEYGADVNAQD 98
A Q V LL+ S + D TPL +A G+I V L + + V D
Sbjct: 352 AQQGHTDIVTLLLKNGAS-PNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 410
Query: 99 RWKNTPLADAE 109
+ + + +
Sbjct: 411 KHRMSFPETVD 421
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 4e-14
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+S L +N+ V++LL SL+ +D D R PLH + ++ L+
Sbjct: 1 MSNYPLH-QACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 59
Query: 92 ADVNAQDRWKN---TPLADAEGAKKFNMMELLNAHG 124
+VN D + TP A +++ L
Sbjct: 60 ENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRP 95
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 2e-13
Identities = 20/64 (31%), Positives = 31/64 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ T LH+A W +V++ LIE GA V +D++ PL A ++ELL
Sbjct: 100 LNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELL 159
Query: 121 NAHG 124
G
Sbjct: 160 CGLG 163
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 1e-12
Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
K + ++ L A + L +S V+ +D TPL A G D A L
Sbjct: 135 IKDKFNQIPLH-RAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLL 193
Query: 88 IE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+E YGA+ + D A + + + +
Sbjct: 194 VEKYGAEYDLVDNKGAKAEDVA--LNE-QVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 1e-09
Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIE--YGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
D TP H+A G ++V K L + D+N T L A G K F + + L
Sbjct: 67 YPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFL 126
Query: 121 NAHG 124
+G
Sbjct: 127 IENG 130
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-14
Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
T A + D A+ +LLE+ D V A D + RT L + G + L E GA
Sbjct: 45 ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 100
Query: 93 DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
D++ +D R T L A G + ++E L G
Sbjct: 101 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 133
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 2e-13
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
RT+L+ + A VR L E D + RD T LH+A+ + +V + L+E
Sbjct: 77 RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 132
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GAD+ +D T L A K G
Sbjct: 133 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 166
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 16/92 (17%), Positives = 27/92 (29%), Gaps = 4/92 (4%)
Query: 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ ++ + + V + TP A+ L+E
Sbjct: 12 GEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEY---ETPWWTAARKADEQALSQLLE-DR 67
Query: 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
DV+A D T L G + LL G
Sbjct: 68 DVDAVDENGRTALLFVAGLGSDKCVRLLAEAG 99
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 7e-08
Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 6/67 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L A V L+E D + D T L +A +++G
Sbjct: 111 LTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILKTTPKGNPMQFG 166
Query: 92 ADVNAQD 98
+ +
Sbjct: 167 RRIGLEK 173
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 2e-06
Identities = 8/51 (15%), Positives = 15/51 (29%), Gaps = 4/51 (7%)
Query: 56 EDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
E ++ +R + + G ADV ++ TP
Sbjct: 1 EVNKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 48
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 6e-14
Identities = 25/64 (39%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
AR +RTPLH+A+ G ++ + L+++GADVNA+D K T L A ++ELL
Sbjct: 60 RDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELL 119
Query: 121 NAHG 124
+G
Sbjct: 120 IKYG 123
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 2e-13
Identities = 18/45 (40%), Positives = 27/45 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+A+D T LH A+ H +V + LI+YGADV+ Q ++ T
Sbjct: 93 VNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAF 137
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 62.8 bits (154), Expect = 4e-12
Identities = 18/60 (30%), Positives = 31/60 (51%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D+ +PLH+A+ +G + L+ G +A+ + TPL A N++E+L HG
Sbjct: 31 DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHG 90
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 52.8 bits (128), Expect = 1e-08
Identities = 16/58 (27%), Positives = 22/58 (37%), Gaps = 1/58 (1%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GA D +PL A F+ E+L G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAG 57
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 6e-14
Identities = 25/64 (39%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+D TPL++A+ HG +++ + L++ GADVNA D TPL A + E+L
Sbjct: 40 VNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVL 99
Query: 121 NAHG 124
HG
Sbjct: 100 LKHG 103
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 65.1 bits (160), Expect = 5e-13
Identities = 23/63 (36%), Positives = 39/63 (61%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH+A+ G +++A+ L+++GADVNAQD++ T + G ++ E+L
Sbjct: 73 VNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEIL 132
Query: 121 NAH 123
Sbjct: 133 QKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 58.2 bits (142), Expect = 1e-10
Identities = 20/58 (34%), Positives = 29/58 (50%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GADVNA+D + TPL A ++E+L +G
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNG 70
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 6e-14
Identities = 20/83 (24%), Positives = 34/83 (40%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ + L+ + + AR +D TPL +A+ + + LI ADVNA D
Sbjct: 66 VSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLG 125
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
+ L A + +L +G
Sbjct: 126 KSALHWAAAVNNVDAAVVLLKNG 148
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 1e-13
Identities = 14/64 (21%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ TPL +A+ G + AK L+++ A+ + D P A+ +++ LL
Sbjct: 151 KDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLL 210
Query: 121 NAHG 124
+ +
Sbjct: 211 DEYN 214
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 3e-13
Identities = 23/76 (30%), Positives = 35/76 (46%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109
+ + + SL + D T LH+A+ + D AK L+E AD N QD TPL A
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 110 GAKKFNMMELLNAHGG 125
A + ++L +
Sbjct: 67 SADAQGVFQILIRNRA 82
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 5e-13
Identities = 18/64 (28%), Positives = 32/64 (50%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D ++ LH A+ +D A L++ GA+ + Q+ + TPL A + ++L
Sbjct: 118 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVL 177
Query: 121 NAHG 124
H
Sbjct: 178 LDHF 181
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 1e-11
Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
A + R T+L A + + A ++LLE + +D RTPLH A
Sbjct: 15 ASLHNQTDRTGETALH-LAARYSRSDAAKRLLEASAD-ANIQDNMGRTPLHAAVSADAQG 72
Query: 83 VAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V + LI A D++A+ TPL A M+E L
Sbjct: 73 VFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSH 115
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 52.0 bits (126), Expect = 7e-08
Identities = 9/38 (23%), Positives = 15/38 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
D+ +R P +A D+ + L EY + Q
Sbjct: 184 RDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQL 221
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 8e-14
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 39 LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
+ A LL + + D T P+H A+ G++D L GA ++
Sbjct: 49 IQVMMMGSARVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105
Query: 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135
+D W P+ AE ++ L A G + G N +
Sbjct: 106 VRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARI 145
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 64.0 bits (157), Expect = 2e-12
Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
S L A + VR LLE + +A + R P+ V G VA+
Sbjct: 8 SMEPSADWLA-TAAARGRVEEVRALLEAGAN---PNAPNSYGRRPIQVMM-MGSARVAEL 62
Query: 87 LIEYGADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
L+ +GA+ N D T P+ DA + + +L+ G
Sbjct: 63 LLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-11
Identities = 10/43 (23%), Positives = 21/43 (48%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+ + L A+ G ++ + L+E GA+ NA + + P+
Sbjct: 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPI 49
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 8e-14
Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+AR D TPLH+A+ +G ++ K L+ GADVNA+ + NTP
Sbjct: 35 VNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPE 79
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 2e-13
Identities = 17/45 (37%), Positives = 24/45 (53%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+AR D TP H+A +G ++ K L GADVNA+ +
Sbjct: 68 VNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHH 112
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 63.9 bits (157), Expect = 7e-13
Identities = 24/60 (40%), Positives = 33/60 (55%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D TPLH A+ +G + K L+ GADVNA+ + NTPL A +++LL A G
Sbjct: 6 SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKG 65
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 8e-14
Identities = 23/87 (26%), Positives = 40/87 (45%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
A+ +++ + D+SL D D+RT LH A G ++ + L++ G VN +D
Sbjct: 11 CNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKD 70
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+PL A A +++ L G
Sbjct: 71 DAGWSPLHIAASAGXDEIVKALLVKGA 97
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 20/65 (30%), Positives = 33/65 (50%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D +PLH+A+ G ++ K L+ GA VNA ++ TPL A + + +L
Sbjct: 66 VNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVML 125
Query: 121 NAHGG 125
G
Sbjct: 126 LEGGA 130
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 22/86 (25%), Positives = 39/86 (45%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + V+A + + TPLH A+ ++A L+E GA+ +A+D
Sbjct: 77 LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ T + A M+ +L +
Sbjct: 137 HYDATAMHRAAAKGNLKMVHILLFYK 162
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + +L ++ + +D + TPLH+A ++ AK L+ GA + ++
Sbjct: 143 MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIEN 202
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ + TPL A+G ++ A G
Sbjct: 203 KEEKTPLQVAKGGL--GLILKRLAEG 226
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-10
Identities = 10/58 (17%), Positives = 21/58 (36%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N ++A ++ + ++ + D+ T L A A ++E L G
Sbjct: 6 SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLG 63
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 26/99 (26%), Positives = 43/99 (43%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L +A + + +L E + A+D+ + T +H A+ G + + L+ Y A N QD
Sbjct: 110 LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQD 169
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
NTPL A ++ + L G Y +N P
Sbjct: 170 TEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTP 208
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 10/57 (17%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95
L A + K L + ++ + + +TPL VA + + + G + +
Sbjct: 176 LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAKGG--LGLILKRLAEGEEAS 230
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 9e-14
Identities = 28/64 (43%), Positives = 42/64 (65%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL
Sbjct: 61 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLL 120
Query: 121 NAHG 124
G
Sbjct: 121 LEAG 124
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 65.4 bits (161), Expect = 3e-13
Identities = 24/45 (53%), Positives = 35/45 (77%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL
Sbjct: 28 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPL 72
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 6e-12
Identities = 25/58 (43%), Positives = 37/58 (63%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 48.5 bits (117), Expect = 3e-07
Identities = 16/32 (50%), Positives = 25/32 (78%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 94 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 28 EKARVSRTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
+ R L+L A + V++ ++E + + T LH A +
Sbjct: 13 KARRARLNPLVLLLDAALTGELEVVQQAVKEMND-PSQPNEEGITALHNAICGANYSIVD 71
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
LI GA+VN+ D TPL A + L HG
Sbjct: 72 FLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHG 110
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 13/67 (19%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKK--FNMM 117
V++ D TPLH A+ + L+++GA + A T + ++ +
Sbjct: 80 VNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCA 139
Query: 118 ELLNAHG 124
L
Sbjct: 140 TYLADVE 146
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 6/67 (8%)
Query: 61 VHARD-YDNRTPLHVASLH--GWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+ A D T + G+ D A L + + + L D + +
Sbjct: 113 IFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDY--SAE-FGD 169
Query: 118 ELLNAHG 124
EL G
Sbjct: 170 ELSFREG 176
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSL----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
+ A+ +++ S + + + LH A L W DVA +E G DVN +
Sbjct: 181 MEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNME 240
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
D PL + A + + L
Sbjct: 241 DNEHTVPLYLSVRAAMVLLTKELLQKT 267
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 18/64 (28%), Positives = 27/64 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
D +N +HVA+ G D + LIE G Q+R+ T L A + + L
Sbjct: 13 RIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYL 72
Query: 121 NAHG 124
+ G
Sbjct: 73 ASVG 76
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 10/105 (9%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKC 86
+ ++ D V ++ H + +T LH G +++ K
Sbjct: 107 AKERGQMPES--LLNECDEREVNEIG------SHVKHCKGQTALHWCVGLGPEYLEMIKI 158
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
L++ GA A+D+ TPL A + ++L+
Sbjct: 159 LVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLR 203
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 7/64 (10%), Positives = 15/64 (23%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V + A+ +V + L E +V + + +
Sbjct: 283 VLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342
Query: 121 NAHG 124
A
Sbjct: 343 LAPS 346
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 2/64 (3%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ T LH+A G +D AK L G + P+ A A K +++ L
Sbjct: 46 PTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWHGQ--KPIHLAVMANKTDLVVAL 103
Query: 121 NAHG 124
Sbjct: 104 VEGA 107
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 12/82 (14%), Positives = 21/82 (25%), Gaps = 2/82 (2%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
V + A V +LL+E V V +
Sbjct: 285 PDRVVWLDFVPA--AADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342
Query: 88 IEYGADVNAQDRWKNTPLADAE 109
+ A V + R + A ++
Sbjct: 343 LAPSAPVRTRSRSRARSSAVSK 364
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 10/69 (14%), Positives = 23/69 (33%), Gaps = 5/69 (7%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEY-----GADVNAQDRWKNTPLADAEGAKKFN 115
A+D + TPL A + +++ ++ ++ N+ L A +
Sbjct: 166 PTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWED 225
Query: 116 MMELLNAHG 124
+ G
Sbjct: 226 VAMRFVEMG 234
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 23/83 (27%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGAD---------------------VNAQDRWKNT 103
+ + P+H+A + D+ L+E + + + T
Sbjct: 81 LWHGQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSHVKHCKGQT 140
Query: 104 PL--ADAEGAKKFNMMELLNAHG 124
L G + M+++L G
Sbjct: 141 ALHWCVGLGPEYLEMIKILVQLG 163
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 13/77 (16%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIE-------------YGADVNAQDRWKNTPLAD 107
V+ D ++ PL+++ + + K L++ G V +
Sbjct: 237 VNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPA 296
Query: 108 AEGAKKFNMMELLNAHG 124
A K +++LL
Sbjct: 297 AADPSKQEVLQLLQEKL 313
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 67.4 bits (166), Expect = 1e-13
Identities = 19/64 (29%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+D +H A+ G++D + L+E+ ADVN +D N PL A ++E L
Sbjct: 63 PDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFL 122
Query: 121 NAHG 124
H
Sbjct: 123 VKHT 126
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 64.3 bits (158), Expect = 2e-12
Identities = 16/65 (24%), Positives = 34/65 (52%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
V+ D + PLH+A+ G + V + L+++ A +V ++ +T A + ++ L
Sbjct: 96 VNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSL 155
Query: 120 LNAHG 124
+ A+G
Sbjct: 156 MQANG 160
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 1e-11
Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A++ RT L V G ++A+ L+ GA+ + +DR + DA A + ++ L
Sbjct: 31 VNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTL 89
Query: 121 NAHG 124
Sbjct: 90 LEFQ 93
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 58.9 bits (144), Expect = 1e-10
Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 3/59 (5%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
L A+ G ++ L++ +VNAQ+ + T L G + + L G
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPE--IARRLLLRG 60
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 48.5 bits (117), Expect = 4e-07
Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
L A + V L++ S V R++ T +A L+G +V + GA
Sbjct: 104 NLPLH-LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 1e-13
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-Y 90
R +LI + +D A+ LL + + V+ R +TPL +A + + + L+E
Sbjct: 183 RNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQE 242
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++N D T L A K + ELL G
Sbjct: 243 HIEINDTDSDGKTALLLAVELKLKKIAELLCKRG 276
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 2e-13
Identities = 17/64 (26%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
R + TP +A++ G + + K + GADVN D + T +A K ++ L
Sbjct: 65 PVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFL 124
Query: 121 NAHG 124
G
Sbjct: 125 YKRG 128
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
LI D V++LLE ++ + TPLH A D+ + L+ +GAD
Sbjct: 6 NHLLI-KAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGAD 64
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + TP A A +++L + G
Sbjct: 65 PVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 3e-11
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+T LI + V++LLE++ ++ D D +T L +A +A+ L + GA
Sbjct: 220 KTPLI-LAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAS 278
Query: 94 VNAQD 98
+ D
Sbjct: 279 TDCGD 283
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 61.7 bits (151), Expect = 7e-11
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 5/96 (5%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
T+L+ A + ++ LL+E + V+A D R L A L + L++
Sbjct: 149 ATALM-DAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLD 207
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
+GADVN + TPL A K +++ L
Sbjct: 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 1e-10
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 10/75 (13%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK----------NTPLADAEG 110
V+ D+ T A+++G + K L + GA+VN + + K T L DA
Sbjct: 98 VNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAE 157
Query: 111 AKKFNMMELLNAHGG 125
++++L G
Sbjct: 158 KGHVEVLKILLDEMG 172
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 4e-10
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAH 123
++ L A + +D+ + L+E GA+VN Q+ TPL +A + +++ELL H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT+L + A ++ V+ L+ E S +D D +TP+ +A+ G I+V LI+ GA
Sbjct: 280 RTALH-YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGAS 338
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V A D +T A+ N++++ +
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCR 369
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSL-------VHARDYDNRTPLHVASLHGWIDVAKC 86
RT L W A + A L+ + V+A D D TPL +A L +
Sbjct: 126 RTVLH-WIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAY 184
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
L++ GAD ++ + + L A + F MM +
Sbjct: 185 LMKAGADPTIYNKSERSALHQAAANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 24/103 (23%), Positives = 47/103 (45%), Gaps = 14/103 (13%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLE-------EDQSLVHARDYDNRTPLHVASLHGWIDVA 84
T+L++ + ++ A+ + L+E + + + Y RT LH A+ + +
Sbjct: 236 MTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIV 295
Query: 85 KCLI-EYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
K L+ E G++ + QD TP+ A EG + ++ L G
Sbjct: 296 KYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIE--VVMYLIQQG 336
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 15/70 (21%), Positives = 25/70 (35%), Gaps = 6/70 (8%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIE---YGADVNAQDRWKNTPL---ADAEGAKKF 114
+ R+ LH A+ + + ++ D+ DR T L A EG +
Sbjct: 192 PTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQV 251
Query: 115 NMMELLNAHG 124
+LL G
Sbjct: 252 ASAKLLVEKG 261
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 13/101 (12%), Positives = 26/101 (25%), Gaps = 14/101 (13%)
Query: 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
K + S+ SL L ++ R L + + P +G +
Sbjct: 29 KNHQSITSSQHSL-LEASYDGYIKRQRNEL----------QHYSLYPNPQGYGNGNDFLG 77
Query: 85 KCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
+ L +A G+ + E +
Sbjct: 78 DFNHTNLQIPTEPEPESPIKLHTEAAGSYA--ITEPITRES 116
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI--------EY 90
L A + E ++ NRT LH + + + ++ LI
Sbjct: 98 LHTEAAGSYAITEPITRESVNI--IDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAA 155
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GADVNA D +NTPL A A++ ++ L G
Sbjct: 156 GADVNAMDCDENTPLMLAVLARRRRLVAYLMKAG 189
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 5/34 (14%), Positives = 11/34 (32%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
V A D + T +A + ++ +
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCRPER 372
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
RT+L+ + A VR L E D + RD T LH+A+ + +V + L+E
Sbjct: 78 RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 133
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GAD+ +D T L A K G
Sbjct: 134 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 167
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
T A + D A+ +LLE+ D V A D + RT L + G + L E GA
Sbjct: 46 ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 101
Query: 93 DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
D++ +D R T L A G + ++E L G
Sbjct: 102 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 134
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 17/104 (16%), Positives = 33/104 (31%), Gaps = 9/104 (8%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
AD R T+L A V L+E D + D T L +A
Sbjct: 101 ADLDHRDMRGGLTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILK 156
Query: 81 IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+++G + + + + + + + E++ G
Sbjct: 157 TTPKGNPMQFGRRIGLEK---VINVLEGQVFEYAEVDEIVEKRG 197
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 16/86 (18%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
++ + + V + + TP A+ L+E DV+A D
Sbjct: 19 YLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQLLE-DRDVDAVD 74
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
T L G + LL G
Sbjct: 75 ENGRTALLFVAGLGSDKCVRLLAEAG 100
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 12/74 (16%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ + A V +++E+ + ++ D + A+ A+D
Sbjct: 178 VLEGQVFEYAEVDEIVEKRG--------KGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD 229
Query: 99 RWKNTPL--ADAEG 110
L A AE
Sbjct: 230 --YEDGLEYAVAES 241
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 6/39 (15%), Positives = 10/39 (25%), Gaps = 3/39 (7%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+ + G ADV ++ TP
Sbjct: 14 EGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 49
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 2e-13
Identities = 21/63 (33%), Positives = 38/63 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D + TPLH+A++ G +++ + L++ GADVNAQD++ T + ++ E+L
Sbjct: 106 VNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEIL 165
Query: 121 NAH 123
Sbjct: 166 QKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 66.2 bits (163), Expect = 4e-13
Identities = 24/64 (37%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH+A+ +G +++ + L++ GADVNA D TPL A ++E+L
Sbjct: 40 VNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVL 99
Query: 121 NAHG 124
+G
Sbjct: 100 LKNG 103
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 65.8 bits (162), Expect = 4e-13
Identities = 24/64 (37%), Positives = 39/64 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D+ TPL +A+L G +++ + L++ GADVNA D +TPL A ++E+L
Sbjct: 73 VNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVL 132
Query: 121 NAHG 124
+G
Sbjct: 133 LKNG 136
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 60.8 bits (149), Expect = 3e-11
Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMEL 119
H D L A+ G D + L+ GADVNA+D TPL A G + ++E+
Sbjct: 8 HHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLE--IVEV 65
Query: 120 LNAHG 124
L +G
Sbjct: 66 LLKNG 70
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 23/186 (12%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI------LPSLSD-----DRLVIQDFRHEVNLLVK 211
IG G FG I A+ + A + L R+ +D + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L + I F G R ++ E L G DL K + G ST + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---TGET 324
+ Y+H N +H D+K N+LL + D + + D+GLS +H Y+ G
Sbjct: 164 LEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 325 GSYRYM 330
G+ +
Sbjct: 222 GTIEFT 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 4e-13
Identities = 39/210 (18%), Positives = 62/210 (29%), Gaps = 50/210 (23%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRH 204
+ IG+G FGE+ + TPVAIK I D + ++
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 205 EVNLLVKL---------RHPNIVQFLGA--VTERKP------------------------ 229
E+ + +L R + V P
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 230 ----LMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
L ++ E+ GG DL + + S +TA + + +A HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR-FEHRDLH 189
Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
NVLL K+ K + +
Sbjct: 190 WGNVLL--KKTSLKKLHYTLNGKSSTIPSC 217
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-13
Identities = 23/60 (38%), Positives = 37/60 (61%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V A+D + TPLH+A+ +G ++V K L+E GADV AQD++ T + ++ E+L
Sbjct: 50 VAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-12
Identities = 19/60 (31%), Positives = 28/60 (46%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GADV A+D+ +TPL A +++LL G
Sbjct: 21 GSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAG 80
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 5/31 (16%), Positives = 10/31 (32%), Gaps = 3/31 (9%)
Query: 75 ASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
S H + L+ G+ + + L
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSDL---GKKL 28
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 6e-13
Identities = 20/60 (33%), Positives = 35/60 (58%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ R+ + TPL VAS +G ++ K L+E GAD++A+D T A A + ++++
Sbjct: 127 VNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIF 186
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 8e-13
Identities = 20/65 (30%), Positives = 30/65 (46%)
Query: 60 LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
L + RD NRTPL VA + G + L+E + +D +T L A + + E
Sbjct: 27 LRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEK 86
Query: 120 LNAHG 124
L + G
Sbjct: 87 LLSKG 91
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 65.1 bits (160), Expect = 1e-12
Identities = 17/64 (26%), Positives = 29/64 (45%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ +D + T L A + + +A+ L+ G++VN +D TPL + M L
Sbjct: 61 LEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFL 120
Query: 121 NAHG 124
HG
Sbjct: 121 LEHG 124
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 63.9 bits (157), Expect = 4e-12
Identities = 18/64 (28%), Positives = 37/64 (57%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D+ +TPL + + G+ +++ L+E+GA+VN ++ TPL A + +++ L
Sbjct: 94 VNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKL 153
Query: 121 NAHG 124
G
Sbjct: 154 LELG 157
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 42.0 bits (100), Expect = 1e-04
Identities = 9/32 (28%), Positives = 12/32 (37%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
+ ARD T A + G +V K E
Sbjct: 160 ISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-13
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV-----NA 96
A +ND A+ KLL+ + VH R T LH+A+L+ ++ A L+E ++ +
Sbjct: 11 AKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTS 70
Query: 97 QDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ T L A + N++ L A G
Sbjct: 71 ELYEGQTALHIAVINQNVNLVRALLARG 98
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 4/68 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKF--NM 116
H Y PL A+ G ++ + LIE+GAD+ AQD NT L + K F M
Sbjct: 114 PHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQM 173
Query: 117 MELLNAHG 124
LL ++
Sbjct: 174 YNLLLSYD 181
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 9e-08
Identities = 14/74 (18%), Positives = 21/74 (28%), Gaps = 10/74 (13%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVA----KCLIEYGADVNA------QDRWKNTPLADAEG 110
+ A+D T LH+ L A L+ Y + + TP A
Sbjct: 147 IRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGV 206
Query: 111 AKKFNMMELLNAHG 124
M + L
Sbjct: 207 EGNIVMFQHLMQKR 220
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 4e-07
Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 1/56 (1%)
Query: 70 TPLHVASLHGWID-VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+PL +A+ + ++K L G +V+ + T L A +L
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAA 60
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 1e-12
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGA 92
T L+ W A++ + +LL V+ D Y T LH A L G V L+E GA
Sbjct: 143 MTPLM-WAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
Query: 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+V+AQ+ + L A+ K M+ L
Sbjct: 202 NVDAQNIKGESALDLAKQRKNVWMINHLQEAR 233
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 1e-12
Identities = 24/106 (22%), Positives = 40/106 (37%), Gaps = 9/106 (8%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
A + ++ T L W Q + V +L++ D D + + +H+A+ G
Sbjct: 66 AIVDQLGGDLNSTPLH-WATRQGHLSMVVQLMKYGAD---PSLIDGEGCSCIHLAAQFGH 121
Query: 81 IDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
+ LI G DV+ D+ TPL A + LL
Sbjct: 122 TSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSV-DPTRLLLTFN 166
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 5e-12
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
++ R+L+E D V D +N T LH A+++ ID+ K I G
Sbjct: 10 TWDIV-KATQYGIYERCRELVEAGYD---VRQPDKENVTLLHWAAINNRIDLVKYYISKG 65
Query: 92 ADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHG 124
A V+ +TPL A +M+ L +G
Sbjct: 66 AIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYG 99
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 63.6 bits (156), Expect = 9e-12
Identities = 11/43 (25%), Positives = 19/43 (44%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
D + + A+ +G + + L+E G DV D+ T L
Sbjct: 4 HIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLL 46
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 1e-07
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 2/65 (3%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T+L W + + LLE + V A++ + L +A + + L E
Sbjct: 178 NTALH-WAVLAGNTTVISLLLEAG-ANVDAQNIKGESALDLAKQRKNVWMINHLQEARQA 235
Query: 94 VNAQD 98
+
Sbjct: 236 KGYDN 240
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 14/99 (14%), Positives = 32/99 (32%), Gaps = 12/99 (12%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV------AKCLIEYGA 92
L + + + L + + +R + T G D+ K +E GA
Sbjct: 46 LRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
Query: 93 DVNAQDRWKNTPLADA------EGAKKFNMMELLNAHGG 125
D+ A + + + + + +L+ + G
Sbjct: 106 DITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSG 144
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 12/105 (11%), Positives = 33/105 (31%), Gaps = 17/105 (16%)
Query: 34 RTSLIL--WHAHQN---DAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
T + + LE+ D + A + + + ++D +
Sbjct: 76 TTLFFPLFQGGGNDITGTTELCKIFLEKGAD---ITALYKPYKIVVFKNIFNYFVDENEM 132
Query: 87 -------LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ G + +D+W T L + +K ++++ +
Sbjct: 133 IPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 6/70 (8%), Positives = 21/70 (30%), Gaps = 5/70 (7%)
Query: 34 RTSLIL--WHAHQNDAAA---VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
+ + ++ ++ + + + + +D T L K +
Sbjct: 115 KIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMME 174
Query: 89 EYGADVNAQD 98
+Y N ++
Sbjct: 175 DYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-11
Identities = 12/101 (11%), Positives = 29/101 (28%), Gaps = 8/101 (7%)
Query: 32 VSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
+S + A +L E+ + + L + ++ LI
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 90 YGADVNAQDRWKNTPLADA------EGAKKFNMMELLNAHG 124
GAD+ ++ + T + + ++ G
Sbjct: 64 KGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKG 104
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 9/65 (13%), Positives = 19/65 (29%), Gaps = 3/65 (4%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN---TPLADAEGAKKFNMMEL 119
+ + A++ G + L E G + N L + ++ +
Sbjct: 1 SNAMSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMF 60
Query: 120 LNAHG 124
L G
Sbjct: 61 LINKG 65
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 18/64 (28%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ + T LH A G ++ K L+++G +VNA D TPL A + + L
Sbjct: 63 PSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFL 122
Query: 121 NAHG 124
G
Sbjct: 123 VESG 126
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 19/67 (28%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ---DRWKNTPLADAEGAKKFNMM 117
V+A D D TPLH A+ + V K L+E GA V A D +
Sbjct: 96 VNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCS 155
Query: 118 ELLNAHG 124
+ L
Sbjct: 156 QFLYGVQ 162
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 13/60 (21%), Positives = 24/60 (40%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ L +SL G D+ + +I D + + T L +A A +++ L G
Sbjct: 34 NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFG 93
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 16/93 (17%), Positives = 26/93 (27%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L A N+ + L+E + D G+ ++ L
Sbjct: 104 WTPLH-CAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ 162
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ ++ L D E N EL G
Sbjct: 163 EKMGIMNKGVIYALWDYE---PQNDDELPMKEG 192
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 7/60 (11%), Positives = 17/60 (28%), Gaps = 1/60 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + L I +G V L D+ +F++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 12/84 (14%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + ++ L D + + A + + L+ GA N +
Sbjct: 6 RINTWKSKQLKSFLSSKD--TFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE-- 61
Query: 101 KNTPLADAEGAKKFNMMELLNAHG 124
PL A + ++++L G
Sbjct: 62 NEFPLHQAATLEDTKIVKILLFSG 85
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 4e-12
Identities = 15/59 (25%), Positives = 23/59 (38%)
Query: 66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+N PLH A+ + K L+ G D + D NT L A + ++L
Sbjct: 60 LENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKN 118
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 4e-12
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+TS ND + V L + + +H+ +G +D+ L++Y
Sbjct: 130 KTSFY-HAVMLNDVSIVSYFLS--EIPSTFDLAILLSCIHITIKNGHVDMMILLLDYMTS 186
Query: 94 VNAQDRWKNTPL---ADAEGAKKFNMMELLNAHG 124
N + P A + M++ L +
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIE--MLQALFKYD 218
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 8/65 (12%), Positives = 18/65 (27%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMEL 119
D T L+ A G + K ++ + + T A +++
Sbjct: 88 DSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSY 147
Query: 120 LNAHG 124
+
Sbjct: 148 FLSEI 152
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 6/45 (13%), Positives = 15/45 (33%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
+ L ++AK +IE + + K+ + +
Sbjct: 223 SANLENVLLDDAEIAKMIIEKHVEYKSDSYTKDLDIVKNNKLDEI 267
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 10/87 (11%), Positives = 25/87 (28%), Gaps = 2/87 (2%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
L++A + KL + + +T + A + + + +
Sbjct: 99 LYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPS-TFD 157
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + +MM LL +
Sbjct: 158 LAILLSCIHITIKNGHVDMMILLLDYM 184
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 5/41 (12%), Positives = 18/41 (43%), Gaps = 1/41 (2%)
Query: 61 VHARDYDNRTP-LHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + P + +A + I++ + L +Y ++ + +
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIYSANLE 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 26/189 (13%), Positives = 55/189 (29%), Gaps = 26/189 (13%)
Query: 165 IGKGSFGEI----------LKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVN 207
+ + G + + + ++K R ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 208 LLVKLRHPNIVQFLG-AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDI 264
L I +G V + K L+ L G L L K LS + + A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---T 321
+ +LH N +H ++ N+ + + + +G + H Y +
Sbjct: 169 LDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 322 GETGSYRYM 330
G ++
Sbjct: 227 PHEGDLEFI 235
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 19/104 (18%), Positives = 32/104 (30%), Gaps = 12/104 (11%)
Query: 23 ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
D + + +T L+ + H + LL+ + Y +T
Sbjct: 44 TDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQT 103
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
LH+A + + L+E GADV A F
Sbjct: 104 ALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYF 147
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 3/51 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPLADA 108
Y PL +A+ + + K L++ AD++A+D NT L
Sbjct: 141 GRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHAL 191
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 12/78 (15%), Positives = 23/78 (29%), Gaps = 7/78 (8%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
E A + + + N+ + L L + TPL +A+ G I V +
Sbjct: 193 EVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYI 252
Query: 88 IEYGADVNAQDRWKNTPL 105
++
Sbjct: 253 LQREIHE-------PECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 20/101 (19%), Positives = 30/101 (29%), Gaps = 18/101 (17%)
Query: 42 AHQNDAAAVRKLLEEDQSL--VHARDYDNRTPLHVASLHG----------------WIDV 83
A N A V+ LL+ + ARD T LH + +
Sbjct: 156 ACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILIL 215
Query: 84 AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L +R TPLA A + K ++ +
Sbjct: 216 GAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQRE 256
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 25/128 (19%)
Query: 23 ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
D + +T L+ + A + LL+ D+ Y +
Sbjct: 33 TDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHS 92
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDR-------------WKNTPLADAEGAKKFNMM 117
LH+A + K L+E GADV+ + + PL+ A K+++++
Sbjct: 93 ALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVV 152
Query: 118 ELLNAHGG 125
L +
Sbjct: 153 TYLLENPH 160
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 5/72 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A + + L + G + + L + TPL A K + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 121 NAHGGLSYGQNG 132
L +G
Sbjct: 241 -----LQREFSG 247
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 14/48 (29%), Positives = 18/48 (37%), Gaps = 3/48 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL 105
Y PL +A+ DV L+E A + A D NT L
Sbjct: 129 QGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVL 176
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 10/71 (14%), Positives = 26/71 (36%), Gaps = 2/71 (2%)
Query: 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
++L++ + + L L ++ TPL +A+ G I++ +
Sbjct: 181 MIADNSPENSALVI--HMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFR 238
Query: 86 CLIEYGADVNA 96
+++ A
Sbjct: 239 HILQREFSGAA 249
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 44/174 (25%), Positives = 69/174 (39%), Gaps = 16/174 (9%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
IG GSFGEI VAIK +L +E + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----LYESKIYRILQGGTGIPNVR 69
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
E +L+ + L G L LS T + A + + ++H+ +H
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--KSFLH 126
Query: 281 RDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ + A+ + + DFGL+K + ++H TG+ RY
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 54/279 (19%), Positives = 95/279 (34%), Gaps = 79/279 (28%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPN- 216
+G G F + ++ VA+K ++ S + E+ LL +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLKSVRNSDPNDPNR 100
Query: 217 --IVQFLGAVTERKP----LMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGM 268
+VQ L + ++ E L G L K++ L + +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 269 AYLHNEPNVIIHRDLKPRNVLLV------------------------------------- 291
YLH + IIH D+KP N+LL
Sbjct: 160 DYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 292 ----------NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
N+ +K+ D G + + + D+ +T YR + EV Y+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI-----QTRQYR--SLEVLIGSGYN 271
Query: 342 KKVDVFSFAMILYEMLEGEP---PLANYEPYEAAKYVAE 377
D++S A + +E+ G+ P + E ++A
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 44/179 (24%), Positives = 66/179 (36%), Gaps = 26/179 (14%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKR-----ILPSLSDDRLVIQDFRHEVNLLVKLRH-PN 216
IG GSFG+I G VAIK P L E + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----------HIESKIYKMMQGGVG 66
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEP 275
I E +++ E L G L S T + A + + Y+H+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 123
Query: 276 NVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
IHRD+KP N L+ + + + + DFGL+K + +H TG+ RY
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 18/176 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG G+FGE+ + VAIK L + E +L I Q
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
K ++ E L G L S T + A+ + M Y+H++ +I+
Sbjct: 72 YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIY 128
Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ N + + + DF L+K + TG+ RYM
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 39/196 (19%), Positives = 66/196 (33%), Gaps = 40/196 (20%)
Query: 165 IGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
IG+G FG I A P +K + + L E+ + P
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVK--VEPSDNGPL-----FTELKFYQRAAKPEQ 95
Query: 218 VQFLGAVTERKPL-------------------MLITEYLRGGDLHKYLKEKG-ALSPSTA 257
+Q + K L +I + G DL K + S T
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV 154
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +L I + Y+H + +H D+K N+LL + D + + D+GL+ + H
Sbjct: 155 LQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 318 YKM---TGETGSYRYM 330
Y G+ +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 15/84 (17%), Positives = 33/84 (39%)
Query: 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
+ Q ++ L ++++A+D + T L++A+ G I
Sbjct: 237 NRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNI 296
Query: 82 DVAKCLIEYGADVNAQDRWKNTPL 105
+ L++YGAD ++ P+
Sbjct: 297 SIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA----EGAKKFNMMELL 120
D TPLH + +++ K L+++G++ D + L A LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 121 NAHG 124
+
Sbjct: 188 DYLY 191
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 12/76 (15%), Positives = 20/76 (26%), Gaps = 6/76 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
T L W + V+ L++ + D + L A L
Sbjct: 132 NTPLH-WLTSIANLELVKHLVKHGSN-RLYGDNMGESCLVKAVKSVNNYDSGTFEALLDY 189
Query: 90 YGADVNAQDRWKNTPL 105
+ +D T L
Sbjct: 190 LYPCLILEDSMNRTIL 205
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 2e-10
Identities = 82/523 (15%), Positives = 145/523 (27%), Gaps = 160/523 (30%)
Query: 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAK 85
K VS T + W V+K +EE V +Y +P+ +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEE----VLRINYKFLMSPIKTEQ----RQPSM 107
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFN------MMELLNA------------HGGLS 127
Y + +DR N D + K+N ++L A G L
Sbjct: 108 MTRMY---IEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 128 YGQN-------------------------GSHFEPKPVPPPLPNKCDWEIDP---SELDF 159
G+ + P+ V L ++IDP S D
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTSRSDH 219
Query: 160 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNI 217
SS+ + S L+ + P + L L + + F +L+ R +
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKP--YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 218 VQFLGAVTERKPLMLITEYLRGG---D-----LHKYLKEKGALSPSTAVN---FALD-IA 265
FL A T + ++ D L KYL + P + L IA
Sbjct: 278 TDFLSAATTTHISL---DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 266 RGMAYLHNEPN------------------------------------VIIHRDLK-PRNV 288
+ + + P +
Sbjct: 335 ---ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 289 LLV-----NSSADHLKVGDFGLSKLIKVQNS------HDVY-----KMTGETGSYRYMAP 332
L + S + V L++ Q +Y K+ E +R +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 333 EVFKHRKYDK------KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386
+ +D +D + ++ I + + E + E + V R F K
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE----HPERMTLFRMVFLDFR-FLEQK 506
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 429
+R + N S L+ L++L+ K + D+
Sbjct: 507 -----IRHDSTAW-----NASGSILNTLQQLKFYKPYI-CDND 538
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 43/176 (24%), Positives = 65/176 (36%), Gaps = 18/176 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG+GSFG I + VAIK R R E L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
E +L+ + L G L L G S T A + + +H +++
Sbjct: 73 YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVY 129
Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ + +A+ + V DFG+ K + + +G+ RYM
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 3/67 (4%)
Query: 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + LL D +V +N +A+ +G + V L E
Sbjct: 102 TGCSSALDTLCLLLTSD-EIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQ 160
Query: 101 KN--TPL 105
Sbjct: 161 AENYHAF 167
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 13/114 (11%), Positives = 27/114 (23%), Gaps = 7/114 (6%)
Query: 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL----VHARDYDNRT 70
G K + ++ + +R LL D
Sbjct: 262 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 321
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L +A G L+ + + N + + G ++ + H
Sbjct: 322 LLRLALRLGNQGACALLLSIPSVLALTKA-NNYYINETGGR--LDLRAVALEHH 372
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 9/59 (15%), Positives = 18/59 (30%), Gaps = 3/59 (5%)
Query: 50 VRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD--RWKNTPL 105
+ +L E + + A +N +A+ +G + V L E
Sbjct: 144 LNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAF 202
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 26/127 (20%)
Query: 24 DKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLE------EDQSLVHA----RDYDNRTP 71
D++ + +T L + + LL+ + +++ Y +T
Sbjct: 37 DEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTA 96
Query: 72 LHVASLHGWIDVAKCLIEYGADVNAQDR--------------WKNTPLADAEGAKKFNMM 117
LH+A + L+E GADV+AQ R + PL+ A + +++
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 118 ELLNAHG 124
L +G
Sbjct: 157 HYLTENG 163
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 19/93 (20%), Positives = 25/93 (26%), Gaps = 10/93 (10%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL--ADAEGAKKFNM 116
Y PL +A+ + L E G AD+ QD NT L A
Sbjct: 134 GGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTREN 193
Query: 117 MELLNAHGG--LSYGQNGSHFEPKPVPPPLPNK 147
+ + L P L N
Sbjct: 194 TKFVTKMYDLLLIKCAKL---FPDTNLEALLNN 223
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 11/45 (24%), Positives = 19/45 (42%)
Query: 54 LEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L D +L + D +PL +A+ G I + + +I A
Sbjct: 211 LFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAH 255
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 1/119 (0%)
Query: 3 SGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILW-HAHQNDAAAVRKLLEEDQSLV 61
G G + T+L L + + + L ++ +
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ T LH L + K L+ A + + TPL A+ K + ELL
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELL 257
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 10/61 (16%), Positives = 22/61 (36%), Gaps = 3/61 (4%)
Query: 67 DNRTPLHVASLHG---WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ T LH+A + + L++ +++ Q +T L ++LL
Sbjct: 168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRG 227
Query: 124 G 124
Sbjct: 228 K 228
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A+ D T LH A+L+ D K L++ A V + T L A ELL
Sbjct: 219 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 278
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 14/74 (18%), Positives = 27/74 (36%), Gaps = 3/74 (4%)
Query: 67 DNRTPLHVASLHGW---IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
LH+A + + +I+ G ++A+ NT L A + + ++LL
Sbjct: 189 PEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKG 248
Query: 124 GGLSYGQNGSHFEP 137
L N +
Sbjct: 249 RALVGTVNEAGETA 262
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 3e-05
Identities = 33/155 (21%), Positives = 54/155 (34%), Gaps = 14/155 (9%)
Query: 6 SSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD 65
P T A + + + T LI N A L ++ + V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLI-QATAANSLLACE-FLLQNGANVNQAD 265
Query: 66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
R PLH A++ G +A ++ GAD+ A+D PL A +++ LL
Sbjct: 266 SAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR---- 321
Query: 126 LSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS 160
L+ + + + D DFS
Sbjct: 322 LAKMREAEAAQGQAG--------DETYLDIFRDFS 348
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 39 LWHA-HQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLH---GWIDVAKCLIE 89
LW A D +V + Q LH+A + + +I+
Sbjct: 136 LWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQ 195
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
G ++A+ NT L A + + ++LL L N +
Sbjct: 196 NGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A+ D T LH A+L+ D K L++ A V + T L A ELL
Sbjct: 200 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 259
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 22/165 (13%)
Query: 150 WEIDPSELDFSS-SAIIGKGSFGEILKAYWRGTPVAIKRIL------PSLSDDRLVIQDF 202
W + +IGKG+ +I + + V IK + L D+ +
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL-DENIRKSRT 386
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
E L ++ I + ++ Y+ G +++ ++ A
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDN--------LDIAY 438
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I + LH N +IH DL N + L + DFGL K
Sbjct: 439 KIGEIVGKLHK--NDVIHNDLTTSNFIF----DKDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.88 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.87 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.83 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.82 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.81 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.81 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.81 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.81 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.8 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.8 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.8 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.79 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.79 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.78 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.78 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.78 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.78 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.78 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.78 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.77 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.77 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.77 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.77 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.77 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.76 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.76 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.76 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.76 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.75 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.75 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.75 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.75 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.75 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.74 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.74 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.74 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.74 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.74 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.74 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.74 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.73 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.73 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.73 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.73 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.73 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.72 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.72 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.72 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.72 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.72 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.72 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.72 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.72 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.71 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.71 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.71 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.71 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.71 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.71 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.7 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.7 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.7 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.7 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.7 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.7 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.7 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.7 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.7 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.7 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.7 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.7 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.7 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.7 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.7 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.7 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.7 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.69 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.69 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.69 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.69 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.69 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.68 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.68 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.68 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.68 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.68 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.67 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.67 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.67 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.67 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.67 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.67 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.66 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.66 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.66 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.66 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.66 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.65 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.64 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.64 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.63 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.6 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.6 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.6 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.58 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.58 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.57 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.52 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.47 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.44 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.41 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.04 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.27 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.14 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-61 Score=449.43 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=223.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|+++ ++.||||++.+....+....+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6999999999999999999986 77899999865432222334778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||+||+|.+++++.+.+++.++..++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||+|+.+......
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl--~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECCTTTTC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEE--cCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999899999999999999999999999988 9999999999999 88899999999999877543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+..+...+ +..+++++++|
T Consensus 189 --~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~dl 264 (311)
T 4aw0_A 189 --ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--PEKFFPKARDL 264 (311)
T ss_dssp --CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTCCHHHHHH
T ss_pred --ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CcccCHHHHHH
Confidence 13456789999999999999999999999999999999999999999999888888888765433 45799999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
|.+||++||++|||+.|++.+
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHccCCHhHCcChHHHcCC
Confidence 999999999999999997544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=441.64 Aligned_cols=269 Identities=33% Similarity=0.549 Sum_probs=221.5
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
...|+|+.+ ++.+.+.||+|+||+||+|.+++ .||||+++... ......+.|.+|+.+|++++|||||++++++.+
T Consensus 28 ~~~Wei~~~--~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 28 SYYWEIEAS--EVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp -CCCBCCTT--SCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CcCcEEcHH--HeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 456888765 56778899999999999999876 49999886443 334556889999999999999999999998765
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
+.++||||||+||+|.+++... +.+++.++..++.||+.||.|||+++ ||||||||+|||+ +.++++||+|||+
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl--~~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFL--HEGLTVKIGDFGL 178 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEE--ETTEEEEECCCSS
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEE--CCCCcEEEeeccC
Confidence 5689999999999999999764 57999999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRP 381 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~ 381 (435)
|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..... ..+..+..+
T Consensus 179 a~~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 179 ATVKSRWSG--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp CBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred ceecccCCc--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 987653321 112345689999999999864 46899999999999999999999999987655443 444454433
Q ss_pred C---CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 382 F---FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 382 ~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+ ..+..+|+++++||.+||+.||++|||+.+++++|+.++..+++
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 2 12357899999999999999999999999999999999988765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-60 Score=442.80 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=230.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.+.||+|+||+||+|.+. +..||||.+... .....++|.+|+++|++++|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 36788899999999999999874 567999998643 34455789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 230 LMLITEYLRGGDLHKYLKEK-------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
+|||||||++|+|.++++.. ..+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl--~~~~ 165 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GENL 165 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGG
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE--CCCC
Confidence 99999999999999999764 35899999999999999999999988 9999999999999 8889
Q ss_pred cEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 375 (435)
.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 166 ~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cEEECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987654322 112233468999999999999999999999999999999999 99999999999998889
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCc
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 429 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 429 (435)
..+.++.. +..+|+++.+|+.+||+.||++|||+.++.+.|+++.+..|...+
T Consensus 244 ~~~~~~~~-p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld 296 (299)
T 4asz_A 244 TQGRVLQR-PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD 296 (299)
T ss_dssp HHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred HcCCCCCC-CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence 88877654 457999999999999999999999999999999999988776544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-60 Score=447.70 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=225.9
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
...|+..++||+|+||+||+|+++ |+.||||++...... .+|+.+|++++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346788889999999999999986 789999998654322 4699999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~~~ 312 (435)
||||+||+|.+++++.+.+++.++..++.||+.||.|||+++ ||||||||+|||+ +.+| ++||+|||+|+.+...
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEE--CTTSCCEEECCCTTCEEC---
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--eCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999899999999999999999999999988 9999999999999 7776 6999999999877644
Q ss_pred Cccc-cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCCH
Q 013833 313 NSHD-VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKGFTP 390 (435)
Q Consensus 313 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 390 (435)
.... .......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+.....+. ..+..+|+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 3211 112334689999999999999999999999999999999999999999877766666666655432 23457999
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC-CCccc
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT-DHHWN 431 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~-~~~~~ 431 (435)
++++||.+||++||++|||+.|++++|....+.+.. .++|.
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 999999999999999999999999999998887765 67785
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-60 Score=450.34 Aligned_cols=250 Identities=25% Similarity=0.471 Sum_probs=217.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++++.||+|+||+||+|+++ |+.||||++.+.... ....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 37999999999999999999986 789999998765544 334578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+||+|.+++...+ .+++.+++.++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEE--CTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCCEEEcccccceeecCC
Confidence 9999999999997643 4799999999999999999999988 9999999999999 88899999999999876533
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..+..+.. +..+|+++
T Consensus 179 ~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-~~~~s~~~ 253 (350)
T 4b9d_A 179 VE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-SLHYSYDL 253 (350)
T ss_dssp HH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-CTTSCHHH
T ss_pred cc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-CccCCHHH
Confidence 21 22345799999999999999999999999999999999999999999999888888888776554 35689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||++||++|||+.|++++
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=433.76 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=207.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||||++.+....+....+++.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 7999999999999999999985 78999999976655544455789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+ +|+|.+++.+.+.+++.++..++.||+.||+|||++| |+||||||+|||+ +.++++||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLL--DEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEE--CCCCCEEEeecCCCeecCCCC--
Confidence 99 6799999999999999999999999999999999988 9999999999999 888999999999998665332
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..+..+.+..+..+. +..+|+++++
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 241 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--PKFLSPGAAG 241 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTSCHHHHH
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHH
Confidence 2345789999999999998886 579999999999999999999999988888888887765443 4568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
||.+||+.||++|||+.|++++
T Consensus 242 li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhHCcCHHHHHcC
Confidence 9999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-59 Score=441.55 Aligned_cols=260 Identities=32% Similarity=0.555 Sum_probs=221.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|.+.++||+|+||+||+|.++ ++.||||.+... .....++|.+|+++|++++|||||++++++.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35677889999999999999874 567999998643 34455789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 230 LMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+|||||||++|+|.++++.. +++++.+++.++.||+.||.|||+++ ||||||||+|||+ +.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl--~~ 193 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV--GQ 193 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ET
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE--CC
Confidence 99999999999999999753 35899999999999999999999988 9999999999999 88
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCcEEEcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 89999999999987654321 112334679999999999999999999999999999999999 999999999998888
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.+..+.++..+ ..+|+++.+|+.+||+.||++|||+.|++++|+.+.+.-+.
T Consensus 272 ~i~~g~~~~~p-~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 272 CITQGRELERP-RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp HHHHTCCCCCC-TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHcCCCCCCc-ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 88888776544 57999999999999999999999999999999999876443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=445.32 Aligned_cols=248 Identities=25% Similarity=0.458 Sum_probs=221.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|+..+.||+|+||+||+|.++ |+.||||++....... .+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35889999999999999999986 7899999986543332 256789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|||+||+|.+++.+ +.+++.++..++.||+.||.|||++| ||||||||+|||+ +.+|++||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--CCCCCEEEecCcCceecCCCCC
Confidence 99999999999975 56999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 393 (435)
.....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..+..+... ...+|++++
T Consensus 226 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 226 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 245678999999999999999999999999999999999999999999998888888776554433 246899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||+.|+++|
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=434.28 Aligned_cols=248 Identities=31% Similarity=0.520 Sum_probs=213.6
Q ss_pred CCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CCcEEE
Q 013833 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLML 232 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 232 (435)
|+..++||+|+||+||+|.++ +..||+|.+...... ....+++.+|+++|++++|||||++++++.+ +..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 456678999999999999986 678999988654433 3445789999999999999999999999865 356899
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~ 311 (435)
|||||+||+|.+++++.+.+++.++..++.||+.||.|||+++.+||||||||+|||+ +. +|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999889999999999999999999999987679999999999999 63 68999999999975432
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.. .......+..+..|...+..+++
T Consensus 185 ~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 185 S------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp T------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred C------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 2 2345689999999999864 69999999999999999999999998654 44556667777666555667899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++||.+||+.||++|||+.|+++|
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=437.99 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=222.2
Q ss_pred CCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+++..+.||+|+||+||+|.+. ++.||||.+...... ...++|.+|+.+|++++|||||++++++.+++.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 4556789999999999999873 467999998654322 2347899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC
Q 013833 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+||||||++|+|.+++... ..+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl--~~ 180 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV--YD 180 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE--CC
Confidence 9999999999999999642 35899999999999999999999988 9999999999999 88
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~ 373 (435)
++++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 89999999999987654321 112345679999999999999999999999999999999999 899999999999988
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.+..+.++.. +..+|+++.+|+.+||+.||++|||+.||+++|+.+
T Consensus 259 ~i~~~~~~~~-p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8888877654 457999999999999999999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=446.61 Aligned_cols=248 Identities=26% Similarity=0.468 Sum_probs=221.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|+..+.||+|+||.||+|.++ |+.||||++........ +.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 36999999999999999999986 78999999865543332 56789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|||+||+|.++++. +.+++.++..++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||+|+.+.....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEE--CTTCCEEECCCTTCEECCSSCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEecCccceECCCCCc
Confidence 99999999999965 56999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 393 (435)
.....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..+..+... ...++++++
T Consensus 303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 378 (423)
T ss_dssp ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHH
Confidence 345678999999999999999999999999999999999999999999998888888877554433 357899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||..||++|||+.|+++|
T Consensus 379 dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-59 Score=436.98 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=212.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.+.||+|+||+||+|++. ++.||||++.+....... ..++.+|+++|++++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 37999999999999999999872 567999998654322211 135778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||||+||+|.+++.+.+.+++.++..++.||+.||.|||++| ||||||||+|||+ +.+|++||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEE--cCCCCEEecccccceeccC
Confidence 99999999999999999999999999999999999999999988 9999999999999 8889999999999986543
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
... ...+.+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+..+....+.++..+. +..+|++
T Consensus 179 ~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--p~~~s~~ 252 (304)
T 3ubd_A 179 HEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--PQFLSPE 252 (304)
T ss_dssp --C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHH
T ss_pred CCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCcCCHH
Confidence 322 2445789999999999999999999999999999999999999999999988888888765443 4569999
Q ss_pred HHHHHHHHhhhcccCCCCH-----HHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~-----~~ll~~ 416 (435)
+++||.+||++||++|||+ +|+++|
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999999984 677764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=433.80 Aligned_cols=265 Identities=30% Similarity=0.543 Sum_probs=225.3
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-Ccceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~ 220 (435)
.|+|+. .+|++.+.||+|+||+||+|.+.+ +.||||.+.... .....+.+.+|+.+|++++| ||||++
T Consensus 58 ~wEi~~--~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCG--GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecH--HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 477764 378889999999999999999753 369999886543 23445789999999999976 899999
Q ss_pred eeeEEe-CCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCC
Q 013833 221 LGAVTE-RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (435)
Q Consensus 221 ~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dl 283 (435)
++++.+ +..++||||||++|+|.++++.. ..+++.+++.++.||+.||.|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 999865 46789999999999999999752 34899999999999999999999988 999999
Q ss_pred CCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCC
Q 013833 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 362 (435)
Q Consensus 284 kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p 362 (435)
||+|||+ +.++.+||+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||++|||+| |..|
T Consensus 212 K~~NILl--~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 212 AARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp SGGGEEE--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cccceee--CCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 9999999 8888999999999987654321 122345678999999999999999999999999999999998 9999
Q ss_pred CCCCCH-HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 363 LANYEP-YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 363 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
|.+... ......+..+.++..+ ..+++++.++|.+||+.||++|||+.+++++|+++.+.-
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~~p-~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 998764 4455667777766544 568999999999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=411.77 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=201.7
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC----cEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 233 (435)
+|.+.+.||+|+||+||+|.++|+.||||++... ......+..|+..+.+++||||+++++++.+++ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 5677889999999999999999999999988532 111123345666777899999999999987653 57999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC------CCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~------~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
||||++|+|.++++.. .++++++.+++.|++.||.|||++ .++||||||||+|||+ +.++++||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEEEeCCCCc
Confidence 9999999999999764 589999999999999999999986 1239999999999999 889999999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCC------CCCCcchHHHHHHHHHHHHcCCCCCCC----------CC----
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLAN----------YE---- 367 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~tg~~p~~~----------~~---- 367 (435)
................+||+.|||||++.+. .++.++|||||||++|||+||.+||.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7765433222233456799999999999754 367799999999999999999776532 11
Q ss_pred -HHHHHHHHH-cCCCCCCCCC----CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 368 -PYEAAKYVA-EGHRPFFRAK----GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 368 -~~~~~~~~~-~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.......+. .+.+|..+.. .+++.+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 122333333 3334443321 1235789999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=409.47 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=193.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 228 (435)
+|++++.||+|+||+||+|.++ ++.||||++.... .+...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 5788899999999999999986 7899999986443 3445578899999999999999999999986544
Q ss_pred -----cEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEE
Q 013833 229 -----PLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (435)
Q Consensus 229 -----~~~lv~e~~~g~sL~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl 300 (435)
.+|||||||+||+|.+++...+. .++..++.++.||+.||.|||++| ||||||||+|||+ +.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl--~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEE--CCCCcEEE
Confidence 37999999999999999987654 345678899999999999999988 9999999999999 88899999
Q ss_pred eeccCcccccccCcccc--------ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHH
Q 013833 301 GDFGLSKLIKVQNSHDV--------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEA 371 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~ 371 (435)
+|||+|+.......... ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||.... ....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999987764432111 12344679999999999999999999999999999999996 776432 2233
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+.....|... ...++.+.+||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 237 LTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3344444333221 2346778899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=419.95 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=212.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe------CCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 229 (435)
+|++++.||+|+||+||+|.++ |+.||||++.+.... ....+.+.+|+.+|++++|||||++++++.. ...
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6999999999999999999986 789999998655433 3445778899999999999999999998753 367
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+|||||||+ |+|.+++.+.+.+++.++..++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~--~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLV--NENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCcccccc--CCCCCEEEeecceeeec
Confidence 899999995 689999998889999999999999999999999988 9999999999999 88899999999999877
Q ss_pred cccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF------ 382 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------ 382 (435)
..............+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.+..+....+......+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 54433223345567899999999998775 56899999999999999999999999988877666554321110
Q ss_pred ----------------CC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 ----------------FR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ----------------~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ...+++++.+||.+||..||++|||+.|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 12468999999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=420.85 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=211.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCC---CCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|+++++||+|+||.||+|+++ |+.||||++.+.. ..........+.++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 348999999999999999999986 7899999986432 12222233445567788888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|||||||+||+|.+++.+.+.+++..+..++.||+.||+|||++| ||||||||+|||+ +.+|++||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILl--d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEE--eCCCCEEecccceeeecC
Confidence 999999999999999999999999999999999999999999988 9999999999999 899999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~ 386 (435)
.. ...+.+||+.|||||++.. ..|+.++|||||||++|||++|.+||.+. +..+....+...... .+.
T Consensus 344 ~~------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~--~p~ 415 (689)
T 3v5w_A 344 KK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPD 415 (689)
T ss_dssp SC------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--CCT
T ss_pred CC------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--CCc
Confidence 33 2345789999999999964 57999999999999999999999999753 334445555554332 245
Q ss_pred CCCHHHHHHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
.+|+++++||.+||+.||++|++ +.|+++|
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 79999999999999999999998 7888865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=424.63 Aligned_cols=249 Identities=24% Similarity=0.442 Sum_probs=220.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ |+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+...+|||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 7899999999999999999986 7899999886543 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||+..+..+.+||+|||+|+.+....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999964 467999999999999999999999988 999999999999955556899999999999875432
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 392 (435)
.....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+..+...+. ....+|+++
T Consensus 312 ----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 312 ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp ----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred ----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 23346899999999999999999999999999999999999999999999888888877654322 235789999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|+++|
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=395.71 Aligned_cols=247 Identities=20% Similarity=0.310 Sum_probs=197.4
Q ss_pred CCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 231 (435)
+|++.+.||+|+||+||+|.++ ++.||+|.+.+... ..++.+|+++|+.+ +||||+++++++.+.+.+|
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 6999999999999999999863 45799998865321 24677899999998 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC-CcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~ 310 (435)
+||||++||+|.++++ .+++.++..++.||+.||+|||++| ||||||||+|||+ +.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl--~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEE--eCCCCeEEECcCCCCcccC
Confidence 9999999999999984 5999999999999999999999988 9999999999999 544 799999999998654
Q ss_pred ccCccc------------------------cccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCC
Q 013833 311 VQNSHD------------------------VYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN 365 (435)
Q Consensus 311 ~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~ 365 (435)
...... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 322100 0112345799999999999765 589999999999999999999999954
Q ss_pred CC-HHHHHHHHHc-------------------------------------C---CCC------------CCCCCCCCHHH
Q 013833 366 YE-PYEAAKYVAE-------------------------------------G---HRP------------FFRAKGFTPEL 392 (435)
Q Consensus 366 ~~-~~~~~~~~~~-------------------------------------~---~~~------------~~~~~~~~~~l 392 (435)
.. ..+....+.. . ..| ......+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 33 3222221110 0 000 00113578999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||++|+++|
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=380.54 Aligned_cols=265 Identities=34% Similarity=0.594 Sum_probs=220.3
Q ss_pred CCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
..+|++.+.||+|+||+||+|.++++.||+|++..... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 44789999999999999999999999999998865443 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|+++++|.+++...+. +++..++.++.||+.||.|||++|++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC--------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCCcccccc
Confidence 9999999999986543 999999999999999999999976669999999999999 88899999999999755432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.........+..+++++
T Consensus 193 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 193 FL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred cc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 21 23346789999999999999999999999999999999999999999988877766654444444456799999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
.+||.+||+.||++|||+.++++.|+.+.+...++
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999998765543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=377.46 Aligned_cols=247 Identities=31% Similarity=0.508 Sum_probs=221.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.+. |+.||||++..... .....+++.+|+++++.++||||+++++++...+.+|+|||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 7999999999999999999984 78999999865443 34455788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL--DADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTCCGGGSSSC--
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEE--cCCCCEEEeeccCceecCCCC--
Confidence 9999999999998889999999999999999999999988 9999999999999 888999999999998665432
Q ss_pred ccccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..+.... +..+++++.+
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 243 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--PFYMSTDCEN 243 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHHH
Confidence 23456899999999999888775 78999999999999999999999999888888777765433 3468999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
|+.+||+.||.+|||+.|++++
T Consensus 244 li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=368.59 Aligned_cols=264 Identities=27% Similarity=0.435 Sum_probs=225.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.+. +..||+|.+...........+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 7999999999999999999975 77899999877666667777889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++.+++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 166 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSL- 166 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCSSSTTC------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEEeCCCccccccccc-
Confidence 9999999999998889999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCCHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF---RAKGFTPEL 392 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 392 (435)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+...............+.. ....+|+.+
T Consensus 167 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 167 --TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred --cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 123345689999999999999999999999999999999999999999887766555555444332 235689999
Q ss_pred HHHHHHHhhhcccCCC-CHHHHHHHHHHHHhhCCCCC
Q 013833 393 RELTEKCWAADMNQRP-SFLDILKRLEKIKETLPTDH 428 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~~~~~~ 428 (435)
.++|.+||+.||++|| +++++.+.|..+.......+
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 9999999999999998 89999999988776554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=376.11 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=218.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.++ ++.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 37899999999999999999986 7889999986432111122467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.+|.+||+|||++........
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEE--CCCCCEEEeeccchhhcccCCC
Confidence 99999999999998888999999999999999999999988 9999999999999 8889999999999975432221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....... +..+++++++
T Consensus 161 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 234 (337)
T 1o6l_A 161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKS 234 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred ----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHH
Confidence 2345689999999999999999999999999999999999999999888877777776654332 3568999999
Q ss_pred HHHHHhhhcccCCC-----CHHHHHHH
Q 013833 395 LTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
||.+||+.||++|| ++.+++++
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999 89999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=371.53 Aligned_cols=265 Identities=32% Similarity=0.537 Sum_probs=226.5
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
...+|++.+.||+|+||.||+|.+. +..||||.+.... .....+.+.+|+.++++++||||+++++++.++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3457899999999999999999984 3359999986433 34445789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++||||+++++|.++++.. +.+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV--DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEE
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--CCCCCEEECCCCcccc
Confidence 99999999999999999764 57999999999999999999999988 9999999999999 8889999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+..+.. +..
T Consensus 201 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 278 (325)
T 3kul_A 201 LEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-PMG 278 (325)
T ss_dssp CC----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-CTT
T ss_pred cccCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-CCC
Confidence 6543321 112334456889999999998899999999999999999999 9999999998888888887765543 357
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
+++++.+||.+||..||++|||+.++++.|+.+.+....-
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 8999999999999999999999999999999998876553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=367.34 Aligned_cols=248 Identities=28% Similarity=0.514 Sum_probs=216.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||+||+|.+. ++.||+|.+........ +.+.+|+.++++++||||+++++++..++.+++||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 47999999999999999999874 78899998865443332 56789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++|++|.+++... .+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--CCCCCEEEeeCCCceecCCccc
Confidence 999999999999765 5899999999999999999999988 9999999999999 8888999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 393 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....+ ...+..+++.++
T Consensus 172 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp ----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred ----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 234567999999999999999999999999999999999999999988877666555443332 333456899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||+.+++++
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=376.44 Aligned_cols=261 Identities=31% Similarity=0.539 Sum_probs=225.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 226 (435)
.+|++.+.||+|+||.||+|.+. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 47899999999999999999863 2359999886542 344567899999999999 89999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
.+.+|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||++| |+||||||+|||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll 236 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV 236 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEE
Confidence 999999999999999999998643 4789999999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~ 369 (435)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred --CCCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 8889999999999986654321 112234567889999999999999999999999999999999 99999998887
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+....+..+.++.. +..+++++.++|.+||+.||++|||+.++++.|+++......
T Consensus 313 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 313 ELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp GHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 77777777765543 356899999999999999999999999999999998875443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=359.06 Aligned_cols=260 Identities=32% Similarity=0.651 Sum_probs=226.4
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
|.++. .+|++.+.||+|+||.||++.+. +..||+|.+....... +++.+|+.++++++||||+++++++.++.
T Consensus 5 ~~i~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 5 WVIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EEeCh--hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 44443 47899999999999999999985 6789999987544332 56889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||+++++|.+++... +.+++.+++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTR 154 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CGGGCEEECCTTGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEE--cCCCCEEeccccccc
Confidence 999999999999999999764 45899999999999999999999988 9999999999999 788899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..+.. +.
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 230 (269)
T 4hcu_A 155 FVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PR 230 (269)
T ss_dssp GBCCHHH---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CT
T ss_pred ccccccc---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-CC
Confidence 6543321 12334567889999999998999999999999999999999 9999999998888888877755543 45
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+++++.+++.+||+.||++|||+.+++++|+++.++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 6899999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=379.16 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=215.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||+|.++ ++.||||++.+.........+.+.+|.++++.+ +||||+++++++.+.+.+|+||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 7999999999999999999986 778999998653222223346678999999988 6999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++++||+|||++........
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl--~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCC---
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEE--CCCCCEEEccccceeecccCCc
Confidence 99999999999998889999999999999999999999988 9999999999999 8889999999999975432221
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.... +..+++++++
T Consensus 180 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~ 253 (353)
T 3txo_A 180 ----TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTWLHEDATG 253 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred ----cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHH
Confidence 2345689999999999998899999999999999999999999999999888888887765443 3468999999
Q ss_pred HHHHHhhhcccCCCCH------HHHHHH
Q 013833 395 LTEKCWAADMNQRPSF------LDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~------~~ll~~ 416 (435)
||.+||+.||++||++ .++++|
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999999999999998 777764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=374.82 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=219.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
..|++.+.||+|+||.||+|.++ |..||+|.+.+...... ...+.+.+|+.++++++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 36899999999999999999986 78899999876543211 12367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC----cEEEeeccCcc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 307 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~----~vkl~Dfg~a~ 307 (435)
+||||++|++|.+++...+.+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++ .+||+|||++.
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCSSCE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--eCCCCCccCEEEEecCCce
Confidence 99999999999999988888999999999999999999999988 9999999999999 5554 79999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--C
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--A 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 385 (435)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+...+.. .
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred EcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 765432 234567999999999999999999999999999999999999999999888888777766543321 1
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+++++++||.+||..||++|||+.+++++
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4689999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=382.73 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=220.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6889999999999999999985 778999988665433 3344678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.||+|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+..+ .++.+||+|||++........
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999889999999999999999999999988 9999999999999432 567899999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..+......+ ..+++++
T Consensus 169 ----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 169 ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp ----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2345679999999999999999999999999999999999999999998888888887765443322 4689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|++++
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=360.31 Aligned_cols=264 Identities=29% Similarity=0.572 Sum_probs=226.3
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
...|.+. ..+|++.+.||+|+||.||++.+++ ..||+|.+....... +.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 3456654 4489999999999999999999874 479999986543332 56889999999999999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
+....++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg 165 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFG 165 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTSCEEECSTT
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEE--cCCCCEEEcccc
Confidence 99999999999999999999986 557999999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+.....
T Consensus 166 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3gen_A 166 LSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242 (283)
T ss_dssp GGGGBCCHHH---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred cccccccccc---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence 9986643321 12334557889999999998899999999999999999998 9999999998888888877765443
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+..+++.+.+++.+||+.||++|||+.+++++|.++.++-
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 3568999999999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=373.78 Aligned_cols=262 Identities=31% Similarity=0.556 Sum_probs=213.9
Q ss_pred CCCCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
....+|++.+.||+|+||.||+|.++ +..||||.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 34558999999999999999999864 5679999986543 3445578999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||+++++|.+++...+ .+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILI--NSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--cCCCCEEECcCcccc
Confidence 9999999999999999998754 6999999999999999999999988 9999999999999 888999999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
........ ........+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+..+.++.. +.
T Consensus 196 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-~~ 273 (373)
T 2qol_A 196 VLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PM 273 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-CT
T ss_pred ccccCCcc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 76543221 112223346788999999998999999999999999999998 9999999988888877777654433 34
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.++.++.+++.+||+.||++||++.++++.|+++.+.
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 6899999999999999999999999999999998763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=371.47 Aligned_cols=269 Identities=33% Similarity=0.562 Sum_probs=231.7
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECC---------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcc
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNI 217 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 217 (435)
..|++. ..+|.+.+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+++++++ +||||
T Consensus 62 ~~~~i~--~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 62 PRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp TTTBCC--GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccc--hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchh
Confidence 345544 3488999999999999999999642 469999886542 344557889999999999 89999
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeC
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~ 281 (435)
+++++++.+++..++||||+++++|.+++.... .+++.+++.++.||+.||.|||+++ |+||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 215 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHR 215 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence 999999999999999999999999999998753 4899999999999999999999988 9999
Q ss_pred CCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CC
Q 013833 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GE 360 (435)
Q Consensus 282 Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~ 360 (435)
||||+|||+ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 216 Dlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 216 DLAARNVLV--TEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp CCCGGGEEE--CTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCcceEEE--cCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999999 8888999999999986654321 112334567899999999999999999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 361 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
.||.+....+....+..+..+.. +..+++++.+||.+||+.||++|||+.+++++|+++....+..
T Consensus 292 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 292 SPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 99999998888888877766554 3568999999999999999999999999999999999866553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=376.59 Aligned_cols=265 Identities=31% Similarity=0.555 Sum_probs=227.3
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
..|.+.. .+|.+.+.||+|+||.||+|.++ ++.||||.+.... .....+.+.+|+++|++++||||+++++++.
T Consensus 107 ~~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 107 DKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3566553 47888999999999999999986 7889999886432 3344467889999999999999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
+.+..++||||+++++|.++++..+ .+++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~--~~~~~~kl~DfG 258 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV--TEKNVLKISDFG 258 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEE--cCCCcEEECcCC
Confidence 9999999999999999999998754 5999999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++....... ........+++.|+|||++....++.++|||||||++|||++ |..||.+....+....+..+.++..
T Consensus 259 ~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 259 MSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp GCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9976432210 001112235778999999998889999999999999999998 9999999998888777877766554
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+|+++.++|.+||+.||++|||+.++++.|+.++++
T Consensus 337 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 -PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 356899999999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=357.27 Aligned_cols=256 Identities=30% Similarity=0.605 Sum_probs=223.6
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..+|++.+.||+|+||.||++.+++ ..||+|.+....... +.+.+|+.++++++||||+++++++.++...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4578999999999999999999874 479999986544332 56889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV--DRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEE--CTTCCEEECCTTCEEECCTTC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEE--CCCCCEEEccCccceecchhh
Confidence 9999999999998754 5999999999999999999999988 9999999999999 888999999999998665432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..+.. +..+++++
T Consensus 159 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 234 (268)
T 3sxs_A 159 Y---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTI 234 (268)
T ss_dssp E---EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-CTTSCHHH
T ss_pred h---hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-CCcChHHH
Confidence 1 12334557888999999998889999999999999999999 9999999888887777777665443 45689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+++.+||+.||++|||+.+++++|+.++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999988765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=380.76 Aligned_cols=257 Identities=33% Similarity=0.636 Sum_probs=223.6
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
..|++.. .+|++.+.||+|+||.||+|.++++.||||.+.... ..+.+.+|+++|++++||||+++++++.+.
T Consensus 186 ~~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNM--KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCG--GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccCh--HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 3455553 478889999999999999999999999999986543 236789999999999999999999998766
Q ss_pred C-cEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 228 K-PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 228 ~-~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
. .+++||||+++|+|.+++...+. +++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG 334 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFG 334 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTSCEEECCCT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--CCCCCEEEeeCC
Confidence 5 79999999999999999987654 799999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++..... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+..+.++..
T Consensus 335 ~a~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 407 (450)
T 1k9a_A 335 LTKEASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 407 (450)
T ss_dssp TCEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred Cccccccc-------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99854322 122357889999999999999999999999999999998 9999998887777778888776554
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+|+++.++|.+||+.||++|||+.++++.|+.+...
T Consensus 408 -p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 -PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 457999999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=367.50 Aligned_cols=246 Identities=28% Similarity=0.512 Sum_probs=217.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 7899999999999999999985 78999998864321111224667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.+|.+||+|||++......
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEE--cCCCCEEEeecCcceecCCc---
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999999865421
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... +..++++++++
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 233 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDL 233 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHHHH
Confidence 234679999999999999999999999999999999999999999988888777777654332 35689999999
Q ss_pred HHHHhhhcccCCC-----CHHHHHHH
Q 013833 396 TEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
|.+||+.||++|| ++++++++
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 9999999999999 89999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=372.31 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=219.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ +..||+|.+...... ....+.+.+|+.++++++||||+++++++.+....|+|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999986 779999998655433 3445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+..+ .++.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 9999999999988888999999999999999999999988 9999999999999432 23569999999998765332
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+......+ ..+++++
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 186 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp ----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred ----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2345679999999999999999999999999999999999999999988888877777665433222 3579999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.+++++
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.12 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=215.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||++.++ ++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+...+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 37899999999999999999986 678999999876666666677889999999988 899999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++|++|.+++.+.+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++++||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEEeccccccccCCC
Confidence 999999999999998888999999999999999999999988 9999999999999 888999999999997543222
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHcCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---------EPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~ 384 (435)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+...... .
T Consensus 165 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~ 238 (345)
T 3a8x_A 165 D----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I 238 (345)
T ss_dssp C----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--C
T ss_pred C----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--C
Confidence 1 234568999999999999999999999999999999999999999752 223334445444332 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCH------HHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSF------LDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 416 (435)
+..+++++++||.+||+.||++||++ .++++|
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 35689999999999999999999995 677765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.93 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=220.5
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--CcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 37899999999999999999999999999998765433 34457899999999999999999999999876 7889999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+++++|.+++...+ .+++.+++.++.||+.||.|||+++..|+||||||+||++ +.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccceeeec--
Confidence 9999999999998755 4899999999999999999999976669999999999999 888899999998876432
Q ss_pred CccccccccCCCcCccccCccccCCCCCCC---cchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDK---KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.....||+.|+|||++.+..++. ++||||||+++|+|++|..||.+....+....+.........+..++
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence 23356899999999998765554 79999999999999999999999888777666554444444456799
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+++.+++.+||+.||++|||+.++++.|+++.+
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=374.18 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=217.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
..+|.+.+.||+|+||.||+|.++ ++.||+|.+.+.........+.+..|..++..+ +||||+++++++.+...+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 348999999999999999999986 678999988653211111235677899999877 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||++||+|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||+++.....
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEE--CCCCCEEEeEChhhhhcccC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88899999999999754322
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.... +..+++++
T Consensus 172 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 245 (345)
T 1xjd_A 172 DA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEA 245 (345)
T ss_dssp TC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHH
T ss_pred CC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC--CcccCHHH
Confidence 21 2345689999999999999999999999999999999999999999998888877777654332 35689999
Q ss_pred HHHHHHHhhhcccCCCCHH-HHHHH
Q 013833 393 RELTEKCWAADMNQRPSFL-DILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~-~ll~~ 416 (435)
++||.+||..||++||++. +++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcC
Confidence 9999999999999999997 66643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=375.51 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=211.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.++||+|+||.||++.++ ++.||+|++.+.........+.+.+|..++.++ +||||+++++++.+...+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 37999999999999999999986 668999998766555444556788999999887 899999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++||+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||+++......
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTT
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--CCCCCEEEeecceeeecccCC
Confidence 999999999999998889999999999999999999999988 9999999999999 889999999999997533222
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHcCCCCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------PYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~ 384 (435)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+...... .
T Consensus 208 ~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~ 281 (396)
T 4dc2_A 208 D----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I 281 (396)
T ss_dssp C----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--C
T ss_pred C----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--C
Confidence 1 2445789999999999999999999999999999999999999996432 22233444444322 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCH------HHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSF------LDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 416 (435)
+..+++++++||.+||+.||++||++ .+++++
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 35689999999999999999999985 677655
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=356.69 Aligned_cols=257 Identities=37% Similarity=0.663 Sum_probs=209.9
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCc-HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||.||++.+.++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 478999999999999999999999999999886543322 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCc-eEeCCCCCCcEEEecC------CCCcEEEeeccCccc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKL 308 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-ivH~Dlkp~NIll~~~------~~~~vkl~Dfg~a~~ 308 (435)
|+++++|.+++. .+.+++.+++.++.|++.||.|||+++.. |+||||||+|||+..+ .++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 999999999985 45799999999999999999999997622 8899999999999321 267899999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+.........+..+
T Consensus 166 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 166 WHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 55332 224568999999999998899999999999999999999999999988877776666665555556778
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
++++.+++.+||+.||++|||+.+++++|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=371.89 Aligned_cols=246 Identities=27% Similarity=0.469 Sum_probs=218.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.++ ++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 7899999999999999999985 78999998854322111224678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++.+.+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.+|.+||+|||++......
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC---
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEE--CCCCCEEEcccccceeccCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999999866432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.... +..++++++++
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~l 268 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDL 268 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTCCHHHHHH
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHH
Confidence 234679999999999999999999999999999999999999999998888888887765433 35689999999
Q ss_pred HHHHhhhcccCCCC-----HHHHHHH
Q 013833 396 TEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
|.+||+.||++||+ +.+++++
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99999999999998 8888865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=363.63 Aligned_cols=263 Identities=33% Similarity=0.578 Sum_probs=219.2
Q ss_pred CCCCCCCCceeecCCceeEEEEEECC------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
...+|++.+.||+|+||.||+|.++. ..||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 34578889999999999999998752 259999886443 3344567899999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||+++++|.+++... +.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC--
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEE--CCCCcEEECCCCcch
Confidence 999999999999999999864 57999999999999999999999988 9999999999999 888899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+.++.. +.
T Consensus 196 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 273 (333)
T 1mqb_A 196 VLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CT
T ss_pred hhcccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-cc
Confidence 76543221 112233456889999999998999999999999999999999 9999999888888887877755443 35
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
.+++++.+++.+||+.||++||++.++++.|+++.+...
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 689999999999999999999999999999999886543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.21 Aligned_cols=246 Identities=30% Similarity=0.453 Sum_probs=207.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHH-HHhCCCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
..+|++.+.||+|+||.||++.++ +..||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 447999999999999999999986 66899999876554444444566777776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEeeCccccccccC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88899999999999864332
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....... +..+++++
T Consensus 193 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~ 266 (373)
T 2r5t_A 193 NS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--KPNITNSA 266 (373)
T ss_dssp CC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC--CSSSCHHH
T ss_pred CC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC--CCCCCHHH
Confidence 21 2345689999999999999999999999999999999999999999988888887777654332 35689999
Q ss_pred HHHHHHHhhhcccCCCCHH
Q 013833 393 RELTEKCWAADMNQRPSFL 411 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~ 411 (435)
++||.+||+.||++||++.
T Consensus 267 ~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHcccCHHhCCCCC
Confidence 9999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=368.79 Aligned_cols=252 Identities=31% Similarity=0.423 Sum_probs=203.8
Q ss_pred CCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
....+|++.+.||+|+||+||++.++ ++.||+|++....... +.+.+|+.+++.++||||+++++++.+...++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 33458999999999999999999985 7789999986544333 56789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
+||||++|++|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+..+..+.+||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999999988888999999999999999999999988 9999999999999444444599999999974432
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCc-chHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK-VDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 386 (435)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+... ......+...........
T Consensus 171 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 171 HS-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred cC-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 21 2234579999999999988887765 8999999999999999999986543 334444444443333344
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++++++||.+||+.||++|||+.+++++
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 689999999999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=364.00 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=216.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
.|.+.+.||+|+||.||+|.++ +..||+|.+....... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 6889999999999999999986 7889999886543321 1123678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC----cEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~----~vkl~Dfg~a~~ 308 (435)
||||+++++|.+++...+.+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++ .+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll--~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEE--ecCCCCCCCEEEEECCCCeE
Confidence 9999999999999988888999999999999999999999988 9999999999999 5555 799999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AK 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 386 (435)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+......... ..
T Consensus 168 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 168 IDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp CCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 65332 123457999999999999999999999999999999999999999988887777666654433221 14
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++.+++||.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 688999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=371.34 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=217.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||+|.++ ++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 37899999999999999999987 568999988653221112236678899999988 799999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++||+|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||++.......
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--cCCCcEEEEeCCcccccccCC
Confidence 999999999999998888999999999999999999999988 9999999999999 888999999999998543222
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....... +..++++++
T Consensus 176 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 249 (353)
T 2i0e_A 176 V----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKSMSKEAV 249 (353)
T ss_dssp C----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred c----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHH
Confidence 1 2345689999999999999999999999999999999999999999998888887777765433 356899999
Q ss_pred HHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 394 ELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
+||.+||..||++||+ +.+++++
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999995 5788765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=366.13 Aligned_cols=264 Identities=30% Similarity=0.499 Sum_probs=226.0
Q ss_pred CCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
....+|++.+.||+|+||.||+|.+.+ ..||+|.+.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 334589999999999999999999864 679999986543 34455789999999999999999999999999
Q ss_pred CCcEEEEEecCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~D 282 (435)
++..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++| |+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~D 199 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 199 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 99999999999999999999863 56899999999999999999999988 99999
Q ss_pred CCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 013833 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (435)
Q Consensus 283 lkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~ 361 (435)
|||+|||+ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 200 lkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLV--GENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEE--CGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEE--CCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999 8888999999999987643321 112234567899999999998899999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 362 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
||.+....+....+..+..+.. +..+++++.++|.+||+.||++|||+.++++.|+++.++...
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred cCCCCChHHHHHHHhCCCcCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 9999988888877777765543 357899999999999999999999999999999998876653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=378.67 Aligned_cols=264 Identities=29% Similarity=0.523 Sum_probs=226.9
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
...|++.. .+|++.+.||+|+||.||+|.++ +..||||.+...... .+.+.+|+.+|++++||||+++++++.
T Consensus 180 ~~~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 180 KDAWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp TTCSBCCG--GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccceeech--HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 34566653 47888999999999999999986 678999998654322 367899999999999999999999886
Q ss_pred eCCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
.+..++||||+++|+|.++++.. ..++..+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DF 328 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADF 328 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTCCEEECST
T ss_pred -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE--CCCCcEEEeeC
Confidence 56789999999999999999753 36899999999999999999999988 9999999999999 88899999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+++...... ........+|+.|+|||++....++.++|||||||++|||++ |..||.+....+....+..+.++.
T Consensus 329 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 405 (454)
T 1qcf_A 329 GLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405 (454)
T ss_dssp TGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred CCceEcCCCc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998764321 112234456889999999998899999999999999999999 999999999888888888876655
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
. +..+|+++.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 406 ~-~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 406 R-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred C-CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 4 45789999999999999999999999999999998876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=364.84 Aligned_cols=250 Identities=18% Similarity=0.323 Sum_probs=217.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ +..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37899999999999999999986 6789999885432 23366889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||++|++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+|||+..+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999997653 6999999999999999999999988 999999999999944347899999999998765432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPE 391 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 391 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..+...+.. ...++++
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 159 -----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 123356899999999999888999999999999999999999999998888877777766544322 1468999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
+.+||.+||..||++|||+.|++++-
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 99999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=371.30 Aligned_cols=248 Identities=26% Similarity=0.438 Sum_probs=210.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.++ ++.||+|.+.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 37999999999999999999986 6789999885432222223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+.||+|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.+|.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--CCCCCEEEeccceeeeccCCC-
Confidence 99999999999998888999999999999999999999988 9999999999999 889999999999998764332
Q ss_pred cccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|..||... ...+....+...... .+..+
T Consensus 170 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~p~~~ 243 (384)
T 4fr4_A 170 ----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--YPSAW 243 (384)
T ss_dssp ----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--CCTTS
T ss_pred ----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--CCCcC
Confidence 2345789999999999964 45889999999999999999999999743 333444444443332 23568
Q ss_pred CHHHHHHHHHHhhhcccCCCC-HHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPS-FLDILK 415 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps-~~~ll~ 415 (435)
++++.+||.+||+.||++||+ +.++++
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999999998 777765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=357.18 Aligned_cols=271 Identities=28% Similarity=0.530 Sum_probs=226.6
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 224 (435)
+.+.+...+|++.+.||+|+||.||+|.+.. ..+|+|.+... ......+.+.+|+.++++++||||+++++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 4455666789999999999999999998642 25889987542 3445567899999999999999999999985
Q ss_pred -EeCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 225 -TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 225 -~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
..+...++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~D 171 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML--DEKFTVKVAD 171 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECS
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--CCCCCEEECc
Confidence 455678999999999999999986 445899999999999999999999988 9999999999999 8889999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
||++..................+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+..+..+
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 99998765443222223445568899999999998999999999999999999999 77788877776666666666554
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
. .+..+++.+.+++.+||+.||++|||+.++++.|+++...+..+
T Consensus 252 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 252 L-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred C-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 4 34568999999999999999999999999999999999887765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=361.83 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=208.4
Q ss_pred CCCCCCceeecCCceeEEEEEE-----CCCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|++.+.||+|+||.||++.+ .++.||+|++.+.... .......+.+|+.++++++||||+++++++..++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3799999999999999999987 3778999998765322 222345678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|+||||++|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEE--CCCCcEEEEeCCcccccc
Confidence 999999999999999998888999999999999999999999988 9999999999999 888999999999997644
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+....... +..+++
T Consensus 173 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~ 246 (327)
T 3a62_A 173 HDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--PPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTSCH
T ss_pred cCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCH
Confidence 3221 2345679999999999999999999999999999999999999999988887777777654432 346899
Q ss_pred HHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
++++||.+||+.||++|| ++.+++++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 999999999999999999 78898875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=370.61 Aligned_cols=274 Identities=28% Similarity=0.535 Sum_probs=219.6
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC---C--CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
.+.+......|.+.+.||+|+||.||+|.+. + ..||+|.+.... .....+.+.+|+.++++++||||++++++
T Consensus 81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 158 (373)
T 3c1x_A 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158 (373)
T ss_dssp TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4456666677888999999999999999874 1 358999875432 33445789999999999999999999998
Q ss_pred EE-eCCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 224 VT-ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 224 ~~-~~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
+. .++..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL~ 234 (373)
T 3c1x_A 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVA 234 (373)
T ss_dssp ECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEEC
T ss_pred EEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEE--CCCCCEEEe
Confidence 65 456789999999999999999864 35899999999999999999999988 9999999999999 888899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++.................+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+.+
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~ 314 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence 999998765433222222334567889999999999999999999999999999999 7889988776666666766665
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCc
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 429 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 429 (435)
+. .+..+++.+.++|.+||+.||++|||+.++++.|+.+...+..+..
T Consensus 315 ~~-~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 315 LL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 44 3457899999999999999999999999999999999998887653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=362.28 Aligned_cols=265 Identities=26% Similarity=0.445 Sum_probs=214.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc----E
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----L 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~ 230 (435)
.+|++.+.||+|+||.||++.+. ++.||||++.............+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 37999999999999999999974 77899999987666666667889999999999999999999999876543 4
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|+||||++|++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--ETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEE--cCCCCEEEeeccCccccc
Confidence 999999999999999998888999999999999999999999988 9999999999999 778899999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGF 388 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 388 (435)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+............. ....+
T Consensus 168 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 43221 1123345689999999999999999999999999999999999999999887776555544432221 12468
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHH-HHHHHHHHHhhCCC
Q 013833 389 TPELRELTEKCWAADMNQRPSFLD-ILKRLEKIKETLPT 426 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~-ll~~L~~~~~~~~~ 426 (435)
++++.+||.+||+.||++||++.+ +.+.|.++....+.
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999996555 55667776654443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=350.35 Aligned_cols=260 Identities=33% Similarity=0.658 Sum_probs=225.7
Q ss_pred cccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
|.++. .+|++.+.||+|+||.||++.+. +..||+|.+....... +.+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~i~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 3 WVIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred eEEch--hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 44443 47899999999999999999985 6689999986544322 57889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||+++++|.+++... +.+++.+++.++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTR 152 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CGGGCEEECCTTGGG
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--CCCCCEEEccccccc
Confidence 999999999999999999875 46899999999999999999999988 9999999999999 888899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+..+.. +.
T Consensus 153 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~ 228 (267)
T 3t9t_A 153 FVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PR 228 (267)
T ss_dssp GBCCHH---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CT
T ss_pred cccccc---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC-Cc
Confidence 654321 112234567889999999998899999999999999999999 8999999888888877877755443 34
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+++.+.+++.+||+.||++|||+.+++++|+++.++
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 6899999999999999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=369.18 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=221.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||.||+|.+. +..||||.+.... .......+.+|+.++++++||||+++++++.+...
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 47889999999999999999954 4479999885432 23344678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEe
Q 013833 230 LMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVG 301 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~ 301 (435)
.++||||++||+|.+++.... .+++.+++.++.||+.||.|||++| |+||||||+|||+..+ .+..+||+
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999998643 4899999999999999999999988 9999999999999321 23359999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..
T Consensus 227 DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCHHHHHHHHHSSC--TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCcccccccccccc--ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999866433211 11233457899999999998999999999999999999998 9999999998888888887765
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+.. +..+++.+.+|+.+||+.||++|||+.+++++|+.+.+
T Consensus 305 ~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 305 MDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 543 45789999999999999999999999999999998876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=362.76 Aligned_cols=257 Identities=34% Similarity=0.602 Sum_probs=215.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|.+.+.||+|+||+||++.+. +..||+|.+... +....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 37888999999999999999986 778999987432 3455678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++.. .+.+++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--CTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEE--CCCCCEEEeecccceeccccc
Confidence 99999999999987 567999999999999999999999988 9999999999999 888999999999998765432
Q ss_pred cccc----------ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHc
Q 013833 314 SHDV----------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE------AAKYVAE 377 (435)
Q Consensus 314 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~ 377 (435)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 2110 01124579999999999999999999999999999999999999987543211 1111111
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
..+..+++++.+++.+||+.||++|||+.++++.|+.++..+.
T Consensus 243 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 -----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1134688999999999999999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=354.19 Aligned_cols=262 Identities=26% Similarity=0.500 Sum_probs=214.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.+. +..||+|.+.............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 37999999999999999999974 7899999987655555666688999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 235 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 235 e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~--~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEE--cCCCCEEEEeccceeeec
Confidence 99999999999874 456899999999999999999999988 9999999999999 888899999999998665
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+. ........+.....+......+
T Consensus 188 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 188 SKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred CCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 3321 123456899999999999999999999999999999999999999754 3445556666666555555678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+++++++|.+||+.||++|||+.++++.|++++.....
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 99999999999999999999999999999999875444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=357.25 Aligned_cols=261 Identities=30% Similarity=0.552 Sum_probs=211.5
Q ss_pred CCCCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--C
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--R 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 227 (435)
..+|++.+.||+|+||+||+|.+ .++.||+|++... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34889999999999999999985 3678999988643 34455789999999999999999999998854 3
Q ss_pred CcEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
..+++||||+++++|.+++...+ .+++.+++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGLT 161 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCSC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEE--cCCCeEEEccCccc
Confidence 56899999999999999998754 4999999999999999999999988 9999999999999 77789999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----------------H
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----------------E 370 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----------------~ 370 (435)
......... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 876543221 11223345788899999999999999999999999999999999998643211 2
Q ss_pred HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 371 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
....+..+.++. .+..+++++.++|.+||+.||++|||+.++++.|+++.++++
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 241 LIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHhccCcCC-CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 223333443333 345789999999999999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=353.01 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=210.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|++.+.||+|+||.||+|.+. +..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 458999999999999999999974 335999987543 23445578999999999999999999999885 4578
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEE--CCCCCEEECcccccccc
Confidence 99999999999999998654 6999999999999999999999988 9999999999999 77789999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+..+.. +..+
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 242 (281)
T 1mp8_A 167 EDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-CTTC
T ss_pred Ccccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC-CCCC
Confidence 54321 12233456889999999998899999999999999999997 9999998887777777776655443 3578
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
++++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.94 Aligned_cols=259 Identities=31% Similarity=0.554 Sum_probs=224.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
..+|.+.+.||+|+||.||++.+. +..||+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 458899999999999999999862 3679999886433 3455678999999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGA------------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~------------------------~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlk 284 (435)
..++||||+++++|.+++..... +++.+++.++.||+.||.|||++| |+|||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dik 177 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLA 177 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccc
Confidence 99999999999999999987543 899999999999999999999988 9999999
Q ss_pred CCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 013833 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363 (435)
Q Consensus 285 p~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~ 363 (435)
|+||++ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 178 p~NIli--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 178 ARNILV--AEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGGEEE--ETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hheEEE--cCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999 7788999999999986654322 112234567889999999998889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 364 ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+.........+..+..+.. +..+++++.++|.+||+.||++|||+.+++++|+++.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGGGHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHhhcCCcCCC-CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 98888777777776655443 357899999999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=358.44 Aligned_cols=269 Identities=32% Similarity=0.519 Sum_probs=224.7
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcce
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 218 (435)
...|++. ..+|++.+.||+|+||.||+|.+. +..||+|.+.... .....+.+.+|+.+++++ +||||+
T Consensus 15 ~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 90 (313)
T 1t46_A 15 DHKWEFP--RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIV 90 (313)
T ss_dssp CGGGBCC--GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccC--hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCee
Confidence 3345543 458999999999999999999862 4689999986543 233457889999999999 899999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH 280 (435)
++++++.+++..++||||+++++|.+++.... .+++.+++.++.||+.||.|||++| |+|
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H 168 (313)
T 1t46_A 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH 168 (313)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 99999999999999999999999999998654 3899999999999999999999988 999
Q ss_pred CCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 013833 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (435)
Q Consensus 281 ~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g 359 (435)
|||||+||++ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 169 ~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 169 RDLAARNILL--THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp SCCSGGGEEE--ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCccceEEE--cCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999 78889999999999876543321 12234457889999999988899999999999999999999 9
Q ss_pred CCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 360 EPPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 360 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
..||.+...... ...+..+..+ ..+..+++++.++|.+||+.||++|||+.+++++|+++.++...
T Consensus 245 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 245 SSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred CCCCCcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 999987664333 3334444333 33456899999999999999999999999999999999887553
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.78 Aligned_cols=264 Identities=31% Similarity=0.520 Sum_probs=221.9
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
..|++.. .+|++.+.||+|+||.||+|.+++ ..||||.+...... .+.+.+|+.+|++++||||+++++++.+
T Consensus 177 ~~~~i~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCh--hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4566653 478889999999999999999975 57999998654322 2578999999999999999999999876
Q ss_pred CCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 227 RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
+..++||||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEE--CCCCCEEECCCc
Confidence 678999999999999999974 346999999999999999999999988 9999999999999 788899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||.+....+....+..+.++..
T Consensus 326 ~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 326 LARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp TTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cceecCCCce---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9987653221 11233457889999999998899999999999999999999 9999999998888888888776554
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+ ..+|+.+.++|.+||+.||++|||+.++++.|+.+.....+
T Consensus 403 ~-~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 P-PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp C-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred C-CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 3 46899999999999999999999999999999988765544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=352.96 Aligned_cols=273 Identities=29% Similarity=0.529 Sum_probs=228.8
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC--CC---cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
++.++.....|...+.||+|+||+||+|.+. +. .+|+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGI 90 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3445555567788899999999999999863 22 6999988542 334456788999999999999999999999
Q ss_pred EEeCCcE-EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 224 VTERKPL-MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 224 ~~~~~~~-~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
+.+.+.. ++||||+.+++|.+++.. ...+++.+++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili--~~~~~~kl~ 166 (298)
T 3pls_A 91 MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML--DESFTVKVA 166 (298)
T ss_dssp ECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEEC
T ss_pred EecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCcEEeC
Confidence 9776655 999999999999999986 456899999999999999999999988 9999999999999 888899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||++..................+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+..
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 999998665433222223344568899999999999999999999999999999999 5666777777777777766654
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCC
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 428 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 428 (435)
+. .+..+++++.+++.+||+.||++|||+.++++.|+++.+++..+.
T Consensus 247 ~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 247 LP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CC-CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 44 345689999999999999999999999999999999999887654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.71 Aligned_cols=249 Identities=33% Similarity=0.474 Sum_probs=219.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|+..+.||+|+||.||+|.+. ++.||||.+...........+.+.+|+.++++++||||+++++++.++...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 35888899999999999999974 7789999987655555556678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+. |+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEeeccCceecCCC-
Confidence 9997 588888864 567999999999999999999999988 9999999999999 78889999999999765422
Q ss_pred ccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+..+..+......+++
T Consensus 208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 280 (348)
T ss_dssp -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence 2457899999999984 567899999999999999999999999998887777777777766666677899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.+++||.+||+.||++|||+.+++++..
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 9999999999999999999999997644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=372.52 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=209.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||+|.+. ++.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 7899999999999999999984 78999998854321111112568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+ +|+|.+++...+.+++.+++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEE--CTTCCEEECCSSCTBTTTTSB--
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEE--cCCCCEEEEEeccceeccCCc--
Confidence 99 7899999988889999999999999999999999988 9999999999999 888999999999998665332
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+..+. ...+..+++++++
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDFLSPGAQS 237 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC--CCCCTTSCHHHHH
T ss_pred ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CCCcccCCHHHHH
Confidence 2345679999999999988776 689999999999999999999998755433222222221 1224568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L 417 (435)
||.+||+.||.+|||+.|++++-
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCH
T ss_pred HHHHHcCCChhHCcCHHHHHhCh
Confidence 99999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=365.36 Aligned_cols=268 Identities=29% Similarity=0.476 Sum_probs=217.4
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 220 (435)
.|++. ..+|.+.+.||+|+||.||+|.+. +..||+|.+..... ....+.+.+|+.+++++ +||||+++
T Consensus 39 ~~~~~--~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 39 KWEFP--RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp GGBCC--GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccC--HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34443 458899999999999999999972 34799999864322 22346789999999999 89999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCc
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------------------ALSPSTAVNFALDIARGMAYLHNEPNV 277 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ 277 (435)
++++...+..++||||+++++|.+++.... .+++.+++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 192 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 192 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999998643 2789999999999999999999988
Q ss_pred eEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 013833 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (435)
Q Consensus 278 ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 357 (435)
|+||||||+|||+ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 193 ivH~Dikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 193 CVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp EEETTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred cccCCCChhhEEE--cCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 9999999999999 78889999999999876543221 1223445788999999998889999999999999999999
Q ss_pred c-CCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 358 E-GEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 358 t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
+ |..||.+....... ..+..+..+. .+..+++++.+||.+||+.||++|||+.+++++|+.+.+.....
T Consensus 269 t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 269 SLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred cCCCCCcccCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 8 99999877644333 3344443333 34568999999999999999999999999999999998776553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=381.00 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=209.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ ++.||||++.............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 47899999999999999999985 7789999986543223334467789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||++|++|.+++...+.+++..+..++.||+.||.|||+ .| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEE--CSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEE--CCCCCEEEccCCCceeccCCC
Confidence 999999999999988899999999999999999999998 88 9999999999999 888999999999997543322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....... +..++++++
T Consensus 304 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~ 377 (446)
T 4ejn_A 304 A----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLGPEAK 377 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred c----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHHH
Confidence 1 2345789999999999999999999999999999999999999999988887777776654432 356899999
Q ss_pred HHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 394 ELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+||.+||+.||++|| ++.++++|
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 999999999999999 99999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=357.09 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=208.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc-----------------------HHHHHHHHHHHHHHHhC
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKL 212 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 212 (435)
+|++.+.||+|+||.||+|.++ ++.||||++....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 7899999999999999999985 6789999986543211 11235688999999999
Q ss_pred CCCcceeeeeeEEe--CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 213 RHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 213 ~h~~iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
+||||+++++++.+ ...+++||||+++++|.+++. ...+++.+++.++.||+.||.|||++| |+||||||+|||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV 170 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE
Confidence 99999999999986 567899999999999988653 456999999999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYE 367 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~tg~~p~~~~~ 367 (435)
+.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 171 --~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 171 --GEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp --CTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 8888999999999987654321 233467999999999997665 3678999999999999999999999888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 368 PYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.......+............+++++++||.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7777666666554444445789999999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=367.85 Aligned_cols=264 Identities=30% Similarity=0.547 Sum_probs=219.0
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 220 (435)
.|++. ..+|++.+.||+|+||.||+|.+. ++.||||.+.... .....+.+.+|+.++.++ +||||+++
T Consensus 16 ~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 16 KWEFP--RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHBCC--GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccc--ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34443 458999999999999999999853 3679999986432 334457789999999999 78999999
Q ss_pred eeeEEeCC-cEEEEEecCCCCCHHHHHHHcCC------------------------------------------------
Q 013833 221 LGAVTERK-PLMLITEYLRGGDLHKYLKEKGA------------------------------------------------ 251 (435)
Q Consensus 221 ~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~------------------------------------------------ 251 (435)
++++.+.+ .+++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987754 48999999999999999986432
Q ss_pred ------------------CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 252 ------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 252 ------------------~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCcEEEEeccceeeecccc
Confidence 899999999999999999999988 9999999999999 888899999999998664332
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPE 391 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.... .....+..+..+. .+..++++
T Consensus 248 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 324 (359)
T 3vhe_A 248 D--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPE 324 (359)
T ss_dssp T--CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-CCTTCCHH
T ss_pred c--chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-CCCCCCHH
Confidence 1 112344568999999999998999999999999999999998 99999876643 3334444444433 34568999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=353.31 Aligned_cols=248 Identities=30% Similarity=0.502 Sum_probs=214.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ +..||+|.+.............+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 7999999999999999999986 56799998854322222223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEE--CTTSCEEECSCCEESCC------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEE--cCCCCEEEEeccccccCCccc--
Confidence 9999999999998888999999999999999999999988 9999999999999 888999999999886544321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+....... +..+++++++|
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 237 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHHHHH
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--CCcCCHHHHHH
Confidence 234578999999999999999999999999999999999999999988877777776654433 34689999999
Q ss_pred HHHHhhhcccCCCCHHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~L 417 (435)
|.+||+.||++|||+.+++++-
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHhccChhhCCCHHHHhhCc
Confidence 9999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=349.70 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=218.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ +..||+|++...... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 37899999999999999999986 778999988654433 344577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+||++..+. .+.+||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99999999999988888999999999999999999999988 99999999999993222 2349999999997665332
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPE 391 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 391 (435)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+..+...... ...++++
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 163 -----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp -----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred -----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 233467899999999999999999999999999999999999999998888777777665443322 2468999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||.+||+.||++|||+.|++++
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=351.41 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=205.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||+|.+....... .....+.+|+.++++++||||+++++++.++..+++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6889999999999999999985 7789999987554332 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++ +|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceecCCccc
Confidence 9976 66665554 677999999999999999999999988 9999999999999 8889999999999987643321
Q ss_pred cccccccCCCcCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHcCCCCC----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPP-LANYEPYEAAKYVAEGHRPF---------- 382 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p-~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.......
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ----cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 234567899999999997765 89999999999999999988777 55555555444443211000
Q ss_pred -----------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.....+++++++||.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0112478999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=379.70 Aligned_cols=248 Identities=28% Similarity=0.485 Sum_probs=218.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||+|.++ |+.||||++.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 7899999999999999999986 78999998854321111224678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++...+.+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll--~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEECCTTC--
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEE--ecCCCeEEEeccchhhccccc--
Confidence 9999999999988888999999999999999999999988 9999999999999 888999999999998765322
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+..+.... +..+++++++
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 245 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT--PQYLNPSVIS 245 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC--CTTCCHHHHH
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC--CccCCHHHHH
Confidence 2345679999999999988765 679999999999999999999999888777777777765432 4568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
||.+||+.||++|||+.+++++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHcCCCchhCcCHHHHHhC
Confidence 9999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=361.29 Aligned_cols=257 Identities=29% Similarity=0.427 Sum_probs=208.1
Q ss_pred CCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC----cEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 231 (435)
..+|++.+.||+|+||+||+|.+.++.||||++... ........+|+.++++++||||+++++++.+.. .++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 458999999999999999999999999999988542 222345567999999999999999999987754 379
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC----------CCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----------PNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~----------~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
+||||+++|+|.++++.. .+++.+++.++.|++.||.|||+. + |+||||||+|||+ +.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill--~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL--KNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE--CTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE--CCCCeEEEc
Confidence 999999999999999764 599999999999999999999997 7 9999999999999 888999999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCC---------
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYE--------- 367 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~tg~~p~~~~~--------- 367 (435)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 174 DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 174 DFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred cCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 99999876543321 123346799999999999863 45668899999999999999999996532
Q ss_pred -------HHHHHHHHHcCC-CCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 368 -------PYEAAKYVAEGH-RPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 368 -------~~~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.......+.... ++.... ...++++.+||.+||+.||++|||+.++++.|+++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222222 222111 12345699999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=356.34 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=215.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|...+.||+|+||.||+|.++ |+.||||++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3566678999999999999985 7899999986544332 3668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++.. ..+++.++..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC-
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCcEEEeeeeeeeecccCcc-
Confidence 9999999999864 46999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+... ...+++++++
T Consensus 197 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 197 ---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred ---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 234567999999999999999999999999999999999999999988887777777766554332 2457899999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+|.+||+.||++|||+.+++++
T Consensus 274 li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.43 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=208.0
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|++.+.||+|+||.||+|.++. ..||+|.+....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4479999999999999999998753 279999886554333 3357899999999999999999999999876654
Q ss_pred ------EEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 231 ------MLITEYLRGGDLHKYLKEKG------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 231 ------~lv~e~~~g~sL~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
++||||+++++|.+++.... .+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli--~~~~~~ 176 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCML--AEDMTV 176 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEE--cCCCCE
Confidence 99999999999999996532 5899999999999999999999988 9999999999999 888999
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 377 (435)
||+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEeeccccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 99999999876543211 11233456889999999999999999999999999999999 9999999888777777776
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+..+.. +..+++++.+|+.+||+.||++|||+.++++.|+++.+..
T Consensus 255 ~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 GNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCCCC-CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 655443 3568999999999999999999999999999999998743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.92 Aligned_cols=249 Identities=22% Similarity=0.420 Sum_probs=215.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+.... ......+.+|+.++++++||||+++++++.+...+++|||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 7899999999999999999986 7789999886433 2233578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++|++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+|||+..+..+.+||+|||++........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999997644 6999999999999999999999988 9999999999999544567899999999987654321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 392 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 207 -----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp -----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred -----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2234689999999999999999999999999999999999999999888777777666543322 224689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.+++++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHhhC
Confidence 999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=357.35 Aligned_cols=268 Identities=31% Similarity=0.553 Sum_probs=228.3
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcce
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 218 (435)
.|.+. ..+|++.+.||+|+||.||+|.+. +..||+|.+.... .....+.+.+|+.+++++ +||||+
T Consensus 29 ~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 29 KWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp TTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 45443 348899999999999999999863 4579999886443 344557899999999999 899999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~D 282 (435)
++++++.+.+..++||||+++++|.+++.... .+++.+++.++.||+.||.|||+.| |+|||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~D 182 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRD 182 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence 99999999999999999999999999998643 3899999999999999999999988 99999
Q ss_pred CCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 013833 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (435)
Q Consensus 283 lkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~ 361 (435)
|||+|||+ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 183 lkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 183 LAARNVLV--TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CSGGGEEE--CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccceEEE--cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999 8889999999999987654321 112234457889999999988889999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 362 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
||.+....+....+..+..+.. +..+++++.++|.+||+.||++|||+.++++.|+++......+
T Consensus 259 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp SSTTCCHHHHHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CcCcCCHHHHHHHHhcCCCCCC-CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 9999888887777777665543 3568999999999999999999999999999999998766543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.55 Aligned_cols=261 Identities=29% Similarity=0.576 Sum_probs=225.5
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
..|++. ..+|++.+.||+|+||.||+|.++ +..||||.+...... .+.+.+|+.+|++++||||+++++++.
T Consensus 213 ~~~~~~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCC--GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccC--HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 456654 346888999999999999999987 678999998654322 367899999999999999999999999
Q ss_pred eCCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+...+++||||+++|+|.++++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF 362 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV--GENHLVKVADF 362 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGGCEEECCT
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEE--CCCCcEEEeec
Confidence 999999999999999999999864 35899999999999999999999988 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+++...... ........+++.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..+.++.
T Consensus 363 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 439 (495)
T 1opk_A 363 GLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439 (495)
T ss_dssp TCEECCTTCC---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred ccceeccCCc---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998764321 112234456789999999998899999999999999999999 999999988877777777766554
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
. +..+++++.+||.+||+.||++|||+.++++.|+.+.+
T Consensus 440 ~-~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 440 R-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp C-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C-CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 3 45789999999999999999999999999999987754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.95 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=223.3
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
...+|.+.+.||+|+||.||++.+. +..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3557999999999999999999986 67899999876655555666889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||+++++|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEE--cCCCCEEEeeccCceecccC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88889999999999876533
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... +..+++++
T Consensus 195 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 268 (335)
T 2owb_A 195 GE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--PKHINPVA 268 (335)
T ss_dssp TC----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHH
T ss_pred cc----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC--CccCCHHH
Confidence 22 2334578999999999998899999999999999999999999999888777666666554332 34689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.+||.+||+.||++|||+.+++++-.
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcc
Confidence 99999999999999999999998633
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=351.86 Aligned_cols=262 Identities=28% Similarity=0.504 Sum_probs=221.4
Q ss_pred CCCCCCCc-eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~-~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|.+.+ .||+|+||.||+|.+. +..||+|.+...... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 34778877 9999999999999653 567999998654332 33457899999999999999999999998 56778
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
++||||+++++|.+++...+.+++.+++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEE--eCCCcEEEccCCcceeec
Confidence 999999999999999998888999999999999999999999988 9999999999999 777899999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+.++.. +..++
T Consensus 169 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (291)
T 1xbb_A 169 ADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCP 246 (291)
T ss_dssp TTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCC
T ss_pred cCCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCC
Confidence 43321 111223456789999999988889999999999999999999 9999999988888777777765544 35689
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
+++.++|.+||+.||++|||+.++++.|+++.....
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999886543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.01 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=198.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ ++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 46889999999999999999986 5689999886532 1256788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++...+.+++.+++.++.||+.||.|||+.| |+||||||+|||+.. +.++.+||+|||++.......
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 99999999999988888999999999999999999999988 999999999999943 337899999999998664322
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCCCC--CCCCCH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFR--AKGFTP 390 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~ 390 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+......... ...++.
T Consensus 206 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 206 -----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred -----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 1234578999999999999999999999999999999999999998765543 44555554433222 246899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++||.+||+.||++|||+.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=354.18 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=213.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||++.+. ++.||+|.+...........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 7899999999999999999975 77899999876655555666889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++.+++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSCCC----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEE--cCCCCEEEecCccCcccccccc-
Confidence 9999999999998888999999999999999999999988 9999999999999 8888999999999976653321
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 394 (435)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+...... ......+|+++++
T Consensus 190 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 190 --TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred --ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence 1223456899999999999999999999999999999999999999987765544444443322 2234578999999
Q ss_pred HHHHHhhhcccCCC-CHHHHHHHHHHHHhhCCC
Q 013833 395 LTEKCWAADMNQRP-SFLDILKRLEKIKETLPT 426 (435)
Q Consensus 395 li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~~~~ 426 (435)
+|.+||+.||++|| +++++++.|+++.+....
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 99999999999999 999999999987765544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=362.74 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=209.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 7899999999999999999986 778999988543322 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++|++|.+++.....+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEE--eCCCCEEEEEeeccceeccCCcc
Confidence 9999999999988778999999999999999999999988 9999999999999 88889999999999866533221
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++++.
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 162 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp --CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred --cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 12345679999999999987765 77899999999999999999999866543 222223333322223356899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||+.|++++
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 99999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=351.88 Aligned_cols=263 Identities=30% Similarity=0.581 Sum_probs=227.0
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 224 (435)
...|++. ..+|++.+.||+|+||.||+|.++ +..||+|.+.... ...+.+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~--~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 78 (288)
T 3kfa_A 5 YDKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC 78 (288)
T ss_dssp CCTTBCC--GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhccccc--ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456654 447899999999999999999987 6789999886432 2347788999999999999999999999
Q ss_pred EeCCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 225 TERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 225 ~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.+....++||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~D 154 (288)
T 3kfa_A 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVAD 154 (288)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEE--CGGGCEEECC
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEE--cCCCCEEEcc
Confidence 9999999999999999999999874 34899999999999999999999988 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.....+
T Consensus 155 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (288)
T 3kfa_A 155 FGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231 (288)
T ss_dssp CCGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred CccceeccCCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC
Confidence 999987653321 12334457889999999998899999999999999999999 99999988877777777666554
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
. .+..+++++.+|+.+||..||++|||+.++++.|+.+.++
T Consensus 232 ~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 E-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 4 3457899999999999999999999999999999988764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=374.40 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=213.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.++||+|+||+||+|.++ ++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999986 6789999885421110111134778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||++........
T Consensus 149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTSE
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeE--CCCCCEEEeccceeEeeccCCc
Confidence 99999999999975 46899999999999999999999988 9999999999999 8899999999999986653321
Q ss_pred cccccccCCCcCccccCccccCCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 388 (435)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+..+. ........+
T Consensus 224 ---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 224 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp ---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred ---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 1234578999999999997665 7899999999999999999999999988888777776542 122223468
Q ss_pred CHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
++++++||.+||..+|.+ ||++.++++|
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 999999999999999998 9999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=348.73 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=223.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|.+.+.||+|+||.||++.++ ++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457999999999999999999986 678999998766555556667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||+++++|.+++...+.+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE--cCCCCEEEEeccCceecccCc
Confidence 999999999999988888999999999999999999999988 9999999999999 888899999999998765332
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+...... .+..+++.+.
T Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 243 (294)
T 2rku_A 170 E----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINPVAA 243 (294)
T ss_dssp C----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCTTSCHHHH
T ss_pred c----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--CccccCHHHH
Confidence 2 223457899999999999889999999999999999999999999988877766666655433 2356899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+++.+||+.||++|||+.+++++-.
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHcccChhhCcCHHHHhhChh
Confidence 9999999999999999999998744
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=363.58 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=208.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
+|++.+.||+|+||+||+|.++ ++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 6899999999999999999985 78999998753210 0011236788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCccc
Q 013833 234 TEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKL 308 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~ 308 (435)
|||++|++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+..+ ..+.+||+|||++..
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 9999999999887642 24899999999999999999999988 9999999999999332 223599999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AK 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 386 (435)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+..+...... ..
T Consensus 183 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 183 LGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT
T ss_pred ecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc
Confidence 654321 2345679999999999999999999999999999999999999998754 3444455554433221 14
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++++++||.+||+.||++|||+.+++++
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 689999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=358.69 Aligned_cols=257 Identities=30% Similarity=0.588 Sum_probs=213.9
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
..+|++.+.||+|+||+||+|.+. +. .||+|.+..... ....+.+.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 457999999999999999999974 33 358887654322 223467899999999999999999999998764
Q ss_pred EEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++|+||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEE--CCCCCEEEccCcceeE
Confidence 7899999999999999987 456999999999999999999999988 9999999999999 7788999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+..... +..
T Consensus 167 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (327)
T 3poz_A 167 LGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPI 243 (327)
T ss_dssp HTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-CTT
T ss_pred ccCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC-Ccc
Confidence 654332 112334557889999999999999999999999999999999 9999998888777777776655443 456
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++.++.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=356.85 Aligned_cols=250 Identities=31% Similarity=0.470 Sum_probs=204.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|++.+.||+|+||+||+|.+. ++.||+|.+...... ......+.+|+.++++++||||+++++++.++..+++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 37999999999999999999985 788999998654322 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++ +|.+++... ..+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEE--CCCCCEEEccCcCceecCCCcc
Confidence 9975 888888764 45999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---CCCCCC-------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE---GHRPFF------- 383 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~~~~~------- 383 (435)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.. ...+..
T Consensus 175 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 ----SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp -------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ----cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2334578999999999876 5689999999999999999999999987665444433322 111100
Q ss_pred ------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 ------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....+++++.+||.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012467899999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=362.88 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=208.1
Q ss_pred CceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.+.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 567999999999999985 7889999886532 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 240 ~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
++|.+++... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||+..+.++.+||+|||++.......
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 9999998764 46999999999999999999999988 999999999999976677899999999998765432
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPELRELT 396 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 396 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......... ...+++++++||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 123456999999999999899999999999999999999999999998887777776665433221 246899999999
Q ss_pred HHHhhhcccCCCCHHHHHHH
Q 013833 397 EKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 397 ~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+||+.||++|||+.+++++
T Consensus 324 ~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=348.95 Aligned_cols=261 Identities=29% Similarity=0.533 Sum_probs=222.7
Q ss_pred CCCCCCc-eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~-~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|.+.. .||+|+||.||+|.+. +..||+|.+.... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 3566665 8999999999999863 6679999986542 344567899999999999999999999998 556789
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+||||+++++|.+++... ..+++.+++.++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEE--cCCCCEEECcccceeeec
Confidence 999999999999999753 45999999999999999999999988 9999999999999 777899999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+.++..+ ..++
T Consensus 162 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~ 239 (287)
T 1u59_A 162 ADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECP 239 (287)
T ss_dssp TCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC-TTCC
T ss_pred cCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC-CCcC
Confidence 43321 112233457899999999988889999999999999999998 99999998888877777777665543 5789
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+++.++|.+||+.||++|||+.+++++|+.+..+...
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999999875443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=350.95 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=218.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|.+...... +.+.+|+.+++.+ +|++++++++++.++...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 37899999999999999999964 789999988544322 4567899999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc-----EEEeeccCcc
Q 013833 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSK 307 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~-----vkl~Dfg~a~ 307 (435)
|||+ +++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++. +||+|||++.
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--ccCCCCCCCeEEEEECcccc
Confidence 9999 999999998754 5999999999999999999999988 9999999999999 55554 9999999998
Q ss_pred cccccCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCC
Q 013833 308 LIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRP 381 (435)
Q Consensus 308 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~ 381 (435)
.......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+.....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7765432111 12345679999999999999999999999999999999999999998743 33333332222111
Q ss_pred C---CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCcccc
Q 013833 382 F---FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 432 (435)
Q Consensus 382 ~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 432 (435)
. .....+|+++.+++.+||+.||++|||+.++++.|+++.+++.. .-+|..
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 1 11246899999999999999999999999999999999987654 356653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=357.70 Aligned_cols=266 Identities=29% Similarity=0.499 Sum_probs=220.9
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcce
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 218 (435)
...|++. ..+|++.+.||+|+||.||+|.+.+ ..||+|.+.... .....+.+.+|+.+++++ +||||+
T Consensus 38 ~~~~~~~--~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv 113 (333)
T 2i1m_A 38 NEKWEFP--RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIV 113 (333)
T ss_dssp CGGGBCC--TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccCC--HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCee
Confidence 3345554 4588999999999999999999852 369999886443 334457889999999999 899999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlk 284 (435)
++++++.++...++||||+++++|.+++... ..+++.+++.++.||+.||.|||++| |+|||||
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk 191 (333)
T 2i1m_A 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVA 191 (333)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcc
Confidence 9999999999999999999999999999753 35799999999999999999999988 9999999
Q ss_pred CCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 013833 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363 (435)
Q Consensus 285 p~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~ 363 (435)
|+|||+ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 192 p~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 192 ARNVLL--TNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp GGGCEE--EGGGEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cceEEE--CCCCeEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999 77889999999999876543221 12234457889999999998899999999999999999999 99999
Q ss_pred CCCCHHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 364 ANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 364 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+....... ..+..+..+ ..+..+++.+.++|.+||+.||++|||+.++++.|+++.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 268 PGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 876544333 333344333 33456899999999999999999999999999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=351.59 Aligned_cols=264 Identities=32% Similarity=0.571 Sum_probs=205.9
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
..+++. ..+|++.+.||+|+||+||++.+.+ .||+|++..... .....+.+.+|+.++++++||||++++++. ..
T Consensus 17 ~~~ei~--~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIP--DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCC--TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccC--ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344554 3479999999999999999998766 499998865433 345567899999999999999999999965 55
Q ss_pred CcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
...++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLA 167 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTTEEEECCCC--
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE--CCCCCEEEccceec
Confidence 678999999999999999964 446999999999999999999999988 9999999999999 77889999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPF 382 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~ 382 (435)
......... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+....+ ....+..+....
T Consensus 168 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 168 TEKSRWSGS--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred ccccccccc--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 765432211 1233456899999999986 5678889999999999999999999998765443 334444443322
Q ss_pred C---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 383 F---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 383 ~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
. ....+|+++.+||.+||+.||++|||+.++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 224688999999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=348.04 Aligned_cols=254 Identities=35% Similarity=0.591 Sum_probs=209.9
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHH----HHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
..+|++.+.||+|+||.||+|.+. ++.||+|.+........... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 347899999999999999999985 77899999866544332222 67889999999999999999999987655
Q ss_pred EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc-----EEEeec
Q 013833 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDF 303 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~-----vkl~Df 303 (435)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||||||+|||+ +.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCCC
Confidence 7999999999999988754 46999999999999999999999976569999999999999 55555 999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccC--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAKYVAEGH 379 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~ 379 (435)
|++..... ......||+.|+|||++. ...++.++||||||+++|+|++|..||....... ....+....
T Consensus 174 g~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 174 GLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp TTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred Cccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99975432 233467899999999984 4567889999999999999999999998665332 234444443
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.....+..+++++.++|.+||+.||++|||+.++++.|+++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 33344567899999999999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=377.94 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=213.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.++||+|+||+||+|.++ ++.||+|++.+...........+.+|..++..++||||+++++++.+.+.+|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 347899999999999999999986 578999988542111111123478899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||++||+|.+++.+ .+.+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+++.....
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeE--cCCCCEEEcchhhhhhcccC
Confidence 999999999999987 567999999999999999999999988 9999999999999 88999999999999766433
Q ss_pred CccccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---RPFFR 384 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~ 384 (435)
.. ......+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+.... ..+..
T Consensus 229 ~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 229 GT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp SC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred CC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 22 1234468999999999986 5678999999999999999999999999988887776665421 11111
Q ss_pred CCCCCHHHHHHHHHHhhhcccC--CCCHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQ--RPSFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 416 (435)
...+++++++||.+||..+|++ ||++++++++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2458999999999999988888 9999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=365.57 Aligned_cols=256 Identities=18% Similarity=0.341 Sum_probs=210.0
Q ss_pred CCCCCCCceeecC--CceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 156 ELDFSSSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
..+|++.+.||+| +||.||+|.++ ++.||||++...... ....+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4489999999999 99999999986 789999998654433 445678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 232 LITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+||||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccccceee
Confidence 999999999999999875 67999999999999999999999988 9999999999999 88899999999998765
Q ss_pred cccCcccc---ccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Q 013833 310 KVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP--- 381 (435)
Q Consensus 310 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--- 381 (435)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 43321111 11223478999999999987 67999999999999999999999999876543332221111110
Q ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -----------------------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -----------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+++++++||.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 01124578899999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=346.94 Aligned_cols=263 Identities=30% Similarity=0.536 Sum_probs=223.8
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
+|++. ..+|++.+.||+|+||.||+|.+++ ..||+|.+...... .+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~v~--~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVP--RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcccC--HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 45554 3478999999999999999999874 58999988654322 2678899999999999999999998864
Q ss_pred CcEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
+..++||||+++++|.+++.... .+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADFGL 155 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEE--cCCCCEEECCCcc
Confidence 56899999999999999997533 6999999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
+........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+..+..
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~- 231 (279)
T 1qpc_A 156 ARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR- 231 (279)
T ss_dssp CEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred cccccCccc---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC-
Confidence 987653321 12234457889999999988889999999999999999999 9999999888887777777655443
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+..+++++.+++.+||+.||++|||+.++++.|+.+......
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 457899999999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=347.84 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=215.3
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-- 226 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 226 (435)
.+......|.+.+.||+|+||.||+|.+. +..||+|.+...... ....+.+.+|+.++++++||||+++++++..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34444557888899999999999999986 567999988654333 3445789999999999999999999998865
Q ss_pred --CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeec
Q 013833 227 --RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDF 303 (435)
Q Consensus 227 --~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Df 303 (435)
...+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.+.+|+||||||+|||+ + .++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeC
Confidence 3568999999999999999998888999999999999999999999976569999999999999 6 6779999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~ 382 (435)
|++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.... .......+..+..+.
T Consensus 177 g~~~~~~~~~------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 177 GLATLKRASF------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp TGGGGCCTTS------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred CCcccccccc------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence 9997544321 23356899999999887 458999999999999999999999998754 444455566665555
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+...++++.++|.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 5556688999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=373.68 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=211.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.++ ++.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 47899999999999999999985 7899999985422111222345789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||++||+|.+++.+.+ .+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++++||+|||++.......
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--d~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeee--cCCCCEEEeechhheeccCCC
Confidence 9999999999998754 7999999999999999999999988 9999999999999 889999999999998765432
Q ss_pred ccccccccCCCcCccccCccccC-------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---RPFF 383 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~ 383 (435)
. ......+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+.... ....
T Consensus 217 ~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 217 T---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp C---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred c---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 2 1233468999999999987 4578999999999999999999999999988877776665422 1111
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCC---CCHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQR---PSFLDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~ 416 (435)
....+|+++++||.+||. +|++| |+++++++|
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 235689999999999999 99998 599999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=349.54 Aligned_cols=256 Identities=34% Similarity=0.637 Sum_probs=214.7
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER- 227 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 227 (435)
.|.+. ..+|++.+.||+|+||.||++.++++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 15 ~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALN--MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCC--GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCC--hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34443 3479999999999999999999999999999886432 236788999999999999999999987544
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
...++||||+++++|.+++...+. +++.+++.++.|++.||.|||++| ++||||||+||++ +.++.++|+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGL 163 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEE--eCCCcEEEeeccc
Confidence 578999999999999999986543 899999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
+....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..+..+..
T Consensus 164 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~- 235 (278)
T 1byg_A 164 TKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA- 235 (278)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC-
T ss_pred cccccccc-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-
Confidence 97654321 23357889999999998899999999999999999998 9999998887777777766654443
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+..+++++.++|.+||+.||++|||+.++++.|++++..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 457899999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=353.83 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=195.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ ++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 37899999999999999999875 7889999886543221 2256788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 235 EYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 235 e~~~g~sL~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
||++ ++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLI--NKRGQLKLGDFGLARA 157 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCSSCEE
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEE--cCCCCEEECcCcccee
Confidence 9997 5999998753 35899999999999999999999988 9999999999999 8889999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------ 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------ 381 (435)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 643321 2334578999999999976 46899999999999999999999999988876665554321000
Q ss_pred -----------C---------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -----------F---------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -----------~---------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....+++++.+||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0112578899999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=354.43 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=217.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH---HHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.+.||+|+||.||+|.++ +..||+|.+........ ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 36889999999999999999986 77899998865443221 12367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC----cEEEeeccCcc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 307 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~----~vkl~Dfg~a~ 307 (435)
+||||+++++|.+++...+.+++.+++.++.|++.||.|||+.| |+||||||+||++ +.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~--~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEE--ecCCCCcCCEEEccCccce
Confidence 99999999999999998888999999999999999999999988 9999999999999 6655 79999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--C
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--A 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 385 (435)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+......... .
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 765432 223456899999999999999999999999999999999999999988887777777665433221 1
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+++.+++||.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 4688999999999999999999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=356.94 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=213.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||+|.+. ++.||||.+...... +.+.+|+.+++++ +||||+++++++..+...++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 37899999999999999999974 788999988644322 3578899999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc-----EEEeeccCcc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSK 307 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~-----vkl~Dfg~a~ 307 (435)
|||+ +++|.+++.. .+.+++.+++.++.||+.||.|||+.| |+||||||+|||+ +.++. +||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLI--GRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CCGGGTCTTSEEECCCTTCE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--ccCCCCCCceEEEEEcccce
Confidence 9999 9999999987 467999999999999999999999988 9999999999999 66666 9999999998
Q ss_pred cccccCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCC
Q 013833 308 LIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRP 381 (435)
Q Consensus 308 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~ 381 (435)
.......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+....+.....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 7654332111 11245679999999999999999999999999999999999999998743 33333333222211
Q ss_pred CC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 382 FF---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 382 ~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.. ....+| ++.+++..||+.||.+||++.++++.|+++.++...
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11 112345 999999999999999999999999999999887643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=345.75 Aligned_cols=248 Identities=28% Similarity=0.476 Sum_probs=216.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ +..+|+|.+....... .+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 6888999999999999999986 5579999886544333 3678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++...+.+++.+++.++.|++.||.|||++| |+||||||+||++.. +.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999999998888999999999999999999999988 999999999999943 456789999999998765432
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+..+....... ..+++++
T Consensus 164 ----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 164 ----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred ----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 23345789999999998754 8999999999999999999999999988888877777765443221 3689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++|.+||+.||++|||+.+++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=351.81 Aligned_cols=264 Identities=31% Similarity=0.508 Sum_probs=214.0
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK- 228 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 228 (435)
...+|.+.+.||+|+||.||+|.+. +..||+|.+..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 3458899999999999999999864 23799998865433 3444578999999999999999999999987654
Q ss_pred ----cEEEEEecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 229 ----PLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 229 ----~~~lv~e~~~g~sL~~~l~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
..++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||++ +.++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~~ 186 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML--RDDMTV 186 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE--CTTSCE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCcE
Confidence 35999999999999999953 346999999999999999999999988 9999999999999 888899
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 377 (435)
||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 187 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEeecCcceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 9999999987654321 111233457889999999999999999999999999999999 9999998888777777777
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+..+.. +..+++++.++|.+||..||++|||+.+++++|+++.++++.
T Consensus 265 ~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 265 GHRLKQ-PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp TCCCCC-BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCCCCC-CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 665543 356899999999999999999999999999999999988763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=351.25 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=204.7
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||+||+|.+. ++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6889999999999999999986 788999988654322 11235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 237 ~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
+++ +|.+++... +.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEeECccccccCcccc-
Confidence 975 999999764 67999999999999999999999988 9999999999999 8889999999999986643221
Q ss_pred ccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HR------------ 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~------------ 380 (435)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+... ..
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2234568999999999875 45899999999999999999999999988776655444321 00
Q ss_pred ---CCC----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ---PFF----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ---~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++++.+||.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 013578999999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.45 Aligned_cols=248 Identities=27% Similarity=0.477 Sum_probs=211.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+.+.... ..+|++++.++ +||||+++++++.++..+|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 6888999999999999999986 678999998654432 34678888887 7999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC--CcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~ 312 (435)
||++||+|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+.++.. +.+||+|||++......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999998888999999999999999999999988 999999999999843222 35999999999876543
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCCC--CCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN---YEPYEAAKYVAEGHRPFFR--AKG 387 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~~~--~~~ 387 (435)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ ....+....+..+...... ...
T Consensus 174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 174 NG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp TC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 22 23456789999999999888899999999999999999999999985 3455666667666544322 246
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+++++++||.+||..||++|||+.+++++-.
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 8999999999999999999999999998743
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=350.23 Aligned_cols=251 Identities=36% Similarity=0.662 Sum_probs=208.5
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
.+|++.+.||+|+||.||++.++++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 37888999999999999999999999999988532 233678999999999999999999998763 47999999
Q ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhc---CCCceEeCCCCCCcEEEecCCCCc-EEEeeccCcccc
Q 013833 237 LRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHN---EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLI 309 (435)
Q Consensus 237 ~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~~~ivH~Dlkp~NIll~~~~~~~-vkl~Dfg~a~~~ 309 (435)
+++++|.+++.... .++...++.++.|++.||.|||+ +| |+||||||+|||+ +.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll--~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLL--VAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEE--ETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEE--eCCCCEEEEccccccccc
Confidence 99999999998654 37899999999999999999999 67 9999999999999 66665 799999999765
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 387 (435)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+..+..+.. ...
T Consensus 157 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (307)
T 2eva_A 157 QTH-------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL-IKN 228 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-BTT
T ss_pred ccc-------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-ccc
Confidence 432 223468999999999999999999999999999999999999998643 3333344445544443 356
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+++.+.+++.+||+.||++|||+.++++.|+.+.+.++.
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 899999999999999999999999999999999987765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=348.65 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=215.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.+. +..||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 7899999999999999999986 56799998854321111123578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++.+++.++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM--GYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECSSS---
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--cCCCCEEEecccccccCccc---
Confidence 9999999999998888999999999999999999999988 9999999999999 88889999999998755432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... +..++++++++
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 242 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF--PPFLSDGSKDL 242 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHH
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC--CCcCCHHHHHH
Confidence 1234578999999999999999999999999999999999999999888777776666544332 34689999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
|.+||+.||++|||+.+++++
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHhhcCHhhCCCHHHHhhC
Confidence 999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=377.57 Aligned_cols=251 Identities=31% Similarity=0.521 Sum_probs=220.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||||++.+.........+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 6899999999999999999985 78999999866543333334778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+.. +.++.+||+|||++........
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999998888999999999999999999999988 999999999999943 3567899999999987654321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..+......+ ..+++++
T Consensus 185 -----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 185 -----MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp -----HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred -----cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 233468999999999875 69999999999999999999999999999988888888775443322 4689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.+++++
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhhC
Confidence 999999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=352.43 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=206.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.+. ++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6889999999999999999986 78899998865433 34445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILI--TKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEE--cCCCCEEEeeCCCchhccCccc-
Confidence 9999999999988888999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred ccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC--------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-------------- 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------- 380 (435)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred ---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2234578999999999875 6789999999999999999999999998877655443322100
Q ss_pred -------CCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -------PFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -------~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++++.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 013578899999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=360.92 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=210.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCC--CcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
.+|++.+.||+|+||.||+|.++ +..||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 47899999999999999999985 66899998754321 112334788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHh
Q 013833 233 ITEYLRGGDLHKYLKE----------------------------------------KGALSPSTAVNFALDIARGMAYLH 272 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~----------------------------------------~~~~~~~~~~~~~~qi~~~l~~LH 272 (435)
||||++|++|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999842 111367788899999999999999
Q ss_pred cCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHH
Q 013833 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFA 350 (435)
Q Consensus 273 ~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG 350 (435)
+++ |+||||||+|||+..+..+.+||+|||++..+...............||+.|+|||++.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 988 999999999999944344489999999998765443333333455679999999999965 6789999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 351 MILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 351 ~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
|++|+|++|..||.+....+....+.........+ ..+++++++||.+||+.||++|||+.+++++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999988887777776655443322 3478999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.21 Aligned_cols=257 Identities=29% Similarity=0.584 Sum_probs=211.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCc----EEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
..+|++.+.||+|+||.||+|.+. +.. |++|.+....... ..+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 457999999999999999999985 444 4777665433222 2367889999999999999999999998764
Q ss_pred EEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++|+|++.+++|.+++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTC---
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEE--cCCCCEEEccCcceeE
Confidence 7899999999999999987 456999999999999999999999988 9999999999999 7788999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+..+.. +..
T Consensus 167 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (327)
T 3lzb_A 167 LGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPI 243 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-CTT
T ss_pred ccCccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-Ccc
Confidence 654322 112334557889999999999999999999999999999999 9999999888777777776655443 456
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+++++.++|.+||+.||++|||+.++++.|+++.+
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=376.94 Aligned_cols=265 Identities=32% Similarity=0.523 Sum_probs=227.0
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
...|++.. .+|++.+.||+|+||.||+|.+++ ..||||.+...... .+.+.+|+++|++++||||+++++++.
T Consensus 259 ~~~~~i~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCCG--GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecch--hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34566653 468889999999999999999975 57999998654332 257899999999999999999999987
Q ss_pred eCCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+ ..++|||||+.+|+|.++++. ...+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+||
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF 407 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 407 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCT
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--cCCCcEEEccc
Confidence 6 678999999999999999975 346999999999999999999999988 9999999999999 78889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+++...... ........++..|+|||++....++.++|||||||++|||++ |..||.+....+....+..+.++.
T Consensus 408 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 484 (535)
T 2h8h_A 408 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484 (535)
T ss_dssp TSTTTCCCHH---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccceecCCCc---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998764321 112234457889999999998899999999999999999999 999999999888888888877655
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.+ ..+++++.+||.+||+.||++|||+.+|++.|+.+......
T Consensus 485 ~~-~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 CP-PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CC-CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 43 46899999999999999999999999999999988765443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=344.48 Aligned_cols=256 Identities=30% Similarity=0.542 Sum_probs=215.3
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 4478999999999999999998642 249999886543 334457899999999999999999999998654 56
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++...
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV--ASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--EETTEEEECCCCGGGCC
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--CCCCcEEeCccCCCccc
Confidence 89999999999999998754 5999999999999999999999988 9999999999999 77789999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+..+.. +..+
T Consensus 164 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (281)
T 3cc6_A 164 EDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLC 239 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-CTTC
T ss_pred ccccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-CCCC
Confidence 54321 12233457889999999988899999999999999999998 9999988777666666666654443 3568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++.+.++|.+||+.||++|||+.+++++|+++.+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=351.54 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=202.1
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcceeeeeeEEe----CCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTE----RKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~----~~~~ 230 (435)
.+|++.+.||+|+||+||+|.++++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 37899999999999999999999999999988532 12445566666666 799999999998654 3458
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH--------~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
++||||+++++|.++++. ..+++..++.++.|++.||.||| +.+ |+||||||+|||+ +.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill--~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV--KKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE--CTTSCEEECC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE--cCCCCEEEee
Confidence 999999999999999954 46999999999999999999999 867 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCC------CCCCcchHHHHHHHHHHHHcC----------CCCCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEG----------EPPLANY 366 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~~l~tg----------~~p~~~~ 366 (435)
||++..................||+.|+|||++.+. .++.++|||||||++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999987655433222223445799999999999876 455789999999999999999 8888653
Q ss_pred CH----HH-HHHHHH-cCCCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 367 EP----YE-AAKYVA-EGHRPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 367 ~~----~~-~~~~~~-~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
.. .. ....+. ...++..+. ..+++++.+|+.+||+.||++|||+.++++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21 22 222222 222222221 22457899999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=358.48 Aligned_cols=257 Identities=29% Similarity=0.544 Sum_probs=215.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCc----EEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
..+|++.+.||+|+||+||+|.+. +.. |++|.+...... .....+.+|+.++++++||||+++++++. +..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 347899999999999999999985 443 777876433221 11245678999999999999999999886 456
Q ss_pred EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++||||+.+++|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL--KSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEE--SSSSCEEECSCSGGGG
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEE--CCCCeEEECCCCcccc
Confidence 89999999999999999864 57999999999999999999999988 9999999999999 8888999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+..+.. +..
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (325)
T 3kex_A 165 LPPDDKQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-PQI 241 (325)
T ss_dssp SCCCTTC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-CTT
T ss_pred cCccccc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-CCc
Confidence 6544321 12234567889999999998899999999999999999999 9999998887777777776655443 345
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+++++.+++.+||+.||++|||+.+++++|+.+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.02 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=222.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
..+|++.+.||+|+||.||+|.++ +..||+|.+.... .......+.+|+.++++++||||+++++++.++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 457999999999999999999865 4679999886432 3334467889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcE
Q 013833 229 PLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~v 298 (435)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli--~~~~~~ 177 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTV 177 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE--CTTCCE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE--cCCCeE
Confidence 999999999999999999752 35789999999999999999999988 9999999999999 888899
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 377 (435)
||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..
T Consensus 178 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 9999999986654321 112234467899999999998899999999999999999999 8999999888887777777
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+..+.. +..+++++.++|.+||+.||++|||+.+++++|+++.+
T Consensus 256 ~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 655443 35789999999999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=372.81 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=213.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ +..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999986 67899999865432221 13678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++||+|.+++.....+++.++..++.||+.||.|||++| |+||||||+|||+... .++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999999988888999999999999999999999988 9999999999999332 24569999999998765432
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+....+..+......+ ..+++++
T Consensus 194 ----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 194 ----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp ----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred ----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 234567999999999986 569999999999999999999999999999888888887776544332 4689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.+++++
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=356.50 Aligned_cols=264 Identities=31% Similarity=0.516 Sum_probs=214.4
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+.....+|+..+.||+|+||.||+|.++ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445568999999999999999999976 78999998765432 234678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILL--DENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEE--CTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEE--CCCCCEEEeeccc
Confidence 999999999999999986543 4899999999999999999999988 9999999999999 8889999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHHcC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA------A-KYVAEG 378 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~------~-~~~~~~ 378 (435)
+......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.+. . .....+
T Consensus 186 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQT--HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCC--CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred cccccccccc--ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9865432211 112345689999999999888999999999999999999999999975443211 1 111111
Q ss_pred CC-----CCC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 379 HR-----PFF---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 379 ~~-----~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.. +.. ....++..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 11 111 1122456789999999999999999999999999988753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=349.25 Aligned_cols=262 Identities=28% Similarity=0.534 Sum_probs=212.3
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CC--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|++.+.||+|+||+||+|.+. ++ .||+|.+...........+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457999999999999999999863 22 58999887654444455688999999999999999999999988765 8
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++... +.+++.++..++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--cCCCCEEEccccccccc
Confidence 8999999999999999864 56999999999999999999999988 9999999999999 77789999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.........+..+
T Consensus 172 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 172 PQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 543321 112234467889999999988889999999999999999999 999999998888777776655544455679
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
++++.++|.+||+.||++|||+.++++.|+++...
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 99999999999999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=346.88 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=210.9
Q ss_pred CCCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 228 (435)
..|++.+.||+|+||.||+|.+ .++.||+|.+...... ...+.+.+|+.++++++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4688999999999999999984 3678999998654322 2346788999999999999999999999776 6
Q ss_pred cEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
.+++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++| |+||||||+|||+ +.++.++|+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEE--cCCCCEEECcccccc
Confidence 78999999999999999965 456999999999999999999999988 9999999999999 777899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--------------C-HHHHH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--------------E-PYEAA 372 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~--------------~-~~~~~ 372 (435)
........ ........||..|+|||++.+..++.++||||||+++|+|++|..|+... . .....
T Consensus 175 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 76544321 11234456888999999999888999999999999999999999876321 1 12223
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
..+..+.... .+..+++++.+||.+||+.||++|||+.++++.|+++.
T Consensus 254 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLP-CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCC-CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 3344444333 34578999999999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=373.80 Aligned_cols=250 Identities=31% Similarity=0.538 Sum_probs=216.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||||++.+...... ....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 7899999999999999999986 78899998854321111 13678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+.|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+.. +.++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 9999999999988888999999999999999999999988 999999999999943 245679999999998665332
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..+......+ ..+++++
T Consensus 179 ----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 179 ----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred ----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 2345679999999999875 58999999999999999999999999999888888887765543322 4689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.+++++
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=344.87 Aligned_cols=249 Identities=28% Similarity=0.482 Sum_probs=207.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||++.++ +..+|+|.+....... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 6889999999999999999985 7789999886544322 23678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCccccc
Q 013833 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 236 ~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~ 310 (435)
|+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||++.. +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999864 367999999999999999999999988 999999999999944 345789999999998665
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 389 (435)
... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+........ ....++
T Consensus 179 ~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred Ccc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 432 123456899999999986 5688999999999999999999999999887776665554433322 224579
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++.+||.+||+.||++|||+.|++++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.69 Aligned_cols=258 Identities=36% Similarity=0.556 Sum_probs=218.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCc--EEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.+.||+|+||.||+|.++ +.. +++|.+..... ....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 37889999999999999999875 443 58998764322 22346788999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC
Q 013833 232 LITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~ 295 (435)
+||||+++++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+|||+ +.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~ 178 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 178 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE--cCC
Confidence 9999999999999998654 6899999999999999999999988 9999999999999 888
Q ss_pred CcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 013833 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (435)
Q Consensus 296 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~ 374 (435)
+.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp GCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 899999999987443221 1223456889999999988889999999999999999998 9999999988887777
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+..+..+.. +..+++++.++|.+||+.||++|||+.+++++|.++.++..+
T Consensus 254 ~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 254 LPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp GGGTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred hhcCCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 777655443 356899999999999999999999999999999999987655
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.24 Aligned_cols=250 Identities=32% Similarity=0.544 Sum_probs=214.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH----------HHHHHHHHHHHHHHhCCCCcceeeeeeE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR----------LVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 224 (435)
.+|++.+.||+|+||+||+|.++ +..||+|++.+...... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 47999999999999999999986 67899999865432211 2236788999999999999999999999
Q ss_pred EeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC---cEEEe
Q 013833 225 TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVG 301 (435)
Q Consensus 225 ~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~---~vkl~ 301 (435)
.+...+++||||++|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++ .+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILL--ENKNSLLNIKIV 191 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SSTTCCSSEEEC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEE--ecCCCCccEEEE
Confidence 999999999999999999999988888999999999999999999999988 9999999999999 4443 69999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+..+...
T Consensus 192 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 192 DFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred ECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998765432 234567999999999987 56899999999999999999999999999988888888776544
Q ss_pred CCCC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+ ..+++++++||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3221 4689999999999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=356.66 Aligned_cols=251 Identities=29% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.+. ++.||||++...... ....+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 7999999999999999999875 778999998654332 2334667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec---CCCCcEEEeeccCccccccc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~---~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|+++ +|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+.. +..+.+||+|||++......
T Consensus 114 ~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred cCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9975 99999999888999999999999999999999988 999999999999942 23446999999999876533
Q ss_pred CccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR------- 384 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 384 (435)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+.........
T Consensus 191 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 191 IR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 21 23345689999999999874 5899999999999999999999999988876665554322110000
Q ss_pred ---------------------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 385 ---------------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 385 ---------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+++++.+||.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 01167899999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.01 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=215.7
Q ss_pred CCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--Cc
Q 013833 158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 229 (435)
.|++++.||+|+||+||++.+ .++.||||++.... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 458999999999999999875 36789999986542 344457899999999999999999999999874 67
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+++||||+++++|.+++... .+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGGGCEEC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--cCCCCEEECCccccccc
Confidence 89999999999999999765 4899999999999999999999988 9999999999999 88889999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHH
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------------EAAKY 374 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------------~~~~~ 374 (435)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 185 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 543221 11233456888999999999888999999999999999999999998653211 12233
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+..+..+. .+..+++++.+||.+||+.||++|||+.++++.|+.+.++...
T Consensus 264 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 264 LERGERLP-RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HhcccCCC-CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 33443333 3457899999999999999999999999999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.12 Aligned_cols=248 Identities=25% Similarity=0.459 Sum_probs=214.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||++.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 37899999999999999999987 7789999886543 3445578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||++|++|.+++...+.+++..+..++.|++.||.|||++ | |+||||||+|||+ +.++.++|+|||++.......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHHC
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEE--CCCCCEEEEECCCCccccccc
Confidence 9999999999999888899999999999999999999996 7 9999999999999 888899999999997654321
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH----------------------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA---------------------- 371 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---------------------- 371 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 187 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 187 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2345789999999999999999999999999999999999999987654332
Q ss_pred --------------------HHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 372 --------------------AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 372 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+.....+......+++++++||.+||+.||++|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 222333444444455689999999999999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.12 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=208.6
Q ss_pred CCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--CcceeeeeeEEeCCc
Q 013833 153 DPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKP 229 (435)
Q Consensus 153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~ 229 (435)
.....+|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++.+++| |||+++++++.++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 344567999999999999999999875 67899998865443 34556789999999999987 999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+++|||+ .+++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ + ++.+||+|||++...
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll--~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSCCC
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--E-CCcEEEeeccccccc
Confidence 9999995 57899999999889999999999999999999999988 9999999999999 4 468999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHc
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAE 377 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~ 377 (435)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+..
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 158 QPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred Cccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 543211 12234579999999999854 6788999999999999999999999987543 333444444
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.......+...++++.+||.+||+.||++|||+.+++++..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 43333344567889999999999999999999999998743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=360.94 Aligned_cols=276 Identities=17% Similarity=0.233 Sum_probs=212.6
Q ss_pred CCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHH--------HHHHHHHHHHHhCCCCcce
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVI--------QDFRHEVNLLVKLRHPNIV 218 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv 218 (435)
....+|++.+.||+|+||.||+|.++ ++.||||.+..........+ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34558999999999999999999885 36799998765432111111 1233566677888999999
Q ss_pred eeeeeEEeC----CcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC
Q 013833 219 QFLGAVTER----KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293 (435)
Q Consensus 219 ~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~ 293 (435)
++++++... ...++||||+ |++|.+++... +.+++.+++.++.||+.||.|||+++ |+||||||+|||+..+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998764 4589999999 99999999875 57999999999999999999999988 9999999999999544
Q ss_pred CCCcEEEeeccCcccccccCccccc---cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-H
Q 013833 294 SADHLKVGDFGLSKLIKVQNSHDVY---KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-Y 369 (435)
Q Consensus 294 ~~~~vkl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~ 369 (435)
.++.+||+|||+++.+......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 7889999999999876544322111 12345699999999999999999999999999999999999999985321 1
Q ss_pred HHHHHHHcC--------CCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCcccc
Q 013833 370 EAAKYVAEG--------HRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 432 (435)
Q Consensus 370 ~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 432 (435)
......... ..+.+....+|+++.+++..||+.||++||++.++++.|+++.++... .-+|..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 111111100 001112256899999999999999999999999999999999886544 355654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=341.78 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=217.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.+.||+|+||.||++.++ ++.||+|.+....... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 5888999999999999999986 7799999886543221 1124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC----cEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~----~vkl~Dfg~a~~ 308 (435)
||||+++++|.+++.....+++.++..++.||+.||.|||++| |+||||||+||++ +.++ .++|+|||++..
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEE--ecCCCCCCceEEEeccccee
Confidence 9999999999999988888999999999999999999999988 9999999999999 5554 799999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AK 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 386 (435)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+......... ..
T Consensus 162 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 162 IEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp CC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 64332 123456899999999999999999999999999999999999999998887777666654433211 14
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhhC
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETL 424 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~ 424 (435)
.+++.+.+++.+||..||++|||+.+++++ ++.+..+.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 678999999999999999999999999985 66665543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=348.83 Aligned_cols=245 Identities=27% Similarity=0.354 Sum_probs=199.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh-CCCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.+.||+|+||+||+|.++ ++.||||++.......... .....|+..+.+ .+||||+++++++.++..+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36889999999999999999986 7899999886654444433 344445555544 4899999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+ +++|.+++...+ .+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEccceeeeecccC
Confidence 9999 679999987644 5999999999999999999999988 9999999999999 88889999999998766433
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.+... ...+..+..+......+++++
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 211 G-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHH
T ss_pred C-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHH
Confidence 2 2234568999999999875 799999999999999999999777654332 233444443333345689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+||.+||+.||++|||+.+++++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhhCcCHHHHHhC
Confidence 999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=353.73 Aligned_cols=243 Identities=27% Similarity=0.455 Sum_probs=187.4
Q ss_pred CceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecCC
Q 013833 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.+.||+|+||.||+|.++ ++.||||++.+. ....+.+|+.+++.+. ||||+++++++.++...|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 468999999999999986 778999988532 2256778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCcccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
|++|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+..+ ....+||+|||++........
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--- 164 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--- 164 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence 9999999999888999999999999999999999988 9999999999999432 223799999999986543322
Q ss_pred ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCCCCCCC--CCC
Q 013833 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------YEAAKYVAEGHRPFFRA--KGF 388 (435)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~~ 388 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....+..+....... ..+
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 23445789999999999999999999999999999999999999976433 34555565554433221 358
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++++||.+||+.||++|||+.+++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 9999999999999999999999998865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=347.41 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=214.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|.+.+.||+|+||.||++.++ ++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 6888999999999999999985 789999998654322 22568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++...+.+++.++..++.|++.||.|||+.| |+||||||+||++.. +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999988888999999999999999999999988 999999999999843 45678999999998754322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 392 (435)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..+...... ...+++++
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 122345899999999999999999999999999999999999999998887777777776543322 25689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+||.+||..||++|||+.+++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.60 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=208.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 7899999999999999999986 78999998854321111224678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++...+.+++.++..++.||+.||.|||+.| |+||||||+||++ +.++.++|+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEE--CTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEE--CCCCCEEEeecccccccCCCc--
Confidence 9999999999998888999999999999999999999988 9999999999999 888899999999998664322
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+..+.... +..+++++.+
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 240 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--PEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHH
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--chhcCHHHHH
Confidence 1234568999999999987765 589999999999999999999999888777777776654332 3568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+|.+||+.||++|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=375.74 Aligned_cols=250 Identities=29% Similarity=0.469 Sum_probs=212.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.++||+|+||.||+|.++ |+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 347899999999999999999985 789999988543211112235678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILl--d~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEE--eCCCCeEEEecccceeccc
Confidence 99999999999998754 3999999999999999999999988 9999999999999 8889999999999987643
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFRAKG 387 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+...... .+..
T Consensus 339 ~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~--~p~~ 411 (576)
T 2acx_A 339 GQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE--YSER 411 (576)
T ss_dssp TC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC--CCTT
T ss_pred Cc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc--CCcc
Confidence 32 2234589999999999999999999999999999999999999998753 34444555544322 2356
Q ss_pred CCHHHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+++++++||.+||+.||++|| ++.++++|
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 899999999999999999999 78999876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=386.86 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=218.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.++||+|+||.||++.++ ++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 47889999999999999999986 567999998643211122235678899999988 699999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++||+|.+++...+.+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++++||+|||+++......
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEE--CSSSCEEECCCTTCEECCCTT
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEE--cCCCcEEEeecceeeccccCC
Confidence 999999999999998889999999999999999999999988 9999999999999 888999999999998543222
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+......+ +..++++++
T Consensus 497 ~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 570 (674)
T 3pfq_A 497 V----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKSMSKEAV 570 (674)
T ss_dssp C----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC--CTTSCHHHH
T ss_pred c----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHHH
Confidence 1 2445789999999999999999999999999999999999999999999988888888765433 456899999
Q ss_pred HHHHHHhhhcccCCCCH-----HHHHHH
Q 013833 394 ELTEKCWAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~-----~~ll~~ 416 (435)
+||.+||+.||++||++ ++++++
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 777754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=359.39 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=198.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC--CcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~l 232 (435)
+|++.+.||+|+||.||+|.++ ++.||||++...... .....++.+|+.+++.+. ||||+++++++... ..+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 7899999999999999999985 789999988654333 344577889999999997 99999999998754 37899
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILL--NAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEESSSC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEE--cCCCCEEecCCccccccccc
Confidence 999996 599999976 47999999999999999999999988 9999999999999 88899999999999865431
Q ss_pred Cc-----------------cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 013833 313 NS-----------------HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374 (435)
Q Consensus 313 ~~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 374 (435)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 10 00112344679999999999976 6789999999999999999999999998887665544
Q ss_pred HHcCCCCC---------------------------------------------CCCCCCCHHHHHHHHHHhhhcccCCCC
Q 013833 375 VAEGHRPF---------------------------------------------FRAKGFTPELRELTEKCWAADMNQRPS 409 (435)
Q Consensus 375 ~~~~~~~~---------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps 409 (435)
+......+ .....+++++.+||.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 43211100 011267899999999999999999999
Q ss_pred HHHHHHH
Q 013833 410 FLDILKR 416 (435)
Q Consensus 410 ~~~ll~~ 416 (435)
+.|+++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=355.45 Aligned_cols=250 Identities=26% Similarity=0.484 Sum_probs=216.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc-----HHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 229 (435)
+|++.+.||+|+||.||+|.++ |+.||||++....... ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 5888899999999999999985 7899999886543221 22345688999999999 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++||||++|++|.+++.....+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.++|+|||++..+
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~--~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILL--DDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEEecCccccc
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..+.....
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 251 EPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 5432 2345679999999999853 3688899999999999999999999998888777777766654432
Q ss_pred CC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+ ..+++++.+||.+||+.||++|||+.+++++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 21 4678999999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=348.59 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=188.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 37889999999999999999974 7899999885422111122367889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEE--CTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEEeecceeeccCCC
Confidence 999999999999875 56999999999999999999999988 9999999999999 888899999999998765332
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.... ...+..++.+++
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 240 (278)
T 3cok_A 167 E----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAK 240 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTSCHHHH
T ss_pred C----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCccccCHHHH
Confidence 2 1234568999999999998899999999999999999999999998765443333222211 122346899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||+.||++|||+.+++++
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcccCHhhCCCHHHHhcC
Confidence 99999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=348.32 Aligned_cols=251 Identities=28% Similarity=0.518 Sum_probs=209.7
Q ss_pred CCCCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe----
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE---- 226 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---- 226 (435)
....+|++.+.||+|+||.||+|.+ .++.||+|++....... ..+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3455899999999999999999998 47899999886543322 5678999999999 79999999999876
Q ss_pred --CCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 227 --RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 227 --~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||++ +.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEE--cCCCCEEEee
Confidence 46789999999999999999864 46999999999999999999999988 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 377 (435)
||++........ ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.........+..
T Consensus 173 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 173 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp CTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 999986643221 123456899999999987 56788999999999999999999999998888777777777
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+......+++.+++||.+||..||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 666666667789999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=380.68 Aligned_cols=254 Identities=28% Similarity=0.522 Sum_probs=215.8
Q ss_pred ceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
+.||+|+||.||+|.+. ++.||||++...... ....+++.+|+.+|++++||||+++++++.. +.+++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999763 467999988654332 2334789999999999999999999999864 56899999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
+|+|.+++...+.+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+++.+...... ..
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~-~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 527 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEE--eCCCCEEEEEcCCccccccCccc-cc
Confidence 9999999998888999999999999999999999988 9999999999999 77889999999999876543221 11
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+.++..+ ..+++++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHHHHHHH
Confidence 2233457889999999999999999999999999999998 99999999998888888887766544 469999999999
Q ss_pred HHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 398 KCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+||+.||++|||+.++++.|+++..++
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=358.34 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=208.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l 232 (435)
...|++.+.||+|+||.||++.+. ++.||||++..... .....+.+.+|+.++++++ ||||+++++++...+.+|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 446999999999999999999876 77899998865443 3455678999999999997 5999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||| +.+++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||+ + ++.+||+|||++......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE--S-SSCEEECCCSSSCCC---
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--E-CCeEEEEecCccccccCC
Confidence 999 558899999998888999999999999999999999988 9999999999999 4 478999999999876533
Q ss_pred CccccccccCCCcCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCC
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHR 380 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~ 380 (435)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 208 TT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred Cc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 21 112345679999999999864 468899999999999999999999998754 3344444554443
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 381 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
....+...++++.+||.+||+.||++|||+.+++++-
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 3333455688999999999999999999999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.72 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=217.1
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 227 (435)
..+|++.+.||+|+||.||+|.+. ++.||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 458999999999999999999853 4679999986543 334456789999999999 689999999998765
Q ss_pred C-cEEEEEecCCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 228 K-PLMLITEYLRGGDLHKYLKEKGA----------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 228 ~-~~~lv~e~~~g~sL~~~l~~~~~----------------~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
+ .+++||||+++++|.+++..... +++.+++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~ 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE
Confidence 4 58999999999999999987543 889999999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCH-
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP- 368 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~- 368 (435)
+.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred --CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 7888999999999986643321 112334567889999999998999999999999999999998 9999987653
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 369 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
......+..+..+. .+..+++++.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 258 EEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 33344455544433 3356899999999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=349.37 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=207.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--C-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--G-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 227 (435)
.+|.+.+.||+|+||.||+|.++ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 47889999999999999999875 2 4699998854322 2346789999999999999999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc--------E
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--------L 298 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~--------v 298 (435)
+..++||||+++++|.+++...+. +++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL--IREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--EECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEE--ecCCccccccccee
Confidence 999999999999999999987654 999999999999999999999988 9999999999999 55554 9
Q ss_pred EEeeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 013833 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376 (435)
Q Consensus 299 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~ 376 (435)
||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++ |.+||.............
T Consensus 161 kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp EECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred eeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99999999765422 12347889999999987 778999999999999999999 556666666555444443
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 377 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
.... .+...++++++++.+||+.||++|||+.+++++|+++..
T Consensus 233 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCC---CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3222 223468899999999999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.40 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=212.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|...++||+|+||.||+|.++ ++.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 347889999999999999999985 789999998643222222236788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 234 TEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
|||++||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.+|++||+|||++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl--~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLL--DDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEE--eCCCCEEEeecceeeec
Confidence 9999999999999763 36999999999999999999999988 9999999999999 88999999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~ 385 (435)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+....+....... +
T Consensus 340 ~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~--p 413 (543)
T 3c4z_A 340 KAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--P 413 (543)
T ss_dssp CTTCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC--C
T ss_pred cCCCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC--C
Confidence 54321 233458999999999999999999999999999999999999999865 3345555555543332 3
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCH-----HHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSF-----LDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 416 (435)
..+++++++||.+||+.||++||++ .+++++
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 5689999999999999999999964 777754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=358.25 Aligned_cols=276 Identities=18% Similarity=0.242 Sum_probs=209.8
Q ss_pred CCCCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHH--------HHHHHHHHHHHHhCCCCcceee
Q 013833 154 PSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLV--------IQDFRHEVNLLVKLRHPNIVQF 220 (435)
Q Consensus 154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~ 220 (435)
....+|++.+.||+|+||.||+|.+. +..+|+|.+.......... ...+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 34458999999999999999999984 4689999886543221111 1235678899999999999999
Q ss_pred eeeEEe----CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 221 LGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 221 ~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
++++.. ....++||||+ +++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+..+..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCC
Confidence 999887 67899999999 9999999988778999999999999999999999988 9999999999999544444
Q ss_pred cEEEeeccCcccccccCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHH
Q 013833 297 HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEA 371 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~--~~~~~ 371 (435)
.+||+|||+++.+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987654332111 1124567999999999999999999999999999999999999999642 22221
Q ss_pred HH---HHHcCCCC----CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCccccc
Q 013833 372 AK---YVAEGHRP----FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWNIF 433 (435)
Q Consensus 372 ~~---~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~~ 433 (435)
.. ........ ......++++++++|.+||+.||++|||+.++++.|+++.-.+ ...+|+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~-~~~d~~~~ 338 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL-GPLDFSTK 338 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC-CCCCCCCT
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc-cCCCcccC
Confidence 11 11111110 0111268999999999999999999999999999998876533 34555543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=375.20 Aligned_cols=254 Identities=29% Similarity=0.541 Sum_probs=213.9
Q ss_pred eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.||+|+||.||+|.++ +..||||.+...... ...+.+.+|+++|++++||||+++++++.. +.+++||||+.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 7999999999999874 456999998754322 234788999999999999999999999876 568999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 240 ~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
|+|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++........ ..
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl--~~~~~vkL~DFGla~~~~~~~~~-~~ 494 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL--VNRHYAKISDFGLSKALGADDSY-YT 494 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCSTTTTCC--------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEE--cCCCcEEEeeccCcccccCCCce-ee
Confidence 9999999754 45999999999999999999999988 9999999999999 77889999999999876533221 11
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
......+|+.|+|||++....++.++|||||||++|||++ |..||.+....+....+..+.++..+ ..+++++.+||.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~ 573 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECPPELYALMS 573 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC-TTCCHHHHHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCHHHHHHHH
Confidence 1223346789999999998999999999999999999998 99999999888888888888766544 469999999999
Q ss_pred HHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 398 KCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+||+.||++||++.++++.|+.+...+..
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999998765544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=347.31 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=202.3
Q ss_pred CCCCC-ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.|++. +.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++.++ +||||+++++++.+++.+++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 57764 78999999999999974 7899999986543322 36788999999985 799999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc---EEEeeccCccccc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIK 310 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~---vkl~Dfg~a~~~~ 310 (435)
|||+++++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++. +||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILC--EHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--SCSSSSCSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--ccCCCcCceEEEEccCccccc
Confidence 999999999999998888999999999999999999999988 9999999999999 55544 9999999998664
Q ss_pred ccCccc---cccccCCCcCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH--------------
Q 013833 311 VQNSHD---VYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEP-------------- 368 (435)
Q Consensus 311 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------------- 368 (435)
...... ........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 322111 111234569999999999865 5688999999999999999999999976542
Q ss_pred -HHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 369 -YEAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 369 -~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+..+....... ..+++++++||.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 23344455544332211 3588999999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.00 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=207.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC--cEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 231 (435)
..+|++.+.||+|+||+||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 347899999999999999999987 7899999986433222 2366789999999999999999999987655 789
Q ss_pred EEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec--CCCCcEEEeeccCc
Q 013833 232 LITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLS 306 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--~~~~~vkl~Dfg~a 306 (435)
+||||+++++|.+++..... +++.+++.++.||+.||.|||++| |+||||||+|||+.. +..+.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999999986433 899999999999999999999988 999999999998732 44557999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccC--------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK--------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----YEAAKY 374 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~ 374 (435)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... .+....
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred eecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 8765432 223457899999999986 57789999999999999999999999964332 333333
Q ss_pred HHcCCCCC-----------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHH
Q 013833 375 VAEGHRPF-----------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421 (435)
Q Consensus 375 ~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 421 (435)
+..+..+. .....+++.+.++|.+||+.||++|||++|++++..+-.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 33332211 001123467899999999999999999999999988543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.38 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=193.9
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
.|.+. .+|++.+.||+|+||+||+|.++ ++.||||++..... .....+++.+|+.+|+.++||||+++++++..
T Consensus 48 ~~~~~---~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 48 DWQIP---DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp SCCSC---TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCccC---CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 45553 37999999999999999999876 77899998865433 34455789999999999999999999999843
Q ss_pred -----CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 227 -----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 227 -----~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
...+|+||||+ +++|.+++.....+++.+++.++.||+.||.|||+.| ||||||||+|||+ +.++.+||+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl--~~~~~~kl~ 198 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLV--NQDCSVKVC 198 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEEC
T ss_pred CCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEE--CCCCCEeec
Confidence 35689999998 5699999998888999999999999999999999988 9999999999999 888999999
Q ss_pred eccCcccccccCccc-----------------------cccccCCCcCccccCcccc-CCCCCCCcchHHHHHHHHHHHH
Q 013833 302 DFGLSKLIKVQNSHD-----------------------VYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEML 357 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~ 357 (435)
|||+++......... .......+||+.|+|||++ ....++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 999998765322110 0123456789999999986 5667999999999999999999
Q ss_pred c-----------CCCCCCCCCHH--------------------HHHHHHH-----------------------cCCCC--
Q 013833 358 E-----------GEPPLANYEPY--------------------EAAKYVA-----------------------EGHRP-- 381 (435)
Q Consensus 358 t-----------g~~p~~~~~~~--------------------~~~~~~~-----------------------~~~~~-- 381 (435)
+ |.++|.+.... +....+. .....
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 358 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence 9 67777654321 1111110 00000
Q ss_pred ----CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ----FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+++++.+||.+||..||++|||+.|+++|
T Consensus 359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00113468999999999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=343.14 Aligned_cols=251 Identities=32% Similarity=0.537 Sum_probs=219.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
..|++.+.||+|+||.||+|.+. ++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36889999999999999999975 7789999986544332 3477899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++++|.+++.. +.+++.++..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++........
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEE--CCCCCEEEeecccceecCcccc
Confidence 99999999999864 56999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+.. ...++..+.+
T Consensus 175 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ 249 (303)
T 3a7i_A 175 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-EGNYSKPLKE 249 (303)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-CSSCCHHHHH
T ss_pred ----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC-ccccCHHHHH
Confidence 23446789999999999999999999999999999999999999998888777777766655443 3568999999
Q ss_pred HHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 395 LTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
||.+||+.||++|||+.+++++..-
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhh
Confidence 9999999999999999999987543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=348.11 Aligned_cols=260 Identities=28% Similarity=0.473 Sum_probs=217.9
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
..+|++.+.||+|+||.||+|.+. +..||+|.+.... ......++.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 458999999999999999999842 5579999985432 3344567889999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEE
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKV 300 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl 300 (435)
..++||||+++++|.+++.... .+++.+++.++.||+.||.|||+.| |+||||||+|||+..+ ....++|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999998753 4899999999999999999999988 9999999999999322 3456999
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~ 379 (435)
+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+.
T Consensus 185 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred Cccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 99999986543321 111223457899999999988899999999999999999998 999999988888777777766
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 380 RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 380 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
.+.. +..+++.+.++|.+||+.||++|||+.+++++|+.+..
T Consensus 263 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 5543 45689999999999999999999999999999998875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=355.62 Aligned_cols=242 Identities=22% Similarity=0.364 Sum_probs=206.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|++.+.||+|+||.||+|.++ ++.||||.+........ .....+.+|+.++++++||||+++++++.+.+.+
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 7899999999999999999875 77899999876542211 1224567899999999999999999999999999
Q ss_pred EEEEecCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI--AEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEE--cCCCcEEEeecccceEC
Confidence 9999998766 99999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... . . .....+..+
T Consensus 181 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~-~--~~~~~~~~~ 247 (335)
T 3dls_A 181 ERGKL-----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V-E--AAIHPPYLV 247 (335)
T ss_dssp CTTCC-----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T-T--TCCCCSSCC
T ss_pred CCCCc-----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H-h--hccCCCccc
Confidence 54321 233568999999999988776 78999999999999999999999864321 1 1 112234568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++++.+||.+||+.||++|||+.+++++
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=348.86 Aligned_cols=262 Identities=29% Similarity=0.492 Sum_probs=214.3
Q ss_pred CCCCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE--eC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ER 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 227 (435)
..+|++.+.||+|+||.||++.+ .+..||+|.+... .....+.+.+|+.++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 34899999999999999999985 3678999988643 3444577899999999999999999999886 45
Q ss_pred CcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
...++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV--ESEAHVKIADFGLA 174 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCGGGC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEE--CCCCCEEEcccccc
Confidence 668999999999999999987 456999999999999999999999988 9999999999999 77889999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---------------HHH
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---------------YEA 371 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---------------~~~ 371 (435)
......... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 175 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 175 KLLPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp EECCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred eecccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 876543321 1123345688899999999988899999999999999999999999854332 122
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 372 AKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
...+..+..+. .+..+++++.+||.+||+.||++|||+.+++++|+.+......
T Consensus 254 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 254 LELLEEGQRLP-APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHhhcccCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 33344444333 3457899999999999999999999999999999988765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=348.18 Aligned_cols=257 Identities=29% Similarity=0.513 Sum_probs=203.6
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCcceeeeeeEEeC----CcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFLGAVTER----KPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~~~~ 231 (435)
+|++.+.||+|+||.||+|.++++.||||++.... ...+..|.+++... +||||+++++++... ..++
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 78999999999999999999999999999874321 13344555555554 899999999998877 6789
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC--------CCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE--------PNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~--------~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+||||+++++|.++++.. .+++.+++.++.|++.||.|||++ + |+||||||+|||+ +.++.+||+||
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kl~Df 186 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILV--KKNGTCCIADL 186 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEE--CTTSCEEECCC
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEE--CCCCCEEEEeC
Confidence 999999999999999754 699999999999999999999998 7 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCc------chHHHHHHHHHHHHcC----------CCCCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK------VDVFSFAMILYEMLEG----------EPPLANYE 367 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~il~~l~tg----------~~p~~~~~ 367 (435)
|++..................||+.|+|||++.+..++.. +|||||||++|||++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765443322222345679999999999987776665 9999999999999999 77775432
Q ss_pred H-----HHHHHHHH-cCCCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 368 P-----YEAAKYVA-EGHRPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 368 ~-----~~~~~~~~-~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
. ......+. ...++..+. ..+++++.+||.+||+.||++|||+.+++++|+.+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 1 12222222 222222221 2456789999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=343.16 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=198.3
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||+||++.+. ++.||+|.+..... .....+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457999999999999999999984 78899998865432 233334555666678889999999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
|||+++ +|.+++.. ...+++.+++.++.||+.||.|||++ | |+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLI--NALGQVKMCDFGISGY 159 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEE--CTTCCEEBCCC-----
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeecCCccc
Confidence 999975 88887754 45799999999999999999999997 8 9999999999999 8888999999999987
Q ss_pred ccccCccccccccCCCcCccccCcccc----CCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~ 383 (435)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||... ..............+..
T Consensus 160 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 160 LVDDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred ccccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 65432 12334689999999996 5567889999999999999999999999863 44444455555555555
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....+++++.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 556789999999999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=350.64 Aligned_cols=250 Identities=28% Similarity=0.482 Sum_probs=200.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 228 (435)
+|++.+.||+|+||.||+|.++ ++.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 6888999999999999999985 78899999865442 233477899999999999999999999886543
Q ss_pred --------------------------------------------------cEEEEEecCCCCCHHHHHHHcCC---CCHH
Q 013833 229 --------------------------------------------------PLMLITEYLRGGDLHKYLKEKGA---LSPS 255 (435)
Q Consensus 229 --------------------------------------------------~~~lv~e~~~g~sL~~~l~~~~~---~~~~ 255 (435)
..++||||++|++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987543 5666
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc--------ccccCCCcCc
Q 013833 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV--------YKMTGETGSY 327 (435)
Q Consensus 256 ~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~ 327 (435)
.++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........... .......||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999988 9999999999999 8888999999999987764422111 1233457999
Q ss_pred cccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 013833 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR 407 (435)
Q Consensus 328 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 407 (435)
.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+.....+.. ....++++++||.+||+.||++|
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCCcC
Confidence 99999999999999999999999999999998876432 2222333333332221 13456789999999999999999
Q ss_pred CCHHHHHHH
Q 013833 408 PSFLDILKR 416 (435)
Q Consensus 408 ps~~~ll~~ 416 (435)
||+.+++++
T Consensus 318 ps~~~~l~~ 326 (332)
T 3qd2_B 318 PEATDIIEN 326 (332)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhhc
Confidence 999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=345.43 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=203.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc--HHHHHHHHHHHHHHHhC---CCCcceeeeeeEEeCC-
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERK- 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~- 228 (435)
.+|++.+.||+|+||+||+|.+. ++.||+|.+....... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 47999999999999999999964 7889999886432111 01113455666666655 5999999999987755
Q ss_pred ----cEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 229 ----PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 229 ----~~~lv~e~~~g~sL~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.+++||||+. ++|.+++..... +++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~D 163 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGTVKLAD 163 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEE--CTTSCEEECS
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEEee
Confidence 4799999996 599999987554 999999999999999999999988 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 164 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 164 FGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998664332 2234578999999999999999999999999999999999999999888776665554321100
Q ss_pred C-------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 F-------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ~-------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....+++++.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 012578999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=358.88 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=195.2
Q ss_pred CCCCC-ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHH-hCCCCcceeeeeeEEe----CCc
Q 013833 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTE----RKP 229 (435)
Q Consensus 158 ~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~ 229 (435)
+|.+. ++||+|+||+||++.++ ++.||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 45555 68999999999999986 778999988531 45667888874 4589999999998865 567
Q ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCc
Q 013833 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a 306 (435)
+|+||||++||+|.+++...+ .+++.++..++.||+.||.|||+.| |+||||||+|||+..+ .++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 899999999999999998643 5999999999999999999999988 9999999999999321 1688999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEGHRPF 382 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~ 382 (435)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+..+....
T Consensus 212 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 212 KETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp EECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 8654322 2345678999999999999999999999999999999999999997654321 223333333222
Q ss_pred --CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 383 --FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 383 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
.....+++++++||.+||+.||++|||+.+++++-.
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 122468999999999999999999999999998744
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=346.20 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=209.0
Q ss_pred CCCCceeecCCceeEEEEEECCCcEEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
|...+.||+|+||.||+|.++++.||+|.+..... ......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 45568999999999999999999999998865432 22334578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 238 RGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 238 ~g~sL~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCSCSS
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--cCCCcEEEeecccccccccccc
Confidence 99999999974 345899999999999999999999988 9999999999999 8888999999999986553321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCC---------C
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHR---------P 381 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~---------~ 381 (435)
........||+.|+|||.+.+ .++.++||||||+++|+|++|..||...... .....+..... .
T Consensus 189 --~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 189 --TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp --CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred --cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 112334578999999999875 5889999999999999999999999765422 11122211110 0
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
...+...++.+.+++.+||+.||++|||+.+++++|+++..
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11112345679999999999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.66 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=214.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 232 (435)
.+|++.+.||+|+||.||++.++ ++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+ +...++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 37899999999999999999985 778999998654433 3445789999999999999999999998743 567899
Q ss_pred EEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCC---CceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 233 ITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ .+|+||||||+||++ +.++.+||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGL 162 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEECCCCH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEecCch
Confidence 99999999999999753 34999999999999999999999964 239999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+..+..+.. +
T Consensus 163 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~ 237 (279)
T 2w5a_A 163 ARILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-P 237 (279)
T ss_dssp HHHC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-C
T ss_pred heeeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC-C
Confidence 986643321 12234689999999999988999999999999999999999999999888887777777766543 3
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
..+++++.++|.+||+.||++|||+.++++++.
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 468999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.92 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=207.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 37899999999999999999986 77899998865443 3444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+++++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEE--cCCCcEEEEeCCCceeecCCcc
Confidence 99999999998887778999999999999999999999988 9999999999999 8888999999999986654322
Q ss_pred cccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------------- 379 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 379 (435)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+....
T Consensus 180 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 180 ----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 23345789999999999765 78999999999999999999999999887665443332110
Q ss_pred -------CCCCC--------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 -------RPFFR--------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 -------~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+... ...+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 12578999999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=352.71 Aligned_cols=267 Identities=28% Similarity=0.521 Sum_probs=219.3
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
.|++. ..+|++.+.||+|+||.||+|.+++ .+|+|.+....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~i~--~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIP--FEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSC--CSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCC--HHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44444 4478999999999999999999876 49999886543222 12255778999999999999999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++||||++|++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+||++ + ++.++|+|||++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~--~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--D-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEE--C---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEE--e-CCCEEEeecCCcc
Confidence 9999999999999999998754 6899999999999999999999988 9999999999999 5 5789999999987
Q ss_pred cccccCcc-ccccccCCCcCccccCccccCC---------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 013833 308 LIKVQNSH-DVYKMTGETGSYRYMAPEVFKH---------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 308 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 377 (435)
........ .........|++.|+|||++.. ..++.++||||||+++|+|++|..||...........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 65432111 1112334568999999999864 4578899999999999999999999999888888888888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
+..+......+++++.+++.+||..||++|||+.++++.|+++.++.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 87777666678999999999999999999999999999999888754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=350.25 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=207.6
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
++.....+|++.+.||+|+||.||+|.++ ++.||+|.+....... ....+.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 34445668999999999999999999875 7899999986543221 11368899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhcC---CCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 230 LMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++ | |+||||||+|||+ +.++.+||+|
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~--~~~~~~kl~D 177 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILL--DEEFEAVVGD 177 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEE--CTTCCEEECC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEE--CCCCCEEecc
Confidence 999999999999999998643 389999999999999999999998 7 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHc
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAE 377 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-----~~~~~~~~~~~ 377 (435)
||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+..
T Consensus 178 fg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 178 FGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CSSCEECCSSSSC---EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred CccccccCccccc---ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999876533221 233456999999999998888999999999999999999999999521 11011111111
Q ss_pred CCCC----CC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 378 GHRP----FF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 378 ~~~~----~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
.... .. .....++.+.+++.+||+.||++|||+.+++++|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 00 001123679999999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.86 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=216.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC------cHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD------DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 227 (435)
.+|++.+.||+|+||.||+|.++ ++.||||.+...... .....+.+.+|+.+++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 47999999999999999999985 678999998654311 1223466889999999996 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
...++||||+++++|.+++.....+++.+++.++.||+.||.|||+.| ++||||||+||++ +.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSC 172 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--cCCCcEEEecccchh
Confidence 999999999999999999998888999999999999999999999988 9999999999999 888899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
...... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...........+..+...
T Consensus 173 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 173 QLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred hcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 765332 233457899999999984 456889999999999999999999999988887777776665443
Q ss_pred CCCC--CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FFRA--KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+ ..+++++.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 3222 3589999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=352.01 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=204.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||+|.+...... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6889999999999999999986 778999988543321 111245579999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|++ ++|.+++...+ .+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEE--CTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEE--CCCCCEEEccCcccccccCCcc
Confidence 996 59999988754 5899999999999999999999988 9999999999999 8888999999999976543321
Q ss_pred cccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC----------
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF---------- 383 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 383 (435)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 2334578999999999876 5689999999999999999999999999887766555433111100
Q ss_pred ------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhhCCC
Q 013833 384 ------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKETLPT 426 (435)
Q Consensus 384 ------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~~~ 426 (435)
....+++++++||.+||+.||++|||+.|++++ +..+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence 012468899999999999999999999999985 5555554443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=350.90 Aligned_cols=266 Identities=16% Similarity=0.229 Sum_probs=214.7
Q ss_pred CCCCCCCCCCceeecCCceeEEEEEEC----------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccee---
Q 013833 153 DPSELDFSSSAIIGKGSFGEILKAYWR----------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ--- 219 (435)
Q Consensus 153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~--- 219 (435)
+....+|++.+.||+|+||.||+|.+. ++.||+|.+... +.+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhh
Confidence 344568999999999999999999975 578999988543 35778999999999999988
Q ss_pred ------------eeeeEEe-CCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 013833 220 ------------FLGAVTE-RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (435)
Q Consensus 220 ------------~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlk 284 (435)
+++++.. +...++||||+ +++|.+++... +.+++.+++.++.||+.||.|||++| |+|||||
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dik 186 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVT 186 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCC
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCC
Confidence 5666665 67889999999 99999999875 67999999999999999999999988 9999999
Q ss_pred CCcEEEecCCCC--cEEEeeccCcccccccCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcC
Q 013833 285 PRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359 (435)
Q Consensus 285 p~NIll~~~~~~--~vkl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg 359 (435)
|+|||+ +.++ .+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 187 p~NIl~--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 187 AENIFV--DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp GGGEEE--ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEE--cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999 6666 899999999987664432111 112345799999999999999999999999999999999999
Q ss_pred CCCCCCCC--HHHHHHH---HHcCCCCCCC----CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----
Q 013833 360 EPPLANYE--PYEAAKY---VAEGHRPFFR----AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT---- 426 (435)
Q Consensus 360 ~~p~~~~~--~~~~~~~---~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~---- 426 (435)
..||.... ....... +......... ...+++++.+||.+||+.||++|||+.++++.|+++.++...
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD 344 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence 99998753 2222221 2222221111 125789999999999999999999999999999999987643
Q ss_pred CCccc
Q 013833 427 DHHWN 431 (435)
Q Consensus 427 ~~~~~ 431 (435)
+.+|.
T Consensus 345 ~~dw~ 349 (352)
T 2jii_A 345 PIGLP 349 (352)
T ss_dssp CCCCC
T ss_pred cccCc
Confidence 35564
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=340.26 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=210.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 6888899999999999999986 788999988544332 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+++++|.+++.....+++.+++.++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEE--ccCCCEEEeeCCCccccCCCcch
Confidence 9999999999987778999999999999999999999988 9999999999999 88889999999999876543211
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...... ..................+++.+.
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 162 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp --CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred --hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 12345678999999999987665 67899999999999999999999876542 222233333222222346899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++|.+||+.||++|||+.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCCchhCCCHHHHhcC
Confidence 99999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.11 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=202.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
.+|++.+.||+|+||.||+|.++ |+.||||++..... .....+++.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47999999999999999999985 78999999865443 3445578899999999999999999999987653
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEE--cCCCCEEEEeeecccc
Confidence 469999999 8899999976 56999999999999999999999988 9999999999999 8889999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCC----
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRP---- 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~---- 381 (435)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... ..+
T Consensus 178 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5422 334678999999999876 67999999999999999999999999988766554443321 000
Q ss_pred ---------------------C--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ---------------------F--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ---------------------~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .....+++++.+||.+||..||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 0113578999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.06 Aligned_cols=248 Identities=26% Similarity=0.498 Sum_probs=210.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||+|.++ ++.||+|.+..... .+.+.+|+.++++++||||+++++++......++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 447899999999999999999986 78999998865332 25678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||+++++|.+++.. ...+++.+++.++.||+.||.|||+.| ++|+||||+||++ +.++.++|+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEE--CCCCCEEEeecccchhhhhh
Confidence 999999999999974 567999999999999999999999988 9999999999999 88889999999999766533
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCHH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGFTPE 391 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 391 (435)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.....+.. .+..+++.
T Consensus 179 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T 3com_A 179 MA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDN 254 (314)
T ss_dssp BS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHH
Confidence 21 23345789999999999999999999999999999999999999998887766665555544332 23457899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 392 LRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 392 l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.+||.+||..||++|||+.+++++
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=337.11 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=205.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||.||+|.+. ++.||+|.+........ ....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6888999999999999999985 78999999876544443 346788899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-----------------
Q 013833 235 EYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS----------------- 293 (435)
Q Consensus 235 e~~~g~sL~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~----------------- 293 (435)
||+++++|.+++... +.+++.+++.++.||+.||.|||++| |+||||||+|||+..+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999764 67999999999999999999999988 9999999999999321
Q ss_pred CCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 013833 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (435)
Q Consensus 294 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 372 (435)
....++|+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+..... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp -CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred CceEEEEcccccccccCCc--------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 3447999999999876532 224589999999999765 566899999999999999999987765433 3
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 373 KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+..+..+.. +..++++++++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 HEIRQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHTTCCCCC-SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHcCCCCCC-CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 34455554443 35689999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=339.77 Aligned_cols=250 Identities=30% Similarity=0.520 Sum_probs=208.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe---------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------- 226 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 226 (435)
+|++.+.||+|+||.||++.+. ++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 6888999999999999999986 7899999886432 346789999999999999999998754
Q ss_pred -------CCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc
Q 013833 227 -------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (435)
Q Consensus 227 -------~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~ 297 (435)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFL--VDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEE--cCCCC
Confidence 44589999999999999999764 57999999999999999999999988 9999999999999 77789
Q ss_pred EEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 013833 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (435)
Q Consensus 298 vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 377 (435)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+..
T Consensus 161 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred EEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 9999999998765432 123456899999999999999999999999999999999999887532 222333333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCCc
Q 013833 378 GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDHH 429 (435)
Q Consensus 378 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~ 429 (435)
... +..++++++++|.+||+.||++|||+.+++++|..+++...+.+.
T Consensus 234 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 234 GII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp TCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 322 245899999999999999999999999999999999987776554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=351.12 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=207.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 226 (435)
.+|++.+.||+|+||.||+|.++ ++.||+|++........ ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 37999999999999999999985 78999998865443321 22567789999999999999999999876
Q ss_pred CCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 227 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
.+.+++||||+++ +|.+.+.. ...+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCCEEEccchh
Confidence 3468999999975 78777765 356999999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---CC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---RP 381 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~ 381 (435)
+..................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... .+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98765433322223445678999999999876 568999999999999999999999999888766655544321 11
Q ss_pred CCCCC---------------------------CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FFRAK---------------------------GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~~~~---------------------------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+. ..++++.+||.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11110 026789999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=365.11 Aligned_cols=249 Identities=14% Similarity=0.230 Sum_probs=198.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHH---HHHHhCCCCcceeee-------ee
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFL-------GA 223 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~-------~~ 223 (435)
..+|++.+.||+|+||+||+|.+. ++.||||++...........+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457899999999999999999964 889999998765444444557889999 555666899999998 66
Q ss_pred EEeCC-----------------cEEEEEecCCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHhcCCCceE
Q 013833 224 VTERK-----------------PLMLITEYLRGGDLHKYLKEKGALSP-------STAVNFALDIARGMAYLHNEPNVII 279 (435)
Q Consensus 224 ~~~~~-----------------~~~lv~e~~~g~sL~~~l~~~~~~~~-------~~~~~~~~qi~~~l~~LH~~~~~iv 279 (435)
+.+.+ ..|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||++| |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 65543 379999999 6799999987655555 788889999999999999988 99
Q ss_pred eCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCC-----------CCCCcchHHH
Q 013833 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFS 348 (435)
Q Consensus 280 H~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s 348 (435)
||||||+|||+ +.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 229 HrDikp~NIll--~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 229 HTYLRPVDIVL--DQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp CSCCCGGGEEE--CTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred cCCCCHHHEEE--cCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999 8889999999999985332 2234567 999999999877 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHHhh
Q 013833 349 FAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIKET 423 (435)
Q Consensus 349 lG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~ 423 (435)
|||++|+|++|..||.+.........+... ...+++++.+||.+||+.||++|||+.+++++ +..+.+.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 999999999999999765543322222211 24689999999999999999999999999974 5555443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.60 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=206.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----CCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||+||+|.+. ++.||||++.. .......+..|+.+++.++ ||||+++++++...+.
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 47999999999999999999984 77899998853 2334466788999999997 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec---------------
Q 013833 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--------------- 292 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--------------- 292 (435)
.++||||+ +++|.+++.... .+++.++..++.||+.||.|||++| |+||||||+|||+..
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccc
Confidence 99999999 889999998754 5999999999999999999999988 999999999999932
Q ss_pred --------CCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 293 --------SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 293 --------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
..++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 12778999999999864432 234578999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCCC--------------------------------------------CCCCCHHHHHHHHHHh
Q 013833 365 NYEPYEAAKYVAEGHRPFFR--------------------------------------------AKGFTPELRELTEKCW 400 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~l~~li~~cl 400 (435)
..+..+....+.....+... ....++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 88776655544432221110 0012377889999999
Q ss_pred hhcccCCCCHHHHHHH
Q 013833 401 AADMNQRPSFLDILKR 416 (435)
Q Consensus 401 ~~dp~~Rps~~~ll~~ 416 (435)
+.||++|||+.+++++
T Consensus 341 ~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 341 QIDPTLRPSPAELLKH 356 (360)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=365.71 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=199.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++++.||+|+||+||+|.+. ++.||||++..... .....+++.+|+.+++.++||||+++++++... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 37999999999999999999985 77899999865432 344557888999999999999999999998654 3
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+||||+++ +|.+.+.. .+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEE--eCCCCEEEEEEEeeee
Confidence 57999999966 67777643 4899999999999999999999988 9999999999999 8889999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------- 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------- 381 (435)
..... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus 214 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 214 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ---CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 65332 234567999999999999999999999999999999999999999988876655444321110
Q ss_pred --------------CCCCCC-------------------CCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 --------------FFRAKG-------------------FTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 --------------~~~~~~-------------------~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...... .++++++||.+||+.||++|||+.|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 14678999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=355.40 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=199.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----Cc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 229 (435)
.+|++.+.||+|+||.||+|.++ ++.||||++..... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 37999999999999999999986 67899999865433 344557889999999999999999999998766 57
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+|+||||+. ++|.+++.....+++.+++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl--~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLL--NQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEE--CCCCCEEEccCCCcccc
Confidence 899999995 599999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred cccCcccc------------------ccccCCCcCccccCcccc-CCCCCCCcchHHHHHHHHHHHHcC-----------
Q 013833 310 KVQNSHDV------------------YKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEG----------- 359 (435)
Q Consensus 310 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~tg----------- 359 (435)
........ .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 54321100 123556899999999986 566799999999999999999984
Q ss_pred CCCCCCCCH-----------------HH------------------------HHHHHHcCCCCCC-----CCCCCCHHHH
Q 013833 360 EPPLANYEP-----------------YE------------------------AAKYVAEGHRPFF-----RAKGFTPELR 393 (435)
Q Consensus 360 ~~p~~~~~~-----------------~~------------------------~~~~~~~~~~~~~-----~~~~~~~~l~ 393 (435)
.++|.+... .+ ....+........ ....+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444443321 00 1111111100000 0135799999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||+.|++++
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=341.70 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=209.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ +..||+|.+...... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 37899999999999999999986 778999988654322 2467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
||+++++|.+++.. ...+++.++..++.||+.||.|||+.| ++||||||+||++ +.++.+||+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTSCEEECCCHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--CCCCCEEEEECCCCccccccc
Confidence 99999999999876 456999999999999999999999988 9999999999999 888899999999876443221
Q ss_pred ccccccccCCCcCccccCcccc-----CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-FRAKG 387 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 387 (435)
. ......||+.|+|||++ ....++.++||||||+++|+|++|..||...........+.....+. ..+..
T Consensus 172 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 172 Q----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp H----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred c----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 1 12345689999999998 46778999999999999999999999999988877766666555443 23456
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++.++.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 89999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.03 Aligned_cols=250 Identities=31% Similarity=0.533 Sum_probs=214.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||.||+|.++ ++.||+|.+........ ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 7889999999999999999985 77899998865433221 23678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++++|.+++...+.+++.+++.++.||+.||.|||++| ++||||||+||++..+ .++.+||+|||++........
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999999999988888999999999999999999999988 9999999999999332 244799999999986643321
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 392 (435)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+....+..+......+ ..+++++
T Consensus 180 -----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 180 -----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp -----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred -----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 223458899999999875 48999999999999999999999999988888777777665443222 4689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.++|.+||+.||++|||+.+++++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcccChhhCcCHHHHhcC
Confidence 999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=349.83 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=203.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc--HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
..+|++.+.||+|+||.||+|.+. ++.||+|.+....... ......+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 347999999999999999999985 7889999986533221 112246789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+||||+++ +|.+++.... .+++.++..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||++....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTT
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEE--cCCCCEEEEecccceecc
Confidence 99999976 8999887643 6899999999999999999999988 9999999999999 888999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CC---C--
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PF---F-- 383 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~---~-- 383 (435)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+..... +. .
T Consensus 164 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 3322 2344678999999999965 4588999999999999999999999998887766555443110 00 0
Q ss_pred --------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 --------------------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 --------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....+++++++||.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 003467899999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=346.85 Aligned_cols=249 Identities=21% Similarity=0.375 Sum_probs=208.6
Q ss_pred CCCCC-ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEE
Q 013833 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 158 ~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 233 (435)
+|.+. +.||+|+||.||+|.++ ++.||+|++........ ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 45555 78999999999999986 78999998865433322 2367889999999995 69999999999999999999
Q ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC---CCcEEEeeccCccc
Q 013833 234 TEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGDFGLSKL 308 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~---~~~vkl~Dfg~a~~ 308 (435)
|||+++++|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +. ++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~--~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILL--SSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--SCBTTBCCEEECCGGGCEE
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEE--ecCCCCCcEEEeeCccccc
Confidence 999999999999864 356999999999999999999999988 9999999999999 54 68999999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--CCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAK 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 386 (435)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ....
T Consensus 184 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 184 IGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp C--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 65332 1234578999999999999999999999999999999999999999988877766665543322 2234
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+++.+++||.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 689999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=338.50 Aligned_cols=268 Identities=20% Similarity=0.291 Sum_probs=213.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE-EeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|++...... +.+.+|+.+++.++|++++..+.++ ..+...++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 37899999999999999999974 789999987654332 3578899999999998876666554 667788999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEe-cCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+. .+.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 8999999984 457999999999999999999999988 99999999999992 12667899999999987665
Q ss_pred cCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCC---CCC
Q 013833 312 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGH---RPF 382 (435)
Q Consensus 312 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~---~~~ 382 (435)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+... ......+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 432111 112445799999999999999999999999999999999999999986432 11111111111 101
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCcccc
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 432 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 432 (435)
.....+|+++.+++.+||+.||++|||+.++++.|+++..+... .-+|..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 11246899999999999999999999999999999999876654 245654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=345.57 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=210.1
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CC
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RK 228 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 228 (435)
...+|++.+.||+|+||.||++.+. ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 3458999999999999999999974 789999987542 34455788999999999999999999999862 34
Q ss_pred cEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeecc
Q 013833 229 PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg 304 (435)
..++||||+.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~dfg 179 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCCEEEEecC
Confidence 78999999999999999976 456999999999999999999999988 9999999999999 888899999999
Q ss_pred CcccccccCccc-----cccccCCCcCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH
Q 013833 305 LSKLIKVQNSHD-----VYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKY 374 (435)
Q Consensus 305 ~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~ 374 (435)
++.......... ........||+.|+|||++.... ++.++||||||+++|+|++|..||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 987654221100 00112235799999999987554 68999999999999999999999953211 011122
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCC
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPTD 427 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 427 (435)
+.... .......+++++.++|.+||+.||++|||+.+++++|+.+....+..
T Consensus 260 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 22222 22233568999999999999999999999999999999987666553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=361.91 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=198.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|.+.+.||+|+||.||+|.++ ++.||+|++.+.... .......+.+|+.+|++++||||+++++++.. +..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence 6889999999999999999986 678999988653211 11222357899999999999999999999754 458
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+..+ .+..+||+|||+++..
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 999999999999999988888999999999999999999999988 9999999999999332 2346999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRA 385 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 385 (435)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+..+.....+.
T Consensus 293 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 293 GETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp C----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred CCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 5322 2345679999999999853 56788999999999999999999999765432 2334444444333221
Q ss_pred --CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 --KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 --~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+++.+.+||.+||+.||++|||+.+++++
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 4689999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=352.79 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=208.2
Q ss_pred CCCCCCceeecCCceeEEEEEE-----CCCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||.||++.+ .++.||||++...... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4799999999999999999997 4788999988643211 111124567899999999 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+++||||+++++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCcEEEeeCCCCeec
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88899999999999865
Q ss_pred cccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~ 383 (435)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+.....+.
T Consensus 210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 285 (355)
T 1vzo_A 210 VADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY- 285 (355)
T ss_dssp CGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC-
T ss_pred ccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC-
Confidence 433221 2234578999999999985 45789999999999999999999999643 2334444444433322
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCC-----CHHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRP-----SFLDILKRL 417 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~L 417 (435)
+..+++.+++||.+||..||++|| ++.+++++.
T Consensus 286 -~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 286 -PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 356899999999999999999999 999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=344.70 Aligned_cols=261 Identities=30% Similarity=0.551 Sum_probs=214.5
Q ss_pred CCCCCCCceeecCCceeEEEEEE------CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC--
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-- 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 227 (435)
..+|++.+.||+|+||.||++.+ .++.||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 45789999999999999999985 3678999998653 234457899999999999999999999988654
Q ss_pred CcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
..+++||||+++++|.+++... ..+++.+++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--cCCCcEEEecCcch
Confidence 3789999999999999999875 45999999999999999999999988 9999999999999 77789999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----------------HH
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----------------YE 370 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----------------~~ 370 (435)
......... ........++..|+|||.+.+..++.++||||||+++|+|++|..||..... ..
T Consensus 193 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 876543221 1112334578889999999888899999999999999999999998863211 01
Q ss_pred HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 371 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
....+..+.++. .+..+++++.++|.+||+.||++|||+.++++.|+++.+++.
T Consensus 272 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 272 LIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 223333333333 345789999999999999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=345.38 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=208.8
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHh--CCCCcceeeeeeEEeCC----cEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~ 231 (435)
+|++.+.||+|+||.||++.++++.||||.+... ....+.+|++++.. ++||||+++++++.... ..+
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 6889999999999999999999999999988532 12567788888887 78999999999998775 789
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH--------~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+||||+++++|.+++.+. .+++.+++.++.|++.||.||| +.+ |+||||||+|||+ +.++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll--~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV--KKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEE--CCCCCEEEEEC
Confidence 999999999999999764 6899999999999999999999 766 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCC------CCCcchHHHHHHHHHHHHcC----------CCCCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEG----------EPPLANYE 367 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~~l~tg----------~~p~~~~~ 367 (435)
|++..................||+.|+|||++.+.. ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876544322111234567999999999997652 33689999999999999999 78886642
Q ss_pred -----HHHHHHHHHcC-CCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 368 -----PYEAAKYVAEG-HRPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 368 -----~~~~~~~~~~~-~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
.......+... .++..+. ..+++.+.+++.+||+.||++|||+.+++++|+++.++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 23333333332 2232221 123467999999999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.56 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=197.7
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEE--
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVT-- 225 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-- 225 (435)
.+.....+|++.+.||+|+||.||++.+ .++.||+|.+... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3444566899999999999999999998 4789999987443 3444577899999999996 999999999984
Q ss_pred ------eCCcEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC
Q 013833 226 ------ERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (435)
Q Consensus 226 ------~~~~~~lv~e~~~g~sL~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~ 296 (435)
....+++||||+. |+|.+++.. .+.+++.+++.++.||+.||.|||+++++|+||||||+|||+ +.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~ 175 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQG 175 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTS
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCC
Confidence 3345899999995 699998865 456999999999999999999999976569999999999999 8888
Q ss_pred cEEEeeccCcccccccCcccc--------ccccCCCcCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 013833 297 HLKVGDFGLSKLIKVQNSHDV--------YKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (435)
Q Consensus 297 ~vkl~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 365 (435)
.+||+|||++........... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999987654322110 011244689999999998 566788999999999999999999999986
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 366 YEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
....... ............+..+.+||.+||+.||++|||+.+++++|+.+......
T Consensus 256 ~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 256 GAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred hhHHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 5543322 22222333456788899999999999999999999999999999875544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=335.90 Aligned_cols=269 Identities=20% Similarity=0.292 Sum_probs=211.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeE-EeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 233 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|++...... ..+.+|+.+++.++|++++..+..+ ..+...++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 37899999999999999999974 778999976543222 3577899999999988877766655 667788999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEe-cCCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+. .+.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 8999999985 456999999999999999999999988 99999999999992 23567899999999987655
Q ss_pred cCcccc---ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCC---CCC
Q 013833 312 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGH---RPF 382 (435)
Q Consensus 312 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~---~~~ 382 (435)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.... .....+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 432111 1233567999999999999999999999999999999999999999764321 1111111111 111
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCccccc
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNIF 433 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~~ 433 (435)
.....+|+++.+++.+||+.||++|||+.++++.|+++.++... .-+|...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 11246799999999999999999999999999999999976543 3567643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=347.75 Aligned_cols=248 Identities=26% Similarity=0.342 Sum_probs=198.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
.+|++.+.||+|+||.||+|.+. ++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37999999999999999999985 77899999865433 3445577889999999999999999999987654
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+++||||+++ +|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEEEeecccc
Confidence 68999999965 8888885 35899999999999999999999988 9999999999999 8888999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-----
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF----- 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 383 (435)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 177 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54321 22345789999999999999999999999999999999999999998887666655544322110
Q ss_pred ----------------CC-------------C------CCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 384 ----------------RA-------------K------GFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 384 ----------------~~-------------~------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
.. . ..++++++||.+||+.||++|||+.+++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 0 0146789999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=349.74 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=202.9
Q ss_pred CCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe------
Q 013833 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------ 226 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 226 (435)
...+|++.+.||+|+||+||+|.+. ++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3458999999999999999999984 789999988654322 2369999999999999999998843
Q ss_pred --------------------------------CCcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Q 013833 227 --------------------------------RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAY 270 (435)
Q Consensus 227 --------------------------------~~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~ 270 (435)
...+++||||+++ +|.+++.. ...+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348899999975 87777653 5679999999999999999999
Q ss_pred HhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHH
Q 013833 271 LHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFS 348 (435)
Q Consensus 271 LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s 348 (435)
||++| |+||||||+|||+ + .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||
T Consensus 157 LH~~g--i~H~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHTTT--EECSCCCGGGEEE--ETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHCc--CccCccCHHHEEE--cCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99988 9999999999999 5 56799999999998764432 22345789999999998765 5899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------------------CCCC--------CCCCCCHHHHHHHHHHhh
Q 013833 349 FAMILYEMLEGEPPLANYEPYEAAKYVAEGH-------------------RPFF--------RAKGFTPELRELTEKCWA 401 (435)
Q Consensus 349 lG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~~~~--------~~~~~~~~l~~li~~cl~ 401 (435)
|||++|+|++|..||.+....+....+.... .+.. .+..+++++.+||.+||+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999888766554443210 0000 123578999999999999
Q ss_pred hcccCCCCHHHHHHH--HHHHHh
Q 013833 402 ADMNQRPSFLDILKR--LEKIKE 422 (435)
Q Consensus 402 ~dp~~Rps~~~ll~~--L~~~~~ 422 (435)
.||++|||+.|++++ +..+++
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999965 555544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.91 Aligned_cols=260 Identities=29% Similarity=0.461 Sum_probs=198.6
Q ss_pred CCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHH--HHhCCCCcceeeeeeEEe-----CCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLRHPNIVQFLGAVTE-----RKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-----~~~ 229 (435)
.+|++.+.||+|+||.||+|.++++.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 378999999999999999999999999999885321 1333444444 456899999999985532 235
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC---------CCceEeCCCCCCcEEEecCCCCcEEE
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------PNVIIHRDLKPRNVLLVNSSADHLKV 300 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---------~~~ivH~Dlkp~NIll~~~~~~~vkl 300 (435)
+++||||+++|+|.+++.... .++..+..++.||+.||.|||+. + |+||||||+|||+ +.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV--KNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE--CTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE--cCCCcEEE
Confidence 789999999999999997654 58899999999999999999998 7 9999999999999 88889999
Q ss_pred eeccCcccccccCcc----ccccccCCCcCccccCccccCC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-
Q 013833 301 GDFGLSKLIKVQNSH----DVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLEGEPPLANYEP- 368 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~- 368 (435)
+|||++......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 999999876532211 1112234579999999999986 4566789999999999999999766532111
Q ss_pred -----------------HHHHHHHHc-CCCCCCCC-----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 369 -----------------YEAAKYVAE-GHRPFFRA-----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 369 -----------------~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
......+.. ..++.++. ..+++++.+||.+||+.||++|||+.++++.|+++.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 111111222 22222211 1134579999999999999999999999999999998766
Q ss_pred CC
Q 013833 426 TD 427 (435)
Q Consensus 426 ~~ 427 (435)
++
T Consensus 322 ~~ 323 (336)
T 3g2f_A 322 RN 323 (336)
T ss_dssp C-
T ss_pred hc
Confidence 64
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=346.69 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=206.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----Cc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 229 (435)
.+|++.+.||+|+||.||++.+. +..||||.+... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 37999999999999999999985 678999988643 2344557889999999999999999999998654 46
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++||||+. ++|.+++.. +.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEE--CCCCCEEEEeCcceEec
Confidence 899999996 599999975 46999999999999999999999988 9999999999999 88889999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------- 381 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------- 381 (435)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......
T Consensus 179 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 5432211 12344579999999998754 55899999999999999999999999887755544333211000
Q ss_pred -----------------CC-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -----------------FF-----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -----------------~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ....+++++.+||.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 013578999999999999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.00 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=194.0
Q ss_pred CCCCCCCceeecCCceeEEEEEE--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||.||++.+ ++..||+|.+..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34899999999999999999987 478999998754332 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 234 TEYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
|||+++++|.+++.. .+.+++.+++.++.||+.||.|||+.| |+||||||+||++ +.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILL--GEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEE--cCCCCEEEEeccc
Confidence 999999999999974 345899999999999999999999988 9999999999999 8888999999999
Q ss_pred cccccccCccc-cccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 306 SKLIKVQNSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 306 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+.......... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.................+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 97665432111 111234568999999999875 5689999999999999999999999998776555444443332221
Q ss_pred --------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 --------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 --------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....++++++++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 124578999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.09 Aligned_cols=251 Identities=22% Similarity=0.399 Sum_probs=208.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-cHHHHHHHHHHHHHHHhCCCCcceeeeeeE--EeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAV--TERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~l 232 (435)
+|++.+.||+|+||.||++.+. +..||+|.+...... .......+.+|+.++++++||||+++++++ .+....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 7999999999999999999985 678999988543211 112346789999999999999999999998 44568899
Q ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 233 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
||||+.++ |.+++.. ...+++.+++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~--~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLL--TTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--cCCCcEEeeccccccccC
Confidence 99999775 8888775 446999999999999999999999988 9999999999999 888999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+....+....+..+.... +..+
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~ 236 (305)
T 2wtk_C 161 PFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI--PGDC 236 (305)
T ss_dssp TTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--CSSS
T ss_pred cccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC--CCcc
Confidence 322211 233456899999999997644 3779999999999999999999999988877777777664432 3568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
++.+.+||.+||+.||++|||+.+++++-
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 99999999999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=350.01 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=189.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------C
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 228 (435)
.+|++.+.||+|+||.||+|.+. |+.||||++..... .....+++.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37999999999999999999875 77899999865433 344457888999999999999999999998654 5
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+++|+|++ +++|.+++.. +.+++.++..++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEE--CCCCCEEEeecccccc
Confidence 679999999 7899999875 56999999999999999999999988 9999999999999 8889999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------- 380 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------- 380 (435)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 182 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5422 234578999999999876 6789999999999999999999999998887655444332100
Q ss_pred ---------------CCCC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ---------------PFFR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ---------------~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+... ...+++++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 12468899999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=350.62 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=212.3
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcH--------------HHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR--------------LVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
+|++.+.||+|+||.||+|.+.+..||+|.+........ ...+.+.+|+.++++++||||++++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 799999999999999999999999999998854321111 112678899999999999999999999
Q ss_pred EEeCCcEEEEEecCCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCC
Q 013833 224 VTERKPLMLITEYLRGGDLHKY------LKE--KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSS 294 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~------l~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~ 294 (435)
+.+.+..++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ .| |+||||||+||++ +.
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~--~~ 187 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM--DK 187 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE--CT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE--cC
Confidence 9999999999999999999998 655 5679999999999999999999999 88 9999999999999 88
Q ss_pred CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCC-CCCC-cchHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 013833 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDK-KVDVFSFAMILYEMLEGEPPLANYEP-YEA 371 (435)
Q Consensus 295 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~-~~~ 371 (435)
++.++|+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred CCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 889999999999876432 23456789999999999877 6666 99999999999999999999988766 666
Q ss_pred HHHHHcCCCCCCCC-----------------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 372 AKYVAEGHRPFFRA-----------------KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 372 ~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...+..+....... ..+++++.+||.+||+.||++|||+.+++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 66666554332211 4689999999999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.99 Aligned_cols=257 Identities=30% Similarity=0.561 Sum_probs=217.7
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|++.+.||+|+||.||+|.+. +..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 346888899999999999999975 235899987543 23445578999999999999999999999985 4568
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl--~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEE--eCCCCEEEEecCCCeec
Confidence 99999999999999998654 6899999999999999999999988 9999999999999 77889999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+.++.. +..+
T Consensus 542 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 617 (656)
T 2j0j_A 542 EDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNC 617 (656)
T ss_dssp CC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC-CTTC
T ss_pred CCCcc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-Cccc
Confidence 43321 12233457889999999998899999999999999999997 9999999988888888877766554 3568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
++.+.++|.+||..||++|||+.++++.|+++.+.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.48 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=201.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
+|.+.+.||+|+||.||+|.++ ++.||||.+...... .......+.+|+.++++++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 6888999999999999999986 678999988654321 1122345789999999999999999999987655 8
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC---cEEEeeccCcc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSK 307 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~---~vkl~Dfg~a~ 307 (435)
++||||+++++|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL--SSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--ecCCCCCeEEEccCccce
Confidence 999999999999999988888999999999999999999999988 9999999999999 5444 59999999998
Q ss_pred cccccCccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFF 383 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~ 383 (435)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+..+.....
T Consensus 166 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 166 ILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp ECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred eccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 664321 122346899999999973 567899999999999999999999999765432 23334444433322
Q ss_pred C--CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 R--AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+ ...+++++.+||.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 14689999999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.55 Aligned_cols=244 Identities=28% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC------CCCcceeeeeeEEeCC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RHPNIVQFLGAVTERK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 228 (435)
.+|++.+.||+|+||+||+|.+. ++.||||++... ......+.+|+++++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 36999999999999999999986 678999988542 33346677888888877 5789999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc--EEEeecc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFG 304 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~--vkl~Dfg 304 (435)
.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl--~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILL--KQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEE--SSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--ccCCCcceEEeecc
Confidence 9999999995 69999998754 4899999999999999999999988 9999999999999 66655 9999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF- 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~- 383 (435)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.+......
T Consensus 248 ~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 248 SSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 99754322 2346789999999999999999999999999999999999999998877655443332100000
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHhhhcccCC
Q 013833 384 --------------------------------------------------------RAKGFTPELRELTEKCWAADMNQR 407 (435)
Q Consensus 384 --------------------------------------------------------~~~~~~~~l~~li~~cl~~dp~~R 407 (435)
.....++++.+||.+||+.||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 011247889999999999999999
Q ss_pred CCHHHHHHH
Q 013833 408 PSFLDILKR 416 (435)
Q Consensus 408 ps~~~ll~~ 416 (435)
||+.|++++
T Consensus 401 pta~e~L~H 409 (429)
T 3kvw_A 401 MTPGQALRH 409 (429)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhCC
Confidence 999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=337.89 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=207.6
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcceeeeeeEEeC
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER 227 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 227 (435)
.+.....+|++.+.||+|+||.||++.+. ++.||+|.+..... .....+.+.+|+.++.+++ ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34445568999999999999999999876 77899998865433 3445678999999999997 59999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
...++||| +.+++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ + ++.+||+|||++.
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIAN 174 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSC
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--E-CCeEEEeeccccc
Confidence 99999999 558899999998888999999999999999999999988 9999999999999 4 3789999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYV 375 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~ 375 (435)
........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+
T Consensus 175 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 175 QMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp C----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccCcccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 76543221 11234568999999999875 4688899999999999999999999987543 3333344
Q ss_pred HcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHH
Q 013833 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 417 (435)
.........+...++++.++|.+||+.||++|||+.+++++-
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 443333333456789999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.13 Aligned_cols=247 Identities=30% Similarity=0.468 Sum_probs=200.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|....+||+|+||.||+|.+. +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 4455568999999999999985 67899998865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCcccccc
Q 013833 236 YLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~ 311 (435)
|+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||++ +. ++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEE--ECCCCCEEEeecccccccCC
Confidence 999999999998642 4678889999999999999999988 9999999999999 55 77999999999986643
Q ss_pred cCccccccccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcCCCCCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA--AKYVAEGHRPFFRAKG 387 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 387 (435)
... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||........ .........+. .+..
T Consensus 176 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 250 (295)
T 2clq_A 176 INP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-IPES 250 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC-CCTT
T ss_pred CCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc-cccc
Confidence 221 12345789999999998754 388999999999999999999999976543222 12222222332 2356
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 388 FTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 388 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++.++|.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.06 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=209.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC--cEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLML 232 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 232 (435)
.+|.+.+.||+|+||+||+|.+. ++.||||++....... ..+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 47899999999999999999986 7899999986433222 2366789999999999999999999988755 7899
Q ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec--CCCCcEEEeeccCcc
Q 013833 233 ITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLSK 307 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--~~~~~vkl~Dfg~a~ 307 (435)
||||+++++|.+++.... .+++.+++.++.||+.||.|||++| |+||||||+|||+.. +..+.+||+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999997643 3999999999999999999999988 999999999999733 445569999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCC--------CCCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHH
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH--------RKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYV 375 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~ 375 (435)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+
T Consensus 165 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp ECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred EccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 765432 2334679999999999864 567789999999999999999999996432 23444444
Q ss_pred HcCCCCCCC-------------------C----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 376 AEGHRPFFR-------------------A----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 376 ~~~~~~~~~-------------------~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
..+..+... . ..+++.+.+++.+||+.||++||++.++++.+..+.++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 444322110 0 12346789999999999999999999999999988764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.62 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=208.6
Q ss_pred ccCCCCCCCCCCceeecCCceeEEEEE-----E--CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcceee
Q 013833 151 EIDPSELDFSSSAIIGKGSFGEILKAY-----W--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQF 220 (435)
Q Consensus 151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~ 220 (435)
.+.....+|.+.+.||+|+||+||+|. . .++.||+|++.... ...+..|+.++..++ |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 334445689999999999999999994 2 37889999986432 246677888888887 9999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS- 294 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~- 294 (435)
++++...+..++||||++||+|.+++.. ...+++.+++.++.||+.||.|||++| ||||||||+|||+ +.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll--~~~ 208 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL--GNG 208 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe--ccc
Confidence 9999999999999999999999999974 456999999999999999999999988 9999999999999 55
Q ss_pred ----------CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 295 ----------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 295 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 78999999999976543221 113455679999999999999999999999999999999999999996
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCC-CCHHHHHHHHHHHHhhC
Q 013833 365 NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQR-PSFLDILKRLEKIKETL 424 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~ll~~L~~~~~~~ 424 (435)
....... .....+.....++.+.+++..||+.+|.+| |++.++.+.|+.+.+..
T Consensus 287 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 287 KNEGGEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEETTEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 4332110 001111122346789999999999999999 68888999898887653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=350.48 Aligned_cols=248 Identities=12% Similarity=0.133 Sum_probs=186.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC--CCCcceeee-------eeEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFL-------GAVT 225 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~ 225 (435)
..|.+.+.||+|+||.||+|.+. ++.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35889999999999999999975 778999999876655556667788885544444 699988754 4443
Q ss_pred eC-----------------CcEEEEEecCCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHhcCCCceEeC
Q 013833 226 ER-----------------KPLMLITEYLRGGDLHKYLKEK-GALSPSTA------VNFALDIARGMAYLHNEPNVIIHR 281 (435)
Q Consensus 226 ~~-----------------~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~------~~~~~qi~~~l~~LH~~~~~ivH~ 281 (435)
.. ..+|+||||++ ++|.+++... ..++.... ..++.||+.||.|||++| |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 32 33799999998 7999999863 34555555 677799999999999988 9999
Q ss_pred CCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcC
Q 013833 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEG 359 (435)
Q Consensus 282 Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg 359 (435)
||||+|||+ +.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 219 Dikp~NIll--~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 219 HFTPDNLFI--MPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TCSGGGEEE--CTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred cCCHHHEEE--CCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999 888999999999998654221 13456799999999987 7799999999999999999999
Q ss_pred CCCCCCCCHHHHHHH-----HHc--CCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 360 EPPLANYEPYEAAKY-----VAE--GHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 360 ~~p~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..||.+..+...... ... ..........+++++++||.+||+.||++|||+.+++++
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999987643211000 000 011111124689999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.30 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=211.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcceeeeeeEEeCCcEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 233 (435)
.+|++.++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.++| ++++.+..++.+....+||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 37899999999999999999975 789999987544332 346789999999987 5566666667788889999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccc
Q 013833 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~ 311 (435)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ ||||||||+|||+.. +.++.+||+|||++..+..
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 8999999985 557999999999999999999999988 999999999999932 3567899999999987765
Q ss_pred cCccc---cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCC---C
Q 013833 312 QNSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---YEAAKYVAEGHRP---F 382 (435)
Q Consensus 312 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~---~ 382 (435)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+...... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 43211 1122356799999999999999999999999999999999999999987543 2222222211110 0
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.....+++++.+||..||+.+|++||++.+|++.|+.+......
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 11146899999999999999999999999999999999875543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.10 Aligned_cols=244 Identities=27% Similarity=0.360 Sum_probs=197.0
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC------
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 227 (435)
..+|++.+.||+|+||.||+|.++ ++.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 347899999999999999999985 78999998864322 234699999999999999999987432
Q ss_pred CcEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEee
Q 013833 228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGD 302 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~D 302 (435)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +. .+.+||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl--~~~~~~~kl~D 200 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--ETTTTEEEECC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEE--eCCCCeEEecc
Confidence 236799999975 77666543 467999999999999999999999988 9999999999999 53 35789999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--- 378 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--- 378 (435)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 201 FG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 201 FGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp CTTCEECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred chhhhhcccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99998764332 12345789999999998764 7999999999999999999999999988765544333221
Q ss_pred ------------C----CCCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 ------------H----RPFF--------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ------------~----~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. .+.. .+..+++++.+||.+||..||++|||+.|++++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000 123568999999999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.38 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=205.6
Q ss_pred CCCCCceeecCCceeEEEEEE---CCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC------cceeeeeeEEeCC
Q 013833 158 DFSSSAIIGKGSFGEILKAYW---RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------NIVQFLGAVTERK 228 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~ 228 (435)
+|++.+.||+|+||.||+|.+ .++.||+|++... ....+.+.+|+.+++.++|+ +++++++++...+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 799999999999999999987 3678999988532 33456788999999988765 4999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC------------
Q 013833 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS------------ 294 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~------------ 294 (435)
..++||||+ +++|.+++...+ .+++.++..++.||+.||.|||++| |+||||||+|||+..+.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999999 889999998765 5899999999999999999999988 99999999999993322
Q ss_pred -----CCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 013833 295 -----ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (435)
Q Consensus 295 -----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 369 (435)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764422 23457899999999999999999999999999999999999999988766
Q ss_pred HHHHHHHcCCCCC------------------------------------------CCCCCCCHHHHHHHHHHhhhcccCC
Q 013833 370 EAAKYVAEGHRPF------------------------------------------FRAKGFTPELRELTEKCWAADMNQR 407 (435)
Q Consensus 370 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~R 407 (435)
+....+.....+. ......++++.+||.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 5443332211110 0011235679999999999999999
Q ss_pred CCHHHHHHH--HHHHHh
Q 013833 408 PSFLDILKR--LEKIKE 422 (435)
Q Consensus 408 ps~~~ll~~--L~~~~~ 422 (435)
||+.|++++ ++.+++
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 999999976 444433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.46 Aligned_cols=245 Identities=26% Similarity=0.434 Sum_probs=202.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE----
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL---- 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---- 230 (435)
.+|.+.+.||+|+||.||+|.++ ++.||||++..... .....+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 37899999999999999999986 77999999865443 344557889999999999999999999999877654
Q ss_pred --EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 231 --MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 231 --~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
++||||+. ++|.+++. ..+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEE--CCCCCEEEEecCcccc
Confidence 99999996 58888874 34999999999999999999999988 9999999999999 8889999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----- 382 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----- 382 (435)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 194 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 5432 234578999999999987 788999999999999999999999999887665554443211000
Q ss_pred -----------------C-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----------------F-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----------------~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....+++++++||.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 013568999999999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=335.67 Aligned_cols=242 Identities=21% Similarity=0.383 Sum_probs=198.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEe--CCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~ 231 (435)
.+|++.+.||+|+||.||+|.+. ++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999874 7899999885322 267889999999997 9999999999987 67789
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Dfg~a~~~~ 310 (435)
+||||+.+++|.+++. .+++.++..++.||+.||.|||++| |+||||||+|||+ +.++ .+||+|||++....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCTTCEECC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--cCCCCEEEEEeCCCceEcC
Confidence 9999999999999885 3899999999999999999999988 9999999999999 6555 89999999998665
Q ss_pred ccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHH-------------H
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKY-------------V 375 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~-------------~ 375 (435)
... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.... +
T Consensus 183 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCC-----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 432 2334578999999999977 678999999999999999999999995432 2221111 1
Q ss_pred HcCCCC----------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 376 AEGHRP----------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 376 ~~~~~~----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...... ......+++++++||.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111100 00112378999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=345.06 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=199.6
Q ss_pred CCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
..+|++.+.||+|+||.||+|.+. +..+|+|++...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 347999999999999999999985 456899987543322 236999999999999999999985443
Q ss_pred cEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeec
Q 013833 229 PLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDF 303 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Df 303 (435)
.+++||||+++ ++.+.+. ....+++..++.++.||+.||.|||++| |+||||||+|||+ + .++.+||+||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~~kL~DF 186 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLL--DPPSGVLKLIDF 186 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCC
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEE--cCCCCcEEEeeC
Confidence 27899999977 4444333 2567999999999999999999999988 9999999999999 6 6789999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--- 379 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--- 379 (435)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 187 G~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 187 GSAKILIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp TTCEECCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCcccccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9998764332 12345789999999998764 58999999999999999999999999888765554433210
Q ss_pred ----------------CCC--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 380 ----------------RPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 380 ----------------~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
.+. ..+..+++++.+||.+||+.||++|||+.++++| +..++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000 0123478999999999999999999999999986 44443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=337.54 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=203.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeC-----Cc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 229 (435)
.+|++.+.||+|+||.||+|.+. ++.||||.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 47899999999999999999986 778999988543 2344456788999999999999999999987654 67
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
.++||||+. ++|.+++.. +.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLI--NSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--cCCCcEEEEeccccccc
Confidence 899999996 599999876 46999999999999999999999988 9999999999999 88889999999999876
Q ss_pred cccCcccc------ccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CC
Q 013833 310 KVQNSHDV------YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HR 380 (435)
Q Consensus 310 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~ 380 (435)
........ .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 54321110 01233578999999998754 67899999999999999999999999987765443332210 00
Q ss_pred ---------------------CCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 ---------------------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ---------------------~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+.. ....+++++++||.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 013578999999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.76 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=198.5
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCC--------cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD--------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE- 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 226 (435)
.+|++.+.||+|+||.||+|.+. +..||||++...... .....+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 37899999999999999999875 788999988543221 23345788999999999999999999999844
Q ss_pred ----CCcEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 227 ----RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 227 ----~~~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
...+++||||+. ++|.+++... ..+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~ 176 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL--ADNNDITIC 176 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEEC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEE--cCCCCEEEE
Confidence 336899999997 5888888754 36999999999999999999999988 9999999999999 888899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 177 Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 177 DFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp CTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999997544332 2234578999999999876 6789999999999999999999999998876655544432100
Q ss_pred -----------------------CCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 -----------------------PFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 -----------------------~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... ....+++.+.+||.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 013468899999999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=334.72 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=204.1
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEE----
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT---- 225 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~---- 225 (435)
..+|++.+.||+|+||.||+|.+. ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347999999999999999999983 67899998864332211 112345666666655 8999999999986
Q ss_pred -eCCcEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 226 -ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 226 -~~~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
.....++||||+. ++|.+++.... .+++.+++.++.||+.||.|||+.| |+||||||+||++ +.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili--~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEE--cCCCCEEEec
Confidence 5567899999997 59999998743 4899999999999999999999988 9999999999999 8888999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP- 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~- 381 (435)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+......
T Consensus 164 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99998664322 234467899999999999999999999999999999999999999988876665554421100
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ------------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+++.+++||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00124578999999999999999999999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=334.85 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=198.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE---------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--------- 225 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------- 225 (435)
.+|++.+.||+|+||.||+|.++ ++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 37899999999999999999986 778999988543 3445678899999999999999999998873
Q ss_pred -----eCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEE
Q 013833 226 -----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLK 299 (435)
Q Consensus 226 -----~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vk 299 (435)
+....++||||+. ++|.+++.. +.+++.+++.++.||+.||.|||++| |+||||||+|||+ + .++.+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~k 161 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFI--NTEDLVLK 161 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTTEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCeEE
Confidence 3467899999997 599999864 56899999999999999999999988 9999999999999 5 456899
Q ss_pred EeeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 013833 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (435)
Q Consensus 300 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 378 (435)
|+|||++.......... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+...
T Consensus 162 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998765332111 11233457899999998865 67899999999999999999999999988876655444332
Q ss_pred CCCC------------------------C----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 HRPF------------------------F----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 ~~~~------------------------~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.... . ....+++++++||.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1110 0 113589999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=335.40 Aligned_cols=249 Identities=27% Similarity=0.505 Sum_probs=183.1
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHH-HHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
..+|++.+.||+|+||.||+|.++ ++.||||.+..... ......+..|+. +++.++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 458899999999999999999986 78899999865432 223345555555 7778899999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 233 ITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. | |+||||||+|||+ +.++.+||+|||++
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILL--DRSGNIKLCDFGIS 173 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEE--ETTTEEEECCCSSS
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEE--cCCCCEEEccCCCc
Confidence 9999975 88888763 56789999999999999999999997 7 9999999999999 78889999999999
Q ss_pred ccccccCccccccccCCCcCccccCcccc----CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRP 381 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~ 381 (435)
....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||...... +....+..+..+
T Consensus 174 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 174 GQLVDSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp CC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred eeccccc-----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 8665332 12234689999999998 4567899999999999999999999999875432 222222222222
Q ss_pred CCC---CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FFR---AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
... ...+++++.+||.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 222 24589999999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=339.15 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=190.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------ 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 229 (435)
+|++.+.||+|+||.||+|.++ +..||||.+....... ..+.+|++.+..++||||+++++++.....
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 7999999999999999999986 7789999885543222 345678888899999999999999865433
Q ss_pred -EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHh--cCCCceEeCCCCCCcEEEecCC-CCcEEEe
Q 013833 230 -LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSS-ADHLKVG 301 (435)
Q Consensus 230 -~~lv~e~~~g~sL~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~ 301 (435)
+++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.| |+||||||+|||+ +. ++.+||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll--~~~~~~~kl~ 174 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLV--NEADGTLKLC 174 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEE--ETTTTEEEEC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEE--eCCCCcEEEe
Confidence 7899999976 5554443 3556899999999999999999999 877 9999999999999 64 7899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 175 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 175 DFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp CCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999998765432 22345789999999998654 489999999999999999999999998887665554432110
Q ss_pred CC------------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 381 PF------------------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 381 ~~------------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
.. ......++++.+||.+||+.||++|||+.|++++ +..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00 0012256889999999999999999999999986 44444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=337.15 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=201.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------ 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 229 (435)
+|.+.+.||+|+||.||+|.++ |+.||||.+..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 7899999999999999999985 78999999865443 34455788999999999999999999999977654
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+++||||+. ++|.+++.. .+++.++..++.||+.||.|||++| |+||||||+||++ +.++.+||+|||++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeE--CCCCcEEEeecccccCC
Confidence 499999996 588888743 4999999999999999999999988 9999999999999 88889999999999865
Q ss_pred cccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---------- 378 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------- 378 (435)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 177 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp --------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred CCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 422 234578999999999876 67899999999999999999999999988765544433221
Q ss_pred -----------------CCCC--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 379 -----------------HRPF--FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 379 -----------------~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+. .....+++++++||.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 1123578999999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=339.86 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=203.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH---HHHHHHHHHHHHHHhCC--CCcceeeeeeEEeCC
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERK 228 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 228 (435)
..+|++.+.||+|+||.||+|.+. ++.||||.+........ .....+.+|+.++++++ ||||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 457999999999999999999975 77899999865432210 01134667999999996 599999999999999
Q ss_pred cEEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCc
Q 013833 229 PLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (435)
Q Consensus 229 ~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a 306 (435)
..++|||++.+ ++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+|||++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEE--eCCCCCEEEeeCccc
Confidence 99999999976 899999998888999999999999999999999988 9999999999999 6 6689999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... +..... ..+
T Consensus 198 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~--~~~ 263 (320)
T 3a99_A 198 ALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV--FFR 263 (320)
T ss_dssp EECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC--CCS
T ss_pred cccccc------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccc--ccc
Confidence 876532 1234568999999999876665 6789999999999999999999975321 222221 234
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+++++.+||.+||+.||++|||+.+++++
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5689999999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=343.55 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=182.3
Q ss_pred CCC-CceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEE
Q 013833 159 FSS-SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLM 231 (435)
Q Consensus 159 ~~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 231 (435)
|++ .++||+|+||+||+|.++ +..||||.+...... ..+.+|+.+|++++||||+++++++.. +..++
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 444 568999999999999965 668999998654322 457789999999999999999999854 67899
Q ss_pred EEEecCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec--CCCCcEEE
Q 013833 232 LITEYLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKV 300 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~--~~~~~vkl 300 (435)
+||||+. ++|.+++... ..+++.+++.++.||+.||.|||+++ |+||||||+|||+.. +.++.+||
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999996 4888887632 24899999999999999999999988 999999999999943 35578999
Q ss_pred eeccCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---------H
Q 013833 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---------E 370 (435)
Q Consensus 301 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------~ 370 (435)
+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.... +
T Consensus 174 ~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 174 ADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp CCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EECCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999987654321 1112345678999999999987 45899999999999999999999999765431 1
Q ss_pred HHHHHHc-CCCCCC-----------------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHH
Q 013833 371 AAKYVAE-GHRPFF-----------------------------------RAKGFTPELRELTEKCWAADMNQRPSFLDIL 414 (435)
Q Consensus 371 ~~~~~~~-~~~~~~-----------------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll 414 (435)
....+.. ...+.. .....++++.+||.+||+.||++|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111111 000000 0012267899999999999999999999999
Q ss_pred HH
Q 013833 415 KR 416 (435)
Q Consensus 415 ~~ 416 (435)
++
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 87
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.14 Aligned_cols=248 Identities=29% Similarity=0.370 Sum_probs=202.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CC-----cceeeeeeEEeCC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP-----NIVQFLGAVTERK 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~ 228 (435)
.+|++.+.||+|+||+||+|.++ ++.||||++... ......+..|+++++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 37999999999999999999986 678999988532 334467788999988885 44 4999999999999
Q ss_pred cEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
..++||||+. ++|.+++... +.+++..+..++.|++.||.|||+...+||||||||+|||+..+.++.+||+|||++
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999995 5999999875 458999999999999999999995323399999999999996556788999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--- 383 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 383 (435)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 209 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 209 CQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp EETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 876432 2346789999999999999999999999999999999999999998887666554433111000
Q ss_pred -------------------------------CCCC----------------------------CCHHHHHHHHHHhhhcc
Q 013833 384 -------------------------------RAKG----------------------------FTPELRELTEKCWAADM 404 (435)
Q Consensus 384 -------------------------------~~~~----------------------------~~~~l~~li~~cl~~dp 404 (435)
.+.. .++++++||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 0000 01478999999999999
Q ss_pred cCCCCHHHHHHH
Q 013833 405 NQRPSFLDILKR 416 (435)
Q Consensus 405 ~~Rps~~~ll~~ 416 (435)
++|||+.|++++
T Consensus 362 ~~Rpta~e~L~h 373 (382)
T 2vx3_A 362 KTRIQPYYALQH 373 (382)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=335.43 Aligned_cols=246 Identities=26% Similarity=0.447 Sum_probs=174.9
Q ss_pred CCCCCc-eeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CCcE
Q 013833 158 DFSSSA-IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL 230 (435)
Q Consensus 158 ~~~~~~-~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 230 (435)
+|.+.+ +||+|+||.||+|.++ ++.||||++... . ....+....++.++||||+++++++.. +..+
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 677754 6999999999999986 789999988542 1 122233344667799999999999876 4558
Q ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcc
Q 013833 231 MLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK 307 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~ 307 (435)
++||||++|++|.+++...+ .+++.+++.++.||+.||.|||++| |+||||||+|||+..+ .++.+||+|||++.
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999998754 5999999999999999999999988 9999999999999432 24569999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHcCC--CC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA----KYVAEGH--RP 381 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~--~~ 381 (435)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+.... .+
T Consensus 180 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 180 ETTQN------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp EC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ecccc------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 65432 123456899999999998888999999999999999999999999766543321 1111111 12
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
......+++++++||.+||+.||++|||+.+++++-.
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 2222468999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=329.27 Aligned_cols=249 Identities=26% Similarity=0.467 Sum_probs=191.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.++ ++.||||.+...... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 47888999999999999999985 789999998654322 233344556667788899999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+ ++.+..+... .+.+++..+..++.||+.||.|||++ | |+||||||+||++ +.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL--DERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEE--CTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEE--CCCCCEEEEECCCchhccCC
Confidence 999 6567666654 56799999999999999999999995 8 9999999999999 88889999999999766433
Q ss_pred CccccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCC-
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRA- 385 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~- 385 (435)
. ......||+.|+|||++. ...++.++||||||+++|+|++|..||... ...+....+.....+..+.
T Consensus 179 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 179 K-----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred c-----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 2 123456899999999984 567889999999999999999999999874 4445555555555444332
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+++++.++|.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4689999999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.25 Aligned_cols=243 Identities=27% Similarity=0.441 Sum_probs=196.8
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHH---HHHHHHHHHHHHHhC----CCCcceeeeeeEEe
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL---VIQDFRHEVNLLVKL----RHPNIVQFLGAVTE 226 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l----~h~~iv~~~~~~~~ 226 (435)
..+|++.+.||+|+||.||+|.+. ++.||+|.+......... ....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 457999999999999999999874 778999998654432211 123456799999998 89999999999998
Q ss_pred CCcEEEEEec-CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeecc
Q 013833 227 RKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG 304 (435)
Q Consensus 227 ~~~~~lv~e~-~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg 304 (435)
.+..++|||+ +.+++|.+++...+.+++.+++.++.||+.||.|||+.| |+||||||+||++ + .++.+||+|||
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~kl~dfg 185 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI--DLRRGCAKLIDFG 185 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEE--ETTTTEEEECCCS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEE--eCCCCeEEEEEcc
Confidence 8999999999 788999999998888999999999999999999999988 9999999999999 6 67899999999
Q ss_pred CcccccccCccccccccCCCcCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 013833 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (435)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 383 (435)
++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|..||..... +..... .
T Consensus 186 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~--~ 251 (312)
T 2iwi_A 186 SGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAEL--H 251 (312)
T ss_dssp SCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC--C
T ss_pred hhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc--C
Confidence 998765332 2345689999999998766664 589999999999999999999975321 112211 1
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+..++++++++|.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 235689999999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=343.73 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=196.0
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--------CCcceeeeeeEE-
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVT- 225 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~- 225 (435)
.+|++.+.||+|+||+||+|.+. ++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47999999999999999999875 678999988532 344577889999999985 788999999887
Q ss_pred ---eCCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCC---
Q 013833 226 ---ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSAD--- 296 (435)
Q Consensus 226 ---~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~--- 296 (435)
.+..+++||||+ +++|.+++... +.+++.+++.++.||+.||.|||++ | |+||||||+|||+ +.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll--~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL--SVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE--CCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE--eccchhh
Confidence 556789999999 66777776653 4699999999999999999999997 8 9999999999999 5443
Q ss_pred ----------------------------------------------cEEEeeccCcccccccCccccccccCCCcCcccc
Q 013833 297 ----------------------------------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330 (435)
Q Consensus 297 ----------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 330 (435)
.+||+|||++...... .....||+.|+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~ 260 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCccc
Confidence 7999999999866432 23457899999
Q ss_pred CccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHc--CCCCC--------------------
Q 013833 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP------YEAAKYVAE--GHRPF-------------------- 382 (435)
Q Consensus 331 aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~--~~~~~-------------------- 382 (435)
|||++.+..++.++|||||||++|+|++|..||..... ......+.. +..+.
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999999999999999999999999999999976542 111111111 00000
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 ------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
..+...++++.+||.+||+.||++|||+.|++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011234578999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=325.00 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=195.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe---------
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------- 226 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 226 (435)
+|++.+.||+|+||.||+|.+. ++.||+|.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5888899999999999999975 78899998843 23455788999999999999999999998755
Q ss_pred ----CCcEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 227 ----RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 227 ----~~~~~lv~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
....++||||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~--~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI--DESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE--cCCCCEEEe
Confidence 456899999999999999998644 5788999999999999999999988 9999999999999 888899999
Q ss_pred eccCcccccccCcc----------ccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCC-CHH
Q 013833 302 DFGLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANY-EPY 369 (435)
Q Consensus 302 Dfg~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~-~~~ 369 (435)
|||++......... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||... ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999866432100 01122345689999999999764 68999999999999999998 55432 233
Q ss_pred HHHHHHHcCCC--CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 370 EAAKYVAEGHR--PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 370 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.....+..... +.......++.++++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 33344443322 222234577889999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=331.01 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=201.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--C-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc------ceeeeeeEEeC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--G-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------IVQFLGAVTER 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~ 227 (435)
.+|++.+.||+|+||+||+|.+. + ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 37999999999999999999985 3 57999988532 334467888999999997665 89999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-------------
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN------------- 292 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~------------- 292 (435)
...++||||+ +++|.+++.... .+++.+++.++.||+.||.|||++| |+||||||+|||+..
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccc
Confidence 9999999999 668888877643 6999999999999999999999988 999999999999943
Q ss_pred ----CCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 013833 293 ----SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (435)
Q Consensus 293 ----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 368 (435)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 24678999999999764322 2345789999999999999999999999999999999999999998776
Q ss_pred HHHHHHHHcCCCCC------------------------------------------CCCCCCCHHHHHHHHHHhhhcccC
Q 013833 369 YEAAKYVAEGHRPF------------------------------------------FRAKGFTPELRELTEKCWAADMNQ 406 (435)
Q Consensus 369 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~ 406 (435)
.+....+.....+. ......++++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 55443332211110 001112457899999999999999
Q ss_pred CCCHHHHHHH
Q 013833 407 RPSFLDILKR 416 (435)
Q Consensus 407 Rps~~~ll~~ 416 (435)
|||+.+++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999865
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=319.90 Aligned_cols=231 Identities=16% Similarity=0.148 Sum_probs=191.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||.||+|.+. ++.||||.+...........+.+.+|+.++.+++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 47999999999999999999986 7899999998776666667788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++|++|.++++.. ....++..++.||+.||.|||++| |+||||||+|||+ +.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll--~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRV--SIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--ETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEE--cCCCCEEEEecc----------
Confidence 999999999999543 466788999999999999999988 9999999999999 778889987543
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHcCCCCC--CCCCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK---YVAEGHRPF--FRAKGFT 389 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~~~--~~~~~~~ 389 (435)
|++ .++.++|||||||++|+|++|..||.+.+...... ....+..+. .....++
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 233 26889999999999999999999998765422110 000111110 1124689
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
+++++||.+||+.||++| |+.++++.|+++.....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 999999999999999999 99999999999886443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.40 Aligned_cols=248 Identities=27% Similarity=0.464 Sum_probs=186.6
Q ss_pred CCCCCceeecCCceeEEEE-EECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|.+.+.||+|+||+||.+ ...|+.||||.+.... .+.+.+|+.+++++ +||||+++++++.++..+++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4556788999999999654 4568999999875421 24567899999876 89999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-----------CCCc
Q 013833 236 YLRGGDLHKYLKEKGAL-------SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-----------SADH 297 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~-------~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-----------~~~~ 297 (435)
|+. |+|.+++...+.. ++..++.++.||+.||.|||++| |+||||||+|||+..+ .++.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 5999999865432 23345679999999999999988 9999999999999432 3458
Q ss_pred EEEeeccCcccccccCccccccccCCCcCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 013833 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (435)
Q Consensus 298 vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~ 369 (435)
+||+|||++..................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998775443221112334579999999999965 678999999999999999999 99999866543
Q ss_pred HHHHHHHcCCCCCC-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 370 EAAKYVAEGHRPFF-----RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 370 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. .+..+..... ....+++++++||.+||+.||++|||+.+++++
T Consensus 247 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 32 2222221111 112345789999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.16 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=192.5
Q ss_pred CCCCCCCCceeecCCceeE-EEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEE
Q 013833 155 SELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 155 ~~~~~~~~~~lg~G~~g~V-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 232 (435)
...+|...++||+|+||+| |++...++.||||++..... ..+.+|+.+++++ +||||+++++++.+....|+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 3457899999999999984 55666799999999865332 2346799999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec---CCCCcEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~---~~~~~vkl~Dfg~a~~ 308 (435)
||||+. ++|.+++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||+.. +....+||+|||++..
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999995 59999998654 4566677899999999999999988 999999999999932 2333688999999987
Q ss_pred ccccCccccccccCCCcCccccCccccC---CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC-
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF- 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~- 383 (435)
....... ........||+.|+|||++. ...++.++|||||||++|+|++ |..||....................
T Consensus 173 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (432)
T 3p23_A 173 LAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251 (432)
T ss_dssp C-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC
T ss_pred ccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC
Confidence 6543211 11234567999999999997 4567889999999999999999 9999976655443332222221111
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.....+..+++||.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 122345668999999999999999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=334.41 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=195.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----------CCcceeeeee
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGA 223 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~ 223 (435)
.+|++.+.||+|+||+||+|.+. ++.||||++... ....+.+.+|+.++++++ ||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 47999999999999999999974 778999988532 334467889999999886 8999999999
Q ss_pred EEeCC----cEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEec----
Q 013833 224 VTERK----PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVN---- 292 (435)
Q Consensus 224 ~~~~~----~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~---- 292 (435)
+.... .+++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ | |+||||||+|||+..
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCC
Confidence 87654 789999999 88999999873 4599999999999999999999997 8 999999999999943
Q ss_pred CCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---
Q 013833 293 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--- 369 (435)
Q Consensus 293 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--- 369 (435)
+..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 23347999999999866432 23457899999999999999999999999999999999999999865421
Q ss_pred ---HHHHHHHc--CCCC--------------------------------------CCCCCCCCHHHHHHHHHHhhhcccC
Q 013833 370 ---EAAKYVAE--GHRP--------------------------------------FFRAKGFTPELRELTEKCWAADMNQ 406 (435)
Q Consensus 370 ---~~~~~~~~--~~~~--------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~ 406 (435)
.....+.. +..| ...+..+++++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111 0000 0001234567899999999999999
Q ss_pred CCCHHHHHHH
Q 013833 407 RPSFLDILKR 416 (435)
Q Consensus 407 Rps~~~ll~~ 416 (435)
|||+.+++++
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.15 Aligned_cols=242 Identities=15% Similarity=0.196 Sum_probs=186.2
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-Cccee-------------
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ------------- 219 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~------------- 219 (435)
...|...++||+|+||+||+|.+. |+.||||++...........+.+.+|+.+++.++| ++...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778889999999999999986 88999998874444443445789999999999987 22111
Q ss_pred --------eeeeEEe-----CCcEEEEEecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceE
Q 013833 220 --------FLGAVTE-----RKPLMLITEYLRGGDLHKYLKE-------KGALSPSTAVNFALDIARGMAYLHNEPNVII 279 (435)
Q Consensus 220 --------~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~iv 279 (435)
+..++.. ...++++|+++ +++|.+++.. .+.+++..++.++.||+.||.|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 1111111 22467788866 6799999852 223778888999999999999999988 99
Q ss_pred eCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCcccc----------CCCCCCCcchHHHH
Q 013833 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF----------KHRKYDKKVDVFSF 349 (435)
Q Consensus 280 H~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~sl 349 (435)
||||||+|||+ +.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 234 HrDiKp~NILl--~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVL--DQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEE--CTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEE--ecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999 88889999999998765432 234567 999999999 56668889999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 350 AMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 350 G~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
||++|+|++|..||......+....+.. ....+|+++++||.+||+.||++||++.+++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999987654332222211 123689999999999999999999998888654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=310.82 Aligned_cols=225 Identities=27% Similarity=0.462 Sum_probs=179.2
Q ss_pred CCCCC-ceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHH-HhCCCCcceeeeeeEEe----CCc
Q 013833 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE----RKP 229 (435)
Q Consensus 158 ~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~ 229 (435)
+|.+. +.||+|+||.||++.++ ++.||+|.+... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 56666 78999999999999985 778999988531 4567788887 56689999999999876 677
Q ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccCc
Q 013833 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLS 306 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~a 306 (435)
+++||||+++++|.+++...+ .+++.+++.++.||+.||.|||+++ |+||||||+|||+..+. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 899999999999999998754 6999999999999999999999988 99999999999993221 678999999988
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR---PFF 383 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~ 383 (435)
.... +..++.++|||||||++|+|++|..||................. ...
T Consensus 168 ~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 168 KETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp EECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred cccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 6432 13467789999999999999999999987654332211111110 000
Q ss_pred C---CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHH
Q 013833 384 R---AKGFTPELRELTEKCWAADMNQRPSFLDILKRLE 418 (435)
Q Consensus 384 ~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 418 (435)
+ ...+++++++||.+||+.||++|||+.+++++-.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 1 0457899999999999999999999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=343.10 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=199.4
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe------CCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 229 (435)
+|++.+.||+|+||.||++.+. +..||||.+.... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 7999999999999999999974 7899999886542 34445789999999999999999999998755 677
Q ss_pred EEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCC-CCcEEEeeccC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGL 305 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~-~~~vkl~Dfg~ 305 (435)
.++||||++|++|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+||++..++ ...+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 899999999999999998744 5899999999999999999999988 99999999999994322 22499999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH---------HHHH
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA---------KYVA 376 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---------~~~~ 376 (435)
+....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......... ..+.
T Consensus 171 a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 171 AKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 98765432 223467899999999999999999999999999999999999999764322110 0000
Q ss_pred -----cCC--------CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHH-----HHHHHHHh
Q 013833 377 -----EGH--------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDIL-----KRLEKIKE 422 (435)
Q Consensus 377 -----~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll-----~~L~~~~~ 422 (435)
.+. .+......+++.+.+||.+||..||++|||+.+++ +.+..+.+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 00001123568899999999999999999998844 55555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.01 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=193.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc----
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 229 (435)
.+|++.+.||+|+||.||++.+. ++.||||.+... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 37999999999999999999984 678999988643 234455778999999999999999999999987665
Q ss_pred -EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 230 -~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.||||||++|++|.+++.. .+++.+++.++.||+.||.|||++| ||||||||+|||+ +. +.+||+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll--~~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIML--TE-EQLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CS-SCEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEE--eC-CcEEEEecccchh
Confidence 7999999999999998765 6999999999999999999999988 9999999999999 54 3899999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... ...........
T Consensus 231 ~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~ 293 (681)
T 2pzi_A 231 INSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKT 293 (681)
T ss_dssp TTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHH
T ss_pred cccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------ccccccccccc
Confidence 5432 345689999999998754 488999999999999999999988753210 00001011124
Q ss_pred CHHHHHHHHHHhhhcccCCC-CHHHHHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRP-SFLDILKRLEKIK 421 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~ 421 (435)
++.+.+||.+||+.||++|| +++++.+.|..+.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 67899999999999999999 5666777777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=322.60 Aligned_cols=241 Identities=20% Similarity=0.202 Sum_probs=184.5
Q ss_pred CCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhCC---------CCcceeee
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLR---------HPNIVQFL 221 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~iv~~~ 221 (435)
..+|++.+.||+|+||+||+|.++++.||||++...... .....+.+.+|+.+++.++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 347999999999999999999999999999998765321 1223367888999998886 55555555
Q ss_pred ee-----------------EEe-------------CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 013833 222 GA-----------------VTE-------------RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271 (435)
Q Consensus 222 ~~-----------------~~~-------------~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~L 271 (435)
+. +.+ ...+|+||||+++|++.+.+.+ +.+++.+++.++.||+.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 44 433 6789999999999976666643 5689999999999999999999
Q ss_pred h-cCCCceEeCCCCCCcEEEecCCCC--------------------cEEEeeccCcccccccCccccccccCCCcCcccc
Q 013833 272 H-NEPNVIIHRDLKPRNVLLVNSSAD--------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330 (435)
Q Consensus 272 H-~~~~~ivH~Dlkp~NIll~~~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 330 (435)
| +++ |+||||||+|||+ +.++ .+||+|||+|+..... ...||+.|+
T Consensus 178 H~~~~--ivHrDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~ 244 (336)
T 2vuw_A 178 EASLR--FEHRDLHWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSM 244 (336)
T ss_dssp HHHHC--CBCSCCCGGGEEE--EECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTT
T ss_pred HHhCC--EeECCCCHHHEEE--eccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeeccc
Confidence 9 888 9999999999999 4444 8999999999876532 236899999
Q ss_pred CccccCCCCCCCcchHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHcC-CCCCCC----CCCCCHHHHHHHHHHhhhc
Q 013833 331 APEVFKHRKYDKKVDVFSFAMI-LYEMLEGEPPLANYEP-YEAAKYVAEG-HRPFFR----AKGFTPELRELTEKCWAAD 403 (435)
Q Consensus 331 aPE~~~~~~~~~~~Dv~slG~i-l~~l~tg~~p~~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~cl~~d 403 (435)
|||++.+.. +.++|||||+++ .+++++|..||.+... ......+... ...... ...+++++++||.+||+.|
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 999998766 889999998777 7788889999854211 1122222211 111111 1246788999999999976
Q ss_pred ccCCCCHHHHH-HH
Q 013833 404 MNQRPSFLDIL-KR 416 (435)
Q Consensus 404 p~~Rps~~~ll-~~ 416 (435)
|+.|++ ++
T Consensus 324 -----sa~e~l~~H 332 (336)
T 2vuw_A 324 -----SATDLLCQH 332 (336)
T ss_dssp -----SHHHHHHHC
T ss_pred -----CHHHHHhcC
Confidence 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=289.79 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=131.8
Q ss_pred eeecCCceeEEEEEE--CCCcEEEEEccCCCCC-------cHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEEEE
Q 013833 164 IIGKGSFGEILKAYW--RGTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 233 (435)
.++.|++|.+..++. .|..+++|.+.+.... .+...+++.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356777776666543 4889999998654321 123346799999999999 699999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|||++|++|.+++.+.+++++. +|+.||+.||.|+|++| ||||||||+|||+ +.+|++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL--~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMV--DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEE--CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEE--CCCCCEEEeecccCeeCCCCC
Confidence 9999999999999998888865 47899999999999988 9999999999999 888999999999998765432
Q ss_pred ccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCC
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~ 360 (435)
. ...+.+||+.|||||++.+ .+...+|+||+|++++++.++.
T Consensus 394 ~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 S----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C----CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred c----cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 2 2344679999999999975 4667899999999988775543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=259.51 Aligned_cols=202 Identities=18% Similarity=0.249 Sum_probs=149.9
Q ss_pred CcccCCCCCCC-CCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhCCCCcceeeee
Q 013833 149 DWEIDPSELDF-SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLG 222 (435)
Q Consensus 149 ~~~~~~~~~~~-~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 222 (435)
.|..+.....+ ...+.||+|+||.||++.+.+..+++|.......... ...+++.+|++++++++||||+++..
T Consensus 327 ~w~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 327 NWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp CCC------------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred cccccccccccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 44433333333 3456899999999999988899999998755433222 22456899999999999999997666
Q ss_pred eEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 223 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
++...+..|+||||++|++|.+++.. +..++.|++.||.|||+++ |+||||||+|||+ +. ++||+|
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl--~~--~~kL~D 472 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIF--DK--DLYIID 472 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEE--SS--SEEECC
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEE--CC--eEEEEE
Confidence 66677788999999999999999965 5689999999999999988 9999999999999 55 899999
Q ss_pred ccCcccccccCcccc---ccccCCCcCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 303 FGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 303 fg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
||+++.......... .......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999987754321110 01234579999999999986 678888999999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=206.12 Aligned_cols=146 Identities=18% Similarity=0.172 Sum_probs=115.3
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcH---------------HHHHHHHHHHHHHHhCCCCcceeee
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR---------------LVIQDFRHEVNLLVKLRHPNIVQFL 221 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~~~ 221 (435)
.|.+.+.||+|+||.||+|.+. |+.||+|.+........ .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4566799999999999999984 77999999864322110 23467889999999999 4 6666
Q ss_pred eeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 222 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
+++.. +..++||||++|++|.+ +. ..+...++.|++.||.|||+.| |+||||||+|||+ + ++.+||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl--~-~~~vkl~ 234 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--S-EEGIWII 234 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--E-TTEEEEC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE--E-CCcEEEE
Confidence 65544 45699999999999988 42 1234579999999999999988 9999999999999 6 8899999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 336 (435)
|||+++. +..++|||.+.
T Consensus 235 DFG~a~~-----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE-----------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE-----------------TTSTTHHHHHH
T ss_pred ECCCCeE-----------------CCCCCHHHHHH
Confidence 9999963 23467888874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=174.35 Aligned_cols=115 Identities=33% Similarity=0.357 Sum_probs=95.0
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
.+.|+++|.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+|+|.+|.
T Consensus 24 l~~Gadvn~~d~~g~t~l~~--a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~ 101 (169)
T 4gpm_A 24 IENGADVNASDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDS 101 (169)
T ss_dssp HHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHCCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCC
Confidence 34677888888888888865 6666777777888888888888888888888888888888888888888888888888
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
+|+||||+|+..|+.+++++|+++|++++..+....+
T Consensus 102 ~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~T 138 (169)
T 4gpm_A 102 DGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRT 138 (169)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 8888888888888888888888888888766655443
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=174.86 Aligned_cols=106 Identities=38% Similarity=0.418 Sum_probs=96.0
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.+|..|.|||++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+|++.+|.+
T Consensus 58 ~~gad~~~~d~~g~TpLh~--A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~ 135 (169)
T 4gpm_A 58 SKGADVNAKDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSD 135 (169)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred hcccchhhhccCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence 4677899999999999976 77777888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
|+||||+|+..|+.+++++|+++|+++.
T Consensus 136 G~TpL~~A~~~g~~~iv~~Ll~~GA~ie 163 (169)
T 4gpm_A 136 GRTPLDLAREHGNEEVVKLLEKQGGWLE 163 (169)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHTC-----
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCcC
Confidence 9999999999999999999999999874
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=149.17 Aligned_cols=93 Identities=42% Similarity=0.541 Sum_probs=85.4
Q ss_pred cccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhc
Q 013833 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (435)
Q Consensus 32 ~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (435)
+|+||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus 1 ~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~ 78 (93)
T 1n0q_A 1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78 (93)
T ss_dssp --CCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence 37788865 6666677888999999999999999999999999999999999999999999999999999999999999
Q ss_pred CchhHHHHHHhcCCC
Q 013833 112 KKFNMMELLNAHGGL 126 (435)
Q Consensus 112 ~~~~~~~~L~~~g~~ 126 (435)
|+.+++++|+++|++
T Consensus 79 ~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 79 GHLEVVKLLLEAGAY 93 (93)
T ss_dssp TCHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHcCCC
Confidence 999999999999974
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=178.67 Aligned_cols=138 Identities=18% Similarity=0.211 Sum_probs=105.9
Q ss_pred CCCCceeecCCceeEEEEEE--CCCc--EEEEEccCCCCC---------------------cHHHHHHHHHHHHHHHhCC
Q 013833 159 FSSSAIIGKGSFGEILKAYW--RGTP--VAIKRILPSLSD---------------------DRLVIQDFRHEVNLLVKLR 213 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~--~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~ 213 (435)
|.+.+.||+|+||.||+|.+ .|+. ||||++...... .......+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 6888 999986543211 0112246789999999998
Q ss_pred CCcc--eeeeeeEEeCCcEEEEEecCCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCC
Q 013833 214 HPNI--VQFLGAVTERKPLMLITEYLRG-G----DLHKYLKEKGALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKP 285 (435)
Q Consensus 214 h~~i--v~~~~~~~~~~~~~lv~e~~~g-~----sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~~ivH~Dlkp 285 (435)
|+++ +.++++ ...+|||||+.+ | +|.++... .++.++..++.|++.+|.||| +.| ||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCH
Confidence 8754 444432 356899999942 3 77776532 235567889999999999999 988 99999999
Q ss_pred CcEEEecCCCCcEEEeeccCcccc
Q 013833 286 RNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 286 ~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+|||+ +. .++|+|||+|...
T Consensus 200 ~NILl--~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMY--ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEE--SS--SEEECCCTTCEET
T ss_pred HHEEE--cC--cEEEEECcccccC
Confidence 99999 55 8999999999754
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7.6e-21 Score=160.96 Aligned_cols=117 Identities=21% Similarity=0.293 Sum_probs=95.3
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCC-HHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~t-pLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
...|++++.++..|.||+++ |+ .+..+++++|++.|+++|.+|..|+| |||+|+..|+.+++++|+++|+++|.+|
T Consensus 32 l~~g~~~~~~~~~g~t~L~~--A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d 108 (156)
T 1bi7_B 32 LEAGANPNAPNSYGRRPIQV--MM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRD 108 (156)
T ss_dssp HTTTCCTTCCCSSSCCTTTS--SC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCC
T ss_pred HHcCCCCCCCCCCCCCHHHH--HH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccC
Confidence 45677889999999999975 55 66788999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~~ 139 (435)
..|+||||+|+..|+.+++++|+++|++++..+.....+..
T Consensus 109 ~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~~~ 149 (156)
T 1bi7_B 109 AWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAAE 149 (156)
T ss_dssp TTCCCHHHHHHHHTCHHHHHHHSSCC---------------
T ss_pred CCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcccc
Confidence 99999999999999999999999999999887766555443
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=155.07 Aligned_cols=113 Identities=24% Similarity=0.244 Sum_probs=99.1
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (435)
|+|+ .+|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+
T Consensus 1 G~d~-~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~ 77 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHI--ASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQND 77 (137)
T ss_dssp ---C-CCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGC
T ss_pred CCCC-CcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCC
Confidence 4455 567889999966 5556677788888899999999999999999999999999999999999999999999999
Q ss_pred chhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
||||+|+..++.+++++|+++|++++..+.....|.
T Consensus 78 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 113 (137)
T 3c5r_A 78 SPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPV 113 (137)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 999999999999999999999999987776665543
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-20 Score=154.80 Aligned_cols=100 Identities=23% Similarity=0.309 Sum_probs=49.4
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCC-CCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~-g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
|++++.++..|.||+++ |+. +..+++++|++.|+++|.+|.. |+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 35 g~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 111 (136)
T 1d9s_A 35 GADPNALNRFGRRPIQV--MMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWG 111 (136)
T ss_dssp TCCTTCCCTTCCTTTTT--STT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSS
T ss_pred CCCcCCcCCCCCCHHHH--HHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCC
Confidence 33444444445554433 333 4444444444555555555544 4555555555555555555555555555555555
Q ss_pred CchhhHhhhcCchhHHHHHHhcCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~ 125 (435)
+||||+|+..++.+++++|+++|+
T Consensus 112 ~tpl~~A~~~~~~~~~~~Ll~~Ga 135 (136)
T 1d9s_A 112 RLPVDLAEEQGHRDIARYLHAATG 135 (136)
T ss_dssp SCHHHHHHHHTCHHHHHHHHHHHC
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCC
Confidence 555555555555555555555444
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.7e-21 Score=152.11 Aligned_cols=108 Identities=31% Similarity=0.323 Sum_probs=96.5
Q ss_pred hhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhH
Q 013833 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107 (435)
Q Consensus 28 ~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 107 (435)
.+|+.|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+
T Consensus 4 ~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~ 81 (115)
T 2l6b_A 4 WGSKDGNTPLHN--AAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHL 81 (115)
T ss_dssp CCSCSSCCHHHH--HHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHH
T ss_pred ccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHH
Confidence 357789999865 666667788888889999999999999999999999999999999999999999999999999999
Q ss_pred hhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 108 AEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 108 A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
|+..++.+++++|+++|++++..+.....|
T Consensus 82 A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~~ 111 (115)
T 2l6b_A 82 AKKNGHHEIVKLLDAKGADVNARSWGSSHH 111 (115)
T ss_dssp HHTTTCHHHHHHHHTTSSSHHHHSCCCC--
T ss_pred HHHCCCHHHHHHHHHcCCCCCcCCcccccc
Confidence 999999999999999999998776665543
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-20 Score=155.69 Aligned_cols=110 Identities=20% Similarity=0.145 Sum_probs=99.9
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC-C
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW-K 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~-g 101 (435)
+++++.++..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+. |+.+++++|+++|+++|.+|.. |
T Consensus 2 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g 78 (136)
T 1d9s_A 2 SPGIHMLGGSSDAGLAT--AAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATL 78 (136)
T ss_dssp CCCCSCCCCCCSCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTT
T ss_pred CCCccCCCCCCccHHHH--HHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCC
Confidence 45778889999999976 666777888899999999999999999999999999 9999999999999999999999 9
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
+||||+|+..|+.+++++|+++|++++..+....
T Consensus 79 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (136)
T 1d9s_A 79 TRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGR 112 (136)
T ss_dssp BCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSS
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 9999999999999999999999999877665443
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.6e-20 Score=148.17 Aligned_cols=104 Identities=23% Similarity=0.241 Sum_probs=91.9
Q ss_pred hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhh
Q 013833 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (435)
Q Consensus 31 ~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (435)
..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 5 ~~~~~~l~~--A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~ 82 (123)
T 3aaa_C 5 SMCDKEFMW--ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVY 82 (123)
T ss_dssp --CHHHHHH--HHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccchHHHH--HHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 456677755 666667778888889999999999999999999999999999999999999999999999999999999
Q ss_pred cCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 111 AKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 111 ~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
.++.+++++|+++|++++..+....+
T Consensus 83 ~~~~~~v~~Ll~~ga~~~~~~~~g~t 108 (123)
T 3aaa_C 83 EGHVSCVKLLLSKGADKTVKGPDGLT 108 (123)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 99999999999999998877665544
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=156.31 Aligned_cols=113 Identities=27% Similarity=0.271 Sum_probs=102.1
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (435)
+.+++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|+
T Consensus 29 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~ 106 (179)
T 3f6q_A 29 ENDLNQGDDHGFSPLHW--ACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGN 106 (179)
T ss_dssp TSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cccccccCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 44677888889999976 6777778899999999999999999999999999999999999999999999999999999
Q ss_pred chhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
||||+|+..++.+++++|+++|++++..+.....|
T Consensus 107 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 141 (179)
T 3f6q_A 107 VPLHYACFWGQDQVAEDLVANGALVSICNKYGEMP 141 (179)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred CHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence 99999999999999999999999998777665544
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.80 E-value=8.5e-20 Score=150.69 Aligned_cols=103 Identities=28% Similarity=0.303 Sum_probs=77.7
Q ss_pred hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhh
Q 013833 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (435)
Q Consensus 31 ~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (435)
..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 12 ~~~~t~l~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~ 89 (136)
T 2jab_A 12 SDLGKKLLE--AARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF 89 (136)
T ss_dssp CHHHHHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred ccccHHHHH--HHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 345566644 555555666777777788888888888888888888888888888888888888888888888888888
Q ss_pred cCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 111 AKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 111 ~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
.++.+++++|+++|++++..+....
T Consensus 90 ~~~~~~v~~Ll~~g~~~~~~~~~g~ 114 (136)
T 2jab_A 90 IGHLEIAEVLLKHGADVNAQDKFGK 114 (136)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCHHHHHHHHHcCCCCcCcCCCCC
Confidence 8888888888888887776665444
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=152.97 Aligned_cols=114 Identities=31% Similarity=0.388 Sum_probs=102.4
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (435)
+.+.+..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+
T Consensus 32 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 109 (165)
T 3twr_A 32 SVNCRDIEGRQSTPLHF--AAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKF 109 (165)
T ss_dssp TTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred CCCccccccCCCCHHHH--HHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCC
Confidence 34566667788899876 7777778999999999999999999999999999999999999999999999999999999
Q ss_pred chhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
||||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 110 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 145 (165)
T 3twr_A 110 TPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL 145 (165)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTG
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChh
Confidence 999999999999999999999999987776655543
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-19 Score=168.30 Aligned_cols=119 Identities=24% Similarity=0.227 Sum_probs=93.4
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHH---------------------------------HHHHHHHhCCCCCccCC
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAA---------------------------------AVRKLLEEDQSLVHARD 65 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~---------------------------------~~~~lL~~~g~~~n~~d 65 (435)
....|+++|.+|.+|.|||++ |+..+.. +++++|++.|+++|.+|
T Consensus 72 Ll~~Gadvn~~d~~G~TpLh~--A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d 149 (269)
T 4b93_B 72 VPASGLGVNVTSQDGSSPLHV--AALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKD 149 (269)
T ss_dssp ---CCCCTTCCCTTSCCHHHH--HHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred HHHCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCC
Confidence 456788888888888888854 4333333 34455556677778888
Q ss_pred CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCCC
Q 013833 66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (435)
Q Consensus 66 ~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~~ 139 (435)
..|+||||+||..|+.+++++||++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..+....+|..
T Consensus 150 ~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~ 223 (269)
T 4b93_B 150 LSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVD 223 (269)
T ss_dssp TTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGG
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHH
Confidence 88999999999999999999999999999999999999999999999999999999999998887776665543
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=154.12 Aligned_cols=113 Identities=27% Similarity=0.316 Sum_probs=101.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.|++++.++..|.|++++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 35 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~ 112 (169)
T 2y1l_E 35 ANGADVNAEDASGWTPLHL--AAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDME 112 (169)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC
Confidence 4567788888999999866 77777788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|+||||+|+..++.+++++|+++|++++..+....
T Consensus 113 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 147 (169)
T 2y1l_E 113 GHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGK 147 (169)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 99999999999999999999999998876654433
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=151.16 Aligned_cols=110 Identities=22% Similarity=0.255 Sum_probs=98.8
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
.+.|.+++.++..|.|+++. |+. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.
T Consensus 25 l~~~~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 101 (162)
T 1ihb_A 25 LQNNVNVNAQNGFGRTALQV--MKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDN 101 (162)
T ss_dssp TTSCCCTTCCCTTSCCHHHH--CCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred HhCCCCccccCccCccHHHH--HHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence 34567788889999999966 666 778899999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCC-CCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLS-YGQNG 132 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~-~~~n~ 132 (435)
.|+||||+|+..|+.+++++|+++|++. +..+.
T Consensus 102 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 135 (162)
T 1ihb_A 102 EGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNH 135 (162)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCC
Confidence 9999999999999999999999999874 44443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=155.99 Aligned_cols=111 Identities=14% Similarity=0.094 Sum_probs=93.7
Q ss_pred hhhhh-hcccchhhhhhhhcCCH---HHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc------HHHHHHHHHcCCCcc
Q 013833 26 QKEKA-RVSRTSLILWHAHQNDA---AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW------IDVAKCLIEYGADVN 95 (435)
Q Consensus 26 ~~~~~-~~~~~~l~~~~a~~~~~---~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~------~~~~~~Ll~~ga~~~ 95 (435)
++.++ ..|+|||++ |+..++. .+++++|++.|+++|.+|..|+||||+|+..|+ .+++++|+++|||+|
T Consensus 30 ~~~~~~~~g~T~Lh~-A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin 108 (186)
T 3t8k_A 30 YEDKESVLKSNILYD-VLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADIT 108 (186)
T ss_dssp SSCHHHHHTTTHHHH-HTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSS
T ss_pred cccccccCCCCHHHH-HHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCC
Confidence 34445 678899865 4444543 368999999999999999999999999999987 689999999999999
Q ss_pred ccccCCC-chhhHhhhcC-----chhHHHHHHh-cCCCCCCCCCCCCCC
Q 013833 96 AQDRWKN-TPLADAEGAK-----KFNMMELLNA-HGGLSYGQNGSHFEP 137 (435)
Q Consensus 96 ~~~~~g~-t~l~~A~~~~-----~~~~~~~L~~-~g~~~~~~n~~~~~~ 137 (435)
.+|..|+ ||||+|+..+ +.+++++|++ +|++++..+....+|
T Consensus 109 ~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 109 ALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp SCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred ccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 9999999 9999999843 4579999999 999999888766544
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=150.57 Aligned_cols=105 Identities=30% Similarity=0.287 Sum_probs=95.2
Q ss_pred hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHh
Q 013833 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (435)
.+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|
T Consensus 30 ~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A 107 (153)
T 1awc_B 30 TDWLGTSPLHL--AAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWA 107 (153)
T ss_dssp CCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHH
T ss_pred cCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence 46678898866 6666778889999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 109 EGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 109 ~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
+..|+.+++++|+++|++++..+....
T Consensus 108 ~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 134 (153)
T 1awc_B 108 TEHNHQEVVELLIKYGADVHTQSKFCK 134 (153)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHcCCHHHHHHHHHcCCCccccCCCCC
Confidence 999999999999999999876665443
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=151.84 Aligned_cols=112 Identities=21% Similarity=0.255 Sum_probs=100.8
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+.+++.+|..|.||+++ |+..+..+++++|++.|+++|..|..|.||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus 25 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 102 (167)
T 3v31_A 25 QENVINHTDEEGFTPLMW--AAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNG 102 (167)
T ss_dssp HSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTS
T ss_pred cCCCcCCCCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCC
Confidence 456678888899999976 666777889999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
+||||+|+..|+.+++++|+++|++++..+....
T Consensus 103 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 136 (167)
T 3v31_A 103 GTPLLYAVHGNHVKCVKMLLESGADPTIETDSGY 136 (167)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 9999999999999999999999998876655443
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=146.74 Aligned_cols=102 Identities=28% Similarity=0.393 Sum_probs=94.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.|++++.+|..|.|++++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 35 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 112 (136)
T 2jab_A 35 ANGADVNAKDEYGLTPLYL--ATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKF 112 (136)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCC
Confidence 4577889999999999976 66667788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHG 124 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g 124 (435)
|+||||+|+..++.+++++|+++|
T Consensus 113 g~tpl~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 113 GKTAFDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred CCCHHHHHHHCCCHHHHHHHHHcC
Confidence 999999999999999999999876
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=151.59 Aligned_cols=109 Identities=24% Similarity=0.211 Sum_probs=96.8
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
.++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|+||
T Consensus 28 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 105 (172)
T 3v30_A 28 LVNKPDERGFTPLIW--ASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTP 105 (172)
T ss_dssp GGGCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCH
T ss_pred cccCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 367778889999876 667777888899999999999999999999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
||+|+..++.+++++|+++|++++..+....
T Consensus 106 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 136 (172)
T 3v30_A 106 LLYAVRGNHVKCVEALLARGADLTTEADSGY 136 (172)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence 9999999999999999999998876655433
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.7e-19 Score=155.83 Aligned_cols=111 Identities=25% Similarity=0.320 Sum_probs=89.6
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus 57 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 134 (192)
T 2rfm_A 57 NFDKLEDKDIEGSTALIW--AVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEG 134 (192)
T ss_dssp HHCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTC
T ss_pred hccccccccccCccHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 456677777778888865 666667778888888888888888888888888888888888888888888888888888
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
+||||+|+..|+.+++++|+++|++++..+...
T Consensus 135 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 167 (192)
T 2rfm_A 135 ETPLIVASKYGRSEIVKKLLELGADISARDLTG 167 (192)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTS
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence 888888888888888888888888776655443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.77 E-value=6.5e-19 Score=163.49 Aligned_cols=120 Identities=24% Similarity=0.226 Sum_probs=102.0
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCC-CCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~-~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
...+.+++.++..|.||+++ |+..+..+++++|++.|+++|.++. .|+||||+|+..|+.+++++|+++|+++|.+|
T Consensus 145 ~~~~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d 222 (282)
T 1oy3_D 145 EDWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARM 222 (282)
T ss_dssp CCGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred hhhhhcCCCcCCCCcCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 44567788899999999976 7777778899999999999999986 49999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP 141 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~~~~ 141 (435)
..|+||||+|+..++.+++++|+++|++++.++....+|....
T Consensus 223 ~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~a 265 (282)
T 1oy3_D 223 YGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSS 265 (282)
T ss_dssp TTSCCHHHHHHTSSCHHHHHHHHHTTCCCCCCC----------
T ss_pred cCCCCHHHHHHHcCCcHHHHHHHHcCCCcCcCCCccccccccc
Confidence 9999999999999999999999999999998888777665443
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-19 Score=150.08 Aligned_cols=104 Identities=21% Similarity=0.194 Sum_probs=94.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC-cccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~-~~~~~~ 99 (435)
..|++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++ ++.+|.
T Consensus 58 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 135 (162)
T 1ihb_A 58 LRGANPDLKDRTGFAVIHD--AARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNH 135 (162)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred HcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCC
Confidence 3567888889999999976 6667778899999999999999999999999999999999999999999998 699999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
.|+||||+|+..|+.+++++|+++|++
T Consensus 136 ~g~t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 136 KGDTACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence 999999999999999999999999985
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=7.6e-19 Score=142.26 Aligned_cols=103 Identities=39% Similarity=0.511 Sum_probs=81.1
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+.+++..+..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 24 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g 101 (126)
T 1n0r_A 24 AGADVNAKDKNGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNG 101 (126)
T ss_dssp HTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCCCCCcCCCCCcHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCC
Confidence 345566667777787755 555666777777778888888888888888888888888888888888888888888888
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
+||||+|+..++.+++++|+++|++
T Consensus 102 ~t~l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 102 RTPLHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred CCHHHHHHHcCcHHHHHHHHHcCCC
Confidence 8888888888888888888888774
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-19 Score=160.51 Aligned_cols=117 Identities=18% Similarity=0.192 Sum_probs=91.4
Q ss_pred CCCCCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcc
Q 013833 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95 (435)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~ 95 (435)
....++.|++++.. ..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|
T Consensus 21 ~~~ll~~g~~~~~~-~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~ 97 (239)
T 1ycs_B 21 GSERIAHGMRVKFN-PLPLALLLD--SSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVN 97 (239)
T ss_dssp -----------------CHHHHHH--HHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTT
T ss_pred HHHHhccCCCcccC-chhhHHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 34567788888754 567788765 666666788888889999999999999999999999999999999999999999
Q ss_pred ccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
.+|..|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 98 ~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~ 137 (239)
T 1ycs_B 98 AADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDM 137 (239)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSC
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCC
Confidence 9999999999999999999999999999999987765443
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=152.58 Aligned_cols=110 Identities=19% Similarity=0.185 Sum_probs=100.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 57 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 134 (172)
T 3v30_A 57 EWGADPHILAKERESALSL--ASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADS 134 (172)
T ss_dssp HHTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCCchhhcccCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence 4567888889999999976 77778888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
|+||||+|+..++.+++++|++++++....+.
T Consensus 135 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 166 (172)
T 3v30_A 135 GYTPMDLAVALGYRKVQQVIENHILKLFQSNL 166 (172)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHHHHHHSCC--
T ss_pred CCCHHHHHHHhCcHHHHHHHHHHHHHHhcccC
Confidence 99999999999999999999999987765543
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=146.60 Aligned_cols=108 Identities=22% Similarity=0.263 Sum_probs=95.3
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
.+++..+..|.||+++ |. .+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|+|
T Consensus 27 ~~~~~~~~~g~t~L~~--~~-~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 103 (156)
T 1bd8_A 27 VHPDALNRFGKTALQV--MM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGAL 103 (156)
T ss_dssp CCTTCCCTTSCCHHHH--SC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred cCccccCCCCCcHHHH--HH-cCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCc
Confidence 4677788889999965 44 45677888888999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|||+|+..|+.+++++|++. ++++..+....
T Consensus 104 ~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~ 134 (156)
T 1bd8_A 104 PIHLAVQEGHTAVVSFLAAE-SDLHRRDARGL 134 (156)
T ss_dssp HHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSC
T ss_pred HHHHHHHhChHHHHHHHHhc-cCCCCcCCCCC
Confidence 99999999999999999988 87776655443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.4e-19 Score=162.99 Aligned_cols=112 Identities=21% Similarity=0.187 Sum_probs=65.0
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
..++..+..+.|+++. |+..++...++++|++.|+++|.+|.+|+||||+||..|+.+++++|++.|++++.++..|.|
T Consensus 43 ~~~~~~~~~~~t~L~~-a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t 121 (269)
T 4b93_B 43 DTVSAADPEFCHPLCQ-CPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAV 121 (269)
T ss_dssp ---------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCC
T ss_pred ccccccCccCCCHHHH-HHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCC
Confidence 3466778888899854 555667777889999999999999999999999999999999999998888887777777777
Q ss_pred hhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|+|+|+..++.+++++|+++|++++..+....+
T Consensus 122 ~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~T 154 (269)
T 4b93_B 122 PLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNT 154 (269)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred ccccccccChHHHHHHHHHCCCCCCCCCCCCCC
Confidence 777777777777777777777776665554443
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=151.36 Aligned_cols=108 Identities=23% Similarity=0.151 Sum_probs=94.1
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc-cCCCch
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTP 104 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~ 104 (435)
....+..|.||++. |+..+..+++++|++ |+++|.+|..|+||||+||..|+.+++++|+++|+++|.+| ..|+||
T Consensus 37 ~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tp 113 (183)
T 3deo_A 37 AADVVSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTA 113 (183)
T ss_dssp CHHHHHHHHHHHHH--HHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCH
T ss_pred cccCCCCCCCHHHH--HHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCH
Confidence 34556788898865 555666667777777 99999999999999999999999999999999999999998 899999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
||+|+..|+.+++++|+++|++++..+....+
T Consensus 114 L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 145 (183)
T 3deo_A 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLT 145 (183)
T ss_dssp HHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred HHHHHhcCcHHHHHHHHHcCCCCcCCCCCCCC
Confidence 99999999999999999999998876655443
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=156.06 Aligned_cols=110 Identities=20% Similarity=0.136 Sum_probs=97.9
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCccccccCCCch
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKNTP 104 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~-ga~~~~~~~~g~t~ 104 (435)
++..+..|.|+|++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++ |+++|.+|..|+||
T Consensus 66 v~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tp 143 (222)
T 3ehr_A 66 VAEQAESIDNPLHE--AAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTA 143 (222)
T ss_dssp HHHHEEEESCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCH
T ss_pred cccccccccccccc--ccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCH
Confidence 56667788898865 5556667788888899999999999999999999999999999999999 99999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
||+|+..|+.+++++|+++|++++..+.....|
T Consensus 144 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 176 (222)
T 3ehr_A 144 LHAAAWKGYADIVQLLLAKGARTDLRNIEKKLA 176 (222)
T ss_dssp HHHHHHHTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCccccCCCCCH
Confidence 999999999999999999999998777665543
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=150.13 Aligned_cols=108 Identities=20% Similarity=0.194 Sum_probs=100.2
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 60 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 137 (179)
T 3f6q_A 60 MRGARINVMNRGDDTPLHL--AASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKY 137 (179)
T ss_dssp HTTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTT
T ss_pred HcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccC
Confidence 4577888899999999976 77777788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~ 130 (435)
|+|||++|+..++.+++++|+++|++++..
T Consensus 138 g~tpl~~A~~~~~~~~~~~L~~~g~~~~~~ 167 (179)
T 3f6q_A 138 GEMPVDKAKAPLRELLRERAEKMGQNLNRI 167 (179)
T ss_dssp SCCGGGGSCHHHHHHHHHHHHHTTCCCSCB
T ss_pred CCCcHHHHHHHHHHHHHHHHHHhhcCcccC
Confidence 999999999999999999999999987643
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=136.77 Aligned_cols=94 Identities=28% Similarity=0.381 Sum_probs=81.2
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
.....+.+|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||
T Consensus 16 ~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tp 93 (110)
T 2zgd_A 16 RGSHMGSDLGKKLLE--AARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTA 93 (110)
T ss_dssp ------CCHHHHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccCCccchHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcH
Confidence 455667788898865 555666778888889999999999999999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHH
Q 013833 105 LADAEGAKKFNMMELL 120 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L 120 (435)
||+|+..|+.+++++|
T Consensus 94 l~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 94 FDISIDNGNEDLAEIL 109 (110)
T ss_dssp HHHHHHHTCHHHHHHH
T ss_pred HHHHHHcCCHHHHHHh
Confidence 9999999999999987
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=161.97 Aligned_cols=99 Identities=19% Similarity=0.158 Sum_probs=90.0
Q ss_pred hhhhcccchhhhhhhhcC--CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 28 EKARVSRTSLILWHAHQN--DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 28 ~~~~~~~~~l~~~~a~~~--~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
..+..|.|||++ |+..+ +..+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|||+|.+|..|+|||
T Consensus 164 ~~~~~g~t~Lh~-A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL 242 (278)
T 1dcq_A 164 NGHEPDETALHL-AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPL 242 (278)
T ss_dssp SCSSTTCBHHHH-HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred ccccCCCCcchH-HHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHH
Confidence 336778999965 44433 788999999999999999999999999999999999999999999999999999999999
Q ss_pred hHhhhcCchhHHHHHHhcCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLS 127 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~ 127 (435)
|+|+..|+.+++++|+++|++.
T Consensus 243 ~~A~~~~~~~~v~~Ll~~ga~~ 264 (278)
T 1dcq_A 243 DIAKRLKHEHCEELLTQALSGR 264 (278)
T ss_dssp HHHHHTTCHHHHHHHHHHHTTC
T ss_pred HHHHHcCCHHHHHHHHHcCCCC
Confidence 9999999999999999999853
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.4e-19 Score=158.58 Aligned_cols=109 Identities=17% Similarity=0.064 Sum_probs=73.8
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc-cC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RW 100 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~-~~ 100 (435)
.|++++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.++ ..
T Consensus 43 ~g~~~~~~d~~g~tpLh~--A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~ 120 (229)
T 2vge_A 43 EMNDPSQPNEEGITALHN--AICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSD 120 (229)
T ss_dssp HSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSST
T ss_pred cCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCC
Confidence 445666666667777654 555556666666667777777777777777777777777777777777777777665 46
Q ss_pred CCchhhHh--hhcCchhHHHHHHhcCCCCCCCCC
Q 013833 101 KNTPLADA--EGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 101 g~t~l~~A--~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
|+||||+| +..|+.+++++|+++|++++..+.
T Consensus 121 g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~ 154 (229)
T 2vge_A 121 GATAFEKCDPYREGYADCATYLADVEQSMGLMNS 154 (229)
T ss_dssp TCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGG
T ss_pred CCCHHHHHHHHhcChHHHHHHHHHcCCCcccccC
Confidence 77777777 667777777777777766655543
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.8e-18 Score=147.00 Aligned_cols=102 Identities=25% Similarity=0.385 Sum_probs=94.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 68 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 145 (169)
T 2y1l_E 68 KNGADVNAVDHAGMTPLRL--AALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKF 145 (169)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 3567788888999999976 77777888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHG 124 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g 124 (435)
|.||||+|+..|+.+++++|+++|
T Consensus 146 g~t~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 146 GKTAFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred CCCHHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999999876
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=146.71 Aligned_cols=102 Identities=25% Similarity=0.302 Sum_probs=93.1
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 63 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 140 (165)
T 3twr_A 63 QHGADVHAKDKGGLVPLHN--ACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRD 140 (165)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred hcCCCCCccCCCCCCHHHH--HHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Confidence 4567888899999999976 77777888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~ 125 (435)
|+||||+|.. ++.+++++|++.|+
T Consensus 141 g~t~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 141 GNTPLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp SCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred CCChhHhHhc-CChHHHHHHhhccc
Confidence 9999999877 89999999998886
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.7e-19 Score=147.89 Aligned_cols=106 Identities=22% Similarity=0.157 Sum_probs=92.5
Q ss_pred hhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc-hh
Q 013833 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT-PL 105 (435)
Q Consensus 27 ~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t-~l 105 (435)
+..++.+.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| ||
T Consensus 6 ~~~~~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL 82 (156)
T 1bi7_B 6 GSSMEPSADWLAT--AAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPV 82 (156)
T ss_dssp ----CCSTTHHHH--HHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHH
T ss_pred cCCCccchHHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHH
Confidence 4556778888866 66667778888888999999999999999999985 99999999999999999999999999 99
Q ss_pred hHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|+|+..|+.+++++|+++|++++..+....
T Consensus 83 ~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (156)
T 1bi7_B 83 HDAAREGFLDTLVVLHRAGARLDVRDAWGR 112 (156)
T ss_dssp HHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred HHHHHCCCHHHHHHHHHcCCCCcccCCCCC
Confidence 999999999999999999999887765544
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=3e-18 Score=144.30 Aligned_cols=99 Identities=27% Similarity=0.377 Sum_probs=91.8
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
...|++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|.
T Consensus 54 l~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~ 131 (153)
T 1awc_B 54 LRAGVSRDARTKVDRTPLHM--AASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSK 131 (153)
T ss_dssp HTTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHcCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCC
Confidence 34677888889999999976 6667778899999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHH
Q 013833 100 WKNTPLADAEGAKKFNMMELL 120 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L 120 (435)
.|+||||+|+..|+.+++++|
T Consensus 132 ~g~t~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 132 FCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp TSCCHHHHHHHTTCHHHHHHH
T ss_pred CCCCHHHHHHHcCCHHHHHHh
Confidence 999999999999999999987
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=155.82 Aligned_cols=107 Identities=23% Similarity=0.153 Sum_probs=94.0
Q ss_pred hhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc-cCCCchh
Q 013833 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTPL 105 (435)
Q Consensus 27 ~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~l 105 (435)
...+..|.|+++. |+..+..+++++|++ |+++|.+|..|+||||+||..|+.+++++|+++|+++|.++ ..|+|||
T Consensus 39 ~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L 115 (244)
T 3ui2_A 39 ADVVSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTAL 115 (244)
T ss_dssp HHHHHHHHHHHHH--HHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHH
T ss_pred cccccCCCCHHHH--HHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHH
Confidence 3445678888865 666667777777778 99999999999999999999999999999999999999998 8899999
Q ss_pred hHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|+|+..|+.+++++|+++|++++..+....+
T Consensus 116 ~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 146 (244)
T 3ui2_A 116 HMAAGYVRPEVVEALVELGADIEVEDERGLT 146 (244)
T ss_dssp HHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred HHHHHcCCHHHHHHHHHCCCCCCCCCCCCCc
Confidence 9999999999999999999998877655443
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-18 Score=152.75 Aligned_cols=113 Identities=25% Similarity=0.184 Sum_probs=99.6
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCccccccCCC
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWKN 102 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~g-a~~~~~~~~g~ 102 (435)
.+++..+..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++| +++|.+|..|+
T Consensus 98 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~ 175 (228)
T 2dzn_A 98 PDLNKITNQGVTCLHL--AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGW 175 (228)
T ss_dssp CCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSC
T ss_pred cccccCCcCCCCHHHH--HHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCC
Confidence 5677778889999876 66777788889999999999999999999999999999999999999999 99999999999
Q ss_pred chhhHhhhcCchhHHHHHH-hcCCCCCCCCCCCCCCC
Q 013833 103 TPLADAEGAKKFNMMELLN-AHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~-~~g~~~~~~n~~~~~~~ 138 (435)
||||+|+..|+.+++++|+ ++|++++..+....+|.
T Consensus 176 t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l 212 (228)
T 2dzn_A 176 TPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 212 (228)
T ss_dssp CHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGG
T ss_pred CHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHH
Confidence 9999999999999999999 89999887776655443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=143.94 Aligned_cols=100 Identities=20% Similarity=0.225 Sum_probs=93.2
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++ ++++.+|..
T Consensus 56 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~ 132 (156)
T 1bd8_A 56 KQGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDAR 132 (156)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTT
T ss_pred HCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCC
Confidence 4577888899999999976 7777788899999999999999999999999999999999999999999 999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhc
Q 013833 101 KNTPLADAEGAKKFNMMELLNAH 123 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~ 123 (435)
|+||||+|+..|+.+++++|+++
T Consensus 133 g~t~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 133 GLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp SCCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCCHHHHHHHcCcHHHHHHHHhh
Confidence 99999999999999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=7.4e-19 Score=168.26 Aligned_cols=143 Identities=12% Similarity=0.071 Sum_probs=99.3
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCC--------------c-HHHH----HHHHHHHHHHHhCCCCcc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD--------------D-RLVI----QDFRHEVNLLVKLRHPNI 217 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~--------------~-~~~~----~~~~~E~~~l~~l~h~~i 217 (435)
-|++.+.||+|+||.||+|.+. |+.||||+++..... . .... -....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4788899999999999999975 889999987542110 0 0000 012356677777754443
Q ss_pred eeeeeeEEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-
Q 013833 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD- 296 (435)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~- 296 (435)
....-+.. . ..+|||||++|++|.++.. .+....++.||+.+|.+||+.| ||||||||.|||+.+++++
T Consensus 176 ~vp~p~~~-~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ-S-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE-E-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec-c-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcc
Confidence 32221111 1 2379999999988865432 2334578899999999999988 9999999999999544332
Q ss_pred -------cEEEeeccCccccc
Q 013833 297 -------HLKVGDFGLSKLIK 310 (435)
Q Consensus 297 -------~vkl~Dfg~a~~~~ 310 (435)
.+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 38999999876544
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=152.40 Aligned_cols=111 Identities=23% Similarity=0.256 Sum_probs=75.6
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.|++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus 95 ~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 172 (231)
T 3aji_A 95 KGAHVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEG 172 (231)
T ss_dssp TTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred cCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCCCC
Confidence 345556666666666654 555555666666667777777777777777777777777777777777777777777777
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
+||||+|+..++.+++++|+++|++++..+...
T Consensus 173 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 205 (231)
T 3aji_A 173 NTPLHLACDEERVEEAKFLVTQGASIYIENKEE 205 (231)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred CCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 777777777777777777777777666554433
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=7.3e-18 Score=136.42 Aligned_cols=102 Identities=38% Similarity=0.471 Sum_probs=91.3
Q ss_pred cccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhc
Q 013833 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (435)
Q Consensus 32 ~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (435)
+|.|+++. |+..+..+++++|++.|+++|..|..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus 1 ~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~ 78 (126)
T 1n0r_A 1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78 (126)
T ss_dssp CCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCccHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Confidence 47788865 6666677788888899999999999999999999999999999999999999999999999999999999
Q ss_pred CchhHHHHHHhcCCCCCCCCCCCC
Q 013833 112 KKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 112 ~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
++.+++++|+++|++++..+....
T Consensus 79 ~~~~~~~~Ll~~g~~~~~~~~~g~ 102 (126)
T 1n0r_A 79 GHLEVVKLLLEAGADVNAKDKNGR 102 (126)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred ChHHHHHHHHHcCCCCcccCCCCC
Confidence 999999999999998876654433
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=150.29 Aligned_cols=109 Identities=22% Similarity=0.169 Sum_probs=97.9
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
.+|.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||
T Consensus 27 ~~n~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 104 (192)
T 2rfm_A 27 LRNYRDSYNRTPLMV--ACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTP 104 (192)
T ss_dssp HHTCCCTTCCCHHHH--HHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred HHhCcCCCCCCHHHH--HHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcH
Confidence 456788899999966 666667788888889999999999999999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
||+|+..++.+++++|+++|++++..+....
T Consensus 105 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 135 (192)
T 2rfm_A 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGE 135 (192)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCSSCCCTTCC
T ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 9999999999999999999998876654433
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.7e-18 Score=156.32 Aligned_cols=107 Identities=22% Similarity=0.199 Sum_probs=74.2
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
+++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||
T Consensus 116 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 193 (253)
T 1yyh_A 116 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP 193 (253)
T ss_dssp CTTCCCTTCCCHHHH--HHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CccccCCCCCcHHHH--HHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 445555666666654 444455566666667777777777777777777777777777777777777777777777777
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
||+|+..|+.+++++|+++|++++..+..
T Consensus 194 L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~ 222 (253)
T 1yyh_A 194 LFLAAREGSYETAKVLLDHFANRDITDHM 222 (253)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHCCCHHHHHHHHHcCCCccccccC
Confidence 77777777777777777777776655444
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-18 Score=152.45 Aligned_cols=115 Identities=20% Similarity=0.167 Sum_probs=93.4
Q ss_pred Cchhhhhhhhh---cccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc
Q 013833 21 SSADKQKEKAR---VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (435)
Q Consensus 21 ~~~~~~~~~~~---~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~ 97 (435)
..+++++..+. .+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+
T Consensus 6 ~~~~~~~~~~~~~~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~ 83 (229)
T 2vge_A 6 RKAGSPRKARRARLNPLVLLLD--AALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSP 83 (229)
T ss_dssp ----CCCCCCCTTSCHHHHHHH--HHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred ccCCCCccccccccchhHHHHH--HHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 34445544433 34455543 55566677788888999999999999999999999999999999999999999999
Q ss_pred ccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCC-CCCCCC
Q 013833 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN-GSHFEP 137 (435)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n-~~~~~~ 137 (435)
|..|+||||+|+..|+.+++++|+++|++++..+ ....+|
T Consensus 84 d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~tp 124 (229)
T 2vge_A 84 DSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATA 124 (229)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCCT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCH
Confidence 9999999999999999999999999999988764 344443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-19 Score=154.07 Aligned_cols=107 Identities=12% Similarity=0.071 Sum_probs=93.8
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCC-----HHHHHHHHHhCCCCCccCCCCCC-CHHHHHHHcC-----cHHHHHHHH
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQND-----AAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHG-----WIDVAKCLI 88 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~-----~~~~~~lL~~~g~~~n~~d~~g~-tpLh~Aa~~~-----~~~~~~~Ll 88 (435)
+..|+++|.+|..|+|||++ |+..+. ..+++++|+++|+++|.+|..|+ ||||+|+..+ +.+++++|+
T Consensus 62 l~~Gadvn~~d~~g~TpLh~-a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll 140 (186)
T 3t8k_A 62 INKGADIKSRTKEGTTLFFP-LFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIF 140 (186)
T ss_dssp HHTTCCSSCCCTTCCCTHHH-HHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCCCcHHHH-HHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHH
Confidence 46789999999999999975 343343 26789999999999999999999 9999999944 467999999
Q ss_pred H-cCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCC
Q 013833 89 E-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (435)
Q Consensus 89 ~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~ 127 (435)
+ +|||+|.+|..|+||||+|+..|+.+++++|.++..+.
T Consensus 141 ~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~~ 180 (186)
T 3t8k_A 141 SQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180 (186)
T ss_dssp TSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHHH
T ss_pred HhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999999999876543
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-18 Score=157.14 Aligned_cols=111 Identities=23% Similarity=0.102 Sum_probs=100.7
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
...|++++.+|..|.|||++ |+..++.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|++++.++.
T Consensus 57 l~~g~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~ 134 (239)
T 1ycs_B 57 IYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTY 134 (239)
T ss_dssp TSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCS
T ss_pred HHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecC
Confidence 45677889999999999976 6667778899999999999999999999999999999999999999999999999998
Q ss_pred CCC-chhhHh--hhcCchhHHHHHHhcCCCCCCCCC
Q 013833 100 WKN-TPLADA--EGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 100 ~g~-t~l~~A--~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
.|. ||||+| +..|+.+++++|+++|++++..+.
T Consensus 135 ~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~~ 170 (239)
T 1ycs_B 135 SDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNK 170 (239)
T ss_dssp SSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTTGG
T ss_pred CCCcchHHHHHHhhhccHHHHHHHHHhhhccccccc
Confidence 887 999999 788999999999999998876543
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-18 Score=138.66 Aligned_cols=94 Identities=18% Similarity=0.186 Sum_probs=83.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.+.+++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 28 ~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 105 (123)
T 3aaa_C 28 AKGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPD 105 (123)
T ss_dssp HTTCCTTSCCTTSSCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCCcCccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 3566788889999999976 77777788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhH
Q 013833 101 KNTPLADAEGAKKFNM 116 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~ 116 (435)
|+||||+|...+..++
T Consensus 106 g~t~l~~A~~~~~~~l 121 (123)
T 3aaa_C 106 GLTAFEATDNQAIKAL 121 (123)
T ss_dssp SCCHHHHCCCHHHHHH
T ss_pred CCCHHHHhCCHHHHHH
Confidence 9999999965544443
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.72 E-value=8.2e-18 Score=152.19 Aligned_cols=116 Identities=26% Similarity=0.334 Sum_probs=80.4
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCC------CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL------VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~------~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~ 93 (435)
...|++++.++..|.||+++ |+..+..+++++|++.|++ ++..|..|.||||+|+..|+.+++++|+++|++
T Consensus 65 l~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~ 142 (236)
T 1ikn_D 65 LGAGCDPELRDFRGNTPLHL--ACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGAD 142 (236)
T ss_dssp CSCCCCSCCCCTTCCCHHHH--HHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred HHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 45566677777777777754 5555556666666666654 456666777777777777777777777777777
Q ss_pred cccccc-CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 94 VNAQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 94 ~~~~~~-~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
++.++. .|+||||+|+..|+.+++++|+++|++++..+.....|
T Consensus 143 ~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 187 (236)
T 1ikn_D 143 VNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP 187 (236)
T ss_dssp TTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred CCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCH
Confidence 777776 77777777777777777777777777776665544433
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.9e-18 Score=151.74 Aligned_cols=111 Identities=22% Similarity=0.303 Sum_probs=96.5
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCC-----ccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-----HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~-----n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~ 97 (435)
|++++.+|..|.||+++ |+..+..+++++|++.|+++ +.+|..|.||||+|+..|+.+++++|+++|++++.+
T Consensus 27 g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 104 (232)
T 2rfa_A 27 GCEVHQRGAMGETALHI--AALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSAR 104 (232)
T ss_dssp CSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcc
Confidence 67888889999999876 77777788888998999887 677889999999999999999999999999999988
Q ss_pred cc-------------CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 98 DR-------------WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 98 ~~-------------~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
+. .|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 105 ~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 155 (232)
T 2rfa_A 105 ATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGN 155 (232)
T ss_dssp CCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 76 799999999999999999999999998876655443
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-18 Score=143.17 Aligned_cols=103 Identities=25% Similarity=0.374 Sum_probs=90.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..|++++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 31 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 108 (137)
T 3c5r_A 31 QNGSDPNVKDHAGWTPLHE--ACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIF 108 (137)
T ss_dssp HTTCCSCCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCCCCcCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC
Confidence 3566788888999999976 77778888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~ 125 (435)
|+||||+|+..+..+++++|.+.+.
T Consensus 109 g~tpl~~A~~~~~~~~l~~l~~~~~ 133 (137)
T 3c5r_A 109 GLRPVDYTDDESMKSLLLLPEKNES 133 (137)
T ss_dssp SCCGGGGCCCHHHHHHHSCC-----
T ss_pred CCCHHHHHhhccHHHHHhhcccccc
Confidence 9999999999999999988876654
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=154.29 Aligned_cols=113 Identities=15% Similarity=0.189 Sum_probs=89.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhC-CCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~-g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
..|++++.+|..|.|+|++ |+..+..+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|.
T Consensus 94 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~ 171 (222)
T 3ehr_A 94 DNRVGVNGLDKAGSTALYW--ACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNI 171 (222)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCT
T ss_pred hCCCCccccCCCCCCHHHH--HHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccC
Confidence 3567788889999999976 6777778899999888 999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
.|+||||+|+..++.++++.|++.++.....+...+
T Consensus 172 ~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~~~~~ 207 (222)
T 3ehr_A 172 EKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDY 207 (222)
T ss_dssp TSCCHHHHCCSHHHHHHHC-----------------
T ss_pred CCCCHHHHhcchhHHHHHHHHhccchhhhccchhhh
Confidence 999999999999999999999999998776665544
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=150.46 Aligned_cols=112 Identities=24% Similarity=0.231 Sum_probs=100.1
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
+++..+..|.|+++. |+..+..+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|+++|.+|..|+|
T Consensus 108 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (241)
T 1k1a_A 108 DLEARNYDGLTALHV--AVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSS 185 (241)
T ss_dssp CTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCB
T ss_pred cccccCcCCCcHHHH--HHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 566777888899866 666777889999999999999998 78999999999999999999999999999999999999
Q ss_pred hhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
|||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 186 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 220 (241)
T 1k1a_A 186 ALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPL 220 (241)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred HHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 99999999999999999999999987776655543
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.8e-18 Score=159.62 Aligned_cols=96 Identities=22% Similarity=0.147 Sum_probs=89.2
Q ss_pred hhhcccchhhhhhhhcC---CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 29 KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~---~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
.+..|.|+|++ |+.. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++||++||+++.+|..|+|||
T Consensus 186 ~~~~g~t~Lh~--A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL 263 (301)
T 2b0o_E 186 AQAPEELVLHL--AVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETAL 263 (301)
T ss_dssp SCSCEECHHHH--HHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHH
T ss_pred cCCCCccHHHH--HHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 57788899866 4443 778899999999999999999999999999999999999999999999999999999999
Q ss_pred hHhhhcCchhHHHHHHhcCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~ 126 (435)
|+|+..++.+++++|+++|++
T Consensus 264 ~~A~~~~~~~iv~~Ll~~ga~ 284 (301)
T 2b0o_E 264 DIARKKHHKECEELLEQAQAG 284 (301)
T ss_dssp HHHHHHTCHHHHHHHHHHHHH
T ss_pred HHHHHcCCHHHHHHHHHhcCC
Confidence 999999999999999999986
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-18 Score=157.55 Aligned_cols=106 Identities=21% Similarity=0.175 Sum_probs=93.4
Q ss_pred Cchhhhhhhhh--------------cccchhhhhhhhcCCHHHHHHHHHh---CCCCCccCCCCCCCHHHHHHHcCc---
Q 013833 21 SSADKQKEKAR--------------VSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHGW--- 80 (435)
Q Consensus 21 ~~~~~~~~~~~--------------~~~~~l~~~~a~~~~~~~~~~lL~~---~g~~~n~~d~~g~tpLh~Aa~~~~--- 80 (435)
..|++++.++. .|.|||++ |+..+..+++++|++ .|+++|.+|..|+||||+|+..|+
T Consensus 122 ~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~ 199 (273)
T 2pnn_A 122 ENGADVQAAANGDFFKKTKGRPGFYFGELPLSL--AACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTV 199 (273)
T ss_dssp HTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCH
T ss_pred HCCCCcCccccccccccccccccccCCCCHHHH--HHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcch
Confidence 35667777776 79999976 777778889999999 999999999999999999999998
Q ss_pred ------HHHHHHHHHcCCCcc-------ccccCCCchhhHhhhcCchhHHHHHHhcCC-CCC
Q 013833 81 ------IDVAKCLIEYGADVN-------AQDRWKNTPLADAEGAKKFNMMELLNAHGG-LSY 128 (435)
Q Consensus 81 ------~~~~~~Ll~~ga~~~-------~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~-~~~ 128 (435)
.+++++|+++|+++| .+|..|+||||+|+..|+.+++++|+++|+ ++.
T Consensus 200 ~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~ 261 (273)
T 2pnn_A 200 DNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPE 261 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC---
T ss_pred hHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCch
Confidence 899999999999997 489999999999999999999999999999 443
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=148.12 Aligned_cols=109 Identities=22% Similarity=0.187 Sum_probs=77.1
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
+++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|+||
T Consensus 84 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 161 (223)
T 2f8y_A 84 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP 161 (223)
T ss_dssp CTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CcccCCCCCCcHHHH--HHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCH
Confidence 455666667777654 555555666777777777777777777777777777777777777777777777777777777
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
||+|+..|+.+++++|+++|++++..+....
T Consensus 162 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 192 (223)
T 2f8y_A 162 LFLAAREGSYETAKVLLDHFANRDITDHMDR 192 (223)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCccccccCC
Confidence 7777777777777777777777766554443
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=148.78 Aligned_cols=114 Identities=25% Similarity=0.221 Sum_probs=92.2
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCC-CCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~-~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
+.|++++.++..|.||+++ |+..+..+++++|++.++ +++..|..|.||||+|+..|+.+++++|+++|++++.+|.
T Consensus 46 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~ 123 (223)
T 2f8y_A 46 EASADANIQDNMGRTPLHA--AVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDD 123 (223)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCT
T ss_pred HcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCC
Confidence 3566778888888888865 666667777777777776 7888888888888888888888888888888888888888
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
.|+||||+|+..++.+++++|+++|++++..+....+
T Consensus 124 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 160 (223)
T 2f8y_A 124 LGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREET 160 (223)
T ss_dssp TSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcC
Confidence 8888888888888888888888888888777655443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=154.25 Aligned_cols=90 Identities=26% Similarity=0.138 Sum_probs=68.6
Q ss_pred CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHh-cC
Q 013833 46 DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNA-HG 124 (435)
Q Consensus 46 ~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~-~g 124 (435)
+..+++++|++.|++++..|..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++ .|
T Consensus 161 ~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~g 240 (276)
T 4hbd_A 161 DDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPS 240 (276)
T ss_dssp HHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTT
T ss_pred hhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCC
Confidence 34444444444444555556668888888888888889999888888888888888999999888888888888888 78
Q ss_pred CCCCCCCCCCC
Q 013833 125 GLSYGQNGSHF 135 (435)
Q Consensus 125 ~~~~~~n~~~~ 135 (435)
++++..+....
T Consensus 241 ad~~~~d~~g~ 251 (276)
T 4hbd_A 241 CDISLTDRDGS 251 (276)
T ss_dssp CCTTCCCTTSC
T ss_pred CCCcCcCCCCC
Confidence 88776665444
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=149.17 Aligned_cols=101 Identities=24% Similarity=0.168 Sum_probs=93.9
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCC-CCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~-~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
.+..+..|.||+++ |+..+..+++++|++.|+++|.+|. .|.||||+|+..|+.+++++|+++|++++.+|..|+||
T Consensus 110 ~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 187 (236)
T 1ikn_D 110 LKATNYNGHTCLHL--ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP 187 (236)
T ss_dssp GGCCCTTCCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred hhccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCH
Confidence 56677789999976 7777778899999999999999997 99999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
||+|+..++.+++++|+++|++..
T Consensus 188 l~~A~~~~~~~~~~~Ll~~ga~~~ 211 (236)
T 1ikn_D 188 YQLTWGRPSTRIQQQLGQLTLENL 211 (236)
T ss_dssp GGGCTTSSCHHHHHHHHTTSCGGG
T ss_pred HHHHHccCchHHHHHHHHcchhhh
Confidence 999999999999999999999765
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=148.96 Aligned_cols=110 Identities=21% Similarity=0.232 Sum_probs=76.0
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
.+++..+..|.||++. |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|+|
T Consensus 102 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 179 (237)
T 3b7b_A 102 MDVNCQDDGGWTPMIW--ATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDS 179 (237)
T ss_dssp CCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCC
T ss_pred CCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 3455556666676654 55555666677777777777777777777777777777777777777777777777777777
Q ss_pred hhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|||+|+..++.+++++|+++|++++..+....
T Consensus 180 ~L~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~ 211 (237)
T 3b7b_A 180 PLHIAARENRYDCVVLFLSRDSDVTLKNKEGE 211 (237)
T ss_dssp HHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSC
T ss_pred HHHHHHHhCCHhHHHHHHHcCCCCCccCCCCC
Confidence 77777777777777777777777665554443
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-17 Score=140.10 Aligned_cols=100 Identities=19% Similarity=0.169 Sum_probs=88.6
Q ss_pred cccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhc
Q 013833 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (435)
Q Consensus 32 ~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (435)
.|.|+++. |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 2 ~~~t~L~~--A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 79 (167)
T 3v31_A 2 ANSLSVHQ--LAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79 (167)
T ss_dssp TTCCCHHH--HHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred CCcchHHH--HHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHc
Confidence 35677754 5556667777777788999999999999999999999999999999999999999999999999999999
Q ss_pred CchhHHHHHHhcCCCCCCCCCC
Q 013833 112 KKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 112 ~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
++.+++++|+++|++++..+..
T Consensus 80 ~~~~~v~~Ll~~g~~~~~~~~~ 101 (167)
T 3v31_A 80 GYTDIVKMLLDCGVDVNEYDWN 101 (167)
T ss_dssp TCHHHHHHHHHHTCCTTCCCTT
T ss_pred CCHHHHHHHHHCCCCCCcCCCC
Confidence 9999999999999988765544
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=154.53 Aligned_cols=100 Identities=25% Similarity=0.270 Sum_probs=91.2
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCccccccCCC
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKN 102 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~~~~~g~ 102 (435)
.+.+..+..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|++ .|+|+|.+|..|+
T Consensus 174 ~~~~~~~~~g~tpLh~--A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 251 (276)
T 4hbd_A 174 NINAKASQAGQTALML--AVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS 251 (276)
T ss_dssp CTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred CCccccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence 3455567779999976 667778889999999999999999999999999999999999999999 8999999999999
Q ss_pred chhhHhhhcCchhHHHHHHhcCC
Q 013833 103 TPLADAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~g~ 125 (435)
||||+|+..|+.+++++|+++..
T Consensus 252 TpL~~A~~~g~~~iv~~Ll~~~~ 274 (276)
T 4hbd_A 252 TALMVALDAGQSEIASMLYSRMN 274 (276)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHCC
T ss_pred CHHHHHHHcCCHHHHHHHHhccC
Confidence 99999999999999999998763
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=157.07 Aligned_cols=108 Identities=31% Similarity=0.361 Sum_probs=77.3
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+.+++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|
T Consensus 47 ~~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g 124 (351)
T 3utm_A 47 LNVNCHASDGRKSTPLHL--AAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQ 124 (351)
T ss_dssp TTTTCCCSSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred cCCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 355566666777777755 555666667777777777777777777777777777777777777777777777777777
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
.||||+|+..|+.+++++|+++|++++..+
T Consensus 125 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 154 (351)
T 3utm_A 125 FTPLHEAASKNRVEVCSLLLSHGADPTLVN 154 (351)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 777777777777777777777777655443
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-17 Score=147.49 Aligned_cols=100 Identities=27% Similarity=0.228 Sum_probs=91.1
Q ss_pred hhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCC-------------CCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013833 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-------------DNRTPLHVASLHGWIDVAKCLIEYGAD 93 (435)
Q Consensus 27 ~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~-------------~g~tpLh~Aa~~~~~~~~~~Ll~~ga~ 93 (435)
+..|..|.||+++ |+..+..+++++|++.|++++.++. .|.||||+|+..|+.+++++|+++|++
T Consensus 69 ~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~ 146 (232)
T 2rfa_A 69 TSELYEGQTALHI--AVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGAD 146 (232)
T ss_dssp CSTTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCC
T ss_pred cccCCCCcCHHHH--HHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCC
Confidence 4556789999976 7777788899999999999998865 799999999999999999999999999
Q ss_pred ccccccCCCchhhHhhhcCchhHH----HHHHhcCCCCC
Q 013833 94 VNAQDRWKNTPLADAEGAKKFNMM----ELLNAHGGLSY 128 (435)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~----~~L~~~g~~~~ 128 (435)
+|.+|..|+||||+|+..++.+++ ++|+++|++..
T Consensus 147 ~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~ 185 (232)
T 2rfa_A 147 IRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH 185 (232)
T ss_dssp TTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred CCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence 999999999999999999999988 99999999764
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=157.38 Aligned_cols=110 Identities=23% Similarity=0.232 Sum_probs=96.9
Q ss_pred chhhhhhhhhcccchhhhhh--hhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCccccc
Q 013833 22 SADKQKEKARVSRTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQD 98 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~--a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~-ga~~~~~~ 98 (435)
.|++++.+|..|.|++++.+ +..++...++++|+++|+++|.+|..|+||||+|+..|+.+++++|++. |+++|.+|
T Consensus 191 ~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d 270 (337)
T 4g8k_A 191 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 270 (337)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBC
T ss_pred cCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcC
Confidence 46788888999999987643 3345677899999999999999999999999999999999999999985 89999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
.+|+||||+|+..|+.+++++|+++|++++.++
T Consensus 271 ~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~~ 303 (337)
T 4g8k_A 271 SDGKTALLLAVELKLKKIAELLCKRGASTDCGD 303 (337)
T ss_dssp TTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTCC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999999999887553
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=152.65 Aligned_cols=96 Identities=26% Similarity=0.223 Sum_probs=89.1
Q ss_pred hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCC-------------CCCHHHHHHHcCcHHHHHHHHH---cCCC
Q 013833 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-------------NRTPLHVASLHGWIDVAKCLIE---YGAD 93 (435)
Q Consensus 30 ~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~-------------g~tpLh~Aa~~~~~~~~~~Ll~---~ga~ 93 (435)
|..|.|||++ |+..+..+++++|++.|+++|.+|.. |.||||+|+..|+.+++++|++ +|++
T Consensus 87 d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~ 164 (256)
T 2etb_A 87 FYQGHSALHI--AIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPAS 164 (256)
T ss_dssp TTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred cccCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCC
Confidence 4678999976 77777889999999999999999886 9999999999999999999999 9999
Q ss_pred ccccccCCCchhhHhhh--cCchh-------HHHHHHhcCCCC
Q 013833 94 VNAQDRWKNTPLADAEG--AKKFN-------MMELLNAHGGLS 127 (435)
Q Consensus 94 ~~~~~~~g~t~l~~A~~--~~~~~-------~~~~L~~~g~~~ 127 (435)
+|.+|..|+||||+|+. .++.+ ++++|+++|+++
T Consensus 165 ~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~ 207 (256)
T 2etb_A 165 LEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL 207 (256)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence 99999999999999998 78888 999999999988
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.2e-17 Score=153.63 Aligned_cols=68 Identities=31% Similarity=0.205 Sum_probs=37.5
Q ss_pred CCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 68 g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 199 g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~ 266 (299)
T 1s70_B 199 GGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQ 266 (299)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 44445555555555555555555555555555555555555555555555555555555554444433
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=164.75 Aligned_cols=114 Identities=27% Similarity=0.295 Sum_probs=91.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
..+++++..+..|.||+++ |+..+..+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..
T Consensus 266 ~~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~ 343 (437)
T 1n11_A 266 SKQANGNLGNKSGLTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKL 343 (437)
T ss_dssp TTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTT
T ss_pred hcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCC
Confidence 3556677777788888865 55666677888888888888888888888888888888888888888888888888888
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|+||||+|+..|+.+++++|+++|++++..+....+
T Consensus 344 g~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t 379 (437)
T 1n11_A 344 GYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 379 (437)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred CCCHHHHHHHCChHHHHHHHHHCcCCCCCCCCCCCC
Confidence 888888888888888888888888888766655443
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.3e-17 Score=163.28 Aligned_cols=113 Identities=25% Similarity=0.209 Sum_probs=91.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.|++++..+..|.|||+. |+..+..+++++|++.|+++|..|..|.||||+||..|+.+++++|+++|+++|.+|.+
T Consensus 2 ~~g~~~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~ 79 (437)
T 1n11_A 2 SPGISGGGGGESGLTPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKD 79 (437)
T ss_dssp -------------CCHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTT
T ss_pred CCCCCccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Confidence 4678899999999999976 66677778888888999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 80 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~ 114 (437)
T 1n11_A 80 DQTPLHCAARIGHTNMVKLLLENNANPNLATTAGH 114 (437)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCC
T ss_pred CCCHHHHHHHCCCHHHHHHHHhCCCCCCCCCCCCC
Confidence 99999999999999999999999998876655433
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=158.85 Aligned_cols=105 Identities=15% Similarity=0.015 Sum_probs=94.7
Q ss_pred hhhcccchhhhhhhhcCC--HHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC-----ccccccCC
Q 013833 29 KARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-----VNAQDRWK 101 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~--~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~-----~~~~~~~g 101 (435)
.+..|.|+|++ |+..+ +.+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|++ +|.+|..|
T Consensus 134 ~~~~g~t~L~~--A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g 211 (364)
T 3ljn_A 134 KHCKGQTALHW--CVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQG 211 (364)
T ss_dssp EEESCCCHHHH--HHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTC
T ss_pred CCCCCCCHHHH--HHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCC
Confidence 78889999976 66666 88999999999999999999999999999999999999999999999 99999999
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
+||||+|+..|+.+++++|+++|++++..+....
T Consensus 212 ~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g~ 245 (364)
T 3ljn_A 212 NSHLHWAILINWEDVAMRFVEMGIDVNMEDNEHT 245 (364)
T ss_dssp CCTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTSC
T ss_pred CcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 9999999999999999999999999876654433
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-17 Score=148.14 Aligned_cols=105 Identities=25% Similarity=0.294 Sum_probs=64.2
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
.+..+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 33 ~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 110 (231)
T 3aji_A 33 ATRTDQDSRTALHW--ACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPL 110 (231)
T ss_dssp GGCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred hhcCCCCCCCHHHH--HHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 34445556666544 4444455555666666666666666666666666666666666666666666666666666666
Q ss_pred hHhhhcCchhHHHHHHhcCCCCCCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
|+|+..++.+++++|++.|++++..+.
T Consensus 111 ~~A~~~~~~~~~~~Ll~~g~~~~~~~~ 137 (231)
T 3aji_A 111 HYAASKNRHEIAVMLLEGGANPDAKDH 137 (231)
T ss_dssp HHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence 666666666666666666666554443
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-17 Score=144.04 Aligned_cols=108 Identities=19% Similarity=0.215 Sum_probs=65.1
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHH-HcCCCccccccCCCc
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWKNT 103 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll-~~ga~~~~~~~~g~t 103 (435)
+++..|..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+ ..+++++.+|..|.|
T Consensus 31 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t 108 (201)
T 3hra_A 31 QVDEVDTEGNTPLNI--AVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGN 108 (201)
T ss_dssp CTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCC
T ss_pred CCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCc
Confidence 455555566666644 44444555666666666666666666666666666666666666666 345566666666666
Q ss_pred hhhHhhhcCchhHHHHHHhcC-CCCCCCCCCC
Q 013833 104 PLADAEGAKKFNMMELLNAHG-GLSYGQNGSH 134 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g-~~~~~~n~~~ 134 (435)
|||+|+..|+.+++++|++.| ++++..+...
T Consensus 109 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g 140 (201)
T 3hra_A 109 ALIPAAEKGHIDNVKLLLEDGREDIDFQNDFG 140 (201)
T ss_dssp SHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTS
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCC
Confidence 666666666666666666666 5555544433
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=157.11 Aligned_cols=116 Identities=19% Similarity=0.042 Sum_probs=93.0
Q ss_pred CCchhhhhh-hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc------------------
Q 013833 20 TSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW------------------ 80 (435)
Q Consensus 20 ~~~~~~~~~-~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~------------------ 80 (435)
...|+++|. +|..|.|||++ |+..+..+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 117 ~~~g~dvn~~~d~~g~TpLh~--Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~ 194 (327)
T 1sw6_A 117 PNTQLNLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCL 194 (327)
T ss_dssp TTSCCCSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGG
T ss_pred HhcCCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccc
Confidence 456778888 78999999976 666777888999999999999999899999998888655
Q ss_pred -----------------------HHHHHHHHHcCC---------------------------------------------
Q 013833 81 -----------------------IDVAKCLIEYGA--------------------------------------------- 92 (435)
Q Consensus 81 -----------------------~~~~~~Ll~~ga--------------------------------------------- 92 (435)
.+++++|++.++
T Consensus 195 ~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~ 274 (327)
T 1sw6_A 195 ILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIAN 274 (327)
T ss_dssp GEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHh
Confidence 345555555432
Q ss_pred CccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
++|.+|..|+||||+|+..|+.+++++|+++|++++..+....+|
T Consensus 275 ~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp 319 (327)
T 1sw6_A 275 MLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 319 (327)
T ss_dssp TTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 577888889999999999999999999999999988877666554
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=153.49 Aligned_cols=112 Identities=20% Similarity=0.175 Sum_probs=98.0
Q ss_pred chhhhhh----hhhcccchhhhhhhhcC---CHHHHHHHHHhCCCCCccC-----------CCCCCCHHHHHHHcCcHHH
Q 013833 22 SADKQKE----KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHAR-----------DYDNRTPLHVASLHGWIDV 83 (435)
Q Consensus 22 ~~~~~~~----~~~~~~~~l~~~~a~~~---~~~~~~~lL~~~g~~~n~~-----------d~~g~tpLh~Aa~~~~~~~ 83 (435)
.|++++. +|..|.|||++ |+.. +..+++++|++.|++++.. |..|.||||+||..|+.++
T Consensus 28 ~g~~i~~~~~~~d~~g~t~L~~--A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~ 105 (256)
T 2etb_A 28 NSKYLTDSAYTEGSTGKTCLMK--AVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQC 105 (256)
T ss_dssp HTCCTTSGGGSBTTTTBCHHHH--HHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHH
T ss_pred cCCCcccccccCCCCCCCHHHH--HHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHH
Confidence 5677777 78999999976 6666 7889999999999887643 4789999999999999999
Q ss_pred HHHHHHcCCCccccccC-------------CCchhhHhhhcCchhHHHHHHh---cCCCCCCCCCCCC
Q 013833 84 AKCLIEYGADVNAQDRW-------------KNTPLADAEGAKKFNMMELLNA---HGGLSYGQNGSHF 135 (435)
Q Consensus 84 ~~~Ll~~ga~~~~~~~~-------------g~t~l~~A~~~~~~~~~~~L~~---~g~~~~~~n~~~~ 135 (435)
+++|+++|+++|.+|.. |+||||+|+..|+.+++++|++ +|++++..+....
T Consensus 106 v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~ 173 (256)
T 2etb_A 106 VKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGN 173 (256)
T ss_dssp HHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSC
T ss_pred HHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCC
Confidence 99999999999999986 9999999999999999999999 8998876665443
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=153.38 Aligned_cols=98 Identities=26% Similarity=0.234 Sum_probs=89.3
Q ss_pred hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC--------------CCCCCHHHHHHHcCcHHHHHHHHH---cC
Q 013833 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD--------------YDNRTPLHVASLHGWIDVAKCLIE---YG 91 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d--------------~~g~tpLh~Aa~~~~~~~~~~Ll~---~g 91 (435)
.|..|.|||++ |+..++.+++++|++.|+++|.+| ..|+||||+||..|+.+++++|++ +|
T Consensus 89 ~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~g 166 (260)
T 3jxi_A 89 VYYRGQTALHI--AIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166 (260)
T ss_dssp SSEESBCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCC
T ss_pred cccCCCCHHHH--HHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccC
Confidence 34488899976 777778889999999999999998 689999999999999999999999 99
Q ss_pred CCccccccCCCchhhHhhhcCc---------hhHHHHHHhcCCCCC
Q 013833 92 ADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLSY 128 (435)
Q Consensus 92 a~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~g~~~~ 128 (435)
+++|.+|..|+||||+|+..++ .+++++|+++|++++
T Consensus 167 a~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~ 212 (260)
T 3jxi_A 167 ADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLF 212 (260)
T ss_dssp CCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999998777 699999999999874
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=151.60 Aligned_cols=120 Identities=23% Similarity=0.137 Sum_probs=90.7
Q ss_pred CCCCCCCchhhhhhh-hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCC-
Q 013833 15 CKGGATSSADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA- 92 (435)
Q Consensus 15 ~~~~~~~~~~~~~~~-~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga- 92 (435)
+-......|.+++.. |..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+
T Consensus 38 ~v~~Ll~~g~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~ 115 (253)
T 1yyh_A 38 VISDFIYQGASLHNQTDRTGETALHL--AARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRAT 115 (253)
T ss_dssp --------------CCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTS
T ss_pred HHHHHHHccCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 344456778777654 7888898866 666777888888889999999999999999999999999999999999886
Q ss_pred CccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
+++.+|..|.||||+|+..++.+++++|++.|++++..+....+
T Consensus 116 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t 159 (253)
T 1yyh_A 116 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKS 159 (253)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCB
T ss_pred CccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCC
Confidence 88999999999999999999999999999999888877655443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-17 Score=151.60 Aligned_cols=108 Identities=23% Similarity=0.235 Sum_probs=94.9
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCH---HHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCccccc
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~---~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~~~ 98 (435)
+++++..+..|.|++++ |+..++. .+++++|++.|+++|.+|..|.||||+|+..|+.+++++|++ .|+++|.+|
T Consensus 172 ~~~~~~~~~~g~t~l~~-a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~ 250 (285)
T 1wdy_A 172 GADVNACDNMGRNALIH-ALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250 (285)
T ss_dssp CCCTTCCCTTSCCHHHH-HHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred CCCCCccCCCCCCHHHH-HHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccC
Confidence 66778888889999865 3333332 789999999999999999999999999999999999999999 899999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
..|+||||+|+..++.+++++|+++|++++..+
T Consensus 251 ~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d 283 (285)
T 1wdy_A 251 SDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999999999887654
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.69 E-value=4e-17 Score=143.65 Aligned_cols=99 Identities=26% Similarity=0.346 Sum_probs=54.5
Q ss_pred ccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcC
Q 013833 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK 112 (435)
Q Consensus 33 ~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 112 (435)
+.|++ ++|+..++.+.+..+|...+.++|..|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|
T Consensus 5 ~~~~L-~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~ 83 (201)
T 3hra_A 5 EVGAL-LEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQG 83 (201)
T ss_dssp CTTHH-HHHHHTTCHHHHHHHHTCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred cccHH-HHHHHhccHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence 34444 33444455554445444444456666656666666666666666666666666666666666666666666666
Q ss_pred chhHHHHHH-hcCCCCCCCCC
Q 013833 113 KFNMMELLN-AHGGLSYGQNG 132 (435)
Q Consensus 113 ~~~~~~~L~-~~g~~~~~~n~ 132 (435)
+.+++++|+ ..+++++..+.
T Consensus 84 ~~~~~~~Ll~~~~~~~~~~~~ 104 (201)
T 3hra_A 84 RTEILAYMLKHATPDLNKHNR 104 (201)
T ss_dssp CHHHHHHHHHHSCCCTTCCCT
T ss_pred CHHHHHHHHhccCcccccccC
Confidence 666666555 33444444443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=151.96 Aligned_cols=112 Identities=28% Similarity=0.295 Sum_probs=75.1
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCC-----------------------------------------
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL----------------------------------------- 60 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~----------------------------------------- 60 (435)
.|++++.++..|.||+++ |+..+..+++++|++.|++
T Consensus 67 ~ga~~~~~~~~g~tpL~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (282)
T 1oy3_D 67 AGAGVLVAERGGHTALHL--ACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRD 144 (282)
T ss_dssp TTCCSSCCCTTSCCHHHH--HTTTTCHHHHHHHSSSCCSSCCCC-----------------------------------C
T ss_pred cCCCCCCCCCCCCCHHHH--HHHcCCcchhHhhhccCCCCchhhHHHHhhcccccCcchhcchhhhccccccchhhhhhh
Confidence 455566666666666654 5555556666666665543
Q ss_pred ------CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc-CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 61 ------VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 61 ------~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~-~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
+|.+|..|.||||+|+..|+.+++++|+++|++++.++. .|+||||+|+..|+.+++++|+++|++++..+..
T Consensus 145 ~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~ 224 (282)
T 1oy3_D 145 EDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYG 224 (282)
T ss_dssp CCGGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred hhhhhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccC
Confidence 556666777777777777777777777777777777764 3777777777777777777777777777665544
Q ss_pred CC
Q 013833 134 HF 135 (435)
Q Consensus 134 ~~ 135 (435)
..
T Consensus 225 g~ 226 (282)
T 1oy3_D 225 GR 226 (282)
T ss_dssp SC
T ss_pred CC
Confidence 33
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=152.53 Aligned_cols=76 Identities=28% Similarity=0.355 Sum_probs=54.9
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
.|++++..+..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++..|.
T Consensus 62 ~g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~ 137 (299)
T 1s70_B 62 RGADINYANVDGLTALHQ--ACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNS 137 (299)
T ss_dssp HCCCTTCBCTTCCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred cCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCC
Confidence 455666677777777755 5556666777777777777777777777777777777777777777777777776554
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=156.09 Aligned_cols=104 Identities=19% Similarity=0.221 Sum_probs=87.7
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHh-CCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~-~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
.+.|++++.++..|.|||++ |+..+..+++++|+. .|+++|.+|..|+||||+||..|+.++|++||++|||+|.+
T Consensus 226 l~~gad~n~~d~~g~t~L~~--a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~- 302 (337)
T 4g8k_A 226 LDHGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG- 302 (337)
T ss_dssp HHTTCCTTCCCGGGCCHHHH--HHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-
T ss_pred HHCCCCCCCcCCCCCCHHHH--HHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-
Confidence 34678899999999999965 444555555555554 68999999999999999999999999999999999999865
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~ 130 (435)
||||+|+..|+.+++++|+++||+++..
T Consensus 303 ----~~L~~A~~~~~~~iv~~Ll~~GA~~d~~ 330 (337)
T 4g8k_A 303 ----DLVMTARRNYDHSLVKVLLSHGAKEDFH 330 (337)
T ss_dssp ----CHHHHHHHTTCHHHHHHHHHTTCCC---
T ss_pred ----CHHHHHHHcCCHHHHHHHHHCcCCCCCC
Confidence 5999999999999999999999998743
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=154.94 Aligned_cols=105 Identities=17% Similarity=0.077 Sum_probs=95.1
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCch
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (435)
+++.+|..|.||+++ |+..+..+++++|++.|+++|..| |+||||+||..|+.+++++|+++|+++|.+|..|+||
T Consensus 23 ~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~ 98 (285)
T 3kea_A 23 DTFKADVHGHSASYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTA 98 (285)
T ss_dssp TTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcH
Confidence 477888999999976 777778888999999999999984 9999999999999999999999999999999999999
Q ss_pred hhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 105 LADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
||+|+..|+.+++++|+++|++++..+..
T Consensus 99 L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~ 127 (285)
T 3kea_A 99 LYYAVDSGNMQTVKLFVKKNWRLMFYGKT 127 (285)
T ss_dssp HHHHHHTTCHHHHHHHHHHCGGGGGCSSS
T ss_pred HHHHHHcCCHHHHHHHHhcCCCCCccCCC
Confidence 99999999999999999999988755543
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.3e-17 Score=157.64 Aligned_cols=88 Identities=20% Similarity=0.139 Sum_probs=46.1
Q ss_pred CHHHHHHHHHhCCCCCccCC--CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhc
Q 013833 46 DAAAVRKLLEEDQSLVHARD--YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123 (435)
Q Consensus 46 ~~~~~~~lL~~~g~~~n~~d--~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ 123 (435)
+..+++++|++.|+++|..| ..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++
T Consensus 211 g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~ 290 (368)
T 3jue_A 211 PSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKR 290 (368)
T ss_dssp CCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHT
T ss_pred CCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHC
Confidence 33444444445555555554 4455555555555555555555555555555555555555555555555555555555
Q ss_pred CCCCCCCCCC
Q 013833 124 GGLSYGQNGS 133 (435)
Q Consensus 124 g~~~~~~n~~ 133 (435)
|++++..+..
T Consensus 291 Gad~~~~d~~ 300 (368)
T 3jue_A 291 GADLGARDSE 300 (368)
T ss_dssp TCCTTCCCTT
T ss_pred cCCCCCcCCC
Confidence 5555544443
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.5e-17 Score=142.17 Aligned_cols=90 Identities=26% Similarity=0.254 Sum_probs=81.5
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
+.+++.+|..|.||+++ |+..+..+++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 66 ~~~~~~~d~~g~t~L~~--A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 143 (183)
T 3deo_A 66 DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERG 143 (183)
T ss_dssp TSCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTS
T ss_pred cCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCC
Confidence 67888999999999976 666677789999999999999998 889999999999999999999999999999999999
Q ss_pred CchhhHhhhcCch
Q 013833 102 NTPLADAEGAKKF 114 (435)
Q Consensus 102 ~t~l~~A~~~~~~ 114 (435)
+||||+|+..++.
T Consensus 144 ~tpl~~A~~~~~~ 156 (183)
T 3deo_A 144 LTALELAREILKT 156 (183)
T ss_dssp CCHHHHHHHHHHT
T ss_pred CCHHHHHHHhccC
Confidence 9999999876443
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-17 Score=157.97 Aligned_cols=108 Identities=21% Similarity=0.215 Sum_probs=99.6
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCC-----CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~-----~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~ 94 (435)
...|++++.+|..|.||+++ |+..++.+++++|++.|++ +|.+|..|+||||+||..|+.+++++|+++|+|+
T Consensus 160 l~~ga~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~ 237 (364)
T 3ljn_A 160 VQLGASPTAKDKADETPLMR--AMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDV 237 (364)
T ss_dssp HHHTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCT
T ss_pred HHcCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 34577889999999999976 7777888999999999998 9999999999999999999999999999999999
Q ss_pred cccccCCCchhhHhhhcCchhHHHHHHhcCCCCCC
Q 013833 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (435)
Q Consensus 95 ~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~ 129 (435)
|.+|..|+||||+|+..|+.+++++|+++|++++.
T Consensus 238 ~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~~ 272 (364)
T 3ljn_A 238 NMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLI 272 (364)
T ss_dssp TCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHHHH
T ss_pred CCCCCCCCCHHHHHHHhChHHHHHHHHHcCCchhh
Confidence 99999999999999999999999999999987643
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.7e-17 Score=150.58 Aligned_cols=99 Identities=22% Similarity=0.191 Sum_probs=90.9
Q ss_pred hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCC--------------CCCCHHHHHHHcCcHHHHHHHHH---cC
Q 013833 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY--------------DNRTPLHVASLHGWIDVAKCLIE---YG 91 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~--------------~g~tpLh~Aa~~~~~~~~~~Ll~---~g 91 (435)
.|..|.|||++ |+..+..+++++|++.|+++|.++. .|.||||+|+..|+.+++++|++ +|
T Consensus 97 ~d~~g~tpL~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~g 174 (273)
T 2pnn_A 97 SYYKGQTALHI--AIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQP 174 (273)
T ss_dssp TTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCC
T ss_pred ccCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCC
Confidence 45688999976 7777788999999999999999987 79999999999999999999999 99
Q ss_pred CCccccccCCCchhhHhhhcCc---------hhHHHHHHhcCCCCCC
Q 013833 92 ADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLSYG 129 (435)
Q Consensus 92 a~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~g~~~~~ 129 (435)
+++|.+|..|+||||+|+..++ .+++++|+++|++++.
T Consensus 175 ad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~ 221 (273)
T 2pnn_A 175 ADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHP 221 (273)
T ss_dssp CCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred CCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhccc
Confidence 9999999999999999999888 7999999999998763
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.6e-17 Score=148.25 Aligned_cols=101 Identities=23% Similarity=0.225 Sum_probs=92.4
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
+++++.+|..|.|||++ |+..++.+++++|++.|+++|.+| ..|+||||+||..|+.+++++|+++|+++|.+|..|
T Consensus 67 ~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g 144 (244)
T 3ui2_A 67 DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERG 144 (244)
T ss_dssp TCCTTCBCTTSCBHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred CCCCCCcCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 77889999999999976 666777789999999999999998 789999999999999999999999999999999999
Q ss_pred CchhhHhh----------------hcCchhHHHHHHhcCC
Q 013833 102 NTPLADAE----------------GAKKFNMMELLNAHGG 125 (435)
Q Consensus 102 ~t~l~~A~----------------~~~~~~~~~~L~~~g~ 125 (435)
+||||+|+ ..|+.+++++|++++.
T Consensus 145 ~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~ 184 (244)
T 3ui2_A 145 LTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVF 184 (244)
T ss_dssp CCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHE
T ss_pred CcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcc
Confidence 99999997 6688999999998764
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=143.48 Aligned_cols=107 Identities=24% Similarity=0.319 Sum_probs=74.3
Q ss_pred hhhh-hhhcccchhhhhhhhcCCHHHHHHHHHhCC--CCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 25 KQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQ--SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 25 ~~~~-~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g--~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
+++. .+..|.||+++ |+..+..+++++|++.| ++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 63 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g 140 (228)
T 2dzn_A 63 NLDDYPDDSGWTPFHI--ACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFN 140 (228)
T ss_dssp CGGGCCCTTSCCHHHH--HHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred cccccCCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCC
Confidence 3444 55666677654 44455566677777776 6777777777777777777777777777777777777777777
Q ss_pred CchhhHhhhcCchhHHHHHHhcC-CCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHG-GLSYGQNGS 133 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g-~~~~~~n~~ 133 (435)
+||||+|+..|+.+++++|++.| ++++..+..
T Consensus 141 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~ 173 (228)
T 2dzn_A 141 QIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQ 173 (228)
T ss_dssp CCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTT
T ss_pred CCHHHHHHHcCCHHHHHHHHhcCcccccCcCCC
Confidence 77777777777777777777777 665544433
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=151.78 Aligned_cols=106 Identities=28% Similarity=0.253 Sum_probs=95.4
Q ss_pred hhhcccchhhhhhhhcC---CHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 29 KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~---~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
.+..+.|++++ |+.. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+|||
T Consensus 207 ~~~~~~t~L~~--A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L 284 (351)
T 3utm_A 207 QPQSHETALHC--AVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTAL 284 (351)
T ss_dssp CTTTCCCHHHH--HHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred CCCCCCCHHHH--HHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 34567788865 4444 678999999999999999999999999999999999999999999999999999999999
Q ss_pred hHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|+|+..|+.+++++|+++|++++..+....+
T Consensus 285 ~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~t 315 (351)
T 3utm_A 285 HRAALAGHLQTCRLLLSYGSDPSIISLQGFT 315 (351)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHcCcHHHHHHHHHcCCCCCCcCCCCCC
Confidence 9999999999999999999998877765544
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=150.51 Aligned_cols=105 Identities=16% Similarity=0.104 Sum_probs=93.8
Q ss_pred Cchhhhhhhh--------------hcccchhhhhhhhcCCHHHHHHHHHh---CCCCCccCCCCCCCHHHHHHHcCc---
Q 013833 21 SSADKQKEKA--------------RVSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHGW--- 80 (435)
Q Consensus 21 ~~~~~~~~~~--------------~~~~~~l~~~~a~~~~~~~~~~lL~~---~g~~~n~~d~~g~tpLh~Aa~~~~--- 80 (435)
..|++++..+ ..|.|||++ |+..+..+++++|++ .|+++|.+|..|+||||+||..|+
T Consensus 114 ~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~ 191 (260)
T 3jxi_A 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSL--AACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTR 191 (260)
T ss_dssp HTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSH
T ss_pred hCCCCcCccccccccCcccccccccCCCCHHHH--HHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCch
Confidence 3566677766 578999976 666777889999999 999999999999999999998887
Q ss_pred ------HHHHHHHHHcCCCc-------cccccCCCchhhHhhhcCchhHHHHHHhcCCCC
Q 013833 81 ------IDVAKCLIEYGADV-------NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (435)
Q Consensus 81 ------~~~~~~Ll~~ga~~-------~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~ 127 (435)
.+++++|+++|+++ +.+|..|+||||+|+..|+.+++++|+++|++.
T Consensus 192 ~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~ 251 (260)
T 3jxi_A 192 ENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD 251 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence 79999999999999 789999999999999999999999999999754
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=143.71 Aligned_cols=107 Identities=28% Similarity=0.330 Sum_probs=57.9
Q ss_pred hhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCccccccCC
Q 013833 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWK 101 (435)
Q Consensus 23 ~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~g-a~~~~~~~~g 101 (435)
|++++..+..|.||++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++| ++++..+..|
T Consensus 34 g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g 111 (237)
T 3b7b_A 34 GANIDTCSEDQRTPLME--AAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGG 111 (237)
T ss_dssp TCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTS
T ss_pred CCCcCccCCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCC
Confidence 44445555555555543 44444455555555555555555555555555555555555555555555 5555555555
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
+||||+|+..++.+++++|++.|++++..+
T Consensus 112 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~ 141 (237)
T 3b7b_A 112 WTPMIWATEYKHVDLVKLLLSKGSDINIRD 141 (237)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCCCccC
Confidence 555555555555555555555555554443
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=148.65 Aligned_cols=101 Identities=25% Similarity=0.227 Sum_probs=93.2
Q ss_pred hhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 26 ~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
.+..|..|.|+|++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+|||
T Consensus 52 ~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L 129 (285)
T 3d9h_A 52 LMGDAVSDWSPMHE--AAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPL 129 (285)
T ss_dssp TCSSSCCSCCHHHH--HHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHH
T ss_pred ccCCCccCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 45678889999976 6667777888899999999999999999999999999999999999999999999999999999
Q ss_pred hHhhhcCchhHHHHHHhcCCCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
|+|+..|+.+++++|+++|++++
T Consensus 130 ~~A~~~~~~~~v~~Ll~~g~~~~ 152 (285)
T 3d9h_A 130 FNACVSGSWDCVNLLLQHGASVQ 152 (285)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCSS
T ss_pred HHHHHcCHHHHHHHHHHCCCCCC
Confidence 99999999999999999998764
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=148.78 Aligned_cols=108 Identities=20% Similarity=0.150 Sum_probs=97.7
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.|++++.+|..|.|||++ |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+ .|
T Consensus 81 ~g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g 157 (285)
T 3d9h_A 81 QGWAVNIITADHVSPLHE--ACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DL 157 (285)
T ss_dssp TTCCSCEECTTCCCHHHH--HHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TT
T ss_pred CCCCCCCcCCCCCCHHHH--HHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CC
Confidence 566788889999999976 777778899999999999999999999999999999999999999999999998755 49
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~ 132 (435)
.||||+|+..|+.+++++|+++|++++..+.
T Consensus 158 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~ 188 (285)
T 3d9h_A 158 ASPIHEAARRGHVECVNSLIAYGGNIDHKIS 188 (285)
T ss_dssp SCHHHHHHHHTCHHHHHHHHHTTCCTTCCBT
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence 9999999999999999999999998765543
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=148.75 Aligned_cols=103 Identities=12% Similarity=-0.016 Sum_probs=93.8
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.|++++.. +|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 52 ~~g~~~~~~--~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~ 127 (285)
T 3kea_A 52 NAGALKNLL--ENEFPLHQ--AATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKT 127 (285)
T ss_dssp HTTGGGSCC--TTCCHHHH--HTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSS
T ss_pred hCCCCCCCC--CCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCC
Confidence 356677766 48899876 77788889999999999999999999999999999999999999999999999999999
Q ss_pred C-CchhhHhhhcCchhHHHHHHhcCCCC
Q 013833 101 K-NTPLADAEGAKKFNMMELLNAHGGLS 127 (435)
Q Consensus 101 g-~t~l~~A~~~~~~~~~~~L~~~g~~~ 127 (435)
| .||||+|+..|+.+++++|+++|++.
T Consensus 128 g~~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 128 GWKTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp GGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 9 79999999999999999999998653
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=151.96 Aligned_cols=104 Identities=23% Similarity=0.259 Sum_probs=94.6
Q ss_pred Cchhhhhhhh--hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 21 SSADKQKEKA--RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 21 ~~~~~~~~~~--~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
..|++++..+ ..|.|+|++ |+..+..+++++|+++|+++|.+|..|+||||+|+..|+.+++++||++||+++.+|
T Consensus 221 ~~Gadvn~~~~~~~g~TpLh~--Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d 298 (368)
T 3jue_A 221 AHGADVNWVNGGQDNATPLIQ--ATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARD 298 (368)
T ss_dssp HTTCCTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HcCCCCCccccccCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcC
Confidence 4566777777 788899866 666777889999999999999999999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
..|+||||+|+..++.+++++|+.++..
T Consensus 299 ~~G~TpL~~A~~~g~~~iv~lLl~~~~~ 326 (368)
T 3jue_A 299 SEGRDPLTIAMETANADIVTLLRLAKMR 326 (368)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 9999999999999999999999988853
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=152.88 Aligned_cols=111 Identities=24% Similarity=0.293 Sum_probs=96.4
Q ss_pred hhhhhhhhcccchhhhhhhhcCC--HHHHHHHHHhCCCCCcc--------CCCCCCCHHHHHHHcCcHHHHHHHHHcC-C
Q 013833 24 DKQKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHA--------RDYDNRTPLHVASLHGWIDVAKCLIEYG-A 92 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~--~~~~~~lL~~~g~~~n~--------~d~~g~tpLh~Aa~~~~~~~~~~Ll~~g-a 92 (435)
.+++..+..|.|++++ |+..++ ..+++++|++.|+++|. .|..|.||||+||..|+.+++++|+++| +
T Consensus 226 ~~~~~~d~~g~t~L~~-A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~ 304 (373)
T 2fo1_E 226 GDIEELDRNGMTALMI-VAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGS 304 (373)
T ss_dssp HTTSCCCTTSCCHHHH-HHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCC
T ss_pred cChhhcCCCCCCHHHH-HHHhCCcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHHHHHHhcCC
Confidence 6778888899999865 444444 89999999999999886 6778999999999999999999999876 9
Q ss_pred CccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
++|.+|..|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 305 ~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~ 347 (373)
T 2fo1_E 305 NKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDH 347 (373)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSC
T ss_pred CccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCC
Confidence 9999999999999999999999999999999999887665544
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.64 E-value=4.8e-16 Score=143.94 Aligned_cols=107 Identities=21% Similarity=0.201 Sum_probs=94.5
Q ss_pred chhhhhhh-hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 22 SADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 22 ~~~~~~~~-~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
.|.+++.. +..|.|++++ |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 27 ~g~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 104 (285)
T 1wdy_A 27 GGANVNFQEEEGGWTPLHN--AVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104 (285)
T ss_dssp TTCCTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTT
T ss_pred cCCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcc
Confidence 34566666 6667888865 77777788999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~ 130 (435)
|+||||+|+..|+.+++++|++.|++++..
T Consensus 105 g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~ 134 (285)
T 1wdy_A 105 GFTAFMEAAVYGKVKALKFLYKRGANVNLR 134 (285)
T ss_dssp CCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred cCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence 999999999999999999999999877644
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-16 Score=140.78 Aligned_cols=69 Identities=22% Similarity=0.180 Sum_probs=35.0
Q ss_pred CCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCC
Q 013833 57 DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 57 ~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~ 125 (435)
.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..++.+++++|++.++
T Consensus 35 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~ 103 (241)
T 1k1a_A 35 GGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAA 103 (241)
T ss_dssp TTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSC
T ss_pred cCCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence 444555555555555555555555555555555555555555555555555555555555555554444
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.63 E-value=4.7e-16 Score=150.73 Aligned_cols=97 Identities=27% Similarity=0.319 Sum_probs=86.1
Q ss_pred hhhhcccchhhhhhhhcCCHHHHHHHHHhC-CCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhh
Q 013833 28 EKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA 106 (435)
Q Consensus 28 ~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~-g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 106 (435)
..|..|.|++++ |+..+..+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||
T Consensus 274 ~~d~~g~t~Lh~--A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~ 351 (373)
T 2fo1_E 274 SEKYKGRTALHY--AAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQ 351 (373)
T ss_dssp SSSCCCCCTHHH--HHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHH
T ss_pred cccccCCCHHHH--HHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHH
Confidence 356688899865 6666667777777765 5999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCchhHHHHHHhcCCC
Q 013833 107 DAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 107 ~A~~~~~~~~~~~L~~~g~~ 126 (435)
+|+..|+.+++++|++++++
T Consensus 352 ~A~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 352 LAQANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp HHHHTTCHHHHHHHHTTC--
T ss_pred HHHHcCCHHHHHHHHhcCcc
Confidence 99999999999999999875
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=136.55 Aligned_cols=111 Identities=21% Similarity=0.167 Sum_probs=86.0
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
+.|++++..+..|.|++++ |+..+..+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.+|.
T Consensus 30 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 107 (240)
T 3eu9_A 30 EAGYDVRQPDKENVTLLHW--AAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDG 107 (240)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred HcCCCcCCCCCCCCCHHHH--HHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCC
Confidence 3456677777778888765 666667778888888888877655 4488888888888888888888888888888888
Q ss_pred CCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCC
Q 013833 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (435)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~ 133 (435)
.|.||||+|+..|+.+++++|++.|++++..+..
T Consensus 108 ~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~ 141 (240)
T 3eu9_A 108 EGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQN 141 (240)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCC
Confidence 8888888888888888888888888776655443
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=153.23 Aligned_cols=97 Identities=16% Similarity=0.036 Sum_probs=85.2
Q ss_pred hhhcCCHHHHHHHHHhCCCCCccC------CCCCCCHHHHHHH---cCcHHHHHHHHHcCCCccccccCCCchhhHhhhc
Q 013833 41 HAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASL---HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (435)
Q Consensus 41 ~a~~~~~~~~~~lL~~~g~~~n~~------d~~g~tpLh~Aa~---~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (435)
.|+..+..++++.|++.|+++|.. |..|+||||+||. .|+.+++++||++|||+|.+|..|+||||+|+..
T Consensus 138 ~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpLh~A~~~ 217 (497)
T 3lvq_E 138 TAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALY 217 (497)
T ss_dssp HHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHHHHHTTT
T ss_pred HHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHHHHHHHc
Confidence 355555556666667899999988 8899999999966 9999999999999999999999999999999999
Q ss_pred CchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 112 KKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 112 ~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
|+.+++++|+++|++++..+....+|
T Consensus 218 g~~~~v~~Ll~~ga~~~~~d~~g~tp 243 (497)
T 3lvq_E 218 NQPDCLKLLLKGRALVGTVNEAGETA 243 (497)
T ss_dssp TCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 99999999999999999887765544
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=2.3e-15 Score=139.69 Aligned_cols=98 Identities=15% Similarity=0.025 Sum_probs=83.0
Q ss_pred hhhhhcCCHHHHHHHHHhCCCCC------ccCCCCCCCHHHHHHHc---CcHHHHHHHHHcCCCccccccCCCchhhHhh
Q 013833 39 LWHAHQNDAAAVRKLLEEDQSLV------HARDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109 (435)
Q Consensus 39 ~~~a~~~~~~~~~~lL~~~g~~~------n~~d~~g~tpLh~Aa~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~ 109 (435)
+.|+..++.. .+..+++.|+++ +..|..|+||||+||.. |+.+++++|+++|+++|.+|..|+||||+|+
T Consensus 135 ~~a~~~~d~~-~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~ 213 (278)
T 1dcq_A 135 CEAVKTRDIF-GLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC 213 (278)
T ss_dssp HHHHHTTCHH-HHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred hhHhhhcccH-HHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHH
Confidence 3444555554 555566889884 44588999999999999 8999999999999999999999999999999
Q ss_pred hcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 110 GAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 110 ~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
..|+.+++++|+++|++++..+....+|
T Consensus 214 ~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 214 LTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp HTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 9999999999999999998877665543
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=140.94 Aligned_cols=98 Identities=16% Similarity=0.066 Sum_probs=84.7
Q ss_pred hhhhhhcCCHHHHHHHHHhCCCCCcc------CCCCCCCHHHHHHHc---CcHHHHHHHHHcCCCccccccCCCchhhHh
Q 013833 38 ILWHAHQNDAAAVRKLLEEDQSLVHA------RDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (435)
Q Consensus 38 ~~~~a~~~~~~~~~~lL~~~g~~~n~------~d~~g~tpLh~Aa~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (435)
+++|+..++...+.. |++.|+++|. .|..|.||||+|+.. |+.+++++|+++|+++|.+|..|+||||+|
T Consensus 155 L~~A~~~g~~~~v~~-ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A 233 (301)
T 2b0o_E 155 LWTAICNRDLLSVLE-AFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYA 233 (301)
T ss_dssp HHHHHHTTCHHHHHH-HHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHH
T ss_pred HhhhhhccCHHHHHH-HHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 345566666555554 5599999998 689999999999997 899999999999999999999999999999
Q ss_pred hhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 109 EGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 109 ~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
+..|+.+++++|+++|++++..+....+
T Consensus 234 ~~~g~~~~v~~Ll~~gad~~~~d~~G~T 261 (301)
T 2b0o_E 234 ALYNQPDCLKLLLKGRALVGTVNEAGET 261 (301)
T ss_dssp HHTTCHHHHHHHHHTTCCCSCCCTTSCC
T ss_pred HHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 9999999999999999998877655443
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=136.65 Aligned_cols=103 Identities=23% Similarity=0.196 Sum_probs=48.0
Q ss_pred hhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCc-HHHHHHHHHcCCCcccccc-CCC
Q 013833 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDR-WKN 102 (435)
Q Consensus 25 ~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~-~~~~~~Ll~~ga~~~~~~~-~g~ 102 (435)
+++..+..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..++ .+++++|++.|++++..+. .|.
T Consensus 101 ~~~~~~~~g~t~l~~--A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~ 178 (240)
T 3eu9_A 101 DPSLIDGEGCSCIHL--AAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKN 178 (240)
T ss_dssp CTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCC
T ss_pred CCcccCCCCCCHHHH--HHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCC
Confidence 333344444444433 333333444444444444444444444444444443333 4444444444444444443 445
Q ss_pred chhhHhhhcCchhHHHHHHhcCCCCCC
Q 013833 103 TPLADAEGAKKFNMMELLNAHGGLSYG 129 (435)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~g~~~~~ 129 (435)
||||+|+..|+.+++++|+++|++++.
T Consensus 179 t~L~~A~~~~~~~~v~~Ll~~g~~~~~ 205 (240)
T 3eu9_A 179 TALHWAVLAGNTTVISLLLEAGANVDA 205 (240)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHTCCTTC
T ss_pred cHHHHHHHcCCHHHHHHHHHcCCCCCC
Confidence 555555555555555555555544443
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.57 E-value=3.8e-15 Score=113.91 Aligned_cols=70 Identities=36% Similarity=0.504 Sum_probs=63.7
Q ss_pred CCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 67 ~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..++.+++++|+++|++++..+....+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 70 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRT 70 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCC
Confidence 4899999999999999999999999999999999999999999999999999999999998877655443
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=4.9e-15 Score=140.85 Aligned_cols=93 Identities=16% Similarity=0.086 Sum_probs=81.8
Q ss_pred hhhcCCHHHHHHHHHhCCCCCcc-CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCc---hhH
Q 013833 41 HAHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKK---FNM 116 (435)
Q Consensus 41 ~a~~~~~~~~~~lL~~~g~~~n~-~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~---~~~ 116 (435)
+++.+...+++++|++.|+++|. +|..|+||||+||..|+.++|++||++||++|.+|..|+||||+|+..|+ .++
T Consensus 103 ~a~~~~~~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~ 182 (327)
T 1sw6_A 103 VSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGT 182 (327)
T ss_dssp -CHHHHHHHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTC
T ss_pred HHHHhhHHHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHH
Confidence 35666778899999999999999 89999999999999999999999999999999999999999999999998 788
Q ss_pred HHHHHhcC-CCCCCCCCC
Q 013833 117 MELLNAHG-GLSYGQNGS 133 (435)
Q Consensus 117 ~~~L~~~g-~~~~~~n~~ 133 (435)
++.|++++ ++++..+..
T Consensus 183 ~~~ll~~~~~~~~~~d~~ 200 (327)
T 1sw6_A 183 FEALLDYLYPCLILEDSM 200 (327)
T ss_dssp HHHHHHHHGGGGGEECTT
T ss_pred HHHHHHhhhccccCCCCC
Confidence 88888776 555544433
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-14 Score=115.39 Aligned_cols=84 Identities=32% Similarity=0.349 Sum_probs=75.1
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
...|++++.+|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++||++|.++.
T Consensus 29 l~~g~~~~~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~ 106 (115)
T 2l6b_A 29 LSKGADVNARSKDGNTPLHL--AAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSW 106 (115)
T ss_dssp TTTTCCSSCCCSSSCCTTHH--HHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSC
T ss_pred HHcCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCc
Confidence 45677888899999999976 7777788999999999999999999999999999999999999999999999999999
Q ss_pred CCCchh
Q 013833 100 WKNTPL 105 (435)
Q Consensus 100 ~g~t~l 105 (435)
.|.||-
T Consensus 107 ~~~~~~ 112 (115)
T 2l6b_A 107 GSSHHH 112 (115)
T ss_dssp CCC---
T ss_pred cccccc
Confidence 999884
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.44 E-value=8.9e-14 Score=109.85 Aligned_cols=75 Identities=27% Similarity=0.213 Sum_probs=65.8
Q ss_pred CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCC
Q 013833 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 61 ~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~ 135 (435)
.+..|.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 91 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGK 91 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCC
Confidence 456678999999999999999999999999999999999999999999999999999999999999877665444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.8e-13 Score=124.42 Aligned_cols=140 Identities=14% Similarity=0.064 Sum_probs=108.5
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
.|++...++.|+++.||++...+..+++|.......... ..+.+|+.+++.+. +..++++++++.+.+..|+|||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 466666788888999999988888999998754221111 35788999999885 67889999999888899999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 275 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----------------------------------------- 275 (435)
++|.+|.+.+. +......++.++..+|..||+..
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999887631 22233467889999999999810
Q ss_pred ----------------CceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 276 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 276 ----------------~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++|+|++|.|||+ ++.+.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhcc
Confidence 238999999999999 554456799999775
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-14 Score=140.19 Aligned_cols=93 Identities=16% Similarity=0.084 Sum_probs=74.3
Q ss_pred hhcccchhhhhhhhcCCHHHHHHHHHhCCCCC---ccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccc--cccCCCch
Q 013833 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV---HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA--QDRWKNTP 104 (435)
Q Consensus 30 ~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~---n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~--~~~~g~t~ 104 (435)
+..+.||+++ |+..++.+++++|+++|+++ +..+.+ +||||+||..|+.++|++|+++|++++. .|..|+||
T Consensus 125 ~~~~~tpL~~--Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~Tp 201 (376)
T 2aja_A 125 QAENYQAFRL--AAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYA 201 (376)
T ss_dssp CHHHHHHHHH--HHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHH
T ss_pred ccCCCCHHHH--HHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCH
Confidence 3456677755 77777888888888998752 222223 8999999999999999999999999887 88889999
Q ss_pred hhHhh-hcCchhHHHHHHhcCC
Q 013833 105 LADAE-GAKKFNMMELLNAHGG 125 (435)
Q Consensus 105 l~~A~-~~~~~~~~~~L~~~g~ 125 (435)
||+|+ ..|+.+++++|++.|+
T Consensus 202 L~~Aa~~~G~~eiv~~Ll~~ga 223 (376)
T 2aja_A 202 FRWAAVGRGHHNVINFLLDCPV 223 (376)
T ss_dssp HHHHHSTTCCHHHHHHHTTSHH
T ss_pred HHHHHHHCCCHHHHHHHHhCCC
Confidence 99999 9999999999988664
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-13 Score=131.43 Aligned_cols=99 Identities=13% Similarity=0.048 Sum_probs=76.4
Q ss_pred hhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCC---ccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC---ccccccC
Q 013833 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV---HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRW 100 (435)
Q Consensus 27 ~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~---n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~---~~~~~~~ 100 (435)
..++.++.||++. |+..+..+++++|++.|+.. +..+..|.||||+||.+|+.++|++|+++|++ .+..+.+
T Consensus 86 ~~~g~~~~T~Lh~--Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~ 163 (376)
T 2aja_A 86 HKKGIKSEVICFV--AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN 163 (376)
T ss_dssp HHHTCCHHHHHHH--HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH
T ss_pred HHcCCCcCCHHHH--HHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC
Confidence 3445556688865 66677788888888998832 23445688999999999999999999999986 3333344
Q ss_pred CCchhhHhhhcCchhHHHHHHhcCCCCC
Q 013833 101 KNTPLADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
+||||+|+..|+.+++++|+++|++++
T Consensus 164 -~TpLh~Aa~~G~~eiv~~Ll~~ga~~~ 190 (376)
T 2aja_A 164 -YHAFRLAAENGHLHVLNRLCELAPTEA 190 (376)
T ss_dssp -HHHHHHHHHTTCHHHHHHHHHSCGGGH
T ss_pred -CCHHHHHHHCCCHHHHHHHHHcCCccc
Confidence 999999999999999999999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=118.95 Aligned_cols=142 Identities=18% Similarity=0.211 Sum_probs=105.8
Q ss_pred CceeecCCceeEEEEEECCCcEEEEEcc--CCCCCcHHHHHHHHHHHHHHHhCC--CCcceeeeeeEEeC---CcEEEEE
Q 013833 162 SAIIGKGSFGEILKAYWRGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER---KPLMLIT 234 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~ 234 (435)
.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999888889999764 22111 12256788999999997 45688898888766 3479999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------------------------------------- 274 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---------------------------------------- 274 (435)
||++|..+.+. ....+++.+...++.++...|..||+.
T Consensus 121 e~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999877542 123467888888999999999999972
Q ss_pred ----------------CCceEeCCCCCCcEEEecCCCC--cEEEeeccCcccc
Q 013833 275 ----------------PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLI 309 (435)
Q Consensus 275 ----------------~~~ivH~Dlkp~NIll~~~~~~--~vkl~Dfg~a~~~ 309 (435)
...++|+|++|.|||+ +.++ .+.|+||+.+..-
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~--~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF--HPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE--CSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEE--eCCCCcEEEEECccccccC
Confidence 1359999999999999 5443 3689999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=6e-11 Score=108.35 Aligned_cols=126 Identities=21% Similarity=0.167 Sum_probs=92.4
Q ss_pred ecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc--ceeeeeeEEeCCcEEEEEecCCCCCH
Q 013833 166 GKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEYLRGGDL 242 (435)
Q Consensus 166 g~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~g~sL 242 (435)
+.|..+.||++... |..+++|...... ...+.+|+.+++.+.+.+ +++++++...++..++||||++|.+|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 46666999999765 5679999865431 145678999988885433 67788888888889999999999888
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 013833 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------------- 275 (435)
Q Consensus 243 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----------------------------------------------- 275 (435)
. . ...+. ..++.+++..|..||+..
T Consensus 103 ~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 103 L--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp T--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred C--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 4 2 11222 245677777777777642
Q ss_pred ---------CceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 276 ---------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 276 ---------~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
..++|+|++|.||++ ++++.+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEE--ECCcEEEEEcchhcc
Confidence 129999999999999 555556799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=9.1e-11 Score=110.06 Aligned_cols=186 Identities=20% Similarity=0.203 Sum_probs=121.0
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCc--ceeeeeeEEeCC---cEEEEEec
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN--IVQFLGAVTERK---PLMLITEY 236 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~ 236 (435)
+.++.|.+..||+.. ..+++|+... ......+.+|+++|+.+. +.. +++++....... ..|+||++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 468999999999864 6789997532 233467889999998873 322 455555443333 34889999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 275 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~----------------------------------------- 275 (435)
++|.+|.+... ..++.++...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988875432 24677788888888888888888611
Q ss_pred ---------------CceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccC----
Q 013833 276 ---------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK---- 336 (435)
Q Consensus 276 ---------------~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---- 336 (435)
..++|+|++|.||++.++..+.+.|+||+.+..-.+.. +........ .-..|+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~---~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDD---EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTT---TSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhc---cccCHHHHHHHHH
Confidence 23899999999999943224567899999886543211 110000000 001222110
Q ss_pred CC----------CCCCcchHHHHHHHHHHHHcCCCCC
Q 013833 337 HR----------KYDKKVDVFSFAMILYEMLEGEPPL 363 (435)
Q Consensus 337 ~~----------~~~~~~Dv~slG~il~~l~tg~~p~ 363 (435)
.. ......+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0112368999999999999999775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-07 Score=86.75 Aligned_cols=133 Identities=20% Similarity=0.222 Sum_probs=97.0
Q ss_pred eeecCCce-eEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecCCC
Q 013833 164 IIGKGSFG-EILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 164 ~lg~G~~g-~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
.+..|..+ .||+.... +..+++|.-.. .....+.+|+..|+.+. +--|++++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34556555 68987754 56799997532 23467888999998885 33478889999888999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------------
Q 013833 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN------------------------------------------- 276 (435)
Q Consensus 240 ~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~------------------------------------------- 276 (435)
.++.+..... ......+..++...|.-||+...
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 9988776532 22334566777777777776310
Q ss_pred -------------ceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 277 -------------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 277 -------------~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.++|+|+.+.|||+ ++.+.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECccccc
Confidence 18999999999999 6555667999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2.3e-07 Score=86.79 Aligned_cols=135 Identities=19% Similarity=0.156 Sum_probs=93.1
Q ss_pred CceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC---cceeeeeeEE-eCCcEEEEEecC
Q 013833 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP---NIVQFLGAVT-ERKPLMLITEYL 237 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~ 237 (435)
.+.++.|....||+. +..+++|+.. .......+.+|+++|+.+.+. .+++++.+.. ..+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 346889999999988 6789999742 123446789999999999742 3677777664 345678999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------------------------------------------- 274 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~------------------------------------------- 274 (435)
+|.+|.+..- ..++.++...++.++...|..||+.
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988866321 1234444444455555554444432
Q ss_pred ---------------CCceEeCCCCCCcEEEecCC---CCc-EEEeeccCccc
Q 013833 275 ---------------PNVIIHRDLKPRNVLLVNSS---ADH-LKVGDFGLSKL 308 (435)
Q Consensus 275 ---------------~~~ivH~Dlkp~NIll~~~~---~~~-vkl~Dfg~a~~ 308 (435)
...++|+|++|.||++ +. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcCC
Confidence 1237999999999999 54 345 47999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=4.3e-07 Score=86.83 Aligned_cols=78 Identities=9% Similarity=0.045 Sum_probs=53.5
Q ss_pred Ccee-ecCCceeEEEEEEC--------CCcEEEEEccCCC---CCcHHHHHHHHHHHHHHHhCCC---CcceeeeeeEEe
Q 013833 162 SAII-GKGSFGEILKAYWR--------GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRH---PNIVQFLGAVTE 226 (435)
Q Consensus 162 ~~~l-g~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~ 226 (435)
.+.| +.|....+|+.... +..+++|...... ... ...+.+|+.+++.+.. -.+++++.+..+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3467 88889999998765 6678999764322 000 1345678888887742 357788877765
Q ss_pred C---CcEEEEEecCCCCCH
Q 013833 227 R---KPLMLITEYLRGGDL 242 (435)
Q Consensus 227 ~---~~~~lv~e~~~g~sL 242 (435)
. ...++|||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.2e-06 Score=83.14 Aligned_cols=76 Identities=20% Similarity=0.281 Sum_probs=48.7
Q ss_pred ceeecCCceeEEEEEE--CCCcEEEEEccCCCC-CcH---HHHHHHHHHHHHHHhCCC--C-cceeeeeeEEeCCcEEEE
Q 013833 163 AIIGKGSFGEILKAYW--RGTPVAIKRILPSLS-DDR---LVIQDFRHEVNLLVKLRH--P-NIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~lv 233 (435)
+.||.|.++.||++.. .+..+++|....... ..+ ....++..|.++++.+.. | .+++++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 4789999999999964 467899997643211 000 112456778888887742 3 45566643 34456899
Q ss_pred EecCCCC
Q 013833 234 TEYLRGG 240 (435)
Q Consensus 234 ~e~~~g~ 240 (435)
||+++|.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.1e-05 Score=76.30 Aligned_cols=73 Identities=15% Similarity=0.164 Sum_probs=42.2
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcceeeee------eEEeCCcEEEEE
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLG------AVTERKPLMLIT 234 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~------~~~~~~~~~lv~ 234 (435)
+.|+.|..+.||++...+..+++|..... . ..+..|..+++.+. .-.+++++. +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 35667788999999877667999987541 2 22334455554442 113344443 223456789999
Q ss_pred ecCCCCCH
Q 013833 235 EYLRGGDL 242 (435)
Q Consensus 235 e~~~g~sL 242 (435)
+|++|.++
T Consensus 111 ~~i~G~~~ 118 (346)
T 2q83_A 111 DWIEGRPF 118 (346)
T ss_dssp ECCCCBCC
T ss_pred EeecCccC
Confidence 99998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.2e-05 Score=73.24 Aligned_cols=75 Identities=21% Similarity=0.118 Sum_probs=60.2
Q ss_pred CceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcceeeeeeEEeCCcEEEEEecCC
Q 013833 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
.+.|+.|....+|+....+..+++|..... ....+..|++.|+.+. ...+++++.+....+..++|||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 346899999999999887888999976432 1366888999888874 3678899988887788999999999
Q ss_pred CCCH
Q 013833 239 GGDL 242 (435)
Q Consensus 239 g~sL 242 (435)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.2e-05 Score=75.55 Aligned_cols=75 Identities=15% Similarity=0.156 Sum_probs=44.9
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCC---Cc-H--HHHHHHHHHHHHHH-hCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLS---DD-R--LVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~-~--~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+.||.|..+.||++...+..++||....... .. . .....+..|+..+. ......+++++.+. ....++|||
T Consensus 40 ~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e 117 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMR 117 (420)
T ss_dssp EECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEEC
T ss_pred EEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEe
Confidence 4688999999999987777899994322110 00 0 00122333333222 22234677777665 456789999
Q ss_pred cC-CC
Q 013833 236 YL-RG 239 (435)
Q Consensus 236 ~~-~g 239 (435)
++ +|
T Consensus 118 ~l~~g 122 (420)
T 2pyw_A 118 YLEPP 122 (420)
T ss_dssp CCCTT
T ss_pred ecCCc
Confidence 99 77
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00018 Score=62.37 Aligned_cols=144 Identities=14% Similarity=0.151 Sum_probs=92.7
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 240 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 240 ~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
-||.++|.. ..+++++++|.++.|.+.+|.-+-.+..+ ..+=+-|..|++ ..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l--~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRV--WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEE--ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEE--ecCCceeccc-cccc-----------
Confidence 389999986 55799999999999999998776211111 122234789999 8888887663 1110
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 398 (435)
.....+.+||... ...+.+.=|||||+++|.-+-=..| .-.+..+|+.+.+||..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDH 152 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHH
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHH
Confidence 1123467888763 4556778899999999998752222 11234689999999999
Q ss_pred Hhhhc-------------------------ccCCCCHHHHHHHHHHHHhhCCC
Q 013833 399 CWAAD-------------------------MNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 399 cl~~d-------------------------p~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
|.... +..|++++++++ .....+.+
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~---~C~~hl~~ 202 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK---LCAAHLPT 202 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHH---HHHTTSSS
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHH---HHHhhccC
Confidence 98652 357788888864 34444444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00028 Score=65.00 Aligned_cols=76 Identities=20% Similarity=0.129 Sum_probs=52.7
Q ss_pred CCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC---CcceeeeeeEEeCCcEEEEEe
Q 013833 160 SSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH---PNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e 235 (435)
..++.+|.|..+.||+.... |+++++|+........ ...+..|++.|+.+.- -.+++++.+ + .-++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 34567999999999999875 8899999764332222 1457789999988842 235555543 2 2378999
Q ss_pred cCCCCCH
Q 013833 236 YLRGGDL 242 (435)
Q Consensus 236 ~~~g~sL 242 (435)
+++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00023 Score=67.01 Aligned_cols=32 Identities=34% Similarity=0.446 Sum_probs=26.3
Q ss_pred CceEeCCCCCCcEEEecCCC----CcEEEeeccCcccc
Q 013833 276 NVIIHRDLKPRNVLLVNSSA----DHLKVGDFGLSKLI 309 (435)
Q Consensus 276 ~~ivH~Dlkp~NIll~~~~~----~~vkl~Dfg~a~~~ 309 (435)
..++|+|+.+.|||+ +.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~--~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLW--LPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEE--CTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEe--ccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999 442 57999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00048 Score=63.79 Aligned_cols=71 Identities=8% Similarity=0.081 Sum_probs=44.2
Q ss_pred CceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc-eeeeeeEEeCCcEEEEEecC-CC
Q 013833 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYL-RG 239 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~g 239 (435)
.+.|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ ++++.+ +.+.-++++||+ +|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 568999999999999 67899976532111 1122457777766642222 556544 333447899999 66
Q ss_pred CCH
Q 013833 240 GDL 242 (435)
Q Consensus 240 ~sL 242 (435)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00067 Score=63.35 Aligned_cols=139 Identities=17% Similarity=0.115 Sum_probs=75.9
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC--cceeeeee------EEeCCcEEEEE
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGA------VTERKPLMLIT 234 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~ 234 (435)
+.|+.|....+|+....+..+++|........ ..+..|+.++..+... .+++++.. ....+..++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 45778888999999877668999987542111 3445677776665311 13444321 22345678999
Q ss_pred ecCCCCCHH-----------HH---HHHc-CCC--------CHHHHHHH---------------HHHHHHHHHHHhc---
Q 013833 235 EYLRGGDLH-----------KY---LKEK-GAL--------SPSTAVNF---------------ALDIARGMAYLHN--- 273 (435)
Q Consensus 235 e~~~g~sL~-----------~~---l~~~-~~~--------~~~~~~~~---------------~~qi~~~l~~LH~--- 273 (435)
++++|..+. .. ++.. ..+ ........ ...+...++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999886531 11 1111 111 11110100 0013334444442
Q ss_pred --CCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 274 --EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 274 --~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
....++|+|+.+.|||+ ++++.+.|+||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEE--eCCceEEEecchhccC
Confidence 11349999999999999 5544457999997753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0014 Score=61.38 Aligned_cols=73 Identities=7% Similarity=0.023 Sum_probs=46.0
Q ss_pred eeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC--Ccceeeeee-----EEeCCcEEEEEe
Q 013833 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGA-----VTERKPLMLITE 235 (435)
Q Consensus 164 ~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~-----~~~~~~~~lv~e 235 (435)
.|+ |....||+.... |..+++|....... .. ..+..|..+++.+.. -.+++++.. ...++..+++|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 466 788899988764 56899998753322 12 455667777776642 124444443 223445678999
Q ss_pred cCCCCC
Q 013833 236 YLRGGD 241 (435)
Q Consensus 236 ~~~g~s 241 (435)
+++|.+
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00041 Score=66.39 Aligned_cols=138 Identities=19% Similarity=0.238 Sum_probs=78.6
Q ss_pred ceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
+.|..|....+|++... +..+++|+.-. .... ...+.+|.++++.+. +.-.+++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 46778888999998863 36789997522 1111 245568999888774 3334667766543 28
Q ss_pred EEecCCCCCHH--------------HHHH---HcC-C----CC--HHHHHHHHHHHHH-------------------HHH
Q 013833 233 ITEYLRGGDLH--------------KYLK---EKG-A----LS--PSTAVNFALDIAR-------------------GMA 269 (435)
Q Consensus 233 v~e~~~g~sL~--------------~~l~---~~~-~----~~--~~~~~~~~~qi~~-------------------~l~ 269 (435)
||||++|.+|. +.+. ... + .. ..++.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999885542 1111 110 1 11 2445555544422 122
Q ss_pred H----Hhc--CCCceEeCCCCCCcEEEecC--CCCcEEEeeccCccc
Q 013833 270 Y----LHN--EPNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSKL 308 (435)
Q Consensus 270 ~----LH~--~~~~ivH~Dlkp~NIll~~~--~~~~vkl~Dfg~a~~ 308 (435)
. |.. ....++|+|+.+.||++..+ ..+.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 222 12349999999999999433 236899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0015 Score=64.16 Aligned_cols=72 Identities=19% Similarity=0.141 Sum_probs=46.2
Q ss_pred ceeecCCceeEEEEEECC--CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ceeeeeeEEeCCcEEEEEecCCC
Q 013833 163 AIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLITEYLRG 239 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~g 239 (435)
+.|+.|-...+|++...+ ..+++|+.......- -+..+|+.+++.+...+ .+++++.+. + .+||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 468889999999998876 678899764321110 11257888888886443 366776663 2 359999987
Q ss_pred CCH
Q 013833 240 GDL 242 (435)
Q Consensus 240 ~sL 242 (435)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0015 Score=63.75 Aligned_cols=71 Identities=13% Similarity=0.127 Sum_probs=47.0
Q ss_pred ceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCC-cceeeeeeEEeCCcEEE
Q 013833 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLML 232 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~l 232 (435)
+.|+.|....||++... +..+++|+.... .. ...+.+|..+++.+... -.+++++.+.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 46888999999999864 367889976332 11 13444788888877532 24667765542 38
Q ss_pred EEecCCCCCH
Q 013833 233 ITEYLRGGDL 242 (435)
Q Consensus 233 v~e~~~g~sL 242 (435)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0084 Score=56.42 Aligned_cols=68 Identities=9% Similarity=0.019 Sum_probs=42.1
Q ss_pred ecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC---CCcceeeeee------EEeCCcEEEEEec
Q 013833 166 GKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGA------VTERKPLMLITEY 236 (435)
Q Consensus 166 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~------~~~~~~~~lv~e~ 236 (435)
|.|....||+....+..+++|+...... ..|+.+++.|. -|++++++.. ....+..+++|+|
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~ 102 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPF 102 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEec
Confidence 3444678999986644899997654331 23444554442 2335555432 2345678999999
Q ss_pred CCCCCH
Q 013833 237 LRGGDL 242 (435)
Q Consensus 237 ~~g~sL 242 (435)
++|..+
T Consensus 103 i~G~~~ 108 (339)
T 3i1a_A 103 IHAPNG 108 (339)
T ss_dssp CCCCBT
T ss_pred cCCCcC
Confidence 998755
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0015 Score=62.25 Aligned_cols=72 Identities=17% Similarity=0.163 Sum_probs=42.4
Q ss_pred ceeecCCceeEEEEEECC----------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCc-ceeeeeeEEeCCcEE
Q 013833 163 AIIGKGSFGEILKAYWRG----------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLM 231 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 231 (435)
+.|+.|....+|++...+ ..+++|+....... ......|..+++.+...+ ++++++.. . -+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 457788889999998754 67888876432110 112356777777774223 45666543 2 26
Q ss_pred EEEecCCCCCH
Q 013833 232 LITEYLRGGDL 242 (435)
Q Consensus 232 lv~e~~~g~sL 242 (435)
+||||++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999988543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.067 Score=51.75 Aligned_cols=72 Identities=13% Similarity=0.120 Sum_probs=46.2
Q ss_pred ceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
+.|..|....+|++... +..+++++....... .-+..+|.++++.+. +.-.+++++.+. + ++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADFP--E--GR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CE
Confidence 45778888999999876 577899975432111 112356788877774 333556665332 2 68
Q ss_pred EEecCCCCCH
Q 013833 233 ITEYLRGGDL 242 (435)
Q Consensus 233 v~e~~~g~sL 242 (435)
||||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.43 Score=45.73 Aligned_cols=31 Identities=32% Similarity=0.470 Sum_probs=25.5
Q ss_pred eEeCCCCCCcEEEec----CCCCcEEEeeccCccc
Q 013833 278 IIHRDLKPRNVLLVN----SSADHLKVGDFGLSKL 308 (435)
Q Consensus 278 ivH~Dlkp~NIll~~----~~~~~vkl~Dfg~a~~ 308 (435)
++|+|+.+.|||+.+ +..+.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999943 3456799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.27 E-value=0.062 Score=52.71 Aligned_cols=62 Identities=8% Similarity=-0.007 Sum_probs=17.9
Q ss_pred CCceeecCCceeEEEEEECC--CcEEE------EEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 161 SSAIIGKGSFGEILKAYWRG--TPVAI------KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 161 ~~~~lg~G~~g~V~~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
+.+.|| ||.||++.+.+ .+||+ |...... ...+....+.+|+.+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEEe
Confidence 344566 99999999874 58888 6543322 223334678889999999999999999987643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.94 E-value=2.1 Score=36.86 Aligned_cols=116 Identities=9% Similarity=0.138 Sum_probs=78.7
Q ss_pred CCCCcceeeeeeEEeCCcEEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 212 LRHPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 212 l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
..||+++.. .+-.+++.+.+.++.-+. .++.. ++ .++..+.++++.+|+....++++ =+|--|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 357877765 455666777777765432 23333 32 37889999999999998876655 2678899999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
+.++.+++.-.|+-..+ +|. ..++..=+-.+=+++..+++++..|.
T Consensus 113 --~~~~~p~i~~RGik~~l---------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 --TRDGLPIAKTRGLQNVV---------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp --CTTSCEEESCCEETTTB---------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred --cCCCCEEEEEccCccCC---------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999998876643221 221 12222334567788899999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.14 E-value=4.6 Score=34.79 Aligned_cols=114 Identities=11% Similarity=0.113 Sum_probs=77.1
Q ss_pred CCCcceeeeeeEEeCCcEEEEEecCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHhcCCCceEeCCCCCCcEEE
Q 013833 213 RHPNIVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMA-YLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 213 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~-sL~~~l~~~~~~~~~~~~~~~~qi~~~l~-~LH~~~~~ivH~Dlkp~NIll 290 (435)
.||++ -...-.+++.+.+.++.-+++ ++. .++ .++..+.++++.+|+.... ++++ -+|--|.|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE
Confidence 57777 333446677777777765343 444 333 3788999999999998887 6655 4678899999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 364 (435)
+.++.+++.-.|.-.. ++|..+ ++..=+-++=|++..++.++..|.
T Consensus 118 --~~~~~p~i~hRGi~~~---------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 --NRALEPFFLHVGVKES---------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp --CTTCCEEESCCEETTT---------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred --eCCCcEEEEEcCCccc---------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 8889999987664322 233221 222224467788888888887664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 435 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-70 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-70 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-64 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-11 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-10 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-09 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-09 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-07 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-06 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-12 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 9e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-05 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 4e-05 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 3e-12 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-07 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-04 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-11 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-07 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-04 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 1e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 4e-08 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 4e-06 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 7e-05 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 7e-10 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 8e-08 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-04 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 0.002 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-10 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-09 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 7e-09 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-06 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 0.002 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-09 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 7e-08 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 0.001 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-08 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 8e-08 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 6e-07 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-05 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 6e-08 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 1e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 0.002 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 4e-07 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 3e-06 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-04 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-05 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 2e-05 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 5e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 4e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 4e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 0.004 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 3e-04 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 4e-78
Identities = 86/285 (30%), Positives = 143/285 (50%), Gaps = 19/285 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YLH + IIHRDLK N+ L +K+GDFGL+ + + ++ +GS
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSI 170
Query: 328 RYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRPFF 383
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + + V G+
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 384 RAK---GFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
+K ++ L +C ++RP F IL +E + +LP
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 7e-75
Identities = 90/276 (32%), Positives = 136/276 (49%), Gaps = 23/276 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ EL IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 54
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M YL +HRDL RNVL+ S + KV DFGL+K
Sbjct: 115 AMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-------STQDTGKLP 163
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-P 222
Query: 386 KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
G P + E+ + CW D RPSFL + ++LE IK
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 226 bits (576), Expect = 1e-71
Identities = 83/271 (30%), Positives = 120/271 (44%), Gaps = 18/271 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
++ DP +L FS IG GSFG + A VAIK++ S QD EV
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L KLRHPN +Q+ G L+ EY G K L +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+AYLH+ +IHRD+K N+LL S +K+GDFG + ++ G+
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMA--------PANSFVGTP 175
Query: 328 RYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
+MAPEV +YD KVDV+S + E+ E +PPL N A ++A+ P +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ ++ R + C RP+ +LK
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-70
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 19/276 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
+WE+ L +G G FGE+ Y+ T VA+K + + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
L+ +L+H +V+ VT+ +P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GMA++ IHRDL+ N+L+ ++ K+ DFGL++LI ++ G
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDT--LSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFR 384
++ APE + + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VR 231
Query: 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
EL +L CW RP+F + LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 7e-70
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 18/268 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
W ++ DF +GKG FG + A + +A+K + + + V R EV
Sbjct: 3 WALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
+ LRHPNI++ G + + LI EY G +++ L++ + ++A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
++Y H+ +IHRD+KP N+LL SA LK+ DFG S + G+
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSRRTTL------CGTL 168
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
Y+ PE+ + R +D+KVD++S ++ YE L G+PP E K ++ F
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDF 226
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
T R+L + + +QRP ++L+
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 9e-70
Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 17/272 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
IDP +L F +G G FG + WR VAIK I + + +F E +++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMM 54
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
L H +VQ G T+++P+ +ITEY+ G L YL+ + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YL ++ +HRDL RN L+ + +KV DFGLS+ + + G R+
Sbjct: 115 YLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388
PEV + K+ K D+++F ++++E+ G+ P + E A+++A+G R + R
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLA 226
Query: 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 420
+ ++ + CW ++RP+F +L + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 9e-70
Identities = 88/275 (32%), Positives = 139/275 (50%), Gaps = 17/275 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
IDPSEL F IG G FG + YW VAIK I + + +DF E +++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 55
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMA 269
KL HP +VQ G E+ P+ L+ E++ G L YL+ + L + T + LD+ GMA
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YL +IHRDL RN L+ +KV DFG+++ + TG ++
Sbjct: 116 YLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKW 168
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388
+PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R + +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLA 227
Query: 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423
+ + ++ CW RP+F +L++L +I E+
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-69
Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K Y++ VA+K + +D L + E N++ +L +P IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVMQQLDNPYIVRM 73
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+G + E + ML+ E G L+KYL++ + + ++ GM YL +H
Sbjct: 74 IG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVH 130
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDL RNVLL + + K+ DFGLSK ++ ++ + G ++ APE + K+
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKF 187
Query: 341 DKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKC 399
K DV+SF ++++E G+ P + E + +G R G E+ +L C
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYDLMNLC 246
Query: 400 WAADMNQRPSFLDILKRLEKI-KETLPTDHH 429
W D+ RP F + RL + + HH
Sbjct: 247 WTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-69
Identities = 79/259 (30%), Positives = 126/259 (48%), Gaps = 16/259 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+GSF + K T VA + Q F+ E +L L+HPNIV+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 222 GA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ V +K ++L+TE + G L YLK + ++ I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
IIHRDLK N+ + + +K+GD GL+ L + + V G+ +MAPE+++
Sbjct: 135 IIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV------IGTPEFMAPEMYE- 186
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKGFTPELRELT 396
KYD+ VDV++F M + EM E P + + + V G +P K PE++E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 397 EKCWAADMNQRPSFLDILK 415
E C + ++R S D+L
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-68
Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 18/274 (6%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + + +R VAIK + ++ E ++ +L +P IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+G V + + LML+ E GG LHK+L ++ + S ++ GM YL + +
Sbjct: 75 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FV 131
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRDL RNVLLVN + K+ DFGLSK + +S+ + G ++ APE RK
Sbjct: 132 HRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRK 188
Query: 340 YDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEK 398
+ + DV+S+ + ++E L G+ P + E ++ +G R PEL L
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECPPELYALMSD 247
Query: 399 CWAADMNQRPSFLDILKRLEKIKETLPTD---HH 429
CW RP FL + +R+ +L + HH
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 7e-68
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 19/269 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ IG GS+G K + G + K + + Q EVNLL +L+HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHP 63
Query: 216 NIVQFLGAVTER--KPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMA 269
NIV++ + +R L ++ EY GGDL + KE+ L + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 270 YLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
H + + ++HRDLKP NV L ++K+GDFGL++++ +HD G+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARIL----NHDTSFAKAFVGT 177
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386
YM+PE Y++K D++S +LYE+ PP + E A + EG +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 387 GFTPELRELTEKCWAADMNQRPSFLDILK 415
++ EL E+ + RPS +IL+
Sbjct: 238 -YSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 78/305 (25%), Positives = 141/305 (46%), Gaps = 16/305 (5%)
Query: 134 HFEPKPVPPPLPNKC-DWEIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKR 187
H + + P L I PS L + +IG+G FG + + A+K
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
+ + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 63 LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 247 K-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
+ E + + F L +A+GM +L ++ +HRDL RN +L +KV DFGL
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGL 176
Query: 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLA 364
++ + + V+ TG ++MA E + +K+ K DV+SF ++L+E++ G PP
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 365 NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424
+ ++ Y+ +G R + + L E+ KCW RPSF +++ R+ I T
Sbjct: 237 DVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 425 PTDHH 429
+H+
Sbjct: 296 IGEHY 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-67
Identities = 83/281 (29%), Positives = 137/281 (48%), Gaps = 20/281 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 56
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFAL 262
E + + HP+IV+ +G +TE P+ +I E G+L +L K +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
++ +AYL ++ +HRD+ RNVL+ SS D +K+GDFGLS+ + YK +
Sbjct: 116 QLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM---EDSTYYKASK 168
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 381
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
P L L KCWA D ++RP F ++ +L I E
Sbjct: 229 PMP-PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-66
Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+++P + + +G G+FG++ KA + A K I ++ +D+ E+++
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDI 62
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L HPNIV+ L A L ++ E+ GG + + + + L+ S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH+ N IIHRDLK N+L + +K+ DFG+S +N+ + + G+
Sbjct: 123 LNYLHD--NKIIHRDLKAGNILF--TLDGDIKLADFGVSA----KNTRTIQRRDSFIGTP 174
Query: 328 RYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
+MAPEV K R YD K DV+S + L EM E EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 383 FRA-KGFTPELRELTEKCWAADMNQRPSFLDILK 415
++ ++ +KC +++ R + +L+
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 2e-66
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 17/282 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFR 203
EID S + +IG G FGE+ + + VAIK + ++ + +DF
Sbjct: 20 AKEIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFL 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
E +++ + HPN++ G VT+ P+M+ITE++ G L +L++ G + V
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 321
IA GM YL + +HRDL RN+L+ +S KV DFGLS+ ++ S Y
Sbjct: 136 GIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
G R+ APE ++RK+ DV+S+ ++++E++ GE P + + + + +R
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 381 PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
L +L CW D N RP F I+ L+K+
Sbjct: 252 LPPP-MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 8e-66
Identities = 78/287 (27%), Positives = 135/287 (47%), Gaps = 17/287 (5%)
Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL 197
+ P PN WE++ +++ +G G +GE+ + W+ VA+K + +D +
Sbjct: 2 MDPSSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTM 55
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPS 255
+++F E ++ +++HPN+VQ LG T P +ITE++ G+L YL + +S
Sbjct: 56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 115
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
+ A I+ M YL + IHRDL RN L+ +KV DFGLS+L+
Sbjct: 116 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLM---TGD 168
Query: 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375
G ++ APE + K+ K DV++F ++L+E+ +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228
Query: 376 AEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
E R +G ++ EL CW + + RPSF +I + E + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 211 bits (538), Expect = 2e-65
Identities = 69/283 (24%), Positives = 126/283 (44%), Gaps = 19/283 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
+ P P+ K D +D + +G G+FG + + R G A K ++ D
Sbjct: 11 QYYPQPVEIKHDHVLD----HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSP 254
+ + R E+ + LRHP +V A + +++I E++ GG+L + + E +S
Sbjct: 67 K---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+ + + S
Sbjct: 124 DEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
V TG+ + APEV + + D++S ++ Y +L G P E +
Sbjct: 182 VKVT-----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 375 VAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 415
V + G + + ++ K AD N R + L+
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-65
Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 55/302 (18%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +G G+ G + K + G +A K I L + E+ +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
IV F GA + + E++ GG L + LK+ G + ++ + +G+ YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ I+HRD+KP N+L+ + +K+ DFG+S + G+ YM+PE
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERL 175
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL-------------------------------- 363
+ Y + D++S + L EM G P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 364 ----------ANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413
+E Y+ P + F+ E ++ KC + +R +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 414 LK 415
+
Sbjct: 296 MV 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-65
Identities = 80/310 (25%), Positives = 129/310 (41%), Gaps = 42/310 (13%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLS 193
WE L+F ++G G+FG+++ A G VA+K +
Sbjct: 23 FREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--- 249
+ E+ ++ +L H NIV LGA T P+ LI EY GDL YL+ K
Sbjct: 81 SSER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 250 --------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L+ + FA +A+GM +L + +HRDL RNVL
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVL 196
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSF 349
+ + +K+ DFGL++ I +++ V ++MAPE Y K DV+S+
Sbjct: 197 V--THGKVVKICDFGLARDIMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 350 AMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRP 408
++L+E+ G P + + + T E+ + + CWA D +RP
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
Query: 409 SFLDILKRLE 418
SF ++ L
Sbjct: 313 SFPNLTSFLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-65
Identities = 87/292 (29%), Positives = 131/292 (44%), Gaps = 20/292 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDR 196
KP L K WEI L +G+G FGE+ W GT VAIK + P
Sbjct: 1 KPQTQGLA-KDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP- 56
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSP 254
+ F E ++ KLRH +VQ V+ +P+ ++TEY+ G L +LK + L
Sbjct: 57 ---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V+ A IA GMAY+ +HRDL+ N+L+ KV DFGL++LI
Sbjct: 113 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLI---ED 165
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225
Query: 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425
V G+R L +L +CW + +RP+F + LE +
Sbjct: 226 QVERGYRMPCP-PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 9e-65
Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 18/281 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFR 203
EI PS + +IG G FGE+ K + + PVAIK + ++ + DF
Sbjct: 2 TEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFL 57
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+EK G S V
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
IA GM YL N +HRDL RN+L+ +S KV DFGLS++++ + Y +G
Sbjct: 118 GIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE-DDPEATYTTSG 172
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 381
R+ APE +RK+ DV+SF ++++E++ GE P +E K + +G R
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ +L +CW + +RP F DI+ L+K+
Sbjct: 233 PTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-64
Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
D +G GSFG + + W + VA+K + P + + DF EVN + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFALDIARGMAYL 271
H N+++ G V P+ ++TE G L K +G T +A+ +A GM YL
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
++ IHRDL RN+LL ++ D +K+GDFGL + + + H V + + A
Sbjct: 128 ESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCA 182
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
PE K R + D + F + L+EM G+ P + + + R +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIK 421
++ + +CWA RP+F+ + L + +
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-64
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ +G+G++GE+ A R VA+K + + D ++ + E+ + L H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
N+V+F G E L EY GG+L ++ + A F + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I HRD+KP N+LL D+LK+ DFGL+ + + N + + G+ Y+APE+
Sbjct: 122 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPYVAPELL 177
Query: 336 KHRKYD-KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393
K R++ + VDV+S ++L ML GE P + + E K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 394 ELTEKCWAADMNQRPSFLDILK 415
L K + + R + DI K
Sbjct: 238 ALLHKILVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 209 bits (532), Expect = 2e-64
Identities = 59/288 (20%), Positives = 121/288 (42%), Gaps = 23/288 (7%)
Query: 133 SHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILP 190
+ P+PV + D + +G G+FG + + + G K I
Sbjct: 13 KKYVPQPVEVKQGSVYD--------YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG 250
D+ ++E++++ +L HP ++ A ++ ++LI E+L GG+L + +
Sbjct: 65 PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 251 -ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+S + +N+ G+ ++H + I+H D+KP N++ A +K+ DFGL+ +
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369
V T + + APE+ D+++ ++ Y +L G P A +
Sbjct: 180 NPDEIVKVT-----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 370 EAAKYVAEGHRPFFRA--KGFTPELRELTEKCWAADMNQRPSFLDILK 415
E + V F +PE ++ + + +R + D L+
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-64
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 16/266 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP + ++ IG+G+ G + A G VAI+++ + + +E+ ++
Sbjct: 17 DPKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMR 72
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++PNIV +L + L ++ EYL GG L + E + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEF 131
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL +K+ DFG I + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWM 183
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 389
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 390 PELRELTEKCWAADMNQRPSFLDILK 415
R+ +C D+ +R S ++L+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-64
Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 37/307 (12%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLS 193
P LP WE + L F +G G+FG++++A VA+K + PS
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
+ E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 67 LTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 251 ----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
AL ++F+ +A+GMA+L ++ IHRDL RN+LL +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG- 181
Query: 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILY 354
K+ DFGL++ IK +++ V ++MAPE + Y + DV+S+ + L+
Sbjct: 182 -RITKICDFGLARDIKNDSNYVVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 355 EML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDI 413
E+ G P + + + E+ ++ + CW AD +RP+F I
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 414 LKRLEKI 420
++ +EK
Sbjct: 299 VQLIEKQ 305
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-64
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 43/294 (14%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
IGKG FGE+ + WRG VA+K E+ V LRH NI+ F+ A
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF----REAEIYQTVMLRHENILGFIAAD 66
Query: 225 TER----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
+ L L+++Y G L YL ++ + AL A G+A+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I HRDLK +N+L+ + D GL+ G+ RYMAPEV
Sbjct: 126 KPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 335 F------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-------------- 374
KH + K+ D+++ ++ +E+ +E Y+ Y
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 375 --VAEGHRPFFRAKGFTPE----LRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
+ RP + + E + ++ +CW A+ R + L I K L ++ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 8e-64
Identities = 82/306 (26%), Positives = 135/306 (44%), Gaps = 43/306 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
E + +++ IG+G+FG + +A T VA+K + S D + D
Sbjct: 7 SLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------- 250
F+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS + + A +A GMAYL +HRDL RN L+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLV--GENMV 178
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGLS+ I + + + R+M PE + +Y + DV+++ ++L+E+
Sbjct: 179 VKIADFGLSRNIYSADYYKA--DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 358 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
G P E YV +G+ + EL L CW+ RPSF I +
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 417 LEKIKE 422
L+++ E
Sbjct: 296 LQRMCE 301
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 4e-63
Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 14/257 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G G+F E++ A + VAIK I + + +E+ +L K++HPNIV
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPNIVALD 73
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
L LI + + GG+L + EKG + A + + YLH+ I+HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHR 131
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+L + D + + DFGLSK+ + ++ G+ Y+APEV + Y
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPY 186
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEK 398
K VD +S +I Y +L G PP + + + + + F + ++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 399 CWAADMNQRPSFLDILK 415
D +R + L+
Sbjct: 247 LMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 5e-63
Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 10/263 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF I+G+GSF ++ A AIK + + E +++ +L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
V+ + + L Y + G+L KY+++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IIHRDLKP N+LL + H+++ DFG +K++ ++ + G+ +Y++PE+
Sbjct: 127 KGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELL 182
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ K D+++ I+Y+++ G PP Y + + + F + F P+ R+L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDL 240
Query: 396 TEKCWAADMNQRPSFLDILKRLE 418
EK D +R ++
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 8e-63
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 16/272 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
+F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMAS 67
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ +P++ + LG ++ G L + K + +N+ + IA+GM YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
+ ++HRDL RNVL+ + H+K+ DFGL+KL+ + Y G ++MA
Sbjct: 128 EDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMA 181
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
E HR Y + DV+S+ + ++E++ G P E + + +G R T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTI 240
Query: 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
++ + KCW D + RP F +++ K+
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 9e-62
Identities = 51/283 (18%), Positives = 117/283 (41%), Gaps = 23/283 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + + K + +D L + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHE 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L++I E++ G D+ + + L+ V++ + + +LH+ I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHF 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D++P N++ + +K+ +FG ++ +K ++ + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA-----PEYYAPEVHQHDVVS 181
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRELTEKC 399
D++S ++Y +L G P + + + F K + E + ++
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 400 WAADMNQRPSFLDIL------KRLEKIK-ETLPTDHHWNIFNA 435
+ R + + L +++E++ + + T H ++
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-61
Identities = 92/298 (30%), Positives = 138/298 (46%), Gaps = 36/298 (12%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEV 206
+D +++ F +IG+G+FG++LKA + AIKR+ S D +DF E+
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGEL 61
Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------- 249
+L KL HPNI+ LGA R L L EY G+L +L++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
LS ++FA D+ARGM YL + IHRDL RN+L+ K+ DFGLS+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIADFGLSRGQ 177
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 368
K T R+MA E + Y DV+S+ ++L+E++ G P
Sbjct: 178 -----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 369 YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426
E + + +G+R E+ +L +CW +RPSF IL L ++ E T
Sbjct: 233 AELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-61
Identities = 91/304 (29%), Positives = 144/304 (47%), Gaps = 38/304 (12%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT---------PVAIKRILPSLSD 194
LP WE+ L +G+G+FG+++ A G VA+K + ++
Sbjct: 2 LPEDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--- 250
+ D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 60 KD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL ++ IHRDL RNVL+ + +
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV--TEDNV 173
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ I + K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 174 MKIADFGLARDI--HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 358 -EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
G P E K + EGHR T EL + CW A +QRP+F +++
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 417 LEKI 420
L++I
Sbjct: 291 LDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (498), Expect = 2e-60
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 16/278 (5%)
Query: 154 PSEL--DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
PS L + I+G G E+ A VA+K + L+ D FR E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 210 VKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
L HP IV P ++ EY+ G L + +G ++P A+ D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
+ + + H IIHRD+KP N+++ S+ + +KV DFG+++ I + + V + G
Sbjct: 122 QALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIG 176
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFF 383
+ +Y++PE + D + DV+S +LYE+L GEPP P A P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 384 RAKGFTPELRELTEKCWAADMNQRP-SFLDILKRLEKI 420
R +G + +L + K A + R + ++ L ++
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-59
Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 29/292 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
+WE+ ++ S +G+GSFG + + + T VAIK + + S +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IE 69
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 251
F +E +++ + ++V+ LG V++ +P ++I E + GDL YL+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
S S + A +IA GMAYL+ +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYE 185
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYE 370
+ + K R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 186 TDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 371 AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422
++V EG L EL CW + RPSFL+I+ +++ E
Sbjct: 244 VLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-58
Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 13/262 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRH 214
DF ++GKGSFG++ A ++ T AIK + + ++ E +L + H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P + ++ L + EYL GGDL +++ S A +A +I G+ +LH+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLK N+L H+K+ DFG+ K +N K G+ Y+APE+
Sbjct: 122 -KGIVYRDLKLDNIL--LDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEI 174
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+KY+ VD +SF ++LYEML G+ P + E + + + + E ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEAKD 232
Query: 395 LTEKCWAADMNQRPSFLDILKR 416
L K + + +R +++
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (477), Expect = 2e-57
Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI------LPSLSDDRLVIQDFRHEVNLL 209
++ I+G+G + + + A+K I S + + + + EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 210 VKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
K+ HPNI+Q L+ + ++ G+L YL EK LS + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH I+HRDLKP N+LL ++K+ DFG S + K+ G+
Sbjct: 124 CALHK--LNIVHRDLKPENILL--DDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPS 174
Query: 329 YMAPEVF------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y+APE+ H Y K+VD++S +I+Y +L G PP + + + + G+ F
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 383 FR--AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
++ +++L + +R + + L
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 31/268 (11%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + A+K + R EV L + + P+IV+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRI 70
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG +K NS T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPE 183
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------PFFRAKG 387
V KYDK D++S +I+Y +L G PP + + + R P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 388 FTPELRELTEKCWAADMNQRPSFLDILK 415
+ E++ L + QR + + +
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-56
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 16/260 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + G A K I S + +D EV++L +++HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 135
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L+ N +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 190
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELREL 395
+ D++S +I Y +L G P E V+ + F + ++
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 396 TEKCWAADMNQRPSFLDILK 415
+ D +R + D L+
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (459), Expect = 3e-54
Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 15/256 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +G GSFG + R G A+K + + ++ E +L + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
I++ G + + + +I +Y+ GG+L L++ A +A ++ + YLH++
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
II+RDLKP N+LL H+K+ DFG +K + G+ Y+APEV
Sbjct: 125 --IIYRDLKPENILL--DKNGHIKITDFGFAKYVP-------DVTYTLCGTPDYIAPEVV 173
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ Y+K +D +SF +++YEML G P + + + + F F ++++L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDL 231
Query: 396 TEKCWAADMNQRPSFL 411
+ D++QR L
Sbjct: 232 LSRLITRDLSQRLGNL 247
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-54
Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 37/306 (12%)
Query: 144 LP-NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDD 195
LP + WE L +G+G+FG++++A G VA+K + +
Sbjct: 1 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58
Query: 196 RLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEKG--- 250
+ E+ +L+ H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 59 E--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
L+ + ++ +A+GM +L + IHRDL RN+LL S +
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNV 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ I D + ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 VKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 358 EG-EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416
P + E + TPE+ + CW + +QRP+F ++++
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 417 LEKIKE 422
L + +
Sbjct: 291 LGNLLQ 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (449), Expect = 4e-52
Identities = 73/259 (28%), Positives = 113/259 (43%), Gaps = 17/259 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN---LLVKL 212
DFS IIG+G FGE+ G A+K + + +E L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
P IV A L I + + GGDLH +L + G S + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N +++RDLKP N+LL H+++ D GL+ + H G++ YMAP
Sbjct: 125 N--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAP 174
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRPFFRAKGFTP 390
EV + YD D FS +L+++L G P ++ + + F+P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 391 ELRELTEKCWAADMNQRPS 409
ELR L E D+N+R
Sbjct: 235 ELRSLLEGLLQRDVNRRLG 253
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-52
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 26/261 (9%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLR--HPN 216
++G G FG + PVAIK + D + + EV LL K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+++ L +LI E DL ++ E+GAL A +F + + + HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
++HRD+K N+L+ + + LK+ DFG L+K T G+ Y PE
Sbjct: 131 --VLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWI 181
Query: 336 KHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
++ +Y + V+S ++LY+M+ G+ P + E + + + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------QRVSSECQH 233
Query: 395 LTEKCWAADMNQRPSFLDILK 415
L C A + RP+F +I
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 6e-52
Identities = 49/269 (18%), Positives = 90/269 (33%), Gaps = 20/269 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG GSFG+I G VAIK + E + ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGVGIPTIR 69
Query: 223 AV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
E +++ E L + S T + A + + Y+H+ IHR
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHR 127
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH 337
D+KP N L+ + + DFGL+K + +H + TG+ RY +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR------AKGFTPE 391
+ ++ D+ S +L G P + + KG+ E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 392 LRELTEKCWAADMNQRPSFLDILKRLEKI 420
C + + +P + + + +
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-51
Identities = 63/254 (24%), Positives = 110/254 (43%), Gaps = 12/254 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF ++GKG+FG+++ + G A+K + + + + E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ A L + EY GG+L +L + + A + +I + YLH+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+++RD+K N++L H+K+ DFGL K + M G+ Y+APEV
Sbjct: 126 --VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVL 177
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ Y + VD + +++YEM+ G P N + + + F + +PE + L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSL 235
Query: 396 TEKCWAADMNQRPS 409
D QR
Sbjct: 236 LAGLLKKDPKQRLG 249
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (417), Expect = 2e-48
Identities = 55/275 (20%), Positives = 96/275 (34%), Gaps = 22/275 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GSFG I + VAIK P SD R E L + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVY 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L G L L G S T A + + +H +++R
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYR 125
Query: 282 DLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVF 335
D+KP N L+ + +A+ + V DFG+ K + + + +G+ RYM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGE---PPLANYEPYEAAKYVAEGHRPFFR---AKGFT 389
R+ ++ D+ + + L G L + + + E + GF
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424
E + + P + + K+ E L
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 3e-48
Identities = 65/265 (24%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
F +G GSFG ++ + G A+K + I+ +E +L + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + + L ++ EY+ GG++ +L+ G S A +A I YLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-- 159
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+I+RDLKP N+L+ +++V DFG +K + G+ +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEII 210
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
+ Y+K VD ++ +++YEM G PP +P + + + G F F+ +L++L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDL 268
Query: 396 TEKCWAADMNQR-----PSFLDILK 415
D+ +R DI
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-48
Identities = 68/283 (24%), Positives = 108/283 (38%), Gaps = 39/283 (13%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G+G F + KA + VAIK+I + + E+ LL +L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
L A + + L+ +++ L+PS + L +G+ YLH + I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWIL 122
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 338
HRDLKP N+LL LK+ DFGL+K T + + Y APE+ F R
Sbjct: 123 HRDLKPNNLLL--DENGVLKLADFGLAKSF----GSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA------------- 385
Y VD+++ IL E+L P L + + E
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 386 -------------KGFTPELRELTEKCWAADMNQRPSFLDILK 415
+L +L + + + R + LK
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-45
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 46/292 (15%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ KA R G VA+K++L + I E+ +L L+H N+V +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIE 76
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ + L+ ++ + S + G+ Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRD+K NVL+ LK+ DFGL++ + + + T + Y PE+
Sbjct: 137 K--ILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 335 F-KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF----------- 382
R Y +D++ I+ EM P + +++
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 383 -------------------FRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
+A P +L +K D QR D L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 44/288 (15%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G++G + AY VAIK+I S + + Q E+ +L++ RH NI+
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 222 GAV----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ E+ + + +L G DL+K LK + LS F I RG+ Y+H+
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN-- 129
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
++HRDLKP N+LL ++ LK+ DFGL+++ + H + +T + Y APE+ +
Sbjct: 130 VLHRDLKPSNLLL--NTTCDLKICDFGLARVADPDHDHTGF-LTEYVATRWYRAPEIMLN 186
Query: 338 -RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----------- 385
+ Y K +D++S IL EML P + ++ +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 386 ------------------KGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ +L +K + ++R L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 3e-45
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 38/280 (13%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IG+G++G + KA G A+K+I D+ + E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
+ +K L+L+ E+L +G L TA +F L + G+AY H+ ++HRDL
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYDK 342
KP+N+L+ + LK+ DFGL++ V K T E + Y AP+V +KY
Sbjct: 127 KPQNLLI--NREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA----------------- 385
+D++S I EM+ G P + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 386 ----------KGFTPELRELTEKCWAADMNQRPSFLDILK 415
KG +L K D NQR + L+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-44
Identities = 64/300 (21%), Positives = 108/300 (36%), Gaps = 52/300 (17%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
P E+ ++ + +IG GSFG + +A G VAIK++L + E+ ++ K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRK 69
Query: 212 LRHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNFAL 262
L H NIV+ L L+ +Y+ Y + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+ R +AY+H+ I HRD+KP+N+LL + LK+ DFG +K + ++
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQL----VRGEPNVSY 182
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y +F Y +DV+S +L E+L G+P + + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 383 FR---------------------------AKGFTPELRELTEKCWAADMNQRPSFLDILK 415
R PE L + R + L+
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-43
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 40/289 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G++G + KA + G VA+K+I + V E++LL +L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIV+ L + L L+ E+L + + ++ + +G+A+ H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
+ ++HRDLKP+N+L+ ++ +K+ DFGL++ V T E + Y APE+
Sbjct: 121 -HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEI 173
Query: 335 FKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-------- 385
KY VD++S I EM+ + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 386 -------------------KGFTPELRELTEKCWAADMNQRPSFLDILK 415
+ R L + D N+R S L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-42
Identities = 64/299 (21%), Positives = 116/299 (38%), Gaps = 50/299 (16%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFR--HEVNLLVKLRHPNIVQ 219
IG+G++G++ KA G VA+KR+ ++ + + R + L HPN+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 220 FLGAVTERKP-----LMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
T + L L+ E++ + + + T + + RG+ +LH+
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++HRDLKP+N+L+ +S+ +K+ DFGL+++ +T + Y APE
Sbjct: 135 HR--VVHRDLKPQNILV--TSSGQIKLADFGLARIY-----SFQMALTSVVVTLWYRAPE 185
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-------- 385
V Y VD++S I EM +P + + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 386 -----------------KGFTPELRELTEKCWAADMNQRPSFLDIL-----KRLEKIKE 422
++L KC + +R S L + LE+ KE
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 18/263 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAY-----WRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVK 211
+F ++G G++G++ G A+K + + + + R E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+R P +V A L LI +Y+ GG+L +L ++ + + +I + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH II+RD+K N+LL S H+ + DFGLSK + Y G YM
Sbjct: 145 LHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGT---IEYM 197
Query: 331 APEVF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAK 386
AP++ +DK VD +S +++YE+L G P + ++ +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 387 GFTPELRELTEKCWAADMNQRPS 409
+ ++L ++ D +R
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-40
Identities = 68/306 (22%), Positives = 112/306 (36%), Gaps = 51/306 (16%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
K WE+ + +G G++G + A G VAIK++ + +
Sbjct: 10 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAY 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL----RGGDLHKYLKEKGALSPSTAVN 259
E+ LL +RH N++ L T + L T++ G L + L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ +G+ Y+H IIHRDLKP N+ + + LK+ DFGL++ +
Sbjct: 126 LVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELKILDFGLARQAD-------SE 174
Query: 320 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378
MTG + Y APEV +Y + VD++S I+ EM+ G+ + + K + +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 379 HRPFFRA-----------------------------KGFTPELRELTEKCWAADMNQRPS 409
+P L EK D QR +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 410 FLDILK 415
+ L
Sbjct: 295 AGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-40
Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 40/282 (14%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R VA+KR+ DD V E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ K L L+ E+ + G L P +F + +G+ + H+ ++HRD
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD 341
LKP+N+L+ + LK+ +FGL++ V + E + Y P+V K Y
Sbjct: 127 LKPQNLLI--NRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 342 KKVDVFSFAMILYEMLEGEPPL----------------------------ANYEPYEAAK 373
+D++S I E+ PL Y+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 374 YVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILK 415
R+L + + QR S + L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (341), Expect = 5e-37
Identities = 56/314 (17%), Positives = 116/314 (36%), Gaps = 65/314 (20%)
Query: 150 WEIDPSELDFSSS------AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
W+ + +++ + +G+G + E+ +A V +K + P +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KK 75
Query: 202 FRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
+ E+ +L LR PNI+ V + + L+ E++ D + + L+
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIR 132
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ +I + + Y H+ I+HRD+KP NV++ + L++ D+GL++ H
Sbjct: 133 FYMYEILKALDYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFY-----HPGQ 184
Query: 319 KMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA----- 372
+ S + PE+ ++ YD +D++S +L M+ + P +
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 373 -------------KYVAEGHRPFFRAKG------------------FTPELRELTEKCWA 401
KY E F G +PE + +K
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 402 ADMNQRPSFLDILK 415
D R + + ++
Sbjct: 305 YDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-34
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 51/306 (16%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + + +G G++G + A+ G VA+K++ +
Sbjct: 10 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTY 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T + L + +L G D + + L+
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQ 124
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
I RG+ Y+H+ IIHRDLKP N+ + LK+ DFGL+ D
Sbjct: 125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLA--VNEDCELKILDFGLA------RHTDDE 174
Query: 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378
+ + Y++ VD++S I+ E+L G + + K +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 379 HRPFFRA-----------------------------KGFTPELRELTEKCWAADMNQRPS 409
G P +L EK D ++R +
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 410 FLDILK 415
L
Sbjct: 295 AAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 7e-33
Identities = 62/276 (22%), Positives = 101/276 (36%), Gaps = 27/276 (9%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG G+ G + AY VAIK++ + + E+ L+ + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIISLL 82
Query: 222 GAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
T E + + L+ E + E + G+ +LH+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG 139
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDLKP N+++ S LK+ DFGL++ + MT + Y APEV
Sbjct: 140 I--IHRDLKPSNIVV--KSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVI 190
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395
Y + VD++S I+ EM+ + + + V E PE +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT------PCPEFMKK 244
Query: 396 TEKCWAADMNQRPSFLDILKRLEKIKETLPTDHHWN 431
+ + RP + + P D N
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 6e-27
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 26/216 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------ 216
+G G F + A T VA+K + D++ + E+ LL ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 217 -----IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
I++ L + P +M+ E + + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
G+ Y+H IIH D+KP NVL+ + ++ L + Y + +
Sbjct: 137 GLDYMHRRCG-IIHTDIKPENVLM-EIVDSPENLIQIKIADLGNACWYDEHYTNS--IQT 192
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y +PEV + D++S A +++E++ G+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 1e-19
Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 42/211 (19%)
Query: 164 IIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDR---------------LVIQDFRHEVN 207
++G+G + Y + +K + + L I+ R+E
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L KL+ + + ++ E + +L++ I
Sbjct: 67 ALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILEE 115
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+A ++ I+H DL NVL+ S + + + DF S + + ++ +
Sbjct: 116 VAKFYH--RGIVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 358
+ R Y + D+ S + +L+
Sbjct: 171 YF-------SRTYRTEKDINS---AIDRILQ 191
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (189), Expect = 5e-16
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 3/180 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ S + + TPLH+A+ G +VAK L++ A VNA+ +
Sbjct: 8 SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 66
Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSS 161
TPL A NM++LL + + P + + + +
Sbjct: 67 QTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQA 126
Query: 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+ K F + A G + +L + ++ +++ V + +IV+ L
Sbjct: 127 --CMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLL 184
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (152), Expect = 2e-11
Identities = 23/82 (28%), Positives = 38/82 (46%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + Q+ V+A+ +PLH A+ G D+ L++ GA N
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360
Query: 99 RWKNTPLADAEGAKKFNMMELL 120
TPLA A+ ++ ++L
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVL 382
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (141), Expect = 5e-10
Identities = 19/55 (34%), Positives = 27/55 (49%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
TPLHVAS G + + K L++ GA N + TPL A A + + L +
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNK 56
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 3e-09
Identities = 26/99 (26%), Positives = 42/99 (42%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + V +LL E + +A + TPLHVA H +D+ K L+ G ++
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
TPL A + + L +GG + ++ P
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTP 234
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (132), Expect = 5e-09
Identities = 34/200 (17%), Positives = 73/200 (36%), Gaps = 2/200 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + + V + L + +A TPLH+A+ G ++ L+ A+ N +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELD 158
+ TPL + ++L HG + + P V +
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVAS--HYGNIKLVKFLLQH 319
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+ K + + +A +G + +L + + V D + + +L + ++
Sbjct: 320 QADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVT 379
Query: 219 QFLGAVTERKPLMLITEYLR 238
L VT+ +L+++ R
Sbjct: 380 DVLKVVTDETSFVLVSDKHR 399
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 25/86 (29%), Positives = 38/86 (44%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A + L E ++ TPLHVA+ +G + VA+ L+E A NA +
Sbjct: 104 HIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGK 163
Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
TPL A ++++LL GG
Sbjct: 164 NGLTPLHVAVHHNNLDIVKLLLPRGG 189
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 26/99 (26%), Positives = 42/99 (42%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + V K L ++++ V+A+ D++TPLH A+ G ++ K L+E A+ N
Sbjct: 37 LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 96
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
+TPL A + L F P
Sbjct: 97 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (158), Expect = 2e-12
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
+ +T LIL V++LLE++ ++ D D +T L +A +A+ L
Sbjct: 214 VRGERGKTPLILAVEK-KHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELL 272
Query: 88 IEYGADVNAQD 98
+ GA + D
Sbjct: 273 CKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.3 bits (150), Expect = 2e-11
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98
+ +D A+ LL + + V+ R +TPL +A + + + L+E ++N D
Sbjct: 191 LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
T L A K + ELL G
Sbjct: 251 SDGKTALLLAVELKLKKIAELLCKRG 276
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (121), Expect = 9e-08
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVA----SLHGWIDVAKCLIEYGAD 93
++ A + ++ LL+E + V+A D R L A + L+++GAD
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
VN + TPL A K +++ L
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 24/95 (25%), Positives = 41/95 (43%)
Query: 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
A V L++ D V++LLE ++ + TPLH A D+ + L+
Sbjct: 1 AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+GAD + + TP A A +++L + G
Sbjct: 61 HGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 4e-05
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
T L A+ G ++V K L+ E GADVNA D L A + + +E
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 120 LNAH 123
+
Sbjct: 201 ITHL 204
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 64.8 bits (156), Expect = 3e-12
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ A ++ V+ L+ E S +D D +TP+ +A+ G I+V LI+ GA V A D
Sbjct: 193 YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDA 252
Query: 100 WKNTPLADAEGAKKFNMMELLN 121
+T A+ N++++ +
Sbjct: 253 TDHTARQLAQANNHHNIVDIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 50.5 bits (119), Expect = 1e-07
Identities = 23/78 (29%), Positives = 35/78 (44%), Gaps = 9/78 (11%)
Query: 36 SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL-------- 87
S I H + A+ + + +S+ NRT LH + + + ++ L
Sbjct: 2 SPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKEC 60
Query: 88 IEYGADVNAQDRWKNTPL 105
I GADVNA D +NTPL
Sbjct: 61 IAAGADVNAMDCDENTPL 78
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 9/52 (17%), Positives = 17/52 (32%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
+ A Q V L + + V A D + T +A + ++
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRC 276
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 62.8 bits (151), Expect = 1e-11
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 2/85 (2%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEED--QSLVHARDYDNRTPLHVASLHGWIDVAK 85
+ + S + + + L + ++++A+D + T L++A+ G I +
Sbjct: 217 QSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVD 276
Query: 86 CLIEYGADVNAQDRWKNTPLADAEG 110
L++YGAD ++ P+ G
Sbjct: 277 ALLDYGADPFIANKSGLRPVDFGAG 301
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.4 bits (119), Expect = 1e-07
Identities = 11/44 (25%), Positives = 21/44 (47%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
D TPLH + +++ K L+++G++ D + L A
Sbjct: 104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKA 147
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 12/98 (12%), Positives = 33/98 (33%), Gaps = 3/98 (3%)
Query: 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI- 88
S + A + ++++ + + + + + + + + L
Sbjct: 185 IITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDL 244
Query: 89 --EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+NAQD +T L A ++++ L +G
Sbjct: 245 KWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYG 282
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 59.7 bits (143), Expect = 1e-10
Identities = 22/71 (30%), Positives = 34/71 (47%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A V KLL + + V+ +DYD TPLH A+ G + + L+E D+ A +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 99 RWKNTPLADAE 109
+ T A+
Sbjct: 263 KVGQTAFDVAD 273
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 52.0 bits (123), Expect = 4e-08
Identities = 20/121 (16%), Positives = 38/121 (31%), Gaps = 8/121 (6%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHAR--------DYDNRTPLHVASLHGWIDVAKCLIEY 90
+ A Q +++ + + L +D+ A G + L+E
Sbjct: 3 MADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLER 62
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
GAD+N + T L A +M++ L +G + + P
Sbjct: 63 GADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIA 122
Query: 151 E 151
E
Sbjct: 123 E 123
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 45.9 bits (107), Expect = 4e-06
Identities = 22/85 (25%), Positives = 31/85 (36%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ R+ L T LHVA+ G+ +V K LI+ DVN +D
Sbjct: 171 KEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDY 230
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A K +L +
Sbjct: 231 DGWTPLHAAAHWGKEEACRILVENL 255
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 42.0 bits (97), Expect = 7e-05
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 1/107 (0%)
Query: 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
++K K + ++ L D V +LLE ++ + D T LH A + +D+
Sbjct: 31 RKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMV 89
Query: 85 KCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
K L+E GA++N D PL A ++ E L + G N
Sbjct: 90 KFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVN 136
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 58.0 bits (139), Expect = 7e-10
Identities = 14/101 (13%), Positives = 27/101 (26%), Gaps = 5/101 (4%)
Query: 28 EKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
+K S + + + LL D+ V +N +A+ +G + V
Sbjct: 85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEI-VKVIQAENYQAFRLAAENGHLHVLN 143
Query: 86 CLIEYGADVNAQDR--WKNTPLADAEGAKKFNMMELLNAHG 124
L E A +++ L
Sbjct: 144 RLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELA 184
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 51.4 bits (122), Expect = 8e-08
Identities = 10/80 (12%), Positives = 21/80 (26%), Gaps = 3/80 (3%)
Query: 48 AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC---LIEYGADVNAQDRWKNTP 104
A + ++ S H + + VA++ G L+ V
Sbjct: 70 AHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQA 129
Query: 105 LADAEGAKKFNMMELLNAHG 124
A +++ L
Sbjct: 130 FRLAAENGHLHVLNRLCELA 149
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 41.4 bits (96), Expect = 1e-04
Identities = 12/86 (13%), Positives = 21/86 (24%), Gaps = 5/86 (5%)
Query: 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE----EDQSLVHARDYDNRT 70
G K + ++ + +R LL + + D
Sbjct: 260 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNA 96
L +A G L+ V A
Sbjct: 320 LLRLALRLGNQGACALLLSIP-SVLA 344
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 37.9 bits (87), Expect = 0.002
Identities = 15/87 (17%), Positives = 26/87 (29%), Gaps = 4/87 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVN---AQ 97
A + +L E + + A +N +A+ +G + V L E Q
Sbjct: 134 AENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQ 193
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
A G N++ L
Sbjct: 194 AENYYAFRWAAVGRGHHNVINFLLDCP 220
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (135), Expect = 9e-10
Identities = 22/85 (25%), Positives = 40/85 (47%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + V+A + + TPLH A+ ++A L+E GA+ +A+D
Sbjct: 74 LHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 133
Query: 99 RWKNTPLADAEGAKKFNMMELLNAH 123
++ T + A M+ +L +
Sbjct: 134 HYEATAMHRAAAKGNLKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (131), Expect = 3e-09
Identities = 18/72 (25%), Positives = 36/72 (50%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + +L ++ + +D + TPLH+A ++ AK L+ GA + ++
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199
Query: 99 RWKNTPLADAEG 110
+ + TPL A+G
Sbjct: 200 KEEKTPLQVAKG 211
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (128), Expect = 7e-09
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 33/121 (27%)
Query: 37 LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----------------- 79
++ A+ +++ + D+SL D D+RT LH A G
Sbjct: 6 MVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVND 65
Query: 80 ----------------WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
++ K L+ GA VNA ++ TPL A + + +L
Sbjct: 66 KDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEG 125
Query: 124 G 124
G
Sbjct: 126 G 126
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 3e-06
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L + A +N LLE + A+D+ T +H A+ G + + L+ Y A
Sbjct: 104 CTPLH-YAASKNRHEIAVMLLEGGAN-PDAKDHYEATAMHRAAAKGNLKMIHILLYYKAS 161
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N QD NTPL A ++ +LL + G
Sbjct: 162 TNIQDTEGNTPLHLACDEERVEEAKLLVSQG 192
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 1/51 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
L A + KLL + ++ + + +TPL VA G + K ++E
Sbjct: 173 LHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 2e-09
Identities = 22/70 (31%), Positives = 41/70 (58%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L HA +N++ ++ +LL + + V+A+ Y + LH AS G + + + L+ GAD + ++
Sbjct: 148 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 207
Query: 99 RWKNTPLADA 108
+TPL A
Sbjct: 208 CHNDTPLMVA 217
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (119), Expect = 7e-08
Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMM 117
D TPLH+A + G + L+ G +++ + + TPL A +++
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 56
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 11/47 (23%), Positives = 18/47 (38%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
L A + + L + ++ N TPL VA ID+ +
Sbjct: 181 LHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.001
Identities = 29/194 (14%), Positives = 59/194 (30%), Gaps = 7/194 (3%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
T L Q + AV +L+ Q + + +TPLH+A + V + L+
Sbjct: 4 DTPLH-IAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTA 62
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
GA A DR T A + + L + + +
Sbjct: 63 GASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTEC 122
Query: 151 EIDPSELDF---SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
+ L A+ K ++ A + ++ +L ++ + ++
Sbjct: 123 QETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALH 182
Query: 208 LLVKLRHPNIVQFL 221
+V+ L
Sbjct: 183 SASGRGLLPLVRTL 196
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.6 bits (127), Expect = 1e-08
Identities = 27/85 (31%), Positives = 34/85 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
DA VR L + L RTPLH+A V + L++ GAD A+
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMY 223
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A + LL AHG
Sbjct: 224 GGRTPLGSALLRPNPILARLLRAHG 248
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 50.9 bits (120), Expect = 8e-08
Identities = 12/47 (25%), Positives = 19/47 (40%), Gaps = 3/47 (6%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADA 108
D T LH+A +H L+ + A ++ Q+ T L A
Sbjct: 6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLA 52
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 48.2 bits (113), Expect = 6e-07
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
A + AA+V +LL + + AR Y RTPL A L +A+ L +GA +D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.5 bits (101), Expect = 2e-05
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 3/94 (3%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L + LL + ++ +T LH+A++ G + L G
Sbjct: 10 DTALH-LAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAG 68
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
A V +R +T L A + +L
Sbjct: 69 AGVLVAERGGHTALHLACRVRAHTCACVLLQPRP 102
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.6 bits (119), Expect = 6e-08
Identities = 14/58 (24%), Positives = 27/58 (46%)
Query: 64 RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121
+D + TPL +A+ G + +K L++ A+ D P A +++ LL+
Sbjct: 152 QDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 12/49 (24%), Positives = 22/49 (44%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
L+ A + + K L ++ + D+ +R P VAS D+ + L
Sbjct: 160 LFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 18/85 (21%), Positives = 34/85 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A + + + L + ++A D +T LH A+ + L+ + A+ +AQD
Sbjct: 95 ILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDD 154
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A + + L +
Sbjct: 155 KDETPLFLAAREGSYEASKALLDNF 179
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.1 bits (84), Expect = 0.002
Identities = 18/51 (35%), Positives = 25/51 (49%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ LL + L D T LH+A+ D AK L++ GAD N+QD
Sbjct: 5 ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNT 55
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 4e-07
Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 4/88 (4%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
D + LH+A +H + +I A +N Q+ + TPL A + + E L
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLG 60
Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
G ++ P +
Sbjct: 61 AGCDPELRDFRGNTPLHLACEQGCLASV 88
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 3e-06
Identities = 17/85 (20%), Positives = 28/85 (32%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ V L+ + + RT LH+A D+ L++ GADVN
Sbjct: 117 LASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTY 176
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
+P G + + L
Sbjct: 177 QGYSPYQLTWGRPSTRIQQQLGQLT 201
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 1e-04
Identities = 3/32 (9%), Positives = 10/32 (31%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ Y +P + + + L + +
Sbjct: 172 NRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.4 bits (108), Expect = 2e-06
Identities = 9/82 (10%), Positives = 23/82 (28%), Gaps = 1/82 (1%)
Query: 70 TPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128
PLH A + + L+ + + +D+ PL + + + L +
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 129 GQNGSHFEPKPVPPPLPNKCDW 150
+ + +
Sbjct: 62 LDDYPDDSGWTPFHIACSVGNL 83
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.0 bits (107), Expect = 3e-06
Identities = 34/224 (15%), Positives = 73/224 (32%), Gaps = 18/224 (8%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+N+ V++LL SL+ +D D R PLH + ++ L+ +VN D
Sbjct: 8 CMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPD 67
Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSE-LDFS 160
++ A +E++ + + + + V + S+ L +
Sbjct: 68 DSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIEN 127
Query: 161 SSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNI 217
+++ K F +I L + + +L L + QD + + + H +
Sbjct: 128 GASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDA 187
Query: 218 VQFL----GAVTERK------PLMLITEYLRGGDLHKYLKEKGA 251
L GA + + + K+
Sbjct: 188 AVLLVEKYGAEYDLVDNKGAKAEDVALNE----QVKKFFLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.3 bits (100), Expect = 2e-05
Identities = 9/54 (16%), Positives = 14/54 (25%), Gaps = 3/54 (5%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ A L+E+ + D VA V K + D
Sbjct: 178 HALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 2e-05
Identities = 8/33 (24%), Positives = 16/33 (48%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102
L A+ G ++ L++ +VNAQ+ +
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGR 35
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 5e-05
Identities = 12/52 (23%), Positives = 21/52 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
A + V L++ S V R++ T +A L+G +V + G
Sbjct: 105 LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.4 bits (95), Expect = 4e-05
Identities = 12/49 (24%), Positives = 25/49 (51%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
L A +++ V +LL + + VH + +T ++ +G D+A+ L
Sbjct: 104 LHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.4 bits (95), Expect = 4e-05
Identities = 16/155 (10%), Positives = 41/155 (26%), Gaps = 3/155 (1%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126
D L A+ G D + L+ GA + A+ LL A
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSR 60
Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIK 186
+ D ++ ++ + A ++
Sbjct: 61 DARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLK---MTALHWATEHNHQEVVE 117
Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++ +D + + ++ + + ++ + L
Sbjct: 118 LLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.6 bits (80), Expect = 0.004
Identities = 19/59 (32%), Positives = 32/59 (54%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+A+D T LH A+ H +V + LI+YGADV+ Q ++ T + ++ E+L
Sbjct: 94 NAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 3e-04
Identities = 12/50 (24%), Positives = 17/50 (34%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
H + +S +H RD TPL +A G D+ L
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.0 bits (87), Expect = 6e-04
Identities = 6/38 (15%), Positives = 12/38 (31%), Gaps = 1/38 (2%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQD 98
+ TPL +A + L + + N+
Sbjct: 108 EIANESGETPLDIAKRLKHEHCEELLTQALSGRFNSHV 145
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.84 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.81 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.8 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.78 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.76 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.74 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.73 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.73 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.71 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.71 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.7 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.67 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.66 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.65 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.65 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.65 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.64 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.64 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.63 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.62 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.61 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.61 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.6 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.6 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.6 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.6 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.59 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.57 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.55 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.53 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.5 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.5 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.49 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.42 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.36 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.34 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.32 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=426.19 Aligned_cols=267 Identities=32% Similarity=0.556 Sum_probs=220.5
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 228 (435)
+|+++.. +|++.+.||+|+||+||+|.+++ .||||++...... ....+.|.+|+.+|++++||||+++++++.+ +
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence 6887754 68899999999999999998766 4999998654433 3345789999999999999999999998754 5
Q ss_pred cEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
.+++||||++||+|.+++... +.+++.++..++.||++||.|||+++ ||||||||+|||+ +.++.+||+|||+|+
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl--~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLAT 152 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTSSEEECCCCCSC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEE--cCCCCEEEcccccee
Confidence 689999999999999999764 56999999999999999999999988 9999999999999 888899999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYVAEGHRPFF 383 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~ 383 (435)
....... ........||+.|||||++.+ ..|+.++|||||||++|||+||..||.+.+.... ...+..+..++.
T Consensus 153 ~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 153 VKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp C--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred eccccCC--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 7654322 112345679999999999864 3588999999999999999999999998765544 344445543321
Q ss_pred ---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 384 ---RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 384 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
.+..+|+++++||.+||+.||++|||+.+++++|+.+.+++|+
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 2356899999999999999999999999999999999998875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-59 Score=427.69 Aligned_cols=247 Identities=30% Similarity=0.506 Sum_probs=220.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||+|++.+....+....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 7999999999999999999986 67899998864332222234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++...+.+++.++..++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||+|.......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCSCSCCCCCC--
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecccccee--cCCCCEeecccceeeecCCCc--
Confidence 9999999999998889999999999999999999999988 9999999999999 888899999999998665322
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... +..+|+++++|
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 234 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTEGARDL 234 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHH
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--CccCCHHHHHH
Confidence 234579999999999999999999999999999999999999999998888888877765432 45689999999
Q ss_pred HHHHhhhcccCCCCHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~ 416 (435)
|.+||+.||++|||++|++++
T Consensus 235 i~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=420.77 Aligned_cols=248 Identities=28% Similarity=0.505 Sum_probs=217.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
.+|++.+.||+|+||+||+|.++ |+.||||++....... .+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 37999999999999999999975 8899999986544333 267889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|||+||+|.+++.+ +.+++.+++.++.||+.||.|||++| ||||||||+|||+ +.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEE--CCCCcEeeccchhheeeccccc
Confidence 99999999998865 46999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 393 (435)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.....+ ...+..+|++++
T Consensus 172 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 247 (293)
T d1yhwa1 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (293)
T ss_dssp ----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred ----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence 234567999999999999999999999999999999999999999998877766655544433 333467899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||+.|+++|
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-57 Score=422.99 Aligned_cols=268 Identities=29% Similarity=0.569 Sum_probs=229.6
Q ss_pred CCCCCCCCcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccee
Q 013833 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219 (435)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 219 (435)
|+.|....|+++.. +|++.+.||+|+||+||+|.++ ++.||||++...... .+++.+|+++|++++||||++
T Consensus 4 p~~p~~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 4 PSSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp TTSTTCCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEec
Confidence 45566678998754 7888999999999999999986 678999998654332 367899999999999999999
Q ss_pred eeeeEEeCCcEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCc
Q 013833 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (435)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~ 297 (435)
+++++.+++.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+|||+ +.++.
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl--~~~~~ 153 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHL 153 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEE--CCCCc
Confidence 999999999999999999999999999764 46899999999999999999999988 9999999999999 88899
Q ss_pred EEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHH
Q 013833 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP-PLANYEPYEAAKYVA 376 (435)
Q Consensus 298 vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~-p~~~~~~~~~~~~~~ 376 (435)
+||+|||+|+....... .......|++.|+|||++.+..|+.++|||||||++|||++|.. ||.+.+.......+.
T Consensus 154 ~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~ 230 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230 (287)
T ss_dssp EEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EEEccccceeecCCCCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh
Confidence 99999999987654322 12334568999999999999999999999999999999999654 556667766667777
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 377 EGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
.+.++.. +..+|+++++||.+||+.||++|||+.++++.|+.+.++
T Consensus 231 ~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 231 KDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred cCCCCCC-CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 7766554 357999999999999999999999999999999887543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-57 Score=424.85 Aligned_cols=247 Identities=32% Similarity=0.472 Sum_probs=223.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|+..+.||+|+||+||+|.++ ++.||||.+...........+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5888999999999999999986 67899999877666666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||.+|+|..++...+.+++.++..++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--CCCCCEEEeecccccccCC----
Confidence 9999999888888888999999999999999999999988 9999999999999 7888999999999986542
Q ss_pred ccccccCCCcCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (435)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+....+....+..+..+......+|+++
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 234579999999999864 4689999999999999999999999999988888888888877777777899999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|+++|
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhC
Confidence 999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=418.12 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=208.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--CCcEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 233 (435)
+|++.+.||+|+||+||+|+++ |+.||+|.+...... +...+.+.+|+++|++++||||+++++++.+ +..+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6889999999999999999986 778999998765443 4456789999999999999999999998864 4668999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcCC---CceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||+++ ++||||||||+|||+ +.++.+||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeeccce
Confidence 999999999999864 457999999999999999999999864 349999999999999 88899999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
+.+..... ......||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+..+....+..+..+.. +.
T Consensus 162 ~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~-~~ 236 (269)
T d2java1 162 RILNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-PY 236 (269)
T ss_dssp HHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-CT
T ss_pred eecccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 87654322 23456899999999999999999999999999999999999999999998888888888766543 35
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+|+++++||.+||+.||++|||+.|++++
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 799999999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=412.71 Aligned_cols=255 Identities=31% Similarity=0.629 Sum_probs=214.8
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|+..+.||+|+||+||+|.++ +..||||++....... +++.+|++++++++||||+++++++.+++.+++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 36888999999999999999986 5679999986543322 578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++|+|.+++... ..++++.++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEE--CGGGCEEECSCC----------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheee--cCCCCeEecccchheeccCCCc
Confidence 99999999998764 46899999999999999999999988 9999999999999 8888999999999987654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
. ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||......+....+..+.++.. +..+++++.
T Consensus 157 ~---~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-p~~~~~~l~ 232 (263)
T d1sm2a_ 157 T---SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-CTTSCHHHH
T ss_pred e---eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-ccccCHHHH
Confidence 1 2334578999999999999999999999999999999999 6777888888888888888876654 456899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+|+.+||+.||++|||+++++++|+++.++
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=424.31 Aligned_cols=252 Identities=25% Similarity=0.453 Sum_probs=218.9
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 6999999999999999999986 77899999864332222334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++...+.+++.+++.++.|++.||.|||+++ ||||||||+|||+ +.++.+||+|||+|+.+......
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll--~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccccc--CCCceEEecccccceecccCCcc
Confidence 9999999999999899999999999999999999999988 9999999999999 88899999999999876543221
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..+.... +..+++++++|
T Consensus 165 --~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 240 (288)
T d1uu3a_ 165 --ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARDL 240 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--CTTCCHHHHHH
T ss_pred --cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--CccCCHHHHHH
Confidence 12345679999999999999999999999999999999999999999999888888887765432 35789999999
Q ss_pred HHHHhhhcccCCCCHHHHHHHH
Q 013833 396 TEKCWAADMNQRPSFLDILKRL 417 (435)
Q Consensus 396 i~~cl~~dp~~Rps~~~ll~~L 417 (435)
|.+||+.||++|||++|++++-
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHH
T ss_pred HHHHccCCHhHCcCHHHHcCCH
Confidence 9999999999999999986653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=413.26 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=213.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe----CCcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 231 (435)
.|+..+.||+|+||+||+|.++ +..||+|.+...... ....+.+.+|+++|++++||||+++++++.+ +..+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 3456678999999999999986 668999988654433 3445789999999999999999999999865 35589
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~ 310 (435)
+||||++||+|.+++.+.+.+++.++..++.||+.||.|||+++.+||||||||+|||+ + .++.+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl--~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee--eCCCCCEEEeecCcceecc
Confidence 99999999999999999889999999999999999999999976679999999999999 5 46789999999997644
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.. .....+.+..+..+...+..++
T Consensus 167 ~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 167 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 32 1234679999999999875 59999999999999999999999998654 4455566777666655556789
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+++++||.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=419.01 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=211.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||||++...... ...+.+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 6899999999999999999986 779999998654322 233678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|.+++...+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+|+........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl--~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEE--CCCCCEEEccchhheeeccCCcc
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999999877543321
Q ss_pred ccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
......+||+.|||||++.+..+ +.++|||||||++|+|++|++||...... ..................++++++
T Consensus 160 --~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 160 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp --CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred --ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 12345689999999999988776 57899999999999999999999765433 222333333333333356899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
+||.+||+.||++|||++|++++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-56 Score=415.60 Aligned_cols=259 Identities=31% Similarity=0.549 Sum_probs=214.1
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC---cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.++||+|+||+||+|.++ +. .||||.+.... .....++|.+|+.+|++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 36788899999999999999985 22 48888775433 3445578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+|||||++|+|.+++... +.+++.++..++.||++||.|||+++ ||||||||+|||+ +.++++||+|||+++...
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC-------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEE--CCCCcEEECCcccceEcc
Confidence 999999999999998874 56999999999999999999999988 9999999999999 888999999999998776
Q ss_pred ccCcccc-ccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 311 VQNSHDV-YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 311 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
....... .......||+.|+|||.+.+..++.++|||||||++|||+| |..||.+....+....+..+.++..+ ..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP-MDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-TTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-ccc
Confidence 5432211 12233468999999999999999999999999999999998 89999999998888888888766543 569
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
|+++++||.+||+.||++|||+.|+++.|+++.+
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=412.47 Aligned_cols=252 Identities=29% Similarity=0.523 Sum_probs=216.0
Q ss_pred ceeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecCC
Q 013833 163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 238 (435)
+.||+|+||+||+|.++ ++.||||++...... ....+++.+|+++|++++||||+++++++.. +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 347999998654433 3345789999999999999999999999864 56789999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccc
Q 013833 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (435)
Q Consensus 239 g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 318 (435)
+|+|.+++.+...+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+++.+...... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~~~~-~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 165 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECCTTCSE-EE
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcc--cccCcccccchhhhhhccccccc-cc
Confidence 9999999999889999999999999999999999988 9999999999999 78889999999999876543321 11
Q ss_pred cccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 013833 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTE 397 (435)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 397 (435)
......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+..+.++..+ ..+|+++++||.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC-cccCHHHHHHHH
Confidence 2334578999999999999999999999999999999998 89999999988888888888776654 579999999999
Q ss_pred HHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 398 KCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 398 ~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+||+.||++|||+.++++.|+.+..
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998887653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-56 Score=419.81 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=205.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|++.+.||+|+||+||+|.++ ++.||||++.+..... ....+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999986 7789999986554332 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++...+.+++.++..++.||+.||.|||++| ||||||||+|||+.. +.++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 9999999999998889999999999999999999999988 999999999999953 456899999999998665332
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 392 (435)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....+....+..+...... ...+|+++
T Consensus 165 ----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 165 ----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred ----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 234567999999999999999999999999999999999999999999888888887776544322 25789999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|++++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=416.58 Aligned_cols=248 Identities=28% Similarity=0.476 Sum_probs=216.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.|++.+.||+|+||+||+|.++ +..||+|++...... ..+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5888999999999999999986 678999998654322 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++.+ .+.+++.++..++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||+|........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeE--CCCCCEEEEechhhhccCCCcc
Confidence 9999999999775 456999999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCCcCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCC
Q 013833 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF-RAKGF 388 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 388 (435)
......||+.|+|||++. ...|+.++|||||||++|+|++|..||.+.+..+....+..+..+.. .+..+
T Consensus 166 ----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 166 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp ----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred ----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 234568999999999984 45688999999999999999999999999888887777777655443 34578
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
|+++++||.+||+.||++|||+.|++++
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=423.12 Aligned_cols=253 Identities=25% Similarity=0.460 Sum_probs=214.5
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 233 (435)
..+|++.+.||+|+||+||+|.++ |+.||+|++...... ...+.+.+|+.+|++++|||||++++++.+...+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999986 778999998654332 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC-CCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
|||++||+|.+++.+.+.+++.++..++.||+.||.|||++ | |+||||||+|||+ +.++++||+|||+|+.....
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeE--CCCCCEEEeeCCCccccCCC
Confidence 99999999999999988999999999999999999999974 7 9999999999999 88899999999999876543
Q ss_pred CccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH----------------------
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---------------------- 370 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---------------------- 370 (435)
. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+
T Consensus 159 ~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp T------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred c------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 2 335689999999999999999999999999999999999999997654221
Q ss_pred --------------------HHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHH
Q 013833 371 --------------------AAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKI 420 (435)
Q Consensus 371 --------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~ 420 (435)
....+.....+..+...+++++++||.+||+.||++|||++|+++| |.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1112222333333334578999999999999999999999999986 5443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=409.81 Aligned_cols=261 Identities=30% Similarity=0.520 Sum_probs=224.5
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
..+|+|+. .+|++.+.||+|+||+||+|.++ ++.||||.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~wei~~--~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCH--HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 45788864 37889999999999999999997 468999998654332 257899999999999999999999876
Q ss_pred eCCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+ +.+++||||+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll--~~~~~~Kl~DF 153 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADF 153 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheee--ecccceeeccc
Confidence 5 567999999999999998754 335999999999999999999999988 9999999999999 88899999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......+....+..+.++.
T Consensus 154 Gla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 154 GLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp TTCEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cceEEccCCcc---ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99987654321 12345678999999999998899999999999999999999 566677777878888888877665
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
.+ ..+|+++++|+.+||+.||++|||++++++.|+.+..
T Consensus 231 ~p-~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RP-DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cc-ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 44 5799999999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=402.77 Aligned_cols=251 Identities=28% Similarity=0.560 Sum_probs=223.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
.+|+..+.||+|+||+||+|+++ ++.||||.+.+..... +++.+|+.++++++||||+++++++.+++.+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 47888999999999999999997 5589999987644332 578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
|+++|+|.+++.. ...+++..+++++.|+++||.|||++| |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSSSSC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEE--cCCCcEEECcchhheeccCCCc
Confidence 9999999999765 456899999999999999999999988 9999999999999 8889999999999986654322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+..+.++.. +..++++++
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-p~~~~~~l~ 231 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVY 231 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-CTTCCHHHH
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-cccccHHHH
Confidence 12344678999999999999999999999999999999998 8999999999999888988876654 457899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
+||.+||+.||++|||+++++++|.+
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=409.90 Aligned_cols=258 Identities=29% Similarity=0.540 Sum_probs=222.3
Q ss_pred CCCCCc-eeecCCceeEEEEEEC----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~-~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|.+.. +||+|+||+||+|.++ +..||||.+.... .....+++.+|+++|++++||||+++++++.+ +.+|+
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 455555 4999999999999874 3479999986543 34456789999999999999999999998865 56899
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
||||+++|+|.+++.. .+.+++.++..++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheee--ccCCceeeccchhhhcccc
Confidence 9999999999999865 457999999999999999999999988 9999999999999 7788999999999987764
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCH
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... ........||+.|+|||++....++.++|||||||++|||+| |..||.+....+....+..+.++..+ ..+|+
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~ 239 (285)
T d1u59a_ 162 DDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECPP 239 (285)
T ss_dssp CSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC-TTCCH
T ss_pred cccc-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCH
Confidence 4321 112334568999999999998999999999999999999998 99999999888888888888877654 57999
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 391 ELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
++.+||.+||+.||++|||+.++++.|+.+..++
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998776543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=419.47 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=222.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++++.||+|+||.||+|+++ ++.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 6899999999999999999985 78999999865432222234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
||+||+|.+++.+.+.++++.++.++.||+.||+|||++| ||||||||+|||+ +.+|.+||+|||+|+.......
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl--~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC-
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEe--cCCCCEEEeecccccccccCCc-
Confidence 9999999999999999999999999999999999999988 9999999999999 8889999999999986643322
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..+.... +..+|+++++|
T Consensus 161 ---~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~dl 235 (337)
T d1o6la_ 161 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSL 235 (337)
T ss_dssp ---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred ---ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHHH
Confidence 3445789999999999999999999999999999999999999999999988888887765443 45799999999
Q ss_pred HHHHhhhcccCCCC-----HHHHHHH
Q 013833 396 TEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
|.+||++||++|++ +.|+++|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhhccCCchhhcccccccHHHHHcC
Confidence 99999999999994 8899875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-55 Score=421.63 Aligned_cols=249 Identities=24% Similarity=0.445 Sum_probs=219.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ |+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 7999999999999999999986 7899999986543 3334778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++.+ .+.+++.++..++.||+.||.|||++| ||||||||+|||+..+.++.+||+|||+|+.+.....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999954 557999999999999999999999988 9999999999999655678999999999987654332
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 392 (435)
.....||+.|||||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+..... ....+|+++
T Consensus 182 -----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 -----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp -----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred -----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3346789999999999999999999999999999999999999999988888877776654332 224689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|+++|
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=418.53 Aligned_cols=260 Identities=30% Similarity=0.507 Sum_probs=215.8
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 220 (435)
.|+++. .+|++.++||+|+||+||+|.+.+ ..||+|.+..... ......+.+|+.+|+++ +|||||++
T Consensus 31 kwei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCG--GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCH--HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 466654 378889999999999999999753 2589998754332 22346788999999998 89999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCc
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNFALDIARGMAYLHNEPNV 277 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----------------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ 277 (435)
++++.+.+.+++|||||++|+|.++++.. +.+++.+++.++.||+.||.|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999753 24889999999999999999999988
Q ss_pred eEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 013833 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (435)
Q Consensus 278 ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 357 (435)
||||||||+|||+ +.++++||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+
T Consensus 185 IiHRDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 185 CVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp EEETTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eeeccCchhcccc--ccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 9999999999999 88899999999999876544321 1233456899999999999999999999999999999999
Q ss_pred c-CCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHH
Q 013833 358 E-GEPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEK 419 (435)
Q Consensus 358 t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 419 (435)
| |..||.+.+..... ..+..+.++. .+..+|+++++||.+||+.||++|||++||+++|..
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 8 89999887654444 4444554443 345799999999999999999999999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=408.90 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=220.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc---HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.+.||+|+||+||+|.++ |+.||||++.+..... ....+.+.+|+.+|++++||||+++++++.+.+.+||
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 6999999999999999999986 7899999986543221 1234778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC----cEEEeeccCccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL 308 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~----~vkl~Dfg~a~~ 308 (435)
|||||+||+|.+++...+.+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++ .+||+|||+|..
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill--~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEE--ecCCCcccceEecchhhhhh
Confidence 9999999999999998889999999999999999999999988 9999999999999 4444 599999999987
Q ss_pred ccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AK 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 386 (435)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+...... ..
T Consensus 167 ~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 167 IDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 65432 234567899999999999999999999999999999999999999999988888888776544322 25
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+|+++++||.+||+.||++|||++|++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 689999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-54 Score=403.36 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=218.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC----cEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~ 231 (435)
+|++.+.||+|+||+||+|.++ ++.||||++.+....+....+.+.+|+++++.++||||+++++++...+ .+|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 6899999999999999999985 7899999998877777777788999999999999999999999987643 379
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 311 (435)
+||||++|++|.+++...+.+++.+++.++.||+.||.|||++| ||||||||+|||+ +.++.++++|||.+.....
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll--~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTSCEEECCCTTCEECC-
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCccccc--Cccccceeehhhhhhhhcc
Confidence 99999999999999999889999999999999999999999988 9999999999999 7888999999999876544
Q ss_pred cCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCC
Q 013833 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGFT 389 (435)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 389 (435)
... .........||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..+....+....... .....+|
T Consensus 164 ~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccc-cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 322 1123445679999999999999999999999999999999999999999988877766655443322 2235789
Q ss_pred HHHHHHHHHHhhhcccCCC-CHHHHHHHHHHHH
Q 013833 390 PELRELTEKCWAADMNQRP-SFLDILKRLEKIK 421 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~ 421 (435)
+++++||.+||+.||++|| |++++++.|.++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999999999998 8999999998875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-55 Score=417.53 Aligned_cols=249 Identities=22% Similarity=0.420 Sum_probs=219.0
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ |+.||||++.... ......+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 6999999999999999999985 7899999886543 2233678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++...+ .+++.+++.++.||+.||.|||++| ||||||||+|||+....++.+||+|||+|..+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999999999876544 6999999999999999999999988 999999999999954477899999999998776432
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 392 (435)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+..... ....+|+++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 184 ----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp ----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred ----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 22345789999999999999999999999999999999999999999998888877776654332 235789999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||+.||++|||+.|+++|
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-55 Score=412.53 Aligned_cols=246 Identities=28% Similarity=0.512 Sum_probs=220.5
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ |+.||||++.+.........+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 6999999999999999999986 78999999864332222234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|++||+|..++.....+++.++..++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl--~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC---
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeE--cCCCCEEEecCccceEeccc---
Confidence 9999999999999889999999999999999999999988 9999999999999 88899999999999876432
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..+.... +..+|++++++
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 231 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDL 231 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCCCCHHHHHH
Confidence 235689999999999999999999999999999999999999999999988888887765433 35689999999
Q ss_pred HHHHhhhcccCCC-----CHHHHHHH
Q 013833 396 TEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
|.+||..||.+|+ |++++++|
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999996 89999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=402.87 Aligned_cols=258 Identities=33% Similarity=0.584 Sum_probs=215.4
Q ss_pred CCCCCceeecCCceeEEEEEECC------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 231 (435)
.|+..++||+|+||+||+|.+++ ..||||.+..... .....++.+|+.++++++||||+++++++.+.+..+
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 57788999999999999998753 3699998865433 334467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+||||+.+++|.+++... +.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEE--CCCCeEEEcccchhhccc
Confidence 999999999999988764 57999999999999999999999988 9999999999999 889999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..... ........||+.|+|||++.+..++.++|||||||++|||++| .+||......+....+..+.++..+ ..+|
T Consensus 162 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 239 (283)
T d1mqba_ 162 DDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP-MDCP 239 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC-TTCB
T ss_pred CCCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc-hhhH
Confidence 43221 1223445689999999999999999999999999999999995 5666777777788888888776644 5699
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 390 PELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 390 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
+++.+||.+||+.||++|||+.++++.|+++.+.
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999999988763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-55 Score=401.52 Aligned_cols=255 Identities=34% Similarity=0.642 Sum_probs=218.1
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-C
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-R 227 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 227 (435)
+|+++.+ +|+..+.||+|+||.||+|.++|+.||||++..+. ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~w~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGG--GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHH--HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 4777755 67888999999999999999999999999986432 23678999999999999999999998855 4
Q ss_pred CcEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccC
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~ 305 (435)
+.+++||||+++|+|.+++...+ .+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGL 149 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhhee--cCCCCEeeccccc
Confidence 66899999999999999997543 4899999999999999999999987 9999999999999 8889999999999
Q ss_pred cccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 013833 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+..+.++..+
T Consensus 150 s~~~~~~-------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 150 TKEASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 222 (262)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred ceecCCC-------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9865432 223467899999999998999999999999999999998 79999988888888888888887765
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 385 AKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
..+++++++||.+||+.||++|||+.+++++|++++.
T Consensus 223 -~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 -DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4689999999999999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=402.03 Aligned_cols=262 Identities=31% Similarity=0.569 Sum_probs=215.8
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC-----CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
+|+|+.+ +|++.+.||+|+||+||+|.+. +..||||.+... ......+.+.+|+.+|++++||||++++++
T Consensus 1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4777643 7899999999999999999875 235888877433 334555789999999999999999999999
Q ss_pred EEeCCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEee
Q 013833 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~D 302 (435)
+. .+.+++||||+++|+|.+++.. .+.+++.+++.++.||++||.|||+++ ||||||||+||++ +.++.+||+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll--~~~~~~Kl~D 151 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGD 151 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheee--cCCCcEEEcc
Confidence 86 4678999999999999998765 456999999999999999999999988 9999999999999 7788999999
Q ss_pred ccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 013833 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 303 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+.++
T Consensus 152 fG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 152 FGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp ----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred chhheeccCCcc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999987654322 12334568999999999999999999999999999999998 89999999988888888888776
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
..+ ..+|+++++||.+||+.||++|||+.+|+++|+++.++
T Consensus 229 ~~~-~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 PMP-PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 544 57999999999999999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-54 Score=412.84 Aligned_cols=246 Identities=27% Similarity=0.469 Sum_probs=220.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++++.||+|+||+||+|.++ |+.||||++.+....+....+.+.+|+.+|+.++||||+++++++.+...+++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 7999999999999999999986 78999998854322222234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
|+.||+|.+++.+.+.+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.+|++||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl--~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC---
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHccc--CCCCCEEeeeceeeeecccc---
Confidence 9999999999999889999999999999999999999988 9999999999999 88899999999999876532
Q ss_pred ccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELREL 395 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 395 (435)
.....||+.|||||++.+..++.++|||||||++|+|+||..||.+.+.......+..+.... +..+++++.+|
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 268 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKDL 268 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTCCHHHHHH
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--CccCCHHHHHH
Confidence 234679999999999999999999999999999999999999999999888888887765443 45799999999
Q ss_pred HHHHhhhcccCCC-----CHHHHHHH
Q 013833 396 TEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 396 i~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
|.+||+.||.+|+ |++++++|
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhhCHHhccccccccHHHHHcC
Confidence 9999999999994 89999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=398.47 Aligned_cols=259 Identities=28% Similarity=0.540 Sum_probs=211.1
Q ss_pred CCCCCCCceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
..+|++.+.||+|+||+||+|.+++ ..||||++.+.........+++.+|+.+|++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3478999999999999999998642 3689998877665555666889999999999999999999999965 467
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll--~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcc--ccccceeeccchhhhhc
Confidence 899999999999988765 456999999999999999999999988 9999999999999 77789999999999977
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+......+..+..+
T Consensus 162 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 162 PQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 544322 122334567889999999999999999999999999999998 899999999988887776554434445679
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHH
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKI 420 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 420 (435)
|+++++||.+||+.||++|||+.++++.|++.
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999999988864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-53 Score=394.06 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=218.4
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc------HHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeC
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER 227 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 227 (435)
.+|++.+.||+|+||+||+|+++ ++.||||++.+..... +...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 37899999999999999999984 7899999986644321 223456889999999997 99999999999999
Q ss_pred CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
+.+||||||++||+|.++++.++.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEE--cCCCCeEEccchhee
Confidence 999999999999999999999999999999999999999999999988 9999999999999 888999999999998
Q ss_pred cccccCccccccccCCCcCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 381 (435)
.+.... ......||+.|+|||.+. ...++.++||||+||++|+|++|+.||.+.+..+....+..+...
T Consensus 159 ~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 159 QLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 775432 223467999999999985 345788999999999999999999999999988877777766433
Q ss_pred CC--CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 FF--RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ...++|+++++||.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22 224789999999999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=397.16 Aligned_cols=264 Identities=31% Similarity=0.522 Sum_probs=219.5
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEECC-CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEE
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 225 (435)
..+|+|+.. +|++.+.||+|+||+||+|.+++ ..||||++...... . +.|.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-~---~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-P---EAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-H---HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-H---HHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 457888754 79999999999999999999874 57999998654332 2 57899999999999999999999985
Q ss_pred eCCcEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 226 ~~~~~~lv~e~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
+ +..++||||+++|+|..++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++++||+||
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll--~~~~~~kl~Df 157 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 157 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEE--CCCCcEEEccc
Confidence 5 567899999999999998864 456999999999999999999999988 9999999999999 88889999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHcCCCCC
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHRPF 382 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~ 382 (435)
|+++....... .......||+.|+|||++....++.++|||||||++|||++| .+|+.+....+....+..+.++.
T Consensus 158 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 158 GLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp CTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred chhhhccCCCc---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99987653321 123445789999999999999999999999999999999995 56667777777777788777665
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCC
Q 013833 383 FRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLP 425 (435)
Q Consensus 383 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 425 (435)
. +..+|+++++||.+||+.||++|||++++++.|+.+.....
T Consensus 235 ~-~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 C-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred C-CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 4 45799999999999999999999999999999988765543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-53 Score=399.26 Aligned_cols=257 Identities=31% Similarity=0.508 Sum_probs=223.9
Q ss_pred CCCCCCceeecCCceeEEEEEECC-------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||+||+|++++ +.||||++.... .....+++.+|+.+|++++||||+++++++.....
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 368999999999999999999754 579999886433 33445789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCC
Q 013833 230 LMLITEYLRGGDLHKYLKEKG------------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKP 285 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~------------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp 285 (435)
.+++|||+++|+|.+++.... .+++.+++.++.||+.||.|||+++ ||||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp 168 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLAT 168 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcc
Confidence 999999999999999996532 3788999999999999999999988 99999999
Q ss_pred CcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCC-CCCC
Q 013833 286 RNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE-PPLA 364 (435)
Q Consensus 286 ~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~-~p~~ 364 (435)
+|||+ +.++.+||+|||+|+........ .......||+.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 169 ~NILl--d~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 169 RNCLV--GENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGEEE--CGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEE--CCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999 88899999999999876543321 1233567899999999999999999999999999999999985 7899
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 365 NYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+.+..+....+.++.++..+ ..+|+++.+||.+||+.||++|||+.|+++.|+++.+
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p-~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHcCCCCCCC-ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 99999998899888876544 5689999999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=404.90 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=217.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++.+.||+|+||+||+|.++ ++.||+|.+.... .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 6899999999999999999986 6789999986542 122567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||+||+|.+++...+ .+++.++..++.||+.||.|||++| |+||||||+|||+..+....+||+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 999999999998655 6999999999999999999999988 999999999999955566789999999998765332
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPEL 392 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 392 (435)
......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+....+..+...+.. ...+|+++
T Consensus 159 ----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 159 ----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp ----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 123356899999999999999999999999999999999999999999988888888776543322 14689999
Q ss_pred HHHHHHHhhhcccCCCCHHHHHHH
Q 013833 393 RELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 393 ~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
++||.+||..||++|||+.|+++|
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=406.43 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=215.3
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHH-hCCCCcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||+||+|.++ ++.||||++.+.........+.+..|..++. .++||||+++++++.+++.+||||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 6889999999999999999985 7789999986432111122345566666654 689999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++||+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++++||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~--~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceee--cCCCceeccccchhhhcccccc
Confidence 99999999999999889999999999999999999999988 9999999999999 8889999999999986553322
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (435)
......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..+... .+..+|+++++
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~p~~~s~~~~d 232 (320)
T d1xjda_ 159 ----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKD 232 (320)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred ----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--CCccCCHHHHH
Confidence 234568999999999999999999999999999999999999999999988888888766433 24578999999
Q ss_pred HHHHHhhhcccCCCCHH-HHHH
Q 013833 395 LTEKCWAADMNQRPSFL-DILK 415 (435)
Q Consensus 395 li~~cl~~dp~~Rps~~-~ll~ 415 (435)
||.+||+.||++|||+. ++++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHhcccCCCCCcCHHHHHHh
Confidence 99999999999999995 6765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=399.50 Aligned_cols=256 Identities=29% Similarity=0.584 Sum_probs=215.7
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CC----cEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 230 (435)
.+|+++++||+|+||+||+|.+. |+ .||+|.+...... ...+.+.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 46999999999999999999985 33 5888887543322 2346789999999999999999999999865 56
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
++++|++.+++|.+++... ..+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+|+..
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll--~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhccee--CCCCCeEeeccccceec
Confidence 7888999999999988764 56999999999999999999999988 9999999999999 78889999999999876
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..+....+..+.++..+ ..+
T Consensus 162 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p-~~~ 238 (317)
T d1xkka_ 162 GAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PIC 238 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC-TTB
T ss_pred cccccc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-ccc
Confidence 543321 12334568999999999999999999999999999999998 89999998888888888887776544 568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 389 TPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 389 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
++++.+|+.+||+.||++|||+.+++++|..+..
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=393.75 Aligned_cols=266 Identities=33% Similarity=0.575 Sum_probs=225.4
Q ss_pred CCCCcccCCCCCCCCCCceeecCCceeEEEEEECC---------CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCC
Q 013833 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHP 215 (435)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 215 (435)
....|+++.+ +|++.+.||+|+||.||+|...+ ..||||++.... ......++.+|...+.++ +||
T Consensus 4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence 3345777654 88899999999999999998642 369999886543 334457788999999888 799
Q ss_pred cceeeeeeEEeCCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceE
Q 013833 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVII 279 (435)
Q Consensus 216 ~iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~iv 279 (435)
||+++++++.+++.+++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+.+ ||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--iv 157 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI 157 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EE
Confidence 9999999999999999999999999999999754 24899999999999999999999988 99
Q ss_pred eCCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-
Q 013833 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE- 358 (435)
Q Consensus 280 H~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t- 358 (435)
||||||+|||+ +.++.+||+|||+++......... ......||+.|+|||.+.++.|+.++|||||||++|||++
T Consensus 158 HrDiKp~NiLl--~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 158 HRDLAARNVLV--TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CSCCSGGGEEE--CTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eeeecccceee--cCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999 888999999999998776543221 2344678999999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 359 GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 359 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
|.+||.+.+..+....+..+.++..+ ..+++++++||.+||+.||++|||+.|+++.|+++..
T Consensus 234 g~~p~~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLKEGHRMDKP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCCC-SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCC-ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 79999999988888888887776654 5699999999999999999999999999999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-53 Score=406.74 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=207.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCC---cHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 232 (435)
+|++.++||+|+||.||+|.++ |+.||||++.+.... .........+|+.+++.++||||+++++++.+.+.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 7999999999999999999986 789999988543211 12222334456788888899999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccccc
Q 013833 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 233 v~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++| ||||||||+|||+ +.+|.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl--~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEE--cCCCcEEEeeeceeeecCCC
Confidence 9999999999999999889999999999999999999999988 9999999999999 88899999999999876533
Q ss_pred CccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCCH
Q 013833 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGFTP 390 (435)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 390 (435)
......||+.|+|||++.. ..|+.++|||||||++|+|+||..||.+....+...... ....+...+..+|+
T Consensus 161 ------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 161 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp ------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred ------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 2345679999999999864 578999999999999999999999998654332222221 11222333457999
Q ss_pred HHHHHHHHHhhhcccCCCC-----HHHHHHH
Q 013833 391 ELRELTEKCWAADMNQRPS-----FLDILKR 416 (435)
Q Consensus 391 ~l~~li~~cl~~dp~~Rps-----~~~ll~~ 416 (435)
++++||.+||+.||++||| ++++++|
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999999 7899875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=397.32 Aligned_cols=264 Identities=29% Similarity=0.528 Sum_probs=210.3
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceee
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 220 (435)
.|+++. .+|++.+.||+|+||.||+|.+. ++.||||.+.... .....+.+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~--~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCG--GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccH--HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 466653 37899999999999999999974 2469999886433 233446777888888777 58899999
Q ss_pred eeeEEe-CCcEEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCC
Q 013833 221 LGAVTE-RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (435)
Q Consensus 221 ~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dl 283 (435)
++++.. +..+++|||||++|+|.++++.. ..+++.+++.++.||++||.|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 998765 45689999999999999999753 24889999999999999999999988 999999
Q ss_pred CCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCC
Q 013833 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPP 362 (435)
Q Consensus 284 kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg-~~p 362 (435)
||+|||+ +.++++||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 161 Kp~NILl--~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 161 AARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CGGGEEE--CGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccceeE--CCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 9999999 8888999999999986654322 1123456799999999999999999999999999999999996 568
Q ss_pred CCCCCH-HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhh
Q 013833 363 LANYEP-YEAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKET 423 (435)
Q Consensus 363 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 423 (435)
|.+... ......+..+.++.. +..+++++++||.+||+.||++|||+.|++++|+++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 877654 344455666666654 356899999999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=394.90 Aligned_cols=258 Identities=35% Similarity=0.533 Sum_probs=220.2
Q ss_pred CCCCCCceeecCCceeEEEEEECC--C--cEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEeCCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWRG--T--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 231 (435)
.+|++.++||+|+||+||+|.+++ . .||||.+..... ....+.+.+|+++|+++ +||||+++++++.+++.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 367888999999999999999863 3 578887653322 22346789999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC
Q 013833 232 LITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~ 295 (435)
+||||++||+|.++++.. ..+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~--~~~ 163 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 163 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEE--cCC
Confidence 999999999999999753 46899999999999999999999988 9999999999999 888
Q ss_pred CcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCC-CCCCCCCHHHHHHH
Q 013833 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE-PPLANYEPYEAAKY 374 (435)
Q Consensus 296 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~-~p~~~~~~~~~~~~ 374 (435)
+.+||+|||+++...... ......||+.|+|||.+....++.++|||||||++|||++|. +||.+.+..+....
T Consensus 164 ~~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp GCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CceEEccccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 899999999998655332 223456899999999999999999999999999999999965 68999999888888
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC
Q 013833 375 VAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT 426 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 426 (435)
+.++.++..+ ..+++++++||.+||+.||++|||+.+++++|+++.+....
T Consensus 239 i~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 239 LPQGYRLEKP-LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp GGGTCCCCCC-TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHhcCCCCCC-ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 8888776654 56899999999999999999999999999999999876554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=392.92 Aligned_cols=267 Identities=32% Similarity=0.527 Sum_probs=224.8
Q ss_pred CCCcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcce
Q 013833 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (435)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 218 (435)
...|+++.. +|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++++ +||||+
T Consensus 15 ~~~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 15 DHKWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp CGGGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEE
Confidence 346877654 7888999999999999999863 3479999986543 234456789999999999 699999
Q ss_pred eeeeeEEeCCcEEEEEecCCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 013833 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (435)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------------~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH 280 (435)
++++++.+....++|||||++|+|.+++.... .+++.+++.++.||+.||.|||+++ +||
T Consensus 91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivH 168 (311)
T d1t46a_ 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH 168 (311)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 99999999999999999999999999997543 4899999999999999999999988 999
Q ss_pred CCCCCCcEEEecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 013833 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (435)
Q Consensus 281 ~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~t-g 359 (435)
|||||+|||+ +.++.++++|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |
T Consensus 169 rDLKp~NIl~--~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 169 RDLAARNILL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp SCCSGGGEEE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccc--cccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 9999999999 7888999999999987654332 123345678999999999999999999999999999999999 6
Q ss_pred CCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 360 EPPLANYEPYEAA-KYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 360 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
.+||......+.. +.+..+.++. .+..+|+++.+||.+||+.||++|||+.++++.|+++..+.
T Consensus 245 ~p~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 245 SSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 7777776654443 4455555554 34568999999999999999999999999999999776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=386.59 Aligned_cols=260 Identities=27% Similarity=0.519 Sum_probs=217.1
Q ss_pred CceeecCCceeEEEEEECC-----CcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe-CCcEEEEEe
Q 013833 162 SAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLITE 235 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 235 (435)
.++||+|+||+||+|.+.. ..||||.+.. .......+++.+|+++|++++||||+++++++.+ +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4689999999999999742 2589998853 2345556889999999999999999999999865 457899999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCc
Q 013833 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (435)
Q Consensus 236 ~~~g~sL~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 314 (435)
||++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeE--CCCCCEEEecccchhhcccccc
Confidence 99999999998854 35778899999999999999999988 9999999999999 8889999999999987765443
Q ss_pred cccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 013833 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA-NYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (435)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (435)
..........||+.|+|||.+....++.++||||||+++|||+||..||. ..+..+....+..+.++.. +..+++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~-p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC-CTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-cccCcHHHH
Confidence 33333445678999999999999999999999999999999999766664 4455566677777777654 457899999
Q ss_pred HHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCCCC
Q 013833 394 ELTEKCWAADMNQRPSFLDILKRLEKIKETLPTDH 428 (435)
Q Consensus 394 ~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 428 (435)
+||.+||+.||++|||+.|++++|+.+.++...+.
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 99999999999999999999999999998766643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=389.81 Aligned_cols=264 Identities=30% Similarity=0.496 Sum_probs=228.3
Q ss_pred CCcccCCCCCCCCCCceeecCCceeEEEEEEC-------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceee
Q 013833 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220 (435)
Q Consensus 148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 220 (435)
.+|+|++. +|++.+.||+|+||+||+|.++ ++.||||++.... .......+.+|+.++++++||||+++
T Consensus 13 ~~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 13 DEWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CTTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 36888754 7889999999999999999874 3579999986433 33445678999999999999999999
Q ss_pred eeeEEeCCcEEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEE
Q 013833 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (435)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll 290 (435)
++++..++..++||||+++|+|.+++... ..++..++..++.|+++||.|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 166 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee
Confidence 99999999999999999999999998642 23688999999999999999999988 9999999999999
Q ss_pred ecCCCCcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHH
Q 013833 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPY 369 (435)
Q Consensus 291 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg-~~p~~~~~~~ 369 (435)
+.++++||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..
T Consensus 167 --d~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 167 --AEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp --CTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred --cCCceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 8899999999999987654332 1223445689999999999999999999999999999999997 5889999998
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh
Q 013833 370 EAAKYVAEGHRPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE 422 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 422 (435)
+....+.++.++..+ ..+|+.+.++|.+||+.||++|||+.+++++|++..+
T Consensus 243 ~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHhCCCCCCc-ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 888888888776544 5689999999999999999999999999999876544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=393.79 Aligned_cols=247 Identities=28% Similarity=0.376 Sum_probs=203.5
Q ss_pred CceeecCCceeEEEEEEC--CCcEEEEEccCCCCCc--HHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEecC
Q 013833 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 162 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
+++||+|+||+||+|.++ |+.||||++....... ....+.+.+|+.+|++++||||+++++++.+++.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999985 7889999986543221 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcccc
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 317 (435)
.++++..+......+++.++..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~~~~~--- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNR--- 155 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSCCC---
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEe--cCCCccccccCccccccCCCcc---
Confidence 88877777766778999999999999999999999988 9999999999999 8889999999999986654322
Q ss_pred ccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Q 013833 318 YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF-------------- 382 (435)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 382 (435)
......||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+.+..+....+.+.....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2345679999999999865 467999999999999999999999999988877665554321000
Q ss_pred -----CC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 -----FR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 -----~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 12468899999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=392.59 Aligned_cols=244 Identities=27% Similarity=0.470 Sum_probs=199.1
Q ss_pred CCCCCc-eeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC-CCCcceeeeeeEEe----CCc
Q 013833 158 DFSSSA-IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RKP 229 (435)
Q Consensus 158 ~~~~~~-~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~ 229 (435)
+|.+.. +||+|+||+||+|.++ ++.||||++... ..+.+|+.++.++ +||||+++++++.+ +..
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 687764 6999999999999985 778999988532 4567899987655 89999999999865 466
Q ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCc
Q 013833 230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a 306 (435)
+|+|||||+||+|.+++.+. ..+++.++..++.||+.||.|||++| |+||||||+|||+..+ ..+.+||+|||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccccee
Confidence 89999999999999999874 36999999999999999999999988 9999999999999432 3568999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----CCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG----HRPF 382 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~ 382 (435)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+.......+... ...+
T Consensus 162 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 162 KETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp EECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred eeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 8765433 234567999999999999999999999999999999999999999876543333222211 1111
Q ss_pred C--CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 383 F--RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 383 ~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
. ....+|+++++||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 113578999999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=385.35 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=203.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++++.||+|+||+||+|.++ ++.||||++...... +...+.+.+|+++|++++||||+++++++.++..+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 7899999999999999999986 789999998654322 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccC
Q 013833 236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (435)
Q Consensus 236 ~~~g~sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 313 (435)
|+.+ ++.+++.. ...+++.++..++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheee--cccCcceeccCCcceeccCCc
Confidence 9965 55555433 456999999999999999999999988 9999999999999 888899999999998765432
Q ss_pred ccccccccCCCcCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--CCC---------
Q 013833 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG--HRP--------- 381 (435)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~--------- 381 (435)
. ......||+.|+|||.+.... ++.++|+|||||++|+|++|+.||.+.+..+....+... ...
T Consensus 157 ~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 334567999999999877655 578999999999999999999999988776654443211 000
Q ss_pred ------CC----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 ------FF----------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 ------~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. ....+++++++||.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 012467899999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=383.10 Aligned_cols=242 Identities=27% Similarity=0.458 Sum_probs=203.3
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcH---HHHHHHHHHHHHHHhCC--CCcceeeeeeEEeCCc
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKP 229 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 229 (435)
.+|++.+.||+|+||+||+|.++ ++.||||.+.+....+. ....++.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 47999999999999999999986 78999998865432211 11134568999999997 8999999999999999
Q ss_pred EEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecC-CCCcEEEeeccCcc
Q 013833 230 LMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK 307 (435)
Q Consensus 230 ~~lv~e~~~g-~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~-~~~~vkl~Dfg~a~ 307 (435)
.++||||+.+ +++.+++...+.+++++++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||+|.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll--~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEE--ecCCCeEEECccccce
Confidence 9999999976 688999988889999999999999999999999988 9999999999999 5 34689999999998
Q ss_pred cccccCccccccccCCCcCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ .+..+.. ..+.
T Consensus 160 ~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~--~~~~ 225 (273)
T d1xwsa_ 160 LLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV--FFRQ 225 (273)
T ss_dssp ECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--CCSS
T ss_pred ecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc--CCCC
Confidence 65432 2345679999999999987665 567999999999999999999998632 2233322 2245
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 387 GFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 387 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+|+++++||.+||+.||++|||++|++++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 799999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-50 Score=377.55 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=206.7
Q ss_pred CCCCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEec
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 236 (435)
+|++.+.||+|+||+||+|.++ |+.||||++...... +...+.+.+|+.+|++++||||+++++++.+++..+++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 7899999999999999999986 789999998654332 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCccc
Q 013833 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (435)
Q Consensus 237 ~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 316 (435)
+.++.+..+....+.+++.++..++.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeE--cCCCCEEecccccceecccCcc--
Confidence 988777777766788999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 013833 317 VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-------------- 381 (435)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------- 381 (435)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2334568999999999875 45689999999999999999999999988776655443211000
Q ss_pred -------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+++++++||.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00123578899999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=379.44 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=201.8
Q ss_pred CCCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC----cEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI 233 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 233 (435)
+|.+.+.||+|+||+||+|+++|+.||||++... .........|+..+.+++||||+++++++.+.. .+|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 5677789999999999999999999999988532 111122334566667889999999999987643 57999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcC------CCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 234 ~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~------~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
|||+++|+|.+++++. .+++.+++.++.|++.||.|||+. .++||||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEEEecCccc
Confidence 9999999999999865 589999999999999999999973 1349999999999999 888999999999999
Q ss_pred cccccCccccccccCCCcCccccCccccCCCC------CCCcchHHHHHHHHHHHHcCCCCCCCC---------------
Q 013833 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK------YDKKVDVFSFAMILYEMLEGEPPLANY--------------- 366 (435)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~~l~tg~~p~~~~--------------- 366 (435)
.................||+.|+|||++.+.. ++.++|||||||++|||+||..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 87655433332344568999999999987643 567899999999999999998876321
Q ss_pred CHHHHHHHHHc-CCCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhC
Q 013833 367 EPYEAAKYVAE-GHRPFFRA----KGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETL 424 (435)
Q Consensus 367 ~~~~~~~~~~~-~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 424 (435)
........+.. +.+|.++. ...+..+.+|+.+||+.||++|||+.|+++.|+++.++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 12222333332 23333222 112346899999999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=379.37 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=202.1
Q ss_pred CCCCCCCceeecCCceeEEEEEEC---CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhC---CCCcceeeeeeEEe---
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE--- 226 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~--- 226 (435)
..+|++++.||+|+||+||+|.+. ++.||||++......... ...+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 358999999999999999999984 456999988653322211 12345666666555 89999999998853
Q ss_pred --CCcEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 227 --RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 227 --~~~~~lv~e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
...++++||++.++++...... ...+++..++.++.|++.||.|||+++ ||||||||+|||+ +..+.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi--~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEE--cCCCCeeecch
Confidence 3468999999988766555443 446899999999999999999999988 9999999999999 88899999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-- 381 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-- 381 (435)
|++....... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+......
T Consensus 161 g~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 9987654332 345678999999999999999999999999999999999999999998877665554321000
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 382 -----------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 382 -----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
......+++++++||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00123578999999999999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=373.49 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=202.9
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe--------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 226 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 226 (435)
.+|++++.||+|+||+||+|+++ |+.||||++......+ ....++.+|+.+|++++||||+++++.+..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 38999999999999999999985 7899999986554332 223667899999999999999999998754
Q ss_pred CCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCc
Q 013833 227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (435)
Q Consensus 227 ~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a 306 (435)
...+|+||||+.++.+..+......+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl--~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheee--cCCCcEEeeeccee
Confidence 3468999999987766666555667999999999999999999999988 9999999999999 88899999999999
Q ss_pred ccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 013833 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.................+||+.|+|||++.+. .+++++|||||||++|+|++|+.||.+.+.......+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 87664433222233446799999999998754 68999999999999999999999999888766655443321111000
Q ss_pred ------------------------------CCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 386 ------------------------------KGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 386 ------------------------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
...++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0125678899999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-48 Score=361.53 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=216.1
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-CcceeeeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||+||+|++. ++.||||++...... ..+.+|++.++.++| +|++.+++++..+...++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 7899999999999999999986 778999987544322 346788999999976 89999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec---CCCCcEEEeeccCccccc
Q 013833 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 235 e~~~g~sL~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~---~~~~~vkl~Dfg~a~~~~ 310 (435)
||+ +++|.+++...+ .++..++..++.|++.||.|||++| ||||||||+|||+.. ...+.+||+|||+|+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999 789999998754 6999999999999999999999988 999999999999943 235789999999998775
Q ss_pred ccCccc---cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCC---CC
Q 013833 311 VQNSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGH---RP 381 (435)
Q Consensus 311 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~---~~ 381 (435)
...... ........||+.|||||++.+..++.++|||||||++|||++|..||.+.. .......+.... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 433221 112345679999999999999999999999999999999999999997543 222222222111 11
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHhhCCC----CCcccc
Q 013833 382 FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKETLPT----DHHWNI 432 (435)
Q Consensus 382 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~----~~~~~~ 432 (435)
......+|+++.+++..|+..+|++||+++.+.+.|+++.++... .-+|+.
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 111246899999999999999999999999999999988765433 246775
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=371.63 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=200.7
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC-----cE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 230 (435)
+|++++.||+|+||+||+|.++ |+.||||++.+.. .....+++.+|+.+|++++||||+++++++.... .+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 6999999999999999999985 8899999986433 3445578899999999999999999999986543 24
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
|++ +++.|++|.+++... .+++..++.++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEE--CCCCCEEEcccCceeecc
Confidence 555 556689999999754 6999999999999999999999988 9999999999999 888999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---------- 379 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------- 379 (435)
...... .......||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+..+.........
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443221 1234567999999999985 4567899999999999999999999998877654433221100
Q ss_pred ------------CCCC-------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 380 ------------RPFF-------RAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 380 ------------~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.+.. ....+++++++||.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 013578899999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=376.42 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=200.6
Q ss_pred CCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe------C
Q 013833 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------R 227 (435)
Q Consensus 156 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 227 (435)
+.+|+..++||+|+||+||+|+++ ++.||||++..... ...+|+++|++++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 347899999999999999999985 78899999865432 22469999999999999999998843 2
Q ss_pred CcEEEEEecCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCC-cEEEeec
Q 013833 228 KPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDF 303 (435)
Q Consensus 228 ~~~~lv~e~~~g~sL~~~l---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~-~vkl~Df 303 (435)
..+|+||||++++.+..+. .....+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++ .+||+||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl--~~~~~~~kl~DF 167 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCDF 167 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTTCCEEECCC
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEE--ecCCCceeEecc
Confidence 3478999999765433332 33557999999999999999999999988 9999999999999 6654 8999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---- 378 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---- 378 (435)
|++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|.+||...+..+....+.+.
T Consensus 168 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 168 GSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp TTCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhccCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9998765432 2344679999999998765 57899999999999999999999999988766554443210
Q ss_pred ---------------CCCC--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 379 ---------------HRPF--------FRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 379 ---------------~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
..+. .....+++++.+||.+||+.||++|||+.|+++| |+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 1123578999999999999999999999999976 55554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-48 Score=365.88 Aligned_cols=267 Identities=21% Similarity=0.295 Sum_probs=207.6
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCccee-eeeeEEeCCcEEEEE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-FLGAVTERKPLMLIT 234 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~ 234 (435)
+|++.+.||+|+||+||+|.+. ++.||||++...... +++..|+++++.++|++++. +..++.+++..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 6999999999999999999986 779999987654332 34678999999998776554 555667788899999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEec-CCCCcEEEeeccCccccccc
Q 013833 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 312 (435)
Q Consensus 235 e~~~g~sL~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~ 312 (435)
||+ +++|.+.+.. .+.+++.++..++.|++.||+|||++| ||||||||+|||+.. +.+..++|+|||+|+.+...
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 5677776654 557999999999999999999999988 999999999999832 34557999999999987654
Q ss_pred Cccc---cccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cC---CCCCC
Q 013833 313 NSHD---VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA---EG---HRPFF 383 (435)
Q Consensus 313 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~---~~~~~ 383 (435)
.... ........||+.|+|||++.+..++.++|||||||++|||++|..||...........+. .. .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 3221 112345679999999999999999999999999999999999999998765433221111 10 11111
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHHHHHHHh--hCCCC--Ccccc
Q 013833 384 RAKGFTPELRELTEKCWAADMNQRPSFLDILKRLEKIKE--TLPTD--HHWNI 432 (435)
Q Consensus 384 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~--~~~~~--~~~~~ 432 (435)
...++|+++.+||..||+.+|++||++.++.+.|+.+.. ....+ -+|+.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~ 292 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence 124689999999999999999999999999988887754 33333 35654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=360.50 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=208.8
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCCcEEEEEe
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 235 (435)
+|++++.||+|+||+||+|+++ ++.||||++...... .....++.+|+.+|+.++||||+++++++.+....++|++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 7999999999999999999985 678999998665433 3345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccccccCcc
Q 013833 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (435)
Q Consensus 236 ~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 315 (435)
++.+++|..++...+.+++.++..++.|++.||+|||++| ||||||||+|||+ +.++.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccc--ccCCceeeeecchhhcccCCCc-
Confidence 9999999999888888999999999999999999999988 9999999999999 8888999999999987654332
Q ss_pred ccccccCCCcCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCC-------------
Q 013833 316 DVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLA-NYEPYEAAKYVAEGHR------------- 380 (435)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~------------- 380 (435)
......+++.|+|||.+.... ++.++|||||||++|||++|..||. +.+..+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 223445788999999987655 6899999999999999999998864 4444444333321100
Q ss_pred --------------CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 --------------PFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 --------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.......+++++.+||.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001123568899999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=372.11 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=203.2
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEeCC------
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 228 (435)
.+|++++.||+|+||+||+|.++ |+.||||++..... .+...+.+.+|+.+|++++|||||++++++...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47999999999999999999986 88999999876543 3445678899999999999999999999997654
Q ss_pred cEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 229 ~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
.+|+||||+ +.+|..+++ ++.+++..++.++.||+.||.|||++| ||||||||+|||+ +.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhc--ccccccccccccceec
Confidence 479999999 668888775 457999999999999999999999988 9999999999999 8899999999999986
Q ss_pred ccccCccccccccCCCcCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Q 013833 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP------ 381 (435)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------ 381 (435)
.... .....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+......
T Consensus 171 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5432 345679999999999875 45789999999999999999999999988765544332211000
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH--HHHHH
Q 013833 382 -----------------------FFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR--LEKIK 421 (435)
Q Consensus 382 -----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 421 (435)
......+++++.+||.+||..||++|||+.|+++| |+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00113578999999999999999999999999987 55443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=373.47 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=206.9
Q ss_pred CCCCCceeecCCceeEEEEEE-----CCCcEEEEEccCCCC-CcHHHHHHHHHHHHHHHhCCC-CcceeeeeeEEeCCcE
Q 013833 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPL 230 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 230 (435)
+|++++.||+|+||+||+|.+ +|+.||||.+.+... .+....+.+.+|+.++++++| |||+++++++.+...+
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 699999999999999999986 267899998865321 111223567899999999977 8999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCccccc
Q 013833 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (435)
Q Consensus 231 ~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 310 (435)
+++|||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+++.+.
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEECC
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceee--cCCCCEEEeeccchhhhc
Confidence 999999999999999999889999999999999999999999988 9999999999999 888999999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcCCCCCCC
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEGHRPFFR 384 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~ 384 (435)
..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+....+ .......... . .
T Consensus 181 ~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-~-~ 255 (322)
T d1vzoa_ 181 ADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-P-Y 255 (322)
T ss_dssp GGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-C-C
T ss_pred ccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-C-C
Confidence 43321 23446789999999999754 46789999999999999999999997654332 2222323222 2 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCC-----CHHHHHHH
Q 013833 385 AKGFTPELRELTEKCWAADMNQRP-----SFLDILKR 416 (435)
Q Consensus 385 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 416 (435)
+..+++++++||.+||++||++|| |++|+++|
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 346899999999999999999999 58999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-47 Score=360.30 Aligned_cols=242 Identities=21% Similarity=0.377 Sum_probs=196.6
Q ss_pred CCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEe--CCcEE
Q 013833 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPLM 231 (435)
Q Consensus 157 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~ 231 (435)
.+|++++.||+|+||+||+|+++ ++.||||++.... .+++.+|+.+|++++ ||||+++++++.. ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36999999999999999999986 7889999985432 256789999999996 9999999999874 45689
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCC-CcEEEeeccCccccc
Q 013833 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK 310 (435)
Q Consensus 232 lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~ 310 (435)
+||||+.+++|..+. +.+++.++..++.||+.||.|||++| ||||||||+|||+ +.+ +.+||+|||+|+...
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi--~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCGGGCEECC
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEE--cCCCCeeeecccccceecc
Confidence 999999999998764 46999999999999999999999988 9999999999999 544 469999999998765
Q ss_pred ccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHc-----------
Q 013833 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAE----------- 377 (435)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~----------- 377 (435)
... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||..... ......+..
T Consensus 182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 182 PGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp TTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCC-----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 432 23456789999999998765 579999999999999999999999975542 211111100
Q ss_pred --CC----------------------CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 --GH----------------------RPFFRAKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 --~~----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. .+......+++++.+||.+||..||++|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0001113478999999999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=364.96 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred CcccCCCCCCCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe
Q 013833 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (435)
Q Consensus 149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 226 (435)
.|++. .+|++.+.||+|+||+||+|.++ |+.||||++.+.... ....+++.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~---~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 13 IWEVP---ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp EEEEE---TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cccCC---CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 46653 26999999999999999999985 789999998765433 3445778899999999999999999999853
Q ss_pred C-----CcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEe
Q 013833 227 R-----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (435)
Q Consensus 227 ~-----~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~ 301 (435)
. ...+++|+++.||+|.+++.. +.+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+|++
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi--~~~~~~kl~ 163 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKIL 163 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEEC
T ss_pred ccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccc--ccccccccc
Confidence 3 334556667779999999854 46999999999999999999999988 9999999999999 888999999
Q ss_pred eccCcccccccCccccccccCCCcCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 013833 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (435)
Q Consensus 302 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 380 (435)
|||++...... .....||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 164 dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 164 DFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236 (348)
T ss_dssp CC----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccchhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999765432 3456789999999987665 468899999999999999999999998876655444432211
Q ss_pred CC----------------------CC-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 381 PF----------------------FR-------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 381 ~~----------------------~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
.. .. ..++++++++||.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 00 13578999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=365.98 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=193.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcceeeeeeEEe------CCc
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP 229 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 229 (435)
+|++++.||+|+||+||+|.++ |+.||||++...... .....++.+|+.++++++||||+++++++.. ...
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6999999999999999999986 789999998765543 4455788999999999999999999999853 367
Q ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeeccCcccc
Q 013833 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (435)
Q Consensus 230 ~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 309 (435)
+|+||||+.+ ++.+.+ ...+++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.++++|||+++..
T Consensus 97 ~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~--~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC----
T ss_pred eEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccccc--ccccceeeechhhhhcc
Confidence 8999999966 455544 346899999999999999999999988 9999999999999 88889999999998866
Q ss_pred cccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------------
Q 013833 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE------------ 377 (435)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------ 377 (435)
.... ......+|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+.......+..
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 170 GTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 5432 23445789999999999999999999999999999999999999988776554433321
Q ss_pred ----------CCCCCCC------------------CCCCCHHHHHHHHHHhhhcccCCCCHHHHHHH
Q 013833 378 ----------GHRPFFR------------------AKGFTPELRELTEKCWAADMNQRPSFLDILKR 416 (435)
Q Consensus 378 ----------~~~~~~~------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 416 (435)
....... ....++++.+||.+||..||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100000 01135678999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-40 Score=319.11 Aligned_cols=246 Identities=19% Similarity=0.282 Sum_probs=183.2
Q ss_pred CCCCCceeecCCceeEEEEEEC--CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-----------CCcceeeeeeE
Q 013833 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGAV 224 (435)
Q Consensus 158 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~ 224 (435)
+|+++++||+|+||+||+|+++ |+.||||++.+. ....+.+.+|+.+++.++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5999999999999999999985 789999998643 233466788998888775 57899999887
Q ss_pred Ee--CCcEEEEEecCCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCcEEEecCCC---
Q 013833 225 TE--RKPLMLITEYLRGG-DLHKYLKE--KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA--- 295 (435)
Q Consensus 225 ~~--~~~~~lv~e~~~g~-sL~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~~~ivH~Dlkp~NIll~~~~~--- 295 (435)
.. ....+++|+++..+ +....... ...+++..+..++.||+.||.|||+ +| |+||||||+|||+..++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 54 34556666665443 33333332 4568999999999999999999997 77 999999999999943222
Q ss_pred -CcEEEeeccCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH----
Q 013833 296 -DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE---- 370 (435)
Q Consensus 296 -~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---- 370 (435)
..++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|+.||.......
T Consensus 168 ~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 14999999999755422 234679999999999999999999999999999999999999997543210
Q ss_pred --HHHHH-H-cCC---------------------CCC-----------------CCCCCCCHHHHHHHHHHhhhcccCCC
Q 013833 371 --AAKYV-A-EGH---------------------RPF-----------------FRAKGFTPELRELTEKCWAADMNQRP 408 (435)
Q Consensus 371 --~~~~~-~-~~~---------------------~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rp 408 (435)
..... . -+. ... ......++++.+||.+||..||++||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 00000 0 000 000 00012356799999999999999999
Q ss_pred CHHHHHHH
Q 013833 409 SFLDILKR 416 (435)
Q Consensus 409 s~~~ll~~ 416 (435)
|++|+|+|
T Consensus 321 ta~e~L~H 328 (362)
T d1q8ya_ 321 DAGGLVNH 328 (362)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhcC
Confidence 99999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-25 Score=195.47 Aligned_cols=169 Identities=18% Similarity=0.204 Sum_probs=119.1
Q ss_pred CCCceeecCCceeEEEEEEC-CCcEEEEEccCCCCC---------------cHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 013833 160 SSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD---------------DRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (435)
Q Consensus 160 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 223 (435)
.+++.||+|+||+||+|.+. |+.||||+++..... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999874 889999986532111 01112345578999999999999988765
Q ss_pred EEeCCcEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCcEEEecCCCCcEEEeec
Q 013833 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (435)
Q Consensus 224 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~ivH~Dlkp~NIll~~~~~~~vkl~Df 303 (435)
. ..+++|||+++..+.+ ++...+..++.|++.+|.|||++| |+||||||+|||+ +. +.++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv--~~-~~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--SE-EGIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--ET-TEEEECCC
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheee--eC-CCEEEEEC
Confidence 3 2379999998865432 555667789999999999999988 9999999999999 43 35999999
Q ss_pred cCcccccccCccccccccCCCcCccccCccccCCCCCCCcchHHHHHH
Q 013833 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAM 351 (435)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 351 (435)
|+|.....+....... ..... -.+ +..+.|+.++|+||+.-
T Consensus 147 G~a~~~~~~~~~~~l~-----rd~~~-~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 147 PQSVEVGEEGWREILE-----RDVRN-IIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp TTCEETTSTTHHHHHH-----HHHHH-HHH-HHHHHHCCCCCHHHHHH
T ss_pred CCcccCCCCCcHHHHH-----HHHHH-HHH-HHcCCCCCcccHHHHHH
Confidence 9997654332111000 00000 001 12367888999999754
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.84 E-value=1.4e-21 Score=155.34 Aligned_cols=103 Identities=23% Similarity=0.233 Sum_probs=93.2
Q ss_pred cchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCc
Q 013833 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKK 113 (435)
Q Consensus 34 ~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 113 (435)
.||+++ |++.+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 3 ~tpL~~--A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~ 80 (118)
T d1myoa_ 3 DKEFMW--ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGH 80 (118)
T ss_dssp HHHHHH--HHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTC
T ss_pred ChHHHH--HHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCc
Confidence 356654 666667778888889999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 114 FNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 114 ~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
.+++++|+++|++++..+....+|.
T Consensus 81 ~~~v~~Ll~~Gad~~~~d~~G~t~l 105 (118)
T d1myoa_ 81 VSCVKLLLSKGADKTVKGPDGLTAL 105 (118)
T ss_dssp CHHHHHHHTTCCCSSSSSSSTCCCC
T ss_pred hhhhhhhhcccccceeeCCCCCCHH
Confidence 9999999999999998887766554
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2e-20 Score=151.28 Aligned_cols=95 Identities=21% Similarity=0.253 Sum_probs=85.0
Q ss_pred hhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhH
Q 013833 37 LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116 (435)
Q Consensus 37 l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~ 116 (435)
+++.||..| ..+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.++
T Consensus 4 lL~~A~~~G-~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 4 LLLDSSLEG-EFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHHHHHHT-CHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHHHHHcC-CHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 344455555 4567778889999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCC
Q 013833 117 MELLNAHGGLSYGQNG 132 (435)
Q Consensus 117 ~~~L~~~g~~~~~~n~ 132 (435)
+++|+++|++++..+.
T Consensus 83 v~~Ll~~ga~v~~~~~ 98 (130)
T d1ycsb1 83 CKFLVESGAAVFAMTY 98 (130)
T ss_dssp HHHHHHTTCCTTCCCS
T ss_pred HHHHHHcCCCcccccC
Confidence 9999999999876543
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.80 E-value=3.6e-20 Score=153.93 Aligned_cols=96 Identities=20% Similarity=0.175 Sum_probs=87.0
Q ss_pred hhcccchhhhhhhh--cCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhH
Q 013833 30 ARVSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107 (435)
Q Consensus 30 ~~~~~~~l~~~~a~--~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 107 (435)
+..|.||||+ |+. ..+..+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|+|++.+|..|+||||+
T Consensus 42 ~~~g~t~Lh~-A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 120 (154)
T d1dcqa1 42 HEPDETALHL-AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 120 (154)
T ss_dssp SSTTCBHHHH-HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCchHHH-HHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHH
Confidence 5568899865 333 2357789999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcCchhHHHHHHhcCCC
Q 013833 108 AEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 108 A~~~~~~~~~~~L~~~g~~ 126 (435)
|+..|+.+++++|++.++.
T Consensus 121 A~~~~~~~i~~~L~~~~~~ 139 (154)
T d1dcqa1 121 AKRLKHEHCEELLTQALSG 139 (154)
T ss_dssp HHHTTCHHHHHHHHHHHTT
T ss_pred HHHcCCHHHHHHHHHhCCC
Confidence 9999999999999998864
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.2e-19 Score=145.50 Aligned_cols=101 Identities=21% Similarity=0.280 Sum_probs=90.0
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCC-CHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~-tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
.+.|++++.++..|.|+++. |.. ++.+++++|+++|+++|.+|..|. ||||+||..|+.+++++|+++|+++|.+|
T Consensus 23 l~~gad~n~~~~~g~t~l~~--a~~-g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d 99 (125)
T d1bi7b_ 23 LEAGANPNAPNSYGRRPIQV--MMM-GSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRD 99 (125)
T ss_dssp HTTTCCTTCCCSSSCCTTTS--SCT-TCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCC
T ss_pred HHcCCccccccccccccccc--ccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45678899999999998853 555 567888999999999999998766 69999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhc
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAH 123 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ 123 (435)
..|+||||+|+..|+.+++++|+..
T Consensus 100 ~~G~T~l~~A~~~g~~~~v~~Llsa 124 (125)
T d1bi7b_ 100 AWGRLPVDLAEELGHRDVARYLRAA 124 (125)
T ss_dssp TTCCCHHHHHHHHTCHHHHHHHSSC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhc
Confidence 9999999999999999999999753
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.4e-19 Score=144.77 Aligned_cols=104 Identities=24% Similarity=0.139 Sum_probs=92.3
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
....|+++|.+|+.|.||+++ |+..+..+++++|++.|+++|.+|.+|+||||+||.+|+.+++++|+++||+++..+
T Consensus 20 Ll~~g~d~n~~d~~g~t~Lh~--A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~ 97 (130)
T d1ycsb1 20 IIYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMT 97 (130)
T ss_dssp HTSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCcccccccccccccc--ccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCccccc
Confidence 356788999999999999976 777778889999999999999999999999999999999999999999999999877
Q ss_pred c-CCCchhhHh--hhcCchhHHHHHHhcC
Q 013833 99 R-WKNTPLADA--EGAKKFNMMELLNAHG 124 (435)
Q Consensus 99 ~-~g~t~l~~A--~~~~~~~~~~~L~~~g 124 (435)
. .|+||+++| ...|+.+++++|+..+
T Consensus 98 ~~~~~~~~~~~~a~~~g~~eiv~~L~~~~ 126 (130)
T d1ycsb1 98 YSDMQTAADKCEEMEEGYTQCSQFLYGVQ 126 (130)
T ss_dssp SSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence 4 588887665 5678999999998654
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.74 E-value=1.2e-19 Score=143.96 Aligned_cols=89 Identities=20% Similarity=0.217 Sum_probs=81.4
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
++.|++++.++..|.||+++ |+..+..+++++|++.|+++|.+|..|+||||+|+.+|+.+++++|+++|||+|.+|.
T Consensus 22 l~~g~d~n~~~~~g~t~lh~--A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~ 99 (118)
T d1myoa_ 22 VAKGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGP 99 (118)
T ss_dssp HTTTCCCCCCSSSSCCTTHH--HHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSS
T ss_pred HHhhhccccccccccccccc--cccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCC
Confidence 45678899999999999976 6666677888999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHhhh
Q 013833 100 WKNTPLADAEG 110 (435)
Q Consensus 100 ~g~t~l~~A~~ 110 (435)
+|+||||+|..
T Consensus 100 ~G~t~l~~a~~ 110 (118)
T d1myoa_ 100 DGLTALEATDN 110 (118)
T ss_dssp STCCCCCTCSS
T ss_pred CCCCHHHHHhH
Confidence 99999999954
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.73 E-value=4.7e-18 Score=153.30 Aligned_cols=106 Identities=25% Similarity=0.209 Sum_probs=96.2
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccC-CCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~-d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~ 97 (435)
....+.+++.++..|.||++. |+..+..+++++|++.+++++.. +..|.||||+||..|+.+++++|+++|||+|.+
T Consensus 144 ~~~~~~~in~~d~~g~TpLh~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~ 221 (255)
T d1oy3d_ 144 DEDWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR 221 (255)
T ss_dssp CCCGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hhhcCcccccccccCcccccc--cccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCC
Confidence 455677888899999999865 66677788899999999988764 578999999999999999999999999999999
Q ss_pred ccCCCchhhHhhhcCchhHHHHHHhcCCC
Q 013833 98 DRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
|..|.||||+|+..++.+++++|+++||+
T Consensus 222 d~~g~t~L~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 222 MYGGRTPLGSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp CTTSCCHHHHHHTSSCHHHHHHHHHTTCC
T ss_pred CCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 99999999999999999999999999995
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=3.3e-18 Score=151.47 Aligned_cols=114 Identities=25% Similarity=0.269 Sum_probs=103.6
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+++++.+|..|.||+++ |+..+..+++++|++.|+++|.+|..|.||||+|+..++.+++++|++.|+++|.+|.+|
T Consensus 92 ~~~d~~~~d~~g~tpL~~--A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g 169 (223)
T d1uoha_ 92 KGAQVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEG 169 (223)
T ss_dssp TTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTC
T ss_pred cCceeEeeCCCCCchhhH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCC
Confidence 456778889999999976 666667789999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
+||||+|+..|+.+++++|+++|++++..|....+|
T Consensus 170 ~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 170 NTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 999999999999999999999999998877665544
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.1e-17 Score=153.21 Aligned_cols=110 Identities=23% Similarity=0.243 Sum_probs=98.8
Q ss_pred chhhhhhhhhcccchhhh--hhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCccccc
Q 013833 22 SADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~--~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~~~ 98 (435)
.|++++..+..+.++... +++..++...+++.|++.|+++|.+|..|.||||+||..|+.+++++||+ .|+++|.+|
T Consensus 171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d 250 (285)
T d1wdya_ 171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250 (285)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence 356777778778776653 45677888899999999999999999999999999999999999999998 599999999
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n 131 (435)
.+|.||||+|+..|+.+++++|+++||+++..+
T Consensus 251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d 283 (285)
T d1wdya_ 251 SDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence 999999999999999999999999999998665
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.8e-18 Score=137.41 Aligned_cols=99 Identities=21% Similarity=0.158 Sum_probs=84.9
Q ss_pred chhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCC-chhhHhhhcCc
Q 013833 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN-TPLADAEGAKK 113 (435)
Q Consensus 35 ~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~ 113 (435)
++| ++||. .++.+++++|+++|+++|.+|..|.||||+| ..|+.+++++|+++|+++|.++..|. ||||+|+..|+
T Consensus 5 ~~L-~~Aa~-~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a-~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 5 DWL-ATAAA-RGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp THH-HHHHH-HTCHHHHHHHHTTTCCTTCCCSSSCCTTTSS-CTTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred hHH-HHHHH-CCCHHHHHHHHHcCCcccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 444 34444 4557788888899999999999999999977 47999999999999999999999876 69999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCCCCC
Q 013833 114 FNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 114 ~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
.+++++|+++|++++..+....+
T Consensus 82 ~~~v~~Ll~~ga~~~~~d~~G~T 104 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRDAWGRL 104 (125)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCCC
T ss_pred ccccccccccccccccccCCCCC
Confidence 99999999999998877765543
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=1.2e-17 Score=145.74 Aligned_cols=97 Identities=20% Similarity=0.241 Sum_probs=87.5
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+++++.++..|.|+++. ++..+...+++.|+..+.++|..|..|.||||+||..|+.+++++||++|||+|.+|..|
T Consensus 112 ~~~~~~~~~~~~~t~l~~--~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g 189 (209)
T d1ot8a_ 112 ADADINAADNSGKTALHW--AAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMD 189 (209)
T ss_dssp TTCCTTCBCTTSCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred hcccccccCCCCCCcchh--hcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCC
Confidence 445667788889998765 556667778888889999999999999999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHH
Q 013833 102 NTPLADAEGAKKFNMMELL 120 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L 120 (435)
+||||+|+.+|+.++|++|
T Consensus 190 ~Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 190 RLPRDVASERLHHDIVRLL 208 (209)
T ss_dssp CCHHHHHHHTTCHHHHHHH
T ss_pred CCHHHHHHHcCCHHHHhhc
Confidence 9999999999999999987
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=4.5e-17 Score=135.57 Aligned_cols=112 Identities=21% Similarity=0.261 Sum_probs=89.4
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+.+++.+|..|.||++. |+.++. ++++.|++.++++|..+..|.+||+.|+..++.+++++++++|+++|.+|..|
T Consensus 25 ~~~~~n~~d~~g~t~L~~--A~~~~~-~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~ 101 (156)
T d1bd8a_ 25 ELVHPDALNRFGKTALQV--MMFGST-AIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTG 101 (156)
T ss_dssp TCCCTTCCCTTSCCHHHH--SCTTCH-HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred CCCCCCccCCCCCccccc--cccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCCC
Confidence 456778888888888754 566665 45566668888888888888899999999999999999999888888888889
Q ss_pred CchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
+||||+|+..|+.+++++|+ .|++++..+....+|
T Consensus 102 ~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~Tp 136 (156)
T d1bd8a_ 102 ALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTP 136 (156)
T ss_dssp CCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCH
T ss_pred Ceeecccccccccccccccc-ccccccccCCCCCCH
Confidence 99999998888888888777 577777666655443
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4.4e-17 Score=144.08 Aligned_cols=99 Identities=19% Similarity=0.232 Sum_probs=90.4
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccC
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (435)
+.|++++.++.++.|+++. |+..+...+.++|.+.|.++|.+|..|+||||+||..|+.+++++||++|||++.+|.+
T Consensus 124 ~~g~d~~~~~~~~~t~L~~--a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~ 201 (223)
T d1uoha_ 124 EGGANPDAKDHYEATAMHR--AAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKE 201 (223)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTT
T ss_pred HCCCCCCCcCCCCCccchh--hhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCC
Confidence 3577888889999999865 66677778899999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHhhhcCchhHHHHHHh
Q 013833 101 KNTPLADAEGAKKFNMMELLNA 122 (435)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~ 122 (435)
|+||||+|. .|+.+++++|++
T Consensus 202 g~tpl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 202 EKTPLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp SCCHHHHCC-TTHHHHHHHHHC
T ss_pred CCCHHHHHH-CCCHHHHhcccC
Confidence 999999985 699999999985
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=2.1e-16 Score=130.90 Aligned_cols=98 Identities=15% Similarity=0.086 Sum_probs=82.5
Q ss_pred hhhhhcCCHHHHHHHHHhCCCCCccC------CCCCCCHHHHHHHc---CcHHHHHHHHHcCCCccccccCCCchhhHhh
Q 013833 39 LWHAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109 (435)
Q Consensus 39 ~~~a~~~~~~~~~~lL~~~g~~~n~~------d~~g~tpLh~Aa~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~ 109 (435)
+.|+..++...+.+++ ..|+|++.. +..|+||||+|+.. |+.+++++|+++|+|+|.+|..|+||||+|+
T Consensus 11 ~~Av~~~dl~~l~~~~-~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~ 89 (154)
T d1dcqa1 11 CEAVKTRDIFGLLQAY-ADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC 89 (154)
T ss_dssp HHHHHTTCHHHHHHHH-HTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred HHHHHhCCHHHHHHHH-HcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccc
Confidence 3445666666666555 678877654 67899999999974 6799999999999999999999999999999
Q ss_pred hcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 110 GAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 110 ~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
..|+.+++++|+++|++++..+....+|
T Consensus 90 ~~~~~~~v~~Ll~~gad~~~~d~~g~tp 117 (154)
T d1dcqa1 90 LTDNAECLKLLLRGKASIEIANESGETP 117 (154)
T ss_dssp HTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccccccccccCccccccCCCCCCH
Confidence 9999999999999999998877665544
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=9.9e-17 Score=154.40 Aligned_cols=108 Identities=23% Similarity=0.261 Sum_probs=89.2
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.|++++..+..+.|+++. ++..+...+++++++.|+++|.+|.+|.||||+|+.+|+.++|++|+++|||+|.+|++|
T Consensus 286 ~g~~~~~~~~~~~t~L~~--~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G 363 (408)
T d1n11a_ 286 HGVMVDATTRMGYTPLHV--ASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDG 363 (408)
T ss_dssp HTCCTTCCCSSCCCHHHH--HHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSS
T ss_pred CCCccccccccccccchh--hcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 355666777778888865 555666778888889999999999999999999999999999999999999999999999
Q ss_pred CchhhHhhhcCchhHHHHHH---hcCCCCCCCC
Q 013833 102 NTPLADAEGAKKFNMMELLN---AHGGLSYGQN 131 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~---~~g~~~~~~n 131 (435)
+||||+|+..|+.++|++|. +.+++....+
T Consensus 364 ~t~L~~A~~~~~~~iv~~L~~~~~~~~~~~~~~ 396 (408)
T d1n11a_ 364 TTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396 (408)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHHCCCCSSCC---
T ss_pred CCHHHHHHHcCCHHHHHHHHHHHhccccccccc
Confidence 99999999999999998665 3444444333
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=8.1e-17 Score=145.01 Aligned_cols=96 Identities=20% Similarity=0.099 Sum_probs=87.7
Q ss_pred hhhcccchhhhhhhhcCCHHHHHHHHHhCCCC---CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchh
Q 013833 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (435)
Q Consensus 29 ~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~---~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (435)
.+++|.||||+ |+..+..+++++|++.|++ +|.+|..|.||||+||..|+.+++++|+++||+++.+|.+|+|||
T Consensus 5 i~~~G~t~Lh~--A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL 82 (255)
T d1oy3d_ 5 VTEDGDTALHL--AVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTAL 82 (255)
T ss_dssp CCTTCCCHHHH--HHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHH
T ss_pred CCcCCCCHHHH--HHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhh
Confidence 46789999976 7777788899999999987 678889999999999999999999999999999999999999999
Q ss_pred hHhhhcCchhHHHHHHhcCCC
Q 013833 106 ADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~g~~ 126 (435)
|+|+..++.+++++|++.+..
T Consensus 83 ~~A~~~~~~~~~~~Ll~~~~~ 103 (255)
T d1oy3d_ 83 HLACRVRAHTCACVLLQPRPS 103 (255)
T ss_dssp HHHTTTTCHHHHHHHSSSCCS
T ss_pred hhhhccCchHHHHHHHhhccc
Confidence 999999999999999877653
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.64 E-value=1.5e-16 Score=147.40 Aligned_cols=113 Identities=19% Similarity=0.046 Sum_probs=90.1
Q ss_pred hhhhhhh-hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcH-------HHHHHH-------
Q 013833 23 ADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI-------DVAKCL------- 87 (435)
Q Consensus 23 ~~~~~~~-~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~-------~~~~~L------- 87 (435)
+.++|.. |+.|+||||+ |+..++.+++++|++.|++++.+|..|+||||.||..++. +++++|
T Consensus 96 ~~dvn~~~D~~G~T~LH~--Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~ 173 (301)
T d1sw6a_ 96 QLNLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILE 173 (301)
T ss_dssp CCCSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEE
T ss_pred CCCcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhc
Confidence 3355544 7889999965 6666667889999999999999999999999999986642 333332
Q ss_pred -----------------------------------HHcCCC-------------------------------------cc
Q 013833 88 -----------------------------------IEYGAD-------------------------------------VN 95 (435)
Q Consensus 88 -----------------------------------l~~ga~-------------------------------------~~ 95 (435)
+..+.. +|
T Consensus 174 d~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in 253 (301)
T d1sw6a_ 174 DSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLN 253 (301)
T ss_dssp CTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTT
T ss_pred ccccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCcc
Confidence 222211 68
Q ss_pred ccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCC
Q 013833 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (435)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~ 137 (435)
.+|..|+||||+|+..|+.+++++|+++|++++..|....+|
T Consensus 254 ~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tp 295 (301)
T d1sw6a_ 254 AQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 295 (301)
T ss_dssp CCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 899999999999999999999999999999999888776655
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.64 E-value=1.3e-17 Score=157.58 Aligned_cols=107 Identities=13% Similarity=0.062 Sum_probs=87.3
Q ss_pred CCchhhhhhhhhcccchhhhhhhhcCCHH--HHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccc
Q 013833 20 TSSADKQKEKARVSRTSLILWHAHQNDAA--AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (435)
Q Consensus 20 ~~~~~~~~~~~~~~~~~l~~~~a~~~~~~--~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~ 97 (435)
.....+.+.++..|.|++++ ||..|+.+ +++++|++.|+++|.+|..|+||||+||.+||.++|++|+++|++++..
T Consensus 77 ~~~~~~~~~~~~~~~t~L~~-Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~ 155 (346)
T d2ajaa1 77 KQLWSDAHKKGIKSEVICFV-AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMA 155 (346)
T ss_dssp TTHHHHHHHHTCCHHHHHHH-HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHH
T ss_pred hhhhhHHHhccCCCCcHHHH-HHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCcccc
Confidence 45567788888899999865 44444433 3345588999999999999999999999999999999999999999987
Q ss_pred c--cCCCchhhHhhhcCchhHHHHHHhcCCCC
Q 013833 98 D--RWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (435)
Q Consensus 98 ~--~~g~t~l~~A~~~~~~~~~~~L~~~g~~~ 127 (435)
+ .+|+||||+|+..|+.+++++|++.|++.
T Consensus 156 ~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 156 MIQAENYHAFRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred ccccCCCChhHHHHHHhhHHHHHHHHHcCCcc
Confidence 6 46999999999999999999999988643
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=5.2e-16 Score=129.03 Aligned_cols=99 Identities=20% Similarity=0.226 Sum_probs=86.6
Q ss_pred chhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCC
Q 013833 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (435)
Q Consensus 22 ~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (435)
.+.+++..+..+.++++. ++..+..++.+++++.|+++|.+|..|+||||+||..|+.+++++|+ .|++++.+|.+|
T Consensus 57 ~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G 133 (156)
T d1bd8a_ 57 QGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARG 133 (156)
T ss_dssp TTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTS
T ss_pred cccccccccccccccccc--ccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCC
Confidence 455677777778888765 66677778888888999999999999999999999999999999887 689999999999
Q ss_pred CchhhHhhhcCchhHHHHHHhc
Q 013833 102 NTPLADAEGAKKFNMMELLNAH 123 (435)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ 123 (435)
+||||+|+..|+.+++++|+++
T Consensus 134 ~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 134 LTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp CCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCHHHHHHHcCCHHHHHHHHhh
Confidence 9999999999999999999875
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.2e-16 Score=150.76 Aligned_cols=94 Identities=29% Similarity=0.277 Sum_probs=85.8
Q ss_pred chhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCch
Q 013833 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114 (435)
Q Consensus 35 ~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 114 (435)
||||+ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++||++||++|.+|.+|+||||+|+..|+.
T Consensus 2 TpL~~--Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~ 79 (408)
T d1n11a_ 2 TPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHT 79 (408)
T ss_dssp CHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCH
T ss_pred ChHHH--HHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCH
Confidence 78866 6666678888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCC
Q 013833 115 NMMELLNAHGGLSYGQ 130 (435)
Q Consensus 115 ~~~~~L~~~g~~~~~~ 130 (435)
+++++|+..+.+....
T Consensus 80 ~~~~~Ll~~~~~~~~~ 95 (408)
T d1n11a_ 80 NMVKLLLENNANPNLA 95 (408)
T ss_dssp HHHHHHHHHTCCTTCC
T ss_pred HHHHHHHHhhhccccc
Confidence 9999999988765443
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.61 E-value=4.2e-16 Score=128.91 Aligned_cols=54 Identities=31% Similarity=0.295 Sum_probs=33.5
Q ss_pred HHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCC
Q 013833 81 IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (435)
Q Consensus 81 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~ 134 (435)
.+++++|+.+|++++.+|.+|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g 133 (153)
T d1awcb_ 80 ANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFC 133 (153)
T ss_dssp HHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred ceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCC
Confidence 345556666666666666666666666666666666666666666665554443
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=1.3e-15 Score=132.68 Aligned_cols=115 Identities=20% Similarity=0.120 Sum_probs=101.4
Q ss_pred CCchhhhhh-hhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccC----------------------------------
Q 013833 20 TSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR---------------------------------- 64 (435)
Q Consensus 20 ~~~~~~~~~-~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~---------------------------------- 64 (435)
++.|++++. .|++|.|||++ |+..++.+++++|++.|+++|.+
T Consensus 9 l~~g~din~~~d~~G~t~L~~--A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (209)
T d1ot8a_ 9 LAQGAELNATMDKTGETSLHL--AARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNAR 86 (209)
T ss_dssp HHHHHHHHHHHHHHCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCC
T ss_pred HHCCCCcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 457899987 58999999976 77778888888989988877643
Q ss_pred ---------------------------------CCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhc
Q 013833 65 ---------------------------------DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (435)
Q Consensus 65 ---------------------------------d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (435)
+..|+||||+|+..+..++++.|++.++++|.+|..|.||||+|+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~ 166 (209)
T d1ot8a_ 87 MHDGTTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166 (209)
T ss_dssp CTTCCCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHT
T ss_pred cccccccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccc
Confidence 67789999999999999999999999999999999999999999999
Q ss_pred CchhHHHHHHhcCCCCCCCCCCCCC
Q 013833 112 KKFNMMELLNAHGGLSYGQNGSHFE 136 (435)
Q Consensus 112 ~~~~~~~~L~~~g~~~~~~n~~~~~ 136 (435)
|+.+++++|+++|++++..+....+
T Consensus 167 g~~~~v~~Ll~~gad~n~~d~~g~T 191 (209)
T d1ot8a_ 167 GSYEASKALLDNFANREITDHMDRL 191 (209)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cHHHHHHHHHHCCCCCCCcCCCCCC
Confidence 9999999999999998877665543
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.60 E-value=6.1e-16 Score=127.88 Aligned_cols=79 Identities=29% Similarity=0.381 Sum_probs=72.2
Q ss_pred hhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHH
Q 013833 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120 (435)
Q Consensus 42 a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L 120 (435)
++.....++++++...|++++.+|..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+.+|+.+++++|
T Consensus 74 ~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 74 AASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp HHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred ccccccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence 3344455567888899999999999999999999999999999999999999999999999999999999999999987
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.60 E-value=3.3e-16 Score=138.55 Aligned_cols=75 Identities=25% Similarity=0.156 Sum_probs=37.4
Q ss_pred HHHHHHHhCC-CCCccCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCC
Q 013833 49 AVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 49 ~~~~lL~~~g-~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~ 126 (435)
+++++|++.| .++|.+|..|+||||+|+..|+.+++++||+ +|||++.+|..|+||||+|+. .+++++|++.|+|
T Consensus 152 ~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~~A~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 152 KLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALN---EQVKKFFLNNVVD 228 (229)
T ss_dssp HHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGGGCSC---HHHHHHHHHHCCC
T ss_pred cccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHHHHhh---HHHHHHHHHcCCC
Confidence 3334444433 3445555555555555555555555555553 355555555555555555542 2455555555543
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.60 E-value=1.3e-15 Score=139.85 Aligned_cols=74 Identities=28% Similarity=0.166 Sum_probs=65.4
Q ss_pred CCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 65 d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
+..|.||||+|+..|+.+++++|+++|+++|.++..|+||||+|+..|+.+++++|+++|++++.++....+|.
T Consensus 196 ~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL 269 (291)
T d1s70b_ 196 AKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAF 269 (291)
T ss_dssp TTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred cCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 34567888888888999999999999999999999999999999999999999999999999988776555544
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.60 E-value=2.9e-16 Score=142.84 Aligned_cols=106 Identities=24% Similarity=0.222 Sum_probs=86.5
Q ss_pred CCCCCCCchhhhhhhh-hcccchhhhhhhhcCCHHHHHHH--------HHhCCCCCccCCCCCCCHHHHHHHcCcHHHHH
Q 013833 15 CKGGATSSADKQKEKA-RVSRTSLILWHAHQNDAAAVRKL--------LEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85 (435)
Q Consensus 15 ~~~~~~~~~~~~~~~~-~~~~~~l~~~~a~~~~~~~~~~l--------L~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~ 85 (435)
+.....+.+.+. .+ +.|+||||+ |+.++..+++++ +++.|+|||.+|.+|+||||+|+..|+.++++
T Consensus 16 ~~~~l~~~~~n~--~~~~~g~T~Lh~--A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~ 91 (277)
T d2fo1e1 16 ITEPITRESVNI--IDPRHNRTVLHW--IASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVA 91 (277)
T ss_dssp CCSCCSTTTTTT--CCCSSCCCHHHH--HHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHH
T ss_pred HHHHHHhcCCCc--CCCCCCccHHHH--HHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccc
Confidence 445555555443 44 458899865 555555554443 36789999999999999999999999999999
Q ss_pred HHHHcCCCccccccCCCchhhHhhhcCchhHHHHHHhcC
Q 013833 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124 (435)
Q Consensus 86 ~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g 124 (435)
+|+++|||+|.+|.+|.|||++|...++.++++++...+
T Consensus 92 ~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~ 130 (277)
T d2fo1e1 92 YLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNST 130 (277)
T ss_dssp HHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSH
T ss_pred cccccccccccccccccccccchhhhcchhhhhhhhhcc
Confidence 999999999999999999999999999999999887554
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.59 E-value=1.8e-15 Score=137.45 Aligned_cols=98 Identities=27% Similarity=0.388 Sum_probs=87.0
Q ss_pred hhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCc
Q 013833 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (435)
Q Consensus 24 ~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (435)
...+..+..|.|+++ +++..++...+..++...+.+++.+|..|+||||+||..|+.+++++|+++|||+|.+|.+|+|
T Consensus 178 ~~~~~~~~~g~t~L~-~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T 256 (277)
T d2fo1e1 178 ARKDSEKYKGRTALH-YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHT 256 (277)
T ss_dssp GGTSSSSCCCCCTHH-HHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCC
T ss_pred ccccccccCCCCccc-cccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCC
Confidence 344555677888885 4566677777777788999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCchhHHHHHHh
Q 013833 104 PLADAEGAKKFNMMELLNA 122 (435)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~ 122 (435)
|||+|+..|+.+++++|++
T Consensus 257 ~L~~A~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 257 ARQLAQANNHHNIVDIFDR 275 (277)
T ss_dssp HHHHHHHTTCHHHHHHHHT
T ss_pred HHHHHHHcCCHHHHHHHHH
Confidence 9999999999999999985
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.5e-15 Score=133.76 Aligned_cols=119 Identities=24% Similarity=0.253 Sum_probs=92.9
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHH--------------
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA-------------- 84 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~-------------- 84 (435)
....++++|.+|..|+|||++ |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++
T Consensus 25 ~~~~~~~in~~d~~g~TpLh~--A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 102 (221)
T d1iknd_ 25 VKGDLAFLNFQNNLQQTPLHL--AVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHS 102 (221)
T ss_dssp ----CCCCCCCCTTCCCHHHH--HHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSC
T ss_pred HHhCCCCcccCCCCCCccccc--cccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccc
Confidence 345677889999999999975 6666677888999999999998888888888888766655555
Q ss_pred -------------------------HHHHHcCCCccccc-cCCCchhhHhhhcCchhHHHHHHhcCCCCCCCCCCCCCCC
Q 013833 85 -------------------------KCLIEYGADVNAQD-RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (435)
Q Consensus 85 -------------------------~~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~~~n~~~~~~~ 138 (435)
++|+..|++++.++ ..|.||||+|+..|+.+++++|+++|+|++..+....+|.
T Consensus 103 ~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl 182 (221)
T d1iknd_ 103 ILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPY 182 (221)
T ss_dssp GGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGG
T ss_pred cccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHH
Confidence 44556666666654 5799999999999999999999999999998887766654
Q ss_pred C
Q 013833 139 P 139 (435)
Q Consensus 139 ~ 139 (435)
.
T Consensus 183 ~ 183 (221)
T d1iknd_ 183 Q 183 (221)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.55 E-value=6.9e-17 Score=152.59 Aligned_cols=108 Identities=18% Similarity=0.042 Sum_probs=92.4
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC--CCCCCHHHHHHHcCcHHHHHHHHHcCCCc--
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD--YDNRTPLHVASLHGWIDVAKCLIEYGADV-- 94 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d--~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~-- 94 (435)
....|+++|.+|..|.||+++ |+.+++.+++++|++.|+++|..+ .+|+||||+||.+||.++|++|++.|++.
T Consensus 112 L~~~~~~in~~~~~g~taL~~--Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~ 189 (346)
T d2ajaa1 112 LLTSDEIVKVIQAENYQAFRL--AAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEAT 189 (346)
T ss_dssp C--CCSSCC--CHHHHHHHHH--HHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHH
T ss_pred HHhCCCcccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCcccc
Confidence 567889999999999999977 888888999999999999999876 46999999999999999999999999875
Q ss_pred -cccccCCCchhhHhhhcCchhHHHHHHhcCCCCC
Q 013833 95 -NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (435)
Q Consensus 95 -~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~~~ 128 (435)
+..+.+|.||++.|+.+|+.+++++|++.|++++
T Consensus 190 ~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~ 224 (346)
T d2ajaa1 190 AMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224 (346)
T ss_dssp HHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHHH
T ss_pred cccccCCCcchhhHHhhcCHHHHHHHHHhCCCCcc
Confidence 4455678889999999999999999999987653
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=5.9e-15 Score=122.21 Aligned_cols=115 Identities=21% Similarity=0.224 Sum_probs=95.7
Q ss_pred CCCchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccc
Q 013833 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (435)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~ 98 (435)
.++.|++++.+|..|.||++. |+.++ .+++++|++.|++++.++..|.|+|+.++..++.++++.|++.+.+++..|
T Consensus 20 Ll~~g~d~n~~d~~g~TpL~~--A~~~~-~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 96 (156)
T d1ihba_ 20 LLQNNVNVNAQNGFGRTALQV--MKLGN-PEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIED 96 (156)
T ss_dssp HTTSCCCTTCCCTTSCCHHHH--CCSSC-HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHCCCCcCccCCcccccccc--ccccc-ccccccccccccccccccccCcccccccccccccccccccccccccccccc
Confidence 356788999999999999853 66654 668888999999999999999999999999999999999999998898888
Q ss_pred cCCCchhhHhhhcCchhHHHHHHhcCC-CCCCCCCCCCC
Q 013833 99 RWKNTPLADAEGAKKFNMMELLNAHGG-LSYGQNGSHFE 136 (435)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g~-~~~~~n~~~~~ 136 (435)
..|.+|+|+|+..++.+++++|+++++ +.+..+....+
T Consensus 97 ~~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~T 135 (156)
T d1ihba_ 97 NEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDT 135 (156)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCC
T ss_pred cccccccccccccccccccccccccccccccccCCCCCC
Confidence 999999999999899999998888876 55555554443
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1.4e-14 Score=127.34 Aligned_cols=95 Identities=24% Similarity=0.178 Sum_probs=82.5
Q ss_pred hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHh
Q 013833 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (435)
Q Consensus 30 ~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d-~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (435)
...+.|+++. |+..+..+++++|...|+++|..+ .+|.||||+|+..|+.+++++|+++|||+|.+|..|+||||+|
T Consensus 108 ~~~~~t~l~~--a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A 185 (221)
T d1iknd_ 108 NYNGHTCLHL--ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLT 185 (221)
T ss_dssp CTTCCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGC
T ss_pred ccccchhhhH--HhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHH
Confidence 3446677754 555666777788888899988866 5799999999999999999999999999999999999999999
Q ss_pred hhcCchhHHHHHHhcCCC
Q 013833 109 EGAKKFNMMELLNAHGGL 126 (435)
Q Consensus 109 ~~~~~~~~~~~L~~~g~~ 126 (435)
+..++.+++++|.+.+.+
T Consensus 186 ~~~~~~~~~~~l~~~~~~ 203 (221)
T d1iknd_ 186 WGRPSTRIQQQLGQLTLE 203 (221)
T ss_dssp TTSSCHHHHHHHHTTSCG
T ss_pred HHCCCHHHHHHHHHcCCc
Confidence 999999999999988764
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1.7e-14 Score=119.30 Aligned_cols=98 Identities=20% Similarity=0.134 Sum_probs=79.8
Q ss_pred chhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcCch
Q 013833 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114 (435)
Q Consensus 35 ~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 114 (435)
++| |+ |+..+..+++++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|++.|++++.++..|.|+++.++..++.
T Consensus 3 ~~L-h~-Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~ 79 (156)
T d1ihba_ 3 NEL-AS-AAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFL 79 (156)
T ss_dssp HHH-HH-HHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred HHH-HH-HHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccc
Confidence 445 33 44455567777777889999999999999999875 6889999999999999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCCC
Q 013833 115 NMMELLNAHGGLSYGQNGSHF 135 (435)
Q Consensus 115 ~~~~~L~~~g~~~~~~n~~~~ 135 (435)
++++.|+..+.+.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~ 100 (156)
T d1ihba_ 80 DTLQTLLEFQADVNIEDNEGN 100 (156)
T ss_dssp HHHHHHHHTTCCTTCCCTTSC
T ss_pred ccccccccccccccccccccc
Confidence 999999988888776655544
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.50 E-value=2.6e-14 Score=126.03 Aligned_cols=107 Identities=26% Similarity=0.202 Sum_probs=93.0
Q ss_pred hhcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCccccccCCCchhhHh
Q 013833 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWKNTPLADA 108 (435)
Q Consensus 30 ~~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~g-a~~~~~~~~g~t~l~~A 108 (435)
+..+.++++. ++..+..++.++|+..|.+.+.+|..|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|
T Consensus 102 ~~~~~~~l~~--~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A 179 (229)
T d1ixva_ 102 TNQGVTCLHL--AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHA 179 (229)
T ss_dssp CTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHH
T ss_pred cccccccccc--ccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhh
Confidence 3445566654 55666778889999999999999999999999999999999999999987 78999999999999999
Q ss_pred hhcCchhHHHHHHh-cCCCCCCCCCCCCCCC
Q 013833 109 EGAKKFNMMELLNA-HGGLSYGQNGSHFEPK 138 (435)
Q Consensus 109 ~~~~~~~~~~~L~~-~g~~~~~~n~~~~~~~ 138 (435)
+..|+.+++++|++ +|++++..+....+|.
T Consensus 180 ~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l 210 (229)
T d1ixva_ 180 LAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 210 (229)
T ss_dssp HHTTCHHHHHHHHHHHCCCSCCCCTTSCCTG
T ss_pred cccccHHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 99999999999995 6999998877666543
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.50 E-value=1.2e-14 Score=133.15 Aligned_cols=97 Identities=25% Similarity=0.274 Sum_probs=84.0
Q ss_pred ccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhhcC
Q 013833 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK 112 (435)
Q Consensus 33 ~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 112 (435)
+.|++ ++||..|+ .+++++|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++..+..+.|||++|+..+
T Consensus 40 ~~t~l-~~A~~~G~-~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~ 117 (291)
T d1s70b_ 40 DGAVF-LAACSSGD-TEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG 117 (291)
T ss_dssp HHHHH-HHHHHHTC-HHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CchHH-HHHHHcCC-HHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence 34555 45555555 56667777999999999999999999999999999999999999999999999999999999999
Q ss_pred chhHHHHHHhcCCCCCCCC
Q 013833 113 KFNMMELLNAHGGLSYGQN 131 (435)
Q Consensus 113 ~~~~~~~L~~~g~~~~~~n 131 (435)
+.++++.|+++|+.....+
T Consensus 118 ~~~~~~~l~~~~~~~~~~~ 136 (291)
T d1s70b_ 118 YLDIAEYLISQGAHVGAVN 136 (291)
T ss_dssp CHHHHHHHHHTTCCTTCCC
T ss_pred ccchhhcccccCccccccc
Confidence 9999999999988655443
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=8e-15 Score=127.81 Aligned_cols=86 Identities=27% Similarity=0.434 Sum_probs=75.7
Q ss_pred hcccchhhhhhhhcCCHHHHHHHHHhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhhh
Q 013833 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (435)
Q Consensus 31 ~~~~~~l~~~~a~~~~~~~~~~lL~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (435)
..+.++++. |+..+...+.+.+++.|.+++.+|..|.||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus 142 ~~~~~~l~~--a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~~ 219 (228)
T d1k1aa_ 142 KSGRSPLIH--AVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARS 219 (228)
T ss_dssp TTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCSS
T ss_pred cchhhHHHH--HHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHh
Confidence 345566644 666777788888889999999999999999999999999999999999999999999999999999999
Q ss_pred cCchhHHH
Q 013833 111 AKKFNMME 118 (435)
Q Consensus 111 ~~~~~~~~ 118 (435)
+|+.++++
T Consensus 220 ~~~~divk 227 (228)
T d1k1aa_ 220 RRVIDILR 227 (228)
T ss_dssp HHHHHHHT
T ss_pred CCCccccC
Confidence 99988875
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=3.8e-13 Score=116.91 Aligned_cols=93 Identities=20% Similarity=0.173 Sum_probs=79.8
Q ss_pred hcccchhhhhhhhcCCHHHHHHHH----HhCCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhh
Q 013833 31 RVSRTSLILWHAHQNDAAAVRKLL----EEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA 106 (435)
Q Consensus 31 ~~~~~~l~~~~a~~~~~~~~~~lL----~~~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~ 106 (435)
++|.||||+ |+..|+ .++++.| .+.|+++|.+|..|+||||+||..|+.+++++|+++|++++..+..|.++++
T Consensus 1 ~dG~TpLh~-A~~~g~-~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~ 78 (228)
T d1k1aa_ 1 EDGDTPLHI-AVVQGN-LPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAH 78 (228)
T ss_dssp CTTCCHHHH-HHHTTC-HHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CCCccHHHH-HHHcCC-HHHHHHHHHHHHHCCCCCCccCCCCCccceehhcccccccccccccccccccccccccccccc
Confidence 368999975 444454 4444444 4689999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCchhHHHHHHhcCC
Q 013833 107 DAEGAKKFNMMELLNAHGG 125 (435)
Q Consensus 107 ~A~~~~~~~~~~~L~~~g~ 125 (435)
.|...++.++++.+.....
T Consensus 79 ~a~~~~~~~~~~~~~~~~~ 97 (228)
T d1k1aa_ 79 LACEHRSPTCLRALLDSAA 97 (228)
T ss_dssp HHHHTTCHHHHHHHHHHSC
T ss_pred cccccccccchhhhhhccc
Confidence 9999999999998877654
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.36 E-value=2.9e-13 Score=124.74 Aligned_cols=49 Identities=27% Similarity=0.398 Sum_probs=47.7
Q ss_pred CccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCccccccCCCchhhHhh
Q 013833 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109 (435)
Q Consensus 61 ~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~ 109 (435)
+|.+|.+|+||||+||..|+.++|++|+++|||+|.+|+.|+|||++|+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 6889999999999999999999999999999999999999999999996
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=2.4e-13 Score=123.64 Aligned_cols=77 Identities=22% Similarity=0.256 Sum_probs=65.3
Q ss_pred CchhhhhhhhhcccchhhhhhhhcCCHHHHHHHHHh-CCCCCccCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCcccccc
Q 013833 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (435)
Q Consensus 21 ~~~~~~~~~~~~~~~~l~~~~a~~~~~~~~~~lL~~-~g~~~n~~d~~g~tpLh~Aa~~~~~~~~~~Ll~~ga~~~~~~~ 99 (435)
+.|++++.++..|.|||+. |+..+..+++++|++ .|+++|.+|.+|.||||+|+.+|+.+++++||++|||+|++|.
T Consensus 207 ~~ga~~n~~~~~g~t~L~~--a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 207 DHGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp HTTCCSSCCCTTSCCHHHH--HHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred HCCCCCCccCCCCCCccch--hhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 4566778888999999865 444555667777665 6999999999999999999999999999999999999999983
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=2.2e-08 Score=89.17 Aligned_cols=140 Identities=14% Similarity=0.062 Sum_probs=93.7
Q ss_pred CCCCceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEEEEecC
Q 013833 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 237 (435)
Q Consensus 159 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 237 (435)
|++.+..+.++.+.||+....+..+++|+........ ...+.+|...+..+. +--+++++.+..+++..++||+++
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 3444444445557899998788888999775432221 134567888877764 334678888888888899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 013833 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP------------------------------------------ 275 (435)
Q Consensus 238 ~g~sL~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~------------------------------------------ 275 (435)
+|.++.+.... ......++.++...+..||+..
T Consensus 93 ~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 93 DGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred ccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 99887654421 1112234555556666666421
Q ss_pred ---------------CceEeCCCCCCcEEEecCCCCcEEEeeccCccc
Q 013833 276 ---------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (435)
Q Consensus 276 ---------------~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~~ 308 (435)
..++|+|+.|.|||+ ++++.+-|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceee--cCCceEEEeechhccc
Confidence 117999999999999 6555566999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=2.1e-06 Score=75.54 Aligned_cols=72 Identities=19% Similarity=0.150 Sum_probs=49.9
Q ss_pred eecCCc-eeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC--CCcceeeeeeEEeCCcEEEEEecCCCC
Q 013833 165 IGKGSF-GEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRGG 240 (435)
Q Consensus 165 lg~G~~-g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~g~ 240 (435)
+..|.. +.||+.... +..+++|....... ..+..|+..++.+. .-.+++++.+..+++..++||++++|.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344443 679998876 44578887644322 34566777777663 234778888888888899999999886
Q ss_pred CH
Q 013833 241 DL 242 (435)
Q Consensus 241 sL 242 (435)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 65
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.00 E-value=1.6e-05 Score=74.61 Aligned_cols=78 Identities=19% Similarity=0.275 Sum_probs=48.2
Q ss_pred ceeecCCceeEEEEEEC--CCcEEEEEccCCC---CC-cHHHHHHHHHHHHHHHhCC-C--CcceeeeeeEEeCCcEEEE
Q 013833 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSL---SD-DRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTERKPLMLI 233 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~-~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv 233 (435)
+.||.|....||++... ++.++||...... .. -.....+...|++.|+.+. + ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999764 5678999653211 00 0111234556887777663 2 356666654 44556899
Q ss_pred EecCCCCCH
Q 013833 234 TEYLRGGDL 242 (435)
Q Consensus 234 ~e~~~g~sL 242 (435)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00073 Score=61.10 Aligned_cols=67 Identities=7% Similarity=0.062 Sum_probs=42.6
Q ss_pred eeEEEEEEC-CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCCCcc--eeee-----eeEEeCCcEEEEEecCCCCC
Q 013833 171 GEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI--VQFL-----GAVTERKPLMLITEYLRGGD 241 (435)
Q Consensus 171 g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~g~s 241 (435)
-.||++..+ |.++++|+.....-.. +.+..|...+..|....+ +..+ ..+..+...+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 589999864 8889999876543222 456678888777642221 1111 12345567788999997743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0028 Score=58.74 Aligned_cols=71 Identities=13% Similarity=0.139 Sum_probs=47.1
Q ss_pred ceeecCCceeEEEEEEC---------CCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCC-CCcceeeeeeEEeCCcEEE
Q 013833 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 232 (435)
+.|+.|-.-.+|++... ...|.+++.- . ... . ....+|..+++.+. +.-.+++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 46888999999999864 2346666543 2 122 1 34567888888775 4445677777643 58
Q ss_pred EEecCCCCCH
Q 013833 233 ITEYLRGGDL 242 (435)
Q Consensus 233 v~e~~~g~sL 242 (435)
|+||++|.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.32 E-value=0.036 Score=49.00 Aligned_cols=138 Identities=15% Similarity=0.045 Sum_probs=70.4
Q ss_pred ceeecCCceeEEEEEECCCcEEEEEccCCCCCcHHHHHHHHHHHHHHHhCCC-----Ccceeeee---eEEeCCcEEEEE
Q 013833 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-----PNIVQFLG---AVTERKPLMLIT 234 (435)
Q Consensus 163 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~~iv~~~~---~~~~~~~~~lv~ 234 (435)
+-|..|.--+.|+....+..+++|+....... +.+..|+.++..|.. |..+...+ +.........++
T Consensus 24 ~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred ecCCCCcccCeEEEEECCCcEEEEEcCCCCCH-----HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 34667877899999888777999987543222 334455666665532 22222111 123344556667
Q ss_pred ecCCCCCHH-----H------HH---HHc-C--------------------------CCCHHHHHHHHHHHHHHHHHHhc
Q 013833 235 EYLRGGDLH-----K------YL---KEK-G--------------------------ALSPSTAVNFALDIARGMAYLHN 273 (435)
Q Consensus 235 e~~~g~sL~-----~------~l---~~~-~--------------------------~~~~~~~~~~~~qi~~~l~~LH~ 273 (435)
.++.|.... . .+ +.. . ..........+..+...+.-.+.
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 766653331 0 00 000 0 00001111122222333333222
Q ss_pred --CCCceEeCCCCCCcEEEecCCCCcEEEeeccCcc
Q 013833 274 --EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (435)
Q Consensus 274 --~~~~ivH~Dlkp~NIll~~~~~~~vkl~Dfg~a~ 307 (435)
...++||+|+.+.||++ +++...-|+||+.+.
T Consensus 179 ~~L~~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFAC 212 (316)
T ss_dssp CSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCE
T ss_pred cccccccccCCcchhhhhc--ccccceeEecccccc
Confidence 11239999999999999 666566899999875
|